Citrus Sinensis ID: 014783
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 418 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.636 | 0.682 | 0.503 | 1e-79 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.641 | 0.292 | 0.389 | 4e-54 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.686 | 0.222 | 0.353 | 7e-49 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.624 | 0.157 | 0.362 | 8e-49 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.607 | 0.190 | 0.387 | 6e-48 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.626 | 0.108 | 0.390 | 2e-47 | |
| Q66L42 | 940 | Mitogen-activated protein | yes | no | 0.624 | 0.277 | 0.378 | 3e-47 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.614 | 0.222 | 0.377 | 3e-47 | |
| Q02779 | 954 | Mitogen-activated protein | yes | no | 0.624 | 0.273 | 0.378 | 1e-46 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.650 | 0.252 | 0.356 | 3e-46 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 297 bits (760), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 134/266 (50%), Positives = 183/266 (68%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
+EWT DL +L +G FA GA ++YRG Y VA+K++ P + E +EQQF+ EV
Sbjct: 77 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEV 136
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L+ L H NIV+FI AC+K V+CI+TEY G++R +L +++ ++ ++ ++ ALD+
Sbjct: 137 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDI 196
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 307
+RGM Y+H G IHRDLKS+NLL++ + +K+ADFG + +E Q GTYRWMAPE
Sbjct: 197 SRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPE 256
Query: 308 MIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367
MI+ +PYT+KVDVYSFGIVLWEL T LLPFQ MT VQAAFAV K RP +P C P L+
Sbjct: 257 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALA 316
Query: 368 EIMTRCWDTNPEVRPPFTEIVRMLEN 393
++ RCW NP RP F+ IV +LE
Sbjct: 317 HLIKRCWSENPSKRPDFSNIVAVLEK 342
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (540), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 106/272 (38%), Positives = 169/272 (62%), Gaps = 4/272 (1%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
P++ + + + I +L + + +G FG +Y+G + G VAIK ++ E+ QV+
Sbjct: 645 PSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED--VNNQVL 702
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
E+ F++E+ +L+ L+H NIV + AC C +TEY GGS+ L ++ + + ++L
Sbjct: 703 EE-FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQL 760
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
K A+ +A+GM Y+H G IHRD+KS NLL+ ++KI DFG+++++ ++ MT G
Sbjct: 761 YKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIG 820
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
+ WM+PE++ YT+KVDVY+FGI+LWEL TG LP+ + +VQ A AV K +RP IP
Sbjct: 821 SPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP 880
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
N LS ++ CW +P RP FTEI+ +L
Sbjct: 881 NAWPYQLSHLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 7e-49, Method: Compositional matrix adjust.
Identities = 107/303 (35%), Positives = 171/303 (56%), Gaps = 16/303 (5%)
Query: 112 QALMDHRYPTEGL-------ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIK 164
Q DH++P + E EW + L ++ +G +G +G+++RG++ G +VA+K
Sbjct: 819 QQNKDHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVK 878
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
+L N + + ++EV +L L+H NIV F+GAC + CIVTEY GS+
Sbjct: 879 MLFNDNVNLK----LISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLA 934
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADF 282
L ++ + L ++ D ARGM Y+H IHRDLK+DNLL+ +K+ADF
Sbjct: 935 NILLD-ESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADF 993
Query: 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA 342
G+A ++ T T GT W+APE++ YT+K DVYS+ IVLWEL+T L+P+
Sbjct: 994 GLATVKSHTFAKT-MCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNT 1052
Query: 343 VQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTV 402
+Q + +++G R +P C P + +M RCW+T+P RP F EI+ ++E +E
Sbjct: 1053 MQVVRS-IDRGERLPMPAWCPPKYAALMNRCWETDPTHRPSFPEILPIMEGMISEFQKEK 1111
Query: 403 RKA 405
+++
Sbjct: 1112 KES 1114
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 8e-49, Method: Compositional matrix adjust.
Identities = 100/276 (36%), Positives = 157/276 (56%), Gaps = 15/276 (5%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA--QVMEQQFQQ 185
D+W ID +L +G GAFG++++GT+ G +VA+K++ +P+K + +E+ F+
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMI-----SPDKTITKDIERNFKD 831
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
EV ++ TL+H N+V F+ A K CIV E+ GS+ L +P L VK A
Sbjct: 832 EVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAY 891
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRW 303
++GM ++H G HRDLKS NLL+ ++K++DFG+ + + + + PE GT +W
Sbjct: 892 QASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQW 951
Query: 304 MAPEMIQHRPYTQKV--DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN- 360
APE++ + DVYSFGI++WELIT P+ M+ A +V+ RPVI +
Sbjct: 952 TAPEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYRPVISDQ 1011
Query: 361 ---DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ P E++T CW +P +RP F EI+ L N
Sbjct: 1012 LRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRLSN 1047
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (486), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 103/266 (38%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA-QVMEQQFQQEVMML 190
I+ + + +G F K+ +G + G+DVA+K L +N +KA + M Q+F+ EV +L
Sbjct: 1068 INYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLN---SNKDKAREEMIQEFKAEVELL 1124
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLK--LAVKQAL 245
+L+H N+V G M CIV E+ G++ + + + Q +++ L L + A
Sbjct: 1125 GSLQHPNLVTCYGYSLNPM--CIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAF 1182
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
D+ARGM ++H IHRDLKS NLL+ +IKIAD G+AR T+ MT GT W A
Sbjct: 1183 DIARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMT-TIGTVAWTA 1241
Query: 306 PEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
PE+++H Y QK DVYS+ IVL+EL+TG P+Q + + A V +KG+RP +P++C P
Sbjct: 1242 PEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPN 1301
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRML 391
+++ CW +P RP F EI L
Sbjct: 1302 WKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 2e-47, Method: Composition-based stats.
Identities = 114/292 (39%), Positives = 166/292 (56%), Gaps = 30/292 (10%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ ID +L G +G FG++ RG + DVAIKI+ R + + + VM FQ EV
Sbjct: 2107 EYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVM---FQNEVG 2163
Query: 189 MLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAV 241
+L+ L+H N+V+F+GAC CIVTE+ GGS+RQFLT QN + LKLA
Sbjct: 2164 ILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLA- 2222
Query: 242 KQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-------------ADKSIKIADFGVAR 286
LD+A+GM Y+HG +HRDL S N+L+ D KI+DFG++R
Sbjct: 2223 ---LDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSR 2279
Query: 287 IEV-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA 345
+++ Q MT G +MAPE+ + ++K DVYS+G+VL+EL+T P Q+M ++
Sbjct: 2280 LKMEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKM 2339
Query: 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397
A + RP IP EI+T+CWD+NP+ RP F +I+ L+ E +
Sbjct: 2340 AHLAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVHLKEMEDQ 2391
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 106/280 (37%), Positives = 156/280 (55%), Gaps = 19/280 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q +QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPERDP---AVTAEQVRQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLA---GRRVPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMS-AAG 265
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
TY WMAPE+I+ +++ DV+SFG++LWEL+TG +P++ + A+ A+ V + IP
Sbjct: 266 TYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTLPIP 325
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399
+ C + ++ CWD +P RP F I++ LE E +
Sbjct: 326 STCPEPFARLLEECWDPDPHGRPDFGSILKQLEVIEQSAL 365
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 103/273 (37%), Positives = 156/273 (57%), Gaps = 16/273 (5%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ ID+ + +GAF +++ G + G VAIK L+ + + +++F +EV
Sbjct: 845 EYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGD----EEQFKERFIREVQ 900
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-----LKLAVKQ 243
L H NIV FIGAC K CI+TEY GGS+ L N + P L +K
Sbjct: 901 NLKKGNHQNIVMFIGACYKPA--CIITEYMAGGSLYNIL-HNPNSSTPKVKYSFPLVLKM 957
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---T 300
A D+A G+ ++H + +HRDL S N+L+ +IKI+DFG++R + + MT G
Sbjct: 958 ATDMALGLLHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGICN 1017
Query: 301 YRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
RW PE+ ++ Y++KVDVY F +V+WE++TG +PF ++ QA+ V G+RP IP
Sbjct: 1018 PRWRPPELTKNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIP 1077
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
C P L ++T+CW+ +P RPPFT IV L+
Sbjct: 1078 EYCDPELKLLLTQCWEADPNDRPPFTYIVNKLK 1110
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 106/280 (37%), Positives = 155/280 (55%), Gaps = 19/280 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRALWRGEEVAVKAARLDPEKDP---AVTAEQVCQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLNPPHLCLVMEYARGGALSRVLA---GRRVPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMS-AAG 265
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
TY WMAPE+I+ +++ DV+SFG++LWEL+TG +P++ + A+ A+ V + IP
Sbjct: 266 TYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTLPIP 325
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399
+ C + ++ CWD +P RP F I++ LE E +
Sbjct: 326 STCPEPFARLLEECWDPDPHGRPDFGSILKRLEVIEQSAL 365
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 103/289 (35%), Positives = 162/289 (56%), Gaps = 17/289 (5%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE + A
Sbjct: 132 IDFAELTLEEIIGIGGFGKVYRAFWAGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKLFA 189
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
LKH NI+ G C K C+V E+A+GG + + L+ + +P + V A+ +ARGM
Sbjct: 190 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGM 246
Query: 252 AYVHG---LGFIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPETGT 300
Y+H + IHRDLKS N+LI ++K +KI DFG+AR +T M+ GT
Sbjct: 247 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGT 305
Query: 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360
Y WMAPE+I+ +++ DV+S+G++LWEL+TG +PF+ + + A+ V + IP+
Sbjct: 306 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 365
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRC 409
C +++M CW+ +P RP FT I+ L E + K F C
Sbjct: 366 TCPEPFAKLMEDCWNPDPHSRPSFTSILDQLTTIEESGFFEMPKDSFHC 414
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 418 | ||||||
| 118488096 | 419 | unknown [Populus trichocarpa] | 1.0 | 0.997 | 0.959 | 0.0 | |
| 224121260 | 415 | predicted protein [Populus trichocarpa] | 0.990 | 0.997 | 0.959 | 0.0 | |
| 224115648 | 415 | predicted protein [Populus trichocarpa] | 0.990 | 0.997 | 0.951 | 0.0 | |
| 255574169 | 414 | serine/thronine protein kinase, putative | 0.988 | 0.997 | 0.934 | 0.0 | |
| 255574171 | 418 | serine/thronine protein kinase, putative | 0.997 | 0.997 | 0.940 | 0.0 | |
| 224121256 | 415 | predicted protein [Populus trichocarpa] | 0.990 | 0.997 | 0.903 | 0.0 | |
| 224115644 | 415 | predicted protein [Populus trichocarpa] | 0.990 | 0.997 | 0.903 | 0.0 | |
| 225429872 | 417 | PREDICTED: serine/threonine-protein kina | 0.985 | 0.988 | 0.904 | 0.0 | |
| 225445686 | 526 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.781 | 0.838 | 0.0 | |
| 297798854 | 412 | kinase family protein [Arabidopsis lyrat | 0.983 | 0.997 | 0.853 | 0.0 |
| >gi|118488096|gb|ABK95868.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 843 bits (2178), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/419 (95%), Positives = 411/419 (98%), Gaps = 1/419 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +Y
Sbjct: 61 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKY 120
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGL+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+M
Sbjct: 121 PTEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLM 180
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL
Sbjct: 181 EQQFQQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 240
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 241 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 300
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP
Sbjct: 301 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 360
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
NDCLPVLS+IMTRCWDTNPEVRPPFTEIVRMLENAETEIMT+VRKARFRCCMTQPMTVD
Sbjct: 361 NDCLPVLSDIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTSVRKARFRCCMTQPMTVD 419
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121260|ref|XP_002330783.1| predicted protein [Populus trichocarpa] gi|222872585|gb|EEF09716.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2158), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/415 (95%), Positives = 407/415 (98%), Gaps = 1/415 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+MEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL
Sbjct: 301 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 360
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVLS+IMTRCWDTNPEVRPPFTEIVRMLENAETEIMT+VRKARFRCCMTQPMTVD
Sbjct: 361 PVLSDIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTSVRKARFRCCMTQPMTVD 415
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115648|ref|XP_002332108.1| predicted protein [Populus trichocarpa] gi|222874928|gb|EEF12059.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2140), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/415 (95%), Positives = 405/415 (97%), Gaps = 1/415 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYS + GQSVFRPGKVTHALNDDALAQALM+ +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSGTAGQSVFRPGKVTHALNDDALAQALMNPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVMEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHALGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL
Sbjct: 301 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 360
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVLS+IMTRCWDTNPEVRPPFTEIVRMLENAETEI+TTVRKARFRCCMTQPMTVD
Sbjct: 361 PVLSDIMTRCWDTNPEVRPPFTEIVRMLENAETEILTTVRKARFRCCMTQPMTVD 415
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574169|ref|XP_002528000.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532626|gb|EEF34412.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/415 (93%), Positives = 401/415 (96%), Gaps = 2/415 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTGL+GG+++N NYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGLVGGSDDN-VNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 59
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRP KVTHALN+DALAQALMD RY TEG
Sbjct: 60 VGSSDSLTHILSHPGLKPVSHHNYSVSVGQSVFRPRKVTHALNEDALAQALMDSRYQTEG 119
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYD+WTIDLRKLNMGTAFAQGAFGKLYRG YNGEDVAIKILERPEN EKAQVMEQQF
Sbjct: 120 LDNYDDWTIDLRKLNMGTAFAQGAFGKLYRGAYNGEDVAIKILERPENCHEKAQVMEQQF 179
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQ LTRRQNRAVPLKLAVKQ
Sbjct: 180 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQALTRRQNRAVPLKLAVKQ 239
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 240 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 299
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM+AVQAAFAVVNKGVRPVIP+DCL
Sbjct: 300 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMSAVQAAFAVVNKGVRPVIPHDCL 359
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE+EIM TVRKARFRCC++QPMTVD
Sbjct: 360 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAESEIMNTVRKARFRCCISQPMTVD 414
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574171|ref|XP_002528001.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532627|gb|EEF34413.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/419 (94%), Positives = 403/419 (96%), Gaps = 2/419 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG NN+N+NNYYDFTQ FYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGANI-NNDNENNYYDFTQSFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 59
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTH LNDDALAQALMD RY
Sbjct: 60 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHPLNDDALAQALMDSRY 119
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PT GL NYDEWTIDLRKL+MGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVM
Sbjct: 120 PTVGLANYDEWTIDLRKLSMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVM 179
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFL +RQNRAVPLKL
Sbjct: 180 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLAKRQNRAVPLKL 239
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLG IHRDLKSDNLLI ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 240 AVKQALDVARGMAYVHGLGCIHRDLKSDNLLIFADKSIKIADFGVARIEVQTEGMTPETG 299
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG+LPFQNMTAVQAAFAVVNKGVRPVIP
Sbjct: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGMLPFQNMTAVQAAFAVVNKGVRPVIP 359
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
NDCLPVLSEIMTRCWDTNPEVRPPF++IVRMLENAETEIMTTVRKARFRCCMTQPMTVD
Sbjct: 360 NDCLPVLSEIMTRCWDTNPEVRPPFSDIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121256|ref|XP_002330782.1| predicted protein [Populus trichocarpa] gi|222872584|gb|EEF09715.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/415 (90%), Positives = 397/415 (95%), Gaps = 1/415 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGL+ +NNN N+YY FTQGFYQ++G+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGKKFTGLMAPSNNNGNDYYGFTQGFYQEIGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPVRH-NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV H NY+VSVG SVFRPGKVTHALNDDALAQALMD+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHRNYNVSVGASVFRPGKVTHALNDDALAQALMDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENIPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGAC+K MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACQKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITG LPFQNMTAVQAAFAVVNKGVRP+IP +CL
Sbjct: 301 MAPEMIQHRPYTQKVDVYSFGIVLWELITGSLPFQNMTAVQAAFAVVNKGVRPIIPYECL 360
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVLS+IMTRCWD NPEVRPPFTEIVRMLENA+TEIMT VRKARFRCCM QPMTV+
Sbjct: 361 PVLSDIMTRCWDANPEVRPPFTEIVRMLENAQTEIMTNVRKARFRCCMAQPMTVE 415
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115644|ref|XP_002332107.1| predicted protein [Populus trichocarpa] gi|222874927|gb|EEF12058.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/415 (90%), Positives = 398/415 (95%), Gaps = 1/415 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGLIG +NNN NNYY FTQGFYQ+LG+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGQKFTGLIGASNNNGNNYYGFTQGFYQELGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQAL+D+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALVDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERP N+PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPGNSPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADK+IKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKTIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITG LPFQNMTAVQAAFAVVNKGVRP+IP DCL
Sbjct: 301 MAPEMIQHRPYTQKVDVYSFGIVLWELITGSLPFQNMTAVQAAFAVVNKGVRPIIPYDCL 360
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVLS IMTRCWD NPE+RPPFT++VRMLENAET+I+T VRKARFRCC+ QPMTV+
Sbjct: 361 PVLSYIMTRCWDANPEIRPPFTDVVRMLENAETQILTNVRKARFRCCIAQPMTVE 415
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225429872|ref|XP_002283465.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839316|emb|CAN72362.1| hypothetical protein VITISV_000134 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1992), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/419 (90%), Positives = 396/419 (94%), Gaps = 7/419 (1%)
Query: 5 MVEGPKFTGLIGGNNNN--DNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDN 62
MVEGPKFTG+IGG N+ DNNY+DFTQGFYQKLGE +NMSIDSLQTSNAG SVSMSVDN
Sbjct: 1 MVEGPKFTGIIGGGGNHNHDNNYFDFTQGFYQKLGEDSNMSIDSLQTSNAGLSVSMSVDN 60
Query: 63 SSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGK--VTHALNDDALAQALMDHRY 119
SSVGSNDSLTHIL+HPGLKPV HNYSV G SV RPGK VTHALN+DALA+ALMD RY
Sbjct: 61 SSVGSNDSLTHILNHPGLKPVATHNYSV--GHSVLRPGKGKVTHALNEDALARALMDTRY 118
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRG YNG+DVAIKILERPEN+PE+AQVM
Sbjct: 119 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGEYNGDDVAIKILERPENSPERAQVM 178
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK + WCIVTEYAKGGSVRQFL RRQNR+VPLKL
Sbjct: 179 EQQFQQEVMMLATLKHPNIVRFIGACRKPLAWCIVTEYAKGGSVRQFLMRRQNRSVPLKL 238
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 239 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETG 298
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP+IP
Sbjct: 299 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPIIP 358
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
+DCLPVLS+IMTRCWD NPEVRPPFTE+VRMLENAE EIMTTVRKARFRCCMTQPMT D
Sbjct: 359 SDCLPVLSDIMTRCWDANPEVRPPFTEVVRMLENAEIEIMTTVRKARFRCCMTQPMTTD 417
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225445686|ref|XP_002267305.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1908), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/421 (83%), Positives = 381/421 (90%), Gaps = 10/421 (2%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDS---LQTSNAGGSVS 57
++GKM+EGPKFTG+IG NNN YD +QGFY KLGEG+NMSI+S LQTSN GGSV+
Sbjct: 113 LVGKMLEGPKFTGIIGMNNNE----YDLSQGFYHKLGEGSNMSIESYGSLQTSNGGGSVA 168
Query: 58 MSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDH 117
MSVDNSSVGSNDS T IL+H GL+ V +NYSV+ + G+V+H L+DDALAQALMD
Sbjct: 169 MSVDNSSVGSNDSHTRILNHQGLRRVNNNYSVAASNN---RGRVSHGLSDDALAQALMDS 225
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQ 177
RYPT GLEN++EWTIDL KLNMG AFAQGAFGKLY+GTYNGEDVAIKILERPEN+ EKAQ
Sbjct: 226 RYPTLGLENFEEWTIDLGKLNMGEAFAQGAFGKLYKGTYNGEDVAIKILERPENDLEKAQ 285
Query: 178 VMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+MEQQFQQEVMMLATLKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLT+RQNR VPL
Sbjct: 286 LMEQQFQQEVMMLATLKHTNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTKRQNRQVPL 345
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
KLA+KQALDVARGMAYVHGLG IHRDLKSDNLLI ADKSIKIADFGVARIEVQTEGMTPE
Sbjct: 346 KLAIKQALDVARGMAYVHGLGLIHRDLKSDNLLIFADKSIKIADFGVARIEVQTEGMTPE 405
Query: 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV 357
TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG+LPFQNMTAVQAAFAVVNKGVRP+
Sbjct: 406 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGMLPFQNMTAVQAAFAVVNKGVRPI 465
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTV 417
IPNDCLPVLSEIMTRCWD NP+VRPPF E+VRMLENAETEIMTTVRKARFRCCM QPMT
Sbjct: 466 IPNDCLPVLSEIMTRCWDANPDVRPPFAEVVRMLENAETEIMTTVRKARFRCCMAQPMTA 525
Query: 418 D 418
+
Sbjct: 526 E 526
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798854|ref|XP_002867311.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313147|gb|EFH43570.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/415 (85%), Positives = 377/415 (90%), Gaps = 4/415 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFNLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+SVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSVGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LANYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN+GVRP +P DCL
Sbjct: 298 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCL 357
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVL EIMTRCWD +PEVRP F EIV +LE AE EIMT VRKARFRCCMTQPMT+D
Sbjct: 358 PVLGEIMTRCWDADPEVRPCFAEIVNLLEAAENEIMTNVRKARFRCCMTQPMTID 412
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 418 | ||||||
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.980 | 0.997 | 0.783 | 5.6e-171 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.983 | 0.997 | 0.771 | 9.7e-167 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.643 | 0.467 | 0.459 | 9.7e-64 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.693 | 0.531 | 0.433 | 6.9e-63 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.645 | 0.473 | 0.45 | 8.8e-63 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.643 | 0.512 | 0.416 | 4.8e-62 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.442 | 0.473 | 0.446 | 1.8e-58 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.643 | 0.755 | 0.452 | 2.2e-57 | |
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.442 | 0.489 | 0.440 | 4.2e-57 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.667 | 0.790 | 0.440 | 7.5e-57 |
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1662 (590.1 bits), Expect = 5.6e-171, P = 5.6e-171
Identities = 325/415 (78%), Positives = 345/415 (83%)
Query: 5 MVEGPKFTGL-IXXXXXXXXXXXXFTQGFYQKLGEGTNMSIDSLQTSNAXXXXXXXXXXX 63
M+EG KF L + FTQ FYQKL EG+NMS++S+QTSNA
Sbjct: 1 MLEGAKFNVLAVGNHHNNDNNYYAFTQEFYQKLNEGSNMSMESMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKPVRH YS+SVGQSVFRPG+VTHALNDDALAQALMD RYPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPVRH-YSLSVGQSVFRPGRVTHALNDDALAQALMDTRYPTEG 116
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NYDEWTIDLRKLNMG AFAQGAFGKLY+GTYNGEDVAIKILERPEN+PEKA
Sbjct: 117 LTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQF 176
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 177 QQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 236
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHG FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 237 ALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 296
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHR Y QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN+GVRP +PNDCL
Sbjct: 297 MAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCL 356
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVLS+IMTRCWD NPEVRP F E+V++LE AETEIMTT RKARFRCC++QPMT+D
Sbjct: 357 PVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEIMTTARKARFRCCLSQPMTID 411
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1622 (576.0 bits), Expect = 9.7e-167, P = 9.7e-167
Identities = 320/415 (77%), Positives = 338/415 (81%)
Query: 5 MVEGPKFTGLIXXXXXXXXXXXXFTQGFYQKLGE-GTNMSIDSLQTSNAXXXXXXXXXXX 63
M+E PKF FTQ FYQKLGE GTNMS+DS+QTSNA
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKA
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN+GVRP +P DCL
Sbjct: 298 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCL 357
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
PVL EIMTRCWD +PEVRP F EIV +LE AETEIMT VRKARFRCCMTQPMTVD
Sbjct: 358 PVLGEIMTRCWDADPEVRPCFAEIVNLLEAAETEIMTNVRKARFRCCMTQPMTVD 412
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 650 (233.9 bits), Expect = 9.7e-64, P = 9.7e-64
Identities = 129/281 (45%), Positives = 182/281 (64%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL--ERPENNPEKAX 177
P +G D W I+L+ L G A G++G LY+GTY ++VAIK+L ER +++ EK
Sbjct: 276 PNDGT---DVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEF 332
Query: 178 XXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ ++H N+V+FIGAC K CIVTE+ GGSV +L +Q L
Sbjct: 333 AQEVFI------MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYL-HKQKGVFKL 385
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
K A+D+ +GM+Y+H IHRDLK+ NLL+ ++ +K+ADFGVAR++ QT MT E
Sbjct: 386 PTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAE 445
Query: 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV 357
TGTYRWMAPE+I+H+PY K DV+S+GIVLWEL+TG LP++ MT +QAA VV KG+RP
Sbjct: 446 TGTYRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPT 505
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398
IP + P L+E++ R W+ + RP F+EI+ L+ E+
Sbjct: 506 IPKNTHPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAKEV 546
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 6.9e-63, P = 6.9e-63
Identities = 130/300 (43%), Positives = 186/300 (62%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVA 162
H + + L A ++ PT+G DEW ID+ +L + A G++G L+RGTY ++VA
Sbjct: 257 HDKSSNELIPACIE--IPTDGT---DEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVA 311
Query: 163 IKILERPENNPEKAXXXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGS 222
IK L+ N E + ++H N+V+F+GAC + CIVTE+ GS
Sbjct: 312 IKFLKPDRVNNEMLREFSQEVFI----MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGS 367
Query: 223 VRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
+ FL +Q A L+ +K ALDVA+GM+Y+H IHRDLK+ NLL+ +K+ADF
Sbjct: 368 IYDFL-HKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADF 426
Query: 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA 342
GVAR+++++ MT ETGTYRWMAPE+I+H+PY K DV+S+ IVLWEL+TG +P+ +T
Sbjct: 427 GVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTP 486
Query: 343 VQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTV 402
+QAA VV KG+RP IP P + ++ RCW +PE RP F EI+ ML+ E+ V
Sbjct: 487 LQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVNVVV 546
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 8.8e-63, P = 8.8e-63
Identities = 126/280 (45%), Positives = 183/280 (65%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN-NPEKAXX 178
PT+G DEW ID+++L + A G++G+L+RGTY ++VAIKIL +PE N E
Sbjct: 278 PTDGT---DEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKIL-KPERVNAEMLRE 333
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ ++H N+V+FIGAC + CIVTE+ GS+ FL + + ++
Sbjct: 334 FSQEVYI----MRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKG-VFKIQ 388
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
+K ALDV++GM Y+H IHRDLK+ NLL+ + +K+ADFGVAR++ ++ MT ET
Sbjct: 389 SLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAET 448
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358
GTYRWMAPE+I+H+PY + DV+S+ IVLWEL+TG LP+ +T +QAA VV KG+RP I
Sbjct: 449 GTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKI 508
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398
P + P L+E++ +CW +P +RP F EI+ ML E+
Sbjct: 509 PKETHPKLTELLEKCWQQDPALRPNFAEIIEMLNQLIREV 548
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
Identities = 113/271 (41%), Positives = 177/271 (65%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
+E +E+ +D+ KL G FA G + +LY G Y + VA+K++ P+++
Sbjct: 194 VEASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEK 253
Query: 184 XXXX--XXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
L+ L H N+++F+GA + V+C++T+Y GS+R FL + +NR++PLK +
Sbjct: 254 QFTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLI 313
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY 301
+ A+D+ARGM Y+H IHRDLK +N+LI + +KIADFG+A E + + + GTY
Sbjct: 314 EFAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTY 373
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
RWMAPEMI+ +P+ +K DVYSFG+VLWE++ G +P+++M +QAAFAVV+K +RP IP D
Sbjct: 374 RWMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGD 433
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
C + ++ +CW P+ RP F +IV++LE
Sbjct: 434 CPVAMKALIEQCWSVAPDKRPEFWQIVKVLE 464
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.8e-58, Sum P(2) = 1.8e-58
Identities = 83/186 (44%), Positives = 132/186 (70%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG++++FL ++ +P+K ++ ALD+ARG++Y+H +HRD+KS+N+L+
Sbjct: 182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 330
+K++KIADFGVAR+E Q + MT ETGT +MAPE+++ +PY +K DVYSFG+ LWE+
Sbjct: 242 QPNKTLKIADFGVARVEAQNPQDMTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEI 301
Query: 331 ITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390
+P+ + + + + AVV++ +RP IP C ++ IM RCWD NP+ RP E+V++
Sbjct: 302 YCCDMPYADCSFAEISHAVVHRNLRPEIPKCCPHAVANIMKRCWDPNPDRRPEMEEVVKL 361
Query: 391 LENAET 396
LE +T
Sbjct: 362 LEAIDT 367
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 2.2e-57, P = 2.2e-57
Identities = 128/283 (45%), Positives = 177/283 (62%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D R L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC++ M+ IVTE GG++R++L + + + ++
Sbjct: 67 RDNRFAREIAMLSKVQHKNLVKFIGACKEPMM-VIVTELLLGGTLRKYLVSLRPKRLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
LAV ALD+AR M +H G IHRDLK +NL++SAD K++K+ADFG+AR E TE MT E
Sbjct: 126 LAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAPEMI--------QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
TGTYRWMAPE+ + + Y KVD YSF IVLWELI LPF+ M+ +QAA+A
Sbjct: 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAA 245
Query: 350 VNKGVRPVIPNDCLPV-LSEIMTRCWDTNPEVRPPFTEIVRML 391
K +RP + LP L I+T CW +P RP FTEI++ML
Sbjct: 246 AFKNLRPSAED--LPGDLEMIVTSCWKEDPNERPNFTEIIQML 286
|
|
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 4.2e-57, Sum P(2) = 4.2e-57
Identities = 82/186 (44%), Positives = 128/186 (68%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG+++Q+L R + + + K+ V+ ALD++RG++Y+H +HRD+K++N+L+
Sbjct: 169 CVVVEYIPGGTLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLL 228
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 330
+++KIADFGVAR+E Q + MT ETGT +MAPE++ +PY ++ DVYSFGI LWE+
Sbjct: 229 DYQRNLKIADFGVARVEAQNPKDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEI 288
Query: 331 ITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390
+P+ +++ + AVV + +RP IP C L+ IM RCW+ NPE RP E+V +
Sbjct: 289 YCCDMPYPDLSFADVSSAVVRQNLRPDIPRCCPTALATIMKRCWEANPEKRPEMEEVVSL 348
Query: 391 LENAET 396
LE +T
Sbjct: 349 LEAVDT 354
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
Identities = 129/293 (44%), Positives = 182/293 (62%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D + L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC K + IVTE GG++R++L + ++ ++
Sbjct: 67 RESRFAREVSMLSRVQHKNLVKFIGAC-KEPIMVIVTELLLGGTLRKYLVSLRPGSLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
+AV ALD+AR M +H G IHRDLK ++L+++AD K++K+ADFG+AR E TE MT E
Sbjct: 126 VAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAPEM-----IQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
TGTYRWMAPE+ ++H + Y KVD YSF IVLWELI LPF+ M+ +QAA+A
Sbjct: 186 TGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAA 245
Query: 350 VNKGVRPVIPNDCLPV-LSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTT 401
K VRP D LP L+ I+T CW +P RP FTEI++ML + I +T
Sbjct: 246 AFKNVRPSA--DDLPKDLAMIVTSCWKEDPNDRPNFTEIIQMLLRCLSTISST 296
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 418 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-83 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-82 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-81 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-76 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-59 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-53 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-52 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-51 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-50 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-49 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-49 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-48 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-48 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-48 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-48 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-47 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-47 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-47 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-47 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-47 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-47 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-46 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-46 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-46 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-45 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-45 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-44 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-44 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-44 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-43 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-43 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-43 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-42 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-42 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-42 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-42 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-42 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-41 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-41 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-40 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-40 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-40 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-39 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-39 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-39 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-39 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-39 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-38 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-38 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-37 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-37 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-37 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-37 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-36 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-36 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-36 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-36 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-36 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-36 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-36 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-35 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-35 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-35 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-35 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-35 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-34 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-34 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-34 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-33 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-33 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-33 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-32 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-32 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-32 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-31 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-31 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-30 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-30 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-30 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-30 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-29 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-29 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-29 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-28 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-28 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-27 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-26 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-25 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-24 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-21 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-20 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-19 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-11 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 255 bits (655), Expect = 2e-83
Identities = 92/257 (35%), Positives = 144/257 (56%), Gaps = 17/257 (6%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+GT G+ VA+K L E E+ + ++F +E ++ L H NI
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEER---EEFLEEASIMKKLSHPNI 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
VR +G C + IVTEY GG + FL R+ + LK ++ AL +A+GM Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAPEMIQHRPYT 315
F+HRDL + N L++ + +KI+DFG++R + + G +WMAPE ++ +T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 316 QKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
K DV+SFG++LWE+ T G P+ M+ + + G R P +C L E+M +CW
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-LEDGYRLPRPENCPDELYELMLQCW 241
Query: 375 DTNPEVRPPFTEIVRML 391
+PE RP F+E+V L
Sbjct: 242 AYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 2e-82
Identities = 87/255 (34%), Positives = 140/255 (54%), Gaps = 15/255 (5%)
Query: 146 GAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG++Y+GT G +VA+K L + ++ ++F +E ++ L H NIV
Sbjct: 10 GAFGEVYKGTLKGKGDGKEVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +G C + IV EY GG + +L + + + + L + AL +ARGM Y+ F
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG--TYRWMAPEMIQHRPYTQK 317
IHRDL + N L+ + +KI+DFG++R + + G RWMAPE ++ +T K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184
Query: 318 VDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376
DV+SFG++LWE+ T G P+ M+ + + P P +C P L ++M +CW
Sbjct: 185 SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLP-KPPNCPPELYKLMLQCWAE 243
Query: 377 NPEVRPPFTEIVRML 391
+PE RP F+E+V +L
Sbjct: 244 DPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 250 bits (642), Expect = 1e-81
Identities = 87/257 (33%), Positives = 143/257 (55%), Gaps = 18/257 (7%)
Query: 145 QGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+G G +VA+K L + ++ ++F +E ++ L H N+
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V+ +G C + IV EY +GG + +L R+ + L + AL +ARGM Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPEMIQHRPYT 315
FIHRDL + N L+ + +KI+DFG++R ++ + + G RWMAPE ++ +T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 316 QKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
K DV+SFG++LWE+ T G P+ M+ + + N P P +C P L ++M +CW
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLP-QPPNCPPELYDLMLQCW 240
Query: 375 DTNPEVRPPFTEIVRML 391
+PE RP F+E+V +L
Sbjct: 241 AEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 4e-76
Identities = 89/268 (33%), Positives = 142/268 (52%), Gaps = 30/268 (11%)
Query: 145 QGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+GAFG++Y+G G+ +VA+K L+ + E+ + F +E ++ L H N+V
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-----KDFLKEARVMKKLGHPNVV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-------VPLKLAVKQALDVARGMA 252
R +G C + +V EY +GG + +L + + + LK + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
Y+ F+HRDL + N L+ D +KI+DFG++R +T G P RWMA
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP----IRWMA 175
Query: 306 PEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
PE ++ +T K DV+SFG++LWE+ T G P+ ++ + + KG R P C
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPD 234
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
L E+M CW +PE RP F+E+V LE
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 3e-67
Identities = 75/250 (30%), Positives = 125/250 (50%), Gaps = 11/250 (4%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+Y G+ VAIK++ +K + ++ +E+ +L LKH NIVR
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVI-----KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V EY +GG + L ++ + A + + Y+H G +HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHR 121
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYS 322
DLK +N+L+ D +K+ADFG+AR E +T GT +MAPE++ + Y + VD++S
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWS 181
Query: 323 FGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRCWDTNPEV 380
G++L+EL+TG PF + F + K P P D P +++ + +PE
Sbjct: 182 LGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEK 241
Query: 381 RPPFTEIVRM 390
R E ++
Sbjct: 242 RLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 2e-65
Identities = 80/253 (31%), Positives = 133/253 (52%), Gaps = 15/253 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ + G+ VA+KIL++ +K +Q ++E+ +L L H NIVR I
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK----DQTARREIRILRRLSHPNIVRLI 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V EY +GG + +L + + A K AL + RG+ Y+H G IHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQ-HRPYTQKVDV 320
DLK +N+L+ + +KIADFG+A+ + + +T GT +MAPE++ Y KVDV
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI-----PNDCLPVLSEIMTRCWD 375
+S G++L+EL+TG PF + + P+ + +++ +C +
Sbjct: 183 WSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLN 242
Query: 376 TNPEVRPPFTEIV 388
+P RP EI+
Sbjct: 243 KDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 68/252 (26%), Positives = 120/252 (47%), Gaps = 44/252 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG +Y G+ VAIKI+ E + + ++ +E+ +L L H NIV+
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKII-----KKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G +V EY +GGS++ L + + + ++ L + G+ Y+H G IHR
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 263 DLKSDNLLISADK-SIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRP-YTQKVD 319
DLK +N+L+ +D +K+ADFG+++ + + GT +MAPE++ + Y++K D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379
++S G++L+E LP L +++ + +PE
Sbjct: 177 IWSLGVILYE---------------------------------LPELKDLIRKMLQKDPE 203
Query: 380 VRPPFTEIVRML 391
RP EI+ L
Sbjct: 204 KRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 74/246 (30%), Positives = 127/246 (51%), Gaps = 14/246 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG +Y GE +A+K +E ++ E+ + ++E+ +L++L+H NIVR+
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYY 65
Query: 203 GACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G+ R I EY GGS+ L ++ +P + K + G+AY+H G +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAPEMIQHRPYTQK 317
HRD+K N+L+ +D +K+ADFG A+ EG GT WMAPE+I+ Y +
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 318 VDVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376
D++S G + E+ TG P+ + + A + + + G P IP + + +C
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243
Query: 377 NPEVRP 382
+P+ RP
Sbjct: 244 DPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-53
Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 15/268 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W I+ ++L +G +G FG + G Y G+ VA+K L+ Q F E +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ TL+H N+V+ +G + IVTEY GS+ +L R + L + ALDV
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAPE 307
GM Y+ F+HRDL + N+L+S D K++DFG+A+ Q + ++G +W APE
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPE 169
Query: 308 MIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366
++ + ++ K DV+SFGI+LWE+ + G +P+ + ++ V KG R P C P +
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEV 228
Query: 367 SEIMTRCWDTNPEVRPPFTEIVRMLENA 394
++M CW+ +P RP F ++ L
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 3e-53
Identities = 88/264 (33%), Positives = 144/264 (54%), Gaps = 13/264 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W ++L+KL +G +G FG + +G Y G+ VA+K + K V Q F +E +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI--------KCDVTAQAFLEETAV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+VR +G ++ IV E G++ FL R V + ++ +LDVA
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI 309
GM Y+ +HRDL + N+L+S D K++DFG+AR+ + G+ +W APE +
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAPEAL 169
Query: 310 QHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368
+H+ ++ K DV+S+G++LWE+ + G P+ M+ ++ V KG R P C +
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVYV 228
Query: 369 IMTRCWDTNPEVRPPFTEIVRMLE 392
+MT CW+T P+ RP F ++ LE
Sbjct: 229 LMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-52
Identities = 84/251 (33%), Positives = 133/251 (52%), Gaps = 12/251 (4%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
+G +GAFG +Y+G G+ VAIK + E E+A + QE+ +L L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEAL---KSIMQEIDLLKNL 56
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH NIV++IG+ I+ EYA+ GS+RQ + + P L V +G+AY
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAY 114
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQH 311
+H G IHRD+K+ N+L + D +K+ADFGVA ++ + GT WMAPE+I+
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
+ D++S G + EL+TG P+ ++ + A F +V P +P P L + +
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLM 232
Query: 372 RCWDTNPEVRP 382
+C+ +P +RP
Sbjct: 233 QCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 93/268 (34%), Positives = 140/268 (52%), Gaps = 14/268 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F QE
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-------AFLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ C + IVTEY GS+ FL + + + L V A +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 305
GMAY+ +IHRDL + N+L+ + KIADFG+AR+ ++ + T G +W A
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTA 172
Query: 306 PEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
PE + +T K DV+SFGI+L E++T G +P+ MT + V +G R P +C
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGYRMPRPPNCPE 231
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
L ++M +CWD +PE RP F + LE
Sbjct: 232 ELYDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 7e-50
Identities = 86/260 (33%), Positives = 131/260 (50%), Gaps = 22/260 (8%)
Query: 146 GAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLN 197
G FG++ RG DVAIK L KA ++Q F E ++ H N
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTL--------KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G K I+TEY + GS+ +FL + +L V +A GM Y+ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-VGMLRGIASGMKYLSEM 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TYRWMAPEMIQHRPY 314
++HRDL + N+L++++ K++DFG++R +E G RW APE I +R +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 315 TQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRC 373
T DV+SFGIV+WE+++ G P+ +M+ Q V G R P DC L ++M C
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDGYRLPPPMDCPSALYQLMLDC 244
Query: 374 WDTNPEVRPPFTEIVRMLEN 393
W + RP F++IV L+
Sbjct: 245 WQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 82/266 (30%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM-EQQFQQEVMM 189
ID +L G FG ++ G + G+ DVAIK++ + M E F +E +
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI--------REGAMSEDDFIEEAKV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+V+ G C K+ IVTEY G + +L R + + + + DV
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
M Y+ GFIHRDL + N L+ D +K++DFG+AR + + T GT +W P
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPP 170
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E+ + ++ K DV+SFG+++WE+ + G +P++ + + + V+ G R P
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-VSAGYRLYRPKLAPTE 229
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRML 391
+ IM CW PE RP F +++ L
Sbjct: 230 VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 76/248 (30%), Positives = 132/248 (53%), Gaps = 24/248 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y+ + G++VAIK++ +++ +++ E+ +L KH NIV++
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVI------KLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-----VKQALDVARGMAYVHG 256
G+ +K +W IV E+ GGS++ L ++ L + K+ L +G+ Y+H
Sbjct: 64 GSYLKKDELW-IVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELL---KGLEYLHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQ 316
G IHRD+K+ N+L+++D +K+ DFG++ T+ GT WMAPE+I +PY
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 317 KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL--PVLSEIMTRCW 374
K D++S GI EL G P+ + ++A F + G P + N + + +C
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCL 235
Query: 375 DTNPEVRP 382
NPE RP
Sbjct: 236 QKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-49
Identities = 81/259 (31%), Positives = 131/259 (50%), Gaps = 19/259 (7%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G FG + +G Y +G+ +VA+K L+ E +++F +E ++A L H IV
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R IG C+ +V E A G + ++L ++ R +P+ + A VA GMAY+ F
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETG---TYRWMAPEMIQHRPYT 315
+HRDL + N+L+ KI+DFG++R + ++ T +W APE I + ++
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 316 QKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
K DV+S+G+ LWE + G P+ M + A++ G R P +C + IM CW
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLSCW 235
Query: 375 DTNPEVRPPFTEIVRMLEN 393
PE RP F+E+
Sbjct: 236 KYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 1e-48
Identities = 86/270 (31%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVME-QQFQQEV 187
W ID + + G FG+++ G +N VA+K L K M+ + F E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL--------KPGTMDPKDFLAEA 52
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ L+H +++ C IVTE K GS+ ++L RA+ L + A V
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
A GMAY+ +IHRDL + N+L+ + K+ADFG+AR+ + G +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWT 171
Query: 305 APEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
APE + ++ K DV+SFGI+L E++T G +P+ MT + V++G R P C
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCPPGCP 230
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L +IM CW +P+ RP F + LE+
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 88/268 (32%), Positives = 139/268 (51%), Gaps = 23/268 (8%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP----ENNPEKAQVMEQQFQQEVMMLATL 193
G +G +G++Y GE +A+K +E P + + + M + + E+ L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGM 251
HLNIV+++G I EY GGS+ L R R ++ +Q L G+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVL---EGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAPE 307
AY+H G +HRDLK+DNLL+ AD KI+DFG+++ I + M+ + G+ WMAPE
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE 180
Query: 308 MIQ--HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
+I + Y+ KVD++S G V+ E+ G P+ + A+ A F + NK P IP D
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240
Query: 366 LSEI----MTRCWDTNPEVRPPFTEIVR 389
LS + + C+ NP+ RP E+++
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 80/275 (29%), Positives = 142/275 (51%), Gaps = 32/275 (11%)
Query: 141 TAFAQGAFGKLYRGTYNGED-------VAIKILE-RPENNPEKAQVMEQQFQQEVMMLAT 192
T +G FG+++ G + V +K L+ + N ++ +F++E+ M
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN------LQSEFRRELDMFRK 64
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK---LAVKQAL---- 245
L H N+VR +G CR+ ++ EY G ++QFL +++ LK L+ KQ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------GMTPETG 299
+A GM ++ F+HRDL + N L+S+ + +K++ +++ +E + P
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--- 181
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
RW+APE +Q ++ K DV+SFG+++WE+ T G LPF ++ + + + +
Sbjct: 182 -LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P C L ++MTRCW NP+ RP F+E+V L
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 93/255 (36%), Positives = 141/255 (55%), Gaps = 15/255 (5%)
Query: 143 FAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++++GT + VA+K + E+ P++ ++ +F E +L H NIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKI---KFLSEARILKQYDHPNIVKL 57
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C +R IV E GG FL R++ + K VK ALD A GMAY+ IH
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG----TYRWMAPEMIQHRPYTQK 317
RDL + N L+ + +KI+DFG++R E +G+ +G +W APE + + Y+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 318 VDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376
DV+S+GI+LWE + G+ P+ MT Q A V KG R P C + ++M RCWD
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233
Query: 377 NPEVRPPFTEIVRML 391
PE RP F+E+ + L
Sbjct: 234 KPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 2e-47
Identities = 89/268 (33%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W + L + G FG+++ G YNG VAIK L++ +PE F E
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-------FLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +VR + ++ I+TEY + GS+ FL + + + + A +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E I + +T K DV+SFGI+L E++T G +P+ MT + + +G R P++C
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLERGYRMPRPDNCPEE 231
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L E+M CW PE RP F + +LE+
Sbjct: 232 LYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 28/261 (10%)
Query: 145 QGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FG +Y+G G +VA+K R P+ ++++F QE +L H NIV+ IG
Sbjct: 5 KGNFGDVYKGVLKGNTEVAVKTC-RSTLPPD----LKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
C ++ IV E GGS+ FL +++NR + +K ++ +LD A GM Y+ IHRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY-----------RWMAPEMIQHR 312
L + N L+ + +KI+DFG++R E E G Y +W APE + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREE--------EGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 313 PYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
YT + DV+S+GI+LWE + G P+ M+ Q + G R P C + +M
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLML 229
Query: 372 RCWDTNPEVRPPFTEIVRMLE 392
+CW +PE RP F+EI L+
Sbjct: 230 QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 84/264 (31%), Positives = 132/264 (50%), Gaps = 42/264 (15%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA G++Y+ T G++VAIK + + N E E++++ KH NIV +
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-------NEILIMKDCKHPNIVDYY 81
Query: 203 GACR-KRMVWCIVTEYAKGGS----VRQF---LTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ +W +V EY GGS + Q + Q V +V +G+ Y+
Sbjct: 82 DSYLVGDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYV--------CREVLQGLEYL 132
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-------GTYRWMAPE 307
H IHRD+KSDN+L+S D S+K+ADFG A Q +T E GT WMAPE
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAPE 186
Query: 308 MIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPV 365
+I+ + Y KVD++S GI+ E+ G P+ ++A F + KG+ P + P P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPE 245
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVR 389
+ + +C +PE RP E+++
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 96/299 (32%), Positives = 139/299 (46%), Gaps = 50/299 (16%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
EW + +L +G +GAFG++ + G D VA+K+L K E+
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--------KDDATEK 57
Query: 182 QFQQEV----MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
V MM KH NI+ +G C + +V EYA G++R FL R R
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGE 115
Query: 238 KLA----------------VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ V A VARGM ++ IHRDL + N+L++ D +KIAD
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175
Query: 282 FGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-G 333
FG+AR T G P +WMAPE + R YT + DV+SFG++LWE+ T G
Sbjct: 176 FGLARDIHHIDYYRKTTNGRLP----VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P+ + V+ F ++ +G R P +C L +M CW P RP F ++V L+
Sbjct: 232 GSPYPGI-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 4e-47
Identities = 82/271 (30%), Positives = 133/271 (49%), Gaps = 16/271 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQ 184
+ I + +G +G FG +Y+G Y E VA+K + +P + +F
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVRE----KFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
QE ++ H +IV+ IG + VW IV E A G +R +L + + L + +
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--R 302
++ +AY+ F+HRD+ + N+L+S+ +K+ DFG++R G +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWE-LITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
WMAPE I R +T DV+ FG+ +WE L+ G+ PFQ + + G R +P +
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLPMPPN 232
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
C P L +MT+CW +P RP FTE+ L
Sbjct: 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 6e-47
Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 33/287 (11%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQ 182
W + K+ + QG+FG +Y G G VAIK + N + +E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIE-- 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVP---- 236
F E ++ ++VR +G +V E G ++ +L R + P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 237 --LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292
L+ ++ A ++A GMAY+ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 293 -----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346
G+ P RWMAPE ++ +T K DV+SFG+VLWE+ T P+Q ++ +
Sbjct: 176 RKGGKGLLP----VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231
Query: 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V++ G +P +C L E+M CW NP++RP F EIV L++
Sbjct: 232 KFVIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 8e-47
Identities = 95/268 (35%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F +E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-------SFLEEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + RA+ L V A VA
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL+S N+L+ KIADFG+AR+ E + + +W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E + +T K DV+SFGI+L EL+T G +P+ M + V +G R P DC
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRMPCPQDCPIS 231
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L E+M +CW +PE RP F + LE+
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 91/277 (32%), Positives = 133/277 (48%), Gaps = 29/277 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
+ + A GAFG++Y G Y G D + + + PE+ E+ E F E ++++
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD---ESDFLMEALIMS 64
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQ----ALD 246
H NIVR IG +R+ I+ E GG ++ FL + R P L +K A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEVQTE-------GMTP 296
VA+G Y+ FIHRD+ + N L++ + KIADFG+AR + M P
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355
+WM PE +T K DV+SFG++LWE+ + G +P+ T Q V G R
Sbjct: 185 ----IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGGGR 239
Query: 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P C + IMT CW PE RP F I+ ++
Sbjct: 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 74/255 (29%), Positives = 129/255 (50%), Gaps = 8/255 (3%)
Query: 139 MGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G G+FG +Y G +G+ A+K + ++ + Q +Q +QE+ +L+ L+H
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-QTGQEAVKQLEQEIALLSKLQHP 62
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAYVH 255
NIV+++G R+ I E GGS+ + L + + P+ +L +Q L G+ Y+H
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLH 119
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI-QHRPY 314
+HRD+K N+L+ + +K+ADFG+A+ V+ G+ WMAPE+I Q Y
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
D++S G + E+ TG P+ + V A F + P IP+ + + +C
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 375 DTNPEVRPPFTEIVR 389
+P +RP E++
Sbjct: 240 QRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 32/274 (11%)
Query: 145 QGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FGK+ Y+ GE VA+K L ++ F++E+ +L TL H NI
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENI 68
Query: 199 VRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V++ G C K ++ EY GS+R +L R +++ + LK + + + +GM Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM----TPETGTYRWMAPEMIQHR 312
+IHRDL + N+L+ ++ +KI+DFG+A++ + + P W APE ++
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQ-----------NMTAVQAAFAVVN---KGVRPVI 358
++ DV+SFG+ L+EL T P Q ++ +G R
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P C + ++M CW+ P+ RP F +++ +++
Sbjct: 248 PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 7e-46
Identities = 84/244 (34%), Positives = 129/244 (52%), Gaps = 12/244 (4%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ G + N VAIKIL+ ++ K Q FQ+EV L L+H +++
Sbjct: 16 SGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQ----DFQKEVQALKRLRHKHLISLFA 69
Query: 204 AC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
C V+ I+TE + GS+ FL + + +P+ + A VA GMAY+ IHR
Sbjct: 70 VCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-YRWMAPEMIQHRPYTQKVDVY 321
DL + N+L+ D K+ADFG+AR+ + ++ + Y+W APE H ++ K DV+
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 322 SFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEV 380
SFGI+L+E+ T G +P+ M + + G R P C + +IM CW PE
Sbjct: 189 SFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPED 247
Query: 381 RPPF 384
RP F
Sbjct: 248 RPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 3e-45
Identities = 70/256 (27%), Positives = 131/256 (51%), Gaps = 20/256 (7%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FGK L R +G+ +K ++ + E+ EV +L L H NI+++
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-----LNEVKILKKLNHPNIIKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHGL 257
+ ++ CIV EYA GG + Q + +++ P +Q LD + + Y+H
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP--EEQILDWFVQLCLALKYLHSR 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAPEMIQHRPYTQ 316
+HRD+K N+ ++++ +K+ DFG++++ T + GT +++PE+ Q++PY
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNY 182
Query: 317 KVDVYSFGIVLWELITGLLPFQ--NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
K D++S G VL+EL T PF+ N+ + A ++ P IP+ L +++
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLEL--ALKILKGQYPP-IPSQYSSELRNLVSSLL 239
Query: 375 DTNPEVRPPFTEIVRM 390
+PE RP +I++
Sbjct: 240 QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 7e-45
Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 30/264 (11%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G+FG + RG + G+ VA+K L+ +K + F +E ++ +L H N++
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLK-----SDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 200 RFIGACR-KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R G ++ +VTE A GS+ L + + A+ +A GM Y+
Sbjct: 60 RLYGVVLTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR----------WMAPEM 308
FIHRDL + N+L+++D +KI DFG+ R Q E Y W APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWCAPES 171
Query: 309 IQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367
++ R ++ DV+ FG+ LWE+ T G P+ ++ Q + +G R P C +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231
Query: 368 EIMTRCWDTNPEVRPPFTEIVRML 391
+M +CW NP RP F + L
Sbjct: 232 NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-44
Identities = 79/271 (29%), Positives = 139/271 (51%), Gaps = 17/271 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVME-QQFQQE 186
W ++ + M G +G++Y G + VA+K L K ME ++F +E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEFLKE 52
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ +KH N+V+ +G C + + I+TE+ G++ +L + V + + A
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G +W
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKW 171
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362
APE + + ++ K DV++FG++LWE+ T G+ P+ + + + ++ KG R P C
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGC 230
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P + E+M CW NP RP F EI + E
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 81/271 (29%), Positives = 138/271 (50%), Gaps = 34/271 (12%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
L GAFG +Y+G + E VAIK+L E KA ++ E ++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKAN---KEILDEAYVM 63
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD---- 246
A++ H ++VR +G C V ++T+ G + ++ R ++ + + L+
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV--RNHKD---NIGSQYLLNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQ---TEGMTPETG 299
+A+GM+Y+ +HRDL + N+L+ + +KI DFG+A++ E + G P
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--- 174
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
+WMA E I HR YT K DV+S+G+ +WEL+T G P++ + AV+ ++ KG R
Sbjct: 175 -IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-DLLEKGERLPQ 232
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
P C + ++ +CW + E RP F E++
Sbjct: 233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-44
Identities = 83/268 (30%), Positives = 142/268 (52%), Gaps = 17/268 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K + K Q F E +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAFLAEASV 52
Query: 190 LATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ F+HRDL + N+L+S D K++DFG+ + E + T +TG +W AP
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAP 168
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E ++ + ++ K DV+SFGI+LWE+ + G +P+ + ++ V KG + P+ C PV
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPV 227
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ ++M +CW + RP F ++ LE+
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 85/276 (30%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 145 QGAFGKLYRGT-YNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
+GAFGK++ G Y+ E VA+K L+ E A + F++E +L +H N
Sbjct: 15 EGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDA---RKDFEREAELLTNFQHEN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--------RQNRAVPLKLAVKQ----AL 245
IV+F G C + +V EY + G + +FL + + +L + Q A+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPET 298
+A GM Y+ F+HRDL + N L+ D +KI DFG++R V M P
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
RWM PE I +R +T + DV+SFG+VLWE+ T G P+ ++ + + +G
Sbjct: 188 --IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIECITQGRLLQ 244
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P C + +IM CW +P+ R +I L+
Sbjct: 245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-43
Identities = 91/268 (33%), Positives = 138/268 (51%), Gaps = 13/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ +PE F QE
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + + L V A +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ E + + +W AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E + +T K DV+SFGI+L EL T G +P+ M + V +G R P +C
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPPECPES 231
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L ++M +CW PE RP F + LE+
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 88/275 (32%), Positives = 139/275 (50%), Gaps = 39/275 (14%)
Query: 142 AFAQGAFGKLYRG---TYNGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+GAFGK+Y+G N VAIK L + P+ ++Q+F+QE +++ L+
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPK----VQQEFRQEAELMSDLQ 66
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALD---- 246
H NIV +G C K C++ EY G + +FL R A VK +LD
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 247 ------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEG 293
+A GM Y+ F+HRDL + N L+ ++KI+DFG++R VQ++
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNK 352
+ P RWM PE I + +T + D++SFG+VLWE+ + GL P+ + + + ++
Sbjct: 187 LLP----VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242
Query: 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
+ P P DC + +M CW+ P RP F +I
Sbjct: 243 QLLPC-PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 1e-42
Identities = 92/268 (34%), Positives = 136/268 (50%), Gaps = 13/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ PE F QE
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V + ++ IVTE+ GS+ FL + + L V A +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL++ N+L+ + KIADFG+AR+ E + + +W AP
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E + +T K DV+SFGI+L EL+T G +P+ M + V +G R P C
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRMPCPQGCPES 231
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L E+M CW +P+ RP F I LE+
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 79/265 (29%), Positives = 131/265 (49%), Gaps = 15/265 (5%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I +L + G FG ++ G + VAIK + + + E+ F +E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-------EGAMSEEDFIEEAQVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C +R C+V E+ + G + +L R Q + + LDV G
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPE 307
MAY+ IHRDL + N L+ ++ +K++DFG+ R V + T TGT +W +PE
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPE 171
Query: 308 MIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366
+ Y+ K DV+SFG+++WE+ + G P++N + + +N G R P +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-ETINAGFRLYKPRLASQSV 230
Query: 367 SEIMTRCWDTNPEVRPPFTEIVRML 391
E+M CW PE RP F+ ++ L
Sbjct: 231 YELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 89/268 (33%), Positives = 134/268 (50%), Gaps = 12/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I + + G FG+++ G Y N VA+K L+ P V Q F +E
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-----PGTMSV--QAFLEEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +VR K I+TEY GS+ FL + V L + + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E I +T K DV+SFGI+L+E++T G +P+ M+ A + +G R +C
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDE 232
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L +IM CW E RP F + +L++
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 90/268 (33%), Positives = 138/268 (51%), Gaps = 13/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ TYN VA+K ++ P V + F E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSV--EAFLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +V+ K ++ I+TE+ GS+ FL + PL + + +A
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+SA KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
E I +T K DV+SFGI+L E++T G +P+ M+ + A + +G R P +C
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEE 231
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L IM RCW PE RP F I +L++
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 91/280 (32%), Positives = 145/280 (51%), Gaps = 20/280 (7%)
Query: 127 YDE-WTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD W L+ G GAFGK+ T G D VA+K+L+ ++ E+ +
Sbjct: 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
M E+ +++ L H NIV +GAC ++TEY G + FL R++ + L
Sbjct: 86 M-----SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
+ + + VA+GMA++ IHRDL + N+L++ K +KI DFG+AR ++ +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVV 199
Query: 298 TGTYR----WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNK 352
G R WMAPE I + YT + DV+S+GI+LWE+ + G P+ M + ++ +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
G R P + +IM CWD +P RP F +IV+++
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-41
Identities = 89/279 (31%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 145 QGAFGKLYR----GTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
QGAFG++++ G E VA+K+L+ E + M+ FQ+E ++A H N
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQADFQREAALMAEFDHPN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV----------------PLKLA- 240
IV+ +G C C++ EY G + +FL R RA PL L+
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 241 ---VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GM 294
+ A VA GMAY+ F+HRDL + N L+ + +KIADFG++R +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353
+ RWM PE I + YT + DV+++G+VLWE+ + G+ P+ M + + V +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN 249
Query: 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
V P++C L +M CW P RP F I R+L+
Sbjct: 250 VLSC-PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-41
Identities = 85/263 (32%), Positives = 133/263 (50%), Gaps = 25/263 (9%)
Query: 145 QGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G FG +Y GT D A+K L R + E Q F +E +++ H N++
Sbjct: 5 KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-----FLKEGIIMKDFSHPNVL 59
Query: 200 RFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+G C +V Y K G +R F+ R + +K + L VA+GM Y+
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-----YRWMAPEMIQHRP 313
F+HRDL + N ++ ++K+ADFG+AR E + T +WMA E +Q +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 314 YTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVN---KGVRPVIPNDCLPVLSEI 369
+T K DV+SFG++LWEL+T G P+ ++ +F + +G R + P C L E+
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 370 MTRCWDTNPEVRPPFTEIVRMLE 392
M CW PE+RP F+E+V +E
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 81/253 (32%), Positives = 133/253 (52%), Gaps = 13/253 (5%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++ G ++ + + E P ++ +F QE +L H NIVR IG
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264
C ++ IV E +GG FL R + + +K ++ + A GM Y+ IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 265 KSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR-----WMAPEMIQHRPYTQKVD 319
+ N L++ +KI+DFG++R E +G+ TG + W APE + + Y+ + D
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREE--EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 320 VYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNP 378
V+SFGI+LWE + G +P+ N++ Q A + +GVR P C + +M RCW+ +P
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQTREA-IEQGVRLPCPELCPDAVYRLMERCWEYDP 237
Query: 379 EVRPPFTEIVRML 391
RP F+ + + L
Sbjct: 238 GQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 11/257 (4%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPE-KAQVMEQQFQQEVMMLATLKHL 196
G QGAFG++Y G ++A+K + ++PE K +V + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV--NALECEIQLLKNLQHE 64
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV++ G R I EY GGSV+ L + A+ + K + G+ Y+H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAPEMIQHR 312
+HRD+K N+L + ++K+ DFG ++ I GM TGT WM+PE+I
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
Y +K DV+S G + E++T P+ A+ A F + + P +P+ P + R
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 373 CWDTNPEVRPPFTEIVR 389
+ N + RP E++R
Sbjct: 243 TFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 81/257 (31%), Positives = 123/257 (47%), Gaps = 33/257 (12%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L RP+ + + F +EV +L+ L NI R +G C C++ EY +
Sbjct: 49 VAVKVL-RPDASDNARE----DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQ---------ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL + L K A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFG 324
+ +IKIADFG++R VQ P RWMA E + +T K DV++FG
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP----IRWMAWESVLLGKFTTKSDVWAFG 219
Query: 325 IVLWELIT--GLLPFQNMT---AVQAAFAVVNKGVRPVI---PNDCLPVLSEIMTRCWDT 376
+ LWE++T P++++T ++ A R + P +C + E+M CW
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279
Query: 377 NPEVRPPFTEIVRMLEN 393
+ E RP F EI L+
Sbjct: 280 DEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 83/257 (32%), Positives = 134/257 (52%), Gaps = 17/257 (6%)
Query: 146 GAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+++RG G VAIK L+ P + Q F E ++ H NI+R
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G K I+TEY + G++ ++L +L V +A GM Y+ + ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSDMNYV 129
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETG---TYRWMAPEMIQHRPYTQ 316
HRDL + N+L++++ K++DFG++R+ E EG +G RW APE I +R +T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 317 KVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
DV+SFGIV+WE+++ G P+ +M+ +N G R P DC + ++M +CW
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 376 TNPEVRPPFTEIVRMLE 392
+ RP F +IV +L+
Sbjct: 249 QDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 90/274 (32%), Positives = 136/274 (49%), Gaps = 36/274 (13%)
Query: 146 GAFGKLYRGTYNGED--------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
GAFG++Y GT VA+K L + + EK + F +E +++ H N
Sbjct: 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFNHPN 60
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFL-----TRRQNRAVPLKLAVKQALDVARGMA 252
IV+ +G C I+ E +GG + +L R + LK + LDVA+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 253 YVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVAR-------IEVQTEGMTPETGT 300
Y+ + FIHRDL + N L+S AD+ +KI DFG+AR + EG+ P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP---- 176
Query: 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359
RWMAPE + +T + DV+SFG+++WE++T G P+ + Q V G R P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAGGRLQKP 235
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+C + ++MT CW +P RP F I +L+N
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 80/266 (30%), Positives = 135/266 (50%), Gaps = 15/266 (5%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + G+ DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ IVTEY G + +L R P +L ++ DV G
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPE 307
MAY+ FIHRDL + N L+ +K++DFG++R + E T G+ RW PE
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE 171
Query: 308 MIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366
++ + ++ K DV++FG+++WE+ + G +P++ + V +G+R P+ +
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKV 230
Query: 367 SEIMTRCWDTNPEVRPPFTEIVRMLE 392
IM CW E RP F +++ +E
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 40/295 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W +L +G +G FG++ R G D VA+K+L+ + + A ++
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------ 227
+ E+M L KH NI+ +G C + ++ EYA G++R+FL
Sbjct: 66 SEM---ELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 228 --TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
T+ + K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF 337
R + + G P +WMAPE + R YT + DV+SFGI++WE+ T G P+
Sbjct: 182 RGVHDIDYYKKTSNGRLP----VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
Query: 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ V+ F ++ +G R P++C L +M CW P RP F ++V L+
Sbjct: 238 PGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 81/240 (33%), Positives = 125/240 (52%), Gaps = 18/240 (7%)
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L KA E+Q F E ++ H NI+ G K IVTEY
Sbjct: 35 VAIKTL--------KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ GS+ FL + + ++L V +A GM Y+ +G++HRDL + N+L++++
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145
Query: 278 KIADFGVARI-EVQTEGMTPETG---TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT- 332
K++DFG++R+ E E G RW APE I +R +T DV+S+GIV+WE+++
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205
Query: 333 GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
G P+ M+ Q + +G R P DC L ++M CW + RP F +IV +L+
Sbjct: 206 GERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-39
Identities = 92/295 (31%), Positives = 144/295 (48%), Gaps = 40/295 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W + +L +G +G FG++ G D VA+K+L+ + + + ++
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------- 231
+ MM KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 66 SEM----EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 232 ------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF 337
R + T G P +WMAPE + R YT + DV+SFG++LWE+ T G P+
Sbjct: 182 RDVHNIDYYKKTTNGRLP----VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
Query: 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ V+ F ++ +G R P +C L IM CW P RP F ++V L+
Sbjct: 238 PGI-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 82/295 (27%), Positives = 144/295 (48%), Gaps = 49/295 (16%)
Query: 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
L +G +G FGK+ + T VA+K+L+ ++ E ++ E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL-----SEFN 55
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------- 232
+L + H ++++ GAC + ++ EYAK GS+R FL +
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 ------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
RA+ + + A ++RGM Y+ + +HRDL + N+L++ + +KI+DFG++R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 287 IEV--------QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF 337
+V +++G P +WMA E + YT + DV+SFG++LWE++T G P+
Sbjct: 176 -DVYEEDSYVKRSKGRIP----VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
Query: 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ A + F ++ G R P +C + +M CW P+ RP F +I + LE
Sbjct: 231 PGI-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 8e-39
Identities = 80/259 (30%), Positives = 141/259 (54%), Gaps = 27/259 (10%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIV 199
+GA+G +YRG + G VA+KI+ + + + + Q+EV +L+ L+ NI
Sbjct: 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-----QREVALLSQLRQSQPPNIT 65
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK-----LAVKQALDVARGMAYV 254
++ G+ K I+ EYA+GGSVR + +A P+ + +++ L VA + Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVL-VA--LKYI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAPEMIQH-R 312
H +G IHRD+K+ N+L++ ++K+ DFGVA + Q + GT WMAPE+I +
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMT 371
Y K D++S GI ++E+ TG P+ ++ A +A ++ K P + ++ +L E +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-LIPKSKPPRLEDNGYSKLLREFVA 236
Query: 372 RCWDTNPEVRPPFTEIVRM 390
C D P+ R E+++
Sbjct: 237 ACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 73/247 (29%), Positives = 121/247 (48%), Gaps = 23/247 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G +Y+ + G+ VAIK++ E+ Q+ +E+ +L IV++
Sbjct: 13 EGSYGSVYKAIHKETGQVVAIKVVPVEEDL--------QEIIKEISILKQCDSPYIVKYY 64
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G+ K +W IV EY GSV + ++A Q L +G+ Y+H
Sbjct: 65 GSYFKNTDLW-IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL---KGLEYLHSNKK 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAPEMIQHRPYTQKV 318
IHRD+K+ N+L++ + K+ADFGV+ T GT WMAPE+IQ Y K
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 319 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK---GVRPVIPNDCLPVLSEIMTRCWD 375
D++S GI E+ G P+ ++ ++A F + NK + P P ++ + +C
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS--DPEKWSPEFNDFVKKCLV 238
Query: 376 TNPEVRP 382
+PE RP
Sbjct: 239 KDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 76/264 (28%), Positives = 132/264 (50%), Gaps = 13/264 (4%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I+ +L G FG ++ G + + VAIK + + + E+ F +E ++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-------EGAMSEEDFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ IVTE+ + G + +L +RQ + + + DV G
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAPEM 308
M Y+ FIHRDL + N L+S+ +K++DFG+ R + E + + +W PE+
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172
Query: 309 IQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367
Y+ K DV+SFG+++WE+ T G +PF+ + + +++G R P +
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM-ISRGFRLYRPKLASMTVY 231
Query: 368 EIMTRCWDTNPEVRPPFTEIVRML 391
E+M CW PE RP F E++R +
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 93/306 (30%), Positives = 147/306 (48%), Gaps = 45/306 (14%)
Query: 123 GLENYD-----EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILER 168
G+ Y+ W + +L +G +G FG++ G D VA+K+L+
Sbjct: 1 GVSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS 60
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
+ + ++ + MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 61 DATEKDLSDLISEM----EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 116
Query: 229 RRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
R+ + K V A VARGM Y+ IHRDL + N+L++ D
Sbjct: 117 ARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176
Query: 275 KSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVL 327
+KIADFG+AR + T G P +WMAPE + R YT + DV+SFG++L
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLP----VKWMAPEALFDRIYTHQSDVWSFGVLL 232
Query: 328 WELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTE 386
WE+ T G P+ + V+ F ++ +G R P++C L +M CW P RP F +
Sbjct: 233 WEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 291
Query: 387 IVRMLE 392
+V L+
Sbjct: 292 LVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 78/264 (29%), Positives = 139/264 (52%), Gaps = 19/264 (7%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP---ENNPEKAQVMEQQFQQEVMMLATLK 194
G G+FG +Y G +GE +A+K +E P ++ ++ + M +E+ +L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAY 253
H NIV+++G+ I EY GGSV L L + V+Q L +G+ Y
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNY 121
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR--------WMA 305
+H G IHRD+K N+L+ IKI+DFG+++ +++ ++ +T R WMA
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 306 PEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
PE+++ YT+K D++S G ++ E++TG PF + T +QA F + P IP++
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPSNISSE 239
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVR 389
+ + + ++ + RP E+++
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 84/264 (31%), Positives = 136/264 (51%), Gaps = 21/264 (7%)
Query: 140 GTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +GA+G +Y G N G+ +A+K +E +N A+ ++ Q+EV +L +LKH+NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV-----KQALDVARGMAY 253
V+++G C I E+ GGS+ L NR PL V KQ LD G+AY
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILD---GVAY 117
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+H +HRD+K +N+++ + IK+ DFG AR + + GT WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN-KGVRPVIPNDCLPV 365
E+I Y +K D++S G ++E+ TG P +M + A F + +G+ P +P+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237
Query: 366 LSEIMTRCWDTNPEVRPPFTEIVR 389
+ +T C + RP +++R
Sbjct: 238 AIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 2e-37
Identities = 86/274 (31%), Positives = 133/274 (48%), Gaps = 39/274 (14%)
Query: 143 FAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ AFGK+Y+G + + VAIK L + NNP++ +FQQE ++A L H
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWG----EFQQEASLMAELHHP 67
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-----VPLKLAVKQALD----- 246
NIV +G + C++ EY G + +FL R + VK +LD
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 247 -----VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGM 294
+A GM Y+ F+H+DL + N+LI +KI+D G++R VQ + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353
P RWM PE I + ++ D++SFG+VLWE+ + GL P+ + + V +
Sbjct: 188 LP----IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243
Query: 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
+ P DC P + +MT CW P RP F +I
Sbjct: 244 LLPC-SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 2e-37
Identities = 87/288 (30%), Positives = 144/288 (50%), Gaps = 35/288 (12%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ- 181
W + K+ M QG+FG +Y G G VAIK + E A + E+
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL----TRRQNRAV-- 235
+F E ++ ++VR +G + ++ E G ++ +L +N V
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 236 --PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
LK ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345
G+ P RWM+PE ++ +T DV+SFG+VLWE+ T P+Q M+ Q
Sbjct: 175 YRKGGKGLLP----VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230
Query: 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V+ G+ P++C +L E+M CW NP++RP F EI+ ++
Sbjct: 231 LRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 139 bits (349), Expect = 3e-37
Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIG 203
+G+FG++Y + VA+K+L + + K ++F +E+ +LA+L H NIV+
Sbjct: 10 EGSFGEVYLARDR-KLVALKVLAKKLESKSKEV---ERFLREIQILASLNHPPNIVKLYD 65
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ L + + A+ + + Y+H G IHR
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125
Query: 263 DLKSDNLLISAD-KSIKIADFGVARI-------EVQTEGMTPETGTYRWMAPEMIQH--- 311
D+K +N+L+ D + +K+ DFG+A++ + GT +MAPE++
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSL 185
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQ---NMTAVQAAFAVVNKGVRPVIPNDCLP---- 364
+ D++S GI L+EL+TGL PF+ N +A ++ + P + + P
Sbjct: 186 AYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPE 245
Query: 365 ----VLSEIMTRCWDTNPEVRP 382
S+++ + +P+ R
Sbjct: 246 LISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 85/288 (29%), Positives = 146/288 (50%), Gaps = 35/288 (12%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGT----YNGE---DVAIKILERPENNPEKAQVMEQ- 181
W + K+ + QG+FG +Y G GE VA+K + E A + E+
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-------TRRQNRA 234
+F E ++ ++VR +G K +V E G ++ +L R
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 235 VP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
P L+ ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345
G+ P RWMAPE ++ +T D++SFG+VLWE+ + P+Q ++ Q
Sbjct: 175 YRKGGKGLLP----VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230
Query: 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V++ G P++C ++++M CW NP++RP F EIV +L++
Sbjct: 231 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 91/294 (30%), Positives = 141/294 (47%), Gaps = 40/294 (13%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
W KL +G +G FG++ G D VA+K+L+ ++ EK +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKD--LS 65
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------- 227
+ MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 228 -TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
R + + K V VARGM Y+ IHRDL + N+L++ + +KIADFG+AR
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 287 -------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338
+ T G P +WMAPE + R YT + DV+SFG+++WE+ T G P+
Sbjct: 186 DVNNIDYYKKTTNGRLP----VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241
Query: 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ V+ F ++ +G R P +C L +M CW P RP F ++V L+
Sbjct: 242 GI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 70/246 (28%), Positives = 120/246 (48%), Gaps = 21/246 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++Y+ + VAIK+++ E E + QQE+ L+ + I ++
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI-----QQEIQFLSQCRSPYITKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
G+ K I+ EY GGS L A L+ +V G+ Y+H G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-------EVLLGLEYLHEEG 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQK 317
IHRD+K+ N+L+S + +K+ADFGV+ ++ GT WMAPE+I+ Y +K
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEK 178
Query: 318 VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMTRCWDT 376
D++S GI EL G P ++ ++ F ++ K P + + + ++ C +
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLF-LIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237
Query: 377 NPEVRP 382
+P+ RP
Sbjct: 238 DPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 4e-36
Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 25/276 (9%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQ---F 183
ID+ + + G FG++ RG G+ VAIK L K+ E+Q F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------KSGYTEKQRRDF 52
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E ++ H NI+ G K I+TE+ + G++ FL + + ++L V
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGM 111
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY-- 301
+A GM Y+ + ++HRDL + N+L++++ K++DFG++R T +
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 302 ----RWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRP 356
RW APE I +R +T DV+S+GIV+WE+++ G P+ +M+ Q + + R
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRL 230
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P DC L ++M CW + RP F +IV L+
Sbjct: 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 95/281 (33%), Positives = 140/281 (49%), Gaps = 46/281 (16%)
Query: 144 AQGAFGKLYRGTY----NGEDVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ R + AIK+L+ EN+ + F E+ +L L H
Sbjct: 11 GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-------HRDFAGELEVLCKLGHHP 63
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ------------- 243
NI+ +GAC R I EYA G++ FL R++R + A +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 244 ---ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTP 296
A DVA GM Y+ FIHRDL + N+L+ + + KIADFG++R E +T G P
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355
RWMA E + + YT K DV+SFG++LWE+++ G P+ MT + + + +G R
Sbjct: 182 ----VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYR 236
Query: 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV----RMLE 392
P +C + E+M +CW P RPPF +I RMLE
Sbjct: 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 82/263 (31%), Positives = 122/263 (46%), Gaps = 41/263 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+KIL P+ + F +EV +L+ LK NI+R +G C C++TEY +
Sbjct: 49 VAVKILR-----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQ--NRAVPLKLAVKQ---------------ALDVARGMAYVHGLGFIHRD 263
G + QFL+ ++ AV AL +A GM Y+ L F+HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 264 LKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQ 316
L + N L+ + +IKIADFG++R +Q + P RWMA E I +T
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP----IRWMAWECILMGKFTT 219
Query: 317 KVDVYSFGIVLWELIT--GLLPFQNMTAVQAA------FAVVNKGVRPVIPNDCLPVLSE 368
DV++FG+ LWE++ P+ +T Q F + V P C L E
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE 279
Query: 369 IMTRCWDTNPEVRPPFTEIVRML 391
+M +CW + RP F++I L
Sbjct: 280 LMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-36
Identities = 76/273 (27%), Positives = 132/273 (48%), Gaps = 17/273 (6%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
L +G +G FG + G N +D +K+ + + + F E + + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 197 NIVRFIGACRKRM------VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALD 246
N++R IG C + + ++ + K G + FL + +P ++ VK D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYR 302
+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++ + +G + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-K 179
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
W+A E + R YT K DV+SFG+ +WE+ T G P+ + + + + +G R P D
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPD 238
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394
CL L +M+ CW NP+ RP F + LE A
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 88/291 (30%), Positives = 143/291 (49%), Gaps = 48/291 (16%)
Query: 135 RKLNMGTAFAQGAFGK--LYR------GTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
R L +G FGK LY GT GE VA+K L+R E Q +++E
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGT--GEMVAVKTLKR-----ECGQQNTSGWKKE 56
Query: 187 VMMLATLKHLNIVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ +L TL H NIV++ G C ++ ++ EY GS+R +L + + L L +Q
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ- 115
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--------IEVQTEGMTP 296
+ GMAY+H +IHRDL + N+L+ D+ +KI DFG+A+ V+ +G +P
Sbjct: 116 --ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN---------------MT 341
W A E ++ ++ DV+SFG+ L+EL+T Q+ MT
Sbjct: 174 ----VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 342 AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
V+ ++ +G+R P +C + +M CW+T + RP F ++ +L+
Sbjct: 230 VVR-LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 86/273 (31%), Positives = 130/273 (47%), Gaps = 39/273 (14%)
Query: 143 FAQGAFGKLYRGTYNG----ED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ + +D VA+K L+ E ++ Q FQ+E +L L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTVLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------QNRAVPL-KLAVKQAL- 245
+IVRF G C + +V EY + G + +FL V +L + Q L
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMT 295
+A GM Y+ L F+HRDL + N L+ +KI DFG++R V M
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354
P RWM PE I +R +T + D++SFG+VLWE+ T G P+ ++ + A + +G
Sbjct: 187 P----IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIECITQGR 241
Query: 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
P C P + IM CW P+ R +I
Sbjct: 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 67/253 (26%), Positives = 127/253 (50%), Gaps = 16/253 (6%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G+FG +++ + A+K ++ N E+ + ++ E +LA L I+R
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-----EARVLAKLDSSYIIR 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + IV EYA+ G + + L ++ R +P + + + G+A++H +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVD 319
HRD+KS NL + A ++KI D GVA++ T GT +++PE+ + +PY +K D
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSD 183
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK---GVRPVIPNDCLPVLSEIMTRCWDT 376
V++ G+VL+E TG PF A++ K GV P + L++++ +C
Sbjct: 184 VWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 377 NPEVRPPFTEIVR 389
+ RP +++R
Sbjct: 240 DYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 82/290 (28%), Positives = 134/290 (46%), Gaps = 52/290 (17%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
L +G +G FG + G + +D VA+K ++ + +++ E F E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIEE--FLSEAACMK 56
Query: 192 TLKHLNIVRFIGAC---------RKRMVWCIVTEYAKGGSVRQFL----TRRQNRAVPLK 238
H N+++ IG C K MV + + K G + FL +PL+
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMV---ILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
+K +D+A GM Y+ FIHRDL + N ++ D ++ +ADFG+++ +
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYS 165
Query: 299 GTY-----------RWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF---QNMTAV 343
G Y +W+A E + R YT K DV++FG+ +WE+ T G P+ +N
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225
Query: 344 QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
G R P DCL L ++M CW +P+ RP FT++ +LEN
Sbjct: 226 DYLR----HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 67/252 (26%), Positives = 128/252 (50%), Gaps = 20/252 (7%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR- 200
+G++G +Y+ + A+K ++ + E+ + E+ +LA++ H NI+
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-----NEIRILASVNHPNIISY 64
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVH 255
F+ + CIV EYA G + + +++R+ + +P + + + + RG+ +H
Sbjct: 65 KEAFLDGNK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT 315
+HRDLKS N+L+ A+ +KI D G++++ + T + GT +MAPE+ + RPY+
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT-QIGTPHYMAPEVWKGRPYS 179
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
K D++S G +L+E+ T PF+ + + V +G P IP L +
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 376 TNPEVRPPFTEI 387
P++RP +I
Sbjct: 239 VKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 86/279 (30%), Positives = 139/279 (49%), Gaps = 42/279 (15%)
Query: 144 AQGAFGKLYRGTYNGE----DVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ + + D AIK ++ +++ + F E+ +L L H
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------NRAVPLKLAVKQAL- 245
NI+ +GAC R + EYA G++ FL + + + L+ +Q L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTPET 298
DVARGM Y+ FIHRDL + N+L+ + KIADFG++R + +T G P
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 174
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
RWMA E + + YT DV+S+G++LWE+++ G P+ MT + + + +G R
Sbjct: 175 --VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLE 231
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV----RMLE 392
P +C + ++M +CW P RP F +I+ RMLE
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 25/266 (9%)
Query: 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G FG + +G Y + VA+KIL+ N+P ++ + +E ++ L +
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IVR IG C W +V E A+ G + +FL ++N+ V K + V+ GM Y+
Sbjct: 57 YIVRMIGICEAE-SWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAPEM 308
F+HRDL + N+L+ KI+DFG+++ + +T G P +W APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP----VKWYAPEC 169
Query: 309 IQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367
+ + ++ K DV+SFG+++WE + G P++ M + ++ G R P C P +
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMY 228
Query: 368 EIMTRCWDTNPEVRPPFTEIVRMLEN 393
++M CW + RP F + L N
Sbjct: 229 DLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 42/289 (14%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
R L +G FG + Y+ GE VA+K L+ A+ + + F++E+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHL-RDFEREIE 57
Query: 189 MLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+L +L+H NIV++ G C R +V EY GS+R +L + + R KL + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPET 298
+ +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ ++ +V+ G +P
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP-- 174
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT----GLLP---FQNMTA--VQAAFAV 349
W APE + ++ DV+SFG+VL+EL T P F M Q V
Sbjct: 175 --IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 350 ------VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ R P C + IM CW+ +P RP F+E+ +E
Sbjct: 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 79/263 (30%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G GAF Y R G +A+K + N + + + + ++E+ ++A L H +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R +GA + + + E+ GGSV L++ A + + + RG++Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPE-----TGTYRWMAPEMIQ 310
IHRD+K NLLI S + ++IADFG A R+ + G E GT +MAPE+++
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-AGEFQGQLLGTIAFMAPEVLR 181
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK----GVRPVIPNDCLPVL 366
Y + DV+S G V+ E+ T P+ N A++ K P IP P L
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 367 SEIMTRCWDTNPEVRPPFTEIVR 389
++ RC + PE RPP E+++
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 77/257 (29%), Positives = 134/257 (52%), Gaps = 26/257 (10%)
Query: 146 GAFGKLYRGTYN--GED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG +Y+G + GE VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHVC 72
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R +G C V ++T+ G + ++ ++ L + + +A+GM Y+
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEERRL 130
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARI------EVQTEG-MTPETGTYRWMAPEMIQHR 312
+HRDL + N+L+ + +KI DFG+A++ E EG P +WMA E I HR
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP----IKWMALESILHR 186
Query: 313 PYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
YT + DV+S+G+ +WEL+T G P+ + A + + +++ KG R P C + IM
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMV 245
Query: 372 RCWDTNPEVRPPFTEIV 388
+CW + + RP F E++
Sbjct: 246 KCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 93/301 (30%), Positives = 150/301 (49%), Gaps = 42/301 (13%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
++ + +G FG++ + + D AIK ++ + + + F E+
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 58
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--------- 237
+L L H NI+ +GAC R + EYA G++ FL R++R +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANS 116
Query: 238 ---KLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEV 289
L+ +Q L DVARGM Y+ FIHRDL + N+L+ + KIADFG++R EV
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 290 ---QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345
+T G P RWMA E + + YT DV+S+G++LWE+++ G P+ MT +
Sbjct: 177 YVKKTMGRLP----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231
Query: 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV----RMLENAETEIMTT 401
+ + +G R P +C + ++M +CW P RP F +I+ RMLE +T + TT
Sbjct: 232 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 291
Query: 402 V 402
+
Sbjct: 292 L 292
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 26/259 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
L QG+ G +Y+ + G+ A+K + + + +Q +E+ L + +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----EEFRKQLLRELKTLRSCE 57
Query: 195 HLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARG 250
+V+ GA ++ + IV EY GGS+ L ++ +P L +Q L G
Sbjct: 58 SPYVVKCYGAFYKEGEI-SIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILK---G 111
Query: 251 MAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEM 308
+ Y+H IHRD+K NLLI++ +KIADFG++++ T GT +M+PE
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER 171
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA----VVNKGVRPVIP-NDCL 363
IQ Y+ D++S G+ L E G PF Q +F + G P +P +
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLP--PGQPSFFELMQAICDGPPPSLPAEEFS 229
Query: 364 PVLSEIMTRCWDTNPEVRP 382
P + ++ C +P+ RP
Sbjct: 230 PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 32/276 (11%)
Query: 143 FAQGAFGKLY------RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G FGK+ G GE VA+K L +PE+ ++E+ +L L H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA----DLKKEIEILRNLYHE 66
Query: 197 NIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
NIV++ G C + I + E+ GS++++L R +N+ + LK +K A+ + +GM Y+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPE---TGTYRWMAPEMIQ 310
++HRDL + N+L+ ++ +KI DFG+ + IE E T + W APE +
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 311 HRPYTQKVDVYSFGIVLWELIT--------------GLLPFQNMTAVQAAFAVVNKGVRP 356
+ DV+SFG+ L+EL+T + P V V+ +G R
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P +C + ++M +CW+ P R F ++ E
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 80/254 (31%), Positives = 125/254 (49%), Gaps = 32/254 (12%)
Query: 146 GAFGKLY--RGTYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G +G +Y R GE VAIK+ LE ++ + QQE+ ML +H NIV +
Sbjct: 14 GTYGDVYKARDIATGELVAIKVIKLEPGDD--------FEIIQQEISMLKECRHPNIVAY 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLA--VKQALDVARGMAYVHGLG 258
G+ +R IV EY GGS+ Q + + + L++A ++ L +G+AY+H G
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPET---GTYRWMAPEMIQHR-- 312
IHRD+K N+L++ D +K+ADFGV A++ T + GT WMAPE+
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 313 -PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND---CLPVLSE 368
Y K D+++ GI EL P ++ ++A F + P D PV +
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 369 IMTRCWDTNPEVRP 382
+ +C +P+ RP
Sbjct: 239 FIKKCLTKDPKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 82/266 (30%), Positives = 141/266 (53%), Gaps = 21/266 (7%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQE 186
+L+K+ + GAFG +Y+G + +GE+ VAIK+L EN KA ++ E
Sbjct: 8 ELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKAN---KEILDE 59
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++A + + R +G C V +VT+ G + ++ ++R L + +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RW 303
+A+GM+Y+ + +HRDL + N+L+ + +KI DFG+AR +++ + G +W
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362
MA E I HR +T + DV+S+G+ +WEL+T G P+ + A + ++ KG R P C
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPIC 236
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEIV 388
+ IM +CW + E RP F E+V
Sbjct: 237 TIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 79/255 (30%), Positives = 130/255 (50%), Gaps = 25/255 (9%)
Query: 146 GAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FG + +G Y DVAIK+L+ N EK+ E + E+M L + IVR
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMH--QLDNPYIVRM 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C + +V E A GG + +FL+ +++ + + V+ V+ GM Y+ G F+H
Sbjct: 61 IGVCEAEALM-LVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 262 RDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAPEMIQHRP 313
RDL + N+L+ KI+DFG+++ + ++ G P +W APE I R
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP----LKWYAPECINFRK 174
Query: 314 YTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
++ + DV+S+GI +WE + G P++ M + + + +G R P +C P + +M
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKD 233
Query: 373 CWDTNPEVRPPFTEI 387
CW E RP F ++
Sbjct: 234 CWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 79/257 (30%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 142 AFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G+FGK+Y + + E IK E + K V E++ ++EV++LA +KH NI
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIK-----EIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL----DVARGMAYV 254
V F + ++ IV EY GG L +R NR + + Q L ++ G+ ++
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSI-KIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHR 312
H +HRD+KS N+ +S + + K+ DFG+AR + E GT +++PE+ Q+R
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
PY K D++S G VL+EL T PF+ Q + P+ PN L ++++
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD-LRSLISQ 236
Query: 373 CWDTNPEVRPPFTEIVR 389
+ +P RP T I++
Sbjct: 237 LFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-32
Identities = 88/277 (31%), Positives = 133/277 (48%), Gaps = 37/277 (13%)
Query: 143 FAQGAFGKLYRGT-YN---GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ YN +D VA+K L+ +N K F +E +L L+H
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK------DFHREAELLTNLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-------PLKLAVKQALDVA 248
+IV+F G C + +V EY K G + +FL AV P +L Q L +A
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 249 R----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------GMTPE 297
+ GM Y+ F+HRDL + N L+ + +KI DFG++R T+ M P
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP- 185
Query: 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRP 356
RWM PE I +R +T + DV+S G+VLWE+ T G P+ ++ + +G
Sbjct: 186 ---IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQGRVL 241
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P C + ++M CW P +R EI +L+N
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 78/255 (30%), Positives = 135/255 (52%), Gaps = 18/255 (7%)
Query: 143 FAQGAFGKLYRGTY--NGEDV----AIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
GAFG +Y+G + GE V AIKIL E KA V +F E +++A++ H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANV---EFMDEALIMASMDHP 69
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
++VR +G C + +VT+ G + ++ ++ + +L + + +A+GM Y+
Sbjct: 70 HLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEE 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RWMAPEMIQHRP 313
+HRDL + N+L+ + +KI DFG+AR +E + + G +WMA E I +R
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 314 YTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
+T + DV+S+G+ +WEL+T G P+ + + ++ KG R P C + +M +
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERLPQPPICTIDVYMVMVK 246
Query: 373 CWDTNPEVRPPFTEI 387
CW + + RP F E+
Sbjct: 247 CWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 87/289 (30%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
I R + + +GAFGK++ T + VA+K L+ P K FQ
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK------DFQ 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--------------TRR 230
+E +L L+H +IV+F G C +V EY K G + +FL R+
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ L + A +A GM Y+ F+HRDL + N L+ A+ +KI DFG++R
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 287 ---IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTA 342
V M P RWM PE I +R +T + DV+SFG++LWE+ T G P+ ++
Sbjct: 176 TDYYRVGGHTMLP----IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231
Query: 343 VQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
+ + +G P C + +IM CW P+ R EI ++L
Sbjct: 232 TE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 95/341 (27%), Positives = 146/341 (42%), Gaps = 85/341 (24%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFGK+ + + G VA+K+L+ E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR----MVWCIVTEYAKGG-------SVRQFLTR 229
E+ +L + HLN+V +GAC K MV + EY K G S R+ +
Sbjct: 59 ---TELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEYCKFGNLSNYLRSKRECFSP 112
Query: 230 RQNRAVPLKLAV-----KQALD-------------------------------------- 246
+N++ + KQ LD
Sbjct: 113 YRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172
Query: 247 ---------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ +
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVR 231
Query: 298 TGTYR----WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNK 352
G R WMAPE I + YT + DV+SFG++LWE+ + G P+ + + + +
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291
Query: 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
G R P P + IM CW NPE RP F+E+V +L +
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA +Y N E VAIK + + EK Q + ++EV ++ H N+V++
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V Y GGS+ + R + +V +G+ Y+H G IH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-----GTYRWMAPE-MIQHRPYT 315
RD+K+ N+L+ D S+KIADFGV+ T + GT WMAPE M Q Y
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 316 QKVDVYSFGIVLWELITGLLPFQN 339
K D++SFGI EL TG P+
Sbjct: 186 FKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 78/255 (30%), Positives = 120/255 (47%), Gaps = 33/255 (12%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L N + F +E+ +++ LK NI+R + C C++TEY +
Sbjct: 49 VAVKMLREDANKNAR-----NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVK---------QALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL+R + + K V A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFG 324
+ +IKIADFG++R +Q + P RWM+ E I +T DV++FG
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMSWESILLGKFTTASDVWAFG 219
Query: 325 IVLWELIT--GLLPFQNMTAVQAA------FAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376
+ LWE++T P+ ++ Q F + V P C L ++M CW
Sbjct: 220 VTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279
Query: 377 NPEVRPPFTEIVRML 391
N + RP F EI L
Sbjct: 280 NAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 22/273 (8%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ + + +G +G +Y V I I E PE + Q + +E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL----HEEIA 57
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQA 244
+ + LKH NIV+++G+ + + I E GGS+ L + ++ + KQ
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFG----VARIEVQTEGMTPETG 299
L+ G+ Y+H +HRD+K DN+L++ + KI+DFG +A I TE TG
Sbjct: 118 LE---GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TG 171
Query: 300 TYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAA-FAVVNKGVRP 356
T ++MAPE+I R Y D++S G + E+ TG PF + QAA F V + P
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP 231
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
IP + RC++ +P+ R ++++
Sbjct: 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 41/273 (15%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG+++ G E +V +K ++ ++ + QV QE +L L H NI
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQV--TLLLQESCLLYGLSHQNI 70
Query: 199 VRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTR------RQNRAVPLKLAVKQALDVA 248
+ + C V + Y G+++ FL + +A+ + V A+ +A
Sbjct: 71 LPILHVCIEDGEPPFV---LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP---------ETG 299
GM+Y+H G IH+D+ + N +I + +KI D ++R + P E
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR------DLFPMDYHCLGDNENR 181
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
+WMA E + ++ Y+ DV+SFG++LWEL+T G P+ + + A A + G R
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQ 240
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
P +C L +M CW +PE RP F+++V+ L
Sbjct: 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 78/273 (28%), Positives = 136/273 (49%), Gaps = 33/273 (12%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME-----QQFQQ 185
+LRKL + G FG +++G + E +IKI P + ++ Q FQ+
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI-------PVAIKTIQDRSGRQTFQE 55
Query: 186 ---EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H IVR +G C + +VT+ + GS+ + + ++ P +L +
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-LN 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMT 295
+ +A+GM Y+ +HR+L + N+L+ +D ++IADFGVA + +E T
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354
P +WMA E I YT + DV+S+G+ +WE+++ G P+ M ++ KG
Sbjct: 174 P----IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLLEKGE 228
Query: 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
R P C + +M +CW + VRP F E+
Sbjct: 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 56/267 (20%), Positives = 113/267 (42%), Gaps = 41/267 (15%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLK-HLN 197
+G+F + ++ AIKIL+ K Q+++++ + V + L L H
Sbjct: 11 EGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHG 256
I++ + V EYA G + Q++ + + + + L + Y+H
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL---ALEYLHS 120
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI------EVQTEGMTPET------------ 298
G IHRDLK +N+L+ D IKI DFG A++ +G
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 299 ---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR 355
GT +++PE++ +P + D+++ G ++++++TG PF+ ++
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240
Query: 356 PVIPNDCLPVLSEIMTRCWDTNPEVRP 382
P + P +++ + +P+ R
Sbjct: 241 --FPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 44/261 (16%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L + + F +E+ +++ LK+ NI+R +G C C++TEY +
Sbjct: 47 VAVKMLR-----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 221 GSVRQFLTRRQNRA----------VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
G + QFL++R+ + V + + A+ +A GM Y+ L F+HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 271 ISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSF 323
+ +IKIADFG++R +Q + P RWMA E I +T DV++F
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMAWESILLGKFTTASDVWAF 217
Query: 324 GIVLWELITGLLPFQNMTAVQAAFAVVNKG-------------VRPVIPNDCLPVLSEIM 370
G+ LWE+ T L Q + + + N G P+ P+ PV ++M
Sbjct: 218 GVTLWEMFT-LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPS---PVF-KLM 272
Query: 371 TRCWDTNPEVRPPFTEIVRML 391
RCW + + RP F +I L
Sbjct: 273 MRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-30
Identities = 75/255 (29%), Positives = 122/255 (47%), Gaps = 25/255 (9%)
Query: 146 GAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+L RG VAI L ++ ++ + F E + L H NIVR
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-----RGFLAEALTLGQFDHSNIVR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHG 256
G + IVTEY G++ FL + + +L Q + +A GM Y+
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSE 125
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+G++H+ L + +L+++D KI+ F + E M+ ++ W APE IQ+
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQYHH 184
Query: 314 YTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
++ DV+SFGIV+WE+++ G P+ +M+ Q V G R P +C +L ++M
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLD 243
Query: 373 CWDTNPEVRPPFTEI 387
CW RP F++I
Sbjct: 244 CWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 71/251 (28%), Positives = 114/251 (45%), Gaps = 18/251 (7%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FGK+Y GE +A+K + +N+P+ ++ E+ +L LKH N+V++
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK----TIKEIADEMKVLELLKHPNLVKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G R I EY GG++ + L R + + L + G+AY+H G +H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-----TGTYRWMAPEMIQHRPYTQ 316
RD+K N+ + + IK+ DFG A E GT +MAPE+I
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 317 K---VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMT 371
D++S G V+ E+ TG P+ + V G +P IP P + +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242
Query: 372 RCWDTNPEVRP 382
RC +++P+ RP
Sbjct: 243 RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 35/283 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG----TYNGED---VAIKILERPENNPEKAQV-MEQQF 183
I+L + + FGK+Y+G T GE VAIK L+ +KA+ + ++F
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK------DKAEGPLREEF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA----VPLKL 239
+ E MM + L+H NIV +G K ++ Y + +FL R +
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 240 AVKQALD----------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289
VK L+ +A GM ++ +H+DL + N+L+ ++KI+D G+ R EV
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EV 174
Query: 290 QTEGMTPETGT----YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQ 344
G RWM+PE I + ++ D++S+G+VLWE+ + GL P+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
Query: 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
+ N+ V P P+DC + +M CW+ P RP F +I
Sbjct: 235 VIEMIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+FGK+ R G+ A+K+L+ K ++ + E +L+ + H I
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 199 VRFIGACRKRMVWCI--------VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ + + V EYA GG + L + + A A ++
Sbjct: 56 VK--------LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA 105
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEM 308
+ Y+H LG I+RDLK +N+L+ AD IK+ DFG+A+ EG T GT ++APE+
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAPEV 164
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
+ + Y + VD +S G++L+E++TG PF
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 60/258 (23%), Positives = 122/258 (47%), Gaps = 20/258 (7%)
Query: 143 FAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
++GA+G+++ + G+ AIK++++ + K QV Q E +L+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKK-ADMIRKNQV--DQVLTERDILSQAQSPYVVK 57
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + +V EY GG + L ++ +A ++ + Y+H G I
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE---------TGTYRWMAPEMIQH 311
HRDLK DN+LI ++ +K+ DFG++++ + + GT ++APE+I
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV--RPVIPNDCLPVLSEI 369
+ +++ VD +S G +L+E + G+ PF + + F + G P ++
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPEDVEV-SDEAIDL 233
Query: 370 MTRCWDTNPEVRPPFTEI 387
+++ +PE R I
Sbjct: 234 ISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 69/260 (26%), Positives = 124/260 (47%), Gaps = 21/260 (8%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG + R +G+ + K ++ EK QQ EV +L LKH NIVR+
Sbjct: 10 KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPNIVRY 64
Query: 202 IGAC--RKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R IV EY +GG + Q + +++ + + + + + + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 258 G-----FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQ 310
+HRDLK N+ + A+ ++K+ DFG+A+I + + +T GT +M+PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370
H Y +K D++S G +++EL PF +Q A + R IP L+E++
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEVI 242
Query: 371 TRCWDTNPEVRPPFTEIVRM 390
+ +P+ RP E++++
Sbjct: 243 KSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 76/281 (27%), Positives = 136/281 (48%), Gaps = 34/281 (12%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME----QQFQQEV 187
+G +G FG + ED VA+K+L KA + ++F +E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML--------KADIFSSSDIEEFLREA 52
Query: 188 MMLATLKHLNIVRFIG-ACRKRM-----VWCIVTEYAKGGSVRQFL--TR--RQNRAVPL 237
+ H N+++ IG + R R + ++ + K G + FL +R + +PL
Sbjct: 53 ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEG 293
+ V+ +D+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++ + +G
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNK 352
+ +W+A E + YT DV++FG+ +WE++T G P+ + + + + K
Sbjct: 173 CASKLPV-KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLIK 230
Query: 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
G R P DCL + E+M +CW P+ RP F + LE
Sbjct: 231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 77/251 (30%), Positives = 125/251 (49%), Gaps = 16/251 (6%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++Y+G N E VAIKI++ E+A+ + QQE+ +L+ I R+
Sbjct: 13 GKGSFGEVYKGIDNRTKEVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGF 259
G+ K I+ EY GGS L + PL+ + ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAPEMIQHRPYTQKV 318
IHRD+K+ N+L+S +K+ADFGVA T+ GT WMAPE+I+ Y K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 319 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNP 378
D++S GI EL G P ++ ++ F ++ K P + E + C + +P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 379 EVRPPFTEIVR 389
RP E+++
Sbjct: 242 RFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 78/252 (30%), Positives = 128/252 (50%), Gaps = 18/252 (7%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQQVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQAL-DVARGMAYVHGLGF 259
G+ K I+ EY GGS L RA P + + L ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQK 317
IHRD+K+ N+L+S +K+ADFGVA T+ + T GT WMAPE+IQ Y K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 318 VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377
D++S GI EL G P +M ++ F ++ K P + + E + C + +
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPPTLTGEFSKPFKEFIDACLNKD 240
Query: 378 PEVRPPFTEIVR 389
P RP E+++
Sbjct: 241 PSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 17/230 (7%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAK 219
+A+K + N + Q++ +E+ +L IV F GA + I EY
Sbjct: 29 MAVKTIRLEINEAIQKQIL-----RELDILHKCNSPYIVGFYGAFYNNGDIS-ICMEYMD 82
Query: 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278
GGS+ + L Q R +P ++ K A+ V +G+ Y+H IHRD+K N+L+++ IK
Sbjct: 83 GGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141
Query: 279 IADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ DFGV+ V + T GT +MAPE IQ Y+ K D++S G+ L EL TG P+
Sbjct: 142 LCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
Query: 339 N-----MTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMTRCWDTNPEVRP 382
+ +VN P +P+ P + + C +P RP
Sbjct: 201 PENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 83/339 (24%), Positives = 136/339 (40%), Gaps = 80/339 (23%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G GAFGK+ + G VA+K+L+ E +M
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAK-------------------- 219
E+ +L + HLN+V +GAC + ++ E+ K
Sbjct: 59 ---SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 220 -----------------------GGSVR----QFLTRRQNRAVPLKLA------------ 240
G +F P +
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 241 -VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ + VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 300 TYR----WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354
+ R WMAPE I + YT + DV+SFG++LWE+ + G P+ + + + G
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294
Query: 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
R P + P + IM CW +P+ RP F+ +V +L +
Sbjct: 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 75/263 (28%), Positives = 124/263 (47%), Gaps = 36/263 (13%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ + + A KI++ E E F E+ +L+ KH NIV
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELE-------DFMVEIDILSECKHPNIVGLY 68
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQF-------LTRRQNRAVPLKLAVKQALDVARGMAYV 254
A + +W I+ E+ GG++ LT Q R V +Q L+ + ++
Sbjct: 69 EAYFYENKLW-ILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLE---ALNFL 119
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMI---- 309
H IHRDLK+ N+L++ D +K+ADFGV A+ + + GT WMAPE++
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 310 -QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVL 366
+ PY K D++S GI L EL P + ++ ++ K P + P+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKWSSSF 238
Query: 367 SEIMTRCWDTNPEVRPPFTEIVR 389
++ + C +P+ RP E+++
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 74/258 (28%), Positives = 125/258 (48%), Gaps = 12/258 (4%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G QGAFG++Y G ++A K ++ +PE ++ + + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQHER 65
Query: 198 IVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G R R I EY GGSV+ L + A+ + K + GM+Y+H
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAPEMIQH 311
+HRD+K N+L + ++K+ DFG ++ I + G+ TGT WM+PE+I
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
Y +K DV+S G + E++T P+ A+ A F + + P +P+ + +
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL- 242
Query: 372 RCWDTNPEVRPPFTEIVR 389
C RP E++R
Sbjct: 243 GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 58/249 (23%), Positives = 113/249 (45%), Gaps = 14/249 (5%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----FIGACR 206
+Y+G +N ++V I+ ++ +V+ + E+ L + NI++ I
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLK 265
++ EY G +R+ L + + + K + A+D +G+ ++ +++L
Sbjct: 93 DLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH--RPYTQKVDVYSF 323
S + L++ + +KI G+ +I Y + +M+ YT K D+YS
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSL 208
Query: 324 GIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPP 383
G+VLWE+ TG +PF+N+T + ++NK +P DC + I+ C + RP
Sbjct: 209 GVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
Query: 384 FTEIVRMLE 392
EI+ L
Sbjct: 269 IKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 47/275 (17%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ + G+ VAIKI++ E+ E++ ++E +L H NI
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIED-------EEEEIKEEYNILRKYSNHPNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGM 251
F GA K+ +W +V E GGSV + R++ + + + + RG+
Sbjct: 68 FYGAFIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMI 309
AY+H IHRD+K N+L++ + +K+ DFGV+ ++ + T GT WMAPE+I
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAPEVI 185
Query: 310 ----QHRP-YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
Q Y + DV+S GI EL G P +M ++A F IP + P
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---------KIPRNPPP 236
Query: 365 VLS----------EIMTRCWDTNPEVRPPFTEIVR 389
L + ++ C N E RP E++
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 72/259 (27%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G QGAFG++Y G ++A+K ++ +PE ++ + + E+ +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV-NALECEIQLLKNLLHE 64
Query: 197 NIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R M I E+ GGS++ L + A+ + K + G++Y+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAPEMIQ 310
H +HRD+K N+L + ++K+ DFG ++ I + GM TGT WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370
Y +K D++S G + E++T P+ A+ A F + + PV+P + +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 371 TRCWDTNPEVRPPFTEIVR 389
R + ++RP E++R
Sbjct: 243 KRIF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 53/151 (35%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
VA GM ++ +HRDL + N+LI K +KI DFG+AR ++ + T+ +W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362
MAPE I + YT DV+SFGI+LWE+ T G P+ + + + + +G R P
Sbjct: 308 MAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHA 367
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ EIM +CW+ E+RP F+++V ++ +
Sbjct: 368 SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 65/252 (25%), Positives = 122/252 (48%), Gaps = 12/252 (4%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPE-NNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG+ LYR T + V K + + E+ + E+++L+ L+H NI+ +
Sbjct: 10 KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLLQHPNIIAY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
I EYA GG++ + R++ + ++ + + ++Y+H G +H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVD 319
RD+K+ N+ ++ IK+ DFG+++I + +E ET GT +M+PE+ Q Y K D
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379
+++ G VL+EL+T F + +V +G + + L ++ +PE
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLNLVVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPE 242
Query: 380 VRPPFTEIVRML 391
RP E++
Sbjct: 243 KRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G ++ G++VAIK + + P+K ++ E++++ LK+ NIV F
Sbjct: 28 GQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELII-----NEILVMKELKNPNIVNF 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDV 320
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAPE++ + Y KVD+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI-PNDCLPVLSEIMTRCWDTNPE 379
+S GI+ E++ G P+ N ++A + + G + P P+ + + RC + + E
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 380 VRPPFTEIVR 389
R E+++
Sbjct: 259 KRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 23/269 (8%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAIK + + P+K ++ E++++ KH NIV ++
Sbjct: 29 QGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKHPNIVNYL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + ++ L + + ++H IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIHR 139
Query: 263 DLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
D+KSDN+L+ D S+K+ DFG A+I + + GT WMAPE++ + Y KVD++
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWDTNPE 379
S GI+ E++ G P+ N ++A + + G P + N + + + RC + + E
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVE 258
Query: 380 VRP--------PFTEIVRMLENAETEIMT 400
R PF +I + L + I
Sbjct: 259 KRGSAKELLQHPFLKIAKPLSSLTPLIAA 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 15/258 (5%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQKVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G+ K I+ EY GGS L + +++ L +G+ Y+H IH
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKKIH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAPEMIQHRPYTQKVDV 320
RD+K+ N+L+S +K+ADFGVA T+ GT WMAPE+I+ Y K D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEV 380
+S GI EL G P + ++ F ++ K P + + L E + C + P
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLF-LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 243
Query: 381 RPPFTEIVR---MLENAE 395
RP E+++ ++ A+
Sbjct: 244 RPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 2e-27
Identities = 64/204 (31%), Positives = 111/204 (54%), Gaps = 27/204 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
G+FG+ L R +G+ A+KIL KA++++ + + V+ +L +++H +
Sbjct: 11 TGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V G+ + +V EY GG + L R++ P +A A V + Y+H
Sbjct: 64 VNLYGSFQDDSNLY--LVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAPEMIQHRP 313
L ++RDLK +NLL+ +D IKI DFG A R++ +T + TPE ++APE+I +
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YLAPEIILSKG 174
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y + VD ++ GI+++E++ G PF
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 54/151 (35%), Positives = 88/151 (58%), Gaps = 6/151 (3%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR---- 302
VA+GM+++ IHRDL + N+L++ + KI DFG+AR +++ + G R
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARLPVK 281
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
WMAPE I + YT + DV+S+GI+LWE+ + G P+ M + ++ +G R + P
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ +IM CWD +P RP F +IV+++E
Sbjct: 342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 67/249 (26%), Positives = 127/249 (51%), Gaps = 10/249 (4%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVME-QQFQQEVMMLATLKHLNIVRF 201
+G+FGK L + +G+ IK E N K E ++ ++EV +L+ +KH NIV++
Sbjct: 10 EGSFGKAILVKSKEDGKQYVIK-----EINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + IV +Y +GG + + + ++ P + + + + +VH +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDV 320
RD+KS N+ ++ D +IK+ DFG+AR+ T E GT +++PE+ ++RPY K D+
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEV 380
++ G VL+E+ T F+ ++ +G P + + L ++++ + NP
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 381 RPPFTEIVR 389
RP I+
Sbjct: 244 RPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VAIK ++ + + + +E+ +L L H NI++ +
Sbjct: 9 EGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELNHPNIIKLL 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R + +V E+ + + + + + R +P L + +G+A+ H G +HR
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWM-APE-MIQHRPYTQKVD 319
DLK +NLLI+ + +K+ADFG+AR T T RW APE ++ + Y+ VD
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVD 181
Query: 320 VYSFGIVLWELITG--LLP 336
++S G + EL++ L P
Sbjct: 182 IWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 70/250 (28%), Positives = 125/250 (50%), Gaps = 13/250 (5%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAI+ + + P+K ++ E++++ K+ NIV +
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 82
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIH 139
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDV 320
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAPE++ + Y KVD+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI-PNDCLPVLSEIMTRCWDTNPE 379
+S GI+ E+I G P+ N ++A + + G + P + + + RC D + E
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 380 VRPPFTEIVR 389
R E+++
Sbjct: 260 KRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 146 GAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIVRFIG 203
G FGK+ G + G A +++ + A EQ F QEV L H N+++ +G
Sbjct: 6 GWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGLG 258
C + + + +V E+ G ++ +L R NR + + A +VA G+ ++H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQH 311
FIH DL N ++AD S+KI D+G+A + P RW+APE+++
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP----LRWLAPELVEI 176
Query: 312 R-------PYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA-AFAVVNKGVRPVIPNDC 362
R T+K +++S G+ +WEL T P+ +++ Q V + ++ P
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236
Query: 363 LPVLS---EIMTRCWDTNPEVRPPFTEIVRML 391
L E+M CW +PE RP E+ +L
Sbjct: 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 80/287 (27%), Positives = 132/287 (45%), Gaps = 58/287 (20%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFI 202
G FG +Y GE VAIK +++ + E+ + +EV L L H NIV+
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-----REVKSLRKLNEHPNIVKLK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARGMAYVHGLGF 259
R+ V EY +G ++ Q + R+ + ++ + Q + +G+A++H GF
Sbjct: 65 EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQ---ILQGLAHIHKHGF 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWM-APEMIQHRP-Y 314
HRDLK +NLL+S + +KIADFG+AR + P T Y RW APE++ Y
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT-DYVSTRWYRAPEILLRSTSY 176
Query: 315 TQKVDVYSFGIVLWELITG--LLP-------FQNMTAV---------QAAFAVVNK-GVR 355
+ VD+++ G ++ EL T L P + +V + + +K G R
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236
Query: 356 -P---------VIPNDCLPVLSEIMTRC--WDTNPEVRPPFTEIVRM 390
P +IPN P +++ WD P+ RP ++ ++
Sbjct: 237 FPQFAPTSLHQLIPN-ASPEAIDLIKDMLRWD--PKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 25/273 (9%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFGK+Y+ G A K++E K++ + + E+ +LAT H IV+ +G
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A I+ E+ GG+V + R +++ +Q L+ + Y+H + IH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIH 133
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMI-----QHRPYT 315
RDLK+ N+L++ D IK+ADFGV+ V+T + GT WMAPE++ + PY
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSEIMTRC 373
K D++S GI L E+ P + ++ + K P + P+ + +
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLSQPSKWSMEFRDFLKTA 252
Query: 374 WDTNPEVRPPFTEIVRMLENAETEIMTTVRKAR 406
D +PE RP ++LE+ +T+ R R
Sbjct: 253 LDKHPETRP---SAAQLLEHPFVSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 23/259 (8%)
Query: 142 AFAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G++G+ L R +G+ IK L N A E++ +QE +L+ LKH NI
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-----NLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 199 VRFIGACRKRMVW-------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
V + R W IV + +GG + L ++ + +P V+ + +A +
Sbjct: 62 VAY------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAPEMIQ 310
Y+H +HRDLK+ N+ ++ IK+ D G+AR+ E Q + + GT +M+PE+
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370
++PY K DV++ G ++E+ T F + ++ +G P +P D P L E++
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELI 234
Query: 371 TRCWDTNPEVRPPFTEIVR 389
PE RP I+R
Sbjct: 235 ATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 65/249 (26%), Positives = 122/249 (48%), Gaps = 12/249 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAFG ++ R + + V IK + + ++ Q E +L L H NI+ +
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EYA GG++ +++ +R N + + + + + +VH +HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 263 DLKSDNLLISADKSI-KIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
DLK+ N+L+ K + KI DFG+++I GT +++PE+ + +PY QK D++
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185
Query: 322 SFGIVLWELITGLLPFQ--NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379
+ G VL+EL + F+ N+ A+ + G I + P L +++ + +P
Sbjct: 186 ALGCVLYELASLKRAFEAANLPALVLK---IMSGTFAPISDRYSPDLRQLILSMLNLDPS 242
Query: 380 VRPPFTEIV 388
RP ++I+
Sbjct: 243 KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 72/244 (29%), Positives = 123/244 (50%), Gaps = 31/244 (12%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV----WCI 213
G VA+K + + K Q E F EV+++ +H NIV + +V W +
Sbjct: 44 GRQVAVKKM-----DLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSS---YLVGDELW-V 93
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
V E+ +GG++ +T R ++A V A V + ++++H G IHRD+KSD++L++
Sbjct: 94 VMEFLEGGALTDIVT--HTRMNEEQIATVCLA--VLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 273 ADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELI 331
+D +K++DFG A++ + GT WMAPE+I PY +VD++S GI++ E++
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
Query: 332 TGLLPFQNMTAVQAAFAVVNKGVRPVIP------NDCLPVLSEIMTRCWDTNPEVRPPFT 385
G P+ N +QA K +R +P + P L + R +P R
Sbjct: 210 DGEPPYFNEPPLQAM-----KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAA 264
Query: 386 EIVR 389
E++
Sbjct: 265 ELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 81/269 (30%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALD 246
L+H N + + G C R+ W +V EY G S L ++ + V + AL
Sbjct: 70 QQLRHPNTIEYKG-CYLREHTAW-LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRW 303
G+AY+H IHRD+K+ N+L++ ++K+ADFG A + ++P GT W
Sbjct: 127 ---GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYW 177
Query: 304 MAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360
MAPE+I Y KVDV+S GI EL P NM A+ A + + + N
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN 237
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
D + C P+ RP E+++
Sbjct: 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 8e-25
Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 13/250 (5%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAIK + + P+K ++ E++++ K+ NIV +
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDV 320
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAPE++ + Y KVD+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI-PNDCLPVLSEIMTRCWDTNPE 379
+S GI+ E++ G P+ N ++A + + G + P V + + RC + + +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 380 VRPPFTEIVR 389
R E+++
Sbjct: 259 RRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 4/177 (2%)
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280
V+ L+ + + + VARGM ++ +HRDL + N+L++ K +KI
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 281 DFGVARIEVQTEGMTPETGTY---RWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLP 336
DFG+AR + + T+ +WMAPE I YT DV+S+GI+LWE+ + G P
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339
Query: 337 FQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ M + + G R P+ + +IM +CW++ PE RP F + ++E+
Sbjct: 340 YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 64/250 (25%), Positives = 122/250 (48%), Gaps = 10/250 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ +G VA+K ++ E KA+ Q +E+ +L L H N+++++
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVIKYL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + ++Q R +P + K + + + ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVD 319
HRD+K N+ I+A +K+ D G+ R +T GT +M+PE I Y K D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 320 VYSFGIVLWELITGLLPF-QNMTAVQAAFAVVNKGVRPVIPNDCLPV-LSEIMTRCWDTN 377
++S G +L+E+ PF + + + + K P +P D L ++++RC + +
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPD 248
Query: 378 PEVRPPFTEI 387
PE RP + +
Sbjct: 249 PEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 66/260 (25%), Positives = 130/260 (50%), Gaps = 14/260 (5%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G +GAFG++Y G ++A+K + ++ E ++ + + E+ +L L+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKNLRHD 64
Query: 197 NIVRFIGACR--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R + I EY GGS++ L + A+ + + + +G++Y+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-----EGMTPETGTYRWMAPEMI 309
H +HRD+K N+L + ++K+ DFG ++ +QT G+ TGT WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 310 QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369
Y +K DV+S + E++T P+ A+ A F + + +P++P+ +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241
Query: 370 MTRCWDTNPEVRPPFTEIVR 389
+ + + + RP ++R
Sbjct: 242 LKQIF-VEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 55/155 (35%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G R
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL 243
Query: 303 ---WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
WMAPE I R YT + DV+SFG++LWE+ + G P+ + + + +G R
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ P + + M CW P RP F+E+V L N
Sbjct: 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 30/203 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
+G +G +Y+ GE VA+K + R +N E+ E+ +L LKH NI
Sbjct: 9 EGTYGVVYKARDKKTGEIVALKKI-RLDNE-------EEGIPSTALREISLLKELKHPNI 60
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V+ + +V EY ++++L +R P +K + Q L RG+AY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL---RGLAYCHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAPEMI-Q 310
+HRDLK N+LI+ D +K+ADFG+AR I ++T T E T YR APE++
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR--APEILLG 172
Query: 311 HRPYTQKVDVYSFGIVLWELITG 333
+ Y+ VD++S G + E+ITG
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 41/299 (13%)
Query: 101 VTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGK--LYRGTYNG 158
VTH AL + ++D P LENY +G+ G + R ++G
Sbjct: 1 VTHEQFKAAL-RMVVDQGDPRSLLENY-------------IKIGEGSTGIVCIAREKHSG 46
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKRMVWCIVTEY 217
VA+K+++ K Q E F EV+++ +H N+V + +W ++ E+
Sbjct: 47 RQVAVKMMDL-----RKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELW-VLMEF 99
Query: 218 AKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ ++ Q R ++A V ++ V + + Y+H G IHRD+KSD++L++ D
Sbjct: 100 LQGGALTDIVS--QTRLNEEQIATVCES--VLQALCYLHSQGVIHRDIKSDSILLTLDGR 155
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335
+K++DFG A+I GT WMAPE+I PY +VD++S GI++ E++ G
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 336 PFQNMTAVQAAFAVVNKGVRPVIP------NDCLPVLSEIMTRCWDTNPEVRPPFTEIV 388
P+ + + VQA K +R P + PVL + + R P+ R E++
Sbjct: 216 PYFSDSPVQAM-----KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 8e-24
Identities = 65/248 (26%), Positives = 113/248 (45%), Gaps = 23/248 (9%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
++GAFG +Y + G+ AIK+L + + K QV + ++ +MM+ + +
Sbjct: 5 SKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESP-YVAKL 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + + +V EY GG + + +P A + +V G+ +H G IH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAPEMIQHRPYTQKVD 319
RD+K +NLLI +K+ DFG++R G+ + GT ++APE I + D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PND----CLPVLSEIMTRC 373
+S G V++E + G PF T A F + + I P + C P +++ R
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAET-PDAVFDNI---LSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 374 WDTNPEVR 381
+P R
Sbjct: 232 LCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 72/256 (28%), Positives = 130/256 (50%), Gaps = 20/256 (7%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKIL-ERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FG +Y + + +K+L E P E NP + Q QE +L+ L H IV
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIV 65
Query: 200 RFIGACRKRMVWCIVTEYAKGG----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+F + +R +CI+TEY +G + + + + + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAPEMIQHRPY 314
+HRDLK+ N+ + + +KI DFGV+R+ + + + T TGT +M+PE ++H+ Y
Sbjct: 124 QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP-VLSEIMTRC 373
K D++S G +L+E+ F+ + +V +G P +P + L+ IM
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLP-ETYSRQLNSIMQSM 240
Query: 374 WDTNPEVRPPFTEIVR 389
+ +P +RP EI+R
Sbjct: 241 LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 58/185 (31%), Positives = 96/185 (51%), Gaps = 10/185 (5%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIV 214
G A+K + + NP+ +++Q +E+ + + K IV++ GA I
Sbjct: 25 TGMIFALKTITT-DPNPD----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79
Query: 215 TEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
EY +GGS+ +++ + K+ K A V +G++Y+H IHRD+K N+L++
Sbjct: 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT 332
+K+ DFGV+ V + T TGT +MAPE IQ +PY+ DV+S G+ L E+
Sbjct: 140 RKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198
Query: 333 GLLPF 337
PF
Sbjct: 199 NRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/154 (32%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRD+ + N+L++ + KI DFG+AR ++ + G R
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARL 276
Query: 303 ---WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
WMAPE I YT + DV+S+GI+LWE+ + G P+ + + +V +G +
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR 336
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P+ P + IM CW+ P RP F++I ++++
Sbjct: 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R GE VAIK E ++ K + +EV +L L+H NIV
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLRQLRHENIVNL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
A R++ +V EY ++ + L P ++ + Q L + +AY H
Sbjct: 66 KEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLL---QAIAYCHSHNI 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWM-APE-MIQHRPY 314
IHRD+K +N+L+S +K+ DFG AR ++ +P T Y RW APE ++ Y
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLT-DYVATRWYRAPELLVGDTNY 179
Query: 315 TQKVDVYSFGIVLWELITG 333
+ VDV++ G ++ EL+ G
Sbjct: 180 GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ +GA G +++ GE VA+K + + Q +E+ L +H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHP 59
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+V+ + + +V EY + L Q ++ L +G
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL--------KG 111
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAPEM 308
+AY+H G +HRDLK NLLISAD +KIADFG+AR+ + E + + T + APE+
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 309 I-QHRPYTQKVDVYSFGIVLWELITG 333
+ R Y VD+++ G + EL+ G
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
GAFGK+Y+ ++ +L + K++ + + E+ +LA+ H NIV+ + A
Sbjct: 16 GAFGKVYKA----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
I+ E+ GG+V + R +++ KQ L+ + Y+H IHRD
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRD 128
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMI-----QHRPYTQK 317
LK+ N+L + D IK+ADFGV+ +T + GT WMAPE++ + RPY K
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188
Query: 318 VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSEIMTRCWD 375
DV+S GI L E+ P + ++ + K P + P+ + + +C +
Sbjct: 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSSEFKDFLKKCLE 247
Query: 376 TNPEVRPPFTEIVR 389
N + R T++++
Sbjct: 248 KNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 75/250 (30%), Positives = 127/250 (50%), Gaps = 28/250 (11%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YN 157
+V+H AL Q ++ P E L+++ + +G +G+ G + T +
Sbjct: 1 RVSHEQFRAAL-QLVVSPGDPREYLDSF---------IKIG----EGSTGIVCIATEKHT 46
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G+ VA+K ++ K Q E F EV+++ H N+V + +V E+
Sbjct: 47 GKQVAVKKMDL-----RKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100
Query: 218 AKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ +T R N + L V R ++Y+H G IHRD+KSD++L+++D
Sbjct: 101 LEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335
IK++DFG A++ + GT WMAPE+I PY +VD++S GI++ E+I G
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 336 PFQNMTAVQA 345
P+ N +QA
Sbjct: 217 PYFNEPPLQA 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 66/247 (26%), Positives = 121/247 (48%), Gaps = 9/247 (3%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+ L + + + A+K + P K+ + ++E ++LA +KH NIV F
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLP-----KSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EY GG + Q + ++ + P ++ + + G+ ++H +HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMT-PETGTYRWMAPEMIQHRPYTQKVDVY 321
D+KS N+ ++ + +K+ DFG AR+ GT ++ PE+ ++ PY K D++
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIW 184
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381
S G +L+EL T PFQ + V +P +P+ L ++ + + NP R
Sbjct: 185 SLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSR 243
Query: 382 PPFTEIV 388
P T I+
Sbjct: 244 PSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 71/266 (26%), Positives = 129/266 (48%), Gaps = 30/266 (11%)
Query: 145 QGAFGKLYRGT----YNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIV 199
G FGK+ G Y V +K L A V EQ +F +E +L+H N++
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELR------VSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ-ALDVARGMAYVHG 256
+ +G C + + +V E+ G ++ +L R+ P +++ A ++A G+ ++H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAPEMIQH-- 311
FIH DL N L++AD ++KI D+G++ + + + + RW+APE++
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 312 -----RPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA-AFAVVNKGVRPVIPNDCLP 364
T++ +V+S G+ +WEL G P+++++ Q + V + ++ P LP
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238
Query: 365 VLS---EIMTRCWDTNPEVRPPFTEI 387
+ E+M CW PE RP E+
Sbjct: 239 LSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 20/204 (9%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHL 196
QG+FGK++ G G+ A+K+L+ KA + + + M +LA + H
Sbjct: 6 QGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEVNHP 58
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAYVH 255
IV+ A + ++ ++ +GG + TR + + VK L ++A + ++H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHRPY 314
LG I+RDLK +N+L+ + IK+ DFG+++ + E GT +MAPE++ R +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 315 TQKVDVYSFGIVLWELITGLLPFQ 338
TQ D +SFG++++E++TG LPFQ
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G++Y+ GE VA+K + R EN E +E+ +L L+H NIVR
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKI-RMENEKEG---FPITAIREIKLLQKLRHPNIVRLK 64
Query: 203 GACRKRMVWCIVTEYAKGG----------SVRQFLTRRQNR--AVPLKLAVKQALDVARG 250
IVT KG + L + + +K +KQ L G
Sbjct: 65 ---------EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---EG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGT--YRWMAP 306
+ Y+H G +HRD+K N+LI+ D +K+ADFG+AR + + T T YR P
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--PP 170
Query: 307 EMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQ 338
E++ Y +VD++S G +L EL G FQ
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 56/174 (32%), Positives = 94/174 (54%), Gaps = 11/174 (6%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
V EY GG + F +R R A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 72 FFVMEYVNGGDL-MFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 272 SADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWE 329
++ IKIADFG+ + E G+T T GT ++APE++ ++PY VD ++ G++L+E
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 330 LITGLLPFQNMTAVQAAFAVVNKGVR-PV-IPNDCLPVLSEIMTRCWDTNPEVR 381
++ G PF+ + +++ VR P + + +L +T+ NPE R
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTK----NPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 73/255 (28%), Positives = 113/255 (44%), Gaps = 21/255 (8%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQ---QEVMMLATLKHLNI 198
G+FG +Y T + E VA+K + + +++Q +EV L LKH N
Sbjct: 30 GHGSFGAVYFATNSHTNEVVAVKKMSY------SGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQF-LTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G K +V EY G + + ++ + V + AL +G+AY+H
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI---QHRPY 314
IHRD+K+ N+L++ +K+ADFG A GT WMAPE+I Y
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQY 197
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
KVDV+S GI EL P NM A+ A + + + N+ + C
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 375 DTNPEVRPPFTEIVR 389
P+ RP E++R
Sbjct: 258 QKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFI 202
G +G++Y+G + G+ AIK+++ E+ E++ + E+ ML H NI +
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYY 79
Query: 203 GACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
GA K+ +W +V E+ GSV + + A+ ++ RG+A++H
Sbjct: 80 GAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMI--QHR 312
IHRD+K N+L++ + +K+ DFGV A+++ GT WMAPE+I
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 313 P---YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
P Y + D++S GI E+ G P +M ++A F +
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 19/239 (7%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
+G+ VA+K ++ K Q E F EV+++ +H N+V + +V E
Sbjct: 44 SGKLVAVKKMDL-----RKQQRRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVME 97
Query: 217 YAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+ +GG++ +T + + + LAV +AL V +H G IHRD+KSD++L++
Sbjct: 98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV------LHAQGVIHRDIKSDSILLTH 151
Query: 274 DKSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT 332
D +K++DFG A++ + GT WMAPE+I PY +VD++S GI++ E++
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 211
Query: 333 GLLPFQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
G P+ N ++ A ++ + P + N P L + R +P R E+++
Sbjct: 212 GEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 29/253 (11%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R + GE A+KI++ + QQE+ M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVAYFG 73
Query: 204 A--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGL 257
+ R+++ C+ EY GGS++ V L+ Q V R G+AY+H
Sbjct: 74 SYLSREKLWICM--EYCGGGSLQDIY------HVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMI---QHRP 313
G +HRD+K N+L++ + +K+ADFGV A+I GT WMAPE+ ++
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL---PVLSEIM 370
Y Q D+++ GI EL P ++ ++A F + +P D +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 371 TRCWDTNPEVRPP 383
NP+ RP
Sbjct: 246 KISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 134 LRKLNMGTAFAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
L MG G+FG++ ++GT GE AIK L++ E K QV Q QE +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK-QV--QHVAQEKSI 71
Query: 190 LATLKHLNIVRFI-GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
L L H IV + + V+ + E+ GG + F R+ P +A ++
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVY-FLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELV 128
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEM 308
Y+H I+RDLK +NLL+ +K+ DFG A+ +V + GT ++APE+
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KV-PDRTFTLCGTPEYLAPEV 186
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPF 337
IQ + + + VD ++ G++L+E I G PF
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 39/291 (13%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 29 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVKFL 79
Query: 191 ATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA- 248
+KH N + + G R+ W +V EY G + ++ PL Q +++A
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAW-LVMEYCLGSASDLLEVHKK----PL-----QEVEIAA 129
Query: 249 ------RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
+G+AY+H IHRD+K+ N+L++ +K+ADFG A I GT
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPY 186
Query: 303 WMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
WMAPE+I Y KVDV+S GI EL P NM A+ A + + +
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS 246
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML----ENAETEIMTTVRKAR 406
N+ + C P+ RP E+++ + E ET ++ +++ +
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTK 297
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 64/254 (25%), Positives = 122/254 (48%), Gaps = 10/254 (3%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + IV E A G + + + ++Q R +P K K + + + ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
+HRD+K N+ I+A +K+ D G+ R +T GT +M+PE I Y K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 319 DVYSFGIVLWELITGLLPFQ-NMTAVQAAFAVVNKGVRPVIPNDCLPV-LSEIMTRCWDT 376
D++S G +L+E+ PF + + + + + P +P+D L +++ C +
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 247
Query: 377 NPEVRPPFTEIVRM 390
+PE RP T + +
Sbjct: 248 DPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 69/212 (32%), Positives = 110/212 (51%), Gaps = 21/212 (9%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM----- 189
N +G+FGK+ G D AIKIL K V+ Q E M
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVVIQDDDVECTMVEKRV 53
Query: 190 LATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
LA + + +C + M V EY GG + + + P AV A ++A
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH--AVFYAAEIA 111
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ ++ IKIADFG+ + E +G+T +T GT ++AP
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
E+I ++PY + VD ++FG++L+E++ G PF+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 20/178 (11%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C V EYA GG + + AV A V G+ Y+H ++RDLK DNLL+
Sbjct: 78 CFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 272 SADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQHRPYTQKVDVYSFGI 325
+ +KIADFG+ + EGM GT ++APE++ YT+ VD + G+
Sbjct: 135 DTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGV 189
Query: 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVR-P-VIPNDCLPVLSEIMTRCWDTNPEVR 381
+++E++ G PF + ++VN VR P + + + ++ ++ R NPE R
Sbjct: 190 LIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR----NPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 65/254 (25%), Positives = 125/254 (49%), Gaps = 19/254 (7%)
Query: 144 AQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHL 196
+G+FGK+ + E+ A+K+L+ K +++++ ++ +M +L +KH
Sbjct: 4 GKGSFGKVLLARHKAEEKFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V + + V +Y GG + L R + P A A ++A + Y+H
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR--ARFYAAEIASALGYLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHRPYT 315
L ++RDLK +N+L+ + I + DFG+ + ++ G T GT ++APE++ +PY
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVRPVIPNDCLPVLSEIMTRC 373
+ VD + G VL+E++ GL PF + + ++NK ++P I N +L ++ +
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234
Query: 374 WDTNPEVRPPFTEI 387
+ F EI
Sbjct: 235 RTKRLGAKDDFMEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 65/266 (24%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
F + ++Y T V +K L+ ++ E + +F Q+ L+H NI++ +
Sbjct: 8 FGKVLLSEIYTDT-GVARVVVKELKANASSKE-----QNEFLQQGDPYRILQHPNILQCL 61
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFI 260
G C + + + +V EY + G ++ +L++ Q R L L + A ++A G+ ++H F+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAPEMIQHR----- 312
H DL N +++D ++K+ D+G+ + + + E RW+APE++
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181
Query: 313 --PYTQKVDVYSFGIVLWELI-TGLLPFQNMTAVQAAFAVV-NKGVRPVIPNDCLPVLS- 367
T+ +V++ G+ LWEL P+ +++ + V+ ++ V+ P LP
Sbjct: 182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241
Query: 368 --EIMTRCWDTNPEVRPPFTEIVRML 391
E++ CW +PE R E+ R+L
Sbjct: 242 WYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 138 NMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM-----L 190
N +G+FGK+ G D AIKIL K V+ Q E M L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVIIQDDDVECTMVEKRVL 54
Query: 191 ATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A + + +C + M V EY GG + + + P AV A ++A
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH--AVFYAAEIAI 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPE 307
G+ ++H G I+RDLK DN+++ A+ IKIADFG+ + E G T T GT ++APE
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPE 171
Query: 308 MIQHRPYTQKVDVYSFGIVLWELITGLLPF 337
+I ++PY + VD ++FG++L+E++ G PF
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G+FGK L + +G A+K+L+ K +++++ Q +M +L LKH
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVKVLQ-------KKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A +VA + Y+H L
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAPEMIQH 311
I+RDLK +N+L+ + + + DFG+ + EG+ PE GT ++APE+++
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPF 337
PY + VD + G VL+E++ GL PF
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R G A+KIL R E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ R+ C V EYA GG + L+R R + A ++ + Y+H +
Sbjct: 62 YAFQTHDRL--CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKV 318
+RD+K +NL++ D IKI DFG+ + E ++G T +T GT ++APE+++ Y + V
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 319 DVYSFGIVLWELITGLLPFQN 339
D + G+V++E++ G LPF N
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNIV 199
G FG++ ++ A+K ++ K ++E Q+ + +L H IV
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVK-------KRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ EY GG + L R A V Y+H G
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQK 317
I+RDLK +NLL+ ++ +K+ DFG A+ ++++ T T GT ++APE+I ++ Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKT-WTFCGTPEYVAPEIILNKGYDFS 172
Query: 318 VDVYSFGIVLWELITGLLPFQN 339
VD +S GI+L+EL+TG PF
Sbjct: 173 VDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 62/259 (23%), Positives = 123/259 (47%), Gaps = 15/259 (5%)
Query: 146 GAFGKLY--RGTYNGED-VAIKILERPENNP-------EKAQVMEQQFQQEVMMLATLKH 195
GAFG +Y R NG++ +A+K E +NP E+ + + + ++ L+H
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALK--EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAY 253
NIVR+ + IV + +G + + + + + + + + + Y
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 254 VHGLGFI-HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
+H I HRDL +N+++ D + I DFG+A+ + +T GT + PE++++
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE 188
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
PY +K DV++FG +L+++ T PF + + A +V P+ +++++T
Sbjct: 189 PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITS 248
Query: 373 CWDTNPEVRPPFTEIVRML 391
C + E RP ++ M+
Sbjct: 249 CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 61/240 (25%), Positives = 119/240 (49%), Gaps = 19/240 (7%)
Query: 141 TAFAQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATL 193
+G+FGK+ + + A+K+L+ K +++++ Q+ +M +L +
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ-------KKAILKKKEQKHIMAERNVLLKNV 53
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH +V + + V +Y GG + L R R+ P A A ++A + Y
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGY 111
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHR 312
+H L I+RDLK +N+L+ + + + DFG+ + ++ T GT ++APE+++ +
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVRPVIPNDCLPVLSEIM 370
PY + VD + G VL+E++ GL PF + + ++NK ++P I +L ++
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 73/219 (33%), Positives = 112/219 (51%), Gaps = 32/219 (14%)
Query: 132 IDLRKLNMGTAFAQGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
+DL+ + MG AFG + R G++VAIK + +P + P V+ ++ +E+ +
Sbjct: 13 VDLQPVGMG------AFGLVCSARDQLTGQNVAIKKIMKPFSTP----VLAKRTYRELKL 62
Query: 190 LATLKHLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ-- 243
L L+H NI+ FI VTE G + + LT R PL+ Q
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIY---FVTELL-GTDLHRLLTSR-----PLEKQFIQYF 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
+ RG+ YVH G +HRDLK N+LI+ + +KI DFG+ARI Q MT T +
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYY 171
Query: 304 MAPE-MIQHRPYTQKVDVYSFGIVLWELITG--LLPFQN 339
APE M+ + Y +VD++S G + E++ G L P ++
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 5/169 (2%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + + A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 74 VMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT 332
D IKIADFG+ + + EG GT ++APE+++ + Y + VD +SFG++L+E++
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191
Query: 333 GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381
G PF + +++N RP P + +++ ++ +P R
Sbjct: 192 GQSPFHGEDEDELFDSILND--RPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 82/293 (27%), Positives = 128/293 (43%), Gaps = 43/293 (14%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R N E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA-- 248
L+H N +++ G + +V EY G + ++ PL Q +++A
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PL-----QEVEIAAV 120
Query: 249 -----RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GT 300
+G+AY+H IHRD+K+ N+L+S +K+ DFG A I M P GT
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGT 174
Query: 301 YRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV 357
WMAPE+I Y KVDV+S GI EL P NM A+ A + + +
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV--RML--ENAETEIMTTVRKAR 406
+ C P+ RP ++ R + E T IM +++ +
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-20
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R GE AIK++ + E + A V QQE++M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVV-----QQEIIMMKDCKHSNIVAYFG 73
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGF 259
+ +R I E+ GGS++ V L+ Q V+R G+ Y+H G
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIY------HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMI---QHRPYT 315
+HRD+K N+L++ + +K+ADFGV A+I GT WMAPE+ + Y
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP 356
Q D+++ GI EL P ++ ++A F + +P
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 46/126 (36%), Positives = 79/126 (62%), Gaps = 5/126 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + P AV A +++ G+ ++H G I+RDLK DN+++ +
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELI 331
+ IKIADFG+ + E +G+T T GT ++APE+I ++PY + VD +++G++L+E++
Sbjct: 137 EGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
Query: 332 TGLLPF 337
G PF
Sbjct: 196 AGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 64/251 (25%), Positives = 126/251 (50%), Gaps = 13/251 (5%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FGK L + +G+ A+K+L++ N E+ +M ++ ++L +KH +V
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER----NVLLKNVKHPFLV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + V ++ GG + F ++ R+ P A A ++A + Y+H +
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
++RDLK +N+L+ + + + DFG+ + + Q++ T GT ++APE+I+ +PY V
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 319 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVRPVIPNDCLPVLSEIMTRCWDT 376
D + G VL+E++ GL PF + +++K +RP +L E++ +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 377 NPEVRPPFTEI 387
+ F EI
Sbjct: 238 RLGAKEDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 29/204 (14%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNI 198
+GA+G +Y+ G VA+K + P + + + +E+ +L L+ H NI
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLS----EEGIPLSTLREIALLKQLESFEHPNI 63
Query: 199 VRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA---- 248
VR + C R+ + +V E+ V Q L ++ L + D+
Sbjct: 64 VRLLDVCHGPRTDRELKLT-LVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
RG+ ++H +HRDLK N+L+++D +KIADFG+ARI +T T YR AP
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR--AP 175
Query: 307 EMIQHRPYTQKVDVYSFGIVLWEL 330
E++ Y VD++S G + EL
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + C+V EY +GG L + A+P+ +A + + Y+H
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQT------EG-MTPET---------GTY 301
G +HRDLK DNLLI++ IK+ DFG+++I + + EG + +T GT
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
++APE+I + Y + VD ++ GI+L+E + G +PF T + V++ + ++
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 362 CLPVLS-EIMTRCWDTNPEVR 381
LP + ++++R NP R
Sbjct: 241 ALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-20
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVR 200
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
+ GA K+ +W +V E+ GSV + + + + ++ RG+++
Sbjct: 68 YYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMI--Q 310
+H IHRD+K N+L++ + +K+ DFGV A+++ GT WMAPE+I
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 311 HRP---YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
P Y K D++S GI E+ G P +M ++A F +
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK L R G+ A+KIL++ E K +V + V+ L +++
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
R+ C V EYA GG + L+R ++RA + AL Y+H
Sbjct: 64 FQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHSCD 115
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQ 316
++RDLK +NL++ D IKI DFG+ + + ++G T +T GT ++APE+++ Y +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 317 KVDVYSFGIVLWELITGLLPFQN 339
VD + G+V++E++ G LPF N
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 28/264 (10%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ T +G A+KIL+ + ++++ + E +L +L H N+V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKILDPISD-------VDEEIEAEYNILQSLPNHPNVVK 83
Query: 201 FIGA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMA 252
F G +W +V E GGSV + + L A+ + G+
Sbjct: 84 FYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMIQ- 310
++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAPE+I
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 311 ----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLP 364
Y + DV+S GI EL G P +M V+ F + + P + P
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPPPTLLHPEKWCR 261
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIV 388
+ +++C + E RP T ++
Sbjct: 262 SFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + G VAIK + ++ A+ + +E+ +L L+H NI+
Sbjct: 10 SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK----RILREIKLLRHLRHENIIGLL 65
Query: 201 --FIGACRKRM--VWCIVTEYAKG--GSV---RQFLTRRQNRAVPLKLAVKQALDVARGM 251
+ V+ IVTE + V Q LT ++ + Q L RG+
Sbjct: 66 DILRPPSPEDFNDVY-IVTELMETDLHKVIKSPQPLTDDH-----IQYFLYQIL---RGL 116
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGT--YRWMA 305
Y+H IHRDLK N+L++++ +KI DFG+AR E + +T T YR A
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--A 174
Query: 306 PEMI--QHRPYTQKVDVYSFGIVLWELITG--LLP 336
PE++ R YT+ +D++S G + EL+T L P
Sbjct: 175 PELLLSSSR-YTKAIDIWSVGCIFAELLTRKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 139 MGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENNPEKAQVME--QQFQQEVMMLATLK 194
+G F L + VA+K L+ + E + QQE++ L+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLD--------SCSKEDLKLLQQEIITSRQLQ 57
Query: 195 HLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR 249
H NI+ FI ++ +V+ GS L +P +LA+ L DV
Sbjct: 58 HPNILPYVTSFI---VDSELY-VVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLN 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---------TPETGT 300
+ Y+H GFIHR +K+ ++L+S D + ++ + + + G
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYS-VSMIKHGKRQRVVHDFPKSSVKN 171
Query: 301 YRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344
W++PE++Q + Y +K D+YS GI EL G +PF++M A Q
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 50/276 (18%)
Query: 144 AQGAFGKLYR--GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR 200
+G +GK+++ NG A+KIL+ + ++++ + E +L L H N+V+
Sbjct: 27 GKGTYGKVFKVLNKKNGSKAAVKILDPIHD-------IDEEIEAEYNILKALSDHPNVVK 79
Query: 201 FIGACRKRMV------WCIVTEYAKGGSV----RQFLTRRQNRAVPL-KLAVKQALDVAR 249
F G K+ V W +V E GGSV + FL R + P+ + +AL
Sbjct: 80 FYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL---M 135
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEM 308
G+ ++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAPE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 309 IQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
I Y + DV+S GI EL G P ++ ++A F IP +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK---------IPRNPP 246
Query: 364 PVL----------SEIMTRCWDTNPEVRPPFTEIVR 389
P L ++ + +C + E RP +++++
Sbjct: 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G + +Y+G GE VA+K L+ E P A +E+ ++ LKH NIVR
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-------REISLMKELKHENIVR 62
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+V EY + T A+ + +G+A+ H +
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAPE-MIQHRPYTQ 316
HRDLK NLLI+ +K+ADFG+AR I V T + E T + AP+ ++ R Y+
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYST 180
Query: 317 KVDVYSFGIVLWELITGLLPF 337
+D++S G ++ E+ITG F
Sbjct: 181 SIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 63/246 (25%), Positives = 115/246 (46%), Gaps = 10/246 (4%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T + + VA+K ++ E KA+ Q +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR---QDCVKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + IV E A G + Q + ++Q R +P + K + + + ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
+HRD+K N+ I+A +K+ D G+ R +T GT +M+PE I Y K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 319 DVYSFGIVLWELITGLLPF--QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376
D++S G +L+E+ PF M + P+ L E+++ C
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
Query: 377 NPEVRP 382
+P+ RP
Sbjct: 248 DPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ +Q +E+ ++ + IV F GA C+ E+ GS L R + P+
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS----LDRIYKKGGPIP 101
Query: 239 LAV--KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295
+ + K A+ V G+ Y++ +HRD+K N+L+++ IK+ DFGV+ + + T
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161
Query: 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF-----------QNMTAVQ 344
GT +M+PE IQ YT K DV+S GI + EL G PF M +
Sbjct: 162 -FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 345 AAFAVVNKGVRPVIPNDCLP-VLSEIMTRCWDTNPEVRPPFTEIVRM 390
+V + P +P+ P L + + C +P RP ++ M
Sbjct: 221 LLQQIVQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 2/146 (1%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E M+L + H +++R + C+V + + +LT+R +R +P+ A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKR-SRPLPIDQALIIEK 164
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
+ G+ Y+H IHRD+K++N+ I+ + I D G A+ V GT A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 306 PEMIQHRPYTQKVDVYSFGIVLWELI 331
PE++ Y K D++S GIVL+E++
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 70/234 (29%), Positives = 101/234 (43%), Gaps = 51/234 (21%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIK-ILERPENN--PEKAQVMEQQFQQEVM 188
LR + +G FG++Y+ G VA+K IL E + P A +E+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-------REIK 59
Query: 189 MLATLKHLNIVRFI--------GACRKRMVWCIVTEYA--------KGGSVRQFLTRRQN 232
+L LKH N+V I + RKR +VT Y + SV+ LT Q
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQ- 116
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQ 290
+K + Q L+ G+ Y+H +HRD+K+ N+LI +KIADFG+AR
Sbjct: 117 ----IKCYMLQLLE---GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 291 TEGMTPETGT---Y------RWM-APEMIQH-RPYTQKVDVYSFGIVLWELITG 333
G Y RW PE++ R YT VD++ G V E+ T
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ- 243
E +L L H +V + + +V + GG +R L+++ V +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKF 104
Query: 244 -ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTY 301
++ + Y+H G IHRD+K DN+L+ + I DF +A V + +T T GT
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTSGTP 163
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
+MAPE++ + Y+ VD +S G+ +E + G P++
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
+++Q E+ +L I+ F GA R+ C TE+ GGS+ + R +P
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC--TEFMDGGSLDVY------RKIP 93
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + A+ V +G+ Y+ L +HRD+K N+L++ +K+ DFGV+ V + T
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT- 152
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-------AV 349
GT +MAPE I Y DV+S GI EL G P+ + Q + +
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212
Query: 350 VNKGVRPVIPNDCL-PVLSEIMTRCWDTNPEVRP 382
V++ PV+P +T+C P+ RP
Sbjct: 213 VDEDP-PVLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ R + A+K++ PE K EQ E +L + H I+R
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLK---QEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ ++ EY GG + +L R + + A ++ + Y+H ++RD
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSF 323
LK +N+L+ + IK+ DFG A+ +++ T GT ++APE+IQ + + + VD ++
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-KLRDRTWT-LCGTPEYLAPEVIQSKGHNKAVDWWAL 184
Query: 324 GIVLWELITGLLPF 337
GI+++E++ G PF
Sbjct: 185 GILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G ++ R G+ VAIK E++P V+++ +E+ ML LKH N+V I
Sbjct: 11 EGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLI 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R++ +V EY +V L + R VP L K + + + H IHR
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM-APEMI----QHRPYTQK 317
D+K +N+LI+ IK+ DFG ARI + RW APE++ Q+ P
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP---P 181
Query: 318 VDVYSFGIVLWELITG 333
VDV++ G V EL+TG
Sbjct: 182 VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG ++ T +G+ VA+K + N V ++ +E+ ML KH N++ +
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQN----LVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 204 ACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGL 257
+ + +VTE + + + + Q + +K+ + Q L RG+ Y+H
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSA 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAPEMIQ-HRPY 314
G +HRD+K NLL++++ +KI DFG+AR+E E MT E T + APE++ R Y
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY 182
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344
T VD++S G + EL+ + FQ + +Q
Sbjct: 183 TSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 5e-19
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R +G+ A+KIL++ E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ + R+ C V EY GG + L+R ++R + ALD Y+H
Sbjct: 62 YSFQTKDRL--CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPY 314
++RDLK +NL++ D IKI DFG+ + E T+ T +T GT ++APE+++ Y
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 315 TQKVDVYSFGIVLWELITGLLPFQN 339
+ VD + G+V++E++ G LPF N
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 10/210 (4%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R E VAIK + E N E +++ +E+ ML TLK NIV
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVEL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A R+R +V EY + ++ + L N P K+ + + + + H +H
Sbjct: 66 KEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKNDIVH 123
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWM-APEMIQHRPYTQKVD 319
RD+K +NLLIS + +K+ DFG AR + + E RW +PE++ PY + VD
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
++S G +L EL G F + + F +
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 64/244 (26%), Positives = 104/244 (42%), Gaps = 45/244 (18%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN 197
+GAFG+ L R G+ A+K+L K+ ++++ V +LA
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRAERDILADADSPW 62
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
IV+ + + +V EY GG + L R+ P + A ++ + VH L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFG-------------VARIEVQTEGMTPET------ 298
GFIHRD+K DN+LI AD IK+ADFG
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 299 -----------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF 347
GT ++APE+++ PY + D +S G++L+E++ G PF + T +
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240
Query: 348 AVVN 351
++N
Sbjct: 241 KIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G + +Y+ G VAIK ++ ++A+ + +E+ +L LKH NI+
Sbjct: 10 EGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQ-ALDVARGMAYVHGLGF 259
+ + +V E+ + + + +++++ L A +K L RG+ Y+H
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETGTYRWM-APEMI-QHRPYTQ 316
+HRDLK +NLLI++D +K+ADFG+AR MT + T RW APE++ R Y
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPELLFGARHYGV 182
Query: 317 KVDVYSFGIVLWELITG--LLPFQN 339
VD++S G + EL+ LP +
Sbjct: 183 GVDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 14/185 (7%)
Query: 158 GEDVAIKI-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
G+ VAIK LE ++ K M +E+ ML L+H N+V I R++ +V E
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +V L + N + K + RG+ + H IHRD+K +N+L+S
Sbjct: 81 FVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138
Query: 277 IKIADFGVAR-IEVQTEGMTPETGTYRWM-APEMIQHRP-YTQKVDVYSFGIVLWELITG 333
+K+ DFG AR + E T T RW APE++ Y + VD+++ G ++ E++TG
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYVAT-RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
Query: 334 --LLP 336
L P
Sbjct: 198 EPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVM----M 189
N G+FG++ TY ED VAIK E K+++++Q+ V +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKI 84
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
L + H V G+ + +V E+ GG FL R+N+ P + A +
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVL 142
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI 309
Y+ L ++RDLK +NLL+ D IK+ DFG A++ V T T GT ++APE++
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT-LCGTPEYIAPEIL 200
Query: 310 QHRPYTQKVDVYSFGIVLWELITGLLPF 337
+ + + D ++ GI ++E++ G PF
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 145 QGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ T G VAIK L RP + A+ + +E+ +L + H N++ +
Sbjct: 25 SGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK----RTYRELRLLKHMDHENVIGLL 80
Query: 203 GACRKRMVWC------------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ +VT G + + ++ ++ V Q L RG
Sbjct: 81 D------VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL---RG 130
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRW-MAPE- 307
+ Y+H G IHRDLK N+ ++ D +KI DFG+AR T+ MT T RW APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT-RWYRAPEI 186
Query: 308 MIQHRPYTQKVDVYSFGIVLWELITG 333
M+ Y Q VD++S G ++ EL+TG
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L + G A+KIL++ E K +V + V+ + L ++
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGF 259
+ R+ C V EYA GG + L+R R A ++ + Y+H
Sbjct: 62 YSFQTHDRL--CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQK 317
++RDLK +NL++ D IKI DFG+ + E +G T +T GT ++APE+++ Y +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 318 VDVYSFGIVLWELITGLLPFQN 339
VD + G+V++E++ G LPF N
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 15/195 (7%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE---RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K + E P A +E+ +L L H NIV
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-------REISLLKELNHPNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + +V E+ +++F+ +PL L + +G+A+ H
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPE-MIQHRPYTQK 317
+HRDLK NLLI+ + +IK+ADFG+AR V T E T + APE ++ + Y+
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 318 VDVYSFGIVLWELIT 332
VD++S G + E++T
Sbjct: 182 VDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 17/230 (7%)
Query: 175 KAQVMEQQFQQEVMML----ATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTR 229
+A V Q+ ++ +M L ++ V F GA R+ VW I E S+ +F +
Sbjct: 35 RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW-ICMEVMDT-SLDKFYKK 92
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ +P + K A+ + + + Y+H L IHRD+K N+LI+ + +K+ DFG++
Sbjct: 93 VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152
Query: 287 IEVQTEGMTPETGTYRWMAPEMI----QHRPYTQKVDVYSFGIVLWELITGLLPFQNM-T 341
V + T + G +MAPE I + Y K DV+S GI + EL TG P+ + T
Sbjct: 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212
Query: 342 AVQAAFAVVNKGVRPVIPNDCL-PVLSEIMTRCWDTNPEVRPPFTEIVRM 390
Q VV + P +P + P + + +C N + RP + E+++
Sbjct: 213 PFQQLKQVV-EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
+L+ + G AQG Y T G++VAIK L RP N A+ + +++ V+M
Sbjct: 20 NLKPIGSG---AQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMK-L 71
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--- 249
+ H NI+ + + + E+ V + + L ++ LD R
Sbjct: 72 VNHKNIIGLLNVFTPQKS---LEEFQDVYLVMELMDAN------LCQVIQMDLDHERMSY 122
Query: 250 -------GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP T
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ APE+I Y + VD++S G ++ E+I G + F
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 141 TAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQ-----QFQQEVMMLATL 193
T QG +G+++ + GE VA+K + K ++ + E +L T
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRM--------KKSLLFKLNEVRHVLTERDILTTT 58
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K +V+ + A + + EY GG R L + A ++ +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDA 116
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT---PETGTYRWMAPEMIQ 310
+H LG+IHRDLK +N LI A IK+ DFG++ +T G+ +MAPE+++
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVTYANSVVGSPDYMAPEVLR 171
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPF 337
+ Y VD +S G +L+E + G PF
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 53/185 (28%), Positives = 95/185 (51%), Gaps = 11/185 (5%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G +VA+K L RP N Q ++ +E+++L + H NI+ + + + E+
Sbjct: 46 GINVAVKKLSRPFQN----QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS---LEEF 98
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V + + + + ++L ++ + G+ ++H G IHRDLK N+++ +
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 158
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG 333
D ++KI DFG+AR MTP T + APE+I Y + VD++S G ++ EL+ G
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
Query: 334 LLPFQ 338
+ FQ
Sbjct: 219 SVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 34/195 (17%)
Query: 164 KILERPENNPEKAQVM--------EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215
K++ RP +V+ +Q +E+ +L + H N+V+ ++
Sbjct: 92 KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR----GMAYVHGLGFIHRDLKSDNLL 270
E+ GGS+ + +A +Q L DVAR G+AY+H +HRD+K NLL
Sbjct: 152 EFMDGGSL-------EGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTP---ETGTYRWMAPEMI----QHRPYTQKV-DVYS 322
I++ K++KIADFGV+RI QT M P GT +M+PE I H Y D++S
Sbjct: 201 INSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWS 258
Query: 323 FGIVLWELITGLLPF 337
G+ + E G PF
Sbjct: 259 LGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 58/189 (30%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI--GACRKRMVWCIVT 215
G +VAIK+L + PE+ +F++E + A L H NIV + G +++ V
Sbjct: 3 GHEVAIKLLR--TDAPEEEH-QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VF 58
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-- 273
EY G ++R+ L + A+P + L V +A H G +HRDLK N+++S
Sbjct: 59 EYVPGRTLREVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 274 -DKSIKIADFGVA-------RIEVQTEGMTPET-GTYRWMAPEMIQHRPYTQKVDVYSFG 324
K+ DFG+ +V T T E GT + APE ++ P T D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 325 IVLWELITG 333
++ E +TG
Sbjct: 177 LIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G++ +Y+G NG+ VA+K+ L+ E P A +E +L LKH NI
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKHANI 65
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V + +V EY + Q++ + P +KL + Q L RG++Y+H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQ 121
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAPE-MIQHRPY 314
+HRDLK NLLIS +K+ADFG+AR + V + + E T + P+ ++ Y
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344
+ +D++ G + E+I G+ F M +Q
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 144 AQGAFGKLY---RGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G++Y R G++ AIK + E+ + Q +E+ +L LKH N+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGD---KEQYTGISQSACREIALLRELKHENVV 65
Query: 200 RFIGACRKRM---VWCIVTEYAKG--GSVRQFLTRRQNRAVP---LKLAVKQALDVARGM 251
+ + V+ ++ +YA+ + +F + + ++P +K + Q L+ G+
Sbjct: 66 SLVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN---GV 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARIEVQTEGMTPETG-----TYR 302
Y+H +HRDLK N+L+ + +KI D G+AR+ T
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDPVVVTIW 180
Query: 303 WMAPE-MIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ APE ++ R YT+ +D+++ G + EL+T F+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 145 QGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ G D AIK+L++ + + V ++ ++ LA KH +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAA-KHPFLTALH 62
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + F +R +R + A +V + ++H G I+R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL-MFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVDV 320
DLK DN+L+ A+ K+ADFG+ + E G+T T GT ++APE++Q Y VD
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 321 YSFGIVLWELITGLLPFQ 338
++ G++++E++ G PF+
Sbjct: 180 WALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
F + +++ L H ++V+ G C R +V EY K G + FL R+
Sbjct: 38 LGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFL-HREK 95
Query: 233 RAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKIADFG 283
V L KL V + L A + Y+ +H ++ N+L++ IK++D G
Sbjct: 96 NNVSLHWKLDVAKQL--ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 284 VARIEVQTEGMTPETGTYR-----WMAPEMIQ--HRPYTQKVDVYSFGIVLWELIT-GLL 335
+ +T + R W+APE I+ T D +SFG L E+ + G
Sbjct: 154 I--------PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
Query: 336 PFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
P +++ + ++ P+ DC L+ ++ +CW +P RP F I+R L
Sbjct: 206 PLSTLSSSEKERFYQDQHRLPMP--DCAE-LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWM 304
G+ Y+H +HRDLK NLL++AD +KI DFG+AR + G E RW
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 305 -APE-MIQHRPYTQKVDVYSFGIVLWELITGLLPF 337
APE M+ + YT+ +DV+S G +L EL+ G P
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 69/258 (26%), Positives = 122/258 (47%), Gaps = 32/258 (12%)
Query: 153 RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW- 211
+ +GE A+K+++ + + + Q EV L +IV+ C +
Sbjct: 52 KRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVK----CHEDFAKK 103
Query: 212 -----------CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG 258
+V +YA G +RQ + R NR A + V + +VH
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH 163
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPET--GTYRWMAPEMIQHRPYT 315
IHRD+KS N+L+ ++ +K+ DFG +++ T T GT ++APE+ + +PY+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 316 QKVDVYSFGIVLWELITGLLPF--QNMTAV-QAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
+K D++S G++L+EL+T PF +NM V A G +P P + EI+T
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----GRYDPLPPSISPEMQEIVTA 279
Query: 373 CWDTNPEVRPPFTEIVRM 390
++P+ RP ++++ M
Sbjct: 280 LLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 46/126 (36%), Positives = 73/126 (57%), Gaps = 3/126 (2%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F + + R L A A ++ G+ ++H G I+RDLK DN+++
Sbjct: 74 VMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 274 DKSIKIADFGVARIEVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT 332
D IKIADFG+ + V + + GT ++APE++Q YT VD +SFG++L+E++
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 333 GLLPFQ 338
G PF
Sbjct: 192 GQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 23/254 (9%)
Query: 124 LENYDEWTIDLRKLNMGT-------AFAQGAFG--KLYRGTYNGEDVAIKILERPENNPE 174
L Y + +R L M +GAFG +L R + A+K+L + E
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
F +E ++A +V+ A + +V EY GG + ++ N
Sbjct: 85 SDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYD 138
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294
VP K A +V + +H +GFIHRD+K DN+L+ +K+ADFG +++ EGM
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGM 197
Query: 295 T---PETGTYRWMAPEMIQHRP----YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF 347
GT +++PE+++ + Y ++ D +S G+ L+E++ G PF + V
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 348 AVVNKGVRPVIPND 361
++N P+D
Sbjct: 258 KIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 36/91 (39%), Positives = 55/91 (60%), Gaps = 7/91 (7%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWM 304
RG+ Y+H +HRDLK NLL++ + +KI DFG+ARI T +T T RW
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWY 175
Query: 305 -APE-MIQHRPYTQKVDVYSFGIVLWELITG 333
APE M+ + YT+ +D++S G +L E+++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 143 FAQGAFGKLYRGTYNGED--VAIKILERP----ENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G+FGK++ G + AIK L++ +++ E V ++ V+ LA +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLA-WEHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V EY GG + F + ++ L A A ++ G+ ++H
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHK-FDLPRATFYAAEIICGLQFLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHRPYT 315
G ++RDLK DN+L+ D IKIADFG+ + + + T GT ++APE++ + Y
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 316 QKVDVYSFGIVLWELITGLLPFQ 338
VD +SFG++L+E++ G PF
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++ + G+ A K L++ K EQ E +L + IV
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVSLA 59
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C+V GG ++ + P A+ A + G+ ++H ++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVD 319
DLK +N+L+ +++I+D G+A V+ +G GT +MAPE++Q Y VD
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 320 VYSFGIVLWELITGLLPFQ 338
++ G L+E+I G PF+
Sbjct: 177 WFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 71/212 (33%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
KLN +G +G +YR T +GE VA+K + R +N + + + E+ +L L
Sbjct: 11 KLNR---IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR---EITLLLNL 63
Query: 194 KHLNIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRR-QNRAVPLKLA-VKQ-ALDVA 248
+H NIV + + I V EY + Q L N P + VK L +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPE 307
RG+ Y+H IHRDLK NLL++ +KIADFG+AR + + MTP+ T + APE
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178
Query: 308 MI-QHRPYTQKVDVYSFGIVLWELITG--LLP 336
++ YT +D+++ G +L EL+ LLP
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 38/166 (22%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 174 EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
EK ++E++ +L + IV A + C+V GG ++ + R
Sbjct: 37 EKMALLEKE------ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGER 90
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+ ++ + + + G+ ++H + ++RD+K +N+L+ + +++D G+A +
Sbjct: 91 GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150
Query: 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
+T GT +MAPE+++ PY+ VD ++ G ++E++ G PF++
Sbjct: 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 69/255 (27%), Positives = 118/255 (46%), Gaps = 33/255 (12%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-------FAQGAFG--KLYRG 154
AL D AL ++ L Y++ + KL M +GAFG +L R
Sbjct: 5 ALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64
Query: 155 TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLN---IVRFIGACRKRM 209
+ + A+K+L + E + A E++ ++M H N IV+ A +
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDSAFFWEER---DIM-----AHANSEWIVQLHYAFQDDK 116
Query: 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
+V EY GG + ++ N +P K A +V + +H +GFIHRD+K DN+
Sbjct: 117 YLYMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 270 LISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPEMIQ----HRPYTQKVDVYS 322
L+ +K+ADFG +++ GM GT +++PE+++ Y ++ D +S
Sbjct: 174 LLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 323 FGIVLWELITGLLPF 337
G+ L+E++ G PF
Sbjct: 233 VGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 37/195 (18%)
Query: 160 DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219
+VAIK L RP N Q ++ +E++++ + H NI+ + +
Sbjct: 51 NVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTP 94
Query: 220 GGSVRQFLTRRQNRAVPLKL-------AVKQALDVAR----------GMAYVHGLGFIHR 262
S+ +F Q+ + ++L ++ LD R G+ ++H G IHR
Sbjct: 95 QKSLEEF----QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYS 322
DLK N+++ +D ++KI DFG+AR + MTP T + APE+I Y + VD++S
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 210
Query: 323 FGIVLWELITGLLPF 337
G ++ E+I G + F
Sbjct: 211 VGCIMGEMIKGGVLF 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 23/199 (11%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVR 200
GA+G +Y R ++G VA+K + R + N + + +EV +L L+ NIVR
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPL---STVREVALLKRLEAFDHPNIVR 66
Query: 201 FIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
+ C R+ V +V E+ +R +L + +P K ++Q L RG+
Sbjct: 67 LMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH 311
++H +HRDLK +N+L+++ +K+ADFG+ARI +TP T + APE++
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 312 RPYTQKVDVYSFGIVLWEL 330
Y VD++S G + E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 38/265 (14%)
Query: 149 GKLYRGTYNGEDVAIKILERPEN-----NPEKAQVMEQQFQQEVMMLATLKHLN---IVR 200
+L +G Y K+L RP + ++ E +F Q +M L L IV
Sbjct: 7 DELGKGNYG---SVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAY--VHGL 257
F GA + EY GS+ + +P DV R + Y V GL
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE--------DVLRRITYAVVKGL 115
Query: 258 GF-------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI- 309
F IHRD+K N+L++ + +K+ DFGV+ V + T G +MAPE I
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIK 174
Query: 310 -----QHRPYTQKVDVYSFGIVLWELITGLLPF--QNMTAVQAAFAVVNKGVRPVIPNDC 362
Q+ YT + DV+S G+ + E+ G P+ + + A + + G P +P+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEI 387
+ + +C + P RP + ++
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
W + R N+ + GA+G + T G VA+K L RP ++ + ++ +E+
Sbjct: 13 WEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 67
Query: 188 MMLATLKHLNIVRFI-----GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+L +KH N++ + + + + G + + ++ ++ +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
Q L RG+ Y+H IHRDLK NL ++ D +KI DFG+AR + MT T
Sbjct: 128 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 303 WMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
+ APE M+ Y Q VD++S G ++ EL+TG
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 2/86 (2%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAPE 307
RG+ Y+H +HRDLK NLL++A+ +KI DFG+AR + MT T + APE
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 308 MIQH-RPYTQKVDVYSFGIVLWELIT 332
++ + YT +DV+S G + EL+
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 9/200 (4%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQ---ILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + AV A ++ G+ +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
++RDLK +N+L+ I+I+D G+A + + + GT +MAPE++++ YT
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 319 DVYSFGIVLWELITGLLPFQ 338
D ++ G +L+E+I G PFQ
Sbjct: 183 DWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 32/194 (16%)
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIADFG 283
L +R +P + K + + + + Y+ HG+ IHRD+K N+L+ A ++K+ DFG
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFG 160
Query: 284 VARIEVQTEGMTPETGTYRWMAPEMI----QHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
++ V ++ T G +MAPE I + Y + DV+S GI L EL TG P++N
Sbjct: 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
Query: 340 MTAVQAAFAVVNKGVRPVIPNDCLPVLS----------EIMTRCWDTNPEVRPPFTEI-- 387
F V+ K I + P L + C + RP + E+
Sbjct: 221 CK---TEFEVLTK-----ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
Query: 388 ---VRMLENAETEI 398
+R E AE ++
Sbjct: 273 HPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R ++ GA+G + GE VAIK L RP ++++ ++
Sbjct: 7 NKTVWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF----QSEIFAKRA 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-- 240
+E+ +L ++H N++ E+ V ++ + + L+
Sbjct: 62 YRELTLLKHMQHENVIGL----LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 241 -----VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295
V Q L G+ Y+H G IHRDLK NL ++ D +KI DFG+AR E MT
Sbjct: 118 KVQYLVYQML---CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAE-MT 172
Query: 296 PETGTYRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
T + APE+I H Y Q VD++S G ++ E++TG F+
Sbjct: 173 GYVVTRWYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 184 QQEVMMLATLKHLN---IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
Q + L L N IV F GA I E+ GGS+ Q L ++ +P +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENIL 101
Query: 241 VKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
K ++ V RG+ Y+ +HRD+K N+L+++ IK+ DFGV+ G ++
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSM 154
Query: 299 -----GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLP 336
GT +M+PE +Q YT + D++S G+ L E+ G P
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 38/212 (17%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG+++ R + VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 77
Query: 203 GACRKR--------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--D 246
CR + +C E+ G L N+ V L+ + +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC---EHDLAG----LL---SNKNVKFTLSEIKKVMKM 127
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR---- 302
+ G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR ++ P T R
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 303 WM-APE-MIQHRPYTQKVDVYSFGIVLWELIT 332
W PE ++ R Y +D++ G ++ E+ T
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK--ILERPENN-PEKAQVMEQQFQQEVMMLATLKHLN-I 198
+G +GK+Y R G+ VA+K LE E P A +E+ +L L I
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-------REISLLQMLSESIYI 63
Query: 199 VRFIGA------CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVAR 249
VR + K ++ +V EY +++F+ R R +P K + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS-IKIADFGVAR-IEVQTEGMTPETGTYRWMAPE 307
G+A+ H G +HRDLK NLL+ K +KIAD G+ R + + T E T + APE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 308 -MIQHRPYTQKVDVYSFGIVLWELITG 333
++ Y+ VD++S G + E+
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 52/192 (27%), Positives = 96/192 (50%), Gaps = 12/192 (6%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
AQG Y + +VAIK L RP N Q ++ +E++++ + H NI+ +
Sbjct: 29 AQGIVCAAYDAVLD-RNVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGF 259
+ + E+ V + + + + ++L ++ + G+ ++H G
Sbjct: 84 VFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVD 319
IHRDLK N+++ +D ++KI DFG+AR + MTP T + APE+I Y + VD
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 320 VYSFGIVLWELI 331
++S G ++ E++
Sbjct: 201 IWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 145 QGAFGKLY----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G+++ +GT G+ A+K+L++ E +V +QE+ LATL H +
Sbjct: 11 KGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRN-KVKRVLTEQEI--LATLDHPFLPT 65
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + C+V +Y GG + + L R+ + + ++A A +V + Y+H LG +
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 261 HRDLKSDNLLISADKSIKIADF------------------------GVARIEVQTEGMTP 296
+RDLK +N+L+ I ++DF V I +T P
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185
Query: 297 ET------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337
GT ++APE+I + VD ++ GI+L+E++ G PF
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 73/262 (27%), Positives = 122/262 (46%), Gaps = 34/262 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEV 187
++L KL +G++ +Y+G NG+ VA+K+ ++ E P A +E
Sbjct: 8 LNLEKL------GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-------REA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQAL 245
+L LKH NIV + V EY + Q++ + P ++L + Q L
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWM 304
RG+AY+HG +HRDLK NLLIS +K+ADFG+AR + + ++ + E T +
Sbjct: 114 ---RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170
Query: 305 APE-MIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVRPVIPND 361
P+ ++ Y+ +D++ G + E++ G F V F + K V V D
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF---PGVSDVFEQLEKIWTVLGVPTED 227
Query: 362 CLPVLSEIMTRCWDTNPEVRPP 383
P +S++ + PE P
Sbjct: 228 TWPGVSKLP----NYKPEWFLP 245
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 142 AFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GA+G + G VAIK L RP ++++ ++ +E+ +L +KH N++
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPF----QSELFAKRAYRELRLLKHMKHENVI 77
Query: 200 RFIGACRKRMVWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + ++ G + + + + ++ V Q L +G+ Y+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML---KGLKYI 134
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAPEMIQH-R 312
H G IHRDLK NL ++ D +KI DFG+AR QT+ MT T + APE+I +
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVILNWM 191
Query: 313 PYTQKVDVYSFGIVLWELITG 333
YTQ VD++S G ++ E++TG
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 16/257 (6%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGA 204
GAFG + + + + + EK Q ++ ++ +++ + IV+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ---KRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYV-HGLGFI 260
+ I E S+ +F +P ++ K A+ + + Y+ L I
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI---QHRPYTQK 317
HRD+K N+L+ + +IK+ DFG++ V + T + G +MAPE I Y +
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVR 190
Query: 318 VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR----C 373
DV+S GI L+E+ TG P+ +V V KG P++ N S C
Sbjct: 191 SDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLC 250
Query: 374 WDTNPEVRPPFTEIVRM 390
+ RP + E++
Sbjct: 251 LIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 45/135 (33%), Positives = 77/135 (57%), Gaps = 13/135 (9%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V EY GG + F +RQ R +P + A A ++ + ++H G I+RDLK DN+L+
Sbjct: 73 LVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAPEMIQHRPYTQKVDVYSFGIV 326
AD IK+ D+G+ + EG+ P GT ++APE+++ Y VD ++ G++
Sbjct: 131 ADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185
Query: 327 LWELITGLLPFQNMT 341
++E++ G PF +T
Sbjct: 186 MFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G++ +Y+G G+ VA+K LE E P A +E +L LKH NIV
Sbjct: 15 EGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHANIVT 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLG 258
+ +V EY ++Q++ ++L + Q L RG+AY H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCHQRR 123
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAPE-MIQHRPYTQ 316
+HRDLK NLLIS +K+ADFG+AR + V ++ + E T + P+ ++ Y+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 317 KVDVYSFGIVLWELITGLLPFQNMTAVQ 344
+D++ G + +E+ TG F T V+
Sbjct: 184 SLDMWGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQ---ILEKVNSQFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
++RDLK +N+L+ I+I+D G+A + E + GT +MAPE++ ++ YT
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSP 182
Query: 319 DVYSFGIVLWELITGLLPFQ 338
D + G +++E+I G PF+
Sbjct: 183 DYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRW 303
RG+ Y+H IHRDLK NLL++ D ++I DFG+AR MT T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176
Query: 304 M-APE-MIQHRPYTQKVDVYSFGIVLWELI 331
APE ++ YT +D++S G + E++
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 46/144 (31%), Positives = 77/144 (53%), Gaps = 13/144 (9%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTY 301
A ++ + ++H G I+RDLK DN+L+ + K+ADFG+ + + G T T GT
Sbjct: 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTP 160
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN- 360
++APE++Q Y VD ++ G++L+E++ G PF+ A++N V V P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTW 218
Query: 361 ---DCLPVLSEIMTRCWDTNPEVR 381
D + +L MT+ NP +R
Sbjct: 219 LSQDAVDILKAFMTK----NPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 26/250 (10%)
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
+ E+ LA H IV+ + ++ EY GG + + + +R +P +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 244 AL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPET 298
L + + VH +HRDLKS N+ + IK+ DFG ++ V + +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358
GT ++APE+ + + Y++K D++S G++L+EL+T PF+ + + V+ P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-F 291
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPP----------------FTEIVRMLE----NAETEI 398
P + ++ NP +RP F +IVR E + EI
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEI 351
Query: 399 MTTVRKARFR 408
+ ++++ R
Sbjct: 352 LRQLQESGER 361
|
Length = 478 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVM 179
LE Y I L KL GT + +Y+G D VA+K LE E P A
Sbjct: 5 LETY----IKLDKLGEGT------YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-- 52
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPL 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 53 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNV 106
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTP 296
KL + Q L RG+ Y H +HRDLK NLLI+ +K+ADFG+AR + + T+ +
Sbjct: 107 KLFLFQLL---RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 297 ETGTYRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
E T + P+ ++ Y+ ++D++ G + +E+ TG
Sbjct: 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 8/175 (4%)
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
I+ R + E + Q +E+ +L IV F GA I E+ GGS+
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIAD 281
Q L ++ + +P ++ K ++ V RG+AY+ H + +HRD+K N+L+++ IK+ D
Sbjct: 92 QVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCD 147
Query: 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLP 336
FGV+ + + + GT +M+PE +Q Y+ + D++S G+ L EL G P
Sbjct: 148 FGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 38/270 (14%)
Query: 145 QGAFGKLYRGTYN---GEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G++Y Y+ VA+K I E NP +++++F +E + A L H IV
Sbjct: 12 KGGMGEVYLA-YDPVCSRRVALKKIREDLSENP----LLKKRFLREAKIAADLIHPGIVP 66
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQAL--------DVARGM 251
C Y +G +++ L + Q ++ +LA K ++ + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-----------IEVQTEG-----MT 295
YVH G +HRDLK DN+L+ + I D+G A I+V MT
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 296 PE---TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK 352
GT +MAPE + P ++ D+Y+ G++L++++T P++ + ++ V
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL 246
Query: 353 GVRPVIP-NDCLPVLSEIMTRCWDTNPEVR 381
V P + P LS+I + +P R
Sbjct: 247 SPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 31/254 (12%)
Query: 108 DALAQALMDHRYPT--------EGLENYDEWTIDLRKLNMGT-------AFAQGAFG--K 150
D L ++D +P L Y++ +RKL M +GAFG +
Sbjct: 1 DGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210
L R + + A+K+L + E F +E ++A +V+ A +
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKY 117
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + ++ N VP K A +V + +H +G IHRD+K DN+L
Sbjct: 118 LYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 271 ISADKSIKIADFGVARIEVQTEGMT---PETGTYRWMAPEMIQHRP----YTQKVDVYSF 323
+ +K+ADFG +++ GM GT +++PE+++ + Y ++ D +S
Sbjct: 175 LDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 324 GIVLWELITGLLPF 337
G+ L+E++ G PF
Sbjct: 234 GVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 55/256 (21%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L A+K L R ++ + QV + ++++ LA + +V+
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDI--LAEADNEWVVKLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R + P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGVAR--------------IEVQTEGMTPE------------ 297
+K DN+LI D IK+ DFG+ ++ + M P
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 298 ----------------------TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335
GT ++APE++ + YTQ D +S G++L+E++ G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246
Query: 336 PFQNMTAVQAAFAVVN 351
PF T + V+N
Sbjct: 247 PFLAPTPTETQLKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 45/180 (25%), Positives = 95/180 (52%), Gaps = 18/180 (10%)
Query: 213 IVTEYAKGGSVRQFLTRRQN---RAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDN 268
++ +Y GG + L +R++ V + +A + ALD ++H LG I+RD+K +N
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQLGIIYRDIKLEN 135
Query: 269 LLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRP--YTQKVDVYSFG 324
+L+ ++ + + DFG+++ + E + GT +MAPE+I+ + + VD +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 325 IVLWELITGLLPFQNMTAVQAAFAVVNKGV---RPVIPNDCLPVLSEIMTRCWDTNPEVR 381
++ +EL+TG PF + Q + + +++ + +P P + + + + +P+ R
Sbjct: 196 VLTFELLTGASPF-TVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R N+ T GA+G + T + VA+K L RP ++ + ++
Sbjct: 7 NKTVWEVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF----QSLIHARRT 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK- 242
+E+ +L +KH N++ + + T + + L VK
Sbjct: 62 YRELRLLKHMKHENVIGLLD---------VFTPATSIENFNEVYLVTNLMGADLNNIVKC 112
Query: 243 QAL----------DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291
Q L + RG+ Y+H G IHRDLK N+ ++ D ++I DFG+AR Q
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QAD 169
Query: 292 EGMTPETGTYRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
+ MT T + APE M+ Y Q VD++S G ++ EL+ G
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 145 QGAFGKLYR-----GTYNGEDVAIKILERPENNPEKAQVMEQQ-----FQQEVMMLATLK 194
+G +GK+++ G G+ A+K+L+ KA ++ Q + E +L +K
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNILEAVK 58
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAY 253
H IV I A + ++ EY GG + L R + ++ L +++ + +
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEH 115
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQH 311
+H G I+RDLK +N+L+ A +K+ DFG+ + + EG T GT +MAPE++
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAPEILMR 174
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPF 337
+ + VD +S G ++++++TG PF
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLA 191
+ +G G+FG +Y E VAIK +L+ P Q +E++++
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------QYKNRELLIMK 114
Query: 192 TLKHLNIVRF--------IGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAV 241
L H+NI+ K + +V E+ +V +++ R N A+PL L
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGT 300
+ + R +AY+H HRDLK NLLI + ++K+ DFG A+ + + +
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 301 YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV 343
+ APE M+ YT +D++S G ++ E+I G F ++V
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 42/130 (32%), Positives = 75/130 (57%), Gaps = 13/130 (10%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + F +RQ R +P + A + +++ + Y+H G I+RDLK DN+L+ +
Sbjct: 74 VIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAPEMIQHRPYTQKVDVYSFGIVL 327
+ IK+ D+G+ + EG+ P GT ++APE+++ Y VD ++ G+++
Sbjct: 132 EGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 328 WELITGLLPF 337
+E++ G PF
Sbjct: 187 FEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR------IEVQTEGMTPETGTYR 302
+ + Y+H IHRDLK N+L+++D +K+ADFG+AR + +T T R
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT-R 176
Query: 303 WM-APE-MIQHRPYTQKVDVYSFGIVLWELITG 333
W APE ++ YT+ VD++S G +L E++ G
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 10/195 (5%)
Query: 144 AQGAFGKLYRG---TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 10 GEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 201 FIGACR-----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT 315
+HRDLK N+L+++ IK+ADFG+ARI +T T + APE++ Y
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 187
Query: 316 QKVDVYSFGIVLWEL 330
VD++S G + E+
Sbjct: 188 TPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 148 FGKLYRGTY----------NGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
KL GTY VA+K LE E P A +EV +L LKH
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKH 62
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAY 253
NIV +V EY ++Q+L N +K+ + Q L RG++Y
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSY 118
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAPE-MIQH 311
H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T + P+ ++
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 312 RPYTQKVDVYSFGIVLWELITG 333
Y+ +D++ G +L+E+ TG
Sbjct: 179 TEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 54/223 (24%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ-------QEVMMLATLKH 195
+G +G +YR GE VA+K L+ ME++ + +E+ +L L+H
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK-----------MEKEKEGFPITSLREINILLKLQH 63
Query: 196 LNIVRFIGACRKRMVW-------CIVTEYAKGGSVRQFL-----TRRQNRAVP-LKLAVK 242
NIV K +V +V EY V L T +Q +K +
Sbjct: 64 PNIVTV-----KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
Q L G+A++H +HRDLK+ NLL++ +KI DFG+AR + T T
Sbjct: 114 QLL---SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170
Query: 301 -YRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITG--LLPFQN 339
YR APE++ Y+ +D++S G + EL+T L P ++
Sbjct: 171 WYR--APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 23/199 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-I-LE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K I LE E P A +E+ +L L H NIV
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKELNHPNIV 61
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + ++ +V E+ +++++ + L + +G+AY H
Sbjct: 62 RLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAPE-MIQHRP 313
+HRDLK NLLI + ++K+ADFG+AR + V+T T E T + APE ++ R
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQ 176
Query: 314 YTQKVDVYSFGIVLWELIT 332
Y+ VD++S G + E++
Sbjct: 177 YSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVA---IKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ E +A I++ + E P A +E+ +L ++H NIV
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-------REISLLKEMQHGNIV 64
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + KR+ +V EY +++ + + A +L + RG+AY H
Sbjct: 65 RLQDVVHSEKRLY--LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 258 GFIHRDLKSDNLLIS-ADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAPE-MIQHR 312
+HRDLK NLLI ++K+ADFG+AR I V+T T E T + APE ++ R
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSR 179
Query: 313 PYTQKVDVYSFGIVLWELIT 332
Y+ VD++S G + E++
Sbjct: 180 HYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 42/126 (33%), Positives = 75/126 (59%), Gaps = 5/126 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F +RQ R +P + A + +++ + ++H G I+RDLK DN+L+ A
Sbjct: 74 VIEFVSGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELI 331
+ IK+ D+G+ + E G T T GT ++APE+++ Y VD ++ G++++E++
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 332 TGLLPF 337
G PF
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 185 QEVMMLATLKHLNIVRF--------------IGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+E+ ++ L H NIV+ +G+ + IV EY + + L +
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG 109
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFGVARI-- 287
+L + Q L RG+ Y+H +HRDLK N+ I+ + + KI DFG+ARI
Sbjct: 110 PLSEEHARLFMYQLL---RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 288 -EVQTEGMTPETGTYRWM-APEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344
+G E +W +P ++ YT+ +D+++ G + E++TG F ++
Sbjct: 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
Query: 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV 388
++ + V V D +L+ I + + E R P +++
Sbjct: 227 -QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLL 269
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 64/256 (25%), Positives = 98/256 (38%), Gaps = 59/256 (23%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIV 199
GAFG+ L R A+K L KA V+ + + E +LA + +V
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLR-------KADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + + V +Y GG + L R LA ++ + VH +GF
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGV------------------ARI-------EVQTEGM 294
IHRD+K DN+LI D IK+ DFG+ R E
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 295 TPET-------------------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335
GT ++APE++ YTQ D +S G++L+E++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 336 PFQNMTAVQAAFAVVN 351
PF T + V+N
Sbjct: 243 PFLADTPAETQLKVIN 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 67/265 (25%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 145 QGAFGKLYRGTYN-----GE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
QG F K+++G GE +V +K+L++ N E F+ MM + L H
Sbjct: 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-----YSESFFEAASMM-SQLSH 58
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++V G C +V EY K GS+ +L + +N + + ++ A +A + ++
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE 117
Query: 256 GLGFIHRDLKSDNLLIS---ADKS-----IKIADFGVARIEVQTEGMTPETGTYRWMAPE 307
G H ++ + N+L+ K+ IK++D G++ I V + + E W+ PE
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLER--IPWVPPE 174
Query: 308 MIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366
I++ + + D +SFG LWE+ +G + ++A+ + + R +P L
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGD--KPLSALDSQKKLQFYEDRHQLPAPKWTEL 232
Query: 367 SEIMTRCWDTNPEVRPPFTEIVRML 391
+ ++ +C D P+ RP F I+R L
Sbjct: 233 ANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 5/150 (3%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E +L + H +I++ G C++ K + +L ++N A+ LA++++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERS- 190
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA--RIEVQTEGMTPETGTYRW 303
V R + Y+H IHRD+K++N+ I+ + + DFG A +++ GT
Sbjct: 191 -VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITG 333
APE++ PY VD++S GIVL+E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 60/257 (23%), Positives = 128/257 (49%), Gaps = 34/257 (13%)
Query: 146 GAFGKLY-----RGTYNGEDVAIKILERP---------ENNPEKAQVMEQQFQQEVMMLA 191
GA+GK++ G +G+ A+K+L++ E+ + QV+E Q L
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--FLV 68
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
TL + A + ++ +Y GG + L++R+ R ++ + ++ +
Sbjct: 69 TLHY--------AFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSG-EIVLAL 118
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAPEMI 309
++H LG I+RD+K +N+L+ ++ + + DFG+++ E + E GT +MAP+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 310 Q--HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV---RPVIPNDCLP 364
+ + + VD +S G++++EL+TG PF + + + A +++ + P P +
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 365 VLSEIMTRCWDTNPEVR 381
+ +I+ R +P+ R
Sbjct: 238 LAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 8/192 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+G G+ VA+K + R E+ E + +E+ +L L+H NIV
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG---VPSTAIREISLLKELQHPNIVCLQ 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E+ + + + + + +L + +G+ + H +HR
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRP-YTQKVDV 320
DLK NLLI IK+ADFG+AR + T E T + APE++ P Y+ VD+
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185
Query: 321 YSFGIVLWELIT 332
+S G + E+ T
Sbjct: 186 WSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 33/240 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIK---ILERPENNPEKAQVMEQ-- 181
++I R + G +G +GK+ + T G+ VAIK I+E + + Q++
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 182 -QFQ--QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-L 237
F +E+ ++ +KH NI+ + + +V + +++ + R+ +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------- 289
K + Q L G+ +H F+HRDL N+ I++ KIADFG+AR
Sbjct: 122 KCILLQIL---NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 290 -------QTEGMTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITG--LLPFQN 339
+ E MT + T + APE++ Y VD++S G + EL+TG L P +N
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 31/210 (14%)
Query: 146 GAFGKLY-----RGTYNGEDVAIKILERP---------ENNPEKAQVMEQQFQQEVMMLA 191
GA+GK++ G G+ A+K+L++ E+ + V+E ++ L
Sbjct: 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV--RQSPFLV 68
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK-QALDVARG 250
TL + A + ++ +Y GG + L +R N + + V+ + ++
Sbjct: 69 TLHY--------AFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILA 117
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAPEM 308
+ ++H LG ++RD+K +N+L+ ++ + + DFG+++ + + E GT +MAPE+
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 309 IQHRP-YTQKVDVYSFGIVLWELITGLLPF 337
I+ + + + VD +S GI+++EL+TG PF
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVMEQQFQ 184
E I L KL GT + +++G + VA+K LE E P A
Sbjct: 6 ETYIKLEKLGEGT------YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------- 52
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVK 242
+EV +L LKH NIV +V EY ++Q++ N +K+ +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTY 301
Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T
Sbjct: 112 QIL---RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 302 RWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
+ P+ ++ Y+ ++D++ G + +E+ +G
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 22/167 (13%)
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
KA + +E+ +L T+ H I+ I A R + C+V K L +R+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD-----LFTYVDRS 179
Query: 235 VPLKLAVKQALDVARGM----AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
PL L +QA+ + R + AY+HG G IHRD+K++N+ + ++ + DFG A +
Sbjct: 180 GPLPL--EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CK 234
Query: 291 TEGMTPET-------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 330
P+T GT +PE++ PY K D++S G+VL+E+
Sbjct: 235 L-DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 12/192 (6%)
Query: 147 AFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206
A GK+Y A K LE+ K + M +Q +L + +V A
Sbjct: 23 ATGKMY---------ACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVVSLAYAYE 70
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266
+ C+V GG ++ + N + AV A ++ G+ +H ++RDLK
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 267 DNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIV 326
+N+L+ I+I+D G+A + E + GT +MAPE++++ YT D + G +
Sbjct: 131 ENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCL 190
Query: 327 LWELITGLLPFQ 338
++E+I G PF+
Sbjct: 191 IYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 17/194 (8%)
Query: 154 GTYNGEDVAIKILERPEN--------NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
G NG V K+ +P + E + Q +E+ +L IV F GA
Sbjct: 14 GAGNG-GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHR 262
I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ H + +HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYS 322
D+K N+L+++ IK+ DFGV+ + + + GT +M+PE +Q Y+ + D++S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 323 FGIVLWELITGLLP 336
G+ L E+ G P
Sbjct: 188 MGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLKHLNI 198
++GAFGK+Y R N + A+K++++ + N M Q Q E LA K I
Sbjct: 13 SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN------MVHQVQAERDALALSKSPFI 66
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V + + +V EY GG V+ L + AVK +VA + Y+H G
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM--AVKYISEVALALDYLHRHG 124
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
IHRDLK DN+LIS + IK+ DFG++++ + E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 55/256 (21%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L R A+K L R ++ + QV + ++++ LA + +VR
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDI--LAEADNEWVVRLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGVA---------------------RIEVQTEGMTPET---- 298
+K DN+LI D IK+ DFG+ ++ E P
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 299 -----------------------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335
GT ++APE++ YTQ D +S G++L+E++ G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 246
Query: 336 PFQNMTAVQAAFAVVN 351
PF T ++ V+N
Sbjct: 247 PFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 41/105 (39%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 233 RAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288
R PL LA Q VAR + Y+HG G IHRD+K++N+L++ + I + DFG A
Sbjct: 253 RLRPLGLA--QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF- 309
Query: 289 VQTEGMTPE----TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWE 329
+ TP GT APE++ PYT VD++S G+V++E
Sbjct: 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/249 (24%), Positives = 109/249 (43%), Gaps = 49/249 (19%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A L +V+
Sbjct: 10 GRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEA--DSLWVVKM 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
+ + ++ ++ E+ GG + L ++ +A + + +H LG
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-----ETVLAIDSIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVA-------RIEV----------------QTEGMT 295
FIHRD+K DNLL+ + +K++DFG+ R E
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 296 PET-------------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA 342
ET GT ++APE+ Y + D +S G++++E++ G PF + T
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 343 VQAAFAVVN 351
+ V+N
Sbjct: 242 QETYKKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 11/160 (6%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ 243
E +LA + IV A + + C+V GG +R + +N P A
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-----QTEGMTPET 298
+ G+ ++H I+RDLK +N+L+ D +++I+D G+A +E+ +T+G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYA--- 158
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
GT +MAPE++Q Y VD ++ G+ L+E+I PF+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF-----IGAC 205
L R T G V ++I + E + + Q EV++ +H NI+ G+
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKAL----QNEVVLSHFFRHPNIMTSWTVFTTGS- 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265
+W +++ + GS L + L RG+ Y+H G+IHR++K
Sbjct: 73 ---WLW-VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128
Query: 266 SDNLLISADKSIKIADFGV--------ARIEVQTEGMTPETGTYRWMAPEMIQH--RPYT 315
+ ++LIS D + ++ + +V + T W++PE+++ Y
Sbjct: 129 ASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYN 188
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQ 344
K D+YS GI EL TG +PFQ+M Q
Sbjct: 189 VKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M E +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALN---EKRILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
++RDLK +N+L+ I+I+D G+A + E + GT +MAPE+I + YT
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 319 DVYSFGIVLWELITGLLPFQ 338
D + G +++E+I G PF+
Sbjct: 183 DWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF- 201
+G +G++Y R GE VA+K + R +N E + + E+ +L L H NIV
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIR---EIKILRQLNHRNIVNLK 72
Query: 202 ---------IGACRKRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ + + + +V EY + G V + ++ +KQ
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIKSF-----MKQL 125
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TY 301
L+ G+ Y H F+HRD+K N+L++ IK+ADFG+AR+ +E P T T
Sbjct: 126 LE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL-YNSEESRPYTNKVITL 181
Query: 302 RWMAPEMI--QHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ PE++ + R Y +DV+S G +L EL T FQ
Sbjct: 182 WYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 273 ADKSIKIADFG--VARIEVQTEGMTPETGTYRWMAPEMIQHRP-----YTQKVDVYSFGI 325
+ I++ADFG + +E T + GT +++PE++Q Y + D +S G+
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196
Query: 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
++E++ G PF + V+ ++N R P
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 30/85 (35%), Positives = 54/85 (63%), Gaps = 1/85 (1%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHR 312
+H I+RDLK +N+L+ I + DFG+ ++ ++ + T GT ++APE++
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
YT+ VD ++ G++L+E++TGL PF
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIK---ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +++ E VA+K + + E P A +E+ +L LKH NIV
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------REICLLKELKHKNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
R +V EY ++++ P +K + Q L +G+A+ H
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAPE-MIQHRP 313
+HRDLK NLLI+ + +K+ADFG+AR I V+ + E T + P+ + +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKL 176
Query: 314 YTQKVDVYSFGIVLWELITG---LLP 336
Y+ +D++S G + EL L P
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAV 241
F + M+ + H +IV G C + + +V E+ + G + F+ R+ + P K V
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV 110
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-------KSIKIADFGVARIEVQTEGM 294
+ L A ++Y+ +H ++ + N+L++ + IK++D G+ I V +
Sbjct: 111 AKQL--ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQE 167
Query: 295 TPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWEL-ITGLLPFQNMTAVQAAFAVVNK 352
E W+APE ++ + + D +SFG LWE+ G +P ++ T +
Sbjct: 168 CVER--IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG 224
Query: 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
V P C L+++MT C + +P RP F I+R
Sbjct: 225 QCMLVTP-SC-KELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 138 NMGTAFAQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQ----QFQQEVMMLA 191
++ + +G FG ++ R G+ A+K+++ K+ ++ Q F++E +L+
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-------KSVLLAQETVSFFEEERDILS 56
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----AVPLKLAVKQALDV 247
I + A + + +V EY GG + L R +++ LA ++
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-----EL 111
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG-VARIEV-QTEGMTPETGTYRWMA 305
+ VH +G++HRD+K +N+LI IK+ADFG AR+ + GT ++A
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 306 PEMIQ------HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344
PE++ Y + D +S G++ +E+I G PF T+ +
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 35/137 (25%), Positives = 59/137 (43%), Gaps = 39/137 (28%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGV------------ARIEVQTEG-------M 294
+H LG+IHRD+K DNLL+ A IK++DFG+ RI
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 295 TPET--------------------GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL 334
P + GT ++APE+ Y ++ D +S G++++E++ G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 335 LPFQNMTAVQAAFAVVN 351
PF + + ++N
Sbjct: 237 PPFCSDNPQETYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 35/127 (27%), Positives = 67/127 (52%), Gaps = 4/127 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+VT+Y GG + F ++ A ++ + ++H ++RDLK +N+L+
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPE-MIQHRPYTQKVDVYSFGIVLWEL 330
A I + DFG+++ + T GT ++APE ++ + YT+ VD +S G++++E+
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
Query: 331 ITGLLPF 337
G PF
Sbjct: 191 CCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWM- 304
R + Y+H HRDLK N+L +AD +KI DFG+AR+ Y RW
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 305 APEMIQ--HRPYTQKVDVYSFGIVLWELITG--LLPFQN 339
APE+ YT +D++S G + E++TG L P +N
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + +H L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHR-----PYTQKVDVYSFG 324
+ I++ADFG +++ +G + GT +++PE++Q Y + D +S G
Sbjct: 137 MNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 325 IVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360
+ ++E++ G PF + V+ ++N R P+
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 32/130 (24%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
++ +Y K G + F ++ + K + + +H IH D+K +N+L
Sbjct: 84 HVLIMDYIKDGDL--FDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141
Query: 271 ISADKS-IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWE 329
K I + D+G+ +I + T GT + +PE I+ Y D ++ G++ +E
Sbjct: 142 YDRAKDRIYLCDYGLCKI-IGTPSC--YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYE 198
Query: 330 LITGLLPFQN 339
L+TG PF+
Sbjct: 199 LLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 49/249 (19%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A + + F
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWV-VKMF 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
KR ++ I+ E+ GG + L ++ A +A + + +H LG
Sbjct: 68 YSFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIA-----ETVLAIDAIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVA-------RIE------------VQTEGMTPE-- 297
FIHRD+K DNLL+ A +K++DFG+ R E + M +
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 298 ---------------TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA 342
GT ++APE+ Y + D +S G++++E++ G PF + T
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 343 VQAAFAVVN 351
+ V+N
Sbjct: 242 QETYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 22/153 (14%)
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
AV L + +H KS N+L++ D +K+ G
Sbjct: 20 WAV--CLQCLGALRELHRQA------KSGNILLTWDGLLKL--DGSV---AFKTPEQSRP 66
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-V 357
Y +MAPE+IQ + YT+K D+YS GI L+E + LP+ + A ++ G+
Sbjct: 67 DPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD 125
Query: 358 IPNDC-------LPVLSEIMTRCWDTNPEVRPP 383
+ + M C P+ R
Sbjct: 126 PRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 28/231 (12%)
Query: 151 LYRGTYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV----RFIGA 204
L R GE V ++ LE N M Q E+ + H NIV FI
Sbjct: 18 LARYKPTGEYVTVRRINLEACTNE------MVTFLQGELHVSKLFNHPNIVPYRATFIA- 70
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAYVHGLGFIHRD 263
+W +VT + GS + + + +LA+ L V + + Y+H +G++HR
Sbjct: 71 --DNELW-VVTSFMAYGSAKDLICTHFMDGMS-ELAIAYILQGVLKALDYIHHMGYVHRS 126
Query: 264 LKSDNLLISADKSIKIADFGV--------ARIEVQTEGMTPETGTYRWMAPEMIQH--RP 313
+K+ ++LIS D + ++ R+ V + W++PE++Q +
Sbjct: 127 VKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG 186
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
Y K D+YS GI EL G +PF++M A Q +N V ++ +P
Sbjct: 187 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +G +G +Y+ +G+D L++ E + +E+ +L LKH N+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNV 60
Query: 199 V---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-DVAR 249
+ + + R VW ++ +YA+ + +F + P++L VK L +
Sbjct: 61 IALQKVFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 250 GMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARIEVQT----EGMTPETGTY 301
G+ Y+H +HRDLK N+L+ + +KIAD G AR+ + P T+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 302 RWMAPE-MIQHRPYTQKVDVYSFGIVLWELIT 332
+ APE ++ R YT+ +D+++ G + EL+T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 6/198 (3%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++Y R G+ A+K L++ ++ + + + + +++T IV
Sbjct: 3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A C + + GG + L+ Q+ K A ++ G+ ++H ++
Sbjct: 63 TYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDV 320
RDLK N+L+ ++I+D G+A + + GT+ +MAPE++Q Y D
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179
Query: 321 YSFGIVLWELITGLLPFQ 338
+S G +L++L+ G PF+
Sbjct: 180 FSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
G +G +G +Y+ + D A+K +E + +E+ +L LKH
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 196 LNIV---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-D 246
N++ + + R VW ++ +YA+ + +F + P++L VK L
Sbjct: 58 PNVISLQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARIEVQT----EGMTPET 298
+ G+ Y+H +HRDLK N+L+ + +KIAD G AR+ + P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 299 GTYRWMAPE-MIQHRPYTQKVDVYSFGIVLWELIT 332
T+ + APE ++ R YT+ +D+++ G + EL+T
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 38/133 (28%), Positives = 73/133 (54%), Gaps = 10/133 (7%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH LG++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRP-----YTQKVDVYSFG 324
+ I++ADFG + + +G GT +++PE++Q Y + D +S G
Sbjct: 137 KNGHIRLADFGSC-LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG 195
Query: 325 IVLWELITGLLPF 337
+ ++E++ G PF
Sbjct: 196 VCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 44/177 (24%), Positives = 70/177 (39%), Gaps = 49/177 (27%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA-------------RIEVQTEGMTPET-- 298
VH LGFIHRD+K DN+LI IK++DFG++ ++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 299 ---------------------------------GTYRWMAPEMIQHRPYTQKVDVYSFGI 325
GT ++APE+ + Y Q+ D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDC-LPVLSEIMTRCWDTNPEVR 381
+++E + G PF + + + ++N P+D L V +E + R TN E R
Sbjct: 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENR 293
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 2/96 (2%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A ++ G+ ++H ++RDLK N+L+ ++I+D G+A + + GT+ +
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGY 161
Query: 304 MAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQ 338
MAPE++Q Y D +S G +L++L+ G PF+
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 4/86 (4%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM-APE 307
+ + ++H G HRD+K +N+LI D +K+ADFG R T T RW APE
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE 168
Query: 308 -MIQHRPYTQKVDVYSFGIVLWELIT 332
++ Y K+D+++ G V +E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 58/246 (23%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E+ + L+H NIV+ IG CR ++ EY +G ++ + L L+ ++
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---------RNLSWERRR 783
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGM----TPETG 299
+A G+A L F+H S +++ + + I I + + G+ T
Sbjct: 784 KIAIGIA--KALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFI 840
Query: 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------ 353
+ ++APE + + T+K D+Y FG++L EL+TG P V ++V
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYCYSD 898
Query: 354 ------VRPVIPNDCLPVLSEIMT------RCWDTNPEVRPPFTEIVRMLENAETEIMTT 401
+ P I D +EI+ C T+P RP ++++ LE+A +
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC 958
Query: 402 VRKARF 407
V +F
Sbjct: 959 VTGLKF 964
|
Length = 968 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ Q EV ++ LKH NIVR+I + I+ E+ G L+R + +
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD----LSRNIQKCYKM 111
Query: 238 --KLAVKQALDVAR----GMAYVHGLG-------FIHRDLKSDNLLISAD---------- 274
K+ +D+ R +AY H L +HRDLK N+ +S
Sbjct: 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 275 ------KSI-KIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQH--RPYTQKVDVYSFG 324
+ I KI DFG+++ + E M GT + +PE++ H + Y K D+++ G
Sbjct: 172 ANNLNGRPIAKIGDFGLSK-NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 325 IVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
+++EL +G PF + + +G P +P
Sbjct: 231 CIIYELCSGKTPFHKANNFSQLISELKRG--PDLP 263
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W + L +G GAFG++ T +G VA+K+L+ + EK +
Sbjct: 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +++ L HLNIV +GAC K I+TEY + G + +L R ++
Sbjct: 88 M-----SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 49/218 (22%), Positives = 98/218 (44%), Gaps = 16/218 (7%)
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
F + +++ + H+++ G C + +V E+ + G + L R++ VP+ +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAWKIT 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLIS----ADKS---IKIADFGVARIEVQTEGMT 295
A +A ++Y+ +H ++ + N+L++ A+ + IK++D GV+ + E
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV 181
Query: 296 PETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWEL-ITGLLPFQNMTAVQAAFAVVNKG 353
W+APE + + D +SFG L E+ G +P + T + K
Sbjct: 182 ERI---PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYEKK 237
Query: 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
R +P L+ ++++C P RP F I+R L
Sbjct: 238 HR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENN 172
PT+ L ++W L G GAFGK+ T G ED VA+K+L+ +
Sbjct: 24 PTQ-LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT 82
Query: 173 PEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
E+ +M E+ +L+ L +H NIV +GAC ++TEY G + FL ++
Sbjct: 83 DEREALM-----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
Query: 232 NRAVPLKLAVKQALD 246
+ +A+ + +
Sbjct: 138 ETFLNFVMALPEISE 152
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFG++ G D VA+K+L+ + E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
E+ +L + HLN+V +GAC K ++ E+ K G++ +L ++ VP K
Sbjct: 59 ---SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W L +G GAFGK+ GT G VA+K+L+ + EK +
Sbjct: 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVP 236
M E+ ++ L HLNIV +GAC K I+TEY G + +L + R N
Sbjct: 88 M-----SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
Query: 237 LKLAVKQALDV 247
K+ LD+
Sbjct: 143 HPEKPKKDLDI 153
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD +W +L+ G GAFGK+ T G D VA+K+L+ + E+ +
Sbjct: 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +L+ L H+NIV +GAC ++TEY G + FL R+++
Sbjct: 86 M-----SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 13/111 (11%)
Query: 230 RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289
+Q RA+ +KQ L + Y+H IHRD+K +N+ ++ D I + DFG A +
Sbjct: 267 KQTRAI-----MKQLLC---AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPF 317
Query: 290 QTEGMTPE---TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLP 336
+ E + GT +PE++ Y + D++S G++L ++++ P
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368
|
Length = 501 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 18/39 (46%), Positives = 27/39 (69%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V G+ +H +G +HRD+K +NLL++ D +KI DFG A
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 26/149 (17%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI----VRF 201
G ++Y ED +KI + ++EV +L L + V
Sbjct: 9 GLTNRVYLLGTKDEDYVLKINPS--------REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---G 258
G ++ E+ +G + L A +A +A +H L
Sbjct: 61 SGESDGWSY--LLMEWIEG----ETLDEVSEEEKE-----DIAEQLAELLAKLHQLPLLV 109
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
H DL N+L+ K + I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 31/122 (25%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V ++A+GG + +++ N +P + + A ++ + +H G + RDL +N+L+
Sbjct: 62 LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 273 ADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELI 331
I++ F +E +G E + APE+ T+ D +S G +L+EL+
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDG---EAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176
Query: 332 TG 333
TG
Sbjct: 177 TG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 36/158 (22%), Positives = 67/158 (42%), Gaps = 31/158 (19%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE------------KAQVMEQQFQQEVMM 189
+GA ++Y G + G IK + + +PE +A++M + + V +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A ++ FI IV EY +G ++ + + L + ++ R
Sbjct: 64 PAVY-FVDPENFI----------IVMEYIEGEPLKDLINSNGMEELEL------SREIGR 106
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+ +H G IH DL + N+++S K I + DFG+A
Sbjct: 107 LVGKLHSAGIIHGDLTTSNMILSGGK-IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 31/150 (20%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKI-LERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNI--- 198
QGA +Y + G +K + + +PE + + ++ ++E +LA + +
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP 64
Query: 199 -VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
V + IV EY +G ++ L L + V + +H
Sbjct: 65 IVYDVDPDNGL----IVMEYIEGELLKDALEEA-----RPDLLREVGRLVGK----LHKA 111
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +H DL + N+++S + I DFG+
Sbjct: 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 18/56 (32%), Positives = 35/56 (62%)
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV 354
GT ++APE++ +P+ VD ++ G+ L+E +TG+ PF + T Q ++N+ +
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI 597
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 418 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.54 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.33 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.0 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.97 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.68 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.57 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.55 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.43 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.33 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.22 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.21 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.15 | |
| PLN02236 | 344 | choline kinase | 96.13 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.64 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.38 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.05 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.9 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.26 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.93 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-68 Score=515.23 Aligned_cols=343 Identities=31% Similarity=0.561 Sum_probs=299.6
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCce--eeccccccc--CCcccc-ccCchHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYS--VSVGQSVFR--PGKVTH-ALNDDALA 111 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~--i~~~~~~~~--~~~v~~-~~~~d~l~ 111 (418)
+|+|++++| ++..|+|++||.+...+.+ ...++||+|+..+ +++. ++ ....|. +..+.+ +.+.++++
T Consensus 104 ~G~flvR~s---e~~~g~yslsv~~~~~~~~---~~~v~hyri~~~~~~~~~~~~~-~~~~F~~l~~lv~~~~~~~~gl~ 176 (468)
T KOG0197|consen 104 EGAFLVRES---ESDKGDYSLSVREGDSGGL---GAKVKHYRIRQLDGGGLYPYID-ERELFSSLQQLVNYYSKNADGLC 176 (468)
T ss_pred ccceeeecc---cCCcCCeeEEEEeccccCC---ccceeeeeeeEcCCCCeecCCC-HHHhhhhHHHHHhhhhccCcchh
Confidence 799999999 7888999999999776542 3478999999988 4455 54 333342 344544 67889999
Q ss_pred HHHhcCCCC------CCCCCCCcccccccccccccCceeeeCceEEEEEEECCc-eEEEEEeecCCCChHHHHHHHHHHH
Q 014783 112 QALMDHRYP------TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQ 184 (418)
Q Consensus 112 ~~l~~~~~~------~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~~~~ 184 (418)
..+..++.. ...-...+.|+|+++.+++++.||+|.||+||.|+|++. +||+|.++...... +.|.
T Consensus 177 ~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~-------~~f~ 249 (468)
T KOG0197|consen 177 TRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP-------EAFL 249 (468)
T ss_pred hcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh-------hHHH
Confidence 999988863 111122789999999999999999999999999999887 99999998765443 5788
Q ss_pred HHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 014783 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (418)
Q Consensus 185 ~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 264 (418)
+|+++|++|+|+|||+|+++|..+..+|||||||+.|+|.+||+...+..+....++.++.|||+||+||+++++|||||
T Consensus 250 ~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDL 329 (468)
T KOG0197|consen 250 REAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDL 329 (468)
T ss_pred HHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhh
Confidence 99999999999999999999999999999999999999999999877788999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeecccceeecccCCCCCCC---CCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014783 265 KSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNM 340 (418)
Q Consensus 265 kp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~ 340 (418)
.++||||+++..+||+|||+|+...+.. ++... -.+.|+|||++..+.|+.|||||||||+||||+| |+.||+++
T Consensus 330 AARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 330 AARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred hhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 9999999999999999999999544433 33332 3489999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+..+.+ +.+.+|+|++.|..||+.++++|..||+.+|++||||+.+...|+++..
T Consensus 409 sn~ev~-~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 409 SNEEVL-ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CHHHHH-HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 998876 5689999999999999999999999999999999999999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=440.76 Aligned_cols=271 Identities=48% Similarity=0.895 Sum_probs=249.2
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEECCce-EEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
...+|.|+..++.+.+.||.|+||+||+|.|.|+. ||||++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34678899999999999999999999999999998 999999876554433 4789999999999999999999999
Q ss_pred EeeCc-eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEEcCCC-CEEEee
Q 014783 205 CRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLISADK-SIKIAD 281 (418)
Q Consensus 205 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NILl~~~~-~vkl~D 281 (418)
|.+.. .++||||||++|+|.+++.......+++..+++++.||+.||+|||+++ ||||||||+|||++.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99987 7999999999999999998755678999999999999999999999999 99999999999999997 999999
Q ss_pred cccceeeccc-CCCCCCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 282 FGVARIEVQT-EGMTPETGTYRWMAPEMIQ--HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 282 fGla~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
||+++..... ...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.+.........++..+.++.+
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI 267 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 9999977654 3455578999999999999 669999999999999999999999999999998888898999999999
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
|..|++.+..+|.+||+.||.+||++.+++..|+.+...+..
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999999887764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=436.25 Aligned_cols=336 Identities=28% Similarity=0.554 Sum_probs=291.2
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC-CCCceeecccccccC--Ccccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRP--GKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~-~~~~~i~~~~~~~~~--~~v~~-~~~~d~l~~~ 113 (418)
.|+|++++| .+.+|-||+|++.. .-+-||+|... ++..+++ ..+.|+. ++|.| +.-.|+++..
T Consensus 173 nGSFLVRES---EsSpgQ~sISlRye---------GRVyHYRINt~~dgK~yvt-~EsrF~TLaELVHHHStvADGLitt 239 (1157)
T KOG4278|consen 173 NGSFLVRES---ESSPGQYSISLRYE---------GRVYHYRINTDNDGKMYVT-QESRFRTLAELVHHHSTVADGLITT 239 (1157)
T ss_pred ccceEEeec---cCCCcceeEEEEec---------ceEEEEEeeccCCccEEEe-ehhhhhHHHHHHhhccccccceeEe
Confidence 899999998 66778899999852 25689999655 4778887 5666653 45543 5567899888
Q ss_pred HhcCCCCC--C---C-CCCCcccccccccccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHH
Q 014783 114 LMDHRYPT--E---G-LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQ 185 (418)
Q Consensus 114 l~~~~~~~--~---~-~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~ 185 (418)
|+.|.... . + -+++|+|+.++.++.+..+||-|.||.||.|.|. .-.||||.++.+... .++|+.
T Consensus 240 LhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLk 312 (1157)
T KOG4278|consen 240 LHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLK 312 (1157)
T ss_pred eeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHH
Confidence 88664321 1 1 2467999999999999999999999999999994 458999999754332 368999
Q ss_pred HHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 186 E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
|+.+|+.++|||+|+|+|+|..+..+|||+|||..|+|.+||++.....++--.++.++.||..||+||+.+++|||||.
T Consensus 313 EAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 313 EAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred HHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 99999999999999999999999999999999999999999998766778888899999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccCCCCCCCC---CccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMT 341 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~ 341 (418)
++|+||+++..|||+|||+++++.. ..++...| .+.|+|||-+....|+.|||||+|||+|||+.| |..||++..
T Consensus 393 ARNCLVgEnhiVKvADFGLsRlMtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 393 ARNCLVGENHIVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred hhhccccccceEEeeccchhhhhcC-CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 9999999999999999999997643 34454444 489999999999999999999999999999999 999999988
Q ss_pred HHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 342 AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
..+ ++..+..++++..|+.|++.+++||+.||+|.|.+||+|.|+-+.|+.+.
T Consensus 472 lSq-VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 472 LSQ-VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHH-HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 766 46789999999999999999999999999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-54 Score=398.43 Aligned_cols=250 Identities=29% Similarity=0.478 Sum_probs=221.1
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
.+...+++.++.||+|..|+||++++ +++.+|+|++...... ...+++.+|++++++++||+||++||+|...
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~-----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP-----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH-----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 35667888889999999999999987 6889999999433222 2346888999999999999999999999998
Q ss_pred c-eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 209 M-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 209 ~-~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
. .++|+||||++|+|.++++.. +.+++..+.+++.++++||.|||+ ++||||||||+||||...|.|||||||.++
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 499999999999999999764 569999999999999999999995 999999999999999999999999999998
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM-----TAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~~~~ 361 (418)
...+. ...+..||..|||||.+.+..|+.++||||||++++|+++|+.||... ...+.+..+ -.+..|.+|..
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I-v~~ppP~lP~~ 305 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI-VDEPPPRLPEG 305 (364)
T ss_pred Hhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH-hcCCCCCCCcc
Confidence 77665 567789999999999999999999999999999999999999999763 444544444 44566777776
Q ss_pred -ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 -CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 -~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++++++|+..||++||.+|||+.||++
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=387.70 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=218.9
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|+++++||+|+||+||.++. +++.||+|++++......+. .+...+|..||.+++||.||+++..|++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e---~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKE---VRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhh---HHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 3467889999999999999999976 78899999998755433211 256789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+|+||+.||.|.-+|++ .+.+++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++...
T Consensus 99 kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999998875 4669999999999999999999999999999999999999999999999999998654
Q ss_pred cc-CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 QT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.. ......|||+.|||||++.+.+|+.++|+|||||++|||++|.+||...+..+....+.... .+..|...+.+.++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ard 255 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARD 255 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHH
Confidence 43 44556799999999999999999999999999999999999999999988877666555443 44555568899999
Q ss_pred HHHHhcccCCCCCC----CHHHHHH
Q 014783 369 IMTRCWDTNPEVRP----PFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RP----t~~ell~ 389 (418)
++.+.++.||++|. ++.+|.+
T Consensus 256 ll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHHhccCHHHhcCCCCChHHhhc
Confidence 99999999999995 4555443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-52 Score=406.53 Aligned_cols=348 Identities=26% Similarity=0.464 Sum_probs=271.8
Q ss_pred CCCccccccccccCCCCce-eEeeccCCCCCCCCcccccccCCcccCCCCceeeccccccc--CCccccccCchHHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSV-SMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQAL 114 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~-s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~~~~~~~~--~~~v~~~~~~d~l~~~l 114 (418)
.|+|+++.|.........+ -+||.-+. ...+.|+.|....+.+... ....|. +..+.+.......+..
T Consensus 68 ~GDfLvR~s~~~~~~~~~~~vlSv~~~~-------~~~~~h~vi~~~~~~~~~~-~~~~F~si~~li~~~~~~~~~~~~- 138 (474)
T KOG0194|consen 68 DGDFLVRASEPKEGEKREFVVLSVKWSV-------FKKIKHYVIKRNGNLFFFE-GLRKFPTISELVNYYKFSKLEITG- 138 (474)
T ss_pred CCceEEEeecccCCcceeEEEEEEEeec-------CCceeEEEEEEcCCeeEEe-ccccCCcHHHHHHHHHhcccceec-
Confidence 6999999886665544444 67776431 1134589888766644432 222232 1222221111000000
Q ss_pred hcCCCCCCCCCCCcccccccccccccCceeeeCceEEEEEEE--C-C---ceEEEEEeecCCCChHHHHHHHHHHHHHHH
Q 014783 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--N-G---EDVAIKILERPENNPEKAQVMEQQFQQEVM 188 (418)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~ 188 (418)
.+......-....|++..++..+.++||+|+||+||+|++ . + ..||||..+...... .....+|.+|++
T Consensus 139 --~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~---~~~~~e~m~EAr 213 (474)
T KOG0194|consen 139 --KNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELT---KEQIKEFMKEAR 213 (474)
T ss_pred --cceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccccc---HHHHHHHHHHHH
Confidence 0000000113467999999999999999999999999986 2 2 238999987522111 122478999999
Q ss_pred HHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 014783 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (418)
Q Consensus 189 il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 268 (418)
+|++++|||||++||++..+.+++||||+|+||+|.+||++... .++......++.+++.||+|||++++|||||.++|
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 99999999999999999999999999999999999999987643 69999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecccceeecccCCCC-CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014783 269 LLISADKSIKIADFGVARIEVQTEGMT-PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346 (418)
Q Consensus 269 ILl~~~~~vkl~DfGla~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 346 (418)
+|++.++.+||+|||+++....-.... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.++...+..
T Consensus 293 cL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~ 372 (474)
T KOG0194|consen 293 CLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK 372 (474)
T ss_pred heecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH
Confidence 999999999999999997543211112 1235689999999999999999999999999999999 89999999999988
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
..++..+++...|...+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 888899999999999999999999999999999999999999999999877653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=401.40 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=224.5
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|..++.||+|+|+.||.+++ +|+.||+|++.+....... ..+.+.+|++|.++|+|||||+++++|++...+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~---~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK---QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc---hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 5688999999999999999987 7899999999764433222 2367889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-cc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~ 291 (418)
||.|+|..++|.+++++ .+.+++..+..++.||+.||.|||+++|||||||..|+|++++.+|||+|||||.... +.
T Consensus 95 ivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999999984 4679999999999999999999999999999999999999999999999999998776 44
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
+...+.||||.|.|||++...+++..+||||+||+||-||.|++||+..+-.+....+....+. +|..++.+..+||.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHLSAEAKDLIR 250 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--cccccCHHHHHHHH
Confidence 6778899999999999999999999999999999999999999999998888887777666555 55688899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
++|+.||.+|||+++|+.
T Consensus 251 ~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCCcccCCCHHHHhc
Confidence 999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=383.16 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=213.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|.+.+.||.|+||+||+|+. ++..||||.+.+...... ..+-+..|+.+|+.++|||||+|++++..++.+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k----~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKK----LVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHH----HHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4677778899999999999987 678999999977653332 2255779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC------CCEEEeecccce
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD------KSIKIADFGVAR 286 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~------~~vkl~DfGla~ 286 (418)
||||||+||+|.+|++.+ +.+++..+..++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+
T Consensus 86 lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999999875 369999999999999999999999999999999999999875 468999999999
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCChHH
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-GVRPVIPNDCLPV 365 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 365 (418)
...+.....+.||++.|||||++..+.|+.|+|+||+|+++|+|++|+.||...+..+....+-.. ...+..+..++..
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence 988777778899999999999999999999999999999999999999999999888866543332 2344555566667
Q ss_pred HHHHHHHhcccCCCCCCCHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTE 386 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~e 386 (418)
+.+++...++.+|.+|-++.+
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFED 264 (429)
T ss_pred hhhhhhHHHhcCccccCchHH
Confidence 778888888888888876654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=389.49 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=216.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHH-HHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
.+.|.+.+.||+|+||.|-+|.. +|+.||||++++........ ..-.....+|+++|++|+|||||++++++.....
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999975 88999999998655433221 1111345799999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCEEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~---~~vkl~DfGla~~ 287 (418)
.|+||||++||.|.+++-.. +.+.+..-..++.|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999764 458888888999999999999999999999999999999876 6799999999999
Q ss_pred ecccCCCCCCCCCccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCC
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRP---YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PND 361 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~ 361 (418)
..+...+.+.|||+.|.|||++..+. +..++|+||+||+||-+|+|.+||.+......+.+.+..|.-... ...
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 88888889999999999999997765 334889999999999999999999877665545555555544333 346
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++..+||.+||..||++|||++|+++
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 7889999999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=372.78 Aligned_cols=255 Identities=26% Similarity=0.462 Sum_probs=216.0
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe-EEeeCc
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG-ACRKRM 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~ 209 (418)
.+.+|+++++||.|+||+||++.. +|..||.|.++-...+.. ..+....|+.+|++|+|||||++++ .+.++.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k----~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAK----ARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHH----HHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 456789999999999999999975 899999999874433322 2367889999999999999999999 455544
Q ss_pred -eEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCcEEEcCCCCEEEeec
Q 014783 210 -VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG--LG--FIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~--iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.++||||+|.+|+|.++++. .+.+.+++..+|+++.|+|.||.++|+ .. |+||||||.||+++.+|.|||.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 49999999999999999974 345789999999999999999999999 45 999999999999999999999999
Q ss_pred ccceeecccCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-C
Q 014783 283 GVARIEVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP-N 360 (418)
Q Consensus 283 Gla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~ 360 (418)
|+++....... ..+..|||+||+||++...+|+.||||||+||++|||+.-++||.+.+-.+.. ..+..+-.+++| .
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~-~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC-KKIEQGDYPPLPDE 251 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH-HHHHcCCCCCCcHH
Confidence 99997654433 45678999999999999999999999999999999999999999998665544 445556555666 6
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
..+..+.+|+..|+..||+.||+.-.++..++
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 67899999999999999999998544444333
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=413.84 Aligned_cols=264 Identities=31% Similarity=0.579 Sum_probs=231.4
Q ss_pred CcccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv 199 (418)
...-+|.+.++...+.||+|+||+||+|+.. .+.||||.++..... .+.++|.+|+.++..++|||||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-----~~~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-----QARQDFRREAELLAELQHPNIV 552 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-----HHHHHHHHHHHHHHhccCCCeE
Confidence 3445688899999999999999999999863 247999999764432 2347999999999999999999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRA----VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~----~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (418)
+|+|+|.+++.+|+|+|||..|+|.+||+.+. +.. ++..+.+.||.|||.||.||-++.+|||||..+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 99999999999999999999999999998642 123 778889999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecccceeecccCCCCCC---CCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014783 268 NLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAV 343 (418)
Q Consensus 268 NILl~~~~~vkl~DfGla~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~ 343 (418)
|+||+++..|||+|||+++..-..+.+... .-.++|||||.|..+.||.+||||||||+|||+++ |+.||.+.++.
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999999999999999999865444443322 23589999999999999999999999999999999 99999999999
Q ss_pred HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 344 QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+++..+.. +.-...|+.||.++++||..||+.+|.+||+|+||-..|+....
T Consensus 713 EVIe~i~~-g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 EVIECIRA-GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHc-CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 98766544 44488999999999999999999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=398.51 Aligned_cols=268 Identities=32% Similarity=0.644 Sum_probs=240.3
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
.-+.|+|+.+.+.-++.||.|+.|.||+|+..++.||||.++. .-..+++-|++|+||||+.+.|+|
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceeeEeeee
Confidence 4567999999999999999999999999999999999998742 122578889999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.....+|||||||..|-|.+.|+. ++.+....+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||.+
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence 999999999999999999999976 456888999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
+...+-...-.++||..|||||+++..+.+.|+|||||||+|||||||..||.+......++-+=..-+..+.|..||+.
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 339 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence 87665555667889999999999999999999999999999999999999999887766666555555667889999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhhhhcccc
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFR 408 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~~~~r~~ 408 (418)
|.-||++||+.+|..||+|.+++..|+-+..++-....+..|.
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~ 382 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFK 382 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHH
Confidence 9999999999999999999999999998877777666665553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=375.48 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=217.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--e
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--V 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--~ 210 (418)
.++..++.||+|+||.||++.. +|+..|||.+....... .+.+.+|+.+|++++|||||+++|...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 4567789999999999999988 47999999987652111 356889999999999999999999744433 6
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeecccceeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEV 289 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfGla~~~~ 289 (418)
++|.|||+++|+|.+++....+ .+++..+..++.||++||+|||++|||||||||+|||++. ++.+||+|||++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999998765 7999999999999999999999999999999999999999 7999999999998655
Q ss_pred c----cCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 290 Q----TEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQN-MTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 290 ~----~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
. ........||+.|||||++..+ ....++|||||||++.||+||..||.. ....+....+......|.+|..++
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 3 1223457899999999999863 233599999999999999999999988 566666666666677778999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+..++|+.+|+..||++|||+++|++.--...
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999999998655443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=361.13 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=214.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|+.+.++|+|+||.||+++. +|+.||||.+.....++. ..+-.++|+.+|++|+|||+|.|+.+|.....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~----VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV----VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH----HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 4577788999999999999986 899999999976655432 3466789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-cc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~ 291 (418)
||+|||+. ++.+-|...+ ..++...+.+++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... ++
T Consensus 78 LVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99999977 5556665554 458899999999999999999999999999999999999999999999999999876 66
Q ss_pred CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Q 014783 292 EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN------------------- 351 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~------------------- 351 (418)
..++-...|..|.|||.+.+ -.|+..+||||+||++.||++|.+-|++.+..+.++.+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 67788889999999999988 5799999999999999999999999999998887766532
Q ss_pred cCCCCCCCC----------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 KGVRPVIPN----------DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 ~~~~~~~~~----------~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.|++.+.|+ ..+..+.+|+++||+.||.+|++.+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 122222221 24556889999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=382.18 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=222.6
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCc
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~ 209 (418)
...+|.+++.||+|+|++|++|+. +++.||||++.+.....++. .+.+.+|..+|.+| .||.|++||..|.++.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K---vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK---VKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc---cchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 357899999999999999999987 78899999997665444332 25677899999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+|+||+++|+|.+++++. +.+.+..+..++.+|+.||+|||++|||||||||+|||+|.|+++||+|||.|+...
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999999875 569999999999999999999999999999999999999999999999999998654
Q ss_pred ccCC--------------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 014783 290 QTEG--------------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR 355 (418)
Q Consensus 290 ~~~~--------------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 355 (418)
+... ..+.+||..|.+||++..+..+..+|+|+|||+||+|+.|.+||.+.+..-....++.-.+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y- 304 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY- 304 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-
Confidence 3211 1346799999999999999999999999999999999999999999988777777666443
Q ss_pred CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 356 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.+|+..++...+|+++.|..||.+|+|.+||.+.
T Consensus 305 -~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 -EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 4788889999999999999999999999998873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=380.51 Aligned_cols=263 Identities=30% Similarity=0.621 Sum_probs=220.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~ 200 (418)
.|+|+.++|++.+.||+|+||.||+|.+ +++.||||++........ .+.+.+|+.++..+ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE-----HKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHH-----HHHHHHHHHHHHHhccCcceee
Confidence 4889999999999999999999999974 235799999864332211 25688999999999 8999999
Q ss_pred EEeEEeeC-ceEEEEEeecCCCCHHHHHhhhc------------------------------------------------
Q 014783 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (418)
Q Consensus 201 l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------ 231 (418)
++++|... ..+++||||+++|+|.+++....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 99998754 46899999999999999997532
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCC
Q 014783 232 ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTP 296 (418)
Q Consensus 232 ------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~ 296 (418)
...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 12477788899999999999999999999999999999999999999999999975432211 122
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 375 (418)
..++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.....+..+.....+..+++.+.+++.+||+
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999999999999999999999999997 9999988665554555566666666677888999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhHH
Q 014783 376 TNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 376 ~dp~~RPt~~ell~~L~~~~~ 396 (418)
.||++|||+.||++.|+++..
T Consensus 316 ~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 316 GDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=388.16 Aligned_cols=264 Identities=34% Similarity=0.709 Sum_probs=229.9
Q ss_pred CcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.++|+|..+++.++..||+|.||+||+|+|.| .||||+++.....+++ .+.|++|+.++++-+|.||+-+.|+|.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q----lqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ----LQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH----HHHHHHHHHHHhhcchhhheeeehhhc
Confidence 47899999999999999999999999999976 6999999988777653 378999999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+... .||+.+|+|-+|+.+++... ..+.....+.|+.||+.||.|||.++|||||||..||++.+++.|||+|||++.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 9876 89999999999999998643 668999999999999999999999999999999999999999999999999997
Q ss_pred eecc---cCCCCCCCCCccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---
Q 014783 287 IEVQ---TEGMTPETGTYRWMAPEMIQHR---PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--- 357 (418)
Q Consensus 287 ~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--- 357 (418)
.... ........|...|||||+++.+ +|+..|||||||+++|||+||..||...+.+..++ ++.+|+-.+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-mVGrG~l~pd~s 615 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-MVGRGYLMPDLS 615 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-EecccccCccch
Confidence 5432 2334556788999999999644 79999999999999999999999999555544443 355554332
Q ss_pred -CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 358 -IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 358 -~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
....|+.++++|+..||..++++||.|.+|+..|+.+...+
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 23478899999999999999999999999999998887654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=353.77 Aligned_cols=241 Identities=24% Similarity=0.428 Sum_probs=216.4
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
...++|+..+.||.|+||.|.+++. +|..+|+|++.+.....-+ ..+...+|..+|+.+.||+++++++.|.+..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklK---QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLK---QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHH---HHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 3567888999999999999999987 6789999999764433222 1357789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+||||++||.|+.++++. +.+++..+..+|.||+.||+|||+++|++|||||+|||+|.+|++||+|||+|+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999999999864 469999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.. .-+.||||.|+|||+++.++|+.++|+|||||++|||+.|.+||-..++......++...+. .|...++.+++|
T Consensus 196 ~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~~~kdL 271 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSSDAKDL 271 (355)
T ss_pred Cc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCHHHHHH
Confidence 43 55679999999999999999999999999999999999999999999998888787777655 677888999999
Q ss_pred HHHhcccCCCCC
Q 014783 370 MTRCWDTNPEVR 381 (418)
Q Consensus 370 i~~cl~~dp~~R 381 (418)
+.+.++.|-.+|
T Consensus 272 l~~LL~vD~t~R 283 (355)
T KOG0616|consen 272 LKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhhhhHhh
Confidence 999999998888
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=410.52 Aligned_cols=266 Identities=33% Similarity=0.630 Sum_probs=232.2
Q ss_pred cccccccccCceeeeCceEEEEEEE---CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
++...+++...||+|+||.||.|.+ .+. .||||.+.+.....+ ..+|++|+.+|++++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-----~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-----VSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-----HHHHHHHHHHHhcCCCcceeeEEEe
Confidence 4577888999999999999999987 332 489998876443322 3689999999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRR-----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
|.+....+|++|||+||+|..||++. +...++...++.++.|||+|++|||++++|||||.++|+|++....|||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 99999999999999999999999874 2456889999999999999999999999999999999999999999999
Q ss_pred eecccceeecccCCCCC--C-CCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 014783 280 ADFGVARIEVQTEGMTP--E-TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~--~-~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 355 (418)
+|||+|+.....+.+.. . .-..+|||||.+..+.||.|+|||||||+|||++| |..||.+.++.+.....+..+ +
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 99999994433332221 1 23479999999999999999999999999999999 999999999999887777777 9
Q ss_pred CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhhh
Q 014783 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVR 403 (418)
Q Consensus 356 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~~ 403 (418)
...|..|++.++++|.+||+.+|++||+|..|++.+.++.+.......
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 999999999999999999999999999999999999888776654433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=395.60 Aligned_cols=261 Identities=31% Similarity=0.585 Sum_probs=233.4
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CC---ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+|+...+.+.++||.|.||+||+|++ .| ..||||.++.....+. ...|+.|+.||.++.||||++|.|+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq-----rrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ-----RRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH-----HhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 47778889999999999999999987 33 4899999986554332 26899999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.......||+|||++|+|..||+.+.+ .+..-++..++..|+.||+||-++|+|||||.++||||+.+..+||+|||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999998764 4888889999999999999999999999999999999999999999999999
Q ss_pred eeecccC--CCCCCCC--CccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 286 RIEVQTE--GMTPETG--TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 286 ~~~~~~~--~~~~~~g--t~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
|...+.. .+++..| .++|+|||.+....+|.+|||||+||+|||.++ |..||.++++.+++. .+..+++.+-|-
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-aIe~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-AIEQGYRLPPPM 857 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-HHHhccCCCCCC
Confidence 9765433 2233333 379999999999999999999999999999998 999999999988764 578899999999
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
+||..|++||..||++|-.+||+|.||+..|+++.-.=
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999999999987433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=375.28 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=220.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCc
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~ 209 (418)
..++|.+.++||.|.||.||+|+. +++.||||.+++....-+.. .=+||++.|++|+ |||||+|..++.+..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-----~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-----MNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-----HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 356888999999999999999986 78899999998776654332 3358999999998 999999999998887
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+|+||||| ..+|.++++.+ ++.+++..+..|+.||+.||+|+|++|++||||||+||||.....+||+|||+||..
T Consensus 83 ~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 83 RILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred ceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 999999999 56999999987 789999999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--------------- 352 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~--------------- 352 (418)
....+++....|..|.|||++. ..-|+.+.|+|++||+++|+.+-++-|++.+..+.++.+..-
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 8888899999999999999984 557999999999999999999999999999988887766420
Q ss_pred ----CCC----------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 353 ----GVR----------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 353 ----~~~----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+++ ..+| .++.+..++|.+|++|||++|||+.|.++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 0122 377889999999999999999999998873
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=361.61 Aligned_cols=259 Identities=22% Similarity=0.394 Sum_probs=221.9
Q ss_pred cccccccccc--CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-
Q 014783 131 TIDLRKLNMG--TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK- 207 (418)
Q Consensus 131 ~i~~~~~~~~--~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 207 (418)
.|+.++++.. ..||+|++|.||+|+++|+.||||+++...... ....+.+.+|+.+|++++||||+++++++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 3445555555 679999999999999999999999987543322 1223678899999999999999999999876
Q ss_pred ---CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 208 ---RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 208 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
...+++||||+++|+|.+++... ..+++...+.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence 34689999999999999999764 458889999999999999999998 499999999999999999999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+...+.++..|..
T Consensus 169 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (283)
T PHA02988 169 LEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLD 246 (283)
T ss_pred hHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCc
Confidence 99754322 234568899999999976 68999999999999999999999999998877766666667777777778
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+++.+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=374.15 Aligned_cols=251 Identities=27% Similarity=0.507 Sum_probs=219.0
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCc
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~ 209 (418)
....|.+++.||+|+||.|++|.. +++.||+|++.+....... ....+.+.+|+.+++.++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 356788999999999999999976 7899999987664222111 223456779999999999 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeecccceee
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIE 288 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfGla~~~ 288 (418)
.+|+||||+.||+|.+++.. .+.+.+..+.+++.|++.|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999987 4568899999999999999999999999999999999999999 99999999999977
Q ss_pred -cccCCCCCCCCCccccccccccCCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-hH
Q 014783 289 -VQTEGMTPETGTYRWMAPEMIQHRP-YT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDC-LP 364 (418)
Q Consensus 289 -~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 364 (418)
.........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...+.......+... ...+|..+ ++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S~ 249 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLSP 249 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCCH
Confidence 4556678889999999999999987 86 7899999999999999999999997766655554333 33466666 89
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIV 388 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell 388 (418)
.+..|+.+|+..||.+|+|+.+++
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHh
Confidence 999999999999999999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=378.20 Aligned_cols=261 Identities=30% Similarity=0.655 Sum_probs=233.6
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC----Cc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~----~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
.++++.++.+.+.+.||.|.||.||+|.++ |+ .||||..+....... .+.|+.|+.+|++++||||++|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIikL 456 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIKL 456 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhhe
Confidence 367788889999999999999999999883 33 689999876443332 2689999999999999999999
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
+|+|.+... +||||+++-|.|..||+... ..++...+..++.||+.+|+|||+.++|||||.++||||.....|||+|
T Consensus 457 IGv~~e~P~-WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 457 IGVCVEQPM-WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eeeeeccce-eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecc
Confidence 999998764 69999999999999998653 5699999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCCCCCCCC--CccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 282 FGVARIEVQTEGMTPETG--TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
||+++...+...+....| .+.|||||.+....||.+||||.|||.+||++. |..||.+..+.+++. .+..|-+.+.
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeRlP~ 613 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGERLPC 613 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCCCCC
Confidence 999998877776666555 489999999999999999999999999999998 999999988877653 4678899999
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
|+.||+.++.||.+||..+|.+||.+.||...|.++..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=359.58 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=222.7
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
...|.++.++|++...||.|..++||+|+. +++.||||++.-...+.. .+.+.+|+..|+.++||||++++..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-----ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-----LDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-----HHHHHHHHHHhhhcCCCCcceEEEE
Confidence 346778889999999999999999999987 789999999976443322 3678899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
|..+..+++||.||.+|++.++++..-...+.+..+..|+.++++||.|||.+|.||||||+.||||+.+|.|||+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999999987777899999999999999999999999999999999999999999999999998
Q ss_pred ceeecccC-C----CCCCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 014783 285 ARIEVQTE-G----MTPETGTYRWMAPEMIQ--HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 285 a~~~~~~~-~----~~~~~gt~~y~aPE~~~--~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 357 (418)
+-...... . .....||++|||||++. ..+|+.|+|||||||+..||++|..||..+.+.+.+...+.......
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 75433222 1 14568999999999963 34799999999999999999999999999999988776665443211
Q ss_pred C----C----CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 358 I----P----NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 358 ~----~----~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. + ...+..+++++..||..||.+|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 1 124567999999999999999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=374.26 Aligned_cols=247 Identities=29% Similarity=0.522 Sum_probs=221.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
...|....+||+|+.|.||.++. +++.||||.+........ +-+.+|+.+|+..+|+|||.+++.+...+.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k------eLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK------ELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch------hhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 34566678999999999999976 678999999976554432 5678999999999999999999999888999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++|||||+||+|.|.+... .+++.++..++.+++.||+|||.+||||||||.+|||++.+|.+||+|||++......
T Consensus 346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999999998753 4899999999999999999999999999999999999999999999999998766544
Q ss_pred C-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHHHHHH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVLSEI 369 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 369 (418)
. ......|||+|||||+...+.|+.|.||||||++++||+-|.+||-..++...++.+...|... ..++.++++|++|
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 3 5677899999999999999999999999999999999999999999999988888777766443 4567789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||..|+++||++.|||+
T Consensus 503 L~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcchhcCCCHHHHhc
Confidence 99999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=367.14 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=216.3
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
.+..++|++++.||+|+||+||+++. +|..+|+|++++...... .+ .+.++.|..+|....+|.||+||..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~-~Q--v~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKK-NQ--VEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhh-hh--HHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 35678999999999999999999975 899999999987654321 11 25778999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+||||||++||++..+|... +.+++..+..++.+++.|++-||+.|||||||||+|+|||..|++||+||||+.-.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999999999764 56999999999999999999999999999999999999999999999999998521
Q ss_pred cc----------------------cC-C-----C--------------------CCCCCCccccccccccCCCCCCcchH
Q 014783 289 VQ----------------------TE-G-----M--------------------TPETGTYRWMAPEMIQHRPYTQKVDV 320 (418)
Q Consensus 289 ~~----------------------~~-~-----~--------------------~~~~gt~~y~aPE~~~~~~~t~~sDv 320 (418)
.. .. . . .+..|||.|+|||++.+.+|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 00 0 0 12249999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 014783 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRCWDTNPEVRPP---FTEIVR 389 (418)
Q Consensus 321 wSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt---~~ell~ 389 (418)
||||||+||||.|.+||...++.+....++........| ..++++..+||.+|+. ||++|.- ++||..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999999999888877766444444 3567899999999999 9999964 666554
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=371.68 Aligned_cols=265 Identities=32% Similarity=0.590 Sum_probs=225.4
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCC
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp 196 (418)
+...+|.++.++|++++.||+|+||.||+|++ ++..||||+++....... .+.+.+|+.++..+ +||
T Consensus 25 ~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~Ei~il~~l~~Hp 99 (375)
T cd05104 25 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHI 99 (375)
T ss_pred CCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----HHHHHHHHHHHHHhcCCc
Confidence 34567899999999999999999999999974 345899999865432221 25678999999999 899
Q ss_pred CeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc---------------------------------------------
Q 014783 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------------------------------------- 231 (418)
Q Consensus 197 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------- 231 (418)
||++++++|......++||||+++|+|.+++....
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 99999999999999999999999999999996532
Q ss_pred ----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 232 ----------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 232 ----------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG 259 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFG 259 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCc
Confidence 1246788899999999999999999999999999999999999999999999
Q ss_pred cceeecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 284 VARIEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 284 la~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
+++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||............+..+.++..|
T Consensus 260 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 339 (375)
T cd05104 260 LARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339 (375)
T ss_pred cceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC
Confidence 99765332211 12234567999999999999999999999999999998 999998877666666777777777777
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
...+.++.+|+.+||+.||++|||+.||++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 77889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.88 Aligned_cols=267 Identities=30% Similarity=0.576 Sum_probs=225.9
Q ss_pred CCCCcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CC
Q 014783 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KH 195 (418)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 195 (418)
++..+.|.++.++|++.+.||+|+||.||++++ ++..||||++........ ...+.+|+.+++.+ +|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~~h 101 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----REALMSELKILSHLGQH 101 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----HHHHHHHHHHHHhhccC
Confidence 445678999999999999999999999999875 224799999965433221 25678999999999 89
Q ss_pred CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------------------------------------
Q 014783 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------------------------------------- 231 (418)
Q Consensus 196 pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------- 231 (418)
|||++++++|.....+++||||+++|+|.+++....
T Consensus 102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (374)
T cd05106 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY 181 (374)
T ss_pred CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence 999999999999999999999999999999986421
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 232 ------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 232 ------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence 12467888999999999999999999999999999999999999999999999975
Q ss_pred ecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 288 EVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 288 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
....... ....++..|+|||++....++.++|||||||++|||++ |+.||............+..+..+..+...+
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAP 341 (374)
T ss_pred ccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCC
Confidence 4332211 12234568999999998899999999999999999997 9999988766555566666667777777778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+.+.+++.+||+.||++|||+.++++.|+++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=369.10 Aligned_cols=258 Identities=33% Similarity=0.582 Sum_probs=207.4
Q ss_pred cccccccccCceeeeCceEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc-
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~- 209 (418)
-..++|.-...||+|+||.||+|... ++.||||.+....... ..+|.+|+.++.+++|||+|+|+|+|.+..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 34466777789999999999999984 5899999876543321 146999999999999999999999999988
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
..+||+|||++|+|.++|.......++|..+++||.++|.||+|||+.. ||||||||+|||+|++.++||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 4999999999999999998754337899999999999999999999854 9999999999999999999999999997
Q ss_pred eecc-cCCCCCC-CCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcC-----
Q 014783 287 IEVQ-TEGMTPE-TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT------AVQAAFAVVNKG----- 353 (418)
Q Consensus 287 ~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~------~~~~~~~~~~~~----- 353 (418)
.... ....... .||..|+|||++..+..|.|+|||||||+|+|++||+.|.+... ..+.....+..+
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 6543 2222222 79999999999999999999999999999999999998876432 122112222222
Q ss_pred CCCCCC-CC-----ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 354 VRPVIP-ND-----CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 354 ~~~~~~-~~-----~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
..+.+. .. ....+..+..+|++.+|.+||++.|++++|+.+.
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 222222 12 2234667889999999999999999999995544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=373.57 Aligned_cols=278 Identities=25% Similarity=0.399 Sum_probs=231.8
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~ 207 (418)
.+..++|.++++||+|+||+|+++.. +++.+|||++++...-..+. .+..+.|..|+... +||.+++|+.+|++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~---Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE---VESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc---HHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 46778999999999999999999987 67799999998765443222 14566788887777 59999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..++|+||||+.||++..+. ..+.+++..+..+++.|+.||.|||++||||||||.+|||+|.+|++||+|||+++.
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred CCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999999954333 336699999999999999999999999999999999999999999999999999987
Q ss_pred ec-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 288 EV-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 288 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
.. ......+.||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+....++... +..|..++.+.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--~~yP~~ls~ea 595 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSKEA 595 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCcccHHH
Confidence 55 5556778899999999999999999999999999999999999999999999999888887764 44677889999
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHH--HHHhh-HHHHhhhhhhccccccCCCCcc
Q 014783 367 SEIMTRCWDTNPEVRPPF-----TEIVR--MLENA-ETEIMTTVRKARFRCCMTQPMT 416 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~-----~ell~--~L~~~-~~~~~~~~~~~r~~~~~~~~~~ 416 (418)
.++|+++|..||++|.-+ ++|.. .+..+ ++++....-+..|+..++.|-+
T Consensus 596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D 653 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPED 653 (694)
T ss_pred HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhh
Confidence 999999999999999765 34433 23333 3555555555556555555443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.59 Aligned_cols=264 Identities=31% Similarity=0.579 Sum_probs=224.9
Q ss_pred CcccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpni 198 (418)
...|+++.++|.+++.||+|+||.||+|++. +..||||++....... ..+.+.+|+.+++++. ||||
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCCe
Confidence 4679999999999999999999999999862 2369999986543221 1257889999999996 9999
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc-----------------------------------------------
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------------------------------- 231 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------- 231 (418)
++++++|.+...+|||||||++|+|.+++....
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 999999999999999999999999999986521
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 014783 232 -----------------------------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (418)
Q Consensus 232 -----------------------------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 264 (418)
...+++..++.++.||+.||+|||+.+|+||||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 124777888999999999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014783 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNM 340 (418)
Q Consensus 265 kp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~ 340 (418)
||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999999976433221 122346688999999998899999999999999999997 99999887
Q ss_pred CHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
.........+..+.++..+..++..+.+++.+||+.||++|||+.+|.+.|+.+.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 7666666666777777777888999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=344.67 Aligned_cols=257 Identities=33% Similarity=0.591 Sum_probs=222.1
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|.|+.++|++.++||+|+||.||+|.+ ++..||+|.+...... .+.+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 788999999999999999999999987 5678999987643221 25788999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999999999998766667899999999999999999999999999999999999999999999999999865
Q ss_pred cccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
..... .....++..|+|||.+....++.++||||||+++|+|++ |..||......+.... +....+.+.+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA-LQRGYRMPRMENCPDE 232 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHH
Confidence 43221 122345678999999998889999999999999999998 9999988776665444 4445555555678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+.+++.+||+.+|++||+++++++.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=346.51 Aligned_cols=256 Identities=29% Similarity=0.541 Sum_probs=217.5
Q ss_pred cccccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
|+..+|++.+.||+|+||.||+|.+ .+..||+|.++...... ....+.+|+.++++++||||+++++++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 4567889999999999999999975 24589999987543221 1256889999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.+...++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999999999999764 3468999999999999999999999999999999999999999999999999876
Q ss_pred eecccCCCC--CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 287 IEVQTEGMT--PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 287 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
......... ...++..|+|||.+.+..++.++|||||||++||+++ |..||......+... .+..+.....+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK-AVEDGFRLPAPRNCP 234 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCCCCCCCCC
Confidence 432221111 2234678999999999999999999999999999876 999999887766544 345566666788899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..+.+++.+||+.+|++||+++||++.|.++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=350.76 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=208.4
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|+..+.||+|+||.||++.. +++.||||.+........ .....+.+|+.++++++|+||+++++++.+...+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 56678899999999999986 688999999865432211 1124577999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999999998887655556899999999999999999999999999999999999999999999999999865444444
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA---AFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ ....+ .......+...++.+.+|++
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcccccCCccCCHHHHHHHH
Confidence 556799999999999999999999999999999999999999987554221 11212 12223455667889999999
Q ss_pred HhcccCCCCCCC-----HHHHHH
Q 014783 372 RCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt-----~~ell~ 389 (418)
+||+.||++||+ ++++++
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhc
Confidence 999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=367.85 Aligned_cols=248 Identities=27% Similarity=0.523 Sum_probs=221.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
-|++++-||.|+.|.|-+|+. +|+.+|||++.+....... ....+.+|+.||+.+.|||+++||+++.+...+|+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s---~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSS---QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccc---cccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 346789999999999999987 8999999999765322211 12467799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
|.||++||.|++++..+ +.+++..+.+++.||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|....++..
T Consensus 90 vlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999865 5699999999999999999999999999999999999999999999999999999888888
Q ss_pred CCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
..+.||++.|.|||++.+.+|. .++||||.||+||.||||+.||++.+-...+..+....+. +|..++++.++|+++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCCHHHHHHHHH
Confidence 8999999999999999999886 6899999999999999999999987777666655544444 568889999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~ 390 (418)
|+..||.+|.|.+||++.
T Consensus 246 ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKH 263 (786)
T ss_pred HhccCccccccHHHHhhC
Confidence 999999999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=329.89 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=226.4
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
...|. .++|++++.||.|-||.||+|+. ++-.||+|++.+.... .....+++.+|++|.+.|+||||+++|++
T Consensus 16 ~~~~~--l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~---~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 16 TKTWT--LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL---KTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred ccccc--hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH---HhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34555 47899999999999999999987 5668999999764421 22345789999999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
|.+...+||++||..+|+|...|.......+++..++.++.|++.||.|+|..+||||||||+|+|++.++.+||+|||.
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 99999999999999999999999987788899999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
+-... .....+.|||..|.|||...+..++..+|+|++|++.||++.|.+||...+..+....+.. .+..+|...+.
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p~~is~ 247 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFPSTISG 247 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCCcccCh
Confidence 86543 5667788999999999999999999999999999999999999999999886665555443 34456678889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
...++|.+|+..+|.+|.+..|++..
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhh
Confidence 99999999999999999999998764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=344.05 Aligned_cols=257 Identities=29% Similarity=0.627 Sum_probs=222.9
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|+++..+|.+.+.||+|+||.||+|.+ +++.||+|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 778888999999999999999999987 5789999998643211 2467899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+..+++||||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+|||+++++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999999765556689999999999999999999999999999999999999999999999999976
Q ss_pred ecccCCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 288 EVQTEGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 288 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ ....+..+..+..+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPP 232 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCH
Confidence 5332211 11234568999999999999999999999999999998 999998876654 3455666677777888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=356.36 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=214.8
Q ss_pred ccc-cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 129 EWT-IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 129 ~~~-i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
.|. .....|+.+.+||+|.||.||++++ +|+.||+|.++......+.. ....+|+.||++|.||||++|.+..
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~----~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP----ITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch----HHHHHHHHHHHhcCCCcccceeeEE
Confidence 443 3446788899999999999999987 78899999998765444332 3456999999999999999999998
Q ss_pred eeC--ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 206 RKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 206 ~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
.+. ..+|+|+|||+. +|.-++.. .+-.|++.++.-++.|++.||+|||++||+|||||.+|||||.+|.+||+|||
T Consensus 186 t~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEecccc
Confidence 876 689999999976 88888764 45579999999999999999999999999999999999999999999999999
Q ss_pred cceeecccC--CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------
Q 014783 284 VARIEVQTE--GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------- 353 (418)
Q Consensus 284 la~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------- 353 (418)
+|+++.... .++..+.|..|.|||++.+. .|+.+.|+||.||||.||+.|++.|++.+..+.+..+..--
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 999765433 57888899999999999876 69999999999999999999999999999988877665310
Q ss_pred -----------CCCCCC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 -----------VRPVIP---------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 -----------~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+..+ ...++...+|+..+|..||.+|.|+.+.++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111 124566778999999999999999988775
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=350.47 Aligned_cols=256 Identities=32% Similarity=0.543 Sum_probs=208.8
Q ss_pred ccccccccCceeeeCceEEEEEEEC------------------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 194 (418)
...+|++.+.||+|+||.||++.+. +..||+|++....... ....+.+|+.++.+++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN-----ARNDFLKEVKILSRLK 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH-----HHHHHHHHHHHHhhcC
Confidence 4567888999999999999999752 2369999986543211 2357889999999999
Q ss_pred CCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 014783 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------------NRAVPLKLAVKQALDVARGMAYVHGL 257 (418)
Q Consensus 195 hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~qi~~gL~yLH~~ 257 (418)
||||+++++++......++||||+.+|+|.+++.... ...+++..+++++.||+.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999999999899999999999999999986532 12467788999999999999999999
Q ss_pred CcccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh--
Q 014783 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-- 332 (418)
Q Consensus 258 ~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-- 332 (418)
||+||||||+|||++.++.+||+|||+++....... .....++..|+|||++....++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999975433221 122345788999999988889999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHh------cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 333 GLLPFQNMTAVQAAFAVVN------KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 333 g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+..||...+..+....... .......++.++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6788987766554332211 112233456788999999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=347.96 Aligned_cols=247 Identities=32% Similarity=0.668 Sum_probs=207.4
Q ss_pred ccCceeeeCceEEEEEEEC------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 139 MGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.+.||.|+||.||+|++. +..|+||.++.. .... ..+.+.+|++++++++||||++++|++.....++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccc----cceeeeeccccccccccccccccccccccccccc
Confidence 4568999999999999987 568999999542 2221 1367889999999999999999999999888899
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+++|+|.+++.......+++..++.++.||+.||+|||+++++|++|+++|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999998756679999999999999999999999999999999999999999999999999997652211
Q ss_pred C---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 293 G---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 293 ~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
. .........|+|||.+....++.++||||||+++|||++ |+.||.+....+....+ ..+.++..+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHH
Confidence 1 222346689999999998889999999999999999999 78999999877765554 667777788889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L 391 (418)
++.+||+.||++|||+.+|++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.38 Aligned_cols=265 Identities=33% Similarity=0.612 Sum_probs=226.7
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCC
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN 197 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn 197 (418)
....|.++.++|.+++.||+|+||.||+|++.+ ..||||+++....... .+.+.+|+.+|.++. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCC
Confidence 345699999999999999999999999998633 5799999975433221 246789999999997 999
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC---------------------------------------------
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------------------------------------- 232 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------- 232 (418)
|++++++|.....+++||||+.+|+|.++++....
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999999999999999999999999999975321
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 014783 233 ---------------------------------------------------RAVPLKLAVKQALDVARGMAYVHGLGFIH 261 (418)
Q Consensus 233 ---------------------------------------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiH 261 (418)
..+++..++.++.||+.||+|||+.+++|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 23567778899999999999999999999
Q ss_pred CCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014783 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF 337 (418)
Q Consensus 262 rDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf 337 (418)
|||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999976432211 122346788999999998889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
......+.....+..+.++..|..++..+.+++.+||..+|.+||+++||++.|+++.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8877767666777777777778888999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.12 Aligned_cols=257 Identities=32% Similarity=0.581 Sum_probs=221.3
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|+++.++|++.+.||+|+||.||+|.+ +++.||||.++..... .+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 778889999999999999999999987 5568999998654322 24678999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...|+||||+.+++|.+++....+..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999999999997755567899999999999999999999999999999999999999999999999999865
Q ss_pred cccCCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
...... .....+..|+|||.+.+..++.++||||||++++||++ |+.||.+.+...... .+........+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-QVDQGYRMPCPPGCPKE 232 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCCCCCCcCCHH
Confidence 432111 11123457999999999899999999999999999999 999998877665544 34455555566778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+.+++.+||+.+|++||++.+|++.|+++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=345.01 Aligned_cols=256 Identities=32% Similarity=0.627 Sum_probs=217.8
Q ss_pred cccccccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
++.++|++.+.||+|+||.||+|...+ ..||+|.+...... .....+.+|+.++..++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----HHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 345688999999999999999998632 46999998643221 123568899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIL 270 (418)
+......+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 9988899999999999999999975321 45788899999999999999999999999999999999
Q ss_pred EcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014783 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346 (418)
Q Consensus 271 l~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 346 (418)
++.++.++|+|||+++....... .....+++.|+|||.+....++.++|||||||++|||++ |..||.+....+..
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999975433221 223456788999999988889999999999999999998 99999888776644
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
..+..+..+..+..+++++.+|+.+||+.||.+||++.||++.|+.
T Consensus 237 -~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 -EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 4455556666788899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=355.78 Aligned_cols=263 Identities=32% Similarity=0.626 Sum_probs=221.0
Q ss_pred ccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~ 200 (418)
.|.++.++|++.+.||+|+||.||+|.+ +++.||+|+++....... .+.+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-----YKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH-----HHHHHHHHHHHHhhccCcchhh
Confidence 4899999999999999999999999964 236899999864332211 24577899999999 8999999
Q ss_pred EEeEEee-CceEEEEEeecCCCCHHHHHhhhcC-----------------------------------------------
Q 014783 201 FIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (418)
Q Consensus 201 l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------- 232 (418)
++++|.. +..+++++||+++++|.+++.....
T Consensus 76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 9998864 4578999999999999999864321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCC
Q 014783 233 ------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPE 297 (418)
Q Consensus 233 ------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~ 297 (418)
..+++..+.+++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....... ....
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 2578889999999999999999999999999999999999999999999999976432211 1223
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 298 ~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
.++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.....+..+.++..+..+++.+.+++.+||+.
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence 45678999999999999999999999999999998 99999876655555556666667677777889999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhHH
Q 014783 377 NPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 377 dp~~RPt~~ell~~L~~~~~ 396 (418)
+|++||++.||++.|+++..
T Consensus 316 ~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 316 NPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=366.03 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=228.1
Q ss_pred cccccccccccCceeeeCceEEEEEEEC---Cc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN---GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
--|..+++++.++||+|.||.|++|.|+ |+ .||||.++...... ....|++|+.+|.+|+|||+++|||+
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEEeee
Confidence 3477788899999999999999999993 43 79999997665543 23789999999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
..+ ..+.+|+|+++.|+|.+.|++.....+....+..++.||+.||.||.++++|||||.++|+|+-....|||+|||+
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 988 5678999999999999999986667889999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCCCC----CCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 285 ARIEVQTEGMTPET----GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 285 a~~~~~~~~~~~~~----gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
.+-...++.+..+. ..+.|+|||.++...|+.+||||+|||++|||+| |..||.+....+.+. .++.+-+...|
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-~iD~~erLpRP 337 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-NIDAGERLPRP 337 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-hccccccCCCC
Confidence 99766555444332 3578999999999999999999999999999999 999999999887664 46688888999
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..|++.++++|++||..+|.+||||..|.+.+-..
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999999999999999998654443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=345.13 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=222.8
Q ss_pred ccccccccccCceeeeCceEEEEEEECC--ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
.+..++|++++.||+|.-|+||++...+ ..+|+|++.+......+ ...+...|..||+.+.||.++.||+.+..+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk---Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK---KLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh---HHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 4567889999999999999999999854 78999999765433211 125667899999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...|+|||||+||+|..++++..++.+++..+..++.+++.||+|||.+|||+|||||+||||-++|++.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999976421
Q ss_pred c-------c----------------------------c----------------------CCCCCCCCCccccccccccC
Q 014783 289 V-------Q----------------------------T----------------------EGMTPETGTYRWMAPEMIQH 311 (418)
Q Consensus 289 ~-------~----------------------------~----------------------~~~~~~~gt~~y~aPE~~~~ 311 (418)
. . . ....+.+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 01123458999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCC----HHHH
Q 014783 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPP----FTEI 387 (418)
Q Consensus 312 ~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~el 387 (418)
.+.+.++|||+|||++|||+.|..||.+.++.+.+..++.+...-+-.+..+..+++||++.|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999999998877665544567889999999999999999987 6666
Q ss_pred HH
Q 014783 388 VR 389 (418)
Q Consensus 388 l~ 389 (418)
.+
T Consensus 390 K~ 391 (459)
T KOG0610|consen 390 KR 391 (459)
T ss_pred hc
Confidence 54
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=355.99 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=212.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
...+|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK---MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 347888999999999999999988 57899999997532111 1123568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999753 4588999999999999999999999999999999999999999999999999986533
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ....|..++..+.+|+
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLV 246 (329)
T ss_pred C--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHH
Confidence 2 23457999999999999999999999999999999999999999887776655444433 3445666788999999
Q ss_pred HHhcccCCCCCCC-----HHHHHH
Q 014783 371 TRCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt-----~~ell~ 389 (418)
.+||+.||.+||+ +++++.
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999997 677774
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=350.03 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=211.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||++........ ...+.+.+|+.++++++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL---KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh---HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 577889999999999999987 588999999865322111 123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~ 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--R 154 (291)
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--C
Confidence 99999999999999764 4588999999999999999999999999999999999999999999999999976533 2
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHh
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRC 373 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 373 (418)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ..+|...++.+.+++++|
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--cCCCccCCHHHHHHHHHH
Confidence 234579999999999999999999999999999999999999999888766555554433 345666788999999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 014783 374 WDTNPEVRPP-----FTEIVRM 390 (418)
Q Consensus 374 l~~dp~~RPt-----~~ell~~ 390 (418)
|+.||.+||+ ++++++.
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcC
Confidence 9999999995 8887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=358.69 Aligned_cols=259 Identities=32% Similarity=0.552 Sum_probs=221.3
Q ss_pred ccccccccccCceeeeCceEEEEEEECC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+++++.+.+.++||+|.||+|.++...+ .+||||.++....... .+.|.+|+++|.+|+||||+.|+|+|..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-----r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-----RNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-----HHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 4678899999999999999999999866 8999999976544332 368999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+++|+|||++|+|.+|+..+....+.-....+|+.||+.||+||.+.++|||||.++|+|++.++++||+|||.++..-
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999999988754444555677899999999999999999999999999999999999999999998543
Q ss_pred ccCCCCC---CCCCccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHH---hcC---CCCCC
Q 014783 290 QTEGMTP---ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT--GLLPFQNMTAVQAAFAVV---NKG---VRPVI 358 (418)
Q Consensus 290 ~~~~~~~---~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt--g~~Pf~~~~~~~~~~~~~---~~~---~~~~~ 358 (418)
....+.. ..-.++|||||.+..+++|.+||||+||+++||+++ ...||..++..+.....- ... .-+..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 3332221 134589999999999999999999999999999876 889999998877655332 111 22356
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
|.-|+..++++|.+||..+.++||+|++|...|++.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 778999999999999999999999999999998864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=354.05 Aligned_cols=242 Identities=25% Similarity=0.410 Sum_probs=205.9
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+.||+|+||.||+++. +|+.||||++....... ......+.+|+.++++++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 3699999999999987 67899999997532211 111246778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCCC
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~~ 297 (418)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999999998753 4689999999999999999999999999999999999999999999999999975322 2223445
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccC
Q 014783 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 298 ~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 377 (418)
+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... ...+|..+++.+.+++.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCC
Confidence 7999999999999999999999999999999999999999887765554444333 23456778899999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 014783 378 PEVRP-----PFTEIVR 389 (418)
Q Consensus 378 p~~RP-----t~~ell~ 389 (418)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 234 PKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHcCCCCCCCHHHHHc
Confidence 99999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=337.46 Aligned_cols=254 Identities=31% Similarity=0.652 Sum_probs=220.0
Q ss_pred cccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe-eC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~ 208 (418)
|.++..+|++.+.||+|+||.||++...+..||+|.++.... .+.+.+|+.++++++|+|++++++++. ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 778889999999999999999999999999999999854321 246789999999999999999999764 45
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...++|+||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 67899999999999999998765556889999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+.. ..+..+..+..+..+++.+.
T Consensus 153 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 153 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred ccc--CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCCCCCCCCCHHHH
Confidence 322 223345678999999999899999999999999999998 99999877665543 34455666677778899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=354.03 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=215.3
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC---CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
..+.+..++|++.+.||+|+||.||+|++. +..||+|++....... ....+.+.+|+.+++.++||||++++++
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK---QKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 345567788999999999999999999862 2589999986532211 1123567899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.+...+|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 99999999999999999999999754 4589999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.... ...|...++
T Consensus 178 a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~ 253 (340)
T PTZ00426 178 AKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--IYFPKFLDN 253 (340)
T ss_pred CeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCH
Confidence 986532 2334579999999999999889999999999999999999999999877765554444332 235667788
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRP-----PFTEIVRM 390 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RP-----t~~ell~~ 390 (418)
.+.+++++||+.||++|+ +++++++.
T Consensus 254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999999999999995 88888764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=353.65 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=209.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+|++ +++.||||++....... ......+.+|+.++..++||||+++++++......|+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 577889999999999999988 57899999997532111 1123567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence 99999999999999753 4588999999999999999999999999999999999999999999999999975433 3
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC------CCChHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP------NDCLPVLS 367 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~ 367 (418)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........| ..+++.+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999999999999999999999999999999999999887766554443322111111 14578999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+++.+||..+|++||+++++++.
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=335.57 Aligned_cols=255 Identities=36% Similarity=0.624 Sum_probs=219.0
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|.+..++|++.+.||+|+||.||++.+ .+..||+|.+....... +.+.+|+.++++++|||++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-------ESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH-------HHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 778889999999999999999999987 55689999987544332 458899999999999999999998854
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...+++|||+++++|.+++.......+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 45789999999999999998655566899999999999999999999999999999999999999999999999999765
Q ss_pred cccCCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.... +..+.....+...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-VERGYRMPCPQDCPIS 231 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCcCCHH
Confidence 332211 12234568999999988889999999999999999999 9999988777665544 4455566677788899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+.+++.+||..+|++|||++++.+.|++
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=337.58 Aligned_cols=257 Identities=35% Similarity=0.601 Sum_probs=218.4
Q ss_pred cccccccccccCceeeeCceEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|.++..+|++.++||+|+||.||+|++. ...||+|.+....... +.+.+|+.+++.++||||+++++.+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH-------HHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 7788899999999999999999999874 3579999987533321 467899999999999999999998754
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||.++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 45789999999999999998655566899999999999999999999999999999999999999999999999999765
Q ss_pred cccCCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... +..+.....+..++..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPES 231 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-HhcCCCCCCccccCHH
Confidence 433221 12345678999999988889999999999999999999 8999988776654433 4444455556678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+.+++.+||+.+|++||+++++++.|+++.
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=335.94 Aligned_cols=250 Identities=30% Similarity=0.599 Sum_probs=212.7
Q ss_pred ccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
+.++|++.+.||+|+||.||++++ .+..+|+|.+...... .+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 456788889999999999999988 4458999987644322 24678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++.....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999999987543 35889999999999999999999999999999999999999999999999998754322
Q ss_pred CCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 EGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+.... +..+.++..|...+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM-ISRGFRLYRPKLASMTVYE 232 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHHHHH
Confidence 211 22235578999999998889999999999999999999 9999988877665544 3444455566677889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L 391 (418)
++.+||+.+|++||+++++++.|
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=323.18 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=209.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|...++||+|.||.||+|++ +|+.||||.++....... ......+|++.|+.++|+||+.|+++|.....+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG----i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG----INRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC----ccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 3567788999999999999987 789999999987643322 1245779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
||+|||+ .+|...++.. ...++...+..++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus 78 lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9999995 5999999864 4568889999999999999999999999999999999999999999999999999875443
Q ss_pred C-CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014783 293 G-MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV---------------- 354 (418)
Q Consensus 293 ~-~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~---------------- 354 (418)
. .+....|..|.|||++.+. .|+..+|+||+||++.||+-|.+-|++.+.-+.+..++..--
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3 3445789999999998765 699999999999999999999988999888776655543110
Q ss_pred -----CCC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 -----RPV-----IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 -----~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.|. +=..+++...+|+.++|..||.+|.|+.|.+++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000 001345667899999999999999999998864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=338.52 Aligned_cols=258 Identities=33% Similarity=0.607 Sum_probs=222.8
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|+....+|++.+.||.|+||.||+|++ .+..+|+|++....... ...+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK------QQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh------HHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 556677899999999999999999988 56789999986543211 24678999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+++||||+++++|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999999998766667899999999999999999999999999999999999999999999999999754
Q ss_pred cccCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 289 VQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 289 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
..... .....++..|+|||.+....++.++||||||+++++|++ |+.||......+.... +..+.+...+..+++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ-ITAGYRMPCPAKCPQEI 233 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-HHhCCcCCCCCCCCHHH
Confidence 32211 122345678999999998899999999999999999998 8999988776665544 44566667778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+++.+||+.||.+|||+.+|++.|+++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 9999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=355.48 Aligned_cols=246 Identities=32% Similarity=0.517 Sum_probs=215.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|.....||+|+||.||+|.+ +++.||+|++.-.....+ .+.+.+|+.+|..++++||.++|+.+..+..+.+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 455568899999999999987 678999999976443332 2578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
+||||.||++.+.++.. ..+.+..+.-++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++-......
T Consensus 89 iMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999999753 344778888889999999999999999999999999999999999999999987654433
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......||+.|||||++....|+.|+||||||++.+||++|.+||....+..+++. +.+..+|.+...+++.+++|+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-Ipk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-IPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-ccCCCCCccccccCHHHHHHHHH
Confidence 34678899999999999998999999999999999999999999999998665543 44555666666889999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||..||+.||++.+|++
T Consensus 246 CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLK 262 (467)
T ss_pred HhhcCcccCcCHHHHhh
Confidence 99999999999999987
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=335.91 Aligned_cols=256 Identities=33% Similarity=0.607 Sum_probs=220.6
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|+|..++|++.++||+|+||.||+|.. +++.||+|.+....... ..+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-------EAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH-------HHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 788899999999999999999999987 67899999987544332 467899999999999999999998754
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...+++|||+.+++|.+++....+..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 45799999999999999997765667899999999999999999999999999999999999999999999999999765
Q ss_pred cccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
..... .....++..|+|||.+....++.++||||||++++|+++ |+.||.+.+..+.. ..+..+.+...+..++.+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGYRMPRPDNCPEE 231 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-HHHHcCCCCCCCCCCCHH
Confidence 42221 122345678999999998889999999999999999999 99999887765544 345556666677778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+.+++.+||+.+|++|||++++++.|+++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=339.80 Aligned_cols=258 Identities=32% Similarity=0.585 Sum_probs=219.3
Q ss_pred cccccccccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
|+++.++|++.+.||+|+||.||+|.+.+ ..||+|.+........ ...+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-----RIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH-----HHHHHHHHHHHHhCCCCceeEEE
Confidence 77889999999999999999999998632 5799999864432211 24678999999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~ 274 (418)
+++......++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+++||||||+|||++.+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence 99999999999999999999999997532 2246788899999999999999999999999999999999999
Q ss_pred CCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014783 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVV 350 (418)
Q Consensus 275 ~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~ 350 (418)
+.+||+|||+++....... .....++..|+|||.+....++.++|||||||++||+++ |..||...+..+.....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~- 234 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV- 234 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH-
Confidence 9999999999875433221 223446789999999988889999999999999999998 99999887776655444
Q ss_pred hcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 351 NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
..+..+..|..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 4555566777889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=339.03 Aligned_cols=258 Identities=31% Similarity=0.570 Sum_probs=215.0
Q ss_pred cccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
|.+..++|++.+.||+|+||.||+|.+. +..||||++....... ....+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 7788899999999999999999998763 3579999885432211 124688999999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~ 274 (418)
+++......++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+|||++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 999998999999999999999999975321 235677889999999999999999999999999999999999
Q ss_pred CCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014783 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVV 350 (418)
Q Consensus 275 ~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~ 350 (418)
+.++|+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 112345778999999998899999999999999999999 799998877765544333
Q ss_pred hcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 351 NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
.+.....+..+++.+.+++.+||+.||++|||+.|+++.|++
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 333445667788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=333.67 Aligned_cols=254 Identities=34% Similarity=0.676 Sum_probs=222.4
Q ss_pred cccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
|.++.++|++.+.||.|+||.||++...++.||||.+..... ..+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 567788999999999999999999999999999999865432 2357889999999999999999999999888
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999999999999987655579999999999999999999999999999999999999999999999999998653
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.. ......+..|+|||.+....++.++||||||++++++++ |..||...+..+.. ..+..+.+...+..+++.+.+
T Consensus 154 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 154 QG--QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred cc--cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhcCCCCCCccCCCHHHHH
Confidence 22 223345678999999988889999999999999999997 99999887665543 344555566677778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
++.+||..+|++|||+++++++|++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.71 Aligned_cols=246 Identities=28% Similarity=0.513 Sum_probs=215.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|.+.+.||+|+||.||||+. +.+.||+|.+.+....... .+.+.+|+.|+++++|||||.+++.|.+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 4677888999999999999975 6789999999765444321 256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+.| +|..++.. .+.++++.+..++.+++.||.|||+.+|+|||+||.|||++..+++|+||||+|+.+....
T Consensus 78 vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 99999976 99999975 4669999999999999999999999999999999999999999999999999999765433
Q ss_pred -CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 293 -GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
..+...|||.|||||+..++.|+..+|+||+||++||+++|++||-...-.+....++.+... .|...+..+.+|+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~--~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK--PPSTASSSFVNFLQ 232 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--CcccccHHHHHHHH
Confidence 345668999999999999999999999999999999999999999877766666666655443 34478899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
..|.+||.+|.|-.+++.
T Consensus 233 gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHhhcChhhcccHHHHhc
Confidence 999999999999988875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=348.35 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=213.3
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHH--------HHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA--------QVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~--------~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
.-..+|++.+.||+|+||.|-+++. +++.||||++.+........ ..-.+...+|+.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457889999999999999999987 78899999997644322111 0112578899999999999999999
Q ss_pred EeEEee--CceEEEEEeecCCCCHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEE
Q 014783 202 IGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRA-VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 202 ~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vk 278 (418)
+.+..+ ...+|||+|||..|.+...- .... +++.++++++.+++.||+|||.+|||||||||+|+||+.+|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999865 45799999999998875442 2333 89999999999999999999999999999999999999999999
Q ss_pred Eeecccceeeccc------CCCCCCCCCccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 014783 279 IADFGVARIEVQT------EGMTPETGTYRWMAPEMIQHRP----YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA 348 (418)
Q Consensus 279 l~DfGla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~ 348 (418)
|+|||.+.....+ .......|||.|+|||+..++. -+.+.||||+||+||.|+.|+.||-+....+....
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998755222 1123357999999999997632 34688999999999999999999999888888888
Q ss_pred HHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 349 VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
++...+..+..++..+.+++||+++|.+||++|.+..+|....
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 8887766555556788999999999999999999999887654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=343.06 Aligned_cols=262 Identities=32% Similarity=0.593 Sum_probs=223.8
Q ss_pred cccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv 199 (418)
.+|.+...+|.+.+.||+|+||.||++++ .+..||||.++...... ..+.+.+|+.+++++ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence 35778888999999999999999999975 23479999986543221 125688999999999 799999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
++++++.....+++||||+.+|+|.+++.......+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999999999997654455899999999999999999999999999999999999999999999
Q ss_pred eecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 014783 280 ADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355 (418)
Q Consensus 280 ~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 355 (418)
+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.....+..+..
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 99999975432221 112345678999999998899999999999999999998 99999887776666666666666
Q ss_pred CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 356 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+..+...++.+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 666667788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.55 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=203.4
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||+|+||.||++++ +++.||+|++....... ......+.+|+.++++++||||+++++++.....+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS---RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 69999999999987 57799999987532111 11225677899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETG 299 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~~~~~g 299 (418)
|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......|
T Consensus 78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9999999753 45899999999999999999999999999999999999999999999999999753322 22344579
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCC
Q 014783 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379 (418)
Q Consensus 300 t~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 379 (418)
|+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+....+... ...+|..+++.+.+++.+||+.||.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999887776655554443 3345677889999999999999999
Q ss_pred CCCC---HHHHHH
Q 014783 380 VRPP---FTEIVR 389 (418)
Q Consensus 380 ~RPt---~~ell~ 389 (418)
+||+ +.|++.
T Consensus 234 ~R~~~~~~~e~l~ 246 (312)
T cd05585 234 RRLGYNGAQEIKN 246 (312)
T ss_pred HcCCCCCHHHHHc
Confidence 9986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=341.83 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=203.0
Q ss_pred cccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEe---
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACR--- 206 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~--- 206 (418)
+|++.+.||+|+||.||+|++ +++.||||.++......... ..+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch----HHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 678889999999999999986 35789999987544322111 2345677666665 6999999999985
Q ss_pred --eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 207 --KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 207 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 3456899999995 6999999876566789999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-------- 356 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------- 356 (418)
++............||+.|+|||.+.+..++.++|||||||++|||++|++||.+.+..+....++.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 986554444455678999999999998899999999999999999999999999887766555544311000
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 -----------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 -----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.+.+++.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011245677899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=333.61 Aligned_cols=256 Identities=35% Similarity=0.623 Sum_probs=221.9
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|+++.++|++.+.||+|+||.||++.+ .+..||||.+....... +.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-------EAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH-------HHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 788899999999999999999999987 45689999987543322 4678999999999999999999999988
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 88999999999999999998765567899999999999999999999999999999999999999999999999998765
Q ss_pred cccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
..... .....++..|+|||.+.+..++.++|+||||++++++++ |+.||.+........ .+..+.....+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE-QVERGYRMPRPPNCPEE 232 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHH
Confidence 32211 112234578999999998889999999999999999998 999998877665444 34555666677778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+.+++.+||+.+|++||+++++++.|++
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=348.82 Aligned_cols=242 Identities=25% Similarity=0.404 Sum_probs=205.4
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+.||+|+||.||+++. +|..||+|++....... ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 3699999999999987 67899999997532211 111246778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCCC
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~~ 297 (418)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 78 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 999999888653 4689999999999999999999999999999999999999999999999999875322 2223345
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccC
Q 014783 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 298 ~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 377 (418)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... ..+|..+++.+.+++.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999998877766555544433 3356678899999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 014783 378 PEVRP-----PFTEIVR 389 (418)
Q Consensus 378 p~~RP-----t~~ell~ 389 (418)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 234 PKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHhCCCCCCCHHHHHc
Confidence 99998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=352.32 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=225.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce-
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~- 210 (418)
.++|..++.+|+|+||.+++.+. .+..|++|.+.-........ +...+|+.++++++|||||.+.+.|.+++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r----~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER----RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh----HHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 35678889999999999998865 56799999997655443222 367799999999999999999999998888
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
++|||+||+||+|.+.+.+.++..++++.+++|+.|++.|+.|||+++|+|||||+.||+++.++.|||.|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999999988778899999999999999999999999999999999999999999999999999998766
Q ss_pred cC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 291 TE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.. ...+..||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+.......+.. +.-.++|...+.++..+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-GLYSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-ccCCCCCccccHHHHHH
Confidence 55 56677899999999999999999999999999999999999999999888777666554 44567788899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~~ 390 (418)
+..|+..+|+.||++.+|+..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.72 Aligned_cols=255 Identities=35% Similarity=0.609 Sum_probs=217.0
Q ss_pred cccccccccccCceeeeCceEEEEEEECC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|++..++|++...||+|+||.||++.+.+ ..+|+|.+...... .+.+.+|+.+++.++|||++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 67777889999999999999999998843 57999987643322 2467889999999999999999998864
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||+++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 45789999999999999998755566889999999999999999999999999999999999999999999999999765
Q ss_pred cccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+... .+..+..+..+...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-QVERGYRMPCPQGCPES 231 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHH
Confidence 33221 122345678999999998889999999999999999999 999998877665443 34455566667778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+.+++.+||..||++||+++++++.|++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=340.80 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=209.6
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||+|+||.||++.. +++.||||++........ .....+.+|+.+++.++||||+++++.+..+..+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh---hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 56778999999999999987 578999999865332211 1234577899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
|||+++|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99999999999887654556899999999999999999999999999999999999999999999999999865444334
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCChHHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN--KGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~ 372 (418)
....|+..|+|||.+.+..++.++||||+||++|||++|+.||.+.........+.. .......+...++.+.+|+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 455789999999999988999999999999999999999999987654332222111 122334555678899999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 014783 373 CWDTNPEVRP-----PFTEIVRM 390 (418)
Q Consensus 373 cl~~dp~~RP-----t~~ell~~ 390 (418)
||+.||.+|| +++++++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.15 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=208.2
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||.||++++ ++..||+|++...... ...+.+.+|+.++++++||||+++++++..+.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3457888999999999999999988 5778999998653211 12357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999999999999763 4589999999999999999999986 6999999999999999999999999999755
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN----------------- 351 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~----------------- 351 (418)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..+.
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccccCcc
Confidence 332 234457899999999999999999999999999999999999999765543321 1111
Q ss_pred -----------------------------cCCCCCCC-CCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 352 -----------------------------KGVRPVIP-NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 352 -----------------------------~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
...++..+ ..+++.+.+|+.+||+.||++|||++||++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 11111111 23578899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=333.45 Aligned_cols=251 Identities=29% Similarity=0.587 Sum_probs=212.9
Q ss_pred ccccccccCceeeeCceEEEEEEECC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
+.++|++.+.||+|+||.||++++.+ ..+|||.+...... .+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 45678889999999999999998854 46999998654322 14688999999999999999999999988889
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||.++.....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999998754332
Q ss_pred CCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 EGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.... +..+.+...+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK-VSQGLRLYRPHLASEKVYA 232 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HhcCCCCCCCCCCCHHHHH
Confidence 211 12235578999999998889999999999999999998 9999988776554444 3445555566677899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
++.+||+.||.+||++.+|++.|+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=348.26 Aligned_cols=243 Identities=24% Similarity=0.389 Sum_probs=205.7
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+.||+|+||.||+++. +++.||||++........ .....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK---DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 678999999975422111 11256778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCCC
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~~ 297 (418)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 78 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 999999888653 4589999999999999999999999999999999999999999999999999875322 2223445
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccC
Q 014783 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 298 ~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 377 (418)
+||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...+|..+++.+.+++.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcCCC
Confidence 7999999999999999999999999999999999999999887765544433322 33466778899999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 014783 378 PEVRP-----PFTEIVRM 390 (418)
Q Consensus 378 p~~RP-----t~~ell~~ 390 (418)
|++|| ++.|+++.
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=331.75 Aligned_cols=250 Identities=30% Similarity=0.590 Sum_probs=213.5
Q ss_pred ccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
+..+|++.+.||+|+||.||++.+ .+..+|+|++....... ..+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH-------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 456788899999999999999988 44589999986543322 4577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++...+.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCC--CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 EGMT--PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+..+.+...+..++..+.+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAGYRLYRPKLAPTEVYT 232 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHH
Confidence 2111 1123457999999998899999999999999999999 89999877765544 345556666777788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L 391 (418)
++.+||..+|++|||+.|+++.|
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.18 Aligned_cols=265 Identities=32% Similarity=0.607 Sum_probs=222.6
Q ss_pred CcccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCC
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp 196 (418)
...|++..++|.+++.||+|+||.||++++. ...+|+|.+........ ...+.+|+.+++.+ +||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~e~~~l~~l~~h~ 84 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHK 84 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH-----HHHHHHHHHHHHHhcCCC
Confidence 4568888899999999999999999999752 24699999865322211 24677899999999 799
Q ss_pred CeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 014783 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (418)
Q Consensus 197 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (418)
||+++++++.....+|+||||+.+|+|.+++..... ..+++..++.++.|++.||+|||++|++||
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999999999999999976421 347888999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014783 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338 (418)
Q Consensus 263 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~ 338 (418)
||||+|||++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999875432211 112234578999999998889999999999999999998 899997
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.....+ ....+..+.....+..++..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 245 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 245 GVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred cCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 766544 4445556666667778899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=351.58 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=206.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+++. +++.||||++....... ......+.+|+.++..++||||+++++.+.+...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE---KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 3577889999999999999987 57899999996532111 112356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999999753 468999999999999999999999999999999999999999999999999987432110
Q ss_pred ------------------------------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014783 293 ------------------------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLP 336 (418)
Q Consensus 293 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~P 336 (418)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 01234799999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCC--CChHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 014783 337 FQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWD--TNPEVRPPFTEIVRM 390 (418)
Q Consensus 337 f~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~--~dp~~RPt~~ell~~ 390 (418)
|.+.+..+....+........+|+ .+++.+.+++.+++. .++..||+++||++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 998887776655554333333333 357889999988553 234456899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=353.90 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=206.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|++++.||+|+||+||+|++ +++.||||++....... ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 467888999999999999987 67899999997532211 1123578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++++||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999998753 458899999999999999999999999999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCCCCCCCccccccccccCCCCCCcchHHHHHH
Q 014783 293 -----------------------------------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGI 325 (418)
Q Consensus 293 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv 325 (418)
......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CChHHHHHHHHH--hcccCCCCCCCHHHHHHH
Q 014783 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTR--CWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 326 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~--cl~~dp~~RPt~~ell~~ 390 (418)
++|||++|..||...+..+....++........|. .+++++.+++.+ |+..+|..||++++++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999988777665555554333333333 468899999998 455666679999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=343.67 Aligned_cols=256 Identities=27% Similarity=0.555 Sum_probs=214.8
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...+|++.+.||+|+||.||+|++ +++ .||||+++...... ..+.+.+|+.+++.++||||++++++|.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 446788899999999999999986 344 48999986432211 2256889999999999999999999998
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.. ..++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 75 4679999999999999997643 458888999999999999999999999999999999999999999999999998
Q ss_pred eecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 287 IEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+ ...++..+.....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPIC 236 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCC
Confidence 65432221 12234678999999999999999999999999999998 999998876655 34556666666677788
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+..+.+++.+||..+|.+||++.+++..|..+..
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 8999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=332.51 Aligned_cols=255 Identities=32% Similarity=0.585 Sum_probs=216.2
Q ss_pred ccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
+.++|++.+.||+|+||.||+|.+. ...||||.+....... ....+.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 4567888999999999999999873 3479999886543221 12568899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++|+|+||||+|||++.++.++|+|||+++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999999997643 3689999999999999999999999999999999999999999999999999986
Q ss_pred eccc-CCCC--CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 288 EVQT-EGMT--PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 288 ~~~~-~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
.... .... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+... .+......+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK-AVEDGYRLPPPMDCP 234 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCC
Confidence 5411 1111 2234578999999998899999999999999999998 999998877665443 344555556677889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+.+.+++.+||+.+|++||++.||++.|+++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=347.89 Aligned_cols=263 Identities=30% Similarity=0.606 Sum_probs=218.5
Q ss_pred ccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~ 200 (418)
.|.++.++|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----HHHHHHHHHHHHhccCCccHhh
Confidence 4888899999999999999999999974 356899999965432211 24677899999999 6899999
Q ss_pred EEeEEee-CceEEEEEeecCCCCHHHHHhhhcC-----------------------------------------------
Q 014783 201 FIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (418)
Q Consensus 201 l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------- 232 (418)
+++++.. +..+++||||+++|+|.+++.....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 9998865 4567899999999999999865321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC-
Q 014783 233 ------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (418)
Q Consensus 233 ------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~- 293 (418)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 2367788889999999999999999999999999999999999999999999975432211
Q ss_pred --CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 294 --MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 294 --~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||............+..+.+...|...++.+.+++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 315 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 112235678999999988899999999999999999997 99999876655545555666666666777788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+||+.||++|||+.||++.|+.+..
T Consensus 316 ~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=353.73 Aligned_cols=249 Identities=28% Similarity=0.451 Sum_probs=211.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||++....... ......+.+|+.++..++||||+++++++.++..+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 577889999999999999998 48899999997532111 1123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999999764 568999999999999999999999999999999999999999999999999997644322
Q ss_pred -----------------------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 014783 293 -----------------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV 343 (418)
Q Consensus 293 -----------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~ 343 (418)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 123456899999999999999999999999999999999999999988876
Q ss_pred HHHHHHHh--cCCCCCCCCCChHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 014783 344 QAAFAVVN--KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPP-FTEIVRM 390 (418)
Q Consensus 344 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~ell~~ 390 (418)
+....+.. .....+....+++.+.+++.+||. ||.+||+ ++++++.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 66655555 222222223468999999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.98 Aligned_cols=265 Identities=32% Similarity=0.596 Sum_probs=222.7
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE---------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCC
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp 196 (418)
...|.+...+|.+.+.||+|+||.||++++ ++..||+|.+....... ..+.+.+|+.+++.+ +||
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~ 81 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHK 81 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchH-----HHHHHHHHHHHHHhhccCC
Confidence 345888899999999999999999999974 12469999886432211 125688999999999 899
Q ss_pred CeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 014783 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (418)
Q Consensus 197 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (418)
||+++++++......|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++|++||
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999999999999999999999999999997642 2357788899999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014783 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338 (418)
Q Consensus 263 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~ 338 (418)
||||+|||++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986533221 222345678999999998889999999999999999998 889998
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
..+..+.. ..+..+.+...+..++..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 242 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 242 GIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred cCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 87765544 44555666667778899999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=345.98 Aligned_cols=243 Identities=23% Similarity=0.389 Sum_probs=205.8
Q ss_pred CceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
+.||+|+||.||+++. +++.||||+++....... ......+.+|+.+|+.++||||+++++++..+..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN--QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh--hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 5799999999999975 467899999975321111 112246778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCC
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~ 294 (418)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999998753 45788899999999999999999999999999999999999999999999998753322 223
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhc
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 374 (418)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... ...+|..+++.+.+++.+||
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHc
Confidence 3457999999999999988999999999999999999999999988776655554443 33566778899999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 014783 375 DTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 375 ~~dp~~RP-----t~~ell~ 389 (418)
+.||++|| +++++++
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhc
Confidence 99999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.86 Aligned_cols=255 Identities=31% Similarity=0.567 Sum_probs=215.2
Q ss_pred ccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..++|.+.+.||+|+||.||+|+.. +..||||.++...... ..+.+.+|+++++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----HHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 4567888999999999999999752 3689999986543321 125788999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~ 273 (418)
......++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 99999999999999999999997532 235788889999999999999999999999999999999999
Q ss_pred CCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014783 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAV 349 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~ 349 (418)
++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~- 236 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC- 236 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-
Confidence 99999999999975432221 122345688999999999999999999999999999998 9999988777665444
Q ss_pred HhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+..+.....+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 34455555566788999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=345.70 Aligned_cols=245 Identities=27% Similarity=0.407 Sum_probs=203.7
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHH---HhCCCCCeEEEEeEEeeCceE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML---ATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il---~~l~hpniv~l~~~~~~~~~~ 211 (418)
|++.+.||+|+||.||++.+ +++.||||+++....... ...+.+.+|+.++ +.++||||+++++++.....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 45678999999999999987 578999999975421111 1124555666554 567899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~- 290 (418)
|+||||+++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999999888754 4589999999999999999999999999999999999999999999999999874322
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+....+.... ...|..+++.+.+++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 232 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSREAISIM 232 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence 222344579999999999999999999999999999999999999999888776655554433 335667889999999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 014783 371 TRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RP-----t~~ell~ 389 (418)
.+||+.||.+|| ++.++++
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=329.32 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=216.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|++.+.||+|++|.||++.. +++.||+|.+.......... ...+.+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETK-KEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhH-HHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 3567789999999999999976 67899999987544332211 12357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998754 458889999999999999999999999999999999999999999999999987543221
Q ss_pred C----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 293 G----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 293 ~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....................+..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1 133467889999999999899999999999999999999999998877766666656665666777888999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~ 390 (418)
++.+||..+|++|||+.++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.60 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=202.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 577889999999999999988 567999999975433221 12567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||++++.+..+... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 78 VFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999988766554432 3468999999999999999999999999999999999999999999999999998653322
Q ss_pred -CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------
Q 014783 293 -GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------------------ 353 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------------------ 353 (418)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2233568999999999999899999999999999999999999998876544333221100
Q ss_pred -CC-CC----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 -VR-PV----------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 -~~-~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. +. ....++..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00 01125678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.72 Aligned_cols=262 Identities=34% Similarity=0.630 Sum_probs=222.2
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv 199 (418)
..|.++.++|++.+.||+|+||.||++.+. ...+|+|.+....... ....+.+|+.+++++ +||||+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 468899999999999999999999999863 2579999986532221 124678999999999 899999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
++++++.....++++|||+.+|+|.+++... ....+++..++.++.|++.||+|||+.+|+|||||
T Consensus 80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999999652 23568899999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMT 341 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~ 341 (418)
|+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999999999986543221 122234578999999998899999999999999999998 999998877
Q ss_pred HHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 342 AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
..+. ...+..+.....+..++..+.+|+.+||..||++|||+.|+++.|+++.
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 VEEL-FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 6554 3445566666677788899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=335.53 Aligned_cols=256 Identities=31% Similarity=0.588 Sum_probs=214.2
Q ss_pred cccccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
++.++|++.+.||+|+||.||+|++ .+..||+|.+...... . ....+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-Q----QWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-H----HHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 3457788999999999999999975 3468999998643321 1 125688999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ---------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIL 270 (418)
......|+||||+.+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 99999999999999999999986432 124788889999999999999999999999999999999
Q ss_pred EcCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014783 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346 (418)
Q Consensus 271 l~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 346 (418)
++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~- 235 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV- 235 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 9999999999999997543221 1223345678999999988889999999999999999998 9999988766544
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
...+........+..+++.+.+++.+||+.||++||++.+|++.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 34455555556677889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=352.62 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=214.3
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..+.+..++|++.+.||+|+||.||+++. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK---RSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34556778899999999999999999987 67899999996432111 11124577899999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+...+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 9999999999999999999998653 4888999999999999999999999999999999999999999999999999
Q ss_pred eeecccC--CCCCCCCCccccccccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 286 RIEVQTE--GMTPETGTYRWMAPEMIQHR----PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
....... ......||+.|+|||++... .++.++|||||||++|||++|+.||...+.......+.........|
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 269 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP 269 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC
Confidence 7654322 22345799999999998654 47899999999999999999999999887766655555443333344
Q ss_pred C--CChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014783 360 N--DCLPVLSEIMTRCWDTNPEV--RPPFTEIVRM 390 (418)
Q Consensus 360 ~--~~~~~l~~li~~cl~~dp~~--RPt~~ell~~ 390 (418)
. .++..+.+++.+||+.+|.+ ||+++|++..
T Consensus 270 ~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 3 46889999999999998987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=352.29 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=208.4
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||++....... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE---KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 578889999999999999987 67899999997532111 1123567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 79 IMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999999753 458999999999999999999999999999999999999999999999999986432111
Q ss_pred --------------------------------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCC
Q 014783 293 --------------------------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL 334 (418)
Q Consensus 293 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~ 334 (418)
.....+||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 011246899999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCC--CChHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWDTNPEVRPP---FTEIVR 389 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPt---~~ell~ 389 (418)
.||...+..+....+.........|. .+++.+.+++.+|+. +|.+|++ ++|++.
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99998887776655554433333333 467899999999996 9999998 888776
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=329.61 Aligned_cols=245 Identities=31% Similarity=0.616 Sum_probs=207.9
Q ss_pred ceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.||+|+||.||+|.+ ++..+|+|+++...... ...+.+.+|+.+++.+.||||+++++++.. ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence 589999999999975 46789999986543332 223678899999999999999999998864 457899999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC----
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---- 293 (418)
+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999999999653 4589999999999999999999999999999999999999999999999999975433221
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.....++..|+|||.+....++.++||||||+++|||++ |..||......+. ...+..+..+..|..+++.+.+++.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQMIESGERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 112234578999999988889999999999999999998 9999988776554 44556666677788899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 014783 373 CWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~L~~~ 394 (418)
||+.||++||++++|.+.|++.
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.25 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=215.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCc
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~ 209 (418)
++|++.+.||+|+||.||+|.+ ++. .+++|.++...... ..+.+.+|+.++.++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-----DHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-----HHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 5678889999999999999987 333 47888875322111 125688999999999 7999999999999988
Q ss_pred eEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~ 275 (418)
.+++|+||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999999999999997532 13578899999999999999999999999999999999999999
Q ss_pred CEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014783 276 SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354 (418)
Q Consensus 276 ~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 354 (418)
.+||+|||++..............+..|+|||.+.+..++.++|||||||++|||++ |..||......+... .+..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~-~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-KLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCC
Confidence 999999999864322111222233567999999998899999999999999999998 999998887766544 345566
Q ss_pred CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 355 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
.+..+..++..+.+|+.+||+.+|.+|||++++++.|.++......
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 6667778899999999999999999999999999999988865543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.82 Aligned_cols=253 Identities=23% Similarity=0.434 Sum_probs=223.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|.||.|-+++. .|+.||||.+++.....+.. . -.+.+|+.||+.|+||||+++|.+|...+.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD-l--vhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD-L--VHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH-H--HHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 5678889999999999999975 78999999997765443322 2 36789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
|||||..+|.|.+|+..+ +.+++..+..++.||+.|+.|+|.++++|||||.+|||+|.++++||+|||++-.+.+..
T Consensus 130 ivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999999875 459999999999999999999999999999999999999999999999999999888888
Q ss_pred CCCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
...+.||++-|.+||++.+.+|. +.+|-|||||+||.|..|.+||++.+-...+.++....++.+ .-+....-||+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIR 284 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIR 284 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHH
Confidence 88999999999999999999885 789999999999999999999999888777766666555533 23455678999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhH
Q 014783 372 RCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+||-.||++|.|+.+|...+.-.+
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeec
Confidence 999999999999999988765433
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=360.14 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=214.0
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc-
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~- 209 (418)
..++|++.+.||+|+||.||++++ +++.||||++......... ...+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 346889999999999999999986 7889999999765443322 246779999999999999999988765332
Q ss_pred -------eEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEe
Q 014783 210 -------VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 210 -------~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
.+++||||+++|+|.+++..+ ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 378999999999999999753 23568999999999999999999999999999999999999999999999
Q ss_pred ecccceeeccc---CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 014783 281 DFGVARIEVQT---EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 281 DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 357 (418)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....... +....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~ 264 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDP 264 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCC
Confidence 99999764322 122345799999999999999999999999999999999999999998877665554443 34445
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.|..+++.+.+++.+||+.||.+||++.+++..
T Consensus 265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 677889999999999999999999999998763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.55 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=210.7
Q ss_pred ccccccCceeeeCceEEEEEEE--C-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--N-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
..|.+.+.||+|+||.||++.. + ++.||+|.+..... . ....+.+|+.+++.++||||+++++++.....+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~----~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--R----QAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--H----HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 4578889999999999999976 3 56889997643221 1 124677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
||||||+++|+|.+++... ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999999988643 23468889999999999999999999999999999999999999999999999998654
Q ss_pred ccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 290 QTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 290 ~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+... .....|..+++.+
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHH
Confidence 3221 33456999999999999999999999999999999999999999887776665554443 3334566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||+.||++||++.+++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHh
Confidence 99999999999999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.40 Aligned_cols=256 Identities=27% Similarity=0.526 Sum_probs=215.2
Q ss_pred cccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
++..+|++.+.||+|+||.||+|++. +..||||++...... ...+.+.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-----PLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45667888999999999999999863 368999998644321 123568899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIL 270 (418)
+......++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 999889999999999999999985321 234788889999999999999999999999999999999
Q ss_pred EcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014783 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346 (418)
Q Consensus 271 l~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 346 (418)
+++++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+..
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999875433221 123345689999999988889999999999999999998 88999887776554
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
.. +..+.....+..++..+.+++.+||+.+|++||++++|+..|+.
T Consensus 237 ~~-i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 44 44444556677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=329.73 Aligned_cols=257 Identities=23% Similarity=0.402 Sum_probs=211.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|+. +++.||||.+......... ....+.+|+.+++.++||||+++++++......+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH---HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 4678889999999999999987 6789999988653322211 2256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999999988642 234578899999999999999999999999999999999999999999999999876533
Q ss_pred cCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcC-CCCCCCCCChHHHH
Q 014783 291 TEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNKG-VRPVIPNDCLPVLS 367 (418)
Q Consensus 291 ~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l~ 367 (418)
... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... .......+... ..+..+...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 221 2234688999999999988899999999999999999999999965432 12222333333 33333345678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+++.+||+.+|++||++.++++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=334.77 Aligned_cols=255 Identities=31% Similarity=0.624 Sum_probs=215.2
Q ss_pred cccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
+|++.+.||+|+||.||+|+... ..+|+|.+........ ...+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-----LRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH-----HHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 46778899999999999998632 4688998864332211 25688999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 266 (418)
...++|+||+.+++|.+++.... ...+++..++.++.|++.||.|||+.+|+||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 99999999999999999986421 13477888999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 014783 267 DNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTA 342 (418)
Q Consensus 267 ~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~ 342 (418)
+|||+++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||++++||++ |..||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999975432221 122345678999999988889999999999999999998 9999988776
Q ss_pred HHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 343 VQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+ ....+..+.....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 55 445566667777778889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=338.05 Aligned_cols=266 Identities=32% Similarity=0.616 Sum_probs=222.4
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCC
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 197 (418)
.+|.+...+|.+.+.||+|+||.||+++.. ...||+|.++....... ...+.+|+.+++.+ +|||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-----LADLISEMELMKLIGKHKN 79 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH-----HHHHHHHHHHHHhccCCCC
Confidence 468888899999999999999999999752 34699999864332211 24678899999999 6999
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (418)
|+++++++.....+|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999998889999999999999999997632 23578888999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014783 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQN 339 (418)
Q Consensus 264 lkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~ 339 (418)
|||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999975432211 112234468999999998899999999999999999999 8999988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 340 MTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
....+.. ..+..+.....+..++..+.+++.+||+.+|++|||+.++++.|+++...+.
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 240 IPVEELF-KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred CCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 7765544 4445555566677888999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=334.32 Aligned_cols=260 Identities=30% Similarity=0.565 Sum_probs=215.9
Q ss_pred cccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
|+++.++|++.+.||+|+||.||+|... +..||+|.+........ ...+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-----RIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-----HHHHHHHHHHHHhCCCCCeeeEE
Confidence 8889999999999999999999998652 34799998764332211 24577899999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~ 274 (418)
+++......|+||||+.+|+|.+++..... ...+...+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 999998899999999999999999975321 234567788999999999999999999999999999999999
Q ss_pred CCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014783 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVV 350 (418)
Q Consensus 275 ~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~ 350 (418)
+.++|+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432221 112234678999999998899999999999999999998 899998877666444333
Q ss_pred hcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 351 NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
.+.....+..+++.+.+++.+||+.||++|||+.++++.|++..
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 34344556677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=335.99 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=203.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||.|+||.||+|+. +++.||+|+++....... ...+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 46788889999999999999987 678999999865432211 13567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99999996 5999988653 345788999999999999999999999999999999999999999999999999754322
Q ss_pred -CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------------
Q 014783 292 -EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV--------------- 354 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~--------------- 354 (418)
.......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 22334568899999999865 5689999999999999999999999988776554433321100
Q ss_pred -----CCC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 -----RPV--------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 -----~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+. ....+++.+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 01235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=334.73 Aligned_cols=259 Identities=30% Similarity=0.542 Sum_probs=217.5
Q ss_pred cccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
|+..+|.+.+.||+|+||.||++.. ++..+|+|.+..... .....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------NARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4567889999999999999999974 234689998864321 123568899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~ 273 (418)
+.....+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155 (288)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999999997532 134899999999999999999999999999999999999999
Q ss_pred CCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014783 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAV 349 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~ 349 (418)
++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++++|++ |..||......+....+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999975432211 122335678999999998899999999999999999998 99999888776655444
Q ss_pred HhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
..+.....+..++..+.+++.+||+.||.+|||+.+++..|+++...
T Consensus 236 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 -TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 44444455667889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=352.74 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=205.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||++....... ....+.+.+|+.++++++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK---KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 577889999999999999987 77899999986432111 1123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999998753 4689999999999999999999999999999999999999999999999999863211000
Q ss_pred ------------------------------------------------CCCCCCCccccccccccCCCCCCcchHHHHHH
Q 014783 294 ------------------------------------------------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGI 325 (418)
Q Consensus 294 ------------------------------------------------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv 325 (418)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 01246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CChHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 014783 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWDTNPEVR---PPFTEIVRM 390 (418)
Q Consensus 326 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~R---Pt~~ell~~ 390 (418)
++|||++|..||......+....+.........|. .++..+.+++.+|+. +|.+| +++.|++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999988777665555544333333343 467899999999997 66665 599988874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=335.54 Aligned_cols=245 Identities=20% Similarity=0.349 Sum_probs=200.0
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||+|+||.||+++. +|+.||+|.+........ .....+..|++++++++||||+++++++..+..+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 68999999999986 688999999864322111 1123456799999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt 300 (418)
++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.............|+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99999887655566889999999999999999999999999999999999999999999999999765444334456789
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCCCCCChHHHHHHHHHhcccC
Q 014783 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV---RPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 301 ~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~d 377 (418)
..|+|||++.+..++.++|||||||++|||++|+.||................. .......+++++.+++.+||+.|
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccC
Confidence 999999999988899999999999999999999999976543221112211111 11122356889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 014783 378 PEVRPPFTEIVRM 390 (418)
Q Consensus 378 p~~RPt~~ell~~ 390 (418)
|++||++.|+++.
T Consensus 238 P~~R~~~~~~~~~ 250 (277)
T cd05607 238 PEDRLGSREKNDD 250 (277)
T ss_pred HhhCCCCccchhh
Confidence 9999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=329.24 Aligned_cols=256 Identities=33% Similarity=0.601 Sum_probs=218.9
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
|++..++|++.+.||+|+||.||++.+ .+..+|+|.+..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-------HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 888999999999999999999999987 556899998864321 12568899999999999999999999887
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 67899999999999999998765667888899999999999999999999999999999999999999999999998754
Q ss_pred cccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
..... .....++..|+|||.+....++.++|+||||++++++++ |+.||...+..... ..+..+.....+...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-RALERGYRMPRPENCPEE 231 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhCCCCCCCcccCCHH
Confidence 33221 112235677999999998889999999999999999999 99999887765544 344555566666778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=329.42 Aligned_cols=252 Identities=34% Similarity=0.675 Sum_probs=217.8
Q ss_pred cccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
|-+..++|++.+.||+|+||.||++..+++.||+|.+..... .+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG 72 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 556678899999999999999999999999999999854321 246789999999999999999999987654
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.++||||+.+++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 6899999999999999987655668999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.. ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.. ..+..+.++..+..++..+.+
T Consensus 152 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 228 (254)
T cd05083 152 MG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECVEKGYRMEPPEGCPADVYV 228 (254)
T ss_pred cc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHHhCCCCCCCCCcCCHHHHH
Confidence 22 223344578999999998899999999999999999998 99999888776544 445566666667778899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
++.+||+.+|++||++++|++.|++
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.44 Aligned_cols=262 Identities=31% Similarity=0.559 Sum_probs=214.8
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
+...+|++.+.||+|+||.||+|.+ ++. .+|+|.+...... .....+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 3456788889999999999999986 444 4577766432211 1225788899999999 8999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~ 272 (418)
....+|+||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999997532 13578899999999999999999999999999999999999
Q ss_pred CCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014783 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~ 351 (418)
.++.+||+|||++.............++..|+|||.+.+..++.++|||||||++|||+| |..||...+..+.. ..+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~ 237 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLP 237 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH-HHHh
Confidence 999999999999864322111222234678999999988889999999999999999998 99999877765543 3344
Q ss_pred cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 352 KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
.+.+...+..+++.+.+++.+||+.+|++||++++++..|.++..+..
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 555555666778899999999999999999999999999998766553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=340.91 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=205.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||.||++++ ++..+|+|.+....... ....+.+|+++++.++||||++++++|....
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 4567889999999999999999988 57789999886542211 2356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999999999753 4588999999999999999999975 7999999999999999999999999998754
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------------
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF--------------------- 347 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~--------------------- 347 (418)
.. .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......+...
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 ID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 32 22334578999999999999889999999999999999999999997644322211
Q ss_pred ----------------------HHHhcCCCCCCCC-CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 348 ----------------------AVVNKGVRPVIPN-DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 348 ----------------------~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+.....+..+. ..+.++.+|+.+||+.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0011111111221 24678999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.17 Aligned_cols=253 Identities=29% Similarity=0.573 Sum_probs=211.5
Q ss_pred ccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce-
Q 014783 137 LNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~- 210 (418)
|++++.||+|+||.||+|+.. +..||||.++....... ....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 467889999999999999862 25799999875433321 12568899999999999999999998865543
Q ss_pred -----EEEEEeecCCCCHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 211 -----WCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 211 -----~~lv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
.++++||+++++|..++.... ...+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999986532 24688999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014783 282 FGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 282 fGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 357 (418)
||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+... .+..+....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-YLRHGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCC
Confidence 999986543221 112235678999999988899999999999999999999 999998877766544 344455566
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=340.76 Aligned_cols=242 Identities=26% Similarity=0.407 Sum_probs=200.4
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+|++ +++.||||+++........ ..+.+..|..++.. .+||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh---hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3699999999999987 5678999999753211111 11334556666664 4899999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999999998753 45899999999999999999999999999999999999999999999999999754322 23344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
.+||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+....+.. ..+..|..++..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccC
Confidence 5799999999999999999999999999999999999999998887665554433 34556677889999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 014783 377 NPEVRPPFT-EIVR 389 (418)
Q Consensus 377 dp~~RPt~~-ell~ 389 (418)
||.+||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05592 234 DPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHcCCChHHHHc
Confidence 999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.84 Aligned_cols=264 Identities=35% Similarity=0.666 Sum_probs=232.0
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCC
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 197 (418)
..|+++.+++.+.+.||+|+||.|++|... ...||||.++......+. +.+..|+++|+.+ +|||
T Consensus 289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~-----~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEK-----KDLMSELNVLKELGKHPN 363 (609)
T ss_pred CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHH-----HHHHHHHHHHHHhcCCcc
Confidence 379999999999999999999999999742 347999999766555332 5788999999999 5999
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------N--RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (418)
|+.++|+|.+...+++|+||+..|+|.+|++... . ..++...++.++.||+.||+||++..+||||
T Consensus 364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD 443 (609)
T KOG0200|consen 364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD 443 (609)
T ss_pred hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence 9999999999999999999999999999998754 0 1388899999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecccceeecccCCCC--CCCC--CccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014783 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMT--PETG--TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338 (418)
Q Consensus 264 lkp~NILl~~~~~vkl~DfGla~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~ 338 (418)
|.++|||+..+..+||+|||+|+.......+. ...+ ..+|||||.+....|+.+||||||||+|||++| |..||+
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999999998654433332 1222 467999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+......+.+.+..|.++..|..|+++++++|+.||+.+|++||+|.|+++.|+....
T Consensus 524 ~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 524 GIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 9774444577899999999999999999999999999999999999999999999654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.78 Aligned_cols=249 Identities=25% Similarity=0.462 Sum_probs=213.8
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|.+.+.||+|+||.||++++ +++.|++|.+........ ....+.+|+.+++.++||||+++++++.....+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 356678899999999999987 678999999865433321 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999999876566789999999999999999999999999999999999999999999999999876543322
Q ss_pred -CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 -MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.....|++.|+|||++.+..++.++|+||||+++++|++|+.||...+....... +..+..+.++..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK-IIRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCCccccCHHHHHHHHH
Confidence 2334688999999999999999999999999999999999999988776554443 34444555666788899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 236 CLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HccCCcccCcCHHHHhh
Confidence 99999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.39 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=203.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~ 212 (418)
+|++.+.||+|+||.||+|+. +++.||||++.+...... ...+.+..|..++..+ +|++|+++++++.....+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---DDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 467788999999999999987 567999999975432111 1124566778888777 5899999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-c
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-T 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~ 291 (418)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999999998653 4589999999999999999999999999999999999999999999999999975332 2
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.... ...|...+..+.+++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 233 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICK 233 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcCCHHHHHHHH
Confidence 22344679999999999999999999999999999999999999999888776665555433 3456678899999999
Q ss_pred HhcccCCCCCCCH
Q 014783 372 RCWDTNPEVRPPF 384 (418)
Q Consensus 372 ~cl~~dp~~RPt~ 384 (418)
+||+.||.+|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05616 234 GLMTKHPGKRLGC 246 (323)
T ss_pred HHcccCHHhcCCC
Confidence 9999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=326.66 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=213.5
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ ++..||+|.++....... .+.+.+|+.+++.++||||+++++.+..+..+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-----VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 366788999999999999987 678999999865432211 2567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999999998765566789999999999999999999999999999999999999999999999999976543222
Q ss_pred -CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 -MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+ ..+.....+..++..+.+++.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH-hcCCCCCCCcccCHHHHHHHHH
Confidence 23356889999999999888999999999999999999999999887765554443 3444455667788899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~ 390 (418)
||+.||++|||+.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.27 Aligned_cols=256 Identities=27% Similarity=0.536 Sum_probs=213.0
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...+|++.+.||+|+||.||+|++ +++ .+++|.+...... .....+..|+.+++++.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-----QTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch-----HHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 346778889999999999999988 454 4777776432111 12256778888999999999999999886
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
. ...++++||+.+|+|.+++... ...+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 4 4567899999999999999754 3468999999999999999999999999999999999999999999999999998
Q ss_pred eecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 287 IEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
....... .....++..|+|||.+.+..++.++||||||+++||+++ |..||.+...... ...+..+..+..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQIC 236 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCC
Confidence 6533221 223346778999999998899999999999999999998 9999988776543 4556666666677778
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+..+.+++.+||..||++|||+.|+++.|..+..
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.88 Aligned_cols=248 Identities=28% Similarity=0.384 Sum_probs=205.8
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|.+.+.||+|+||.||+|+. +++.||||++...... .......+.+|+.+++.++||||+++++.+.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 467889999999999999987 6789999998643211 11223578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc--
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-- 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-- 291 (418)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 79 VMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999999998753 45889999999999999999999999999999999999999999999999997522100
Q ss_pred ----------------------------------------------CCCCCCCCCccccccccccCCCCCCcchHHHHHH
Q 014783 292 ----------------------------------------------EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGI 325 (418)
Q Consensus 292 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv 325 (418)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 0012246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 014783 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRCWDTNPEVRPP---FTEIVR 389 (418)
Q Consensus 326 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt---~~ell~ 389 (418)
++|||++|+.||...+..+....++........| ...++++.+++.+++ .+|++|++ ++|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999888777666665543333333 346788999998876 59999987 877765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.65 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=201.9
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
...+|+..+.||+|+||.||++++ +++.||||++...... .....+.+|+.+++.++|+||+++++++.....
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-----HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 456778889999999999999987 5789999998643221 223578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+++++|.+.. ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 147 ~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999999999986432 355677889999999999999999999999999999999999999999999986543
Q ss_pred cC-CCCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCC
Q 014783 291 TE-GMTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMTAV--QAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 362 (418)
.. ......||..|+|||.+.. ...+.++|||||||++|||++|+.||...... ......+.....+..+..+
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 22 2344579999999998843 23456899999999999999999999743321 2222223334445566678
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+..+.+|+.+||+.||++|||+.|+++.
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999999873
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.06 Aligned_cols=252 Identities=30% Similarity=0.565 Sum_probs=207.4
Q ss_pred cccCceeeeCceEEEEEEEC--Cc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC-----
Q 014783 138 NMGTAFAQGAFGKLYRGTYN--GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----- 208 (418)
.+++.||+|+||.||+|.+. +. .||+|.++........ .+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 46788999999999999873 32 6899998754333222 25788999999999999999999987432
Q ss_pred -ceEEEEEeecCCCCHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
...++++||+.+|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2468999999999999987532 22457899999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 284 VARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 284 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+... .+..+.....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 236 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD-YLRQGNRLKQP 236 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHcCCCCCCC
Confidence 9986543221 122345678999999999999999999999999999999 899998877655443 34445455566
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=344.84 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=204.7
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+.||+|+||.||+++. +++.||+|++........ .....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 3699999999999986 678999999975322111 11245678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
++|+|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 999999888653 458999999999999999999997 7999999999999999999999999999875322 222334
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ...+|..+++.+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhc
Confidence 57999999999999999999999999999999999999999887765554443332 3345667889999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 014783 377 NPEVRP-----PFTEIVRM 390 (418)
Q Consensus 377 dp~~RP-----t~~ell~~ 390 (418)
||++|+ ++.++++.
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=336.96 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=199.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|+. +++.||||++........ ...+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 35788899999999999999987 678999999865432211 13566899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~- 290 (418)
|+||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99999995 6888888653 34588899999999999999999999999999999999999999999999999875322
Q ss_pred cCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh---cC------------
Q 014783 291 TEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-AVVN---KG------------ 353 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~-~~~~---~~------------ 353 (418)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .+.. ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 222344568999999999865 458899999999999999999999998765432221 1111 00
Q ss_pred -CCC-----CCCC---------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 -VRP-----VIPN---------DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 -~~~-----~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+ ..+. ..++.+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0010 13456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=352.31 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=205.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||++...... .....+.+.+|+.+++.++||||+++++.+.++..+|+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 578889999999999999987 6789999998643211 11123567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc--
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-- 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-- 291 (418)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 79 v~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 79 VMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999999753 45889999999999999999999999999999999999999999999999997422100
Q ss_pred ------------------------------------------CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHH
Q 014783 292 ------------------------------------------EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWE 329 (418)
Q Consensus 292 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~e 329 (418)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 014783 330 LITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRCWDTNPEVRP---PFTEIVRM 390 (418)
Q Consensus 330 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---t~~ell~~ 390 (418)
|++|+.||......+....+.........+ ..+++.+.+++.+|+ .+|.+|+ ++.|++..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999888766555544332222222 357888999999977 5999999 88988864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.45 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=196.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC-----
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----- 208 (418)
+|++.+.||+|+||.||+|+. +++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh----HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 467788999999999999987 6789999998643222111 14678999999999999999999988543
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 77 KDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 2479999999 56899988653 45899999999999999999999999999999999999999999999999999754
Q ss_pred cccC----CCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 014783 289 VQTE----GMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN----------- 351 (418)
Q Consensus 289 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~----------- 351 (418)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2221 1234568999999999865 6789999999999999999999999987654332211100
Q ss_pred -----------cCCCCCC-------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 -----------KGVRPVI-------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 -----------~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....... -+.+++.+.+++.+||+.||++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 1235677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.08 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=200.0
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-- 208 (418)
...+|++++.||+|+||.||+|.. +++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 346788999999999999999987 67899999885432 1234799999999999999998876432
Q ss_pred ------ceEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEE
Q 014783 209 ------MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKI 279 (418)
Q Consensus 209 ------~~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl 279 (418)
..+++||||+. ++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 24679999996 578777753 2345789999999999999999999999999999999999999665 7999
Q ss_pred eecccceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----
Q 014783 280 ADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG----- 353 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~----- 353 (418)
+|||+|+............||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....++...
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999999866544444556789999999998664 69999999999999999999999999877665544433210
Q ss_pred ----------------------CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 ----------------------VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 ----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+...+|...++++.+|+.+||+.||.+|||+.|++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 001133456788999999999999999999999885
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=341.20 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=203.1
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEEEEeEEeeCceEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWC 212 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-niv~l~~~~~~~~~~~ 212 (418)
+|++.+.||+|+||.||+|++ +++.||||++........ ...+.+..|..++..+.|+ +|+++++++.....+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD---DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 467889999999999999987 467899999975322111 1124677899999999765 5888999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-cc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~ 291 (418)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999998653 458899999999999999999999999999999999999999999999999987432 22
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+... ....|...+..+.+++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~ 233 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICK 233 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence 2233457999999999999999999999999999999999999999988776665554433 34456678899999999
Q ss_pred HhcccCCCCCCCH
Q 014783 372 RCWDTNPEVRPPF 384 (418)
Q Consensus 372 ~cl~~dp~~RPt~ 384 (418)
+||+.||.+|++.
T Consensus 234 ~~l~~~P~~R~~~ 246 (324)
T cd05587 234 GLLTKHPAKRLGC 246 (324)
T ss_pred HHhhcCHHHcCCC
Confidence 9999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.69 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=204.0
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+|++ +++.||||++........ ...+.+..|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD---DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh---hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 3689999999999987 467999999875322111 1124566788888866 799999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999999988653 4588999999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.... ...|..++..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--VLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhcc
Confidence 578999999999999999999999999999999999999999888777665555433 234556788999999999999
Q ss_pred CCCCCC-------CHHHHHHH
Q 014783 377 NPEVRP-------PFTEIVRM 390 (418)
Q Consensus 377 dp~~RP-------t~~ell~~ 390 (418)
||++|| +++++++.
T Consensus 234 dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcC
Confidence 999999 77877754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.47 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=211.4
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
..+..++|++.+.||+|+||.||+++. +++.||+|++.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 345567889999999999999999987 577999999864322111 112457789999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+..+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999999998653 488999999999999999999999999999999999999999999999999986
Q ss_pred ecccCC--CCCCCCCccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 014783 288 EVQTEG--MTPETGTYRWMAPEMIQHRP----YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN- 360 (418)
Q Consensus 288 ~~~~~~--~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 360 (418)
...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.........|.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 543222 23457999999999997643 78899999999999999999999998887766666665444444444
Q ss_pred -CChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014783 361 -DCLPVLSEIMTRCWDTNPEV--RPPFTEIVRM 390 (418)
Q Consensus 361 -~~~~~l~~li~~cl~~dp~~--RPt~~ell~~ 390 (418)
..+..+.+++..|+..++.+ |+++.|+++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 45788999999999855543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.66 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=199.9
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+++. +++.||||++.+...... ...+.+..|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc---cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 3699999999999987 578999999875321111 1124566788888776 699999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-ccCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999999988753 458999999999999999999999999999999999999999999999999987532 2222344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ....|..+++.+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccc
Confidence 57999999999999999999999999999999999999999988877665554433 2345566789999999999999
Q ss_pred CCCCCCCH
Q 014783 377 NPEVRPPF 384 (418)
Q Consensus 377 dp~~RPt~ 384 (418)
||++||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=344.64 Aligned_cols=238 Identities=25% Similarity=0.409 Sum_probs=203.1
Q ss_pred CceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
+.||+|+||.||+++. +|+.||+|++........ ....+.+|+.++++++||||+++++++.....+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR----DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh----hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 5799999999999864 578999999975322111 1245678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCC
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~ 294 (418)
||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999999998653 45899999999999999999999999999999999999999999999999999764333 223
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhc
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 374 (418)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.... ..+|..+++.+.+++.+||
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 34578999999999999889999999999999999999999999888776665554433 3456678899999999999
Q ss_pred ccCCCCCCCHHH
Q 014783 375 DTNPEVRPPFTE 386 (418)
Q Consensus 375 ~~dp~~RPt~~e 386 (418)
+.||++||++.+
T Consensus 234 ~~~P~~R~~a~~ 245 (318)
T cd05582 234 KRNPANRLGAGP 245 (318)
T ss_pred hcCHhHcCCCCC
Confidence 999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=325.00 Aligned_cols=245 Identities=31% Similarity=0.608 Sum_probs=206.3
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+.||+|+||.||+|++ +++.||+|.+...... .....+.+|+.+++.++||||+++++++.....+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 3689999999999987 6889999987543221 12256889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCC---
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT--- 295 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~--- 295 (418)
++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 76 ~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999999998653 3458899999999999999999999999999999999999999999999999987543211111
Q ss_pred CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhc
Q 014783 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 296 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 374 (418)
....+..|+|||.+.+..++.++||||||+++|||++ |..||......... ..+....+...+..++..+.+++.+||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-EAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 1123457999999998889999999999999999998 99999877765543 334455566677788899999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 014783 375 DTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 375 ~~dp~~RPt~~ell~~L~ 392 (418)
+.+|++|||+.+++++|+
T Consensus 234 ~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 234 EYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCChhhCcCHHHHHHHHh
Confidence 999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.38 Aligned_cols=245 Identities=29% Similarity=0.611 Sum_probs=206.7
Q ss_pred ceeeeCceEEEEEEEC----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 142 AFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-----SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 4899999999999763 446999998654221 122568899999999999999999998864 467899999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC----
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---- 293 (418)
+++++|.+++... ...+++..+++++.|++.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999999998753 34689999999999999999999999999999999999999999999999999975432211
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.....++..|+|||.+....++.++||||||+++||+++ |..||......+.. ..+..+.++..+..+++++.+++.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 111233578999999988889999999999999999996 99999988776644 4556667777888899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 014783 373 CWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~L~~~ 394 (418)
||+.+|++||++.++.+.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=333.17 Aligned_cols=258 Identities=31% Similarity=0.560 Sum_probs=216.7
Q ss_pred ccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..++|.+.+.||+|+||.||++++ ++..+++|.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 456778889999999999999975 234688998754321 1125688999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl 271 (418)
......++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 99999999999999999999997532 2347889999999999999999999999999999999999
Q ss_pred cCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014783 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF 347 (418)
Q Consensus 272 ~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 347 (418)
+.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975432211 123346788999999999999999999999999999999 999998877766443
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+..+..+..+..++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 -CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 3455555556667889999999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=332.78 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=208.0
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|+..+.||+|+||.||++.+ +++.||||.+........ .....+.+|+.++++++|++++.+++.+.....+|+|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 45667899999999999987 678999999865432221 1124567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999999987655556999999999999999999999999999999999999999999999999999765443333
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---QAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... +...... .......+..+++.+.+|+.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHHH
Confidence 4457899999999999999999999999999999999999999865431 2222221 22233455667889999999
Q ss_pred HhcccCCCCCCC-----HHHHHH
Q 014783 372 RCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt-----~~ell~ 389 (418)
+||+.||++||| ++|+++
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHc
Confidence 999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.24 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=208.0
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|+..+.||+|+||+||++++ +++.||+|.+........ .....+.+|+.+++.++|+||+.+++.+..+..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR---KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 45567899999999999987 678999999865432211 1124577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
|||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999999999887655557999999999999999999999999999999999999999999999999999765433334
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCChHHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN--KGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~ 372 (418)
....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. .......+..+++.+.+|+.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 456789999999999988999999999999999999999999987665433222211 112234456678899999999
Q ss_pred hcccCCCCCCC-----HHHHHH
Q 014783 373 CWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt-----~~ell~ 389 (418)
||+.||++||+ +.+++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HccCCHhHcCCCcccChHHHHc
Confidence 99999999999 666666
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=330.23 Aligned_cols=260 Identities=28% Similarity=0.532 Sum_probs=218.3
Q ss_pred cccccccccCceeeeCceEEEEEEEC------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
++.++|++.+.||+|+||.||+|.+. +..||+|.+....... ..+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-----QVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 56778899999999999999999873 4789999886432211 125678999999999999999999987
Q ss_pred ee-CceEEEEEeecCCCCHHHHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEE
Q 014783 206 RK-RMVWCIVTEYAKGGSVRQFLTRRQN------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 206 ~~-~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vk 278 (418)
.. ....++++||+.+++|.+++..... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 66 4678899999999999999976422 4588999999999999999999999999999999999999999999
Q ss_pred EeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014783 279 IADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354 (418)
Q Consensus 279 l~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 354 (418)
|+|||+++....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+. ...+..+.
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYLKDGY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-HHHHHcCC
Confidence 999999975432211 122345678999999998889999999999999999999 9999988776553 34455566
Q ss_pred CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 355 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+...+..+++.+.+++.+||+.+|++|||+.++++.|+++..+
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 6566667889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=330.92 Aligned_cols=254 Identities=33% Similarity=0.583 Sum_probs=213.8
Q ss_pred cccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
|+.+++.+.++||+|+||.||++.. ++..+|+|.+..... .....+.+|+.+++.+.||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------HHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence 4567888899999999999999964 345789998754321 123578899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN-------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl 271 (418)
+......+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+.|++||||||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~ 155 (280)
T cd05092 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155 (280)
T ss_pred EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence 9998999999999999999999975432 347889999999999999999999999999999999999
Q ss_pred cCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014783 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF 347 (418)
Q Consensus 272 ~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 347 (418)
++++.+||+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 9999999999999975432221 112234678999999999999999999999999999998 999998877766554
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
. +..+.....+..+++.+.+++.+||+.||++||++++|++.|+
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 C-ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 4 3444455667788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=341.04 Aligned_cols=243 Identities=23% Similarity=0.397 Sum_probs=200.4
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||++++ +++.||||++++...... ...+.+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 3699999999999987 678999999975432211 1124677899999998 799999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-ccCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9999999888653 469999999999999999999999999999999999999999999999999987422 2223344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT--------AVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+...+.+.. ....+|..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHH
Confidence 679999999999999999999999999999999999999996321 12222232322 233466778899999
Q ss_pred HHHHhcccCCCCCCC------HHHHHH
Q 014783 369 IMTRCWDTNPEVRPP------FTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt------~~ell~ 389 (418)
++.+||+.||.+||+ ++++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 999999999999997 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.24 Aligned_cols=256 Identities=29% Similarity=0.560 Sum_probs=213.5
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...+|++.+.||+|+||.||+|++ +++ .||+|+++...... ....+.+|+.+++.+.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 456788899999999999999986 444 48999986543221 1256889999999999999999999997
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.. ..++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~-~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 80 TS-TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CC-CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 64 467999999999999998754 3468999999999999999999999999999999999999999999999999998
Q ss_pred eecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 287 IEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...+..+.....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERLPQPPIC 236 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCccC
Confidence 6532221 112234678999999998899999999999999999998 9999987766543 3445566666667778
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+..+.+++.+||+.||++||++.++++.|.++..
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 8999999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=325.18 Aligned_cols=252 Identities=31% Similarity=0.562 Sum_probs=212.3
Q ss_pred cccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
+|++++.||+|+||.||+|.. +++.+|||.+................+.+|+.++++++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 356788999999999999987 7789999998765433322223346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc----
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ---- 290 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~---- 290 (418)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999999753 3588999999999999999999999999999999999999999999999999875321
Q ss_pred ---cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCChHHH
Q 014783 291 ---TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-GVRPVIPNDCLPVL 366 (418)
Q Consensus 291 ---~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 366 (418)
........++..|+|||.+.+..++.++||||||+++++|++|..||...........+... ...+..+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11123346889999999999988999999999999999999999999877665544333322 34455677788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=344.37 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=208.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||+++..... .....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 577889999999999999987 6789999999753221 11223568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999999764 34689999999999999999999999999999999999999999999999999976543222
Q ss_pred --CCCCCCCcccccccccc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCh
Q 014783 294 --MTPETGTYRWMAPEMIQ------HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCL 363 (418)
Q Consensus 294 --~~~~~gt~~y~aPE~~~------~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~ 363 (418)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......+.........| ...+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 22346899999999986 4568899999999999999999999998887766655554433222222 3567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+|+.+||+ +|.+|||+++++.
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 899999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.38 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=199.7
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-- 209 (418)
.++|++.+.||+|+||.||++++ +++.||||++......... ...+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH----AKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH----HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 36788889999999999999987 6789999999755332221 256779999999999999999999986443
Q ss_pred ----eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 210 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999965 67666642 3788899999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------------ 353 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------------ 353 (418)
+............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+............
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 76544444455678999999999999999999999999999999999999998765433221111100
Q ss_pred --------CCCC--------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 354 --------VRPV--------------------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 354 --------~~~~--------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
..+. .....++.+.+|+.+||+.||++|||+.|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 011234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=342.28 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=202.8
Q ss_pred cccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCc
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~ 209 (418)
+|++.+.||+|+||.||+++. +++.||+|++.+..... .....+.+.+|+.++..+ +||||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 367789999999999999875 56799999986532111 111235677899999999 5999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999998753 458999999999999999999999999999999999999999999999999997543
Q ss_pred ccC--CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCh
Q 014783 290 QTE--GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 290 ~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~ 363 (418)
... ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... .......+ ....+.++...+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFIG 235 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCC
Confidence 222 22345799999999999865 478999999999999999999999964321 12222212 223455667788
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RP-----t~~ell~ 389 (418)
+.+.+++.+||+.||++|| +++++++
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 9999999999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=338.76 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=203.4
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||++++ +++.||||++.+...... .....+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD---DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3699999999999987 567999999975321111 1124566888888888 699999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999999988653 4689999999999999999999999999999999999999999999999999875322 222334
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ....|..+++.+.+++.+||+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccC
Confidence 56899999999999999999999999999999999999999887766655444433 2345667889999999999999
Q ss_pred CCCCCCCH-----HHHHH
Q 014783 377 NPEVRPPF-----TEIVR 389 (418)
Q Consensus 377 dp~~RPt~-----~ell~ 389 (418)
||.+||++ .++++
T Consensus 234 dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 99999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.61 Aligned_cols=263 Identities=33% Similarity=0.614 Sum_probs=221.2
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCC
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 197 (418)
.+|++...+|++++.||+|+||.||++.+. ...||+|.++...... ..+.+.+|+.+++++ +|||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-----DLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-----HHHHHHHHHHHHHhhcCCCC
Confidence 578999999999999999999999999752 1368999876432221 125788999999999 7999
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (418)
|++++++|.....+++++||+++|+|.+++.... ...+++..+..++.|++.||.|||++||+|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999999999999999999999999997532 23477888899999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014783 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQN 339 (418)
Q Consensus 264 lkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~ 339 (418)
|||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999976533221 122234568999999999999999999999999999998 8999988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 340 MTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+..+.. ..+..+.....+..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 240 IPVEELF-KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 7765544 4455556666777888999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=341.50 Aligned_cols=238 Identities=24% Similarity=0.414 Sum_probs=198.3
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHH-HHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||+||++++ +++.||||++........ .....+.+|.. +++.++||||+++++.+.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 3699999999999988 688999999865322111 11133444544 56889999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999999998753 4689999999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.... ...+...++.+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhc
Confidence 579999999999999999999999999999999999999999887766555554432 234556789999999999999
Q ss_pred CCCCCCCHH
Q 014783 377 NPEVRPPFT 385 (418)
Q Consensus 377 dp~~RPt~~ 385 (418)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=338.26 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=199.9
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||++++ +++.||||+++....... ...+.+..|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 3699999999999987 678999999975321111 0113456677777654 899999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 78 LNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9999999998753 4588999999999999999999999999999999999999999999999999874321 222345
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ..+..|..++..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccC
Confidence 6799999999999999999999999999999999999999988776554443322 23455667888999999999999
Q ss_pred CCCCCCCHH-HHH
Q 014783 377 NPEVRPPFT-EIV 388 (418)
Q Consensus 377 dp~~RPt~~-ell 388 (418)
||++||++. +++
T Consensus 234 dP~~R~~~~~~~~ 246 (316)
T cd05620 234 DPTRRLGVVGNIR 246 (316)
T ss_pred CHHHcCCChHHHH
Confidence 999999974 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=340.27 Aligned_cols=251 Identities=26% Similarity=0.463 Sum_probs=221.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~ 210 (418)
...|++.+.||.|.||.||+++. +|+.+|+|++.+....... ....+.+|+.+|+++. |||||++++++.+...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 35677889999999999999987 6889999999765543221 1257889999999998 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC----CCEEEeecccce
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVAR 286 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~----~~vkl~DfGla~ 286 (418)
+++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+... +.+|++|||+|.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999876 39999999999999999999999999999999999999743 479999999999
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChH
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLP 364 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 364 (418)
...........+||+.|+|||++....|+..+||||+||++|.|++|..||.+.+.......+....+.. ......+.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 8777666778899999999999999999999999999999999999999999999888777776665532 22345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
...++++.++..||.+|+|+.++++.
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcC
Confidence 99999999999999999999999984
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.48 Aligned_cols=258 Identities=23% Similarity=0.401 Sum_probs=212.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|+||.||++.. ++..||||.+........ .....+.+|+.+++.++||||+++++++......+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhH---HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 4677889999999999999986 788999998865432221 12257889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
++|||+++++|.+++... ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999999998742 235689999999999999999999999999999999999999999999999999875433
Q ss_pred cC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc-CCCCCCCCCChHHHH
Q 014783 291 TE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV-QAAFAVVNK-GVRPVIPNDCLPVLS 367 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~ 367 (418)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... ......+.. ...+..+..+++.+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 22 223456889999999999889999999999999999999999999654432 122222222 222233345778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+++.+||..||++|||+.+|++.++++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.81 Aligned_cols=255 Identities=31% Similarity=0.591 Sum_probs=214.1
Q ss_pred ccccccccCceeeeCceEEEEEEE--CC---ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
+..+|++.+.||+|+||.||+|.+ ++ ..+|+|.++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 456788899999999999999976 22 369999886533221 13578899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
....|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+|||++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999999997643 4589999999999999999999999999999999999999999999999999976
Q ss_pred ecccCC--C--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 288 EVQTEG--M--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 288 ~~~~~~--~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
...... . ....++..|+|||.+.+..++.++|+||||+++||+++ |..||......+.... +..+.+.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-IEEGYRLPAPMDC 234 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-HhCCCcCCCCCCC
Confidence 433211 1 11223568999999998889999999999999999887 9999988776554433 4455566666678
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 89999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=328.15 Aligned_cols=251 Identities=30% Similarity=0.552 Sum_probs=204.9
Q ss_pred ccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--
Q 014783 137 LNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-- 208 (418)
|++.+.||+|+||+||++.+ ++..||+|++....... ....+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 47788999999999988753 46689999986543211 125678999999999999999999988653
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+++||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999998653 4899999999999999999999999999999999999999999999999999765
Q ss_pred cccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHH
Q 014783 289 VQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV--------------QAAFAVV 350 (418)
Q Consensus 289 ~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~--------------~~~~~~~ 350 (418)
..... .....++..|+|||.+....++.++||||||++++||++|..||...... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221 12234567799999998888999999999999999999999998643211 1112223
Q ss_pred hcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 351 NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 351 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
..+.....+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 334444556778899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=341.10 Aligned_cols=241 Identities=23% Similarity=0.389 Sum_probs=198.7
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHH-HHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE-VMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E-~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||++++ +++.||+|++........ .....+..| ..+++.++||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh---hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 3699999999999987 567899999975321111 111233344 4457889999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999999998753 4588888999999999999999999999999999999999999999999999975322 222344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ...++.++..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHccc
Confidence 579999999999999999999999999999999999999999887766555544432 234556789999999999999
Q ss_pred CCCCCCCHHHHH
Q 014783 377 NPEVRPPFTEIV 388 (418)
Q Consensus 377 dp~~RPt~~ell 388 (418)
||.+||++.+.+
T Consensus 234 ~p~~R~~~~~~~ 245 (325)
T cd05602 234 DRTKRLGAKDDF 245 (325)
T ss_pred CHHHCCCCCCCH
Confidence 999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.98 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=198.8
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||+|+||+||++.+ +++.||+|.+........ ...+.+..|+.+++.++||||+++++++.....+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR---KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh---HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 68999999999987 678999999865332211 1124577899999999999999999999999999999999999
Q ss_pred CCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-CCCCC
Q 014783 221 GSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPE 297 (418)
Q Consensus 221 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-~~~~~ 297 (418)
|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9999887542 33568999999999999999999999999999999999999999999999999997543322 22335
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCChHHHHHHHHHhcc
Q 014783 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVRPVIPNDCLPVLSEIMTRCWD 375 (418)
Q Consensus 298 ~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~ 375 (418)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||............... ......+..+++.+.+++.+||+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 6899999999999999999999999999999999999999764432111111111 11234456688999999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 014783 376 TNPEVRP-----PFTEIVR 389 (418)
Q Consensus 376 ~dp~~RP-----t~~ell~ 389 (418)
.||++|| +++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.71 Aligned_cols=243 Identities=27% Similarity=0.418 Sum_probs=204.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC-----
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----- 208 (418)
.|.-.+.+|.|+||.||+|.. +++.||||..-....-. .+|+++|+.+.|||||+|..+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 345567899999999999987 56899999987654432 2799999999999999999988532
Q ss_pred ceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeecccc
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVA 285 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfGla 285 (418)
-.+.+|||||+. +|.++++.. .+..++.-.+.-++.||++||+|||+.||+||||||.|+|||.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 246799999965 999998752 34567888888899999999999999999999999999999976 89999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--------- 355 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--------- 355 (418)
+....+++..+...|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|++.+..+.+..++.---.
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 999888888888999999999999765 6999999999999999999999999999888877666431100
Q ss_pred ---------C---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ---------P---------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ---------~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+ ......+++..+|+.+++..+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 022346788999999999999999999988775
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=344.96 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=211.9
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
..++.+..++|++.+.||+|+||.||+++. +++.||+|++........ ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 344566778999999999999999999987 677999999864321111 112457789999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+..+..+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999999998653 488899999999999999999999999999999999999999999999999
Q ss_pred ceeecccC--CCCCCCCCccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 285 ARIEVQTE--GMTPETGTYRWMAPEMIQHRP----YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
++...... ......||+.|+|||++.... ++.++|||||||++|||++|+.||...+.......+.........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 268 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 268 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 98654322 123457999999999997543 789999999999999999999999988776655555543323333
Q ss_pred C--CCChHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 014783 359 P--NDCLPVLSEIMTRCWDTNPEV--RPPFTEIVRML 391 (418)
Q Consensus 359 ~--~~~~~~l~~li~~cl~~dp~~--RPt~~ell~~L 391 (418)
| ..++..+.+++.+|+..++.+ ||+++++++..
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 3 357889999999999843433 78999888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=336.69 Aligned_cols=242 Identities=25% Similarity=0.398 Sum_probs=199.8
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+|++ +++.||||+++........ ..+.+..|..++.. ++||||+++++++.+...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD---DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcc---hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 3699999999999987 5678999999753211110 11345567777776 4899999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9999999998753 45889999999999999999999999999999999999999999999999998753221 22334
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... .+..|..++..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhcc
Confidence 56899999999999999999999999999999999999999887776554443322 2345666788999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 014783 377 NPEVRPPFT-EIVR 389 (418)
Q Consensus 377 dp~~RPt~~-ell~ 389 (418)
||++||++. +++.
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05619 234 EPERRLGVKGDIRQ 247 (316)
T ss_pred CHhhcCCChHHHHc
Confidence 999999996 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=313.05 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=214.7
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~ 204 (418)
..+..+..+++.+..||.|..|.||+++. +|..+|||.+.+..+..+. ++++..+.++...+ .|.||+.+|+
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~-----kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN-----KRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH-----HHHHHhhhHHhhccCCCeeeeeeeE
Confidence 34556778889999999999999999987 5689999999877665443 45667777766664 8999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
|..+....|.||.| ...+..+++ +-...+|+..+-++...++.||.||.+ +||||||+||+|||+|+.|++||||||
T Consensus 160 Fi~n~dV~IcMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 160 FITNTDVFICMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred EeeCchHHHHHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence 99988889999999 335555554 445679999999999999999999985 599999999999999999999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
++....+....+...|.+.|||||.+.- ..|+.++|||||||+++||.||+.||.+.+........+....+|.++.
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence 9998888888888899999999999953 4699999999999999999999999998665444433444455565554
Q ss_pred --CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 --DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 --~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+.+|+..||+.|+.+||.+.+|++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 37899999999999999999999999986
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=329.96 Aligned_cols=256 Identities=31% Similarity=0.558 Sum_probs=210.6
Q ss_pred ccccccccCceeeeCceEEEEEEECC------------------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYNG------------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 194 (418)
..++|++.+.||+|+||.||++++.. ..||+|.+...... ...+.+.+|+.++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAREDFLKEVKILSRLS 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhcC
Confidence 45788999999999999999987632 35899998654322 12357889999999999
Q ss_pred CCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 195 hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
||||+++++++..+...++|+|++.+++|.+++.... ...+++..++.++.|++.||+|||++||+|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999999999999899999999999999999997643 1258899999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT--GLLPFQNM 340 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt--g~~Pf~~~ 340 (418)
|+||+++.++.++|+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ +..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999875432221 223346788999999988889999999999999999998 78899877
Q ss_pred CHHHHHHHHHhc------CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 341 TAVQAAFAVVNK------GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 341 ~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+..+........ ......+..++.++.+++.+||+.||++|||+.||++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 665544333221 11122344577899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.99 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=206.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
..+|++.+.||+|+||.||+|+. +++.||+|++....... ...+.+|+.++++++||||+++++++..+..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 45788999999999999999987 67899999986543221 13577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999999998653 45899999999999999999999999999999999999999999999999999865322
Q ss_pred C-CCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCChH
Q 014783 292 E-GMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PNDCLP 364 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 364 (418)
. ......++..|+|||.+. ...++.++|||||||++|||++|..||....+.+....+......+.. +..++.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 2 223456889999999984 445788999999999999999999999766554433322222222222 224578
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
.+.+++.+||+.+|++|||++++++.|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.02 Aligned_cols=254 Identities=33% Similarity=0.588 Sum_probs=211.0
Q ss_pred ccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..++|.+.+.||+|+||.||+|.+. +..||+|.+....... ....+.+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-----DESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4567888899999999999999873 3578999875332211 125688999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CE
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SI 277 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~v 277 (418)
.+....++||||+++++|.+++..... ..+++..+++++.||+.||+|||+++++||||||+|||++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 988889999999999999999976432 2588899999999999999999999999999999999998765 59
Q ss_pred EEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 014783 278 KIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353 (418)
Q Consensus 278 kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~ 353 (418)
||+|||+++....... ......+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+.. ..+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcC
Confidence 9999999976532211 112223468999999998889999999999999999997 99999887766544 445555
Q ss_pred CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
.+...+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 556667788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=324.94 Aligned_cols=248 Identities=25% Similarity=0.467 Sum_probs=207.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC---
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~--- 208 (418)
..|++.+.||+|+||.||+|.+ +++.||+|.+....... ..+.+|+.+++++ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccH-------HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4577788999999999999987 67799999986543221 4567899999998 799999999998653
Q ss_pred ---ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
..+|+||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45899999999999999998755567899999999999999999999999999999999999999999999999999
Q ss_pred eeeccc-CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 286 RIEVQT-EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
...... .......|+..|+|||++. ...++.++|||||||++|||++|..||.................+...+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 754322 2234456899999999986 3468889999999999999999999998776655554444444444445
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..++..+.+|+.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 567889999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=326.30 Aligned_cols=255 Identities=30% Similarity=0.575 Sum_probs=213.1
Q ss_pred ccccccccCceeeeCceEEEEEEEC--C---ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN--G---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
+..+|++.+.||+|+||.||+|.+. + ..||||.+...... . ....|..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~-~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE-K----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH-H----HHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 3456788899999999999999872 3 36999998653221 1 12578899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+...++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999999999998764 34688999999999999999999999999999999999999999999999999875
Q ss_pred ecccCCC---CCCC---CCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 288 EVQTEGM---TPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 288 ~~~~~~~---~~~~---gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
....... .... .+..|+|||.+.+..++.++||||||+++||+++ |..||......+.... +....+.+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~ 234 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA-IEQDYRLPPPM 234 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCcCCCcc
Confidence 4332211 1111 2357999999999999999999999999999987 9999988776655444 34455556667
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=329.52 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=199.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEee---
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK--- 207 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~--- 207 (418)
+|++.+.||+|+||.||+++. +++.||+|.+.......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP----LSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 367788999999999999987 67899999987543222111 2344666666655 79999999998854
Q ss_pred --CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
...+++|+||+. ++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 77 DRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 345899999996 58999987655556899999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------------ 353 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------------ 353 (418)
+............+|..|+|||++.+..++.++|||||||++|+|++|++||......+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 86654444455678999999999998899999999999999999999999998776655443332210
Q ss_pred ------CCC-------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 ------VRP-------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 ------~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+ ...+.++..+.+++.+||+.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 011245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=325.93 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=205.0
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----C
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-----R 208 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~ 208 (418)
.|...+.||.|+||.|+.+.+ +|+.||||.+.++...... .++..+|+++|+.++|+||+.+++++.. -
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~----akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID----AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH----HHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344478999999999999987 7889999999766554433 3677899999999999999999999865 3
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+|+|+| +.+|.+.++.. ..++.+.+..++.||+.||+|+|+.+|+||||||.|+|++.+..+||+|||+|+..
T Consensus 99 ~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 4689999999 66999998763 44899999999999999999999999999999999999999999999999999977
Q ss_pred cc---cCCCCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Q 014783 289 VQ---TEGMTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN------------- 351 (418)
Q Consensus 289 ~~---~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~------------- 351 (418)
.. ...++....|..|.|||++. ...||.+.||||+||+|.||++|++-|++.+..+.+..++.
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 53 34456777899999999984 55799999999999999999999999998775544433321
Q ss_pred -----------cCCCCCCC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 -----------KGVRPVIP-----NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 -----------~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....+..| +...+...+|+.+||..||.+|+|++|.++
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111 245677889999999999999999999876
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=322.07 Aligned_cols=250 Identities=30% Similarity=0.572 Sum_probs=212.2
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCCh---HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP---EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
|.++..||+|+||.||+|.. +++.||+|.+....... .......+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999987 57899999987654332 22233446788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999754 45888999999999999999999999999999999999999999999999998755321
Q ss_pred C-------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 292 E-------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 292 ~-------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+........ .....+..+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIPSNISS 238 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH-hccCCCcCCcccCH
Confidence 1 112235788999999999888999999999999999999999999887665544433 33555667778889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.+++.+||+.||.+||++.|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhh
Confidence 9999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=323.50 Aligned_cols=256 Identities=31% Similarity=0.598 Sum_probs=213.5
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCc---eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
|...+|+..+.||+|+||.||+|+. ++. .+|+|.+........ .+.+.+|+.++++++||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-----RQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHH-----HHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 3456777889999999999999986 333 699998865432221 256889999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.....|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999999999999754 3468899999999999999999999999999999999999999999999999987
Q ss_pred eecccCCC----CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 287 IEVQTEGM----TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 287 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
........ .....+..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+.... +..+...+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~ 234 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA-INDGFRLPAPMD 234 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH-HhcCCCCCCCCC
Confidence 55332211 11123457999999998889999999999999999998 9999988776554444 444455555667
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=337.61 Aligned_cols=246 Identities=23% Similarity=0.440 Sum_probs=222.8
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|.+.+.||+|.|..|-+++. +|+.||||++.+....... ...+.+|+..|+.++|||||+||.+..++..+|||
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s----t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS----TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh----hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 45667899999999999975 9999999999876554322 24677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCEEEeecccceeecccCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~vkl~DfGla~~~~~~~~ 293 (418)
+|+-.+|+|++|+.++. ..+.++.+.+++.||+.|+.|+|+..+|||||||+||.+- .-|-|||+|||++-.+.+...
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999998754 5699999999999999999999999999999999999875 568999999999998888888
Q ss_pred CCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.+..||+..|.|||++.+..|+ +++|||||||+||.|.+|++||+..+..+.+-.+++-.+. +|..++.++++||..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--vPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--VPSHVSKECRDLIQS 252 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--CchhhhHHHHHHHHH
Confidence 9999999999999999999988 5899999999999999999999999999988888777665 677888999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||..||.+|.+.+||..
T Consensus 253 MLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHhcCchhhccHHHHhc
Confidence 99999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=324.82 Aligned_cols=259 Identities=30% Similarity=0.596 Sum_probs=215.7
Q ss_pred ccccccccccCceeeeCceEEEEEEECC-----ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
++...+|.+.+.||+|+||.||+|.+.. ..||||........ . ..+.+.+|+.+++++.||||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-~----~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-S----VREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-H----HHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 3456678888999999999999998622 36899987543321 1 225788999999999999999999998
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
... ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||++
T Consensus 77 ~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 77 TEN-PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cCC-CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 764 4679999999999999997643 35899999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCC--CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 286 RIEVQTEGM--TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 286 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
+........ ....++..|+|||.+....++.++||||||++++|+++ |..||......+... .+..+.+...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENGERLPMPPNC 233 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCcCCCCCCC
Confidence 765333211 12234468999999988889999999999999999996 999998887766543 34455566677888
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+..+.+++.+||..+|++|||+.++++.|+++..+
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=321.59 Aligned_cols=258 Identities=24% Similarity=0.433 Sum_probs=213.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|+||.||+|.. +++.||+|.++........ ..+.+.+|+.++++++|+|++++++++......+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK---ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh---hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4678889999999999999987 6889999998653322211 1256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+||||+++++|.+++... ....+++..++.++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999998652 234588999999999999999999999999999999999999999999999999875433
Q ss_pred cC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCC-CChHHHH
Q 014783 291 TE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNKGVRPVIPN-DCLPVLS 367 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~l~ 367 (418)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......+..+..+..+. .++..+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 22 22334688999999999988899999999999999999999999955432 112223333344444444 6778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+++.+||..+|++|||+.+|++.|+++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=320.63 Aligned_cols=245 Identities=32% Similarity=0.616 Sum_probs=206.6
Q ss_pred CceeeeCceEEEEEEE--CC---ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 141 TAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
+.||+|+||.||+|++ .+ ..||+|.+...... ...+.+.+|+.+++.+.||||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEE
Confidence 3699999999999986 22 57999998754432 123578899999999999999999998764 4578999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC-
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM- 294 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~- 294 (418)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+++|+||||+|||++.++.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999999997643 6899999999999999999999999999999999999999999999999999765332211
Q ss_pred ---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 295 ---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 295 ---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.. ..+........+..++..+.+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHH
Confidence 11123468999999998899999999999999999998 99999887765543 44455556667778899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhh
Q 014783 371 TRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+||..+|++||++.+|++.|++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=328.42 Aligned_cols=256 Identities=32% Similarity=0.592 Sum_probs=213.6
Q ss_pred cccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
++..+|++.+.||+|+||.||++.+ ++..||+|++...... .....+.+|+.+++++.||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-----HHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 4567888999999999999999986 3468999998643221 123568899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 264 (418)
+..+...++|+||+.+++|.+++.... ...+++..++.++.|++.||.|||+.+++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999889999999999999999997532 124678888999999999999999999999999
Q ss_pred CCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014783 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNM 340 (418)
Q Consensus 265 kp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~ 340 (418)
||+|||++.++.++|+|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875432211 122234577999999998899999999999999999998 88999887
Q ss_pred CHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
...+.... +..+.....+..++..+.+|+.+||+.+|++|||+.|++..|++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYY-VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHH-HhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 77665544 33444445566788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=320.85 Aligned_cols=246 Identities=35% Similarity=0.673 Sum_probs=213.4
Q ss_pred CceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 141 TAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
+.||+|+||.||++.+. +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 36899999999999874 7799999987654332 2357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 216 EYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999999998642 356899999999999999999999999999999999999999999999999999865
Q ss_pred cccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 289 VQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 289 ~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
.... ......++..|+|||.+....++.++||||||+++++|++ |..||......+.... +..+.....+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-LRKGYRLPKPEYCPD 234 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCh
Confidence 4432 1233457889999999988889999999999999999999 6999998876655444 444666777888899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
.+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.66 Aligned_cols=238 Identities=22% Similarity=0.393 Sum_probs=195.9
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+++. +++.||+|++++...... ...+.+.+|+.++.++ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 3699999999999987 577999999976432211 1124577888888777 799999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9999999888653 4689999999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM--------TAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... .........+.. ....+|..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHH
Confidence 57999999999999999999999999999999999999999521 111222222222 234567778899999
Q ss_pred HHHHhcccCCCCCCCH
Q 014783 369 IMTRCWDTNPEVRPPF 384 (418)
Q Consensus 369 li~~cl~~dp~~RPt~ 384 (418)
++.+||+.||++||++
T Consensus 235 ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 235 VLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHhcCCHHHcCCC
Confidence 9999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=343.99 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=204.7
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||||++....... ......+.+|+.++..++||||+++++.+.+...+|+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE---KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 567789999999999999987 67899999996432111 1123567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999998753 458999999999999999999999999999999999999999999999999986432110
Q ss_pred -----------------------------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 293 -----------------------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 293 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 011346999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCC--CChHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 014783 338 QNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWDTNPEVRPP---FTEIVR 389 (418)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPt---~~ell~ 389 (418)
...+..+....+.........|. .+++.+.+++.+++. ||.+|++ ++|+++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 98887776655554332333333 367889999998774 9999985 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=324.05 Aligned_cols=248 Identities=32% Similarity=0.580 Sum_probs=205.0
Q ss_pred ceeeeCceEEEEEEE--CCc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEe
Q 014783 142 AFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E 216 (418)
.||+|+||.||+|++ ++. .+|+|.+....... ..+.+.+|+.+++++ +||||+++++++.....+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHH-----HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 589999999999987 333 56888875322111 124678999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 217 YAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999997532 124788999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
|++..............+..|+|||.+....++.++||||||+++|||++ |..||...+..+.. ..+..+.....+..
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 235 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQGYRLEKPLN 235 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-HHHhCCCCCCCCCc
Confidence 99863322111122234567999999988899999999999999999997 99999887665543 33455556566677
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
++..+.+++.+||+.||.+|||+.+++..|.++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.10 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=200.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--- 208 (418)
.++|++.+.||+|+||.||++.+ .++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH----HHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 46788899999999999999986 6789999998765433221 24677899999999999999999988543
Q ss_pred ---ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999964 77777643 3788899999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV----------- 354 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~----------- 354 (418)
+............||..|+|||++.+..++.++|||||||++|+|++|+.||.+....+.....+..-.
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 865544444556789999999999999999999999999999999999999987665443222211000
Q ss_pred ------------------C-----------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 ------------------R-----------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 ------------------~-----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
. ...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00111234578899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=321.26 Aligned_cols=246 Identities=30% Similarity=0.573 Sum_probs=210.0
Q ss_pred CceeeeCceEEEEEEEC---Cc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 141 TAFAQGAFGKLYRGTYN---GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
+.||+|++|.||+|.+. ++ .||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 36899999999999872 22 6899998664432 234678899999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC--
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~-- 293 (418)
||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||+++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999999999875435689999999999999999999999999999999999999999999999999976533211
Q ss_pred --CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 294 --MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 294 --~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.........+..++..+.+++
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 122346789999999999899999999999999999999 99999888877765555545555556667889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~L~ 392 (418)
.+||+.+|++||++.++++.|.
T Consensus 235 ~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 235 LQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=317.20 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=215.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|.+...||+|.|+.||++.. +|+.+|+|++........ -.+++.+|+.|-+.|+|||||+|.....+....|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 5677788999999999999865 789999998864333222 1267889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfGla~~~~ 289 (418)
||+|+|+|++|..-+-.+ ..+++..+-..+.||+++|.|+|.+||||||+||+|+|+-. .-.+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997766544 44788889999999999999999999999999999999963 3469999999999877
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 367 (418)
.....-...|||.|||||++...+|+..+|||+-||+||-||.|.+||.+.+.......+....+..+- .+..+++.+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 666677788999999999999999999999999999999999999999998888877777766655433 356789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+++||..||.+|.|+.|.+.
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHhccChhhhccHHHHhC
Confidence 9999999999999999998764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.55 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=214.1
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|+..+.||+|+||.||.++. +++.+++|.+......... ...+.+|+.++++++|+||+++++++.+...+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE----RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH----HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 367788999999999988876 6789999998655433321 2467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
+|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999999987655678999999999999999999999999999999999999999999999999997653332
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.... ....+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHH
Confidence 2334568999999999988889999999999999999999999998877766655554433 334456678899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~ 390 (418)
||+.+|++||+++++++.
T Consensus 236 ~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcccCcccCCCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=338.55 Aligned_cols=239 Identities=25% Similarity=0.419 Sum_probs=198.3
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHH-HHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+++. +|+.||||++........ .....+.+|.. +++.++||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 3699999999999987 688999999965322111 11134445544 57789999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-ccCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~~~~~~ 296 (418)
+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 78 VNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 999999988865 3468999999999999999999999999999999999999999999999999987532 2223344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.... ...++..+..+.+++.+|++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhcc
Confidence 579999999999999999999999999999999999999999887766555544432 234456788999999999999
Q ss_pred CCCCCCCHHH
Q 014783 377 NPEVRPPFTE 386 (418)
Q Consensus 377 dp~~RPt~~e 386 (418)
+|.+||++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05604 234 DRQRRLGAKE 243 (325)
T ss_pred CHHhcCCCCC
Confidence 9999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.98 Aligned_cols=238 Identities=26% Similarity=0.420 Sum_probs=197.2
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHH-HHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||++++ +++.||+|++.+...... .....+.+|. .+++.++||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK---KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh---hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 3699999999999987 678999999865322111 1123344454 467889999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 78 VNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 999999988865 34588899999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
..||+.|+|||.+.+..++.++|||||||++|||++|..||...+.......+... ...+|...+..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccC
Confidence 57899999999999989999999999999999999999999887766555444433 3445667788999999999999
Q ss_pred CCCCCCCHH
Q 014783 377 NPEVRPPFT 385 (418)
Q Consensus 377 dp~~RPt~~ 385 (418)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=319.60 Aligned_cols=251 Identities=28% Similarity=0.590 Sum_probs=212.3
Q ss_pred ccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
+..+|++.+.||+|+||.||++.+ ++..+|+|.+....... ..+.+|+.+++.+.|||++++++++......
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH-------HHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 345778889999999999999987 47889999986543322 4678999999999999999999999998899
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999999987543 45788999999999999999999999999999999999999999999999998754322
Q ss_pred CC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 EG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+... .+..+.+...+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE-TINAGFRLYKPRLASQSVYE 232 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHhCCCCCCCCCCCCHHHHH
Confidence 11 112234578999999998889999999999999999998 999998776655443 34555555566667899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
|+.+||+.+|++|||+.++++.|+
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhhC
Confidence 999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.06 Aligned_cols=238 Identities=23% Similarity=0.382 Sum_probs=197.6
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+++. +++.||+|+++....... ...+.+.+|+.++.++ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD---EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 3699999999999987 567999999975432211 1235677899999888 699999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-ccCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~~~~~~~ 296 (418)
+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999999888653 459999999999999999999999999999999999999999999999999987532 2223345
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM------TAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.....+.. ....+|...+..+.+++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Confidence 67999999999999999999999999999999999999999532 222333333332 23346777889999999
Q ss_pred HHhcccCCCCCCCH
Q 014783 371 TRCWDTNPEVRPPF 384 (418)
Q Consensus 371 ~~cl~~dp~~RPt~ 384 (418)
.+||+.||.+|+++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.71 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=208.1
Q ss_pred cccccccccCceeeeCceEEEEEEECC----------------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG----------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 195 (418)
++..+|++.+.||+|+||.||+++..+ ..||+|.+...... . ..+.+.+|++++++++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~ei~~l~~l~h 76 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-T----ARNDFLKEIKIMSRLKN 76 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-H----HHHHHHHHHHHHHhCCC
Confidence 345688999999999999999987522 25899998643221 1 23568899999999999
Q ss_pred CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 196 pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
||++++++++......++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++|++|||||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 9999999999999999999999999999999865321 236788899999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT--GLLPFQNM 340 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt--g~~Pf~~~ 340 (418)
|+|||++.++.+||+|||++........ .....++..|+|||.+.+..++.++|||||||++++|++ +..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999975432221 122234678999999988889999999999999999998 67888877
Q ss_pred CHHHHHHHHHh------cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 341 TAVQAAFAVVN------KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 341 ~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+..+....... .......+..+++.+.+|+.+||+.||++|||++++++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 66554332211 111223455678899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=320.66 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=207.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe--eCc
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRM 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~~~ 209 (418)
.++|+.+..|++|.||.||+|++ +++.||+|.++.......-. -..++|+.+|.+++|||||.+-.+.. +-+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP----ItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP----ITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc----chhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 35778889999999999999987 67899999997654322111 23569999999999999999988764 445
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|||||||+. +|..++.... ..+....+.-++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+||.+.
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 69999999976 9999998754 568899999999999999999999999999999999999999999999999999765
Q ss_pred cc-CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CC-----------
Q 014783 290 QT-EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG-VR----------- 355 (418)
Q Consensus 290 ~~-~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~-~~----------- 355 (418)
.. ..++....|..|.|||++.+. .|+.+.|+||+||++.||+++++-|++....+.+..++..- .+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 43 557888899999999999775 69999999999999999999999999998887776665311 00
Q ss_pred --------CC---------CCCC-ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 --------PV---------IPND-CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 --------~~---------~~~~-~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+. ++.. +++.-.+|+...|..||.+|.|++|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 1111 3466778999999999999999999876
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=334.38 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=202.3
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~l 213 (418)
|++.+.||+|+||.||+++. +++.||||++........ ...+.+..|..++..+. |++|+++++++.....+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 56778999999999999987 678999999875321111 11245677888888885 5778889999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-C
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~ 292 (418)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 79 v~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999999998653 45899999999999999999999999999999999999999999999999998753222 2
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ...|..++..+.+++.+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKG 234 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHH
Confidence 2334568999999999999999999999999999999999999999888766665555433 34566788899999999
Q ss_pred hcccCCCCCCCH
Q 014783 373 CWDTNPEVRPPF 384 (418)
Q Consensus 373 cl~~dp~~RPt~ 384 (418)
||+.+|.+|++.
T Consensus 235 ~l~~~p~~R~~~ 246 (323)
T cd05615 235 LMTKHPSKRLGC 246 (323)
T ss_pred HcccCHhhCCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=317.77 Aligned_cols=244 Identities=36% Similarity=0.642 Sum_probs=207.5
Q ss_pred ceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 142 AFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
.||+|+||.||+|.. ++..||+|.+....... ....+.+|+.+++.++||||+++++++......++||||+++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-----LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHH-----HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 689999999999987 56789999986543211 224688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC--CCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM--TPET 298 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~--~~~~ 298 (418)
++|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++......... ....
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99999987543 45789999999999999999999999999999999999999999999999998754322111 1223
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccC
Q 014783 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 299 gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 377 (418)
++..|+|||.+....++.++||||||+++|++++ |..||.......... .+..+.+...+..++..+.+++.+||+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-QVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4577999999998889999999999999999998 999998887665443 34556666777788999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 014783 378 PEVRPPFTEIVRMLE 392 (418)
Q Consensus 378 p~~RPt~~ell~~L~ 392 (418)
|++||++.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.30 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=196.3
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+...+|++.+.||+|+||.||++.+ +++.||||.... ..+.+|+.++++++||||+++++++....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 4456789999999999999999987 678999997532 24568999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
..++|+|++ +++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 157 ~~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 157 FTCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred eeEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999999 47898888654 458899999999999999999999999999999999999999999999999997532
Q ss_pred cc--CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh---------
Q 014783 290 QT--EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT-------AVQAAFAVVN--------- 351 (418)
Q Consensus 290 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~-------~~~~~~~~~~--------- 351 (418)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||.... .......++.
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 21 22334579999999999999999999999999999999999998764321 1111111100
Q ss_pred -----------------cCCC-CC-CC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 -----------------KGVR-PV-IP-----NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 -----------------~~~~-~~-~~-----~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.... +. .+ ...+..+.+|+.+||+.||++|||++|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00 00 123567889999999999999999999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=327.60 Aligned_cols=256 Identities=30% Similarity=0.534 Sum_probs=207.4
Q ss_pred ccccccccCceeeeCceEEEEEEEC------------------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 194 (418)
+.++|++.+.||+|+||.||++.+. +..||+|++...... ...+.+.+|+.+++.++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-----NARNDFLKEIKIMSRLK 77 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-----HHHHHHHHHHHHHHhCC
Confidence 4567889999999999999998542 236899998643221 12357889999999999
Q ss_pred CCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 195 hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
||||+++++++......++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 99999999999999999999999999999999976321 246778899999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT--GLLPFQNM 340 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt--g~~Pf~~~ 340 (418)
|+|||++.++.++|+|||+++....... .....+++.|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999975433221 112234578999999888889999999999999999998 78999876
Q ss_pred CHHHHHHHHHh------cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 341 TAVQAAFAVVN------KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 341 ~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+..+....... .....+.+..+++.+.+++.+||+.||++||++.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 65553322111 111223455678999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=339.01 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=201.4
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--- 208 (418)
.++|++.+.||+|+||.||++.+ .++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 46788899999999999999987 6789999998764433222 24677899999999999999999987543
Q ss_pred ---ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
..+|+||||+. ++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 99 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 577777743 3788889999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV----------- 354 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~----------- 354 (418)
+............+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....++..-.
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 865544444556789999999999999999999999999999999999999988776554433322100
Q ss_pred ---------CC--------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 ---------RP--------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 ---------~~--------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
++ .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0001123568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=356.78 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=215.1
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeE-E
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA-C 205 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~-~ 205 (418)
.+|...++++.+.|.+|||+.||++.. .+ ..||+|.+-..+.. ..+.+.+|+.+|+.|. |+|||.+++. .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~------~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEE------ALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHH------HHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 345667788899999999999999998 34 89999988654221 2367889999999997 9999999993 2
Q ss_pred ee------CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCE
Q 014783 206 RK------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 206 ~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~~~~v 277 (418)
.. ...++|.||||.||.|-|++..+....|.+..+++|+.|+|+|+++||... |||||||-+||||+.+|+.
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 11 235789999999999999999887778999999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecccCCCC----------CCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014783 278 KIADFGVARIEVQTEGMT----------PETGTYRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344 (418)
Q Consensus 278 kl~DfGla~~~~~~~~~~----------~~~gt~~y~aPE~~---~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~ 344 (418)
||||||.|.......... ...-|+.|+|||++ .+.+.+.|+|||+|||+||-|+....||+....
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 999999987432211110 11257999999998 577899999999999999999999999987543
Q ss_pred HHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.++++..+..+..+..+..+.+||+.||+.||++||++-|+++.+..+..
T Consensus 264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 34566666655556789999999999999999999999999999988875
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=323.31 Aligned_cols=256 Identities=29% Similarity=0.586 Sum_probs=215.2
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...+|++.+.||+|+||.||+|.+ +++ .||+|.+...... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-----KANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 456788899999999999999986 333 5899987654331 12256889999999999999999999998
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
. ...++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 7 67889999999999999997643 358999999999999999999999999999999999999999999999999997
Q ss_pred eecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 287 IEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
........ ....++..|+|||.+....++.++|+||||+++||+++ |+.||......+.. ..+..+.....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-DLLEKGERLPQPPIC 236 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHhCCCCCCCCCCC
Confidence 65432211 11223578999999988889999999999999999999 99999988776544 344455555666778
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+..+.+++.+||..||.+||++.++++.|.++..
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 8899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=363.83 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=210.6
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
+..+.+...+|++.+.||+|+||.||++++ ++..||+|++......... ...+.+|+.+++.|+|||||+++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~----~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE----KSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHH----HHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 344455667899999999999999999987 5678999998754433221 2568899999999999999999998
Q ss_pred Eee--CceEEEEEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCcEEEcC
Q 014783 205 CRK--RMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL-------GFIHRDLKSDNLLISA 273 (418)
Q Consensus 205 ~~~--~~~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-------~iiHrDlkp~NILl~~ 273 (418)
+.. ...+||||||+.+|+|.+++.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 457899999999999999997532 34699999999999999999999985 4999999999999964
Q ss_pred -----------------CCCEEEeecccceeecccCCCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCC
Q 014783 274 -----------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGL 334 (418)
Q Consensus 274 -----------------~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~ 334 (418)
.+.+||+|||++.............||+.|+|||++.+ ..++.++|||||||+||||++|.
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 23599999999986544433445679999999999854 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.||............+........ ...+..+.+||.+||+.+|.+||++.|++.
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999877665555555544432222 346789999999999999999999999984
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=320.75 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=212.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEEEEeEEeeCc-
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~- 209 (418)
...|...++||+|+||+||+|+. +|+.||+|.++-...... ......+|+.+|++++|+| |+.|++++.+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG----~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG----VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC----CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 45566777899999999999986 789999999976544211 1134569999999999999 999999998877
Q ss_pred -----eEEEEEeecCCCCHHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 210 -----VWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 210 -----~~~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.+++|+||++ .+|..++..... ..++...+..++.||+.||+|||+++|+||||||.||||+++|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 8999999994 599999987543 35777889999999999999999999999999999999999999999999
Q ss_pred ccceeec-ccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------
Q 014783 283 GVARIEV-QTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------- 353 (418)
Q Consensus 283 Gla~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------- 353 (418)
|+|+... +...+++..+|..|.|||++.+. .|+...||||+||+++||++++.-|++.+..+....+..--
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9998654 44457788899999999999887 79999999999999999999999999999877776664311
Q ss_pred ---------CCCCC-----CCC-------ChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 014783 354 ---------VRPVI-----PND-------CLPVLSEIMTRCWDTNPEVRPPFTEIVRM--LENA 394 (418)
Q Consensus 354 ---------~~~~~-----~~~-------~~~~l~~li~~cl~~dp~~RPt~~ell~~--L~~~ 394 (418)
+.... +.. ..+...+++.+|++.+|.+|.|++..++. +..+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11001 111 12367889999999999999999998885 5554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=338.65 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=201.4
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc----
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---- 209 (418)
+|++.+.||+|+||.||+++. +++.||||.+........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 467789999999999999986 688999999865432221 1256789999999999999999999998766
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+|+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999995 688888754 346899999999999999999999999999999999999999999999999999864
Q ss_pred cccC--CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014783 289 VQTE--GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN-------------- 351 (418)
Q Consensus 289 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~-------------- 351 (418)
.... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3222 23344678999999999774 479999999999999999999999988776544333221
Q ss_pred ---------cCCCC-------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 352 ---------KGVRP-------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 352 ---------~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
....+ ......++.+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11111 1223457789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.52 Aligned_cols=249 Identities=25% Similarity=0.423 Sum_probs=213.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++.. +++.+|||.+......... .+.+.+|+.+++.++|||++++++.+.....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH----HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 367778999999999999877 6779999998754433221 2578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccceeecccC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~~~~~ 292 (418)
||||+++++|.+++.......+++..+..++.+++.||+|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999999876566689999999999999999999999999999999999998654 68999999998665444
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. .....++..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHH
Confidence 44445688999999999988899999999999999999999999988776655544433 33445666788999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||+.+|++|||+.|++.
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.77 Aligned_cols=246 Identities=26% Similarity=0.487 Sum_probs=196.0
Q ss_pred CceeeeCceEEEEEEEC----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
+.||+|+||.||+|.+. +..+|+|.++....... ...+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 35899999999999863 34789998865432211 2468889999999999999999999998888999999
Q ss_pred ecCCCCHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 217 YAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
|+++|+|.+++..... ...++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999999975322 2456777889999999999999999999999999999999999999999999975432221
Q ss_pred ---CCCCCCCccccccccccCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC-CC---CCC
Q 014783 294 ---MTPETGTYRWMAPEMIQHR-------PYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG-VR---PVI 358 (418)
Q Consensus 294 ---~~~~~gt~~y~aPE~~~~~-------~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~-~~---~~~ 358 (418)
.....++..|+|||++... .++.++||||||+++|||++ |..||......+.....+... .. +..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 1234567889999998643 35789999999999999997 999998877665443333221 11 222
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
....++.+.+++.+|| .+|++|||++||+..|.
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2346788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.90 Aligned_cols=245 Identities=28% Similarity=0.513 Sum_probs=196.6
Q ss_pred ceeeeCceEEEEEEE-C---CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 142 AFAQGAFGKLYRGTY-N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~-~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.||+|+||.||+|.. + ...+|+|.+....... ....+.+|+.+++.++||||+++++.+.....+|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-----EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChH-----HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 589999999999975 3 3467888765432211 125678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC-
Q 014783 218 AKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~- 293 (418)
+++|+|.+++..... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999999976432 2346778899999999999999999999999999999999999999999999865322211
Q ss_pred --CCCCCCCccccccccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC----CCCCC
Q 014783 294 --MTPETGTYRWMAPEMIQH-------RPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV----RPVIP 359 (418)
Q Consensus 294 --~~~~~gt~~y~aPE~~~~-------~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~----~~~~~ 359 (418)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+.....+.... .+..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 122345678999999743 356889999999999999999 8899988877665555444332 12334
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
..++..+.+++..|| .||++|||+++|++.|.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 467888999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.92 Aligned_cols=244 Identities=30% Similarity=0.472 Sum_probs=214.8
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCCh-HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP-EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
|.-++.||.|+||.||-+++ +.+.||||.+.-..... ++. +.+..|+..|.+++|||++.+-|++..+...+|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKW----qDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW----QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHH----HHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 44456899999999999987 77899999987554333 222 678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||| -|+-.|++.-. .+++.+..+..|+.+.+.||+|||+++.||||||+.|||+++.|.|||+|||.|.+..+
T Consensus 104 VMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99999 56888888653 35688899999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~---~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
..++.|||+|||||++ ..+.|+-++|||||||+..||.-.++|+-+++....++.+.....+......+++.|..|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 5678999999999998 3567999999999999999999999999999999999887776655555667889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
..||+.-|.+|||.+++++
T Consensus 259 d~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHhhCcccCCcHHHHhh
Confidence 9999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.35 Aligned_cols=249 Identities=26% Similarity=0.466 Sum_probs=210.5
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-CceEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWC 212 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~~ 212 (418)
.|++.+.||.|++|.||+++. +++.||+|.+........ ..+.+.+|+.++++++|||++++++.+.. +..+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR----ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 367889999999999999987 567999999865433222 12567889999999999999999998764 44689
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
++|||+++++|.+++.......+++..++.++.|++.|+++||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999999998755567899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.......+++.|+|||.+.+..++.++||||||+++++|++|+.||...+........ ..+..+..+...++.+.+++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HhcCCCCCccccCHHHHHHHH
Confidence 2233456889999999999999999999999999999999999999877765544443 334444566678899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||+.||++|||+.++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 236 TMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHhccCcccCCCHHHHhc
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=331.30 Aligned_cols=247 Identities=23% Similarity=0.395 Sum_probs=198.1
Q ss_pred ccCceeee--CceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 139 MGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 139 ~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
++.+||+| +||+||+++. +|+.||||.+........ ..+.+.+|+.+++.++||||+++++++..+..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 45789999 6889999987 688999999865433222 235677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC--
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-- 292 (418)
|||+++|+|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999999976555568999999999999999999999999999999999999999999999998653221111
Q ss_pred ------CCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 014783 293 ------GMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--------- 355 (418)
Q Consensus 293 ------~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--------- 355 (418)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0112346678999999976 46899999999999999999999999876654433332221110
Q ss_pred -----------------------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 -----------------------------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 -----------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......+++.+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0011124568999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.65 Aligned_cols=250 Identities=28% Similarity=0.532 Sum_probs=213.2
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|+..+.||+|+||.||+|.. +++.||+|.+........ .....+.+.+|+.+++.++||||+++++++.....+++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 56678899999999999987 578999999875443221 111235788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999999999999754 35888999999999999999999999999999999999999999999999998765443334
Q ss_pred CCCCCCccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHh
Q 014783 295 TPETGTYRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRC 373 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 373 (418)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.||......+...........+.++..+++.+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHH
Confidence 4567889999999997776 899999999999999999999999887765555554443455566777889999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 014783 374 WDTNPEVRPPFTEIVR 389 (418)
Q Consensus 374 l~~dp~~RPt~~ell~ 389 (418)
|+.+|.+||++.+++.
T Consensus 239 l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 239 LQRDPSLRPTAAELLE 254 (258)
T ss_pred hhcCcccCcCHHHHhc
Confidence 9999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.14 Aligned_cols=254 Identities=30% Similarity=0.548 Sum_probs=205.2
Q ss_pred cccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
..+|++.+.||+|+||.||++.+ ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------EHLRDFEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 45778889999999999999874 467899999864321 112568899999999999999999998753
Q ss_pred --CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
...+++|+||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 34689999999999999999753 245889999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCC----CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Q 014783 286 RIEVQTEGM----TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---------------QAA 346 (418)
Q Consensus 286 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---------------~~~ 346 (418)
+........ ....++..|+|||.+.+..++.++||||||++++||++|..|+...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 865332211 1122345699999999888999999999999999999987765432211 111
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
...+........+..++..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 223344444455667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=333.17 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=204.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+++. +++.||||++.+.... .....+.+.+|+.+++.++|+||+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 3678889999999999999987 5789999998642211 1112356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999999753 3468999999999999999999999999999999999999999999999999987543322
Q ss_pred C--CCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCC
Q 014783 293 G--MTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP---NDC 362 (418)
Q Consensus 293 ~--~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~ 362 (418)
. .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+........++ ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 2 223468999999999863 457889999999999999999999998877766555554433222222 346
Q ss_pred hHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNP--EVRPPFTEIVRM 390 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp--~~RPt~~ell~~ 390 (418)
++.+.+++.+|+..++ ..||+++++++.
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 8899999999886533 337899888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=318.61 Aligned_cols=251 Identities=28% Similarity=0.509 Sum_probs=208.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee--Cce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~ 210 (418)
.+|++.+.||+|+||.||++.. ++..||||.+.......... ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH-HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 4677889999999999999987 57899999986433222111 122578899999999999999999998865 356
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+++||||+++++|.+++... ..+++..+.+++.|++.||+|||+.+++|+||||+|||++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 88999999999999998754 3478888999999999999999999999999999999999999999999999875422
Q ss_pred c----CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 291 T----EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 291 ~----~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||..................+..|...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 1 123335688999999999888899999999999999999999999988766665555544444556676777889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||. +|++||+++++++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhc
Confidence 999999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.75 Aligned_cols=248 Identities=33% Similarity=0.599 Sum_probs=202.5
Q ss_pred ceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe-eCceEEEEE
Q 014783 142 AFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KRMVWCIVT 215 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~~lv~ 215 (418)
.||+|+||.||+|.+. ...||+|.+....... ..+.+.+|+.+++.++||||+++++++. .+...++|+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-----EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHH-----HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 6899999999999862 2479999875422211 1256788999999999999999999875 455678999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC---
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~--- 292 (418)
||+.+++|.+++.... ...++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999999997543 346777788999999999999999999999999999999999999999999987543211
Q ss_pred --CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 293 --GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 293 --~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
......++..|+|||.+....++.++||||||+++|||++ |.+||...+..+... .+..+..+..+..+++.+.++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhcCCCCCCCCcCCHHHHHH
Confidence 1122345678999999988899999999999999999999 577787776655443 344445555566778999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+.+||+.+|++||++.++++.|+++..
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.19 Aligned_cols=256 Identities=29% Similarity=0.590 Sum_probs=213.3
Q ss_pred cccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
++.++|++.+.||+|+||.||+|+.. ...||+|.+...... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-----NLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-----HHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 34578889999999999999999852 357999987543221 122568899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCE
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNR-------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~v 277 (418)
+......++||||+++++|.+++...... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 77 CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred ECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence 99988899999999999999999764421 58999999999999999999999999999999999999999999
Q ss_pred EEeecccceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 014783 278 KIADFGVARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354 (418)
Q Consensus 278 kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 354 (418)
+++|||++....... ......++..|+|||.+.+..++.++||||||+++++|++ |..||.................
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 999999986432211 1223346778999999988889999999999999999998 8899987776665554443344
Q ss_pred CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 355 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
....+..++..+.+++.+||+.+|++|||+.|++..|.
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 44456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.92 Aligned_cols=247 Identities=30% Similarity=0.595 Sum_probs=203.3
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||+|+||.||+++. +++.||+|++......... .....+|+.++++++||||+++++++......++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccccccc
Confidence 46778999999999999998 5568999999865433221 12345699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee-cccCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~-~~~~~ 293 (418)
||++.+++|.+++.. ...+++..++.++.||+.||++||+.||+|+||||+||+++.++.++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999983 355899999999999999999999999999999999999999999999999999753 23334
Q ss_pred CCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCChHHHH
Q 014783 294 MTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF---AVVNKGVRP--VIPNDCLPVLS 367 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~ 367 (418)
.....++..|+|||++. +..++.++||||||+++++|++|..||.......... ......... .........+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 55667899999999998 8889999999999999999999999999874322222 222111111 11122348999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||++||++.++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=321.42 Aligned_cols=243 Identities=25% Similarity=0.438 Sum_probs=200.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+|.+ +++.||+|++....... ..+.+.+|+.++++++||||+++++.+......++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 567888999999999999986 67899999986542211 12568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... .
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-c
Confidence 99999999996552 3778889999999999999999999999999999999999999999999999755332 2
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCCCCC-CCCChHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ------AAFAVVNKGVRPVI-PNDCLPVL 366 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~l 366 (418)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .....+.....+.. ....++.+
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 344578999999999999999999999999999999999999996532211 11111222222222 23467789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.+++.+||+.+|++||+++|+++.
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=323.11 Aligned_cols=254 Identities=28% Similarity=0.527 Sum_probs=206.9
Q ss_pred ccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
+.|++.+.||+|+||.||++++ ++..||+|.+....... ....+.+|+.+++.+.||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-----HIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 4568889999999999999974 46789999986432211 125688999999999999999999998765
Q ss_pred --ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+++
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 5689999999999999998654 2358899999999999999999999999999999999999999999999999997
Q ss_pred eecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--------------CHHHHHHH
Q 014783 287 IEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM--------------TAVQAAFA 348 (418)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~--------------~~~~~~~~ 348 (418)
....... .....++..|+|||.+.+..++.++||||||+++|||++++.|+... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 5433221 12345677899999998888999999999999999999977654221 11112223
Q ss_pred HHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 349 VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+..+.....+..++..+.+|+.+||+.||++|||++++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 3344445556677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.20 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=210.1
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..|-...+.|++.+.||+|+||.||+|+. ++..||+|.+..... . ..+.+.+|+.+++.++||||+++++.+
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--E----ELEDYMVEIEILATCNHPYIVKLLGAF 78 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--H----HHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence 44555667899999999999999999987 578999999864321 1 125678899999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
..+..+|+||||+++++|..++.+.. ..+++..+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 79 YWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999988876533 45899999999999999999999999999999999999999999999999998
Q ss_pred eeeccc-CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCC
Q 014783 286 RIEVQT-EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVI 358 (418)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~ 358 (418)
...... .......++..|+|||.+. ...++.++|||||||++|+|++|..||...+............. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQ 237 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCC
Confidence 753222 1223446789999999984 34578899999999999999999999988776554444332221 1223
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+..++..+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 4567789999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=318.20 Aligned_cols=250 Identities=29% Similarity=0.510 Sum_probs=208.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee--CceE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVW 211 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~ 211 (418)
+|+..+.||+|+||.||++.. ++..||+|.+.......... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhH-HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 567788999999999999986 67899999987544322211 122568899999999999999999998865 3578
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+|+||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999999753 34888999999999999999999999999999999999999999999999998754221
Q ss_pred ----CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 292 ----EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 292 ----~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||......+...........+.++...++.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 1122345789999999999988999999999999999999999999887766655555555555666767778889
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++ +||..+|++||+++|+++
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhc
Confidence 998 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.53 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=205.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+++. +++.||+|+++...... ...+.+|+.+++.++||||+++++.+.....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 35778889999999999999987 67899999986543211 13567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+|+||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999999998653 45899999999999999999999999999999999999999999999999998754322
Q ss_pred C-CCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCChH
Q 014783 292 E-GMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PNDCLP 364 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 364 (418)
. ......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+.............+.. ...++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence 1 223457899999999984 456889999999999999999999999766654444333333332221 124667
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.+++.+||+.+|++||++++|++
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhc
Confidence 8999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.65 Aligned_cols=245 Identities=29% Similarity=0.515 Sum_probs=210.0
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||.|+||.||+|++ +++.||+|.+........ ...+.+|+.+++.++||||+++++++..+..+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-----IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH-----HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 577888999999999999987 678999999865432211 2467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-C
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~ 292 (418)
|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++..... .
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999999998753 6899999999999999999999999999999999999999999999999999866443 2
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-ChHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND-CLPVLSEIMT 371 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 371 (418)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+....... +.....+..+.. ++..+.+++.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHH
Confidence 23345688899999999988899999999999999999999999987766554433 333444444444 7889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||..+|++|||++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 233 LCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=332.78 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=206.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ +++.||+|++.+.... .......+.+|+.++..++|++|+++++++.+...+|+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 577889999999999999987 4678999998642111 11123457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999999753 34589999999999999999999999999999999999999999999999999875432221
Q ss_pred --CCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCCh
Q 014783 294 --MTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP---NDCL 363 (418)
Q Consensus 294 --~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~ 363 (418)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+...| ..++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 22357999999999986 3468899999999999999999999999888777666665544333333 3568
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEV--RPPFTEIVRM 390 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~--RPt~~ell~~ 390 (418)
+.+.+++.+|+..++++ |++++|+++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 89999999988654443 6889988775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.35 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=202.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|.+.+.||+|+||.||+|++ +++.||+|.++....... ...+.+|+.++++++||||+++++++..+..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 35678889999999999999987 577899999875432221 13466899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 80 TLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99999996 4888888653 345888999999999999999999999999999999999999999999999999754322
Q ss_pred -CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------
Q 014783 292 -EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK----------------- 352 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~----------------- 352 (418)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 22234567899999999865 46899999999999999999999999887665443332210
Q ss_pred ----CCCCC-------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 ----GVRPV-------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ----~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..... ....+++.+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 11245678899999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.17 Aligned_cols=248 Identities=26% Similarity=0.465 Sum_probs=204.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK---- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---- 207 (418)
..|++.+.||+|+||.||+|++ +++.||+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-------HHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 5667788999999999999987 678999999864321 114577899999998 69999999999853
Q ss_pred --CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
...+|++|||+.+|+|.+++.......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 457899999999999999998766667889999999999999999999999999999999999999999999999998
Q ss_pred eeeccc-CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 286 RIEVQT-EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
...... .......|+..|+|||.+. ...++.++|||||||++|||++|..||....+......+.........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 754322 2233456889999999985 3468889999999999999999999998776655544433333333334
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..++..+.+++.+||+.||.+|||+.||++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 467889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=332.80 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=206.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+++. +++.||+|++.+.... .......+.+|..++..++|+||+++++++......|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML---KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3678889999999999999987 5678999998642211 1112345788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999999763 3468999999999999999999999999999999999999999999999999997654322
Q ss_pred C--CCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC---CC
Q 014783 293 G--MTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN---DC 362 (418)
Q Consensus 293 ~--~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~ 362 (418)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+...|. .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 2 123469999999999875 4688999999999999999999999998877766665555443333333 45
Q ss_pred hHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEV--RPPFTEIVRM 390 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~--RPt~~ell~~ 390 (418)
++.+.+++.+|+..++++ |+++++++..
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 789999999999865544 4678877753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.72 Aligned_cols=246 Identities=33% Similarity=0.636 Sum_probs=205.3
Q ss_pred ceeeeCceEEEEEEECC--------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 142 AFAQGAFGKLYRGTYNG--------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.||+|+||.||+|++.. ..+|||.+........ ...+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-----KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhh-----HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 58999999999998632 5799998864322111 2467899999999999999999999998889999
Q ss_pred EEeecCCCCHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-----CEEEeecc
Q 014783 214 VTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-----SIKIADFG 283 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-----~vkl~DfG 283 (418)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999999997532 23478889999999999999999999999999999999999887 89999999
Q ss_pred cceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 284 VARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 284 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+... .+..+.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 235 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-HVTAGGRLQKP 235 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH-HHhcCCccCCc
Confidence 9875432211 122345688999999998899999999999999999998 999998877665443 34444555666
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
..++..+.+++.+||..+|.+||+++++++.|++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 7788999999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=316.76 Aligned_cols=249 Identities=29% Similarity=0.498 Sum_probs=209.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++.. +++.+|+|++...... ..+.+.+|+.++++++||||+++++++.....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence 35678889999999999999987 5678999998754322 125788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999999998764 246899999999999999999999999999999999999999999999999998754332
Q ss_pred C-CCCCCCCCccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCChH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHR---PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PNDCLP 364 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~---~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 364 (418)
. ......++..|+|||.+... .++.++||||||+++|+|++|..||......+.........+.+.. +...+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 23345688899999999776 8899999999999999999999999887766655544444333222 234567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.+++.+||..+|.+|||+.+++.
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 8999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.98 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=208.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 4678889999999999999987 57899999986543221 123467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 213 IVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
+||||++|++|.+++.... ....+...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999986421 1235567788999999999999999999999999999999999999999999
Q ss_pred cceeecccC-------------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014783 284 VARIEVQTE-------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344 (418)
Q Consensus 284 la~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~ 344 (418)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 997541100 0112468999999999999999999999999999999999999998755433
Q ss_pred HHHHHHh-cCCCCCCCCCChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhHH
Q 014783 345 AAFAVVN-KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRP-PFTEIVRMLENAET 396 (418)
Q Consensus 345 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~ell~~L~~~~~ 396 (418)
....... ..........+++.+.+++.+||+.||++|| +++++++.|+....
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3222111 1111111135778899999999999999995 57778888887654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=314.77 Aligned_cols=249 Identities=25% Similarity=0.461 Sum_probs=213.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.||+|.+........ ....+.+|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK----EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH----HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 467788999999999999987 678999999875433221 12467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
|+||+.+++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999999765555689999999999999999999999999999999999999999999999999975433221
Q ss_pred -CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 -MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.....|++.|+|||.+.+..++.++|+|||||++++|++|+.||......+....++ .+..+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHH
Confidence 123457889999999998889999999999999999999999998877766655544 344555677788999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||+.+|.+||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 236 LFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=322.39 Aligned_cols=246 Identities=27% Similarity=0.486 Sum_probs=207.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|+||.||+|.. +++.||+|.+....... .+.+.+|+.+++.+.||||+++++.+......|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 5778888999999999999986 67899999987543322 146779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+++++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred EeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999999999864 347888999999999999999999999999999999999999999999999987543222
Q ss_pred -CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCChHHHHHHH
Q 014783 293 -GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-PVIPNDCLPVLSEIM 370 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 370 (418)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+............. ...+...++.+.+++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence 223456889999999999888999999999999999999999999877765544433332222 123456778899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||..+|++|||+.+++.
T Consensus 251 ~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHCcCCcccCcCHHHHhh
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.50 Aligned_cols=248 Identities=35% Similarity=0.710 Sum_probs=211.2
Q ss_pred cccCceeeeCceEEEEEEECC------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 138 NMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
++.+.||.|+||.||++++.. ..||+|++....... ..+.+.+|+.+++.++|+||+++++++.+....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 567889999999999998843 789999986543321 125788999999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999997654433899999999999999999999999999999999999999999999999999865443
Q ss_pred CCCC--CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 EGMT--PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ~~~~--~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.... ...+++.|+|||.+....++.++||||||+++++|++ |..||...+....... +..+.....+..++..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-LKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHH
Confidence 2222 2336789999999988889999999999999999998 8999988766555443 4445556667778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L 391 (418)
++.+||..||++|||+.|+++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=317.87 Aligned_cols=246 Identities=29% Similarity=0.493 Sum_probs=210.1
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|+..+.||+|+||.||+|++ ++..||||++...... .....+.+|+.+++++.||||+++++++.+....|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 456778899999999999987 5789999998653322 123578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+.+++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999999999864 348888999999999999999999999999999999999999999999999997653322
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......++..|+|||.+.+..++.++|+||||+++|||++|..||........... +.....+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCCchhhhHHHHHHHHH
Confidence 12334578899999999988899999999999999999999999988776654433 33444555666788899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~ 390 (418)
||+.+|++||++.+++..
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=323.88 Aligned_cols=257 Identities=29% Similarity=0.584 Sum_probs=212.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...+|+..+.||+|+||.||+|++ ++. .||+|.+....... ....+.+|+.+++.++||||++++++|.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 446778889999999999999986 444 57888876433211 1246789999999999999999999987
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
... .++++||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~-~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPT-IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CCC-ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 654 57999999999999998754 3458899999999999999999999999999999999999999999999999998
Q ss_pred eecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 287 IEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+ ....+..+.....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPIC 236 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCC
Confidence 6432221 122345678999999998899999999999999999997 999998776544 33455555555666678
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+..+.+++.+||..+|++||+++++++.|..+..+
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=316.42 Aligned_cols=257 Identities=22% Similarity=0.408 Sum_probs=211.7
Q ss_pred ccccCceeeeCceEEEEEEEC---CceEEEEEeecCCCChH----HHHHHHHHHHHHHHHHHh-CCCCCeEEEEeEEeeC
Q 014783 137 LNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKR 208 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~----~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~ 208 (418)
|++.+.||+|+||.||++.+. ++.+|+|.+........ ........+.+|+.++.+ ++||||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 667789999999999999873 47899998864322111 111223456788888865 7999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999988542 34568999999999999999999996 78999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
.............++..|+|||.+.+..++.++||||||+++|+|++|+.||..................+.....+++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSED 241 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHH
Confidence 86554444455678899999999998889999999999999999999999998776655555544444443333367889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+.+++.+||+.||++||++.|+..++.+
T Consensus 242 l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 242 VTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 9999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=319.84 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=200.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+|+. +++.||||.+........ ....+.+|+.+++.++||||+++++++..+..+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG----VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 367788999999999999987 578999999865432211 12457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
||||+. ++|.+++.... +..+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999996 68988886533 356899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 014783 292 EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV---------------- 354 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~---------------- 354 (418)
.......+++.|+|||.+.+. .++.++||||||+++++|+||+.||.+...............
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 222334578999999988654 578999999999999999999999987665443333221100
Q ss_pred -----------CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 -----------RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 -----------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.......+++++.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00112246788899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=324.71 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=210.7
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++.. +++.||+|.+........ ...+.+.+|+.+++.++||||+++++.+......|+
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH---HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 577888999999999999987 578999999976543321 123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999999865556799999999999999999999999999999999999999999999999998864321110
Q ss_pred ------------------------------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 014783 294 ------------------------------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV 343 (418)
Q Consensus 294 ------------------------------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~ 343 (418)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 11235788999999999888999999999999999999999999888776
Q ss_pred HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 014783 344 QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPP----FTEIVR 389 (418)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~ell~ 389 (418)
.....+.............++.+.+++.+||..||++||| ++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 6665555444333323336889999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.37 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=214.7
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCC--CChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
.|.-.+.||.|..+.|-++.. +|..+|+|++.... ...+....+.+.-.+|+.||+++ .||+|+++.+++.++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 344456799999999998865 78899999886432 22233555667778999999999 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+++|+|.|+.|.|+|+|... -.+++....+|+.|+.+|++|||.++||||||||+|||++++.++||+|||+|....+
T Consensus 98 ~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999864 4599999999999999999999999999999999999999999999999999999888
Q ss_pred cCCCCCCCCCccccccccccC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCC
Q 014783 291 TEGMTPETGTYRWMAPEMIQH------RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDC 362 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 362 (418)
+......||||.|+|||.+.. .+|+..+|.|+.||+||.||.|.+||......-.+..+....+.- +...+.
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence 888888999999999999954 368899999999999999999999998765544444444444332 233456
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+...++|+.+||+.||.+|.|++|.+.
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhc
Confidence 788999999999999999999999876
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=319.67 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=205.9
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~ 204 (418)
+.+....++|++.+.||+|+||.||+++. +++.+|+|++...... ...+.+|+.+++.+ +||||++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 44455667888999999999999999987 6789999987542211 14577899999999 69999999998
Q ss_pred Ee-----eCceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCE
Q 014783 205 CR-----KRMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 205 ~~-----~~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~v 277 (418)
+. .+..+++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 74 345689999999999999988642 23468889999999999999999999999999999999999999999
Q ss_pred EEeecccceeecccC-CCCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 278 KIADFGVARIEVQTE-GMTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 278 kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
||+|||+++...... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||..............
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999987653322 2234468899999999853 4578999999999999999999999987766444333221
Q ss_pred cC-CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 352 KG-VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 352 ~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.. .....+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11 1112344467789999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=312.23 Aligned_cols=245 Identities=33% Similarity=0.616 Sum_probs=207.0
Q ss_pred CceeeeCceEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecC
Q 014783 141 TAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 219 (418)
++||+|+||.||++.+. ++.||+|.+...... .....+.+|+.+++++.||||+++++++......++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 36899999999999874 789999998654332 122578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC---CC
Q 014783 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TP 296 (418)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~---~~ 296 (418)
+++|.+++.... ..+++..+..++.+++.+|+|||+++++||||+|+|||++.++.+||+|||++......... ..
T Consensus 76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999999997543 35788999999999999999999999999999999999999999999999999754321111 11
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 375 (418)
..++..|+|||.+.+..++.++|+||||+++|||++ |..||......... ..+........+..++..+.+++.+||.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-HHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 223567999999998899999999999999999999 89999887765433 3344455556677788999999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 014783 376 TNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 376 ~dp~~RPt~~ell~~L~ 392 (418)
.+|++|||+.||++.|+
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=313.34 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=211.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe--eCceE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRMVW 211 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~~~~~ 211 (418)
+|++.+.||.|+||.||++.. +++.||+|.+......... .+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 467788999999999999986 6789999998754433222 256788999999999999999999875 34568
Q ss_pred EEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVH-----GLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH-----~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+++|||+++++|.+++... ....+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999999753 2456899999999999999999999 89999999999999999999999999999
Q ss_pred ceeecccCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 285 ARIEVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 285 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
+........ .....++..|+|||.+....++.++|+||||+++++|++|..||....... ..+.+..+..+..+...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LASKIKEGKFRRIPYRYS 235 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHHHHhcCCCCCCccccC
Confidence 986544332 334568899999999998889999999999999999999999998877544 334455555566777888
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhh
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=319.78 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=207.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||++++ ++..||+|++...... ..+.+.+|+.++++++||||+++++.+..+...|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE------ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH------HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 5678889999999999999987 5789999998643211 1256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred EEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999999998754 346899999999999999999999999999999999999999999999999988654322
Q ss_pred CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCChHH
Q 014783 292 EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-PVIPNDCLPV 365 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 365 (418)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...........+...... ...+..++..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 2223346889999999975 345788999999999999999999999888766655444332211 1234567889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=318.61 Aligned_cols=246 Identities=27% Similarity=0.467 Sum_probs=204.6
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||+|+||.||++.+ ++..+|+|.+..... . ..+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~----~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--E----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--H----HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 56778999999999999988 467889998854321 1 125678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~ 293 (418)
+||+++++|..++... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 9999999999887643 346899999999999999999999999999999999999999999999999998754322 12
Q ss_pred CCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCChHHHH
Q 014783 294 MTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG-VRPVIPNDCLPVLS 367 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 367 (418)
.....++..|+|||++. +..++.++|||||||++|+|++|..||...+..+......... .....+..++..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 33456889999999984 4457889999999999999999999998877766555443322 22234556788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=315.15 Aligned_cols=245 Identities=25% Similarity=0.507 Sum_probs=195.8
Q ss_pred ceeeeCceEEEEEEE-CCc---eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 142 AFAQGAFGKLYRGTY-NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~-~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.||+|+||.||++.. ++. .+++|.+....... ..+.+.+|+.+++.++||||+++++.|......|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH-----HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 689999999999975 333 45666654332211 135788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC---
Q 014783 218 AKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (418)
Q Consensus 218 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~--- 292 (418)
+++|+|.+++.... ....++..+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999999997542 2346677788999999999999999999999999999999999999999999986422111
Q ss_pred CCCCCCCCccccccccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC----CCCCCCC
Q 014783 293 GMTPETGTYRWMAPEMIQH-------RPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG----VRPVIPN 360 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~-------~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~----~~~~~~~ 360 (418)
......++..|+|||++.. ..++.++||||||+++|||++ |..||......+....++... .++.++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1233467899999999843 245789999999999999997 688998877766555544332 2334455
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
..++.+.+++..|| .+|++||++++|++.|.
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 67788999999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=323.69 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=203.0
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++.+ ++..||+|.+..... . .....+.+|++++++++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-P----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 577889999999999999987 577899999864322 1 123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999999999754 458999999999999999999997 59999999999999999999999999998754322
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------------
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-------------------- 352 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-------------------- 352 (418)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.... ...+..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCC
Confidence 23445788999999999888899999999999999999999999975443221 111111
Q ss_pred ----------------CCCCCCCC-CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 353 ----------------GVRPVIPN-DCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 353 ----------------~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
...+..|. .++..+.+++.+||..+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111221 256789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=333.01 Aligned_cols=241 Identities=22% Similarity=0.323 Sum_probs=194.7
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEeeCceEEEEEee
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
||+|+||.||+++. +++.||||++........ .....+..|..++..+ .||||+++++++.....+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK---KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh---hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 69999999999987 578999999864321111 1113345566676665 699999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~~~~~ 296 (418)
+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 78 MSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 999999998875 34689999999999999999999999999999999999999999999999999875322 222345
Q ss_pred CCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcc
Q 014783 297 ETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 375 (418)
.+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+.....+ .....+++.+.+++.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcC
Confidence 6799999999998754 5899999999999999999999999887766554444333222 1223467899999999999
Q ss_pred cCCCCCC----CHHHHHH
Q 014783 376 TNPEVRP----PFTEIVR 389 (418)
Q Consensus 376 ~dp~~RP----t~~ell~ 389 (418)
.||.+|| ++.++++
T Consensus 235 ~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 235 RNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHCCCCCCCHHHHhc
Confidence 9999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=313.55 Aligned_cols=247 Identities=28% Similarity=0.500 Sum_probs=208.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++++ ++..||+|.+..... .+.+.+|+.++++++||||+++++.+.....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 35788889999999999999988 468999999864311 36788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+++||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999999998653 356899999999999999999999999999999999999999999999999998765433
Q ss_pred C-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSEI 369 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 369 (418)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..... ....+..++..+.++
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF 232 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence 2 22334578999999999999999999999999999999999999987766554433222111 112233466789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||+.||++|||+.|++.
T Consensus 233 i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHhcChhhCcCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.38 Aligned_cols=246 Identities=27% Similarity=0.504 Sum_probs=209.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||.|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+.....+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 5678889999999999999986 78899999986543222 246788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999999998864 348899999999999999999999999999999999999999999999999987543322
Q ss_pred C-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCChHHHHHHH
Q 014783 293 G-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-PVIPNDCLPVLSEIM 370 (418)
Q Consensus 293 ~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 370 (418)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+...... ...+..+++.+.+++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 2 23346889999999999888999999999999999999999999887776554444333222 234556788999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||..||++||++.+++.
T Consensus 250 ~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHhhcChhhCCCHHHHhh
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=318.17 Aligned_cols=255 Identities=31% Similarity=0.615 Sum_probs=211.1
Q ss_pred cccccccCceeeeCceEEEEEEEC------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
.++|++.+.||+|+||.||+++++ +..||||++...... ...+.+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 456788899999999999999863 568999998754432 123678999999999999999999999877
Q ss_pred --CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
....++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 557899999999999999997643 35899999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCC----CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHH
Q 014783 286 RIEVQTEGM----TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA--------------VQAAF 347 (418)
Q Consensus 286 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~--------------~~~~~ 347 (418)
......... ....++..|+|||.+....++.++||||||++++||++|..|+..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 865422211 122345679999999888899999999999999999999999865322 11222
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..+....+...+..++..+.+++.+||+.+|++|||+.||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 33444555555667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=317.67 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=202.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ +++.||+|++........ ..+.+.+|+.++++++|||++++++++.....+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 577788999999999999987 578999999865432211 12457799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++++|..++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 78 VFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999888777653 3458999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------
Q 014783 293 GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------------------ 353 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------------------ 353 (418)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2234467889999999876 458899999999999999999999998877665544332100
Q ss_pred -CCCCCC----------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 -VRPVIP----------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 -~~~~~~----------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....+ ...+..+.+|+.+||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 134677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=319.40 Aligned_cols=245 Identities=25% Similarity=0.412 Sum_probs=208.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++.+ +++.||+|++....... ....+.+.+|+++++++.||||+++++++.....+|+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 577889999999999999987 57899999986532211 1123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999999999764 46899999999999999999999999999999999999999999999999999765433
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHh
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRC 373 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 373 (418)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.. ....+|...+..+.+++.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCccCCccCCHHHHHHHHHH
Confidence 3445688999999999888899999999999999999999999988775544444332 23456667789999999999
Q ss_pred cccCCCCCC-----CHHHHHH
Q 014783 374 WDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 374 l~~dp~~RP-----t~~ell~ 389 (418)
|..||.+|+ +++|++.
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHccCcccCCHHHHHc
Confidence 999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=316.08 Aligned_cols=237 Identities=23% Similarity=0.464 Sum_probs=191.9
Q ss_pred ceeeeCceEEEEEEEC--------------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 142 AFAQGAFGKLYRGTYN--------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~--------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
.||+|+||.||+|++. ...||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------DISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------hHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 6899999999999852 12588888754321 123567889999999999999999999998
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-------EEEe
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKIA 280 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~-------vkl~ 280 (418)
....++||||+++++|..++... ...+++..+++++.||+.||+|||+++|+||||||+|||++.++. ++++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 88899999999999999888653 345899999999999999999999999999999999999987664 8999
Q ss_pred ecccceeecccCCCCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 281 DFGVARIEVQTEGMTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELI-TGLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 281 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
|||++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.. ........ .
T Consensus 155 d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~--~ 228 (262)
T cd05077 155 DPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM--L 228 (262)
T ss_pred CCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc--C
Confidence 9999865422 23345788999999986 567899999999999999998 589999876544332 22222221 2
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
....++.+.+|+.+||+.||++||++.+|++.|
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 233467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.15 Aligned_cols=248 Identities=26% Similarity=0.469 Sum_probs=208.8
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||.|+||.||+|.. ++..+|+|++....... ..+.+.+|+.+++.++|+||+++++.+......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 578889999999999999987 67799999986543332 12578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 214 VTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
|+|++++++|.+++..... ..+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||++.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999999976433 568999999999999999999999999999999999999999999999999987544322
Q ss_pred C-----CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----CC
Q 014783 293 G-----MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP-----ND 361 (418)
Q Consensus 293 ~-----~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~ 361 (418)
. .....|+..|+|||.+... .++.++|+||||+++++|++|+.||...+..+......... .+..+ ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKK 235 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCcccccc
Confidence 1 1234588999999998776 78999999999999999999999998877766555544432 22121 24
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+.+++.+||..||++|||+.+|++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 6788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=344.46 Aligned_cols=255 Identities=29% Similarity=0.580 Sum_probs=223.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
..++..++||+|+||+||+|.| .|+ +||||++........ ..+++.|+.+|.++.|||+++|+++|...
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-----s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-----SIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-----hHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 3566778999999999999998 443 799999876544322 25788999999999999999999999877
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
. +-||++||+.|+|.+|++..+ ..+....++.|..||++||.|||+++++||||.++||||..-.++||.|||+|+..
T Consensus 771 ~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 771 T-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred h-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 6 679999999999999998754 56888999999999999999999999999999999999999999999999999875
Q ss_pred ccc-CCCCCCC--CCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 289 VQT-EGMTPET--GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 289 ~~~-~~~~~~~--gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
... ..+.... ..+.|||-|.+....|+++||||||||++||++| |..||.++...+. ...+..+.+...|+.|+.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGERLSQPPICTI 927 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccccCCCCCCccH
Confidence 432 2233333 3589999999999999999999999999999999 9999999988774 567888999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.++.+|.+||..|++.||+|+++...+.++..+
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999887653
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=314.93 Aligned_cols=251 Identities=33% Similarity=0.574 Sum_probs=206.9
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCCh----HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP----EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
|.+.+.||+|+||.||+|.. +++.||||.++...... .......+.+.+|+.+++.++|||++++++++.....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 56678999999999999976 67899999886432211 1122234578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999999764 4688899999999999999999999999999999999999999999999999875432
Q ss_pred cC---CCCCCCCCccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC----C
Q 014783 291 TE---GMTPETGTYRWMAPEMIQHRP--YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN----D 361 (418)
Q Consensus 291 ~~---~~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~ 361 (418)
.. ......++..|+|||.+.... ++.++|+||||+++|++++|..||......+...........+..+. .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence 11 122346789999999987654 88999999999999999999999987766555544443333333332 4
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
++..+.+++.+||..+|++|||++++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 5789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.22 Aligned_cols=250 Identities=25% Similarity=0.468 Sum_probs=202.5
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
+...+.....||+|+||.||+|++ ++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++..+..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR------YVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 344444556899999999999986 5678999988643221 12578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfGla~~ 287 (418)
.++|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999999997642 224 77888899999999999999999999999999999986 67999999999875
Q ss_pred ecccC-CCCCCCCCccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCh
Q 014783 288 EVQTE-GMTPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELITGLLPFQNMTAV-QAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 288 ~~~~~-~~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 363 (418)
..... ......++..|+|||.+... .++.++||||||+++|+|++|+.||...... ............+.+|..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 43222 22334688999999998654 3789999999999999999999999764432 22222222234455677788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+++.+||+.+|.+|||+.|+++
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.87 Aligned_cols=237 Identities=22% Similarity=0.436 Sum_probs=191.9
Q ss_pred ceeeeCceEEEEEEEC--------------------------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 014783 142 AFAQGAFGKLYRGTYN--------------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 195 (418)
+||+|+||.||+|... ...||+|++.... ......+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence 6999999999999741 1258888875321 1223568889999999999
Q ss_pred CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC
Q 014783 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (418)
Q Consensus 196 pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~ 275 (418)
|||++++++|......++||||+++|+|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999999999999999999999999999998653 34689999999999999999999999999999999999998654
Q ss_pred -------CEEEeecccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHH
Q 014783 276 -------SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELI-TGLLPFQNMTAVQAA 346 (418)
Q Consensus 276 -------~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~ell-tg~~Pf~~~~~~~~~ 346 (418)
.+|++|||++..... .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 389999998864322 223457788999998865 56899999999999999995 699999877665432
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
. ..... ...+....+.+.+++.+||+.+|++|||+.++++.|
T Consensus 232 ~-~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 R-FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H-HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2 22222 223344557899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.25 Aligned_cols=251 Identities=29% Similarity=0.513 Sum_probs=207.9
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|+..+.||+|+||.||+++. +++.||+|++..............+.+.+|+.++++++||||+++++++.....+++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 56678999999999999986 7789999998754433322223347888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccceeecccCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~~~~~~ 293 (418)
+||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 82 VEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999753 4588999999999999999999999999999999999998776 599999999875433211
Q ss_pred -----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCChHH
Q 014783 294 -----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 294 -----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
.....++..|+|||.+.+..++.++||||+|+++++|++|..||..... .............+..+...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1224578899999999888899999999999999999999999965432 22222223334455666677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+++.+||..+|++||++.+++.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=317.85 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=207.3
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++.+.||+|+||.||++.+ +++.||+|++....... ..+.+.+|+.+++.++||||+++++.+.....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-----VRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch-----HHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 456788999999999999999987 48899999986542211 23578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
+++||||+++++|.+++... ..+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999999998653 458999999999999999999997 699999999999999999999999999986542
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCCCC
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV-----------QAAFAVVNKGVRPVI 358 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~-----------~~~~~~~~~~~~~~~ 358 (418)
.. ......|+..|+|||.+.+..++.++|||||||++|++++|..||...... +....+.. ...+.+
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRL 233 (284)
T ss_pred hh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCC
Confidence 22 223457899999999998888999999999999999999999999865442 11122222 222223
Q ss_pred CC-CChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 359 PN-DCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 359 ~~-~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
+. .++..+.+|+.+||+.||++|||++|+++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 32 3778899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=328.35 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=217.0
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
-+....|+.-++||+|+||+||-+.. +|+-||.|.+.+......+. +...++|..||++++.+.||.+-.++.+.
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g---e~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG---ETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh---hHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 45667788889999999999998764 89999999987654433333 34577999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
+.+|+|+..|+||+|.-+|....+..+++..+..++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999999988877778999999999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcCCCCCCCCCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV--VNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 366 (418)
.+........||.+|||||+++...|+...|+|||||+||||+.|+.||..........++ ....-....++..+++.
T Consensus 338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 8888888889999999999999999999999999999999999999999765433222111 11122335667889999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 014783 367 SEIMTRCWDTNPEVRPPF 384 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~ 384 (418)
++|.+..|+.||.+|.-.
T Consensus 418 kslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHccCHHHhccC
Confidence 999999999999999654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.26 Aligned_cols=247 Identities=26% Similarity=0.475 Sum_probs=199.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeEEEEeEEeeCceEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+|++.+.||+|+||.||++++ +|+.||||.+......... ..+..|..+ ++.++||||+++++++..+...|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-----KRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-----HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 577888999999999999987 6889999998754333221 234445554 66779999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
+||||++ |+|.+++... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999996 6898888652 234689999999999999999999997 99999999999999999999999999998654
Q ss_pred ccCCCCCCCCCccccccccccC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCC-CCCh
Q 014783 290 QTEGMTPETGTYRWMAPEMIQH----RPYTQKVDVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIP-NDCL 363 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~-~~~~ 363 (418)
.....+...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.... ..+...... .+..+..+ ..++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 4333344568899999998864 457899999999999999999999997543 233333333 33333333 3568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+.+++.+||..+|++||+++++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 89999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=318.02 Aligned_cols=248 Identities=23% Similarity=0.430 Sum_probs=206.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ ++..||+|.+....... ....+.+|+.++++++||||+++++.+.....+|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-----KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 578889999999999999988 57899999886432211 12568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
||||+++++|..++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999999887532 2368999999999999999999996 59999999999999999999999999998754322
Q ss_pred CCCCCCCCCccccccccccCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhcCCCCCCCCCCh
Q 014783 292 EGMTPETGTYRWMAPEMIQHR------PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF--AVVNKGVRPVIPNDCL 363 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~------~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~ 363 (418)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.......... ..+..+..+..+..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 23334678899999998544 35889999999999999999999997655433222 1223344556677788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+++.+||+.+|++||++++++.
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhc
Confidence 99999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.81 Aligned_cols=248 Identities=29% Similarity=0.526 Sum_probs=207.5
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++.. +++.||+|.+...... ....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 367778999999999999987 6789999999765443 1223678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999998753 3478889999999999999999999999999999999999999999999999876543222
Q ss_pred C-----CCCCCCccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--h
Q 014783 294 M-----TPETGTYRWMAPEMIQHRP---YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDC--L 363 (418)
Q Consensus 294 ~-----~~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 363 (418)
. ....++..|+|||.+.... ++.++||||||++++++++|+.||............+..+..+..|... +
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence 1 1245788999999998766 8899999999999999999999997764333333333334455555544 8
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 89999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=320.27 Aligned_cols=246 Identities=26% Similarity=0.485 Sum_probs=207.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++++......|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 5778889999999999999986 68899999986543322 145778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999999999864 347888999999999999999999999999999999999999999999999987543322
Q ss_pred C-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHHHHHHH
Q 014783 293 G-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVLSEIM 370 (418)
Q Consensus 293 ~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 370 (418)
. .....+++.|+|||.+.+..++.++|+||||+++|++++|..||...+...........+... ..+...++.+.+++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 1 233568899999999999889999999999999999999999997766544333222222211 23456778899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.+|++||+++++++
T Consensus 250 ~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.19 Aligned_cols=245 Identities=23% Similarity=0.394 Sum_probs=197.4
Q ss_pred cccccccccCceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
+-..+|++.+.||+|+||.||++.. .+..||+|.+... ....+|+.++++++||||+++++++..
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 3446789999999999999999975 3468999987542 134589999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+|+|||++. ++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++..
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999999999994 689888843 35689999999999999999999999999999999999999999999999999975
Q ss_pred ecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----------
Q 014783 288 EVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---QAAFAVVN---------- 351 (418)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~~~~---------- 351 (418)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..++.
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 433221 22356899999999999999999999999999999999999999654321 11111110
Q ss_pred ---------------cCCCCC--CC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 352 ---------------KGVRPV--IP-----NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 352 ---------------~~~~~~--~~-----~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
...++. .+ ...+..+.+++.+||..||++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001111 11 1235678899999999999999999998874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.89 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=205.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-C-----CCeEEEEeEEee
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-H-----LNIVRFIGACRK 207 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pniv~l~~~~~~ 207 (418)
+|.+++.||+|+||+|.+|.+ +++.||||+++.... ..++...|+.+|..|+ | -|+|+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 788899999999999999987 788999999975322 2256678999999997 4 389999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC--CEEEeecccc
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--SIKIADFGVA 285 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~--~vkl~DfGla 285 (418)
.+++|||+|.+ .-+|.++++...-..+++..+..++.||+.||.+||+.||||+||||+||||.+-+ .|||+|||.|
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999999 56999999998888899999999999999999999999999999999999997543 7999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN-------------- 351 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~-------------- 351 (418)
....+.- .....+..|.|||++.+.+|+.+.||||||||++||++|.+-|++.+..+.+..++.
T Consensus 339 c~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 339 CFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 8765432 267788999999999999999999999999999999999999999887776654421
Q ss_pred -------c-C----------------------------CCCCCCC-----------CChHHHHHHHHHhcccCCCCCCCH
Q 014783 352 -------K-G----------------------------VRPVIPN-----------DCLPVLSEIMTRCWDTNPEVRPPF 384 (418)
Q Consensus 352 -------~-~----------------------------~~~~~~~-----------~~~~~l~~li~~cl~~dp~~RPt~ 384 (418)
. . .....|. .....+.+++++||.+||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0 0 0000110 122457899999999999999999
Q ss_pred HHHHH
Q 014783 385 TEIVR 389 (418)
Q Consensus 385 ~ell~ 389 (418)
.|.++
T Consensus 497 ~qal~ 501 (586)
T KOG0667|consen 497 AQALN 501 (586)
T ss_pred HHHhc
Confidence 88776
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.33 Aligned_cols=261 Identities=20% Similarity=0.303 Sum_probs=210.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...|+.++|++.+.||+|||+-||+++. ++..||+|.+.-..... .+..++|+..-++++|||++++++++.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~------~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED------IEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH------HHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 3457889999999999999999999985 78899999987654222 256779999999999999999998874
Q ss_pred eC-----ceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCE
Q 014783 207 KR-----MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~~~~v 277 (418)
.+ ...||++.|...|+|.+.+... .+..+++...++|+.+|++||++||+.. +.||||||.|||++.++.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 33 3489999999999999999754 3557999999999999999999999998 9999999999999999999
Q ss_pred EEeecccceeecc---c-------CCCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-
Q 014783 278 KIADFGVARIEVQ---T-------EGMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV- 343 (418)
Q Consensus 278 kl~DfGla~~~~~---~-------~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~- 343 (418)
+|.|||.++...- + ..+.....|..|.|||.+. +...+.++|||||||+||+|+.|..||+..-..
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 9999999864321 1 1123345789999999995 445788999999999999999999999532110
Q ss_pred -HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 344 -QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 344 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
....++....+.-+.....++.+.++++.|++.||.+||++.+|+..++++.
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111222222222233347889999999999999999999999999998764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=329.43 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=200.0
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|++ .++|++.+.||+|+||.||++.. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 11 WEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL----IHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh----HHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 444 36788999999999999999986 67799999986543221 122457789999999999999999998753
Q ss_pred C------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 208 R------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 208 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
. ..+|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 86 ATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcC
Confidence 3 3478999988 7899888753 3589999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV------ 354 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~------ 354 (418)
||+++.... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.....
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986433 2344578999999999876 5689999999999999999999999987665443332221000
Q ss_pred ---------------CCCCC--------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 ---------------RPVIP--------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 ---------------~~~~~--------~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.+..+ ...++.+.+|+.+||+.||++|||+.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011 1245568899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=314.95 Aligned_cols=246 Identities=29% Similarity=0.475 Sum_probs=206.5
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||.|+||.||++.. +++.||+|.+...... ...+.+.+|++++++++||||+++++.+.....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 467778999999999999988 4789999998764332 123578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999999997643 568999999999999999999999 999999999999999999999999999987543322
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCCCCCCCC-ChHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT-----AVQAAFAVVNKGVRPVIPND-CLPVL 366 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~l 366 (418)
.. ...++..|+|||.+.+..++.++||||||+++++|++|..||.... ..+.. +.......+..+.. ++..+
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-QYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH-HHHhcCCCCCCChhhcCHHH
Confidence 22 2678899999999999999999999999999999999999997652 22222 22223334444444 78889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||..||++|||+.+++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhh
Confidence 99999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.20 Aligned_cols=253 Identities=27% Similarity=0.559 Sum_probs=206.1
Q ss_pred ccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--
Q 014783 137 LNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-- 209 (418)
|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 45678899999999999975 3578999998654433221 256889999999999999999999885432
Q ss_pred ----eEEEEEeecCCCCHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 210 ----VWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 210 ----~~~lv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
..++++||+.+|+|.+++.... ...+++..+.+++.||+.||+|||+.||+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 3478999999999998875321 12478889999999999999999999999999999999999999999999
Q ss_pred cccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014783 282 FGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 282 fGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 357 (418)
||+++....... .....+++.|++||.+....++.++||||||+++|+|++ |..||......+....+. .+....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence 999975432211 122345678999999998889999999999999999999 999998877655443333 333444
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+..++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 5567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=310.31 Aligned_cols=251 Identities=25% Similarity=0.484 Sum_probs=211.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--ce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~ 210 (418)
.+|++.+.||+|+||.||+++. ++..||+|.+......... ......+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET-SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh-hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 4678889999999999999986 6789999987543221111 11235788999999999999999999998653 46
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 88999999999999998753 3488899999999999999999999999999999999999999999999999975422
Q ss_pred c----CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 291 T----EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 291 ~----~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
. .......++..|+|||.+.+..++.++|+|||||++++|++|+.||..........+......++.+|...++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 1 112334688999999999988899999999999999999999999988877776666665666677788889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||. +|..||++.+++.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhc
Confidence 999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.05 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=201.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|.+.+.||+|+||.||+|++ +++.||+|.+........ ...+.+|+.+++.++||||+++++++.....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 46788889999999999999987 578999999865432221 13466899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+. ++|.+++... ...+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99999996 5999888754 346889999999999999999999999999999999999999999999999998754322
Q ss_pred -CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------
Q 014783 292 -EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG---------------- 353 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~---------------- 353 (418)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+...-
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 122334578999999998654 57889999999999999999999998776654332221100
Q ss_pred C-C---C--------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 V-R---P--------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 ~-~---~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. . + .....+++.+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0 0 011246778899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.14 Aligned_cols=242 Identities=25% Similarity=0.372 Sum_probs=206.4
Q ss_pred eeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||.|+||.||+++.. ++.||+|++........ ...+.+.+|+.+++.++||||+++++.+..+..+|+|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999985 88999999975433221 1235788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt 300 (418)
++|.+++... ..+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 78 GELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 9999999764 34889999999999999999999999999999999999999999999999999865443333345688
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCC
Q 014783 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT--AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNP 378 (418)
Q Consensus 301 ~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 378 (418)
..|+|||.+....++.++|+||||+++|+|++|..||.... ..+....+.........|..+++.+.+++.+||+.+|
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 99999999988889999999999999999999999998776 5454444444344556666778999999999999999
Q ss_pred CCCCC-----HHHHHH
Q 014783 379 EVRPP-----FTEIVR 389 (418)
Q Consensus 379 ~~RPt-----~~ell~ 389 (418)
++||+ ++|+++
T Consensus 236 ~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 236 EERLGNLKGGIKDIKK 251 (262)
T ss_pred hhCcCCcccCHHHHhc
Confidence 99999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=318.08 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=208.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++.. +++.||+|.+....... ....+.+.+|+.+++.++||||+++++.+..+..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 567789999999999999987 56799999986542211 1123567799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999999999754 458999999999999999999999999999999999999999999999999986421100
Q ss_pred ---------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C
Q 014783 293 ---------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-P 356 (418)
Q Consensus 293 ---------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~ 356 (418)
......++..|+|||.+....++.++|+||||+++|||++|..||.+....+........... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 011235778999999998888999999999999999999999999887776655554443322 2
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 357 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..+..+++.+.+++.+||+.+|++||++.++.+.|+.-
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 22335788999999999999999999976666666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=318.54 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=200.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~ 210 (418)
.++|...+.||+|+||.||+++. +++.||+|.+....... ....+.+|+.++.++. ||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-----EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-----HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 34666778999999999999987 57899999986543321 1256789999999996 9999999999998888
Q ss_pred EEEEEeecCCCCHHHHHh---hhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 211 WCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.+++|||+. ++|.++.. ......+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 999999985 46655432 23345689999999999999999999974 99999999999999999999999999997
Q ss_pred eecccCCCCCCCCCccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC----C
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHR---PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI----P 359 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----~ 359 (418)
............|+..|+|||.+... .++.++|||||||++|+|++|+.||...............+..+.+ +
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred HhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 65443334445688999999999766 6899999999999999999999999766532211111222222222 2
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
..++..+.+|+.+||+.+|++|||+++++..
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3478899999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=315.42 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=209.5
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ +++.||+|++........+ ..+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKG---SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchh---HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 367788999999999999987 5789999999754332211 23678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
|+||+.+++|.+++... ..+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 78 VVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999999999764 4688999999999999999999999999999999999999999999999999876544433
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA--VQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.....|+..|+|||.+....++.++|+||||+++|+|++|..||..... .......... .....|...+..+.+++.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHH
Confidence 4456688999999999988899999999999999999999999987664 2222222222 445667778899999999
Q ss_pred HhcccCCCCCCCH--HHHH
Q 014783 372 RCWDTNPEVRPPF--TEIV 388 (418)
Q Consensus 372 ~cl~~dp~~RPt~--~ell 388 (418)
+||+.||.+||++ +|++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHccCChhHcCCccHHHHh
Confidence 9999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=317.65 Aligned_cols=245 Identities=30% Similarity=0.512 Sum_probs=207.7
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|+..+.||+|+||.||+|.+ +++.||+|.+....... ..+.+.+|+.++++++||||+++++.+......|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 455667899999999999987 57799999986443221 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999999998854 458889999999999999999999999999999999999999999999999997544322
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... .+.....+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-hhhcCCCCCCCcccCHHHHHHHHH
Confidence 1233457899999999999899999999999999999999999998766554433 233444555566678899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||+.+|++||++.+++.
T Consensus 236 ~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 236 CLNKDPRFRPTAKELLK 252 (277)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.91 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=204.7
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCc-
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~- 209 (418)
.++|++.+.||+|+||.||+|.. +++.+++|++...... .+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 46788899999999999999987 5678999998654321 24688999999999 7999999999996644
Q ss_pred -----eEEEEEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 210 -----VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 210 -----~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999987543 467899999999999999999999999999999999999999999999999
Q ss_pred ccceeecccC-CCCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 014783 283 GVARIEVQTE-GMTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP 356 (418)
Q Consensus 283 Gla~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 356 (418)
|++....... ......++..|+|||.+.. ..++.++||||||+++++|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 9987543322 2234568899999998853 347789999999999999999999998766655554443322211
Q ss_pred -CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 -VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+..++..+.+++.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 112336788999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=316.14 Aligned_cols=238 Identities=24% Similarity=0.497 Sum_probs=194.7
Q ss_pred ceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 142 AFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.||+|+||.||+|... ...||+|.+.... ....+.+.+|+.+++.+.|||++++++++......+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 6899999999999762 2348888874321 122357788999999999999999999999988899
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--------EEEeeccc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFGV 284 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~--------vkl~DfGl 284 (418)
+||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999999997643 36889999999999999999999999999999999999987765 69999999
Q ss_pred ceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITG-LLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++| ..||......... ..... +...|...
T Consensus 155 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~--~~~~~~~~ 228 (258)
T cd05078 155 SITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYED--RHQLPAPK 228 (258)
T ss_pred ccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHc--cccCCCCC
Confidence 864432 233567889999999976 4589999999999999999998 5677665554432 22222 33455566
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
+..+.+++.+||+.||++|||++++++.|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=320.79 Aligned_cols=245 Identities=27% Similarity=0.463 Sum_probs=211.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
-|.++.+||+|+||.||++.. .|+.+|||.+-.... .+++..|+.||++++.|++|++||.+.....++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 356778999999999999965 789999998743211 2678899999999999999999999999889999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-C
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~ 292 (418)
|||||-.|++.+.++.+ .+.+++..+..++...++||+|||...-||||||+.|||+..+|+.||+|||+|....+. .
T Consensus 106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999999999864 578999999999999999999999999999999999999999999999999999765433 2
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVLSEIMT 371 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 371 (418)
..+...||+.|||||++..-+|+.++||||||++..||..|++||.+..+....+-+-....+. ..|+.++.++.++++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 3456789999999999999999999999999999999999999999988876554332222111 235567889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||-.+|++|.|+.+|++
T Consensus 265 ~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHhcCCHHHHHHHHHHhh
Confidence 999999999999999876
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.83 Aligned_cols=247 Identities=17% Similarity=0.318 Sum_probs=193.1
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC------CCeEEEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH------LNIVRFI 202 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h------pniv~l~ 202 (418)
.+...+|++.+.||+|+||.||++.+ +++.||||+++..... ...+..|+.+++.++| +++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34567899999999999999999987 5779999998642211 1334566666666654 4688999
Q ss_pred eEEeeC-ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCC-----
Q 014783 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK----- 275 (418)
Q Consensus 203 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~----- 275 (418)
+++... ..+|+|||++ +++|.+++... ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 888654 5789999988 78999988754 468999999999999999999998 5999999999999998765
Q ss_pred -----------CEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014783 276 -----------SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344 (418)
Q Consensus 276 -----------~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~ 344 (418)
.+||+|||.+... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999988642 223445689999999999999999999999999999999999999998876654
Q ss_pred HHHHHHhcC-------------------------CCCCCC---------------CCChHHHHHHHHHhcccCCCCCCCH
Q 014783 345 AAFAVVNKG-------------------------VRPVIP---------------NDCLPVLSEIMTRCWDTNPEVRPPF 384 (418)
Q Consensus 345 ~~~~~~~~~-------------------------~~~~~~---------------~~~~~~l~~li~~cl~~dp~~RPt~ 384 (418)
....+.... +.+... ....+.+.+||.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 333221100 000000 0013457799999999999999999
Q ss_pred HHHHH
Q 014783 385 TEIVR 389 (418)
Q Consensus 385 ~ell~ 389 (418)
+|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99987
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.70 Aligned_cols=241 Identities=22% Similarity=0.354 Sum_probs=185.3
Q ss_pred cCceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee--CceEEE
Q 014783 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~~l 213 (418)
+++||+|+||.||+|+. +++.||+|.+...... ..+.+|+.++++++||||+++++++.. +..+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 46899999999999985 3468999998654322 346689999999999999999998853 456899
Q ss_pred EEeecCCCCHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCEEEeec
Q 014783 214 VTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl----~~~~~vkl~Df 282 (418)
|+||+. ++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 999995 58888876321 2358899999999999999999999999999999999999 45678999999
Q ss_pred ccceeecccC----CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHH
Q 014783 283 GVARIEVQTE----GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAV---------QAAFA 348 (418)
Q Consensus 283 Gla~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---------~~~~~ 348 (418)
|+++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...... .....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 9998653321 22345789999999999764 5899999999999999999999999643210 11111
Q ss_pred HHhc-C----------------------CCC-------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 349 VVNK-G----------------------VRP-------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 349 ~~~~-~----------------------~~~-------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
++.. + +.. ......+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1000 0 000 000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.39 Aligned_cols=237 Identities=25% Similarity=0.496 Sum_probs=192.9
Q ss_pred CceeeeCceEEEEEEECCc------------eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 141 TAFAQGAFGKLYRGTYNGE------------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
+.||+|+||.||+|++... .+++|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 3689999999999987322 4788876543221 2578899999999999999999999987
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-------CEEEee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-------SIKIAD 281 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-------~vkl~D 281 (418)
...++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 66799999999999999997643 2689999999999999999999999999999999999999888 799999
Q ss_pred cccceeecccCCCCCCCCCccccccccccCC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
||++..... .....++..|+|||.+... .++.++||||||+++|+|++ |..||...+..+... ....... .
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~~~--~ 225 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHR--L 225 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcCCC--C
Confidence 999975433 2234567889999999876 78999999999999999999 688887765433222 2222222 2
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 2223378999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.77 Aligned_cols=245 Identities=27% Similarity=0.480 Sum_probs=210.1
Q ss_pred cccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 138 NMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
.+...||.|+||.||++... +-..|.|++..... .-.+.+.-|+.||..+.||+||+|++.|.-.+.++|+.
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse------EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE------EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccch------hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 45678999999999999764 34567888754321 12367889999999999999999999998888899999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee-cccCCC
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGM 294 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~-~~~~~~ 294 (418)
|||.||-+...+-.. +..+.++.+..++.|++.||.|||+++|||||||+.|||++.+|.++|+|||++-.. ......
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 999999998887664 567999999999999999999999999999999999999999999999999987532 333456
Q ss_pred CCCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHHHHH
Q 014783 295 TPETGTYRWMAPEMI-----QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVLSE 368 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~-----~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 368 (418)
++..|||+|||||+. ...+|+.++|||||||+|.||..+.+|--..++..++..+.....+. ..|..++..+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 778999999999987 45689999999999999999999999999999998887766544333 346678889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
|+.+||..||+.||++.+|++
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhh
Confidence 999999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=329.63 Aligned_cols=242 Identities=23% Similarity=0.393 Sum_probs=192.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
...|++.+.||+|+||.||+|++ +++.||+|+.... ....|+.++++++||||+++++++......
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 34688899999999999999998 4568999985321 234689999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++|+|++ .++|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9999999 46898888653 356899999999999999999999999999999999999999999999999999754433
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCHH---------HHHHHHHhc-CCC-CCCC
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL-LPFQNMTAV---------QAAFAVVNK-GVR-PVIP 359 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~-~Pf~~~~~~---------~~~~~~~~~-~~~-~~~~ 359 (418)
.......||+.|+|||++.+..++.++|||||||++|||+++. .+|...... .....++.. +.. ...+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 3344567999999999999999999999999999999999854 444332110 011111110 000 0011
Q ss_pred ------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 ------------------------------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ------------------------------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..++..+.+||.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 123455677999999999999999999886
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=339.43 Aligned_cols=242 Identities=28% Similarity=0.509 Sum_probs=205.6
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
-+||+|.||+||.|++ +...+|||-+...... ..+.+..|+.+-++|+|.|||+++|.|.+++.+-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 3799999999999998 4447789987533222 2356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCEEEeecccceeecccCC-C
Q 014783 219 KGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTEG-M 294 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~vkl~DfGla~~~~~~~~-~ 294 (418)
+||+|.++++..-+ ++ .+..+-.+..||++||.|||++.|||||||.+||||. ..|.+||+|||-++....-.+ .
T Consensus 655 PGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 99999999987654 34 6778888999999999999999999999999999997 579999999999876544333 4
Q ss_pred CCCCCCccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCChHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-AVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.+.+||..|||||++..+ +|+.++|||||||++.||.||++||-.+.....+. ++=.-..-|++|.+.+.+.+.+|.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence 567899999999999655 59999999999999999999999997766555433 222233567899999999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+|+.++|.+||++.+|+.
T Consensus 814 rcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHcCCCcccCccHHHhcc
Confidence 999999999999999875
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=307.64 Aligned_cols=248 Identities=28% Similarity=0.489 Sum_probs=211.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|++|.||+++. +++.||||.+...... .....+.+|+.++.+++|||++++++++.....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 567789999999999999987 5789999998765432 123678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
|+||+++++|.+++... ..+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999999764 568999999999999999999999 999999999999999999999999999998654332
Q ss_pred CC-CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCC-ChHHHHH
Q 014783 293 GM-TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT--AVQAAFAVVNKGVRPVIPND-CLPVLSE 368 (418)
Q Consensus 293 ~~-~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 368 (418)
.. ....++..|+|||.+....++.++|+||||+++|+|++|..||.... ........+.....+..+.. ++..+.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 22 24467899999999999899999999999999999999999998774 33333333344444455555 7889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~ 390 (418)
++.+||+.+|++||++.|+++.
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=315.94 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=206.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|.+.+.||+|+||.||+|+. +++.||+|.+......... ..+.+.+|+.+++.++||||++++++|......|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHH---HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 4577889999999999999987 6789999998654332211 1256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9999996 6887777643 34589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||...........+.........+..++..+.++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 23446788999999874 45688999999999999999999999988777665554443332223334577889999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~~ 390 (418)
+.+||+.+|++||++.+++..
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=313.35 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=200.4
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||+|+||+||++.. +|+.||+|.+........ .....+.+|+.+++.++||||+++++++.....+|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR---KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh---hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 68999999999976 688999999865322111 1234567899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt 300 (418)
++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999998765557999999999999999999999999999999999999999999999999998765443333445678
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccC
Q 014783 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 301 ~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 377 (418)
..|+|||.+.+..++.++||||||+++++|++|+.||...... +..... ........+...++.+.+++.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-cccccccCCccCCHHHHHHHHHHccCC
Confidence 8999999998888999999999999999999999999765431 111111 112233455667899999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 014783 378 PEVRP-----PFTEIVR 389 (418)
Q Consensus 378 p~~RP-----t~~ell~ 389 (418)
|.+|| ++.+++.
T Consensus 237 p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 237 PEKRLGCRGGSADEVRE 253 (277)
T ss_pred hhHccCCCcccHHHHHh
Confidence 99999 5655654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=310.37 Aligned_cols=246 Identities=28% Similarity=0.498 Sum_probs=209.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
-|+..+.||.|+||.||+|.+ +++.||||++....... ..+.+.+|+.++++++||||+++++.+..+...|+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH-----HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 356778899999999999986 67899999875432211 22578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+.+++|.+++.. ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999999864 358899999999999999999999999999999999999999999999999987543321
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||........... +.....+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCCCCcccCHHHHHHHHH
Confidence 22334678899999999888899999999999999999999999987766554433 34444555666788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~ 390 (418)
||+.+|.+||++.+++..
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=311.23 Aligned_cols=245 Identities=31% Similarity=0.565 Sum_probs=203.4
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC---CCCeEEEEeEEeeCce
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMV 210 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~ 210 (418)
.|+..+.||+|+||.||+|.+ +++.||+|.+........ ...+.+|+.+++.++ |||++++++++.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 356778999999999999987 678999999865432221 146778999999997 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
.|+||||+++++|.+++... .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999999998642 588999999999999999999999999999999999999999999999999976543
Q ss_pred cC-CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CChHHHH
Q 014783 291 TE-GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN-DCLPVLS 367 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 367 (418)
.. ......|+..|+|||.+.. ..++.++|+||||+++|+|++|..||........... +.....+.++. ..+..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-IPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-cccCCCCCCCcccCCHHHH
Confidence 32 2233468899999999865 4578999999999999999999999987766544322 22222233333 3778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||++||++.++++
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhh
Confidence 9999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=312.93 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=203.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-- 208 (418)
.++|++...||+|+||.||+++. +++.+|+|++...... ...+.+|+.++.++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 46678889999999999999987 6789999998643211 24567899999999 899999999998653
Q ss_pred ---ceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 209 ---MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
..+++||||+++++|.++++.. ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 3589999999999999988642 34568999999999999999999999999999999999999999999999999
Q ss_pred cceeecccC-CCCCCCCCccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CC
Q 014783 284 VARIEVQTE-GMTPETGTYRWMAPEMIQHR-----PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RP 356 (418)
Q Consensus 284 la~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~ 356 (418)
++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||...........+..... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 987543322 22334688999999998543 368999999999999999999999988776655544332211 11
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+...+..+.+++.+||+.+|++||++.|++.
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 234456778999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.24 Aligned_cols=249 Identities=27% Similarity=0.483 Sum_probs=209.6
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|.+.+.||+|+||.||++.+ ++..||+|.+......... .+.+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE----KEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh----hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 366778999999999999987 5789999998654322111 2467799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccceeecccC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~~~~~ 292 (418)
|+||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .+||+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999999775555689999999999999999999999999999999999999886 46999999987654322
Q ss_pred C-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 293 G-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 293 ~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
. .....|++.|+|||.+....++.++|+||||+++++|++|..||...+..+....... ......+...+..+.+++.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHH
Confidence 1 2234588999999999888899999999999999999999999987776665554443 3334455567889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||..+|++|||+.+++.
T Consensus 236 ~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 236 QLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.85 Aligned_cols=243 Identities=24% Similarity=0.437 Sum_probs=202.9
Q ss_pred ccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
....||+|+||.||++.. +++.||+|.+....... .+.+.+|+.++..+.||||+++++.+..+...|+|+|
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 345799999999999987 67899999986533221 2457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-CCC
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMT 295 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-~~~ 295 (418)
|+++++|.+++.. ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 9999999998754 358899999999999999999999999999999999999999999999999986443221 233
Q ss_pred CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCChHHHHHHHHHhc
Q 014783 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-PVIPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 296 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl 374 (418)
...++..|+|||.+.+..++.++||||||++++||++|+.||......+....+...... ...+...+..+.+++.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 456889999999999888999999999999999999999999877765554433222111 1223356788999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 014783 375 DTNPEVRPPFTEIVRM 390 (418)
Q Consensus 375 ~~dp~~RPt~~ell~~ 390 (418)
+.+|++||+++++++.
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=313.33 Aligned_cols=245 Identities=24% Similarity=0.429 Sum_probs=212.4
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
.+..++|.++++||+|.||.|-+++- +++.||+|++++...... .+ ...-+.|-.+|+..+||.+..|-..|+..
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-dE--VAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-DE--VAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-HH--hhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 35678899999999999999999975 788999999976543221 11 13456788999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
+.+|+||||.+||.|+-+|.+ .+.++++.+..+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++..
T Consensus 241 drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999999999877765 456999999999999999999999999999999999999999999999999999854
Q ss_pred c-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 V-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
. ........||||.|+|||++....|+.++|+|.+||++|||++|+.||-..........++...++ .|..++++..
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k--FPr~ls~eAk 396 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK--FPRTLSPEAK 396 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc--CCccCCHHHH
Confidence 3 334467789999999999999999999999999999999999999999887766655555555443 6778899999
Q ss_pred HHHHHhcccCCCCCC
Q 014783 368 EIMTRCWDTNPEVRP 382 (418)
Q Consensus 368 ~li~~cl~~dp~~RP 382 (418)
.|+...|..||.+|.
T Consensus 397 tLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHhhcChHhhc
Confidence 999999999999994
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=314.80 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=205.7
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~ 204 (418)
..|.++.++|++.+.||+|+||.||++++. ++.||||.++....... ...+.+|+.++.+. .||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhee
Confidence 457778889999999999999999999984 88999999975433221 13455677666666 49999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
+......|+||||+. ++|.+++... ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 83 FITDSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eecCCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 999999999999984 5787777653 3478999999999999999999997 599999999999999999999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRP----YTQKVDVYSFGIVLWELITGLLPFQNMTAV-QAAFAVVNKGVRPVI 358 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGv~l~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~ 358 (418)
++.............++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +....+.... .+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~ 239 (296)
T cd06618 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSL 239 (296)
T ss_pred cchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCC
Confidence 997654444444456788999999997553 889999999999999999999999765432 3333333332 2222
Q ss_pred C--CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 359 P--NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 359 ~--~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+ ..++..+.+++.+||+.||++||+++++++.
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 2467899999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=312.11 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=204.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+|++ +++.||+|++........ ....+.+|+.++++++||||+++++++..+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 467888999999999999987 678999999876543221 12568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
|+||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999 999999987543 568999999999999999999999999999999999999999999999999987654332
Q ss_pred -CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 014783 293 -GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-------------- 356 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------------- 356 (418)
......++..|+|||.+.+. .++.++||||+|++++||++|.+||.+....+....++..--.+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 13445688999999998654 46899999999999999999998888766554433332210000
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 --------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 --------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+..+..+.+++.+||+.+|++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=313.41 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=201.9
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||.|+||.||+|++ +++.||||.+........ ....+.+|++++++++||||+++++++......++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 66778999999999999987 678999998864432221 124677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~ 293 (418)
|||+. ++|.+++.......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99995 68999987765667899999999999999999999999999999999999999999999999998754322 12
Q ss_pred CCCCCCCccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 014783 294 MTPETGTYRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---------------- 356 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------- 356 (418)
.....++..|+|||.+.+.. ++.++||||||+++|+|+||+.||...+..+...........+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 23345688999999886644 6889999999999999999999998776554443333211100
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 -----------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 -----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....+++.+.+++.+||+.||.+|||+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=310.56 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=194.0
Q ss_pred ceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHH---HHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV---MMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~---~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
.||+|+||.||+++. +++.||+|.+........... ..+.+|. .++...+||||+.+++.+...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 489999999999987 578999999876543322211 1233343 33444579999999999999889999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCC
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~ 296 (418)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+|||++...... ....
T Consensus 78 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (279)
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence 99999999998753 45899999999999999999999999999999999999999999999999998754332 2233
Q ss_pred CCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCCCCChHHHHHHHHHhc
Q 014783 297 ETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ-AAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 297 ~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 374 (418)
..|+..|+|||.+. +..++.++|||||||++++|++|..||....... .............++..+++.+.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence 56899999999986 4568999999999999999999999997543211 111122223445567778899999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 014783 375 DTNPEVRP-----PFTEIVRM 390 (418)
Q Consensus 375 ~~dp~~RP-----t~~ell~~ 390 (418)
..||.+|| |++|+++.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 99999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.59 Aligned_cols=247 Identities=30% Similarity=0.560 Sum_probs=212.1
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--ceEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVWC 212 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~~ 212 (418)
|+..+.||+|++|.||+|.. +++.|++|++....... ...+.+.+|+.++++++||||+++++.+... ..++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE----EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 56678999999999999988 48899999987654331 1236788999999999999999999999888 8899
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999999997643 68999999999999999999999999999999999999999999999999998765544
Q ss_pred C---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 293 G---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 293 ~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
. .....++..|+|||.+....++.++||||||+++++|++|..||.... ..............+.++...+..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 3 345678899999999988889999999999999999999999998766 333333333334455677778899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
++.+||+.||++||++.+++.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.39 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=196.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||++++ +|+.||+|.+........ ....+.+|+.++++++||||+++++++.+...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 366778999999999999988 688999999865432211 12456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-C
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~ 292 (418)
|+||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus 77 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 77 VFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 999996 5888887653 345899999999999999999999999999999999999999999999999999754322 2
Q ss_pred CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhc------------------
Q 014783 293 GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPF-QNMTAVQAAFAVVNK------------------ 352 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf-~~~~~~~~~~~~~~~------------------ 352 (418)
......++..|+|||.+.+. .++.++|||||||++|+|++|..|| .+.+..+....+...
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22344678999999998764 4789999999999999999988885 433332222111100
Q ss_pred CCCC---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 GVRP---------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+ ...+.+++.+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=312.72 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=202.4
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+|.+ +++.||||.++....... ..+.+.+|+.++++++|+||+++++++.....+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED----VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc----chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 577888999999999999987 578999999865332221 22578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+.++.+..+... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 78 VFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999988666655543 3458999999999999999999999999999999999999999999999999987654433
Q ss_pred -CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------C
Q 014783 293 -GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG----------------V 354 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~----------------~ 354 (418)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+......... +
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 23345678899999999888 88999999999999999999999998766554433322100 0
Q ss_pred C-----C---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 R-----P---------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ~-----~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. . ..+..++..+.+++++||..+|++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0 112234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=303.50 Aligned_cols=249 Identities=27% Similarity=0.534 Sum_probs=213.7
Q ss_pred cccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||.|+||.||++.+. +..||+|.+......... ...+.+|+++++.++|||++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH----HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 3667789999999999999984 789999998765443222 2567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||+++++|.+++.... ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999999998653 467999999999999999999999999999999999999999999999999999765433
Q ss_pred C-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
. ......|++.|+|||.+....++.++|+||+|+++++|++|..||......+...... ......++..++..+.+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHH
Confidence 2 2233468899999999998889999999999999999999999998877665554444 3345556677889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||..+|++|||+.++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=312.53 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=201.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--ce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~ 210 (418)
++|++.+.||+|+||.||+|++ +++.+|+|.++....... ....+.+|+.++.+++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 5678889999999999999998 578999999975433211 123567899999999999999999998776 78
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
.|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999999996 59999887543 3689999999999999999999999999999999999999999999999999986543
Q ss_pred c-CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------------
Q 014783 291 T-EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG--------------- 353 (418)
Q Consensus 291 ~-~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~--------------- 353 (418)
. .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||......+....+...-
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 223345578899999998754 46899999999999999999999998776654433322100
Q ss_pred --------------CCCCCCCC-ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 --------------VRPVIPND-CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 --------------~~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....+.. .++.+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 01112222 4778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=328.66 Aligned_cols=248 Identities=28% Similarity=0.473 Sum_probs=220.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
..|.+.+.||.|.|+.|.+++. ++..||||.+.+...+.... +.+.+|+++|+.++|||||+++.+......+|
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~----~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR----QKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH----HHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 4567789999999999999987 78999999998876665432 45789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+.+|.+++|+.+.. ...+..+..++.|++.+++|||+++|||||||++|||++.+.++||+|||++..+....
T Consensus 132 lV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999999998753 36668889999999999999999999999999999999999999999999999988888
Q ss_pred CCCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
...+.||++.|.|||++.+..|+ +.+|+||+|+++|-|++|..||++.+-.+.....+...++ +|...+.++.++|+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLr 287 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLR 287 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHH
Confidence 88899999999999999988764 7899999999999999999999988776665565655555 45556778899999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~~ 390 (418)
+++-.+|.+|++.+++.+.
T Consensus 288 k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HhhccCccccCCHHHhhhh
Confidence 9999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=321.52 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=199.4
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--- 208 (418)
..+|+..+.||+|+||.||+++. +++.||||.+......... ...+.+|+.++++++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 35688889999999999999987 6889999998654333221 24567899999999999999999988643
Q ss_pred ---ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
...|+||||+. ++|.+.+... ++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 34799999995 5888887542 888999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR---------- 355 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---------- 355 (418)
+............++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......++..-..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 8655443344556889999999999999999999999999999999999999876643332222110000
Q ss_pred ----------C---------CC------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ----------P---------VI------------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ----------~---------~~------------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+ .. +...++.+.+++.+||+.||++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00 1123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=313.78 Aligned_cols=255 Identities=15% Similarity=0.247 Sum_probs=190.8
Q ss_pred cccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHH-----HHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l 201 (418)
+..++|++.+.||+|+||.||+|.+. +..+|+|+............ ........+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 44568889999999999999999873 34677776443322111110 011122344455667789999999
Q ss_pred EeEEeeCc----eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCE
Q 014783 202 IGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 202 ~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~v 277 (418)
++++.... ..++++|++ ..++.+.+... ...++..+..++.|++.||+|||+.+|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99876543 346788877 34777776543 336788899999999999999999999999999999999999999
Q ss_pred EEeecccceeecccC--------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Q 014783 278 KIADFGVARIEVQTE--------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-- 347 (418)
Q Consensus 278 kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~-- 347 (418)
+|+|||+|+...... ......||+.|+|||++.+..++.++|||||||+++||++|..||..........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999998653211 1123469999999999999999999999999999999999999998764322111
Q ss_pred ------HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 348 ------AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 348 ------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
..+..+ ......++..+.+++..||+.+|++||++++|++.|
T Consensus 246 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111 112345678999999999999999999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=311.58 Aligned_cols=248 Identities=28% Similarity=0.451 Sum_probs=208.2
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|...+.||+|+||.||++++ ++..||+|.+........ .....+.+|+.+++.++|||++++++++..+...++
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 356678899999999999987 678999999875433222 122568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 999996 5888877643 34588999999999999999999999999999999999999999999999999865332
Q ss_pred CCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.....+++.|+|||.+. ...++.++|||||||++|||++|..||...........+.........+..+++.+.+++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23456889999999973 456899999999999999999999999887776666666555554444556788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~L 391 (418)
.+||+.+|.+||++.++++.+
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHccCCcccCcCHHHHHhCh
Confidence 999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.27 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=200.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee--CceE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVW 211 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~ 211 (418)
+|...+.||.|++|.||++.. +++.+|+|.+....... ....+.+|++++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 456678999999999999987 67899999987543321 22568899999999999999999998864 3468
Q ss_pred EEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
|+||||+++++|.+++... ....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999999987642 23558889999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCC-----
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM-----TAVQAAFAVVNKGVRPVIP----- 359 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~-----~~~~~~~~~~~~~~~~~~~----- 359 (418)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||... ...+.... +.....+..+
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEPGN 234 (287)
T ss_pred ccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCCCC
Confidence 222 22345788999999999989999999999999999999999999765 22222222 2221122111
Q ss_pred -CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 -NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 -~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...++.+.+++.+||+.+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 134578999999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.96 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=196.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|+. +++.||||.+......... ..+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-----FTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc-----hhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 35678889999999999999987 6789999998754322111 3456899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99999997 59999887543 36889999999999999999999999999999999999999999999999998753221
Q ss_pred -CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc---C------------
Q 014783 292 -EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNK---G------------ 353 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~~~~~---~------------ 353 (418)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+....+... .
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 11222346789999999865 4588999999999999999999999976652 2221111110 0
Q ss_pred ------CCCC--C-----CCCCh--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 ------VRPV--I-----PNDCL--PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 ------~~~~--~-----~~~~~--~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.... . ..... ..+.+++.+||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 01122 67789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.20 Aligned_cols=247 Identities=31% Similarity=0.543 Sum_probs=209.5
Q ss_pred ccccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
..|.....||+|+||.||++.+. +..||+|++..... ....+.+|+.+++.++|+|++++++.+......|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 45677789999999999999884 78999999975433 1256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999998753 46899999999999999999999999999999999999999999999999988643322
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-CCCChHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI-PNDCLPVLSEIM 370 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li 370 (418)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......... +..++..+.+++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 1223345788999999998888999999999999999999999999887776655544444333222 223788999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.+|.+|||+.++++
T Consensus 251 ~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHhccChhhCcCHHHHhh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=315.40 Aligned_cols=242 Identities=27% Similarity=0.457 Sum_probs=201.7
Q ss_pred ccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
....||+|+||.||++.. ++..||||.+..... ...+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 346799999999999987 678999999854321 123568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCCC
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMT 295 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~~ 295 (418)
|+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 9999999998854 34888999999999999999999999999999999999999999999999998754322 1223
Q ss_pred CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHHHHHHHh
Q 014783 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRC 373 (418)
Q Consensus 296 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~c 373 (418)
...++..|+|||.+.+..++.++||||||+++|||++|..||........... +........+ ...+..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCccccccccCHHHHHHHHHH
Confidence 34688999999999888899999999999999999999999988776554433 2222222222 24677899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 014783 374 WDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 374 l~~dp~~RPt~~ell~~ 390 (418)
|..||.+|||++|+++.
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=331.17 Aligned_cols=242 Identities=22% Similarity=0.345 Sum_probs=193.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
..|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+.+|++++||||+++++++......+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4678889999999999999988 567899996421 23568999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|||++ .++|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 237 lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 999999 47998888653 3468999999999999999999999999999999999999999999999999997643321
Q ss_pred C---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcC-C-------
Q 014783 293 G---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT-------AVQAAFAVVNKG-V------- 354 (418)
Q Consensus 293 ~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~-------~~~~~~~~~~~~-~------- 354 (418)
. .....||..|+|||++.+..++.++|||||||+||||++|..|+-... ....+..++... .
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1 223469999999999999999999999999999999999776542211 011122222211 0
Q ss_pred ------------------CCCCCC-------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 ------------------RPVIPN-------DCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 ------------------~~~~~~-------~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
++.... ..+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 123468899999999999999999999874
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.86 Aligned_cols=240 Identities=21% Similarity=0.354 Sum_probs=183.9
Q ss_pred CceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe--eCceEEEE
Q 014783 141 TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRMVWCIV 214 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~~~~~~lv 214 (418)
.+||+|+||.||+|+. ++..||+|.+...... ..+.+|+.+++.++||||+++++++. .+..+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 5799999999999986 3468999998654321 34668999999999999999999884 35678999
Q ss_pred EeecCCCCHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCEEEeecc
Q 014783 215 TEYAKGGSVRQFLTRR-------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl----~~~~~vkl~DfG 283 (418)
+||+. ++|.+++... ....+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99995 5888887532 12357889999999999999999999999999999999999 566799999999
Q ss_pred cceeecccC----CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH
Q 014783 284 VARIEVQTE----GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---------QAAFAV 349 (418)
Q Consensus 284 la~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---------~~~~~~ 349 (418)
+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...... ......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998653321 1234568899999999876 45899999999999999999999999643211 000000
Q ss_pred Hhc-C----------------------C-CC------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 350 VNK-G----------------------V-RP------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 350 ~~~-~----------------------~-~~------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
... + . .. .........+.+|+.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0 0 00 001112356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=299.71 Aligned_cols=245 Identities=29% Similarity=0.590 Sum_probs=208.5
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|...+.||+|++|.||++.. +++.+++|++...... ..+.+.+|+.+++.++|||++++++++......+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE------KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 56678999999999999998 4789999999764431 125788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
+||+++++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence 99999999999987643 46899999999999999999999999999999999999999999999999999765443323
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--ChHHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND--CLPVLSEIMTR 372 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~ 372 (418)
....++..|+|||.+....++.++||||||+++++|++|+.||...+.......... ...+..+.. ++..+.+++.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHH
Confidence 455688999999999888899999999999999999999999988766555444333 222233322 37889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||+.||++|||+.|+++
T Consensus 234 ~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 234 CLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.49 Aligned_cols=243 Identities=26% Similarity=0.471 Sum_probs=202.9
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|.-.+.||+|++|.||++.. +++.+|+|.+....... .+.+.+|+.+++.+.||||+++++++......++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR------RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH------HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 33446899999999999986 57799999886432211 24578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~ 293 (418)
+||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999999999999876 35888999999999999999999999999999999999999999999999988644322 12
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCChHHHHHHHH
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSEIMT 371 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 371 (418)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+. ....+.. +..++..+.+++.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR-DNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-hcCCCCCcccccCCHHHHHHHH
Confidence 233468899999999998889999999999999999999999998777655544333 2322222 2337789999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||+.+|++||++.++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 251 RMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHcccChhhCcCHHHHcc
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=299.83 Aligned_cols=247 Identities=33% Similarity=0.605 Sum_probs=212.1
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|++|.||+++. +++.||+|.+........ ..+.+.+|++++++++|||++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE----ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHH----HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 366788999999999999987 567999999976543311 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
|+||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999998764 5689999999999999999999999999999999999999999999999999986544332
Q ss_pred -CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHH
Q 014783 294 -MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372 (418)
Q Consensus 294 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 372 (418)
.....++..|+|||...+..++.++||||||+++++|++|..||.............. ...+..+...++.+.+++.+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHH
Confidence 2345688999999999888889999999999999999999999987776555554443 34445667788999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 014783 373 CWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~ 389 (418)
||..+|++|||+.+++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.56 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=202.0
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||+|+||.||+|.+ +++.||||.+........ .......+.+|+.+++.++|+||+++++++.+...+++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 66778899999999999987 578999999976543311 112235677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~ 293 (418)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++||+|+||+|+|||++.++.++|+|||+++..... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 9999 899999997543 36899999999999999999999999999999999999999999999999999765432 22
Q ss_pred CCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 014783 294 MTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----------------- 355 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------- 355 (418)
.....+++.|+|||.+.+ ..++.++|||||||+++||++|.+||......+...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 333456788999999854 46789999999999999999998888776654433222211000
Q ss_pred ----CC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 356 ----PV-----IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 356 ----~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 112346788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.74 Aligned_cols=248 Identities=23% Similarity=0.416 Sum_probs=200.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+|.+ +++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..+..+|+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 567789999999999999998 57899999986543322 122567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-C
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~ 292 (418)
|+||+++++|.++... ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 78 VFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999999888877654 234899999999999999999999999999999999999999999999999998764332 2
Q ss_pred CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------
Q 014783 293 GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK------------------- 352 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~------------------- 352 (418)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2334567899999999865 35788999999999999999999999766654432222210
Q ss_pred C-CCCC---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 G-VRPV---------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~-~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+ ..+. ..+.++..+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000 12345778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.98 Aligned_cols=245 Identities=21% Similarity=0.323 Sum_probs=197.1
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeC--ceE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR--MVW 211 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~--~~~ 211 (418)
|++.+.||+|+||.||+++. +++.||+|.++........ ....+|+.++.++. |||++++++++.+. ..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 45678899999999999987 6789999998654322211 23347888888885 99999999999877 889
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++|+||+. ++|.+++.... ..+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||+++.....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99999996 58888886532 46899999999999999999999999999999999999999 99999999999866544
Q ss_pred CCCCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------C
Q 014783 292 EGMTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG----------------V 354 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~----------------~ 354 (418)
.......++..|+|||.+. ...++.++|||||||++|||++|..||.+.+..+......... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 4445556889999999764 4557899999999999999999999998876654333222100 0
Q ss_pred CCCC-----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 RPVI-----------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ~~~~-----------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.... ...++..+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0001 1245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.58 Aligned_cols=247 Identities=27% Similarity=0.488 Sum_probs=205.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|.+.+.||+|+||.||++.. ++..||+|.+....... .+.+.+|+.+++.++|||++++++.+......|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 5778889999999999999986 67899999985432221 256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+++++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999999998653 47888999999999999999999999999999999999999999999999886543322
Q ss_pred -CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHHHHHHH
Q 014783 293 -GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVLSEIM 370 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 370 (418)
......+++.|+|||.+....++.++||||||+++|++++|+.||...+...........+... ..+...+..+.+++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 2233468899999999988889999999999999999999999998776654433322222111 12334567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~ 390 (418)
.+||..+|++||++.+++..
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.43 Aligned_cols=248 Identities=26% Similarity=0.486 Sum_probs=211.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|+||.||+++. +++.+|+|.+......... ...+.+|+.+++.++||||+++++++......|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE----REDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH----HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 366778999999999999987 6779999998754433221 2466789999999999999999999999899999
Q ss_pred EEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999999987632 356888999999999999999999999999999999999999999999999999765443
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
......++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..+.... +..+..+..+..++..+.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-VQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCCCCchhhCHHHHHHHH
Confidence 33345688999999999999999999999999999999999999988876654443 3444445566678889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||+.+|++||++.+++.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 235 SMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHcCCCcccCCCHHHHhc
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=303.14 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=197.3
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.||+|+||.||+|+. +++.||||++........ .....+..|..+ ....+|||++++++++.....+|+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK---NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH---HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 5699999999999987 678999999864322111 111233445444 4455899999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~ 297 (418)
+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.... ....
T Consensus 79 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 9999999999753 4589999999999999999999999999999999999999999999999999875432 2334
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCChHHHHHHHHHhcc
Q 014783 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG--VRPVIPNDCLPVLSEIMTRCWD 375 (418)
Q Consensus 298 ~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~ 375 (418)
.++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... .....+..+++.+.+++.+||+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 68899999999988889999999999999999999999998877665444433322 2223344678999999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 014783 376 TNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 376 ~dp~~RPt~~ell~~L~ 392 (418)
.+|++||++.++.+.|.
T Consensus 234 ~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 234 MDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHccCCCcHHHHHc
Confidence 99999997765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=308.75 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=201.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|++|.||+|++ +++.||+|.+........ ....+.+|+.++++++||||+++++++.....+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 4677889999999999999987 578999999865432211 1246778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeecccceeeccc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQT 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfGla~~~~~~ 291 (418)
+||||++ ++|.+++.......+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999995 58888886655555788889999999999999999999999999999999985 457999999999754221
Q ss_pred -CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------------
Q 014783 292 -EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV--------------- 354 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~--------------- 354 (418)
.......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||......+.........-
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 222344678999999998664 578999999999999999999999987766554443322100
Q ss_pred --------CC----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 --------RP----VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 --------~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. ...+..++.+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011345678899999999999999999999886
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=305.56 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=194.3
Q ss_pred ceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecC
Q 014783 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 219 (418)
.||+|+||.||++.. +++.||+|.+................-.....+++...||+|+.+++++......|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 678999999876433221111111111223345555689999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCC
Q 014783 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299 (418)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~g 299 (418)
|++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++...... ......|
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCC
Confidence 99999988653 46899999999999999999999999999999999999999999999999998754322 2234578
Q ss_pred CccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc
Q 014783 300 TYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAV--QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376 (418)
Q Consensus 300 t~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 376 (418)
+..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... .... ..........+..++..+.+++.+||..
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999754 6899999999999999999999999765321 1111 2223334556667789999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 014783 377 NPEVRP-----PFTEIVR 389 (418)
Q Consensus 377 dp~~RP-----t~~ell~ 389 (418)
+|.+|| ++.++++
T Consensus 237 ~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHhccCCCCCCHHHHHh
Confidence 999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.51 Aligned_cols=245 Identities=23% Similarity=0.409 Sum_probs=195.9
Q ss_pred Cceeee--CceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 141 TAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 141 ~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
..||.| +||+||++++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 346666 9999999987 789999999875443322 12578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC---
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~--- 293 (418)
|+.+++|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999999999876555689999999999999999999999999999999999999999999999986532211110
Q ss_pred -----CCCCCCCccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Q 014783 294 -----MTPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV------------ 354 (418)
Q Consensus 294 -----~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~------------ 354 (418)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||............+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0112345679999999763 578999999999999999999999987765444333322110
Q ss_pred ---------------------------------CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 ---------------------------------RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ---------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....+..+++.+.+|+++||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 01112235677899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.47 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=201.7
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-- 208 (418)
+.++|++.+.||+|+||.||+|++ +|+.||+|.++........ ...+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 346788899999999999999987 6889999998754322111 12456799999999999999999998654
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+++||||+. ++|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 81 DSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred CeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 56899999996 5898888753 356899999999999999999999999999999999999999999999999999865
Q ss_pred ccc-CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 014783 289 VQT-EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----------- 355 (418)
Q Consensus 289 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----------- 355 (418)
... .......++..|+|||.+.+ ..++.++|||||||++|||++|..||...+..+....+......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 432 22233346788999999865 56899999999999999999999999988876655444331100
Q ss_pred ------CCCC-----------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ------PVIP-----------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ------~~~~-----------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+ ...++.+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 124677899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.54 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=199.0
Q ss_pred cccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.+++.+|.|+++.||+++.+++.||||++......... .+.+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED----LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhH----HHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 34556667777777777778999999999764322221 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC----
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---- 293 (418)
+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999999876556789999999999999999999999999999999999999999999999998865432211
Q ss_pred ----CCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Q 014783 294 ----MTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP----------- 356 (418)
Q Consensus 294 ----~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------- 356 (418)
.....++..|+|||++.. ..++.++|||||||++|||++|..||..........+.+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 123346788999999866 358899999999999999999999998766554433322211100
Q ss_pred ---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ---------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 001122456889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=307.23 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=201.1
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||.|++|.||+|.+ +|..||+|++........ ....+.+|+.+++.++|||++++++++.+....|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 45678899999999999987 688999999865432211 114577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~ 293 (418)
|||++ ++|.+++.......+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||++...... ..
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99994 69999987655456899999999999999999999999999999999999999999999999998754322 12
Q ss_pred CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 014783 294 MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----------------- 355 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----------------- 355 (418)
.....++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2334568899999988654 5789999999999999999999999877665443333221000
Q ss_pred ----------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ----------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.......+..+.+++.+||+.+|.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=306.58 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=195.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|+||.||+|.. +++.||+|++........ ...+.+|+.+++.++|+||+++++++..+...|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 5678889999999999999986 678999999865432221 134668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+|+||+. ++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9999995 68877775432 45778888999999999999999999999999999999999999999999998753222
Q ss_pred CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc----------------C
Q 014783 292 EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA-AFAVVNK----------------G 353 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~-~~~~~~~----------------~ 353 (418)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ ....+.. .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 122334578999999998754 578899999999999999999999976554221 1111110 0
Q ss_pred CCCC-----CC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 VRPV-----IP---------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 ~~~~-----~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+... .+ ...+..+.+++.+|+..||.+|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 00 012467889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=303.77 Aligned_cols=243 Identities=24% Similarity=0.432 Sum_probs=203.1
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||.|+||.||++++ +++.||+|++....... ....+.+.+|+.++++++||||+++++.+......|+++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 68899999999998 48899999986543221 12236788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC--------
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------- 292 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-------- 292 (418)
++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999997643 68999999999999999999999999999999999999999999999999987543221
Q ss_pred -CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC--hHHHHHH
Q 014783 293 -GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDC--LPVLSEI 369 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~l 369 (418)
......++..|+|||.+....++.++||||||++++++++|..||......+........... .+..+ +..+.++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE--WPEDVEVSDEAIDL 233 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC--CCccccCCHHHHHH
Confidence 123345788999999998888999999999999999999999999888776665554443322 33333 8899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~~L~ 392 (418)
+.+||+.+|.+|||+.++.+.|+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhc
Confidence 99999999999999966555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=307.76 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=198.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCce--
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV-- 210 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~-- 210 (418)
+|++.+.||+|+||.||+|.+ +++.||||.+........ ....+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 567788999999999999987 678999998865432211 1145778999999995 6999999999877655
Q ss_pred ---EEEEEeecCCCCHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeecc
Q 014783 211 ---WCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFG 283 (418)
Q Consensus 211 ---~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfG 283 (418)
+|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988886532 246899999999999999999999999999999999999998 8899999999
Q ss_pred cceeeccc-CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 014783 284 VARIEVQT-EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP----- 356 (418)
Q Consensus 284 la~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~----- 356 (418)
+++..... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...-..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98754322 22233457889999998865 457999999999999999999999998877655444332210000
Q ss_pred ---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ---------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+.+++.+.+++.+||..||.+||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=303.76 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=209.5
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~ 204 (418)
.-|++...+++-+..||.|+||+|++... .|+.+|||.++......+. ++++.|... ++.-+.||||++||+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-----~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-----KRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-----HHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34677778888888999999999999977 6889999999765553332 456666654 555579999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHh---hhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEe
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
+..++..+|.||+| .-||..+.+ ..+...+++..+..|+.-.+.||.||.+ ..|||||+||+|||++..|.+|||
T Consensus 132 ~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 132 LFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence 98888889999999 457765543 3456779999999999999999999985 599999999999999999999999
Q ss_pred ecccceeecccCCCCCCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 281 DFGVARIEVQTEGMTPETGTYRWMAPEMIQ--HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 281 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
|||++....++-..+...|...|||||.+. ..+|+.+|||||||++|+|++||+.||.+.+..-....++..+-.|.+
T Consensus 211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL 290 (361)
T ss_pred cccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence 999998766666667778999999999994 346999999999999999999999999987764433334444433332
Q ss_pred --CC---CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 359 --PN---DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 359 --~~---~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+. ..+..+..++.-|+..|-..||.+.+|++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22 25678999999999999999999999876
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.33 Aligned_cols=248 Identities=27% Similarity=0.464 Sum_probs=215.0
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+++-+..||.|.||.||.|.. +|+..|+|.++-.... . .....+.+|..++..++|||+|++||+-......+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~---k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-H---KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-c---ccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 445677899999999999986 7889999987643332 1 112567799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
.||||++|+|.+.+.. ++..++.....+..|++.|++|||++|||||||||+|||++.+|.+|++|||.|.......
T Consensus 1312 FMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999999975 3446677777889999999999999999999999999999999999999999998654432
Q ss_pred ----CCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 293 ----GMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 293 ----~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
......||+.|||||++.+ ++...++|||||||++.||+||+.||..+++...+...+..|-.|.+|+..+++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 1234579999999999964 456779999999999999999999999999888888888899999999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
-.+|+.+||..||.+|-++.||++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHH
Confidence 999999999999999988877765
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=304.42 Aligned_cols=248 Identities=24% Similarity=0.409 Sum_probs=200.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|++.+.||+|++|.||+|++ +++.||||.+........ ...+.+|+.++++++||||+++++++.....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 367788999999999999997 578999999875433221 1356689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999974 8988886543 245899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------C
Q 014783 292 EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG----------------V 354 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~----------------~ 354 (418)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+.... +
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 122334578899999998654 57899999999999999999999998776554433332210 0
Q ss_pred CCC-----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 RPV-----------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ~~~-----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
... ..+.+++.+.+++.+||+.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 11234677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=303.97 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=200.2
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEeeCce-
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMV- 210 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~~~~- 210 (418)
|++.+.||+|+||.||++++ +++.||+|.+........ ....+.+|+.+++++ .|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG----IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch----hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 45678899999999999998 478999999975433221 113455777777666 59999999999987766
Q ss_pred ----EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 211 ----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 211 ----~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
++++|||+. ++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 77 RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 589998876554568999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----------- 355 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----------- 355 (418)
............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 764443334456788999999999989999999999999999999999999887766655444321100
Q ss_pred ------CCC--------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ------PVI--------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ------~~~--------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.. ....++.+.+++.+||+.||.+||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 0123466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=304.09 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=201.4
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~l 213 (418)
|++.+.||+|+||.||+|+. +++.||||.+......... ....+|+..+++++ ||||+++++++..+...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE-----CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhH-----HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 45678999999999999998 5678999998654332211 23457899999999 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~ 293 (418)
||||+ +|+|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99999 88999998765545789999999999999999999999999999999999999999999999999986655444
Q ss_pred CCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------------CC
Q 014783 294 MTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG-----------------VR 355 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~-----------------~~ 355 (418)
.....++..|+|||.+. ...++.++|+||||+++++|++|+.||......+....+.... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 45567889999999884 4458999999999999999999999998776554433222100 00
Q ss_pred CC-----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 PV-----------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~~-----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. .....+..+.+++++||+.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00 01122577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.57 Aligned_cols=246 Identities=29% Similarity=0.457 Sum_probs=203.4
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|...+.||+|+||.||+|+. +++.||+|.+......... ....+.+|+.+++.++|||++++++++.+....|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 44456799999999999987 6789999998654332211 124678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
|||+. ++|.+++... ...+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.+||+|||++... ...
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---~~~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA 174 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc---CCC
Confidence 99995 5888877643 345889999999999999999999999999999999999999999999999998643 223
Q ss_pred CCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
....|+..|+|||.+. ...++.++||||||+++|+|++|..||........................++..+.+++.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 3456889999999984 4568899999999999999999999998877666555554443333333456778999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~~ 390 (418)
+||+.+|.+||++.+++..
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=306.77 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=200.6
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc-
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~- 209 (418)
..++|++.+.||+|+||.||+|+. +++.||||.++....... ....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 456788899999999999999998 578999999975432221 1135678999999999999999999987654
Q ss_pred ---------eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEe
Q 014783 210 ---------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 210 ---------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
.+++|+||+++ +|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 777777653 3468999999999999999999999999999999999999999999999
Q ss_pred ecccceeecccC--CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-
Q 014783 281 DFGVARIEVQTE--GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP- 356 (418)
Q Consensus 281 DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~- 356 (418)
|||++....... ......++..|+|||.+.+ ..++.++|||||||++++|++|+.||...+..+....+......+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999997654332 1223346788999998864 357899999999999999999999998766555443322210000
Q ss_pred ---------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ---------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....++..+.+++.+||+.||.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.21 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=205.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
..|...+.||+|+||.||+|+. +++.+|+|.+......... ..+.+.+|+.+++.++|+|++++++++......+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChH---HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3456678899999999999987 6778999998643222211 1246778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||+. |+|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+|||++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999996 6888877543 34588999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.....+++.|+|||.+. ...++.++|||||||++|+|++|..||......+..............+..++..+.++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 23456889999999974 34678899999999999999999999988776665555444433333344677889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~~L~ 392 (418)
+.+||+.+|++||++.++++...
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcc
Confidence 99999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=315.93 Aligned_cols=253 Identities=20% Similarity=0.325 Sum_probs=202.8
Q ss_pred cccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~ 207 (418)
..|..+.|++++.||.||.+.||++.. +.+.||+|.+...... ..+..-|.+|+..|.+|+ |.+||+||++-..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D----~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD----NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC----HHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 457788999999999999999999987 4567888876543332 233477999999999995 8999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
++.+|+|||+= ..+|..+|+++... .+.-.+..+..|++.++.++|++||||.||||.|+|+- .|.+||+|||+|..
T Consensus 432 d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 432 DGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred CceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 99999999976 56999999876443 33347778889999999999999999999999999996 68999999999986
Q ss_pred ecccC---CCCCCCCCccccccccccCC-----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc
Q 014783 288 EVQTE---GMTPETGTYRWMAPEMIQHR-----------PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA-VVNK 352 (418)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~-~~~~ 352 (418)
..... .....+||+.||+||++... ..+.+||||||||+||+|+.|+.||....+...... +.+.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 54322 24567899999999999433 256799999999999999999999988765444333 3333
Q ss_pred CCCCCCCCCCh-HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 GVRPVIPNDCL-PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~~~~~~~~~~~-~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+...++|.--. .++.++|+.||++||++|||..+|+.
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 33333333222 34899999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=313.27 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=195.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
++|++.+.||+|+||.||+|++ +++.||||.+...... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 5688899999999999999987 6789999998642221 1224677899999999999999999987543
Q ss_pred -ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..+|+|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 35799999995 588877754 4589999999999999999999999999999999999999999999999999876
Q ss_pred ecccCC----CCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Q 014783 288 EVQTEG----MTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN----------- 351 (418)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~----------- 351 (418)
...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 433221 123467899999998754 5689999999999999999999999977654332211110
Q ss_pred ----c-------C--CCCC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 352 ----K-------G--VRPV-----IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 352 ----~-------~--~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
. . .... ..+..++.+.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 0000 012346778999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=308.97 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=194.1
Q ss_pred cccccCceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--c
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--M 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~ 209 (418)
+|++.+.||+|+||.||+|.+ +++.||+|.+........ ...+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc---CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 366778999999999999987 468999999976431111 1114567899999999999999999999887 7
Q ss_pred eEEEEEeecCCCCHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC----CCCEEEeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA----DKSIKIADF 282 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~----~~~vkl~Df 282 (418)
.+++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+||
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 8999999996 47777775432 236889999999999999999999999999999999999999 899999999
Q ss_pred ccceeecccCC----CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHH
Q 014783 283 GVARIEVQTEG----MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ---------AAFA 348 (418)
Q Consensus 283 Gla~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~---------~~~~ 348 (418)
|++........ .....+++.|+|||.+.+. .++.++||||||+++++|++|+.||.+..... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876433221 2334678899999988664 58999999999999999999999997554321 0000
Q ss_pred HHh------------------------cCCCCCCC-----------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 349 VVN------------------------KGVRPVIP-----------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 349 ~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
++. .......+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00001111 034567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=301.16 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=199.6
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC--ceEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVWC 212 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~~ 212 (418)
|++.+.||+|+||.||+|++ +++.+|+|.+........ ....+.+|+.+++.++|||++++++++... ...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 45678899999999999987 468999999976542211 124677899999999999999999999887 7899
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+||++ ++|.+++... ...+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 77 MVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9999996 4898888654 2468999999999999999999999999999999999999999999999999998654432
Q ss_pred --CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q 014783 293 --GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP------------- 356 (418)
Q Consensus 293 --~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------- 356 (418)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+......+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2333456889999998765 457899999999999999999999998777654443332210000
Q ss_pred ----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ----------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ----------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....+++.+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001113778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.69 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=194.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-- 209 (418)
.++|++.+.||+|+||.||+++. +++.||||.+......... ...+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc----hhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 45788889999999999999987 6789999998654322111 134568999999999999999999986543
Q ss_pred ------eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 210 ------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 210 ------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
..++||||+. ++|.+++... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999995 5888887653 3468999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC-----CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCC
Q 014783 284 VARIEVQTEG-----MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN--KGVR 355 (418)
Q Consensus 284 la~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~--~~~~ 355 (418)
++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9975432221 1234567889999988664 478899999999999999999999987665433221111 0000
Q ss_pred C---------------CC-------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 P---------------VI-------------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~---------------~~-------------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+ .. +...+..+.+++.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00 0112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.86 Aligned_cols=240 Identities=25% Similarity=0.449 Sum_probs=201.0
Q ss_pred cCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
...||+|+||.||++.. +++.||||.+..... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 35799999999999987 678999998753321 1135688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-CCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-~~~~ 296 (418)
+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 999999998754 347889999999999999999999999999999999999999999999999986543221 2233
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCChHHHHHHHHHhc
Q 014783 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl 374 (418)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+... .+....... ....+++.+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 568899999999988889999999999999999999999998776654433 233333322 22356788999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 014783 375 DTNPEVRPPFTEIVR 389 (418)
Q Consensus 375 ~~dp~~RPt~~ell~ 389 (418)
+.+|.+||++.++++
T Consensus 255 ~~~P~~R~~~~~ll~ 269 (292)
T cd06657 255 VRDPAQRATAAELLK 269 (292)
T ss_pred hCCcccCcCHHHHhc
Confidence 999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.00 Aligned_cols=247 Identities=25% Similarity=0.413 Sum_probs=202.5
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|++.+.||+|++|.||++.. +++.+|+|.+........ ....+.+|+.++++++||||+++++++..+..+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 35567899999999999987 678999999875543321 225677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-C
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-~ 293 (418)
+||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 999964 8888887643 568999999999999999999999999999999999999999999999999997654432 2
Q ss_pred CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 014783 294 MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---------------- 356 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------------- 356 (418)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 3334578899999999776 78999999999999999999999998877655433332211000
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+.++..+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=299.69 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=204.5
Q ss_pred cccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|.+.+.||+|+||.||++++. +..+++|+++......... .....+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 4677889999999999999873 4567777765432211110 011356689999999999999999999998888999
Q ss_pred EEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 214 VTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999988642 3456899999999999999999999999999999999999975 67999999998765332
Q ss_pred C-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... +..+..+..+..++..+.+++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR-IVEGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHcCCCCCCcchhcHHHHHHH
Confidence 2 23345688999999999888899999999999999999999999987666554443 334455556677889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.+|++||++.|+++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHhcCChhhCcCHHHHhh
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.52 Aligned_cols=248 Identities=22% Similarity=0.369 Sum_probs=199.7
Q ss_pred ccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 137 LNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
|++.+.||+|+||.||+++. +|..||+|++...... ......+.+.+|+.+++++ +|+||+++++.+..+..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV--QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh--hcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 66788999999999999975 5789999998653221 1111235678899999999 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
.|+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999999754 4588899999999999999999999999999999999999999999999999976433
Q ss_pred cC--CCCCCCCCccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCh
Q 014783 291 TE--GMTPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELITGLLPFQNMTAV---QAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 291 ~~--~~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 363 (418)
.. ......|+..|+|||.+... .++.++||||||+++|+|++|..||...... ......+.. ..+..+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCC
Confidence 22 12234688999999998653 4788999999999999999999999643221 111121211 2334566788
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RP-----t~~ell~ 389 (418)
+.+.+++.+||+.||++|| +.++++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 9999999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=302.65 Aligned_cols=247 Identities=23% Similarity=0.437 Sum_probs=207.7
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~ 212 (418)
+|.+.+.||+|+||.||+++. +++.||+|++......... ..+.+.+|+.+++++. ||||+++++++......+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchH---HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 577889999999999999987 6889999998653322111 1256789999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|||++++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999999999764 369999999999999999999999999999999999999999999999999987543221
Q ss_pred ---------------------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 293 ---------------------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 293 ---------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
......++..|+|||.+....++.++|+||||++++++++|+.||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 11223578899999999888899999999999999999999999988775554443332
Q ss_pred cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 014783 352 KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPF----TEIVR 389 (418)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~ell~ 389 (418)
.....+...++.+.+++.+||+.+|.+||++ ++++.
T Consensus 237 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 237 --LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 2334566778899999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=321.09 Aligned_cols=247 Identities=28% Similarity=0.498 Sum_probs=204.0
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--eE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--VW 211 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--~~ 211 (418)
-+++..+||+|+|-+||+|.+ +|-.||=-.++... ..+.....++|..|+.+|+.|+||||+++|.+|.+.. .+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 345667899999999999987 45455421111110 0111122368999999999999999999999997655 48
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEc-CCCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--GFIHRDLKSDNLLIS-ADKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NILl~-~~~~vkl~DfGla~~~ 288 (418)
.+|+|++..|+|..|+++. +.+....+..|+.||++||.|||++ -|||||||-+||+|+ ..|.|||+|+|||...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999999999999875 4588889999999999999999988 599999999999997 4589999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-ChHHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND-CLPVLS 367 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~ 367 (418)
.... .....|||.|||||+.. ..|+..+||||||+.|+||+|+..||..+.+...++..+..|..|..-.. -.++++
T Consensus 197 r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 197 RKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred hccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 5544 44478999999999987 67999999999999999999999999999888888888888877642211 247899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+||.+|+.. ..+|||+.||+.
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhh
Confidence 999999998 899999999886
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.87 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=206.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc----
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---- 209 (418)
+|++.+.||+|+||.||+|+. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 467788999999999999997 47899999987543211 12256889999999999999999999987765
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 7899999996 5898888653 36899999999999999999999999999999999999999999999999999865
Q ss_pred cccC----CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 014783 289 VQTE----GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP------- 356 (418)
Q Consensus 289 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~------- 356 (418)
.... ......++..|+|||.+.+. .++.++|+||||+++++|++|..||...+..+....+....-.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 4432 23345678999999999887 89999999999999999999999998877655443333211000
Q ss_pred ----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhHH
Q 014783 357 ----------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM--LENAET 396 (418)
Q Consensus 357 ----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~--L~~~~~ 396 (418)
......++.+.+++.+||+.+|++|||+++++.. |++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0112356788999999999999999999999973 555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.35 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=197.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee----C
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~ 208 (418)
++|++.+.||+|+||.||+++. +++.||+|.+........ ....+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 5677888999999999999986 688999999875432211 12467789999999999999999988753 3
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 46899999995 6898888653 44899999999999999999999999999999999999999999999999999764
Q ss_pred cccCC-----CCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 014783 289 VQTEG-----MTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK---------- 352 (418)
Q Consensus 289 ~~~~~-----~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~---------- 352 (418)
..... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 123468899999999865 46899999999999999999999999876543322211110
Q ss_pred --------------CCCCCC-----CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 --------------GVRPVI-----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 --------------~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...... .+..++.+.+++.+||+.+|++|||+++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001111 1345788999999999999999999999877
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=307.19 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=198.4
Q ss_pred cccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHH--------HHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQ--------VMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~--------~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
.+.+.||+|+||.||++.+ +++.||||.+........... .....+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 4567899999999999986 678999999875433221100 011246789999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
....++||||+. ++|.+++... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||+++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence 999999999996 6999998653 4589999999999999999999999999999999999999999999999999875
Q ss_pred ecc---------------cCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 288 EVQ---------------TEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 288 ~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 431 1112233467889999998764 478999999999999999999999988776554433322
Q ss_pred cCC---C----------------CC-------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 KGV---R----------------PV-------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 ~~~---~----------------~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
... . .. ....+++.+.+++.+||+.+|++|||++|++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 100 0 00 01234677899999999999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.99 Aligned_cols=238 Identities=23% Similarity=0.371 Sum_probs=197.3
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee----CceEEE
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK----RMVWCI 213 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~----~~~~~l 213 (418)
++||-|-.|.|-.+.. +++++|+|++... ....+|+++--.. .|||||++++++.+ ...+.+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 5799999999999865 7899999998642 2344777765444 69999999998753 457899
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecccceeecc
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQ 290 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfGla~~~~~ 290 (418)
|||+|+||.|+..+.++....+.+..+..|+.||+.|+.|||+++|.||||||+|+|... |-.+||+|||+|+....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999999999988888999999999999999999999999999999999999975 45799999999998766
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcC-CCCC--CCCCChH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---QAAFAVVNKG-VRPV--IPNDCLP 364 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~~~~~~-~~~~--~~~~~~~ 364 (418)
.....+.|.|++|.|||++....|+...|+||+||++|-||+|.+||-..... ......+..+ +.-+ -..+.++
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 66778889999999999999999999999999999999999999999654321 0111222223 2211 1224567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++|+.+|..+|.+|.|+.|++.
T Consensus 297 ~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 297 AAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHHHHHHhcCCchhheeHHHhhc
Confidence 7899999999999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=297.44 Aligned_cols=238 Identities=19% Similarity=0.301 Sum_probs=190.1
Q ss_pred cccccCc--eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEEEEeEEeeCce
Q 014783 136 KLNMGTA--FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 136 ~~~~~~~--lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~~~ 210 (418)
+|.+.+. ||+|+||.||+++. ++..+|+|.+....... .|+..... .+||||+++++.+.....
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3344444 59999999999986 67899999986532211 12222221 279999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccceeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEV 289 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~~ 289 (418)
+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999764 3689999999999999999999999999999999999999998 99999999987543
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCCCCCCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVRPVIPNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~ 367 (418)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||............+.. ......+..+++.+.
T Consensus 162 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 162 T---PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238 (267)
T ss_pred C---CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence 2 23346889999999999989999999999999999999999999755433211111111 222234456789999
Q ss_pred HHHHHhcccCCCCCCC-HHHHHH
Q 014783 368 EIMTRCWDTNPEVRPP-FTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt-~~ell~ 389 (418)
+++.+||+.+|.+||+ ++|+++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhc
Confidence 9999999999999996 688874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.52 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=200.4
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
.+|.+.+.||+|+||.||+++. +++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID----AKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch----hHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4678889999999999999987 6789999998654322211 13566899999999999999999987644
Q ss_pred -ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...|+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 34799999995 6898888653 4699999999999999999999999999999999999999999999999999976
Q ss_pred eccc-CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014783 288 EVQT-EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN-------------- 351 (418)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~-------------- 351 (418)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5432 22334567899999998864 4689999999999999999999999977653322211110
Q ss_pred ---------c-C--CCC---CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 014783 352 ---------K-G--VRP---VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM--LENA 394 (418)
Q Consensus 352 ---------~-~--~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~--L~~~ 394 (418)
. . ... ...+.+++.+.+++++||+.+|++|||++|+++. |..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 0 000 1123567889999999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.42 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=197.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC--c
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--M 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~--~ 209 (418)
++|++.+.||+|+||.||+|.+ +++.+|||.+......... ...+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 5678889999999999999987 5789999988643322221 13566899999999 999999999998643 4
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 6899999996 5999888653 57888889999999999999999999999999999999999999999999987543
Q ss_pred ccC------CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 014783 290 QTE------GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-------- 354 (418)
Q Consensus 290 ~~~------~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-------- 354 (418)
... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+....-
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 221 1223457889999998754 4678999999999999999999999987665443322211100
Q ss_pred --------------C-------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 --------------R-------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 --------------~-------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
. ......++..+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 01112367889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.46 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=203.8
Q ss_pred ccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 137 LNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
|++.+.||+|+||.||+++. +++.||||+++..... ......+.+.+|+.++.++ +||||+++++.+..+..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH--hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 56778999999999999875 4578999998643221 1112235678999999999 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||+++....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999998653 4588999999999999999999999999999999999999999999999999876433
Q ss_pred cCC--CCCCCCCccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCh
Q 014783 291 TEG--MTPETGTYRWMAPEMIQHRP--YTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 291 ~~~--~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~ 363 (418)
... .....|+..|+|||.+.+.. .+.++||||||+++++|++|..||..... .......... .....+..++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMS 236 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccC
Confidence 221 12345889999999987664 78899999999999999999999964321 1111111212 2344566678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 8999999999999999999998887777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.16 Aligned_cols=255 Identities=18% Similarity=0.269 Sum_probs=188.1
Q ss_pred cccccccCceeeeCceEEEEEEEC---CceEEEEEeecCCCCh-----------HHHHHHHHHHHHHHHHHHhCCCCCeE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNP-----------EKAQVMEQQFQQEVMMLATLKHLNIV 199 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~hpniv 199 (418)
..+|++.+.||+|+||+||++... +..+++|.+....... .........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998752 2233333211110000 00111235688999999999999999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~ 276 (418)
++++++......|+|+|++ +++|.+++.... ........+..++.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 568888775422 122345667889999999999999999999999999999999999
Q ss_pred EEEeecccceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCC-CCCCC--CHHHHHHHHHh
Q 014783 277 IKIADFGVARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL-PFQNM--TAVQAAFAVVN 351 (418)
Q Consensus 277 vkl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~-Pf~~~--~~~~~~~~~~~ 351 (418)
+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|.. ||... ........++.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999986543221 223579999999999999999999999999999999999765 45332 22222222211
Q ss_pred cC------C---------------CCCCC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 KG------V---------------RPVIP---------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 ~~------~---------------~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. + ....+ ...+..+.+++.+||+.||.+|||+.|++.
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0 00000 123456778899999999999999999986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.98 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=216.0
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
.....++|.++++||+|+||.|..++. +++.||+|++.+........ ...|..|..+|..-+.+=|++|+..|.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~---tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE---TACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh---HHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345778999999999999999999987 67899999997533221111 2568899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+|+|||||+||+|..++.+.. .+|++++..++..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence 999999999999999999998754 799999999999999999999999999999999999999999999999998765
Q ss_pred ecccC--CCCCCCCCcccccccccc----C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-
Q 014783 288 EVQTE--GMTPETGTYRWMAPEMIQ----H-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP- 359 (418)
Q Consensus 288 ~~~~~--~~~~~~gt~~y~aPE~~~----~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~- 359 (418)
+.... .....+|||.|.+||+++ + +.|+..+|+||+||++|||+.|..||-..+..+....+.+......+|
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 54322 234567999999999994 3 569999999999999999999999999888888887877765555555
Q ss_pred -CCChHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 014783 360 -NDCLPVLSEIMTRCWDTNPEVRPP---FTEIVR 389 (418)
Q Consensus 360 -~~~~~~l~~li~~cl~~dp~~RPt---~~ell~ 389 (418)
..+++..++||.+.+. +|+.|.. ++++..
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 4588999999999885 6788877 776654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.02 Aligned_cols=245 Identities=21% Similarity=0.397 Sum_probs=207.9
Q ss_pred cCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.+.||+|.||+||-|+. +|+.||||++.+-.....+. ..+.+|+.||++++||.||.|--.|.+.+.++.|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe----sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE----SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH----HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence 46899999999999975 89999999998755444332 5778999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEeecccceeecccCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~~~~~~~~~ 294 (418)
+ +|+..+++-....+.+++.....++.||+.||+|||-++|+|+||||+|||+.... .+||||||+|++..+..-.
T Consensus 645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 9 56888888776777899999999999999999999999999999999999997553 6999999999998887777
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhc
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 374 (418)
.+..||+.|+|||+++.++|...-|+||+||++|--|+|..||.....-....+....-+++....+.++..-+||...|
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 88899999999999999999999999999999999999999996544322111111122333333467788899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 014783 375 DTNPEVRPPFTEIVR 389 (418)
Q Consensus 375 ~~dp~~RPt~~ell~ 389 (418)
+.+-++|-|.+.-+.
T Consensus 804 qVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHhcchHhhcc
Confidence 999999999887665
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=291.00 Aligned_cols=237 Identities=26% Similarity=0.397 Sum_probs=201.6
Q ss_pred eeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||+|+||.||++.. +++.||+|++........ .....+.+|+.++++++||||+++++.+..+...|+||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 68999999999987 478999999876433221 1235788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETG 299 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~~~~~~g 299 (418)
++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 GELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 9999999764 35899999999999999999999999999999999999999999999999999765433 22344568
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCC
Q 014783 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379 (418)
Q Consensus 300 t~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 379 (418)
+..|+|||.+.+...+.++|+||||+++|++++|..||...........+.. .....+...+..+.+++.+||..||+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 8999999999888899999999999999999999999987765444333333 34456677789999999999999999
Q ss_pred CCCCHHH
Q 014783 380 VRPPFTE 386 (418)
Q Consensus 380 ~RPt~~e 386 (418)
+||++.+
T Consensus 234 ~R~~~~~ 240 (250)
T cd05123 234 KRLGSGG 240 (250)
T ss_pred hCCCccc
Confidence 9999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=305.62 Aligned_cols=249 Identities=24% Similarity=0.417 Sum_probs=200.2
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|.+ ..+|++.+.||+|+||.||++.. ++..||||.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 11 WEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 444 35688899999999999999986 67899999986543221 122467799999999999999999999865
Q ss_pred Cc------eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 208 RM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 208 ~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
.. .+++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEee
Confidence 43 358999999 7799888764 4589999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----- 355 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----- 355 (418)
||++..... ......+++.|+|||.+.+ ..++.++|+||||++++++++|..||...........+......
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 162 FGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999975432 2234467899999999876 45889999999999999999999999876654433322211100
Q ss_pred ------------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ------------------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......+++.+.+++.+|++.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112346678999999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=321.75 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=202.5
Q ss_pred cccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc------
Q 014783 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM------ 209 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------ 209 (418)
.....||+|+||.||+|+. +|+.||||.++........ +...+|+++|++++|||||+++++-.+..
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~-----e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPR-----ERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchH-----HHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3456899999999999985 8999999999765433322 46679999999999999999999865433
Q ss_pred eEEEEEeecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--CCC--CEEEeeccc
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIKIADFGV 284 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~--~~~--~vkl~DfGl 284 (418)
...+|||||.||+|...+.+.. ...+++...+.++.+++.||.|||++|||||||||.||++- .+| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 4579999999999999998643 35799999999999999999999999999999999999984 344 479999999
Q ss_pred ceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCC----
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNM----TAVQAAFAVVNKGVR---- 355 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~----~~~~~~~~~~~~~~~---- 355 (418)
|+...++....+..||..|++||+... +.|+..+|.|||||++|+++||..||... ++.+..+.++.+...
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 999988888999999999999999984 78999999999999999999999999432 233445544433211
Q ss_pred ---------------CCCCCCChHH----HHHHHHHhcccCCCCCC--CHHHHHHHHHhhHH
Q 014783 356 ---------------PVIPNDCLPV----LSEIMTRCWDTNPEVRP--PFTEIVRMLENAET 396 (418)
Q Consensus 356 ---------------~~~~~~~~~~----l~~li~~cl~~dp~~RP--t~~ell~~L~~~~~ 396 (418)
.+.|...++. +...+..+|.++|++|- .+.+....+.++..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1122222332 34456677788888887 77777777777654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=307.28 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=199.5
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|++. .+|.+.+.||+|+||.||+|++ +++.||||.+.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 85 (342)
T cd07879 11 WELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIGLLDVFTS 85 (342)
T ss_pred hccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc----chhHHHHHHHHHHhcCCCCccchhheecc
Confidence 5553 4688889999999999999986 688999999875432211 12457789999999999999999999865
Q ss_pred C------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 208 R------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 208 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
. ..+|+|+||+. .+|.+++. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred cccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 4 24699999995 47766642 3588999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV------ 354 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~------ 354 (418)
||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......++...-
T Consensus 161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 161 FGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999875422 2334467889999999876 4689999999999999999999999987665443333222000
Q ss_pred ---------------CCCC--------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 014783 355 ---------------RPVI--------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM--LENA 394 (418)
Q Consensus 355 ---------------~~~~--------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~--L~~~ 394 (418)
.+.. .+..++.+.+++.+||+.||++||++++++.. ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 12356678999999999999999999999853 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=332.86 Aligned_cols=246 Identities=28% Similarity=0.494 Sum_probs=188.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 207 (418)
.+|+.+..||+||||.||+++. +|+.||||.+.-.. . ......+.+|+.+|.+|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s----~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S----DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H----HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4667778999999999999986 89999999986543 1 1223578899999999999999998731100
Q ss_pred --------------------------------------------------------------------------------
Q 014783 208 -------------------------------------------------------------------------------- 207 (418)
Q Consensus 208 -------------------------------------------------------------------------------- 207 (418)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 014783 208 --------------------------R--------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (418)
Q Consensus 208 --------------------------~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (418)
+ ..+||-||||+..+|.+++.+..... ....+|+++.+|++||.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHH
Confidence 0 23699999999988888887543211 467899999999999999
Q ss_pred HHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-------------------ccCCCCCCCCCccccccccccCC--
Q 014783 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------------------QTEGMTPETGTYRWMAPEMIQHR-- 312 (418)
Q Consensus 254 LH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~-- 312 (418)
+|++|||||||||.||+++.++.|||.|||+|.... .....+...||.-|+|||++.+.
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999997611 01123456799999999999665
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 014783 313 -PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PNDCLPVLSEIMTRCWDTNPEVRPPFTEIV 388 (418)
Q Consensus 313 -~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ell 388 (418)
.|+.|+|+|||||+|+||+ .||......-.....+..+.-|.. ...--+.-..+|+++++.||.+|||+.||+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 4999999999999999999 567554333333333333322222 111224457899999999999999999988
Q ss_pred H
Q 014783 389 R 389 (418)
Q Consensus 389 ~ 389 (418)
.
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 5
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.42 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=207.5
Q ss_pred ccccccccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~ 207 (418)
.|...+|.++.+||+|+||.|.++... .+.||||++++........- +--..|..+|... +.|.+++++.++++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv---ectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV---ECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc---cceehhhhheecCCCCchHHHHHHHhhh
Confidence 467789999999999999999999764 46899999986543221110 1223566666655 57899999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
-+.+|+||||++||+|--.+++. +.+.++.+..+|.+|+-||-+||++|||+||||.+|||+|.+|++||+|||+++.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999997777653 5688999999999999999999999999999999999999999999999999975
Q ss_pred ec-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 288 EV-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 288 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
.. ......+.||||.|+|||++.+++|+.++|+||+||+||||+.|++||++....+....+.+.... .|..++.+.
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs--yPKslSkEA 577 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS--YPKSLSKEA 577 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--CcccccHHH
Confidence 32 233345679999999999999999999999999999999999999999999998887777666543 666788889
Q ss_pred HHHHHHhcccCCCCCC
Q 014783 367 SEIMTRCWDTNPEVRP 382 (418)
Q Consensus 367 ~~li~~cl~~dp~~RP 382 (418)
.++.+..+...|.+|.
T Consensus 578 v~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHhhcCCcccc
Confidence 9999999999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=314.50 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=220.2
Q ss_pred cccccccccCceeeeCceEEEEEEECCce--EEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++++....||-|+||.|=++..+++. +|+|++++......+. .+.+..|..||..++.|.||+||-.|.+..
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ---qeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ---QEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH---HHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 55678888899999999999999987665 8999998765544433 256779999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|++||-|-||.|+..++++ +.+....+..++.-+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+...
T Consensus 494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999999875 458999999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.+....+.||||.|.|||++..++++.++|.||||+++|||++|.+||.+-++......++..--...+|........+|
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 88888889999999999999999999999999999999999999999999998887665554333346777888889999
Q ss_pred HHHhcccCCCCCCC
Q 014783 370 MTRCWDTNPEVRPP 383 (418)
Q Consensus 370 i~~cl~~dp~~RPt 383 (418)
+++....+|.+|.-
T Consensus 652 ik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 652 IKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHhcCcHhhhc
Confidence 99999999999965
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=300.13 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=195.4
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--- 208 (418)
.++|++.+.||+|+||.||++++ +++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 46788899999999999999987 5789999998654322111 13456899999999999999999987443
Q ss_pred -----ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 209 -----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 209 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
..+++|+||+. ++|...+... ...+++..+..++.|+++||+|||++||+|+||||+|||++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 34699999995 4777777543 3469999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC------------CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014783 284 VARIEVQTEG------------MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVV 350 (418)
Q Consensus 284 la~~~~~~~~------------~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~ 350 (418)
+++....... .+...+++.|+|||.+.+. .++.++||||||+++|||++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9975432211 1223467889999988654 58899999999999999999999998777655443332
Q ss_pred hcCCC---------------------CCCC-------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 351 NKGVR---------------------PVIP-------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 351 ~~~~~---------------------~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..... ...+ ....+.+.+++.+||+.||.+|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 21100 0000 123357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.56 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=197.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
++|.+.+.||+|+||.||++.. +++.||+|.+........ ..+.+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 6788899999999999999986 678999999875432221 124677899999999999999999988543
Q ss_pred --ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3468888887 7899888754 348999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR---------- 355 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---------- 355 (418)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........++.....
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5432 2334567899999999866 56889999999999999999999999876654433222111000
Q ss_pred -----------CCC--------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 356 -----------PVI--------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 356 -----------~~~--------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+.. ....++.+.+++.+||+.||.+||++.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 11346778999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.75 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=194.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
.+|.+.+.||.|+||.||+|.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 5788889999999999999987 57899999986544321 24677899999999999999999776543
Q ss_pred ----------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCE
Q 014783 209 ----------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSI 277 (418)
Q Consensus 209 ----------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~v 277 (418)
..+|+|+||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35799999996 589888753 35889999999999999999999999999999999999984 5678
Q ss_pred EEeecccceeecccCC----CCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014783 278 KIADFGVARIEVQTEG----MTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK 352 (418)
Q Consensus 278 kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~ 352 (418)
||+|||+++....... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..+.....+..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999975432211 122357889999998754 56889999999999999999999999877665544333221
Q ss_pred C-----------------------CCCC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 G-----------------------VRPV-----IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~-----------------------~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. .... .....+.++.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000 11245678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.53 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=192.4
Q ss_pred ccccCceeeeCceEEEEEEEC----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC---
Q 014783 137 LNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--- 208 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~--- 208 (418)
|++.+.||+|+||.||++++. +..||||.+........ ..+.+.+|+.+++++ .||||+++++.+...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI----LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 567789999999999999873 56899999864322211 124677899999999 599999999875432
Q ss_pred -ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..+|+++|++. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 45789999985 689988864 34689999999999999999999999999999999999999999999999999975
Q ss_pred ecccC-----CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Q 014783 288 EVQTE-----GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--------- 352 (418)
Q Consensus 288 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~--------- 352 (418)
..... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...........++..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 43221 1223468899999998765 46899999999999999999999999876543322221110
Q ss_pred ---------------CCC--C---CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 ---------------GVR--P---VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ---------------~~~--~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
... . ...+.++..+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0 111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.23 Aligned_cols=251 Identities=33% Similarity=0.616 Sum_probs=202.6
Q ss_pred cccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC--CCCCeEEEEeEEeeCc--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~~~~~~~~-- 209 (418)
.+++.+.+.||+|.||+||+|+|.|+.||||++...+. +.+.+|.+|.+.. +|+||+.+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---------RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccch---------hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 35678889999999999999999999999999975432 4567888887765 9999999999864432
Q ss_pred --eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEcCCCCEEE
Q 014783 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 210 --~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NILl~~~~~vkl 279 (418)
.++||++|.+.|||+|||.. ..++.+.+++++.-++.||+|||.. .|.|||||+.||||..++.+-|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 58999999999999999986 4588999999999999999999952 4999999999999999999999
Q ss_pred eecccceeeccc-----CCCCCCCCCccccccccccCCC----CC--CcchHHHHHHHHHHHHhC----------CCCCC
Q 014783 280 ADFGVARIEVQT-----EGMTPETGTYRWMAPEMIQHRP----YT--QKVDVYSFGIVLWELITG----------LLPFQ 338 (418)
Q Consensus 280 ~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~t--~~sDvwSlGv~l~elltg----------~~Pf~ 338 (418)
+|+|+|-..... ...+..+||-+|||||++...- |. ..+||||||.++||++.. ++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999654332 2345678999999999985431 21 368999999999999852 57886
Q ss_pred CCCHHHHHHHH-----HhcCCCCCCCCCC-----hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 339 NMTAVQAAFAV-----VNKGVRPVIPNDC-----LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 339 ~~~~~~~~~~~-----~~~~~~~~~~~~~-----~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+..+.+.-++. ..+.++|.+|... ...+.++|+.||..||.-|.|+-.+.+.|.++.+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 65443322222 2456788777643 3457788999999999999999999998888764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=299.75 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=196.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-Cce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 210 (418)
..+|++.+.||.|+||.||++.. +++.||||.+........ ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 35688899999999999999986 678999998865432211 12467789999999999999999999865 557
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
.|+|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+++|+||||+|+|||++.++.++|+|||++.....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 89999999 6689888763 3478888899999999999999999999999999999999999999999999875422
Q ss_pred cCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Q 014783 291 TEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN------------------ 351 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~------------------ 351 (418)
......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...........+..
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2234467889999998865 5689999999999999999999999987654322111110
Q ss_pred -----c-CCCCCC-----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 352 -----K-GVRPVI-----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 352 -----~-~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
. ...... .+.+++.+.+++.+||+.+|++|||+++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000011 12456889999999999999999999998774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.12 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=199.8
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|+..+.||+|+||.||+|+. +++.||+|++........ ..+.+.+|+.+++.++|||++++++++.....+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 34567899999999999987 578999999876532111 124567899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-C
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-~ 293 (418)
+||+. ++|.+++.... ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||+++...... .
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99997 59999997643 458999999999999999999999999999999999999999999999999987653322 2
Q ss_pred CCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------CC-
Q 014783 294 MTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG----------------VR- 355 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~----------------~~- 355 (418)
.....++..|+|||.+... .++.++||||||++++||++|..||...+..+....+.... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 3344567889999998766 78999999999999999999999998776554433322100 00
Q ss_pred --CC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 --PV--------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 --~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+. ..+..+..+.+++.+||..||++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 01123568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=305.98 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=200.7
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|++ .++|++...||+|+||.||+|++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 11 WEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred ecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 444 34688899999999999999988 578999999865432221 12456789999999999999999988765
Q ss_pred Cce------EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 208 RMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 208 ~~~------~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
... +|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcc
Confidence 544 89999999 6799998864 3589999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---- 356 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 356 (418)
||++..... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+....+....-.+
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 162 FGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 999975432 2344567889999999865 367899999999999999999999998776655443332210000
Q ss_pred -------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 -------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 -------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......++.+.+++.+||+.||++|||+.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 001234778999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.09 Aligned_cols=148 Identities=34% Similarity=0.486 Sum_probs=130.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.++||+|+||.||+|.+ +++.||||++........ .....+.+|+.+++.++||||+++++++.....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK---NMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH---HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 35678889999999999999998 488999999975433211 2235688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
||||||+.+++|.+++... ..+++..++.++.||+.||.|||+++||||||||+||||+.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999753 458889999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=309.97 Aligned_cols=238 Identities=21% Similarity=0.345 Sum_probs=199.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
.++|.+...+|.|+|+.|-.+.. +++..++|++.+.... -.+|+.++... .||||+++.+++.++..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----------cccccchhhhhcCCCcceeecceecCCce
Confidence 56778888899999999999976 7789999999766222 22566555555 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE-cCCCCEEEeecccceeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEV 289 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl-~~~~~vkl~DfGla~~~~ 289 (418)
.|+|||.+.|+-|.+.+..... +. ..+..|+.+|+.++.|||++|+|||||||+|||+ +..++++|+|||.++...
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999999999999888865332 22 6777899999999999999999999999999999 689999999999998654
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.. ....+-|..|.|||++...+||.++||||||++||+||+|+.||........+...+ ..+.....+++..++|
T Consensus 468 ~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~~vS~~AKdL 542 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSECVSDEAKDL 542 (612)
T ss_pred hh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccccccCHHHHHH
Confidence 33 445577899999999999999999999999999999999999998776653333333 2334447788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||+.||.+||++.++..
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHhccCChhhCcChhhhcc
Confidence 99999999999999999875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.36 Aligned_cols=266 Identities=27% Similarity=0.498 Sum_probs=223.6
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
.+.++.+.++++...+-+|.||.||+|.|. .+.|-+|.++.... +.-...++.|..++..+.|||+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-----~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-----QIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-----HHHHHHHHHHHHHHhcCcCCCccc
Confidence 345566777888889999999999999662 23577777754221 222367889999999999999999
Q ss_pred EEeEEeeC-ceEEEEEeecCCCCHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 014783 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (418)
Q Consensus 201 l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~ 273 (418)
..+++.++ ...+.++.++.-|+|..|+..-+ ...++..++..++.|++.||+|||++|+||.||.++|++||+
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD 431 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence 99998654 45678889998899999998322 235666778899999999999999999999999999999999
Q ss_pred CCCEEEeecccceeecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014783 274 DKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAV 349 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~ 349 (418)
...|||+|=.++|...+.+.. +...-..+||+||.+....|+.+||||||||+||||+| |+.||...++.+. ...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-~~y 510 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-EHY 510 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-HHH
Confidence 999999999999865443321 12234579999999999999999999999999999999 9999999999875 467
Q ss_pred HhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
+.+|+|...|.+||+++..+|.-||...|++||+++|++.-|.+...++.
T Consensus 511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 88999999999999999999999999999999999999999999887764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=339.96 Aligned_cols=242 Identities=23% Similarity=0.410 Sum_probs=191.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.+.....||+|+||.||+|++ ++..||||.+...... ...|+.++++++|||||+++++|.+....|+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 455667899999999999986 6789999998643221 1246888999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH---GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
||||+++|+|.++++. +++..+.+++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999999999953 788999999999999999999 6799999999999999999888876 666543221
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH-----hcCCCCCC--
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA-----VQAAFAVV-----NKGVRPVI-- 358 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-----~~~~~~~~-----~~~~~~~~-- 358 (418)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... .+...... .....+.+
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 2234688999999999999999999999999999999999999853211 11110000 00111111
Q ss_pred ----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 359 ----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 359 ----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+.....++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11223457789999999999999999999999998754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=282.97 Aligned_cols=218 Identities=19% Similarity=0.231 Sum_probs=181.4
Q ss_pred eCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCH
Q 014783 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSV 223 (418)
Q Consensus 146 G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL 223 (418)
|.||.||++++ +++.||+|.+.... .+.+|...+....||||+++++++......++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 89999999987 78899999986532 123445555566799999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccc
Q 014783 224 RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303 (418)
Q Consensus 224 ~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y 303 (418)
.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence 9998764 34899999999999999999999999999999999999999999999999987654322 2334567789
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 014783 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPP 383 (418)
Q Consensus 304 ~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt 383 (418)
+|||.+.+..++.++||||+|+++|||++|+.|+...... ........+|..+++.+.+++.+||+.||++||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 9999998888999999999999999999999887543221 1112223456667889999999999999999999
Q ss_pred H
Q 014783 384 F 384 (418)
Q Consensus 384 ~ 384 (418)
+
T Consensus 223 ~ 223 (237)
T cd05576 223 A 223 (237)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=267.06 Aligned_cols=217 Identities=26% Similarity=0.415 Sum_probs=182.9
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
.+++..++.-+..||.|++|.|-+.+. +|+..|+|.+...-++.+. ++.++|+.+..+. ..|.+|.+||...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-----~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-----KRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-----HHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 456667777788999999999877765 8999999999776655443 4667888876665 6899999999998
Q ss_pred eCceEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
.+....|.||.| ..||..|.++ ..+..+++..+-+|+..+++||.|||++ .+||||+||+||||+.+|+||+||||
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 888889999999 5688887764 4567899999999999999999999976 89999999999999999999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccC----CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQH----RPYTQKVDVYSFGIVLWELITGLLPFQNM-TAVQAAFAVVNK 352 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~~~~~ 352 (418)
.+....++-..+...|.-.|||||.+.. ..|+.+|||||||+++.||.+++.||+.. ++.+.+.+++.+
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9988776665666788999999999843 37999999999999999999999999764 566666555544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.56 Aligned_cols=245 Identities=28% Similarity=0.501 Sum_probs=211.0
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee-----C
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK-----R 208 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-----~ 208 (418)
+++...||.|.+|.||+++. +++.+|+|++....... +++..|..||+.+ .|||++.+||++.. +
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 45567899999999998864 88999999987654432 4677889999888 69999999999853 5
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
+.++||||||.+||..|+++...+..+.|..+..|+..++.||.+||.+.+||||||-.|||++.++.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 67999999999999999999888889999999999999999999999999999999999999999999999999998765
Q ss_pred ccc-CCCCCCCCCccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCC
Q 014783 289 VQT-EGMTPETGTYRWMAPEMIQHR-----PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPN 360 (418)
Q Consensus 289 ~~~-~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~ 360 (418)
..+ ....+..||+.|||||++... .|+..+|+||||++..||.-|.+|+.++.+...++.+-.. .+|. .|.
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~ 252 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPK 252 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchh
Confidence 443 345667899999999999544 4788999999999999999999999999998877664332 2222 256
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+.++.++|..||..|-++||+..++++
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 78899999999999999999999999886
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=292.56 Aligned_cols=253 Identities=32% Similarity=0.530 Sum_probs=204.7
Q ss_pred ccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC--CCCCeEEEEeEEeeCc-
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFIGACRKRM- 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~~~~~~~~- 209 (418)
+...+++.+.||+|.||.||+|.++++.||||++... -.+.|.+|..|.+.. +|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHH---------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 4556778899999999999999999999999998531 125788888887654 7999999999865444
Q ss_pred ---eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcccCCCCCCcEEEcCCCCE
Q 014783 210 ---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 210 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---------~~iiHrDlkp~NILl~~~~~v 277 (418)
.+.||+||.+.|+|.+||+. ..+++....+++.-++.||+|||+ ..|+|||||++||||.+|+++
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 78999999999999999986 459999999999999999999996 359999999999999999999
Q ss_pred EEeecccceeecccCC---CCCCCCCccccccccccCCC-CC-----CcchHHHHHHHHHHHHhCC------------CC
Q 014783 278 KIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRP-YT-----QKVDVYSFGIVLWELITGL------------LP 336 (418)
Q Consensus 278 kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~t-----~~sDvwSlGv~l~elltg~------------~P 336 (418)
-|+|||+|..+..... .-...||.+|||||++.+.- +. .+.||||+|.+||||++.. .|
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 9999999987654332 23467999999999996542 22 3689999999999999853 23
Q ss_pred CCC-----CCHHHHHHHHHhcCCCCCCCCC-----ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 337 FQN-----MTAVQAAFAVVNKGVRPVIPND-----CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 337 f~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
|+. -+-.+....++.+..||.+|.. ....+.+.+..||..||+-|.|+.=+.+++.++..-
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 331 1122333345667778887754 346788999999999999999999999988887653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=281.41 Aligned_cols=240 Identities=21% Similarity=0.426 Sum_probs=196.9
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
..||+|+|+.|-.+.. +|..||||++.+..... ..+..+|++++.++ .|+||++|+.+|.++...|||||-
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 5799999999998864 89999999997653322 25677999999999 499999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEeecccceeeccc---
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQT--- 291 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~~~~~~--- 291 (418)
|.||+|...+.++ ..+.+..+.++..+|+.||.+||.+||.||||||+|||...-. .||||||.++.-....
T Consensus 158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999999875 4599999999999999999999999999999999999997554 4899999987533211
Q ss_pred -----CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHH
Q 014783 292 -----EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTA--------------VQAAF 347 (418)
Q Consensus 292 -----~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~--------------~~~~~ 347 (418)
....+.+|+..|||||+.. .-.|+.+.|.|||||+||-||+|.+||.+.-. .+.++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1233457889999999873 33589999999999999999999999975331 23445
Q ss_pred HHHhcCCCCCCCC----CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 348 AVVNKGVRPVIPN----DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 348 ~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+|... +|+ ..+.+..+++...+..|+.+|.++.+++.
T Consensus 316 esIQEGkYe-FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQEGKYE-FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHhccCCc-CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 555555432 333 35677889999999999999999988776
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.79 Aligned_cols=236 Identities=32% Similarity=0.532 Sum_probs=201.3
Q ss_pred CceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHH
Q 014783 147 AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224 (418)
Q Consensus 147 ~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~ 224 (418)
+||.||+|++ +++.+|+|++........ .+.+.+|+..+++++|+|++++++.+......++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999998 468999999875443321 367889999999999999999999999989999999999999999
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCcccc
Q 014783 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304 (418)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~ 304 (418)
+++..... ++...++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+.............++..|+
T Consensus 76 ~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 99876432 8899999999999999999999999999999999999999999999999998765544455667889999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--ChHHHHHHHHHhcccCCCCCC
Q 014783 305 APEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND--CLPVLSEIMTRCWDTNPEVRP 382 (418)
Q Consensus 305 aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~RP 382 (418)
|||.+....++.++||||||++++++++|..||.....................+.. ++..+.+++.+||..+|++||
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 999999888999999999999999999999999874444444555554444333322 778999999999999999999
Q ss_pred CHHHHHH
Q 014783 383 PFTEIVR 389 (418)
Q Consensus 383 t~~ell~ 389 (418)
++.++++
T Consensus 234 ~~~~~~~ 240 (244)
T smart00220 234 TAEEALQ 240 (244)
T ss_pred CHHHHhh
Confidence 9999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=282.21 Aligned_cols=249 Identities=22% Similarity=0.405 Sum_probs=206.7
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~ 204 (418)
..|.+...+|.++.+||.|+|.+|.+++. +.+.||+|++++.-.+.... .+-...|..+...- +||.+|.|+.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded---idwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED---IDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc---chhHHhhHHHHHhccCCCeEEehhhh
Confidence 46888999999999999999999999976 67899999997654333211 12334555555544 79999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
|.++..+++|.||++||+|--.++ +++.+|++.+..+..+|+.||.|||+.|||+||||.+|||+|..|++||+|+|.
T Consensus 320 fqtesrlffvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hcccceEEEEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 999999999999999999955554 456799999999999999999999999999999999999999999999999999
Q ss_pred ceeec-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHh-cCCC
Q 014783 285 ARIEV-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ-------NMTAVQAAFAVVN-KGVR 355 (418)
Q Consensus 285 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~-------~~~~~~~~~~~~~-~~~~ 355 (418)
.+... +....++.||||.|.|||++++..|...+|+|+|||+++||+.|+.||+ .++..+.+++++. +.++
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 97543 4445667899999999999999999999999999999999999999994 3455556665544 3333
Q ss_pred CCCCCCChHHHHHHHHHhcccCCCCCCC
Q 014783 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPP 383 (418)
Q Consensus 356 ~~~~~~~~~~l~~li~~cl~~dp~~RPt 383 (418)
+|...+-....+++.-|..||.+|..
T Consensus 478 --iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 56666777788999999999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=296.37 Aligned_cols=245 Identities=26% Similarity=0.368 Sum_probs=197.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
.+.+-|..++.||-|+||+|.+++. +...||+|.+++.+.-. +.+ ....++|..||..-..+=||+||..|.+.+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQ--vaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQ--VAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhh--hhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 3445667778999999999999975 56689999997644322 111 246788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee-
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE- 288 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~- 288 (418)
.+|+||||++||++-.+|-+. +.|++..+..++.++.+|+++.|.+|+|||||||+|||||.+|++||+||||+.-+
T Consensus 703 nLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999999988764 56999999999999999999999999999999999999999999999999998521
Q ss_pred --------cccC-----C-----------------------------CCCCCCCccccccccccCCCCCCcchHHHHHHH
Q 014783 289 --------VQTE-----G-----------------------------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIV 326 (418)
Q Consensus 289 --------~~~~-----~-----------------------------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~ 326 (418)
.++. . .....||+.|+|||++...+|+..+|+||.||+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1000 0 012249999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHHHHHHHhcccCCCCCC
Q 014783 327 LWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRCWDTNPEVRP 382 (418)
Q Consensus 327 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP 382 (418)
||||+.|+.||-..++.+....+++......++ .+++.+..++|.+.+. .++.|.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999998877766665555544444444 3567788888776432 355553
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.31 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=194.4
Q ss_pred cccccccCceeeeCceEEEEEEE---C---CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY---N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~---~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
...|+..+.||+|.||.||++.. + ...+|||.++.......- .....+|+.+++.++|||++.|..++.+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi----S~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI----SMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc----CHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 45678889999999999999953 1 237999998755322211 1345699999999999999999999877
Q ss_pred -CceEEEEEeecCCCCHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC----CCEEE
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKI 279 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~----~~vkl 279 (418)
+..+++++||.+. +|.+.++.+ ..+.++...+..|+.||+.|+.|||++-|+||||||.||||..+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 7889999999976 898888743 23578999999999999999999999999999999999999877 89999
Q ss_pred eecccceeecccC----CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------HH
Q 014783 280 ADFGVARIEVQTE----GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAV---------QA 345 (418)
Q Consensus 280 ~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---------~~ 345 (418)
+|||+|+.+...- ..+....|+.|.|||++.+. .||++.|||++||++.||+|-.+-|.+.... +.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999764321 23455679999999999775 6999999999999999999988877543211 11
Q ss_pred HHHHHh-cCCCC--------CCCC--------------C------------ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 346 AFAVVN-KGVRP--------VIPN--------------D------------CLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 346 ~~~~~~-~~~~~--------~~~~--------------~------------~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+..++. -|.+. ..|+ . -++.-.+|+.++|+.||-+|.|++|.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111 00000 0000 0 12336789999999999999999988764
Q ss_pred H
Q 014783 391 L 391 (418)
Q Consensus 391 L 391 (418)
-
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 3
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=251.34 Aligned_cols=248 Identities=22% Similarity=0.365 Sum_probs=200.8
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
+|...++||+|.||+||+++. +++.||+|.++-......- ....++|+-+++.++|.|||+++++...+..+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv----pssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC----cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 345567899999999999986 6789999999865544321 1456799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-cC
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TE 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~-~~ 292 (418)
|+||| ..+|..|.... ++.+..+.+..++.|++.||.++|++++.||||||.|+||..+|.+|++|||+|+-+.- ..
T Consensus 79 vfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred eHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 99999 45999988754 56688899999999999999999999999999999999999999999999999986532 23
Q ss_pred CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC-------CC--------
Q 014783 293 GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG-------VR-------- 355 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~-------~~-------- 355 (418)
-++....|..|.+|.++.+. -|+...|+||.||++.|+.. |++-|++..-.+.+..+...- ++
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 35566789999999998765 58999999999999999997 999999988777666554210 00
Q ss_pred ---CCCCC---------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ---PVIPN---------DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ---~~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
|..|. .....=++++++.+.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 01111 11122357889999999999999987654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=282.31 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=204.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERP-ENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+-..-.++|-++..||.|+|++||++.+ ..+.||||+-... ....++...+.+...+|..|-+.|.||.||++|+++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3334456788899999999999999976 5678999986533 344456667778889999999999999999999998
Q ss_pred e-eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEcC---CCCEEE
Q 014783 206 R-KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--GFIHRDLKSDNLLISA---DKSIKI 279 (418)
Q Consensus 206 ~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NILl~~---~~~vkl 279 (418)
. +.+.+|-|+|||+|.+|.-||+.. +.+++..+..|+.||+.||.||.+. -|||-||||.|||+-. .|.+||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 6 556789999999999999999764 5699999999999999999999976 5999999999999953 478999
Q ss_pred eecccceeecccCCC--------CCCCCCccccccccccCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 014783 280 ADFGVARIEVQTEGM--------TPETGTYRWMAPEMIQHR----PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF 347 (418)
Q Consensus 280 ~DfGla~~~~~~~~~--------~~~~gt~~y~aPE~~~~~----~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~ 347 (418)
+|||+++++.+.... ....||..|++||++.-. ..+.|+||||+||++|.++.|+.||...-....+.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 999999987543321 234689999999998432 57889999999999999999999997644332211
Q ss_pred H---HHhc-CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 014783 348 A---VVNK-GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV 388 (418)
Q Consensus 348 ~---~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell 388 (418)
+ ++.. ....+..+-++.+...||++||+...++|....||.
T Consensus 695 qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 1111 011122235678899999999999999997776654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=278.49 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=200.1
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC--C----CeEEEEeE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--L----NIVRFIGA 204 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----niv~l~~~ 204 (418)
-..+|.+...+|+|.||.|-.+.+ ++..||||+++.- ..+.+..+-|+.+|+++.+ | -+|++.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 367889999999999999999977 5679999998642 2334567789999999943 2 37788889
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-----------
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA----------- 273 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~----------- 273 (418)
|.-.+++|||+|.+ |-|+++++......+++...+..++.|+++++++||+.+++|.||||+|||+..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999998 679999999877788999999999999999999999999999999999999842
Q ss_pred ---------CCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014783 274 ---------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344 (418)
Q Consensus 274 ---------~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~ 344 (418)
+-.++|+|||.|+...+. .+....|..|.|||++.+-+++.++||||+||+|+|+.||..-|+.-.+.+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 235899999999875443 366678999999999999999999999999999999999999998776555
Q ss_pred HHH--HHHhcCC-----------------CCC-----------------CC--------CCChHHHHHHHHHhcccCCCC
Q 014783 345 AAF--AVVNKGV-----------------RPV-----------------IP--------NDCLPVLSEIMTRCWDTNPEV 380 (418)
Q Consensus 345 ~~~--~~~~~~~-----------------~~~-----------------~~--------~~~~~~l~~li~~cl~~dp~~ 380 (418)
.+. +.+...+ +.. .| ......|.+|+++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 321 1110000 000 00 011235789999999999999
Q ss_pred CCCHHHHHH
Q 014783 381 RPPFTEIVR 389 (418)
Q Consensus 381 RPt~~ell~ 389 (418)
|+|+.|.+.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=270.11 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=196.5
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee---
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--- 207 (418)
..+.|.-..+||+|.||+||+++. +|+.||+|.+-....... .-....+|+.+|..|+|+|++.++.+|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG----fpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC----CcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 345667778999999999999975 677899886643222111 11345699999999999999999998843
Q ss_pred -----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 208 -----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 208 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
...+|+|+++|+. +|.-++... ...++...+.+++.++..||.|+|++.|+|||+||+|+||+.+|.+||+||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3358999999976 888888654 345899999999999999999999999999999999999999999999999
Q ss_pred ccceeeccc-----CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCC
Q 014783 283 GVARIEVQT-----EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN--KGV 354 (418)
Q Consensus 283 Gla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~--~~~ 354 (418)
|+|+.+... ..++....|..|.+||.+.+. .|+++.|||..||++.||+|+.+-+++.+....+..+.. ...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999765432 235566779999999998765 699999999999999999999999988776655443311 111
Q ss_pred CC------------------CCCCC-------------ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 RP------------------VIPND-------------CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ~~------------------~~~~~-------------~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+ ++|.. -.+...+|+.+++..||.+|+++++.+.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 10 01110 1235668999999999999999988764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.40 Aligned_cols=259 Identities=17% Similarity=0.270 Sum_probs=185.2
Q ss_pred ccccccccccCceeeeCceEEEEEEE------------------CCceEEEEEeecCCCChHHH--------HHHHHHHH
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY------------------NGEDVAIKILERPENNPEKA--------QVMEQQFQ 184 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~------------------~~~~vAvK~~~~~~~~~~~~--------~~~~~~~~ 184 (418)
.+..++|.+.++||+|+||.||+|.+ .++.||||.+.......... ....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 44678999999999999999999964 24579999986533211100 00113344
Q ss_pred HHHHHHHhCCCCCe-----EEEEeEEee--------CceEEEEEeecCCCCHHHHHhhhcC-------------------
Q 014783 185 QEVMMLATLKHLNI-----VRFIGACRK--------RMVWCIVTEYAKGGSVRQFLTRRQN------------------- 232 (418)
Q Consensus 185 ~E~~il~~l~hpni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~------------------- 232 (418)
.|+.++.+++|.++ ++++++|.. ....+|||||+.+++|.++++...+
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888876654 567777643 3457899999999999999864211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCC--CCCccccccc
Q 014783 233 ---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAPE 307 (418)
Q Consensus 233 ---~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~--~gt~~y~aPE 307 (418)
..+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++............ .+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12456778899999999999999999999999999999999999999999999754332222222 3478999999
Q ss_pred cccCCC--------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCCHHHHH----------HHHHh-cC
Q 014783 308 MIQHRP--------------------Y--TQKVDVYSFGIVLWELITGLL-PFQNMTAVQAA----------FAVVN-KG 353 (418)
Q Consensus 308 ~~~~~~--------------------~--t~~sDvwSlGv~l~elltg~~-Pf~~~~~~~~~----------~~~~~-~~ 353 (418)
.+.... | ..+.||||+||++++|+++.. ||......... +.... ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 885432 1 234799999999999999875 77543221111 11111 11
Q ss_pred CCCCCCCCChHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 014783 354 VRPVIPNDCLPVLSEIMTRCWDTNP---EVRPPFTEIVR 389 (418)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~ell~ 389 (418)
+........++...+|+.+++..+| .+|+|++|+++
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 2222334567889999999999765 68999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.85 Aligned_cols=250 Identities=16% Similarity=0.181 Sum_probs=168.9
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--C----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--N----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
.+....++|.+.+.||+|+||.||+|++ + +..||||.+....... .+..| .+....+.++..++
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--------~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--------IWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--------HHHHH--HHHhhchhhHHHHH
Confidence 3455678999999999999999999987 4 6799999875422110 11111 11111222222211
Q ss_pred eE------EeeCceEEEEEeecCCCCHHHHHhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 203 GA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNR------------------AVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 203 ~~------~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
.. +.....+++|+||+.+++|.+++...... ......+..++.||+.||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24566789999999999999998753210 1112345678999999999999999
Q ss_pred cccCCCCCCcEEEcC-CCCEEEeecccceeeccc--CCCCCCCCCccccccccccCC----------------------C
Q 014783 259 FIHRDLKSDNLLISA-DKSIKIADFGVARIEVQT--EGMTPETGTYRWMAPEMIQHR----------------------P 313 (418)
Q Consensus 259 iiHrDlkp~NILl~~-~~~vkl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~ 313 (418)
|+||||||+|||++. ++.+||+|||+|+..... .......+++.|+|||.+... .
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 999999999999996 579999999999754322 223445789999999976322 2
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C---------CCCCCC----------CCChHHHHHHHHHh
Q 014783 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-G---------VRPVIP----------NDCLPVLSEIMTRC 373 (418)
Q Consensus 314 ~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-~---------~~~~~~----------~~~~~~l~~li~~c 373 (418)
++.++|||||||+||||+++..|+... .......+.. + ...... ........+|+.+|
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 345679999999999999976665432 1111111111 0 000000 01123455899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 014783 374 WDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 374 l~~dp~~RPt~~ell~~ 390 (418)
|+.||++|||+.|+++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999873
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=252.09 Aligned_cols=246 Identities=18% Similarity=0.384 Sum_probs=198.6
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGAC 205 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~ 205 (418)
+|. ..++|++.+++|.|-+++||.|.. ++++++||++++.. .+.+.+|+.||..|. ||||++|+++.
T Consensus 33 ~wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 33 DWG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred ecc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 344 567899999999999999999984 78899999997521 257889999999997 99999999998
Q ss_pred eeC--ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeec
Q 014783 206 RKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADF 282 (418)
Q Consensus 206 ~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~Df 282 (418)
.+. ....||+||+++.+...+... ++...+..++.+++.||.|+|++||+|||+||.|++||.. ..++|+|+
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred cCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeec
Confidence 653 457899999988777666533 6667788899999999999999999999999999999965 57999999
Q ss_pred ccceeecccCCCCCCCCCcccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH----------
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPF-QNMTAVQAAFAVV---------- 350 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDvwSlGv~l~elltg~~Pf-~~~~~~~~~~~~~---------- 350 (418)
|+|.+..+...++....+..|--||++. .+.|+..-|+|||||+|..|+..+.|| -+.++.+.+..+.
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 9999998888888888889999999985 456899999999999999999988887 3444433332221
Q ss_pred -----------------hcCCCC----CCC----CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 351 -----------------NKGVRP----VIP----NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 351 -----------------~~~~~~----~~~----~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....+. .++ ...+++..+|+.+.|..|..+|||+.|.+.
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 011110 011 124578889999999999999999998765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=292.96 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=196.4
Q ss_pred cCceeeeCce-EEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEEee
Q 014783 140 GTAFAQGAFG-KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 140 ~~~lG~G~fg-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.+.+|.|+-| .||+|.+.|+.||||.+-.. ......+|++.|+.- .|||||++|+.-.++...||+.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE---------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH---------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 4578999987 58999999999999987532 124567999999888 699999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCC---CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---C--CCEEEeecccceeec
Q 014783 218 AKGGSVRQFLTRRQNRAV---PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKIADFGVARIEV 289 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~---~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~--~~vkl~DfGla~~~~ 289 (418)
| ..+|.+++... .... .--..+....|+++||+|||+.+||||||||.||||+. + ..++|+|||+++...
T Consensus 585 C-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 585 C-ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9 56999999863 1111 11335678899999999999999999999999999986 3 368999999998654
Q ss_pred ccC----CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCh
Q 014783 290 QTE----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV-IPNDCL 363 (418)
Q Consensus 290 ~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 363 (418)
... ......||.+|+|||.+....-+.++||||+||++|+.++ |.+||.+.-..+. .++...+... +.+...
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD 740 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence 322 2344579999999999998888889999999999999999 6999987554332 2333333221 111111
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHH------------HHHHhhHHHHhhhhhhc
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIV------------RMLENAETEIMTTVRKA 405 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell------------~~L~~~~~~~~~~~~~~ 405 (418)
.+..+||.+|++.+|..||++.+|+ +.|+++-+.+....|..
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~ 794 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDS 794 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccC
Confidence 1788999999999999999999986 45666666665555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=265.28 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=195.3
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc----
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---- 209 (418)
+++-.+.||.|+||.||..++ +|+.||+|.+-.-..+ -...+.+.+|+++|..++|.|++..+++.....
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~----L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN----LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH----HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 345567999999999999988 7899999987433222 222367779999999999999999988875543
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+|.++|.|. .+|...+-.. ..++.+.+.-+..||+.||+|||+.+|.||||||.|+|+..+..+||||||+|+..
T Consensus 130 qEiYV~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence 3688999984 5787777543 45888889999999999999999999999999999999999999999999999965
Q ss_pred ccc--CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Q 014783 289 VQT--EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN-------------- 351 (418)
Q Consensus 289 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~-------------- 351 (418)
... ..++....|.+|.|||++.+. .|+.+.||||+||++.|++..+.-|+..++.+.+.-+.+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 433 234555678999999999775 699999999999999999999999987777665543322
Q ss_pred ---------cCCCC-CCC--------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 352 ---------KGVRP-VIP--------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 352 ---------~~~~~-~~~--------~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
.+.++ ..+ ..-..+-..++.+++..||++|.+.++.+..+..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11111 111 1112345567888999999999998887766554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=281.73 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=214.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
..+|.+++.+|.|.||.||++++ +++..|+|+++-.....- +-+..|+-+++.++|||||.++|.+.....+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 46788899999999999999987 788999999986544332 3466899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec-c
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-Q 290 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~-~ 290 (418)
+|+||||.+|+|.+..+- .+.+++.++...+.+.+.||+|||++|=+|||||..|||+++.|.+|++|||.+-.+. .
T Consensus 88 wicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999999998653 4678999999999999999999999999999999999999999999999999875432 2
Q ss_pred cCCCCCCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCChH
Q 014783 291 TEGMTPETGTYRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PNDCLP 364 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~---~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 364 (418)
........||++|||||+. +.+.|...+|||++|++..|+..-++|.-...+....+-+-..++.++. +...++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2345667899999999987 4667999999999999999999988998888888888777777776543 345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.|.+|++.|+..+|++||+++.++.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999999987764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=238.40 Aligned_cols=209 Identities=31% Similarity=0.647 Sum_probs=183.2
Q ss_pred eeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
||+|++|.||+++.. ++.+++|++....... ..+.+.+|+..++.+.|++++++++++......++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 689999999999985 8899999987654322 235788999999999999999999999998899999999998
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeecccceeecccC-CCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTE-GMTPET 298 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfGla~~~~~~~-~~~~~~ 298 (418)
++|.+++.... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999987642 45889999999999999999999999999999999999999 8999999999997654322 133355
Q ss_pred CCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccC
Q 014783 299 GTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377 (418)
Q Consensus 299 gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 377 (418)
+...|++||.+... .++.++|+|++|++++++ ..+.+++.+|++.+
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCC
Confidence 78899999999887 888999999999999999 57889999999999
Q ss_pred CCCCCCHHHHHHH
Q 014783 378 PEVRPPFTEIVRM 390 (418)
Q Consensus 378 p~~RPt~~ell~~ 390 (418)
|.+||++.++++.
T Consensus 202 p~~R~~~~~l~~~ 214 (215)
T cd00180 202 PEKRPSAKEILEH 214 (215)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=252.48 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=195.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc---
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 209 (418)
.+|.-++.+|.|+- .|..+-+ .++.||+|.+..+..+... .+...+|..++..+.|+||++++.++....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc----chhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 45556677888887 5555544 6889999998877544322 256779999999999999999999986543
Q ss_pred ---eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 210 ---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 210 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
..|+|||+| ..+|.+.+.. .+.-..+..+..|+++|+.|||+.||+||||||+||++..+..+||.|||+|+
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 469999999 4599888873 36678889999999999999999999999999999999999999999999998
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-------------- 352 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-------------- 352 (418)
.....-..+....|..|.|||++.+-.|...+||||+||++.||++|..-|++..--+.-.++++.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 766555678888999999999999888999999999999999999999998875543322222110
Q ss_pred -------C--------CCCCCC-----------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 -------G--------VRPVIP-----------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 -------~--------~~~~~~-----------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. +...+| ..-....++++.+||-.||++|-+++++++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 000011 112345789999999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=269.36 Aligned_cols=246 Identities=26% Similarity=0.445 Sum_probs=201.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC------CCCeEEEEeEEe
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK------HLNIVRFIGACR 206 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~~~~~ 206 (418)
.+|.+....|+|-|+.|.+|.+ .|..||||++.. .+.|.+.=++|++||++|+ .-|+++|+-.|.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 5677778899999999999987 577999999964 2345567789999999995 348999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeeccc
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGV 284 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfGl 284 (418)
..+++|||+|-+ ..+|.+.|++.. .-.+.+..+..++.|+..||..|...||+|.||||+||||.+. ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999988 679999998754 3467788889999999999999999999999999999999976 4689999999
Q ss_pred ceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------cC
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN-----------KG 353 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~-----------~~ 353 (418)
|....++ ..++...+..|.|||++.+.+|+...|+||+||+||||.||+.-|++.++...+....+ .+
T Consensus 584 A~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 584 ASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 9866543 35666677889999999999999999999999999999999999999887664433211 00
Q ss_pred --------------------------------CCC------------CCCCC---ChHHHHHHHHHhcccCCCCCCCHHH
Q 014783 354 --------------------------------VRP------------VIPND---CLPVLSEIMTRCWDTNPEVRPPFTE 386 (418)
Q Consensus 354 --------------------------------~~~------------~~~~~---~~~~l~~li~~cl~~dp~~RPt~~e 386 (418)
..| .+|.+ ....|.+|+.+||..||++|.|..|
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 000 01111 1245788999999999999999988
Q ss_pred HHH
Q 014783 387 IVR 389 (418)
Q Consensus 387 ll~ 389 (418)
.+.
T Consensus 743 AL~ 745 (752)
T KOG0670|consen 743 ALK 745 (752)
T ss_pred Hhc
Confidence 764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=256.19 Aligned_cols=131 Identities=23% Similarity=0.412 Sum_probs=114.9
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-----C---CCeEEEE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----H---LNIVRFI 202 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---pniv~l~ 202 (418)
...+|.+.++||.|.|++||++.+ +.+.||+|+.+. ++.+.+....|+++|++++ | .+||+|+
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 347899999999999999999987 567899999864 4455577889999999984 2 3799999
Q ss_pred eEEe----eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEE
Q 014783 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLI 271 (418)
Q Consensus 203 ~~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl 271 (418)
+.|. .+.++|+|+|++ |.+|..++.....+.+++..+.+|+.||+.||.|||+. ||||.||||+|||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9985 456899999999 88999999988888899999999999999999999965 99999999999996
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=237.16 Aligned_cols=215 Identities=32% Similarity=0.560 Sum_probs=181.2
Q ss_pred ccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv 214 (418)
|.+.+.||+|++|.||++... ++.+|+|.+...... ...+.+.+|+..+.+++|+|++++++.+......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 345678999999999999883 689999998764433 1236788999999999999999999999988899999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC--
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-- 292 (418)
+|++.+++|.+++..... .+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999999976422 27889999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCccccccccc-cCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCC
Q 014783 293 GMTPETGTYRWMAPEMI-QHRPYTQKVDVYSFGIVLWELITGLLPFQN-MTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~-~~~~~t~~sDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~ 357 (418)
......++..|++||.+ ....++.++|||+||+++++|++|+.||.. .+......+.+..+....
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 23445678899999998 667788899999999999999999999987 566656666666655443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=262.66 Aligned_cols=201 Identities=23% Similarity=0.400 Sum_probs=170.3
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHH----HHHHHHHHHHHHhCC---CCCeEEEEeE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVM----EQQFQQEVMMLATLK---HLNIVRFIGA 204 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~----~~~~~~E~~il~~l~---hpniv~l~~~ 204 (418)
..+|..++.+|+|+||.|++|.+ +...|+||.+.+...-... .+ .-...-|++||..++ |+||++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~Dt--WvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDT--WVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhh--hhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 35688899999999999999988 4568999998653211100 00 012346999999997 9999999999
Q ss_pred EeeCceEEEEEeec-CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 205 CRKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 205 ~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
|.+++.+||+||-- ++-+|++++..+. .+++..+..|+.|++.|+++||+.||||||||-+||.++.+|-+||+|||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 99999999999964 5568999998754 49999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQN 339 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~ 339 (418)
.|... ...+.....||..|.|||++.+..|- ..-|||++|++||.+.....||-+
T Consensus 716 saa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99754 45678889999999999999998874 568999999999999988888853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=235.53 Aligned_cols=256 Identities=31% Similarity=0.553 Sum_probs=218.2
Q ss_pred cccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
|+.+++.+..+|.+...|+.|+|+|+|..+++|++......... .+.|..|.-.|+-+.||||+.+++.|.....+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ri----srdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARI----SRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhh----cchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 67788889999999999999999999999999998765444332 26788898889999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.++..||+.|+|+..++...+-.+...++.+++++++.||+|||+.. |.---|.+..++||++.+.+|+ .+-+++..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee
Confidence 99999999999999999876667788899999999999999999874 3334689999999999887765 22222111
Q ss_pred ccCCCCCCCCCccccccccccCCCCC---CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYT---QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t---~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
+ .....-.+.||+||.++..+-+ .++|+|||++++||+-|...||.+..+.+--..+.-+|++..+|+..+..+
T Consensus 342 q---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 342 Q---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred e---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 1 1122345899999999877544 579999999999999999999999999998888999999999999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
..||.-|+..||.+||.|+.++-.|+++.
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999999998763
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=235.62 Aligned_cols=255 Identities=19% Similarity=0.304 Sum_probs=201.5
Q ss_pred cccccCceeeeCceEEEEEEECC---ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC----CCeEEEEeEE-ee
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYNG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH----LNIVRFIGAC-RK 207 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h----pniv~l~~~~-~~ 207 (418)
+|.+.++||+|+||.||++.... ..+|+|+......... ..+..|..++..+.. +++..+++.. ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 67889999999999999999743 3689998765433221 145678888888863 6899999998 47
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-----CCEEEeec
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADF 282 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-----~~vkl~Df 282 (418)
...-|+||+.+ |.+|.++......+.++..+++.++.|++.+|++||+.|+|||||||.|++++.. ..++|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 77789999988 8899999877666789999999999999999999999999999999999999865 46999999
Q ss_pred ccce--eecccCC---------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 283 GVAR--IEVQTEG---------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 283 Gla~--~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
|+|+ ....... .....||.+|.++.+..+...+.+.|+||++.++.|++.|..||..............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 3221111 1234599999999999999999999999999999999999999977664322222211
Q ss_pred cC--CCCC-CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 352 KG--VRPV-IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 352 ~~--~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.. .... .....+..+..++..+-..+...+|....+...|++....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11 1111 2334567888888888889999999999999998777653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=227.36 Aligned_cols=248 Identities=20% Similarity=0.318 Sum_probs=190.4
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeE-EeeCce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA-CRKRMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~-~~~~~~ 210 (418)
+.|.+.+.||+|.||.+-++.. ..+.+++|.+.++... .++|.+|..---.| .|.||+.-|++ |.+.+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4567788999999999999987 4568999998665332 36788887654445 58999988775 677778
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCEEEeecccceee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIE 288 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~--~~~vkl~DfGla~~~ 288 (418)
+++++||++.|+|..-+.. ..+.+....+++.|+++|+.|+|++++||||||.+||||-. ...|||||||+.+..
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 8999999999999887754 45888889999999999999999999999999999999953 347999999998754
Q ss_pred cccCCCCCCCCCccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCCCCC
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHR-----PYTQKVDVYSFGIVLWELITGLLPFQNM---TAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDvwSlGv~l~elltg~~Pf~~~---~~~~~~~~~~~~~~~~~~~~ 360 (418)
... .....-+..|.|||..... ...+.+|+|.||++++.++||.+||+.. ...-..+.....+..+..|.
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 322 1122345678999987432 3567899999999999999999999743 23333445555666666664
Q ss_pred ---CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 361 ---DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 361 ---~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+++.+..+.++-+..++++|=...+..++....
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 3567888999999999999995555555544443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=218.86 Aligned_cols=164 Identities=24% Similarity=0.340 Sum_probs=132.1
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt 300 (418)
|+|.+++..+ +..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 6899999754 356999999999999999999999998 999999999999999 9999865432 23689
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC------CCCChH--HHHHHHHH
Q 014783 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI------PNDCLP--VLSEIMTR 372 (418)
Q Consensus 301 ~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~--~l~~li~~ 372 (418)
+.|+|||++.+..++.++|||||||++|||++|+.||............+........ +...+. .+.+++.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999999999999999999999999999999999765443322222222222221 112223 58999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 373 CWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
||..+|++||++.|+++.+.....+
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHHHH
Confidence 9999999999999999988877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=274.81 Aligned_cols=192 Identities=18% Similarity=0.230 Sum_probs=141.6
Q ss_pred CCC-CCeEEEEeEE-------eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 014783 193 LKH-LNIVRFIGAC-------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (418)
Q Consensus 193 l~h-pniv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 264 (418)
+.| +||++++++| .....+++++|++ +++|.+++... ...+++..++.++.||+.||+|||++|||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 445 5777777776 2334577889988 66999999753 356899999999999999999999999999999
Q ss_pred CCCcEEEcC-------------------CCCEEEeecccceeecccC-----------------CCCCCCCCcccccccc
Q 014783 265 KSDNLLISA-------------------DKSIKIADFGVARIEVQTE-----------------GMTPETGTYRWMAPEM 308 (418)
Q Consensus 265 kp~NILl~~-------------------~~~vkl~DfGla~~~~~~~-----------------~~~~~~gt~~y~aPE~ 308 (418)
||+||||+. ++.+|++|||+++...... ......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999964 3456666777665321100 0011357889999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 014783 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV 388 (418)
Q Consensus 309 ~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell 388 (418)
+.+..|+.++|||||||+||||++|..|+..... .... +.....+.......+....++.+||+.+|.+||++.|++
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSS-LRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHH-HHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9999999999999999999999999888754321 1111 111122211112234567889999999999999999997
Q ss_pred H
Q 014783 389 R 389 (418)
Q Consensus 389 ~ 389 (418)
+
T Consensus 264 ~ 264 (793)
T PLN00181 264 Q 264 (793)
T ss_pred h
Confidence 5
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=234.62 Aligned_cols=242 Identities=23% Similarity=0.384 Sum_probs=187.5
Q ss_pred ccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
..|....+||+|.|++||++++ ..+.||+|.+...... ..+.+|+++|..+ .+.||+++.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4567788999999999999975 3468999998654433 4577999999999 589999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfGla~~ 287 (418)
+...+|+||++.....+++.. ++...+..++..++.||+++|.+|||||||||.|+|.+. .+.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999999988865 667889999999999999999999999999999999985 57889999999972
Q ss_pred ecc--------c-------------------------CC------------CCCCCCCccccccccccC-CCCCCcchHH
Q 014783 288 EVQ--------T-------------------------EG------------MTPETGTYRWMAPEMIQH-RPYTQKVDVY 321 (418)
Q Consensus 288 ~~~--------~-------------------------~~------------~~~~~gt~~y~aPE~~~~-~~~t~~sDvw 321 (418)
... . .. .....||++|.|||++.. ...+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 100 0 00 011239999999999854 4678999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-------------hcC-------------------CCCC-----------
Q 014783 322 SFGIVLWELITGLLPFQNMTA-VQAAFAVV-------------NKG-------------------VRPV----------- 357 (418)
Q Consensus 322 SlGv~l~elltg~~Pf~~~~~-~~~~~~~~-------------~~~-------------------~~~~----------- 357 (418)
|.||+++-+++++.||-.... ...+.++. ..+ +...
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 999999999999999843211 01010000 000 0000
Q ss_pred -----CC-CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 358 -----IP-NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 358 -----~~-~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. +..+..+.+|+.+|+..||.+|.|+++.+.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 112347899999999999999999999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=214.57 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=205.1
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~ 212 (418)
.|+++++||+|+||+++.|+. +++.||||.--+....+ ++..|....+.| ..++|.+.|.+..++..-.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--------QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcc--------hHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 578999999999999999985 99999999865443332 455777777777 4689999999988888888
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-----CCEEEeeccccee
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADFGVARI 287 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-----~~vkl~DfGla~~ 287 (418)
||+|++ |-||.|++. -.++.|+..++..+|.|++.-++|+|++.+|.|||||+|+||+.- ..+.|+|||+|+.
T Consensus 101 LVidLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 999998 889988875 356789999999999999999999999999999999999999853 3599999999987
Q ss_pred ecccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCC-
Q 014783 288 EVQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ--AAFAVVNKGVRP- 356 (418)
Q Consensus 288 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~--~~~~~~~~~~~~- 356 (418)
+.+... ..+..||.+||+-....+...+...|+-|||-++++.|-|..||++..... ..++.+-+..+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 654332 345679999999999999999999999999999999999999999865322 222233222221
Q ss_pred C---CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 357 V---IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 357 ~---~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
+ +-...|.++..-|+-.-..+-.+-|..+-+...+.++...+
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1 22356778888888777788889999999999988887643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-25 Score=210.51 Aligned_cols=250 Identities=25% Similarity=0.444 Sum_probs=201.6
Q ss_pred ccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEEEEeEEeeCceEEEEE
Q 014783 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-niv~l~~~~~~~~~~~lv~ 215 (418)
|.+.+.||.|+||.||++.+. ..+|+|.+........ .....+.+|+.++..+.|+ +++++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 456778999999999999988 8899999876554432 1236788999999999988 7999999997777789999
Q ss_pred eecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccceeecccC-
Q 014783 216 EYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE- 292 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~~~~~- 292 (418)
+++.++++.+++..... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765322 2688899999999999999999999999999999999999988 79999999997544332
Q ss_pred ------CCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC----
Q 014783 293 ------GMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVRP---- 356 (418)
Q Consensus 293 ------~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~~---- 356 (418)
......|+..|+|||.+.+ ..++...|+||+|++++++++|..||..... .......+.....+
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 2356689999999999987 5788999999999999999999999877663 23333333333322
Q ss_pred CCCCCC----hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 357 VIPNDC----LPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 357 ~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
...... ...+.+++..|+..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 2578899999999999999998877664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=201.59 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=203.6
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC-CCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~ 208 (418)
|-..+|++.++||+|+||.+|.|.. +|+.||||+-+.....+ ++..|..+...|++ ..|..+..+..+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--------qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--------QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--------chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 3456889999999999999999986 89999999976544433 46688888888875 6777777888888
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCEEEeecccc
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVA 285 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~---~~vkl~DfGla 285 (418)
..-.+|||.+ |-+|.+++.- ..+.++..+++-++-|++.-++|+|.+++|||||||+|+|.+-+ ..+.++|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 8889999998 8899888764 34569999999999999999999999999999999999999754 46899999999
Q ss_pred eeecccC--------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCC
Q 014783 286 RIEVQTE--------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ---AAFAVVNKGV 354 (418)
Q Consensus 286 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~---~~~~~~~~~~ 354 (418)
+.+.+.. .....+||.+|.+-.+..+...+...|+-|+|.+|.++.-|..||++..+.. ....+.....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 8654322 1234579999999999988888999999999999999999999999976533 2233333333
Q ss_pred CCCC---CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 355 RPVI---PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 355 ~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
..++ -...|.++.-.+.-|-..--++-|...-|.+.+.-+..
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 2222 23567889999999988888888998877776665544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=221.52 Aligned_cols=166 Identities=17% Similarity=0.217 Sum_probs=126.1
Q ss_pred ccccccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE-EEeEEeeC
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKR 208 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~-l~~~~~~~ 208 (418)
-...|.+.+.||+|+||+||+|.+ +++.||||++........ .....+.+.+|+.+|++++|+|++. ++..
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~-~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS-KPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc-cHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346788999999999999999976 467789998753211000 1122356899999999999999985 5442
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEcCCCCEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl-kp~NILl~~~~~vkl~DfGla~~ 287 (418)
...|+||||++|++|... . .. . ...++.+++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~--~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R--PH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C--cc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 347999999999999632 1 11 1 1457889999999999999999999 99999999999999999999986
Q ss_pred ecccCC---------CCCCCCCccccccccccCC
Q 014783 288 EVQTEG---------MTPETGTYRWMAPEMIQHR 312 (418)
Q Consensus 288 ~~~~~~---------~~~~~gt~~y~aPE~~~~~ 312 (418)
...... .....+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 543221 1334578889999998543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-26 Score=225.03 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=197.2
Q ss_pred ceeeeCceEEEEEE-----ECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEEE
Q 014783 142 AFAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv~ 215 (418)
.+|+|+||.|++++ +.|.-+|+|++++......... ....|..++..++ ||.+|++...+..+..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~----~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT----HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc----ccccHHHHHhhccCCCceeeeeeeeccccchhHhh
Confidence 37899999999764 3567899999876544322211 3446777888886 999999999999999999999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCC
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~ 295 (418)
++..||.|...+.. ...+.+.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++...+....
T Consensus 77 d~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99999999777654 345777777788889999999999999999999999999999999999999999876543322
Q ss_pred CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcc
Q 014783 296 PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375 (418)
Q Consensus 296 ~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 375 (418)
|||..|||||++. ....++|+||||++++||+||..||.. +....+... ....|...+...++++.+++.
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHh
Confidence 9999999999998 578899999999999999999999988 333333332 345677888899999999999
Q ss_pred cCCCCCCCH--HHHHHHHHhh------HHHHhhhhhhccccccC
Q 014783 376 TNPEVRPPF--TEIVRMLENA------ETEIMTTVRKARFRCCM 411 (418)
Q Consensus 376 ~dp~~RPt~--~ell~~L~~~------~~~~~~~~~~~r~~~~~ 411 (418)
.+|..|.-. .-+.+.++.. ++++..+.+...|+...
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 999999654 2333333222 24445555554444433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=194.96 Aligned_cols=176 Identities=12% Similarity=0.163 Sum_probs=135.7
Q ss_pred cccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHH---HHHHHHHHHHHHhCCCCCeEEEEeEEeeC--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~~~~~~~-- 208 (418)
..+|+..+.||.|+||.||+...++..+|||++.......+..... ...+.+|+..+.++.||+|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4678899999999999999987778899999997655443322111 12368999999999999999988875432
Q ss_pred ------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 209 ------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 209 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
...+|||||++|.+|.++.. +++ ....+++.+|..+|+.|++|||++|+||+++.+| ++|+||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988732 333 2456899999999999999999999999999998 999999
Q ss_pred ccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHH
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELI 331 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ell 331 (418)
|............ .......|..++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9886442221111 1334445778999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=223.85 Aligned_cols=249 Identities=21% Similarity=0.295 Sum_probs=184.6
Q ss_pred cccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
.....+|.|++|.|+.... ..+.++.|.........+....+...+..|.-+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3557899999998877654 33334444332110011111222223667888888999999988888777766666669
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC---
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~--- 292 (418)
|||++ +|+.++... ..+....+..++.|++.|++|+|++||.|||||++|+++..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99998 999998753 357778888999999999999999999999999999999999999999999997653322
Q ss_pred --CCCCCCCCccccccccccCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HH-HhcCCCC-----CCCCCC
Q 014783 293 --GMTPETGTYRWMAPEMIQHRPYTQ-KVDVYSFGIVLWELITGLLPFQNMTAVQAAF-AV-VNKGVRP-----VIPNDC 362 (418)
Q Consensus 293 --~~~~~~gt~~y~aPE~~~~~~~t~-~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~-~~-~~~~~~~-----~~~~~~ 362 (418)
.....+|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+..+ .. ....... .+...+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 234467899999999999999886 5899999999999999999996544433221 11 0111111 111235
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+...+.+|.++|++||.+|.|+++|++
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhh
Confidence 667788999999999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=185.15 Aligned_cols=144 Identities=21% Similarity=0.188 Sum_probs=109.4
Q ss_pred cCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHH--------------------HHHHHHHHHHHHHHHHhCCCCCe
Q 014783 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~il~~l~hpni 198 (418)
...||+|+||.||+|.. +|+.||||+++........ .........+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 7899999999764321111 11122344569999999987776
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcEEEcCCCCE
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~NILl~~~~~v 277 (418)
.....+.... .+|||||++++++...... ...+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEecC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 4333222222 3799999988777654322 24688999999999999999999 799999999999999998 5789
Q ss_pred EEeecccceee
Q 014783 278 KIADFGVARIE 288 (418)
Q Consensus 278 kl~DfGla~~~ 288 (418)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=179.58 Aligned_cols=144 Identities=18% Similarity=0.157 Sum_probs=111.2
Q ss_pred cCceeeeCceEEEEEEE-CCceEEEEEeecCCCChH--------------------HHHHHHHHHHHHHHHHHhCCCCCe
Q 014783 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE--------------------KAQVMEQQFQQEVMMLATLKHLNI 198 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~--------------------~~~~~~~~~~~E~~il~~l~hpni 198 (418)
...||+|+||.||+|+. +|+.||||+++....... ........+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 699999999986532111 111112345689999999999987
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCE
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~v 277 (418)
.....+.... .||||||++|+++...... ...++...+..++.|++.+|.++|+ .||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 5443333332 3799999988765443222 2347788899999999999999999 9999999999999999 8999
Q ss_pred EEeecccceee
Q 014783 278 KIADFGVARIE 288 (418)
Q Consensus 278 kl~DfGla~~~ 288 (418)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=189.11 Aligned_cols=234 Identities=20% Similarity=0.320 Sum_probs=148.4
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC----------CCeEEEEe
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH----------LNIVRFIG 203 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h----------pniv~l~~ 203 (418)
.+..+..||.|+++.||.+++ +++.+|||+...+..... . . .+.+++|.-....+.+ -.++-.++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~-~-~-~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA-N-E-YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT-T-H-HHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch-H-H-HHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 456678899999999999999 678999999887663222 1 1 2455566544444322 12222222
Q ss_pred EE---------eeC---c-----eEEEEEeecCCCCHHHHHhh---hcCCC--CCHHHHHHHHHHHHHHHHHHHhCCccc
Q 014783 204 AC---------RKR---M-----VWCIVTEYAKGGSVRQFLTR---RQNRA--VPLKLAVKQALDVARGMAYVHGLGFIH 261 (418)
Q Consensus 204 ~~---------~~~---~-----~~~lv~E~~~~gsL~~~l~~---~~~~~--~~~~~~~~i~~qi~~gL~yLH~~~iiH 261 (418)
.. ... . ..+++|+-+ .++|.+++.. ..... +.......+..|++..+++||+.|++|
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 21 111 1 236788877 5688888653 22221 222334566789999999999999999
Q ss_pred CCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccccC--------CCCCCcchHHHHHHHHHHHHhC
Q 014783 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH--------RPYTQKVDVYSFGIVLWELITG 333 (418)
Q Consensus 262 rDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDvwSlGv~l~elltg 333 (418)
+||+|+|++++.+|.++|+||+........ ......+..|.+||.... -.++.+.|.|+||+++|.|+++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999999877643322 121345578999997743 2478899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCC
Q 014783 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381 (418)
Q Consensus 334 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 381 (418)
+.||........... .-.... ..|+.++.||..+|+.||++|
T Consensus 247 ~lPf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986644221110 111233 667899999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=186.79 Aligned_cols=256 Identities=22% Similarity=0.356 Sum_probs=176.8
Q ss_pred ccccccccccCceeeeCceEEEEEEEC--C-----------------------------------ceEEEEEeecCCCCh
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----------------------------------EDVAIKILERPENNP 173 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~-----------------------------------~~vAvK~~~~~~~~~ 173 (418)
.+..++|+++..||+|.-..||.++.. | -+.|||.+-.-....
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 355678999999999999999987531 0 025666654333222
Q ss_pred HHHHHHHHHHHHHHH------HH-----------H----h-CCCCCeEEEEeEEee------------------------
Q 014783 174 EKAQVMEQQFQQEVM------ML-----------A----T-LKHLNIVRFIGACRK------------------------ 207 (418)
Q Consensus 174 ~~~~~~~~~~~~E~~------il-----------~----~-l~hpniv~l~~~~~~------------------------ 207 (418)
.....+ +.+-+|.. ++ + + -+|||||++.++|.+
T Consensus 233 ~~~~iL-~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 233 GDAHIL-KSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred chHHHH-HHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 222221 22222221 11 1 1 259999999876532
Q ss_pred ---CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--CCC--CEEEe
Q 014783 208 ---RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIKIA 280 (418)
Q Consensus 208 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~--~~~--~vkl~ 280 (418)
...+|+||.... .+|.+|+-.+ ..+.....-++.|+++|+.|||++||.|||+|++||||. +|+ .+.|+
T Consensus 312 ~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 336899999884 5999999753 366677788999999999999999999999999999985 343 47899
Q ss_pred ecccceeeccc-------CCCCCCCCCccccccccccCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 014783 281 DFGVARIEVQT-------EGMTPETGTYRWMAPEMIQHRP------YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF 347 (418)
Q Consensus 281 DfGla~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~------~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~ 347 (418)
|||.+--.... ...-...|...-||||+....+ --.|+|.|+.|.+.||+++...||-+....-.-.
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 99976321110 0011234778899999985432 1148999999999999999999996633211111
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
....+..-|.+|..|++.+++++...|+.||.+|++..-....|
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 12334445678889999999999999999999999865444433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=175.60 Aligned_cols=185 Identities=16% Similarity=0.103 Sum_probs=138.2
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEEEeec
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
...|+.|+||+||.+...+.+++.+.+.....-.. ......+.+|+++|++|. |+++++++++ ...+++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~--~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR--GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhh--hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 46799999999998888888998877754332111 111235789999999995 5889999886 3358999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEcCCCCEEEeecccceeecccCCC---
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARIEVQTEGM--- 294 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl-kp~NILl~~~~~vkl~DfGla~~~~~~~~~--- 294 (418)
.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 81 ~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 81 AGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred cCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 99998654321 1 1346789999999999999999999 799999999999999999999854432210
Q ss_pred -----------CCCCCCccccccccccCC-CCC-CcchHHHHHHHHHHHHhCCCCCCC
Q 014783 295 -----------TPETGTYRWMAPEMIQHR-PYT-QKVDVYSFGIVLWELITGLLPFQN 339 (418)
Q Consensus 295 -----------~~~~gt~~y~aPE~~~~~-~~t-~~sDvwSlGv~l~elltg~~Pf~~ 339 (418)
--...++.|++|+....- ..+ ...++++.|+-+|.++|++.|..+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 001256778888765332 223 567999999999999998888644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-23 Score=212.21 Aligned_cols=245 Identities=20% Similarity=0.259 Sum_probs=175.2
Q ss_pred cccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
++...+.||.+.|=+|.+|+++.-.|+||++.+....-. -....+++ .|++ ....+|||.+.+.-+-..+..-|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~s-L~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTIS-LRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCC-chHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 456678899999999999998666699999876543211 11122222 3444 55568999999988777777778999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee--cc--c
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE--VQ--T 291 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~--~~--~ 291 (418)
+|..+ +|.|.+..++- +.+-....|+.|++.||..+|+.||+|+|||.+||||+.-+-+.|+||..-+.. .+ .
T Consensus 101 qyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99855 99998876432 555666788999999999999999999999999999999999999999765421 11 1
Q ss_pred CCC----CCCCCCccccccccccCC----------C-CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC-C
Q 014783 292 EGM----TPETGTYRWMAPEMIQHR----------P-YTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG-V 354 (418)
Q Consensus 292 ~~~----~~~~gt~~y~aPE~~~~~----------~-~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~-~ 354 (418)
..+ ++..--.+|.|||.+... . .+++-||||+||+++||++ |++||.-.. +.+.-..+ .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCcc
Confidence 111 112223679999998431 2 6789999999999999998 899985211 11100000 0
Q ss_pred CC--CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 355 RP--VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 355 ~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.+ .+..-....+++++..|++.||.+|.++++.++.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 0000012368999999999999999999999886
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=196.49 Aligned_cols=206 Identities=31% Similarity=0.526 Sum_probs=163.4
Q ss_pred HHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCc
Q 014783 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-IHRDLKSDN 268 (418)
Q Consensus 190 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i-iHrDlkp~N 268 (418)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... .-.+++.....++.+|+.||.|||...| .|+-|++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35689999999999999999999999999999999999863 3457777778889999999999998866 999999999
Q ss_pred EEEcCCCCEEEeecccceeeccc---CCCCCCCCCccccccccccCC-------CCCCcchHHHHHHHHHHHHhCCCCCC
Q 014783 269 LLISADKSIKIADFGVARIEVQT---EGMTPETGTYRWMAPEMIQHR-------PYTQKVDVYSFGIVLWELITGLLPFQ 338 (418)
Q Consensus 269 ILl~~~~~vkl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------~~t~~sDvwSlGv~l~elltg~~Pf~ 338 (418)
++++....+||+|||+....... .......-..-|.|||.+... ..+.+.||||||++++|+++...||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998765421 111112234679999999763 14778999999999999999999997
Q ss_pred CCC----HHHHHHHHHhcC---CCCCCCC--CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 339 NMT----AVQAAFAVVNKG---VRPVIPN--DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 339 ~~~----~~~~~~~~~~~~---~~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
... +.+....+...+ ++|.+.. +.++.+..++.+||..+|..||+++++...++.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 632 223333322213 3333331 455678999999999999999999999988887765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-20 Score=170.99 Aligned_cols=140 Identities=19% Similarity=0.346 Sum_probs=115.7
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChH--HHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+.||+|++|.||+|.+.|..|+||+......... ........+.+|+.++..+.|+++.....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998754332211 11222356789999999999999887776766667788999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+|++|.+++.... . ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986421 1 6788999999999999999999999999999999 88999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=198.08 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=185.5
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC---CCCeEEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRF 201 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l 201 (418)
...+.++..+.|.+.+.||+|+||.||+|.. +|+.||||+-+++.. - +|.-=.+++.+|+ -+.|..+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-W--------EfYI~~q~~~RLk~~~~~~~~~~ 759 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-W--------EFYICLQVMERLKPQMLPSIMHI 759 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-e--------eeeehHHHHHhhchhhhcchHHH
Confidence 3455667788999999999999999999986 789999999765432 1 1112234455555 1223333
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-------C
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-------D 274 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-------~ 274 (418)
..+..-.+.-+||+||.+-|+|.+++. ..+.+++.....++.|++..+++||.++|||+||||+|+||.. .
T Consensus 760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 760 SSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred HHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcc
Confidence 333333444579999999999999997 4567899999999999999999999999999999999999953 3
Q ss_pred CCEEEeeccccee---ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 275 KSIKIADFGVARI---EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 275 ~~vkl~DfGla~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
.-++|+|||-+-. +.+.......++|-.+-.+|...+.+++...|.|.|+.+++-||.|+.- + +.
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q-~~ 905 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------E-VK 905 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------H-hc
Confidence 3599999998853 3344445667789999999999999999999999999999999998531 1 22
Q ss_pred cCCCCC----CCCCCh-HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhh
Q 014783 352 KGVRPV----IPNDCL-PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTV 402 (418)
Q Consensus 352 ~~~~~~----~~~~~~-~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~ 402 (418)
.+..-. ++.... +...+|+..+|..|-..=|...+|...|+....+.....
T Consensus 906 ~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~ 961 (974)
T KOG1166|consen 906 NGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGL 961 (974)
T ss_pred CCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHH
Confidence 221111 121111 234567777777554445888888888888877665533
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=168.97 Aligned_cols=134 Identities=16% Similarity=0.245 Sum_probs=103.0
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-----CCCCeEEEEeEEeeCc---e-
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-----KHLNIVRFIGACRKRM---V- 210 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~~~---~- 210 (418)
.+.||+|+||.||.-..++.. +||++....... .+.+.+|+.+++.+ .||||+++++++.++. .
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 367999999999963224444 699886533221 24688999999999 5799999999998763 3
Q ss_pred EEEEEee--cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCcEEEcCC----CCEEEeecc
Q 014783 211 WCIVTEY--AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM-AYVHGLGFIHRDLKSDNLLISAD----KSIKIADFG 283 (418)
Q Consensus 211 ~~lv~E~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL-~yLH~~~iiHrDlkp~NILl~~~----~~vkl~DfG 283 (418)
+.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5579999999652 35555 35677888777 99999999999999999999743 379999954
Q ss_pred cc
Q 014783 284 VA 285 (418)
Q Consensus 284 la 285 (418)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=197.88 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=153.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|..++.|..|+||.||..++ +.+.+|+|+=++. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------------lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------------LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc------------hhhhc--cccccCCccee-------------
Confidence 5778889999999999999976 4678999652211 11111 22223334333
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
|+-...++.. +.++.+ ++.+++|||+.||+|||+||+|.||..-|++|+.|||+++.....
T Consensus 136 --------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4554555432 234433 277899999999999999999999999999999999998742111
Q ss_pred ---------------CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-
Q 014783 292 ---------------EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR- 355 (418)
Q Consensus 292 ---------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~- 355 (418)
-.....+||+.|.|||++..++|...+|||++|+++||.+-|..||.+.++++.+-.++.....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0123458999999999999999999999999999999999999999999998877766654322
Q ss_pred CCCCCCChHHHHHHHHHhcccCCCCCC
Q 014783 356 PVIPNDCLPVLSEIMTRCWDTNPEVRP 382 (418)
Q Consensus 356 ~~~~~~~~~~l~~li~~cl~~dp~~RP 382 (418)
++-.+..+++.++++.+.|+.+|..|-
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 333455778999999999999999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=165.05 Aligned_cols=136 Identities=19% Similarity=0.316 Sum_probs=108.9
Q ss_pred ceeeeCceEEEEEEECCceEEEEEeecCCCCh--HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecC
Q 014783 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNP--EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 219 (418)
.||+|+||.||+|.+++..|++|+........ .........+.+|+.++..+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999999999999975433211 1122223667899999999998875544444445556689999999
Q ss_pred CCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999875421 0 7889999999999999999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-20 Score=168.71 Aligned_cols=145 Identities=18% Similarity=0.221 Sum_probs=111.4
Q ss_pred cccccCceeeeCceEEEEEE-E--CCceEEEEEeecCCCCh------------------HHHHHHHHHHHHHHHHHHhCC
Q 014783 136 KLNMGTAFAQGAFGKLYRGT-Y--NGEDVAIKILERPENNP------------------EKAQVMEQQFQQEVMMLATLK 194 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~-~--~~~~vAvK~~~~~~~~~------------------~~~~~~~~~~~~E~~il~~l~ 194 (418)
-|.+.+.||+|+||.||+|. . +|+.||||++....... .........+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 2 78999999997543210 011122345678999999997
Q ss_pred CC--CeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEE
Q 014783 195 HL--NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLI 271 (418)
Q Consensus 195 hp--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NILl 271 (418)
+. .+.++++. . ..++||||+.|.+|...... ........+..++.||+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455543 1 24899999999888765432 223555667889999999999999999 9999999999999
Q ss_pred cCCCCEEEeeccccee
Q 014783 272 SADKSIKIADFGVARI 287 (418)
Q Consensus 272 ~~~~~vkl~DfGla~~ 287 (418)
+ ++.++|+|||.+..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=186.23 Aligned_cols=139 Identities=21% Similarity=0.303 Sum_probs=114.0
Q ss_pred cccCceeeeCceEEEEEEECCceEEEEEeecCCC-Ch-HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEE
Q 014783 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN-NP-EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~-~~-~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~ 215 (418)
...+.||+|+||.||+|.+.+..+++|+...... .. .......+.+.+|+.+++.++|++++....++......++||
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 4578999999999999999877777776433221 11 112223467889999999999999998877777766778999
Q ss_pred eecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999885 246788999999999999999999999999999 678999999999974
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=183.15 Aligned_cols=169 Identities=30% Similarity=0.528 Sum_probs=133.5
Q ss_pred eEEEEEeecCCCCHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 VWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+||.|++|...+|.+++.. ......++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 57999999999999999974 344567888899999999999999 99999999999999999999999999998765
Q ss_pred cccC-------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCC
Q 014783 289 VQTE-------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPN 360 (418)
Q Consensus 289 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~ 360 (418)
.... ..+...||..||+||.+.++.|+.|+||||||++|+|++. +|............+..+.-| ....
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~ 483 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQ 483 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhh
Confidence 5444 4566779999999999999999999999999999999996 222222222222333333333 2222
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFT 385 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ 385 (418)
+. +.-+.|+.+++.+.|.+||++.
T Consensus 484 d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 484 DY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred cC-cHHHHHHHHhcCCCcccCchHH
Confidence 22 3447899999999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-19 Score=158.03 Aligned_cols=139 Identities=20% Similarity=0.212 Sum_probs=107.1
Q ss_pred ccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHH----------------HHHHHHHHHHHHHHHhCCCC--C
Q 014783 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------QVMEQQFQQEVMMLATLKHL--N 197 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~----------------~~~~~~~~~E~~il~~l~hp--n 197 (418)
|.+.+.||+|+||.||++.. +|+.||||++.......... ......+.+|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 45668899999999999987 78999999976543111100 01123467889999999877 4
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCE
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~v 277 (418)
++..++. ...++||||++|++|.+.... .....++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 4445442 334899999999998765421 2356788899999999999999999999999999999999
Q ss_pred EEeeccccee
Q 014783 278 KIADFGVARI 287 (418)
Q Consensus 278 kl~DfGla~~ 287 (418)
+|+|||.+..
T Consensus 165 ~liDfg~~~~ 174 (198)
T cd05144 165 YIIDWPQMVS 174 (198)
T ss_pred EEEECCcccc
Confidence 9999999954
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=147.27 Aligned_cols=140 Identities=21% Similarity=0.220 Sum_probs=98.6
Q ss_pred cCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHH------------------HHHHHHHHHHHHhCCCCC--e
Q 014783 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVM------------------EQQFQQEVMMLATLKHLN--I 198 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~------------------~~~~~~E~~il~~l~hpn--i 198 (418)
++.||+|+||.||++.. +++.||||++............. ......|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999987 48899999987543322111100 011235666666665433 4
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHH-HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCC
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKS 276 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~ 276 (418)
.+.++.. ..++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4454432 3489999999854321 111110 11 5578899999999999999 9999999999999999 999
Q ss_pred EEEeecccceee
Q 014783 277 IKIADFGVARIE 288 (418)
Q Consensus 277 vkl~DfGla~~~ 288 (418)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-17 Score=150.97 Aligned_cols=140 Identities=19% Similarity=0.197 Sum_probs=107.4
Q ss_pred Ccee-eeCceEEEEEEECCceEEEEEeecCCCCh-----H--HHHHHHHHHHHHHHHHHhCCCCCe--EEEEeEEeeCc-
Q 014783 141 TAFA-QGAFGKLYRGTYNGEDVAIKILERPENNP-----E--KAQVMEQQFQQEVMMLATLKHLNI--VRFIGACRKRM- 209 (418)
Q Consensus 141 ~~lG-~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~-----~--~~~~~~~~~~~E~~il~~l~hpni--v~l~~~~~~~~- 209 (418)
..|| .|+.|+||.+...+..++||.+.++..-. . ........+.+|+.++..+.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 89999999999889999999886533100 0 000122567899999999998875 67777654322
Q ss_pred e---EEEEEeecCC-CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 210 V---WCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 210 ~---~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
. .++|||+++| .+|.+++.. ..++... +.+|+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2599999997 689888754 2355443 568999999999999999999999999999999999999998
Q ss_pred ee
Q 014783 286 RI 287 (418)
Q Consensus 286 ~~ 287 (418)
+.
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=136.01 Aligned_cols=131 Identities=21% Similarity=0.266 Sum_probs=111.1
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEEEEeEEeeCceEEEEEee
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~~~~lv~E~ 217 (418)
.+.||+|.++.||+++..+..+++|....... ...+.+|..++..++| .++++++.+....+..++++||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46799999999999999888999999865432 1467789999999976 5899999988877788999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+.++.+..+ +......++.+++.+|++||.. +++|+||+|+|||++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988877554 3455667889999999999985 799999999999999989999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-18 Score=180.57 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=191.0
Q ss_pred ccccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~ 210 (418)
..|++.+.||+|+|+.|-.... ....+|+|.+........ .......|..+-+.+. |+|++.+++.......
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~----~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSED----SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccc----hhhhcCccccccccccccccccccCCccCCCcc
Confidence 4566777899999999987755 334677777765542221 1134456777777886 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCCC-CEEEeecccceee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADK-SIKIADFGVARIE 288 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~ 288 (418)
.++++++..|+++.+.+........+...+-.++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999999988883222225666778889999999999999 99999999999999999999 9999999999865
Q ss_pred cc-cC---CCCCCCC-CccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcC-C-CCCCC
Q 014783 289 VQ-TE---GMTPETG-TYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA-VVNKG-V-RPVIP 359 (418)
Q Consensus 289 ~~-~~---~~~~~~g-t~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~-~~~~~-~-~~~~~ 359 (418)
.. .. .....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||........... ..... . .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 54 22 1234568 9999999999885 446789999999999999999999976444332211 11111 1 12223
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
........+++.+++..+|..|.+.+++..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccc
Confidence 345677888999999999999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=145.87 Aligned_cols=145 Identities=20% Similarity=0.260 Sum_probs=98.9
Q ss_pred CceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHH----------------------------HHH------HHHHHH
Q 014783 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QVM------EQQFQQ 185 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~----------------------------~~~------~~~~~~ 185 (418)
+.||.|++|+||+|+. +|+.||||+.++.....-.. ... +-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 89999999986432111000 000 113556
Q ss_pred HHHHHHhCC----CCCeEEEEeEE-eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 014783 186 EVMMLATLK----HLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR-GMAYVHGLGF 259 (418)
Q Consensus 186 E~~il~~l~----hpniv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~-gL~yLH~~~i 259 (418)
|+..+.+++ |.+-+.+-.++ .-....+|||||++|++|.++...... ... ...++.+++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666652 33223322222 112335899999999999988754221 122 2345555555 4788999999
Q ss_pred ccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 260 IHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 260 iHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
+|+|+||.||+++.++.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-15 Score=149.51 Aligned_cols=246 Identities=20% Similarity=0.274 Sum_probs=183.8
Q ss_pred cccccccCceee--eCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 134 LRKLNMGTAFAQ--GAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 134 ~~~~~~~~~lG~--G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
...+.+.+.+|. |.+|.||.++. ++..+|+|.-+.+...+... ..=.+|+..-.++ .|+|.++.+..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~----~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS----KRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc----ccccchhhcccccCccccccccCcccc
Confidence 345667788999 99999998865 56789999865444322111 1223566555556 4999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCcEEEcCC-CCEEEee
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISAD-KSIKIAD 281 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~----gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~D 281 (418)
..+.+++-+|++ +.+|.++.... ...++...++....+... ||.++|+.+++|-|+||.||+...+ ..++++|
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 999999999999 57998888753 455888889999999999 9999999999999999999999999 8899999
Q ss_pred cccceeecccCCCC------CCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCC
Q 014783 282 FGVARIEVQTEGMT------PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM-TAVQAAFAVVNKGV 354 (418)
Q Consensus 282 fGla~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~~~~~~~ 354 (418)
||+.....+..-.. ...|...|++||..++- ++.++|++++|.++.+..++..+.... +. .|..+..++
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---~W~~~r~~~ 342 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNS---SWSQLRQGY 342 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCC---Ccccccccc
Confidence 99987665443211 12577899999998764 789999999999999999876655332 11 122223332
Q ss_pred CC-CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 RP-VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+ ..-...+.++...+.++++.+|..|++++.+..
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 111223456777899999999999999876653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.1e-13 Score=138.76 Aligned_cols=150 Identities=18% Similarity=0.243 Sum_probs=92.7
Q ss_pred ccccccCceeeeCceEEEEEEE-C-CceEEEEEeecCCCCh----------------------------HHHHHHH----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY-N-GEDVAIKILERPENNP----------------------------EKAQVME---- 180 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~-~-~~~vAvK~~~~~~~~~----------------------------~~~~~~~---- 180 (418)
.+|.. +.||+|++|+||+|+. + |+.||||++++.-... +-.....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45555 7899999999999997 4 8999999997542110 0000111
Q ss_pred --HHHHHHHHHHHhCC----CCCeEEEEeEEee-CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 014783 181 --QQFQQEVMMLATLK----HLNIVRFIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (418)
Q Consensus 181 --~~~~~E~~il~~l~----hpniv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (418)
-.+.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+++.++-.-.. .......+..... ..-+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v--~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGV--EVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHH--HHHHHH
Confidence 22445555555542 4333332222221 233479999999999987532111 1122222211111 112334
Q ss_pred HHhCCcccCCCCCCcEEEcCCC----CEEEeecccceee
Q 014783 254 VHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (418)
Q Consensus 254 LH~~~iiHrDlkp~NILl~~~~----~vkl~DfGla~~~ 288 (418)
+...|++|+|+||.||+++.++ .++++|||++...
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 4579999999999999999988 9999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-13 Score=120.99 Aligned_cols=126 Identities=16% Similarity=0.171 Sum_probs=94.7
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCceEEEEEeecC
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAK 219 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~lv~E~~~ 219 (418)
+.|+.|.++.||+++..+..|++|+........ ..+.+|+.+++.+.+.++ .+++..... ..++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~-------~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELL-------INRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccc-------cCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 468899999999999999999999975432111 234578888888865444 455554432 2479999999
Q ss_pred CCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-----IHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i-----iHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
|.++.+. . . ....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887543 0 1 112346789999999999885 9999999999999 6789999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.3e-12 Score=111.25 Aligned_cols=137 Identities=23% Similarity=0.304 Sum_probs=101.9
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeec-CCCChH-HHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILER-PENNPE-KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~-~~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
..+++|+-+.+|.+.+-|.++.+|.-.+ ....++ ........-.+|+.++.+++--.|...+=+..+.....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578999999999988887777775432 222222 23334567789999999987555544333334444557999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+|..|.+++... ...++..+-.-+.-||..||||+||.++||+++.++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998764 134566677778889999999999999999998665 99999999974
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.3e-12 Score=113.66 Aligned_cols=140 Identities=14% Similarity=0.148 Sum_probs=99.9
Q ss_pred cCceeeeCceEEEEEEEC--------CceEEEEEeecCCCC--------------------hHHHHHHHHHHHHHHHHHH
Q 014783 140 GTAFAQGAFGKLYRGTYN--------GEDVAIKILERPENN--------------------PEKAQVMEQQFQQEVMMLA 191 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~--------~~~vAvK~~~~~~~~--------------------~~~~~~~~~~~~~E~~il~ 191 (418)
...||.|--+.||.|... +..+|||+.+..... ............+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999999753 369999988632210 1112222334458999999
Q ss_pred hCCC--CCeEEEEeEEeeCceEEEEEeecCCCCHHH-HHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCC
Q 014783 192 TLKH--LNIVRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSD 267 (418)
Q Consensus 192 ~l~h--pniv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~ 267 (418)
++.. -++.+++++ ..-+|||||+.+..+.. .++. ..++...+..+..+++.+|..| |+.||||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9954 456667764 23479999996643322 2222 2345556677889999999999 8999999999999
Q ss_pred cEEEcCCCCEEEeeccccee
Q 014783 268 NLLISADKSIKIADFGVARI 287 (418)
Q Consensus 268 NILl~~~~~vkl~DfGla~~ 287 (418)
|||++ ++.++|+|||.+-.
T Consensus 155 NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HEEEE-CCcEEEEECCCcee
Confidence 99997 57899999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.1e-14 Score=147.83 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=184.4
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
+.+....+.+.+.+-.|+++.++..+- .|...++|+........... .+....+-.++-..++|-++.....+..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~---~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND---YESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc---ccccCCccCccccCCCCceecccCCCCC
Confidence 455667778888899999999998764 34444555443221111000 0223344444444567878877776667
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
....+|+++|..+++|...++... ..+.+-+......+..+++|||...++|||++|.|+|+..+++.+++|||....
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccc
Confidence 778899999999999998887643 355555666777888999999999999999999999999999999999984332
Q ss_pred eccc--------------------------------CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 014783 288 EVQT--------------------------------EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335 (418)
Q Consensus 288 ~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~ 335 (418)
.... .......||+.|.|||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1000 00112348999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCC-CCCCCCChHHHHHHHHHhcccCCCCCCCHH
Q 014783 336 PFQNMTAVQAAFAVVNKGVR-PVIPNDCLPVLSEIMTRCWDTNPEVRPPFT 385 (418)
Q Consensus 336 Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 385 (418)
||....+......+...... +.-+...++..++++...+..+|.+|..+.
T Consensus 1034 p~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99998887766555444333 233456778899999999999999997664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=137.61 Aligned_cols=248 Identities=20% Similarity=0.212 Sum_probs=180.7
Q ss_pred ccccccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
...+|..+..||.|.|+.|+.... ++..|++|.+.+........ ..-..|+.+...+ -|.+++.++..|..-
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----IFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 445788889999999999998765 46789999887654443221 1233566555555 588999999988888
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfGla~~ 287 (418)
...||-.|||+++++...+... ..+.+...+++..|++.++.++|++.++|+|++|+||++..+ +..++.|||.+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 8889999999999987666332 236777789999999999999999999999999999999986 7889999998864
Q ss_pred ecccCCCCCCCCCccc-cccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 288 EVQTEGMTPETGTYRW-MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
..-.. .....++..| .+|++.....+..+.|++|||..+.+.+++..--.... .+..+..+..+..+.. ...+
T Consensus 417 ~~~~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~-~~~~ 490 (524)
T KOG0601|consen 417 LAFSS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGL-KLQL 490 (524)
T ss_pred cceec-ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCch-HHhh
Confidence 21111 1111223344 35666667788899999999999999998754222211 1222334444444433 3788
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
..+.+.+...++..||.+.++.....
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccch
Confidence 88999999999999999987765443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4e-12 Score=109.24 Aligned_cols=149 Identities=22% Similarity=0.281 Sum_probs=109.9
Q ss_pred ccCceeeeCceEEEEEEECCceEEEEEeec-CCCCh-HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILER-PENNP-EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~-~~~~~-~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
.+..|-||+-+.|+++.+.|+...||.--. ....+ -..+...++.++|+.+|.+++--.|.-.-=++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 346788999999999999999988885322 22222 2334456788899999999864444332223333333468899
Q ss_pred ecCC-CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEeeccccee
Q 014783 217 YAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARI 287 (418)
Q Consensus 217 ~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~~ 287 (418)
|++| .++.+++...............++.+|-+.+.-||..+|||+||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9966 4888998876555454455578888999999999999999999999999997665 468999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-11 Score=124.21 Aligned_cols=162 Identities=16% Similarity=0.284 Sum_probs=124.6
Q ss_pred CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCC
Q 014783 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236 (418)
Q Consensus 157 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~ 236 (418)
++.+|.|.+.+.... +. .....+-++-|+.++||||++++..+.+.+.+|||+|.+ ..|..++++..
T Consensus 36 ~~~~vsVF~~~~~~~--~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----- 102 (690)
T ss_pred cCCceEEEEEeCCCc--hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----
Confidence 677888888876544 11 134667788899999999999999999999999999998 57888887632
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC-CCCCCCCccccccccccCCCC
Q 014783 237 LKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAPEMIQHRPY 314 (418)
Q Consensus 237 ~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 314 (418)
......-+.||+.||.+|| +.+++|++|.-+.|+|+..|..||.+|.++........ .....--..|..|+.+....
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 4556667889999999998 66899999999999999999999999998864332221 11111123456666654332
Q ss_pred CCcchHHHHHHHHHHHHhC
Q 014783 315 TQKVDVYSFGIVLWELITG 333 (418)
Q Consensus 315 t~~sDvwSlGv~l~elltg 333 (418)
-..|.|.||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999988
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.2e-13 Score=123.66 Aligned_cols=195 Identities=25% Similarity=0.331 Sum_probs=138.2
Q ss_pred HHhCCCCCeEEEEeEEeeC-----ceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Q 014783 190 LATLKHLNIVRFIGACRKR-----MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGL--GFI 260 (418)
Q Consensus 190 l~~l~hpniv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~--~ii 260 (418)
|-.+.|.|||+++.++.+. ....+++|||..|+|..+|++. .+..+....+.+|+-||+.||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455799999999998543 3577899999999999999863 345678888999999999999999987 599
Q ss_pred cCCCCCCcEEEcCCCCEEEeeccccee-----ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCC
Q 014783 261 HRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL 335 (418)
Q Consensus 261 HrDlkp~NILl~~~~~vkl~DfGla~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~ 335 (418)
|+.+.-+-|++..+|-+|+.--..... ...........+.++|.|||.=..-..+.++|||+||...+||.-+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999999999999888753221110 001111223346789999998766667789999999999999987654
Q ss_pred CCCC-CCHHHHHH--HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 336 PFQN-MTAVQAAF--AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 336 Pf~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
--.. .+..+... +...-+... ..=++++.+|++..|..||++.+++...
T Consensus 281 q~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred ccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 3222 11111111 111111111 1124679999999999999999987643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.6e-11 Score=115.19 Aligned_cols=253 Identities=18% Similarity=0.297 Sum_probs=169.2
Q ss_pred cccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEE--------EEeEEeeC
Q 014783 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR--------FIGACRKR 208 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~--------l~~~~~~~ 208 (418)
..+..||+|+-+.+|..---+ ..+.|+...+...... .-+..|... .||-+-. |+|- ..+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~a---------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQA---------QKVAELAATPDAPLLNYRVAWPQATLHGG-RRG 82 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCchHHH---------HHHHHhccCCCCcchhhhhcccHHHhhCC-Ccc
Confidence 456789999999999542211 2345777665433211 111222222 4553322 1111 122
Q ss_pred ceEEEEEeecCCCC-HHHHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 209 MVWCIVTEYAKGGS-VRQFLTR----RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 209 ~~~~lv~E~~~~gs-L~~~l~~----~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
..+.+.|..+.+.. +..++.- ..-....++.+++.+..++.+.+-||+.|.+-+|+.++|+||++++.|.|.|-.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 33677888876642 3333321 112346688899999999999999999999999999999999999999999865
Q ss_pred cceeecccCCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC-------HHHHHHHH-
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELIT-GLLPFQNMT-------AVQAAFAV- 349 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~-------~~~~~~~~- 349 (418)
.-.+...........|...|++||.-. +-.-+..+|.|.||++++++|. |++||.+.. +.+.....
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 544444444556678999999999864 3355678999999999999998 599997632 22211100
Q ss_pred -------HhcCCCCC---CC-CCChHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhHHHHhhh
Q 014783 350 -------VNKGVRPV---IP-NDCLPVLSEIMTRCWDT--NPEVRPPFTEIVRMLENAETEIMTT 401 (418)
Q Consensus 350 -------~~~~~~~~---~~-~~~~~~l~~li~~cl~~--dp~~RPt~~ell~~L~~~~~~~~~~ 401 (418)
...++++. +| .-+++.+..|..+|+.. ++.-|||++.++..|..+.+++.+=
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 11122211 11 12568899999999965 4678999999999999999988643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.4e-11 Score=108.43 Aligned_cols=139 Identities=19% Similarity=0.258 Sum_probs=101.0
Q ss_pred CceeeeCceEEEEEEECC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC--CeEEEEeEEeeC---ceEEEE
Q 014783 141 TAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRKR---MVWCIV 214 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~~~---~~~~lv 214 (418)
+.|+.|.++.||+++..+ +.+++|+........ ....+.+|+.+++.+.+. ++.+++.+.... +..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 468899999999998754 899999976543210 113567899999999763 456777776653 256899
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (418)
|||++|.++.+.+.. ..++......++.+++..|..||+
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999999887665421 234555555666666666666663
Q ss_pred ------------------CCcccCCCCCCcEEEcC--CCCEEEeeccccee
Q 014783 257 ------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARI 287 (418)
Q Consensus 257 ------------------~~iiHrDlkp~NILl~~--~~~vkl~DfGla~~ 287 (418)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-10 Score=106.59 Aligned_cols=141 Identities=15% Similarity=0.074 Sum_probs=98.1
Q ss_pred eCceEEEEEEECCceEEEEEeecCCCChHHHH-----HHHHHHHHHHHHHHhCCCCCeE--EEEeEEee-----CceEEE
Q 014783 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLNIV--RFIGACRK-----RMVWCI 213 (418)
Q Consensus 146 G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv--~l~~~~~~-----~~~~~l 213 (418)
.....|++..+.|+.|.||............. .-...+.+|...+.+|...+|. .++++... ...-+|
T Consensus 33 ~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 33 LEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 33445778888899999997643221100000 0001467888888888433332 34444432 224689
Q ss_pred EEeecCCC-CHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-------CCCEEEeecccc
Q 014783 214 VTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-------DKSIKIADFGVA 285 (418)
Q Consensus 214 v~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-------~~~vkl~DfGla 285 (418)
|||++++. +|.+++........+......++.+++..+..||+.||+|+|+++.|||++. +..+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999875 7999986433344566677789999999999999999999999999999985 467999999988
Q ss_pred e
Q 014783 286 R 286 (418)
Q Consensus 286 ~ 286 (418)
+
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-10 Score=101.06 Aligned_cols=129 Identities=22% Similarity=0.296 Sum_probs=83.2
Q ss_pred EEEEEEE-CCceEEEEEeecCCCC--------------------hHHHHHHHHHHHHHHHHHHhCCCC--CeEEEEeEEe
Q 014783 150 KLYRGTY-NGEDVAIKILERPENN--------------------PEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACR 206 (418)
Q Consensus 150 ~Vy~~~~-~~~~vAvK~~~~~~~~--------------------~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~ 206 (418)
.||.|.. +|..+|||+.+..... ............+|...|+++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 7889999998642211 111223346778999999999766 466776543
Q ss_pred eCceEEEEEeecC--CCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 207 KRMVWCIVTEYAK--GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY-VHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 207 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y-LH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
. -+|||||+. |..+..+.... ++......++.+++..+.. +|+.||||+||.+.|||++++ .+.|+|||
T Consensus 80 -~--~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 -R--NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp -T--TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred -C--CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2 269999998 65564443321 1123345566777775555 579999999999999999977 99999999
Q ss_pred ccee
Q 014783 284 VARI 287 (418)
Q Consensus 284 la~~ 287 (418)
.+..
T Consensus 152 qav~ 155 (188)
T PF01163_consen 152 QAVD 155 (188)
T ss_dssp TEEE
T ss_pred ccee
Confidence 8853
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.8e-09 Score=103.21 Aligned_cols=230 Identities=17% Similarity=0.235 Sum_probs=159.7
Q ss_pred ceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee----CceEEEEEeecCC-
Q 014783 148 FGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKG- 220 (418)
Q Consensus 148 fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~~~~lv~E~~~~- 220 (418)
-.+.|++.. +|..|++|.++-...... .....-+++++++.|+|+|++..++.+ +..+++|++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 357788875 899999999843221111 112245778999999999999998763 4568999999875
Q ss_pred CCHHHHHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 221 GSVRQFLTRR-------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 221 gsL~~~l~~~-------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
++|.++.... .+...++..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+..++|+..|....
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence 5777765321 234578899999999999999999999999999999999999988999999998876
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLP-FQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
..... . |.+.. -.+-|.=.||.+++.|.||..- +......+.....+ ....+..+
T Consensus 443 l~~d~-----------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I--------~~~yS~D~ 498 (655)
T KOG3741|consen 443 LQEDP-----------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI--------TTTYSTDL 498 (655)
T ss_pred ecCCC-----------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh--------hhhhhHHH
Confidence 54322 1 11211 2367899999999999998532 22222222212222 22456677
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH---------------HHhhHHHHhhhhhhcccc
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRM---------------LENAETEIMTTVRKARFR 408 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~---------------L~~~~~~~~~~~~~~r~~ 408 (418)
++++.-....++++ -++.+++.+ -+.++.++-.+++..|+.
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE~~Ls~emENGRLf 554 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVMETELSREMENGRLF 554 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHhcchHH
Confidence 78888777777775 555555543 344456677777777763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-09 Score=94.69 Aligned_cols=105 Identities=21% Similarity=0.297 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHhCCCCC--eEEEEeEEeeC----ceEEEEEeecCCC-CHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 014783 181 QQFQQEVMMLATLKHLN--IVRFIGACRKR----MVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (418)
Q Consensus 181 ~~~~~E~~il~~l~hpn--iv~l~~~~~~~----~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~y 253 (418)
....+|...+..|..-. .+..+++.... ..-+||+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 45667888777775333 33455555432 2348999999874 79999876332 5556677889999999999
Q ss_pred HHhCCcccCCCCCCcEEEcCCC---CEEEeeccccee
Q 014783 254 VHGLGFIHRDLKSDNLLISADK---SIKIADFGVARI 287 (418)
Q Consensus 254 LH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~~ 287 (418)
||+.||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.9e-09 Score=97.49 Aligned_cols=138 Identities=20% Similarity=0.232 Sum_probs=99.4
Q ss_pred cccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHH----------------HHHHHHHHHHHHHHHHhCCCC--Ce
Q 014783 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK----------------AQVMEQQFQQEVMMLATLKHL--NI 198 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~----------------~~~~~~~~~~E~~il~~l~hp--ni 198 (418)
.++..||.|--+.||.|.. .|.++|||.-+-...+..+ .........+|.++|++|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999998 6999999976532211110 012235667899999999655 66
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEE
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vk 278 (418)
.+.+++ +...+|||+++|-.|...- +.....-.++..|++-+.-+=..||||+|+++-||+++++|.++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 666664 3347999999987764432 12233444555566666666689999999999999999999999
Q ss_pred Eeecccce
Q 014783 279 IADFGVAR 286 (418)
Q Consensus 279 l~DfGla~ 286 (418)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99996653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4e-10 Score=114.27 Aligned_cols=144 Identities=18% Similarity=0.310 Sum_probs=102.8
Q ss_pred HHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeecccceeecccC-----CCCCC-----CCCccccccccccCCC
Q 014783 245 LDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-----GMTPE-----TGTYRWMAPEMIQHRP 313 (418)
Q Consensus 245 ~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-----~~~~~-----~gt~~y~aPE~~~~~~ 313 (418)
.+++.||.|+|.. ++||+.|.|++|.++..+.+||+.|+++-...... .++.. .-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3455899999965 89999999999999999999999999875332211 11111 1347899999999988
Q ss_pred CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHH-hcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 014783 314 YTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF-AVV-NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIV 388 (418)
Q Consensus 314 ~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell 388 (418)
.+.++|+||+|+++|.+.. |+.-+.......... ... ..-...-.+..+++++.+=+.+++..++..||++.++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 8999999999999999994 655554332211111 111 11111123356788999999999999999999776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-08 Score=88.34 Aligned_cols=144 Identities=12% Similarity=0.100 Sum_probs=101.7
Q ss_pred eeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEEEEeEEee----CceEEEEEee
Q 014783 144 AQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRK----RMVWCIVTEY 217 (418)
Q Consensus 144 G~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~~~----~~~~~lv~E~ 217 (418)
|.||-+.|++-...|..+=+|.-.......-....-...|.+|...+.+|..-+ +.+....... ...-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 458888999988888888888764110000000001246889999999885332 4444422211 1235899997
Q ss_pred cCC-CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--EEEeeccccee
Q 014783 218 AKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (418)
Q Consensus 218 ~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~--vkl~DfGla~~ 287 (418)
+.| -+|.+++....-...+......+..+|+..++-||+.|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 753 58888886644445566777789999999999999999999999999999987777 99999977653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.1e-07 Score=91.30 Aligned_cols=144 Identities=17% Similarity=0.252 Sum_probs=92.3
Q ss_pred CceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHH----------------------------HH------HHHHHHH
Q 014783 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QV------MEQQFQQ 185 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~----------------------------~~------~~~~~~~ 185 (418)
..|+.++-|+||+|++ +|+.||||+.++.-...-.. .. .+-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999998 59999999986532211000 00 1123445
Q ss_pred HHHHHHhCC-----CCCeEEEEeEE-eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 014783 186 EVMMLATLK-----HLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259 (418)
Q Consensus 186 E~~il~~l~-----hpniv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i 259 (418)
|+.-+.+++ .|++. +=.++ .-...-.|+|||+.|-.+.+...... ..++...+.....++ -+..+=..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 555555552 23322 22222 11223379999999999988854332 335544333332222 2333445899
Q ss_pred ccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 260 IHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 260 iHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
+|.|.+|.||+++.+|.+.+.|||.....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999998654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.4e-07 Score=82.30 Aligned_cols=141 Identities=16% Similarity=0.211 Sum_probs=89.7
Q ss_pred ccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHH---HHHHHHHHHHHHhCCCC---CeEEEEeEEe--
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLKHL---NIVRFIGACR-- 206 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~---~~~~~~E~~il~~l~hp---niv~l~~~~~-- 206 (418)
.+|...+.+-......|.+-..+|..+.+|..+......++.-.. -....+.+..+.+++.. ....++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 455555666666667777777889999999986544333221110 01123334434444322 2222222222
Q ss_pred ---eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 207 ---KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 207 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
-....+++|||++|..|.++.. +++. ++..+.+++.-||+.|+.|+|.+|.|++++.++ ++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 1234568999999998877642 2222 445677789999999999999999999999555 9999997
Q ss_pred cce
Q 014783 284 VAR 286 (418)
Q Consensus 284 la~ 286 (418)
-.+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.7e-07 Score=84.73 Aligned_cols=135 Identities=13% Similarity=0.143 Sum_probs=83.5
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEEEEeEEeeCceEEEEEeec
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~~~~~~~~lv~E~~ 218 (418)
..||+|..+.||+. .+..+++|...... .. ....+|.++++.+..-. +.+.++++.......+|||++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~-------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK-------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH-------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 46899999999984 35577889875422 11 24568999988886433 467788877777788999999
Q ss_pred CCCC-HHHH--------------Hhh----hcC---CCCCHHHHHH-HHH----------HHHH-HHHHHHh----CCcc
Q 014783 219 KGGS-VRQF--------------LTR----RQN---RAVPLKLAVK-QAL----------DVAR-GMAYVHG----LGFI 260 (418)
Q Consensus 219 ~~gs-L~~~--------------l~~----~~~---~~~~~~~~~~-i~~----------qi~~-gL~yLH~----~~ii 260 (418)
+|.+ +.+. +.. -.. ...+...... +.. .+.. ..++|.+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 1111 110 000 1111111111 000 0111 1222321 2478
Q ss_pred cCCCCCCcEEEcCCCCEEEeecccce
Q 014783 261 HRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 261 HrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
|+|+.|.||+++.++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.1e-07 Score=80.20 Aligned_cols=131 Identities=22% Similarity=0.334 Sum_probs=94.5
Q ss_pred cccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE-EEEeEEeeCceEEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIGACRKRMVWCIV 214 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv-~l~~~~~~~~~~~lv 214 (418)
..+..+.|++|.+|.||+|.|.|..+|+|+-+.+... ..+..|+++|..+.-.++. ++|.+... ++.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r--------~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~ 90 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR--------RNLEKEAKILEILAGEGVTPEVYFYGED----FIR 90 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcch--------hhHHHHHHHHHHhhhcCCCceEEEechh----hhh
Confidence 3456678999999999999999999999997654432 3577899999999876665 45544333 466
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCcEEEcCCCCEEEeeccccee
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK-SDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk-p~NILl~~~~~vkl~DfGla~~ 287 (418)
|||+.|-+|.+.-... ... -...+++.---|-..||-|..|. |...+|..++.+.|+||..|+.
T Consensus 91 me~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 91 MEYIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9999998887765421 122 23455555555677899999985 4444454556999999999874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.3e-07 Score=81.96 Aligned_cols=139 Identities=20% Similarity=0.221 Sum_probs=92.9
Q ss_pred CceeeeCceEEEEEEE-CCceEEEEEeecCCCChHH------------------HHHHHHHHHHHHHHHHhCC--CCCeE
Q 014783 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK------------------AQVMEQQFQQEVMMLATLK--HLNIV 199 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~------------------~~~~~~~~~~E~~il~~l~--hpniv 199 (418)
..|.+|--+.||+|.. ++..+|||+.+.......+ .+....-..+|..-|+++. +=.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677788889999875 6889999998753332211 1222233456777777774 33344
Q ss_pred EEEeEEeeCceEEEEEeecCCCCH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCE
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSV-RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSI 277 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~v 277 (418)
+.+++... .|||||+....+ .-.|+ .-.+....+..+..++++.|.-|=. .++||+||+.-|||+. ++.+
T Consensus 134 ~Pi~~~~n----VLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 134 EPIAFRNN----VLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CceeecCC----eEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 45554332 599999944311 11111 1123333567777888888888876 8999999999999999 8999
Q ss_pred EEeeccccee
Q 014783 278 KIADFGVARI 287 (418)
Q Consensus 278 kl~DfGla~~ 287 (418)
.|+|||-|-.
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.8e-08 Score=99.19 Aligned_cols=197 Identities=21% Similarity=0.225 Sum_probs=138.5
Q ss_pred CCCCCCCCCCcccccccccccccCceeeeCceEEEEEEECCc-eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC
Q 014783 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196 (418)
Q Consensus 118 ~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 196 (418)
.+....+...+.|.-. ...+++|++++++|.+.+-+ ....+++... ....-++++|.+++||
T Consensus 231 ~~qpp~lkDk~kws~~------fh~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P 293 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEF------FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNP 293 (829)
T ss_pred CCCCCcccCCccchHH------HHHHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCC
Confidence 4444555666777543 34567899999999886433 3335555432 1223578899999999
Q ss_pred C-eEEEEeEEeeCceEEEEEeecCCC-CHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC
Q 014783 197 N-IVRFIGACRKRMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (418)
Q Consensus 197 n-iv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~ 274 (418)
| .+..++-+..+....++++++.++ +...-.. ...-.+.+-....+...-++++++||+.-=+||| |||..+
T Consensus 294 ~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~- 367 (829)
T KOG0576|consen 294 NPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE- 367 (829)
T ss_pred CCcccccccCCcccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-
Confidence 9 777777777777888999999777 2211110 0011122233445566677899999988778998 777764
Q ss_pred CCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 275 KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 275 ~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
+..+..||+.+.............+++.|+|||+.....+..+.|+|++++--.++.-|-+|-
T Consensus 368 ~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 368 EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 789999999987655544455667999999999999999999999999998777776676654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.6e-06 Score=77.90 Aligned_cols=139 Identities=19% Similarity=0.220 Sum_probs=82.4
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC--CeEEEEeEEe---eCceEEEEE
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACR---KRMVWCIVT 215 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~---~~~~~~lv~ 215 (418)
+.|+.|..+.||+....+..+++|..... .....+.+|..+++.+... .+.+++..+. .....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 46899999999999997789999997532 1124566888888877433 3556666443 233578999
Q ss_pred eecCCCCHHH----------------HHhh---h--cCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 014783 216 EYAKGGSVRQ----------------FLTR---R--QNRAVPLKL---------AVKQ------------ALDVAR-GMA 252 (418)
Q Consensus 216 E~~~~gsL~~----------------~l~~---~--~~~~~~~~~---------~~~i------------~~qi~~-gL~ 252 (418)
++++|..+.. .+.. . ....+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 1111 1 001111100 0000 111222 333
Q ss_pred HHHh-------CCcccCCCCCCcEEEc-CCCCEEEeeccccee
Q 014783 253 YVHG-------LGFIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (418)
Q Consensus 253 yLH~-------~~iiHrDlkp~NILl~-~~~~vkl~DfGla~~ 287 (418)
.+++ ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 4432 4599999999999999 566668999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.36 E-value=7e-06 Score=73.04 Aligned_cols=131 Identities=19% Similarity=0.327 Sum_probs=92.7
Q ss_pred ccccccCceeeeCc-eEEEEEEECCceEEEEEeecC---CC--------Ch----HHHHHHHHHHHHHHHHHHhCC---C
Q 014783 135 RKLNMGTAFAQGAF-GKLYRGTYNGEDVAIKILERP---EN--------NP----EKAQVMEQQFQQEVMMLATLK---H 195 (418)
Q Consensus 135 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~vAvK~~~~~---~~--------~~----~~~~~~~~~~~~E~~il~~l~---h 195 (418)
.+++.++.||.|.- |.||+++.+|+.||||+.+.- .. .. .....+...|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888999999999 999999999999999994320 00 00 001123456778887777664 5
Q ss_pred CCe--EEEEeEEeeC------------------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014783 196 LNI--VRFIGACRKR------------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255 (418)
Q Consensus 196 pni--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH 255 (418)
.++ |+.+|+..-. ..+.||-||++... .+. ..-+.+|.+-|.-+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHHH
Confidence 566 8888886211 23578888876544 122 223457777888999
Q ss_pred hCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 256 GLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 256 ~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 2489999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.8e-06 Score=77.31 Aligned_cols=135 Identities=16% Similarity=0.143 Sum_probs=82.9
Q ss_pred eeeeCc-eEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEEEeecCC
Q 014783 143 FAQGAF-GKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 143 lG~G~f-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
|-.|+. ..||+....+..+.||...... . ..+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~--~-------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP--T-------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc--c-------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 445666 7899998777788899875432 0 23557888877773 33455777777666667899999999
Q ss_pred CCHHHHH----------------hhhcC---C--CCCHH--HHHHHHH--------------------HHHHHHHHHH--
Q 014783 221 GSVRQFL----------------TRRQN---R--AVPLK--LAVKQAL--------------------DVARGMAYVH-- 255 (418)
Q Consensus 221 gsL~~~l----------------~~~~~---~--~~~~~--~~~~i~~--------------------qi~~gL~yLH-- 255 (418)
.+|.+.. ..-.. . .+... ....... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776432 10000 0 11100 0000000 0111122221
Q ss_pred -----hCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 256 -----GLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 256 -----~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998888999998875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.7e-06 Score=85.46 Aligned_cols=143 Identities=19% Similarity=0.309 Sum_probs=90.7
Q ss_pred CceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHH-----------------------------HH--HHHHHHHHHH
Q 014783 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA-----------------------------QV--MEQQFQQEVM 188 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~-----------------------------~~--~~~~~~~E~~ 188 (418)
+.||.-+.|+||+++. +|+.||||+-++.-...-.. .. .+-.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999998 78999999986533221000 00 0123444554
Q ss_pred HHH----hCCCCC------eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 189 MLA----TLKHLN------IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 189 il~----~l~hpn------iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
-.. .++|-+ |.++|..+... -.|+||||+|..+.|.-.-. ...++...+..-+.++.. +.+=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTK--RVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcc--eEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 333 334555 44555444443 37999999998876654322 233555544433333222 2233568
Q ss_pred cccCCCCCCcEEEcC----CCCEEEeecccceee
Q 014783 259 FIHRDLKSDNLLISA----DKSIKIADFGVARIE 288 (418)
Q Consensus 259 iiHrDlkp~NILl~~----~~~vkl~DfGla~~~ 288 (418)
++|.|=+|.||+++. ++.+.+-|||+....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 999999999999994 568999999998654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.9e-06 Score=91.20 Aligned_cols=198 Identities=18% Similarity=0.239 Sum_probs=144.0
Q ss_pred HHHHHHHHHHHhCCCCCeEEEEeEEeeCce----EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014783 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMV----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256 (418)
Q Consensus 181 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~----~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~ 256 (418)
....-|...+.++.|+|++.++.+..+... +.+..|+++..++...+... ..++...+..+..++.+||+|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 344567788889999999999998765433 33456788888888888653 458889999999999999999999
Q ss_pred CCcccCCCCCC---cEEEcCCCCEEEe--ecccceeecccCCCCCCCCCccccccccccCCCCCCc--chHHHHHHHHHH
Q 014783 257 LGFIHRDLKSD---NLLISADKSIKIA--DFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQK--VDVYSFGIVLWE 329 (418)
Q Consensus 257 ~~iiHrDlkp~---NILl~~~~~vkl~--DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~--sDvwSlGv~l~e 329 (418)
....|.-|..+ +-.++.++.+.++ ||+................+..|.|||......++.+ .|+|.+|.++..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 97777666555 5555667777777 8988876655554455556678889998877766554 799999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 014783 330 LITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391 (418)
Q Consensus 330 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L 391 (418)
+..|..+-..... .....+..+.....++..+|+..++++|+++.+++...
T Consensus 385 ~~~~~~i~~~~~~-----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 385 LSQGEDISEKSAV-----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhcCcccccccc-----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9886543211110 01112222223677889999999999999999888743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-05 Score=70.90 Aligned_cols=100 Identities=23% Similarity=0.320 Sum_probs=79.3
Q ss_pred HHHHHHHhCCC-CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 014783 185 QEVMMLATLKH-LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHG---LGF 259 (418)
Q Consensus 185 ~E~~il~~l~h-pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~i 259 (418)
.|.-+|+.+.+ +++++++|+|.. ++|+||...+++...... .+-...+|..+.++|.++++.+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 68888899976 699999999955 579999987766422000 011247899999999999999999997 347
Q ss_pred ccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 260 IHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 260 iHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.-.|++|+|+-+++++.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 77899999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.7e-05 Score=84.96 Aligned_cols=77 Identities=13% Similarity=0.198 Sum_probs=54.1
Q ss_pred CceeeeCceEEEEEEECC----ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCe--EEEEeEEeeC---ce
Q 014783 141 TAFAQGAFGKLYRGTYNG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNI--VRFIGACRKR---MV 210 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpni--v~l~~~~~~~---~~ 210 (418)
+.|+.|.+..+|+....+ ..+++|+......... ...+.+|+.+|+.+. |+++ .+++.+|.+. +.
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 568899999999987743 4677776532221111 135779999999995 6655 7888888664 35
Q ss_pred EEEEEeecCCCC
Q 014783 211 WCIVTEYAKGGS 222 (418)
Q Consensus 211 ~~lv~E~~~~gs 222 (418)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 689999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.5e-05 Score=71.16 Aligned_cols=31 Identities=29% Similarity=0.513 Sum_probs=26.3
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998776667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00017 Score=69.16 Aligned_cols=76 Identities=16% Similarity=0.122 Sum_probs=55.6
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC---CCeEEEEeEEee---CceEEE
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRK---RMVWCI 213 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~~~---~~~~~l 213 (418)
.+.||.|..+.||+....+..+.+|..+. .... ..+.+|+..|+.+.. -.+.+.+++|.. .+..+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARS-FSTP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecc-cccc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 35799999999999887555678888533 1111 367789999988853 357788887754 355799
Q ss_pred EEeecCCCCH
Q 014783 214 VTEYAKGGSV 223 (418)
Q Consensus 214 v~E~~~~gsL 223 (418)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00046 Score=61.81 Aligned_cols=137 Identities=17% Similarity=0.278 Sum_probs=90.8
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHH----------HHHHHHHHHHHHHHHHhCC------CCCeEEEEeE
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK----------AQVMEQQFQQEVMMLATLK------HLNIVRFIGA 204 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~----------~~~~~~~~~~E~~il~~l~------hpniv~l~~~ 204 (418)
..||+|+.=.||.-- ......||+.......... .....++..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 579999998888533 3345678988765400000 0001234555665555554 8899999999
Q ss_pred EeeCceEEEEEeecCC------CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---
Q 014783 205 CRKRMVWCIVTEYAKG------GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--- 275 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~--- 275 (418)
..++..+.+|+|.+.. -+|.++++.. .++. .+. ..+-+-..||-+.+|+.+||+|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999998743 3688888542 3444 233 3333455688899999999999999997432
Q ss_pred -CEEEee-cccc
Q 014783 276 -SIKIAD-FGVA 285 (418)
Q Consensus 276 -~vkl~D-fGla 285 (418)
.+.|+| ||..
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 477777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00031 Score=64.65 Aligned_cols=72 Identities=13% Similarity=0.231 Sum_probs=45.3
Q ss_pred CceeeeCceEEEEEEEC---CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEEEEeEEeeCceEEEEEe
Q 014783 141 TAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~~lv~E 216 (418)
+.|..|-...||+.... +..|++|+........ ....+|..+++.+...+ .+++++.+. . .++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEE
Confidence 35677888899998864 5789999765322110 11236777888775333 334444332 2 37999
Q ss_pred ecCCCCH
Q 014783 217 YAKGGSV 223 (418)
Q Consensus 217 ~~~~gsL 223 (418)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.001 Score=64.00 Aligned_cols=139 Identities=18% Similarity=0.194 Sum_probs=79.6
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEEEEeEE------eeCceE
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGAC------RKRMVW 211 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~------~~~~~~ 211 (418)
.+.++.|....+|+...++..+++|+...... . +.+..|..++..|.... +.+++... ...+..
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~-~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK-A-------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCC-H-------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 45677787789999876666788998754211 1 22334556666663222 33443321 123456
Q ss_pred EEEEeecCCCCHH-----------HHH---hhh-cCC-----C-CCHHHHH---------------HHHHHHHHHHHHHH
Q 014783 212 CIVTEYAKGGSVR-----------QFL---TRR-QNR-----A-VPLKLAV---------------KQALDVARGMAYVH 255 (418)
Q Consensus 212 ~lv~E~~~~gsL~-----------~~l---~~~-~~~-----~-~~~~~~~---------------~i~~qi~~gL~yLH 255 (418)
++++||++|..+. ..+ +.. .+. . ....... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 111 110 000 0 0011000 00112334555554
Q ss_pred h-------CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 256 G-------LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 256 ~-------~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 589999999999999998877999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00042 Score=66.20 Aligned_cols=138 Identities=19% Similarity=0.181 Sum_probs=82.2
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEEEEeE------EeeCceE
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGA------CRKRMVW 211 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~------~~~~~~~ 211 (418)
.+.|..|....+|+...++..+++|+... ... ..+..|+.++..+.+.+ +.+++.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 34677788789999877777899998753 111 24556777777774322 4444432 1223456
Q ss_pred EEEEeecCCCCHHH-----------HHh---hhc-CCC------CCHHHHHH------------HHHHHHHHHHHHHh--
Q 014783 212 CIVTEYAKGGSVRQ-----------FLT---RRQ-NRA------VPLKLAVK------------QALDVARGMAYVHG-- 256 (418)
Q Consensus 212 ~lv~E~~~~gsL~~-----------~l~---~~~-~~~------~~~~~~~~------------i~~qi~~gL~yLH~-- 256 (418)
++|++|++|..+.. .+. ... ... ........ ....+...+.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998866421 111 000 000 00000000 11112334455543
Q ss_pred -----CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 -----LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 -----~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=4.5e-05 Score=72.02 Aligned_cols=136 Identities=18% Similarity=0.240 Sum_probs=93.8
Q ss_pred cccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChH----------------HHHHHHHHHHHHHHHHHhCCC--CCe
Q 014783 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE----------------KAQVMEQQFQQEVMMLATLKH--LNI 198 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~----------------~~~~~~~~~~~E~~il~~l~h--pni 198 (418)
.++..||-|--+.||.+-+ .|++.++|.-+-...+.. -.....-...+|...|+.|.. --+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4677899999999999988 689999996542211110 001112345678888888843 234
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEE
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vk 278 (418)
.+.++++ ..++|||++.|-.|.+.-+- .. .-.+...+..-+--|-.+|+||+|..-=||+|++++.++
T Consensus 175 PkpiD~~----RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 175 PKPIDHN----RHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCccccc----ceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 5555543 34799999999888655321 11 223344555556678889999999999999999999999
Q ss_pred Eeecccc
Q 014783 279 IADFGVA 285 (418)
Q Consensus 279 l~DfGla 285 (418)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00044 Score=64.67 Aligned_cols=134 Identities=18% Similarity=0.198 Sum_probs=76.7
Q ss_pred eeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCceEEEEEeecCCC
Q 014783 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAKGG 221 (418)
Q Consensus 143 lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~lv~E~~~~g 221 (418)
+..|-...+|+...++..+++|.......... -...+|..+++.+....+ .++++.+. + ++|+||++|.
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~--~--~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE--H--WLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC--C--EEEEEeccCc
Confidence 45677889999988888899997543221110 023467788887754323 34444432 2 5899999886
Q ss_pred CHHH--------------HHhhhc-----CCCCCHH-HHHHHHHH---------HHHHHHHHHh--------CCcccCCC
Q 014783 222 SVRQ--------------FLTRRQ-----NRAVPLK-LAVKQALD---------VARGMAYVHG--------LGFIHRDL 264 (418)
Q Consensus 222 sL~~--------------~l~~~~-----~~~~~~~-~~~~i~~q---------i~~gL~yLH~--------~~iiHrDl 264 (418)
.+.. .+.+-. ...++.. .+..+..+ +...+..+-+ ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 111111 1111211 11111111 1111222221 25899999
Q ss_pred CCCcEEEcCCCCEEEeeccccee
Q 014783 265 KSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 265 kp~NILl~~~~~vkl~DfGla~~ 287 (418)
.|.||+++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0021 Score=62.16 Aligned_cols=30 Identities=40% Similarity=0.509 Sum_probs=26.3
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976666899999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=1.7e-05 Score=87.36 Aligned_cols=157 Identities=13% Similarity=0.060 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHhCCCCCeEEEEeEEe--eCceEEEEEeecCCCCHHHHHhhhcCCCCCH--HHHHHHHHHHHHHHHHHHh
Q 014783 181 QQFQQEVMMLATLKHLNIVRFIGACR--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHG 256 (418)
Q Consensus 181 ~~~~~E~~il~~l~hpniv~l~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~--~~~~~i~~qi~~gL~yLH~ 256 (418)
+....|...++...|+++...+.-.. +....+.+++++.+|.+.+.+-+...+..+. .-+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 44555666666778998887665442 3344578999999999999987643322222 1122222232555556564
Q ss_pred C-----CcccCCCCCCcEEEcCCCCEEEeecccceee-cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHH
Q 014783 257 L-----GFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 330 (418)
Q Consensus 257 ~-----~iiHrDlkp~NILl~~~~~vkl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~el 330 (418)
. =-+|++||+-|.+|..+..+|+.++|++++. ..........+++.|++|++...-.++.++|+|+.|+.+|+.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 3 1689999999999999999999999999843 222334445678899999999888899999999999999998
Q ss_pred HhCCCCC
Q 014783 331 ITGLLPF 337 (418)
Q Consensus 331 ltg~~Pf 337 (418)
.-|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887776
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00082 Score=64.42 Aligned_cols=72 Identities=13% Similarity=0.252 Sum_probs=44.4
Q ss_pred ceeeeCceEEEEEEEC--------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCceEE
Q 014783 142 AFAQGAFGKLYRGTYN--------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWC 212 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~ 212 (418)
.|..|-...||+.+.. ++.|++|+........ ....+|..++..+....+ .++++.+. + .
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~ 73 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELL-------IDRERELVVFARLSERNLGPKLYGIFP-N---G 73 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcce-------echHHHHHHHHHHHhCCCCCceEEEeC-C---C
Confidence 4555666789988764 4789999975432211 123467777777743333 34555553 2 2
Q ss_pred EEEeecCCCCHH
Q 014783 213 IVTEYAKGGSVR 224 (418)
Q Consensus 213 lv~E~~~~gsL~ 224 (418)
+|+||++|.++.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 689999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0009 Score=66.97 Aligned_cols=155 Identities=20% Similarity=0.233 Sum_probs=97.2
Q ss_pred HHHHHHHHHHhCCCCCeEEEEeEEee-CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 014783 182 QFQQEVMMLATLKHLNIVRFIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260 (418)
Q Consensus 182 ~~~~E~~il~~l~hpniv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~ii 260 (418)
+++-..++++.+.|+|+.+++++-.. ..+..+|+|++ +.+|.+++..+.... . + ++ .+++.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~---~-------s---~~----~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD---E-------S---LL----AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch---h-------h---hc----ccccc
Confidence 45566788999999999999998753 33467899999 679999987643111 1 0 11 22222
Q ss_pred cCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014783 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM 340 (418)
Q Consensus 261 HrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~ 340 (418)
|- |+ .+.+| -++.. . .... .+|+||||+|.++.|+.-|..-+...
T Consensus 90 ~~-----~~-------~~~td-~~~t~----~--~~~~----------------~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 90 HL-----NI-------IYITD-HFLTK----Y--PSPI----------------GPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred ee-----hh-------hhccc-ccccc----C--CCCC----------------CcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 21 22 23333 11110 0 1111 14999999999999999998887776
Q ss_pred CHHHHHHHHHhcCCCCC----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 341 TAVQAAFAVVNKGVRPV----------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 341 ~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+....+..-...+. +-..++..+..+..+|+...|..||...++.+
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 66555544333222211 11235566778889999999999987777654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0035 Score=62.20 Aligned_cols=80 Identities=13% Similarity=0.019 Sum_probs=50.4
Q ss_pred CceeeeCceEEEEEEEC-C-ceEEEEEeecCCCC-hHHHHHHHHHHHHHHHHHHhCC---CCCeEEEEeEEeeCceEEEE
Q 014783 141 TAFAQGAFGKLYRGTYN-G-EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~-~-~~vAvK~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~lv 214 (418)
+.||.|.+..||+.+.. | +.|.||.-.+.... .+......+++..|...|+.+. ..++++++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 57899999999999884 3 48999985321110 0000011245566777777762 346777777744 335799
Q ss_pred EeecCCCC
Q 014783 215 TEYAKGGS 222 (418)
Q Consensus 215 ~E~~~~gs 222 (418)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0025 Score=61.46 Aligned_cols=142 Identities=19% Similarity=0.191 Sum_probs=93.4
Q ss_pred ccCceeeeCceEEEEEEE-CCceEEEEEeecC--------------------CCChHHHHHHHHHHHHHHHHHHhCCCCC
Q 014783 139 MGTAFAQGAFGKLYRGTY-NGEDVAIKILERP--------------------ENNPEKAQVMEQQFQQEVMMLATLKHLN 197 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~--------------------~~~~~~~~~~~~~~~~E~~il~~l~hpn 197 (418)
+-..|..|--+-||.++- +|..+|||+++.. ....+...+..--...|+.-|++++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 335788888999999987 7889999987631 1111222333334556777788876554
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCCCC
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKS 276 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NILl~~~~~ 276 (418)
|.-.--+.... ..|||+|+. ++=+..-+ .....++...+..+-.+++.-|.-|- ..++||.||+--|+|+. +|.
T Consensus 228 IP~PePIlLk~--hVLVM~FlG-rdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 228 IPCPEPILLKN--HVLVMEFLG-RDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCCceeeec--ceEeeeecc-CCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 43222222222 269999994 33211111 12344666777788888888888774 56999999999999995 788
Q ss_pred EEEeecccc
Q 014783 277 IKIADFGVA 285 (418)
Q Consensus 277 vkl~DfGla 285 (418)
++|+|-+-+
T Consensus 303 lyiIDVSQS 311 (520)
T KOG2270|consen 303 LYIIDVSQS 311 (520)
T ss_pred EEEEEcccc
Confidence 999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0061 Score=58.50 Aligned_cols=139 Identities=17% Similarity=0.256 Sum_probs=79.8
Q ss_pred eCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEEEEeEEeeCc--eEEEEEeecCCC
Q 014783 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM--VWCIVTEYAKGG 221 (418)
Q Consensus 146 G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~--~~~lv~E~~~~g 221 (418)
|..-.+|....+++++++. .-........ .....+|..+++.+.- --+...++.|.++. ..+.||+|++|.
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~----~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVES----AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchh----hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 3334556666667888888 2111111111 2455678888887753 23445677777665 678999999873
Q ss_pred CH------------------HHHHhhhcC------CC------CCHHHHHHHHH--------------HHHHHHHHHHhC
Q 014783 222 SV------------------RQFLTRRQN------RA------VPLKLAVKQAL--------------DVARGMAYVHGL 257 (418)
Q Consensus 222 sL------------------~~~l~~~~~------~~------~~~~~~~~i~~--------------qi~~gL~yLH~~ 257 (418)
.+ .++|..-.. .. .....+..+.. ....-..+|+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 22 122211000 00 00001111111 122334555432
Q ss_pred --------CcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 258 --------GFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 258 --------~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.++|+|+.+.||+++.++.+=|.||+++....
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 48999999999999999999999999997543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.019 Score=55.16 Aligned_cols=29 Identities=28% Similarity=0.565 Sum_probs=25.6
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.059 Score=52.64 Aligned_cols=77 Identities=10% Similarity=-0.041 Sum_probs=42.9
Q ss_pred ceeeeCceEEEEEEECC--ceEEEEEeecCCCC-hHHHHHHHHHHHHHHHHHHhCC--CC-CeEEEEeEEeeCceEEEEE
Q 014783 142 AFAQGAFGKLYRGTYNG--EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~--hp-niv~l~~~~~~~~~~~lv~ 215 (418)
.||-|....||++...+ +.|+||.-..-... .+.......+..-|...|+... -| .++++|.+-.+ ...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e--~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE--MAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccc--cceehH
Confidence 57889999999998743 57999965321110 0000001123345666666553 24 45555544333 235899
Q ss_pred eecCC
Q 014783 216 EYAKG 220 (418)
Q Consensus 216 E~~~~ 220 (418)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.019 Score=54.58 Aligned_cols=73 Identities=16% Similarity=0.199 Sum_probs=47.3
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC---CCCeEEEEeEEeeCceEEEEEe
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~lv~E 216 (418)
.+.++-|....+|+.+.+++.+.||+-..... ..|..|+.-|+.|. .-.+++.+++....+.-+||+|
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35688888999999888888999999763221 35678888888773 3457788888877666799999
Q ss_pred ecCCC
Q 014783 217 YAKGG 221 (418)
Q Consensus 217 ~~~~g 221 (418)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0071 Score=57.27 Aligned_cols=30 Identities=27% Similarity=0.523 Sum_probs=25.6
Q ss_pred CcccCCCCCCcEEEcCCCC-EEEeeccccee
Q 014783 258 GFIHRDLKSDNLLISADKS-IKIADFGVARI 287 (418)
Q Consensus 258 ~iiHrDlkp~NILl~~~~~-vkl~DfGla~~ 287 (418)
.++|+|++|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 57999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.014 Score=56.77 Aligned_cols=29 Identities=31% Similarity=0.549 Sum_probs=25.5
Q ss_pred cccCCCCCCcEEEcC-CCCEEEeeccccee
Q 014783 259 FIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (418)
Q Consensus 259 iiHrDlkp~NILl~~-~~~vkl~DfGla~~ 287 (418)
++|.|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 57899999998853
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.044 Score=54.47 Aligned_cols=79 Identities=11% Similarity=-0.030 Sum_probs=49.0
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHH-HHHHHHHHHHHHHHHHhCC---CCCeEEEEeEEeeCceEEEEE
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK-AQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~-~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~lv~ 215 (418)
.+.||-|....||+....+..|+||.-......... ......+-..|...|+.+. ..++++++.++.+.. +++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--LIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC--EEEE
Confidence 357899999999998877778999975421110000 0000012224455555543 357888999888543 6889
Q ss_pred eecCC
Q 014783 216 EYAKG 220 (418)
Q Consensus 216 E~~~~ 220 (418)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.075 Score=51.10 Aligned_cols=29 Identities=17% Similarity=0.259 Sum_probs=27.2
Q ss_pred CcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 258 GFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 258 ~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+++|+|+.+.|||++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.016 Score=57.26 Aligned_cols=79 Identities=11% Similarity=0.055 Sum_probs=46.1
Q ss_pred cCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC--CC-CeEEEEeEEeeCceEEEE
Q 014783 140 GTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp-niv~l~~~~~~~~~~~lv 214 (418)
.+.||-|.-.-||++.+. ++.|+||.-..--...+......++..-|...|+... -| +++++|.+-.+. ..+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~--~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVM--NCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHH--hhHH
Confidence 357899999999999974 5689999654211111110111234445666666553 24 455666543332 3578
Q ss_pred EeecCC
Q 014783 215 TEYAKG 220 (418)
Q Consensus 215 ~E~~~~ 220 (418)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.047 Score=52.90 Aligned_cols=135 Identities=21% Similarity=0.252 Sum_probs=79.1
Q ss_pred eeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC------eEEEEe----EEeeCceEE
Q 014783 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIG----ACRKRMVWC 212 (418)
Q Consensus 143 lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------iv~l~~----~~~~~~~~~ 212 (418)
|.+ .--.||+....+..+++|+.+.. ... .++.-|...|..|.-.. +..+=| ........+
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~-------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WTR-------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CCH-------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 444 45578988886666699998765 332 34556677777663211 222212 122223677
Q ss_pred EEEeecCCCCHHH------------HHhh-------hc----C--CCCCHHH-------------HHHHHHHHHHHHHHH
Q 014783 213 IVTEYAKGGSVRQ------------FLTR-------RQ----N--RAVPLKL-------------AVKQALDVARGMAYV 254 (418)
Q Consensus 213 lv~E~~~~gsL~~------------~l~~-------~~----~--~~~~~~~-------------~~~i~~qi~~gL~yL 254 (418)
-+.+|++|..+.. ++-+ .. . ....+.. -.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8899998877762 1110 00 0 0111210 011233455555555
Q ss_pred Hh--------CC--cccCCCCCCcEEEcCCCC-EEEeecccce
Q 014783 255 HG--------LG--FIHRDLKSDNLLISADKS-IKIADFGVAR 286 (418)
Q Consensus 255 H~--------~~--iiHrDlkp~NILl~~~~~-vkl~DfGla~ 286 (418)
.+ .+ +||+|+.|.|||++.+.. +.++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 53 23 999999999999998885 8999999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.031 Score=54.70 Aligned_cols=135 Identities=16% Similarity=0.253 Sum_probs=75.7
Q ss_pred ceeeeCceEEEEEEEC------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE-EEEeEEeeCceEEEE
Q 014783 142 AFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIGACRKRMVWCIV 214 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv-~l~~~~~~~~~~~lv 214 (418)
.|-.|-.-.+|+..+. ++.|++|+........- + -.+|..+++.+..-++- ++++.+..+ .|
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i------d-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF------D-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee------c-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 4445777899998752 25789998754321110 1 14677777777543333 455655332 57
Q ss_pred EeecCCCCHHHH--------------HhhhcC-----CC-C-CHHHHHHHHHH-----------------HHHHHHHHH-
Q 014783 215 TEYAKGGSVRQF--------------LTRRQN-----RA-V-PLKLAVKQALD-----------------VARGMAYVH- 255 (418)
Q Consensus 215 ~E~~~~gsL~~~--------------l~~~~~-----~~-~-~~~~~~~i~~q-----------------i~~gL~yLH- 255 (418)
+||+++.+|..- +.+-.. .. . ....+.++..+ +...+..|.
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987665311 111000 00 1 11222222211 111122221
Q ss_pred -------hCCcccCCCCCCcEEEcC-CCCEEEeeccccee
Q 014783 256 -------GLGFIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (418)
Q Consensus 256 -------~~~iiHrDlkp~NILl~~-~~~vkl~DfGla~~ 287 (418)
...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 235899999999999986 47899999988853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.059 Score=48.75 Aligned_cols=135 Identities=13% Similarity=0.126 Sum_probs=82.3
Q ss_pred eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHH
Q 014783 160 DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239 (418)
Q Consensus 160 ~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~ 239 (418)
+..+|.+......-.. .-|..+..++.+++ .|++|..- ....+.++.|.|..-.. .+
T Consensus 87 ~L~lKKi~slp~~~~~-----~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~--- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCIND-----ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF--- 143 (308)
T ss_pred hhhhhhccCCCcccch-----hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch---
Confidence 4456665443333121 34567778877764 57777633 45567899999843211 11
Q ss_pred HHHHHHHHHHHHHHHHh--CCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCc
Q 014783 240 AVKQALDVARGMAYVHG--LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQK 317 (418)
Q Consensus 240 ~~~i~~qi~~gL~yLH~--~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~ 317 (418)
..++..=+.+|.-+|+ .+.+|+|..|+||+-|..|.+||.|=+.--. .+.-|.- ......|++
T Consensus 144 -~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-----------~~V~~vN---~~Y~~lT~~ 208 (308)
T PF07387_consen 144 -SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-----------NQVNMVN---IEYESLTQE 208 (308)
T ss_pred -hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh-----------heeeEEe---eeccccChH
Confidence 1111111456777884 4799999999999999999999999764310 1122222 122345778
Q ss_pred chHHHHHHHHHHHHh
Q 014783 318 VDVYSFGIVLWELIT 332 (418)
Q Consensus 318 sDvwSlGv~l~ellt 332 (418)
+.+=+|-.-++++..
T Consensus 209 aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 209 AEVKVFVKSCLKLVE 223 (308)
T ss_pred HHHHHHHHHHHHHHH
Confidence 888777776777665
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.11 Score=47.18 Aligned_cols=74 Identities=19% Similarity=0.221 Sum_probs=53.2
Q ss_pred ceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC---CCeEEEEeEEeeCceEEEEEeec
Q 014783 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~~~~~~~~lv~E~~ 218 (418)
.+.-|---+.|...+...++-||+-.+ .+...|.+|+.-|..+.. -.+.+.+.+......-|+|+||+
T Consensus 23 ~v~gG~inea~~v~dg~~~~FvK~n~~---------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 23 EVSGGDINEAWRLRDGTDPFFVKCNQR---------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred ccCCccccceeEeecCCcceEEEecch---------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 344455556677777778999998432 123567788877776643 45778899988999999999999
Q ss_pred CCCCHH
Q 014783 219 KGGSVR 224 (418)
Q Consensus 219 ~~gsL~ 224 (418)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.57 Score=45.45 Aligned_cols=28 Identities=32% Similarity=0.386 Sum_probs=24.0
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.072 Score=51.67 Aligned_cols=101 Identities=16% Similarity=0.256 Sum_probs=65.8
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...|++|++- |++|. .++ .....++..++.+.+..+.-+... .+=||++.-.||||+ +|+|-|+||-++|.
T Consensus 299 ~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3457777765 55553 221 134567788888888777777754 689999999999999 99999999999984
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYS 322 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwS 322 (418)
...... .---..--|-.+.|.. +..-|||-
T Consensus 371 ~~~q~~----isy~rldhp~lF~G~d-d~QFeIYr 400 (488)
T COG5072 371 SYSQGI----ISYNRLDHPDLFNGVD-DYQFEIYR 400 (488)
T ss_pred ccCCce----eeccccCchhhhcCcc-ceeeeHHH
Confidence 322211 1112233455555443 55566665
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.18 Score=50.13 Aligned_cols=29 Identities=34% Similarity=0.383 Sum_probs=24.4
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
..++|.|+-+.|||.++ +.++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 45799999999999764 569999998775
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.22 Score=46.42 Aligned_cols=78 Identities=15% Similarity=0.131 Sum_probs=52.7
Q ss_pred cCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEeec
Q 014783 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
...+-.|..+.|+.++. +|++.++|+......... +. .....|+..+-...|+++..-.+.. .+++|.+
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-------E~-~g~~~L~~w~G~GaVrll~~d~~~~--AlLLErl 76 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-------EA-RGEAALRWWNGRGAVRLLAADPERG--ALLLERL 76 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-------hh-hHHhHhheeCCCCceeeeccccccc--hhhhhhc
Confidence 34566799999999976 889999999864332211 11 1124577777788899998765444 5788988
Q ss_pred -CCCCHHHHH
Q 014783 219 -KGGSVRQFL 227 (418)
Q Consensus 219 -~~gsL~~~l 227 (418)
.+.+|.+..
T Consensus 77 ~~g~~L~~~~ 86 (253)
T PF04655_consen 77 DPGRSLASLP 86 (253)
T ss_pred cCCCchhhcc
Confidence 445676554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.1 Score=51.38 Aligned_cols=61 Identities=28% Similarity=0.356 Sum_probs=41.9
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEcCC
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISAD 274 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NILl~~~ 274 (418)
..++=+|+.|-++..+++... .++....+++.--+.|+-.+= -.+++|.|+.|.||++-.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 356777888999998887532 445455555554444444333 3589999999999999643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.73 Score=51.72 Aligned_cols=30 Identities=40% Similarity=0.597 Sum_probs=25.7
Q ss_pred CCcccCCCCCCcEEEcCCC--CEE-Eeecccce
Q 014783 257 LGFIHRDLKSDNLLISADK--SIK-IADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~--~vk-l~DfGla~ 286 (418)
.++||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 455 99999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 418 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-42 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-39 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-37 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-36 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-36 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-36 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-35 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-35 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-35 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-35 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-35 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-35 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-35 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-35 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-35 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-35 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-35 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-35 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-35 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-35 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-35 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-35 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-35 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-35 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-35 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-35 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-35 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-35 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-35 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-35 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-34 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-34 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-34 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-34 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-34 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-34 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-34 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-34 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-34 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-34 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-34 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-34 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-34 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-34 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-34 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-34 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-34 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-34 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-34 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-34 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-34 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-34 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-34 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-34 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-34 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-34 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-33 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-33 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-33 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-33 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-33 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-33 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-33 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-33 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-33 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-33 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-32 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-32 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-32 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-32 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-32 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-32 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-32 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-32 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-32 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-32 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-32 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-32 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-32 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-32 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-32 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-31 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-31 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-31 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-31 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-31 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-31 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-31 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-31 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-31 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-31 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-31 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-31 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-31 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-31 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-31 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-31 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-31 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-31 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-31 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-31 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-31 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-31 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-31 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-31 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-31 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-31 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-31 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-31 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-31 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-31 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-31 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-31 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-31 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-31 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-30 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-30 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-30 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-30 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-30 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-30 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-30 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-30 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-30 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-30 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-30 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-30 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-30 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-30 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-30 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-30 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-30 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-30 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-30 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-30 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-30 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-30 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-30 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-30 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-30 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-30 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-30 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-30 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-30 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-30 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-30 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-30 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-30 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-30 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-30 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-30 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-30 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-30 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-30 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-30 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-30 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-30 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-30 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-30 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-30 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-30 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-30 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-30 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-30 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-30 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-30 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-30 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-30 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-30 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-30 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-30 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-29 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-29 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-29 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-29 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-29 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-29 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-29 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-28 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-28 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-28 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-28 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-28 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-28 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-28 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-28 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-28 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-28 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-28 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-28 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-28 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-28 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-28 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-28 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-28 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-28 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-28 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-28 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-28 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-28 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-28 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-28 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-28 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-28 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-28 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-27 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-27 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-27 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-27 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-27 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-27 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-27 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-27 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-27 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-27 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-26 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-26 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-26 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-26 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-26 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-26 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-26 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-26 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-26 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-26 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-26 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-26 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-26 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-26 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-26 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-26 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-26 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-26 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-26 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-26 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-26 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-26 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-26 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-26 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-25 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-25 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-25 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-25 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-25 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-25 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-25 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-25 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-25 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-25 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-25 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-25 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-25 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-24 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-24 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-24 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-24 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-24 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-24 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-24 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-24 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-24 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-24 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-24 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-24 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-24 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-24 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-24 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-24 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-24 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-24 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-24 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-24 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-24 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-24 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-24 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-24 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-24 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-24 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-23 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-23 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-23 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-23 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-23 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-23 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-23 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-23 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-23 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-23 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-22 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-22 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-21 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-21 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-21 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-21 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-20 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-17 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-09 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-143
Identities = 98/289 (33%), Positives = 152/289 (52%), Gaps = 8/289 (2%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME 180
+G + D+ I LN+ G+FG ++R ++G DVA+KIL + + E
Sbjct: 23 FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE----RV 78
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKL 239
+F +EV ++ L+H NIV F+GA + IVTEY GS+ + L + R + +
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTP 296
+ A DVA+GM Y+H +HR+LKS NLL+ ++K+ DFG++R++ T
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP 356
GT WMAPE+++ P +K DVYSFG++LWEL T P+ N+ Q AV K R
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKA 405
IP + P ++ I+ CW P RP F I+ +L + ++
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-134
Identities = 98/275 (35%), Positives = 154/275 (56%), Gaps = 17/275 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKL 59
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A LKH NI+ G C K C+V E+A+GG + + L + +P + V A+ +AR
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIAR 116
Query: 250 GMAYVHGLG---FIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPET 298
GM Y+H IHRDLKS N+LI ++K +KI DFG+AR +T M+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AA 175
Query: 299 GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358
G Y WMAPE+I+ +++ DV+S+G++LWEL+TG +PF+ + + A+ V + I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ C +++M CW+ +P RP FT I+ L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-132
Identities = 80/277 (28%), Positives = 137/277 (49%), Gaps = 15/277 (5%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
ID ++LN T + G+L++G + G D+ +K+L+ + + + F +E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR----KSRDFNEEC 58
Query: 188 MMLATLKHLNIVRFIGACRKRMVW--CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
L H N++ +GAC+ ++T + GS+ L N V AVK AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 246 DVARGMAYVHGLGF--IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+ARGMA++H L L S +++I D + +I+ V M W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAW 174
Query: 304 MAPEMIQHRPY---TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360
+APE +Q +P + D++SF ++LWEL+T +PF +++ ++ V +G+RP IP
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397
P +S++M C + +P RP F IV +LE + +
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-130
Identities = 84/295 (28%), Positives = 146/295 (49%), Gaps = 24/295 (8%)
Query: 113 ALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE 170
A+ +P T+ ++ +G FG +++G + VAIK L +
Sbjct: 2 AMGGSEFPK-----SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 171 NNPEKAQVME-QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ E + + Q+FQ+EV +++ L H NIV+ G +V E+ G + L
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL-L 113
Query: 230 RQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-----ADKSIKIADF 282
+ + + ++ LD+A G+ Y+ +HRDL+S N+ + A K+ADF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 283 GVARIEVQTEGMTPETGTYRWMAPEMI--QHRPYTQKVDVYSFGIVLWELITGLLPFQNM 340
G+++ V + ++ G ++WMAPE I + YT+K D YSF ++L+ ++TG PF
Sbjct: 174 GLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 341 TAVQAAF--AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + F + +G+RP IP DC P L ++ CW +P+ RP F+ IV+ L
Sbjct: 232 SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-130
Identities = 79/303 (26%), Positives = 146/303 (48%), Gaps = 24/303 (7%)
Query: 107 DDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL 166
+ +L A R ++ EW I +L +G +G FG++Y G ++G +VAI+++
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLI 63
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQF 226
+ +N + + F++EVM +H N+V F+GAC I+T KG ++
Sbjct: 64 DIERDNED----QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ R + + + A ++ +GM Y+H G +H+DLKS N+ + + I DFG+
Sbjct: 120 V-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 287 IE------VQTEGMTPETGTYRWMAPEMIQHR---------PYTQKVDVYSFGIVLWELI 331
I + + + + G +APE+I+ P+++ DV++ G + +EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 332 TGLLPFQNMTAVQAAFAVVNKGVRPVIPN-DCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390
PF+ A + + G++P + +S+I+ CW E RP FT+++ M
Sbjct: 238 AREWPFKTQPAEAIIW-QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 391 LEN 393
LE
Sbjct: 297 LEK 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-129
Identities = 93/296 (31%), Positives = 143/296 (48%), Gaps = 18/296 (6%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
ID +++ + +GAFG + + + +DVAIK +E + F E+
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELR 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDV 247
L+ + H NIV+ GAC + C+V EYA+GGS+ L A+ L
Sbjct: 54 QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 248 ARGMAYVHGL---GFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRW 303
++G+AY+H + IHRDLK NLL+ A +KI DFG A MT G+ W
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAW 169
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM-TAVQAAFAVVNKGVRPVIPNDC 362
MAPE+ + Y++K DV+S+GI+LWE+IT PF + V+ G RP + +
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARFRCCMTQPMTVD 418
+ +MTRCW +P RP EIV+++ + ++ C + P D
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-129
Identities = 91/288 (31%), Positives = 149/288 (51%), Gaps = 17/288 (5%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ- 62
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
Q F+ EV +L +H+NI+ F+G + IVT++ +G S+ L
Sbjct: 63 ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL-HASETKF 117
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293
+K + A ARGM Y+H IHRDLKS+N+ + D ++KI DFG+A + + G
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 294 -MTPETGTYRWMAPEMIQHR---PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
+G+ WMAPE+I+ + PY+ + DVY+FGIVL+EL+TG LP+ N+ +
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237
Query: 350 VNKGVR----PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V +G + ++C + +M C + RP F I+ +E
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-126
Identities = 92/290 (31%), Positives = 137/290 (47%), Gaps = 25/290 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ 184
L G +G FG+ + T+ GE + +K L R + ++ F
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE------TQRTFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+EV ++ L+H N+++FIG K +TEY KGG++R + + + P V A
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFA 114
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------------ 292
D+A GMAY+H + IHRDL S N L+ +K++ +ADFG+AR+ V +
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 293 ---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
G WMAPEMI R Y +KVDV+SFGIVL E+I + + F +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
Query: 350 -VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398
V + P +C P I RC D +PE RP F ++ LE +
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-112
Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 53/308 (17%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+++ M +G +G+++ G + GE VA+K+ E + E+
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-------SWFRETEIY 83
Query: 189 MLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
++H NI+ FI A K ++T+Y + GS+ +L ++ + K +K A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLA 140
Query: 245 LDVARGMAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293
G+ ++H F HRDLKS N+L+ + + IAD G+A +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 294 --MTPETGTYRWMAPEMI------QHRPYTQKVDVYSFGIVLWELITGL----------L 335
GT R+M PE++ H D+YSFG++LWE+ L
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 336 PFQNMTAVQAAF-----AVVNKGVRPVIPN-----DCLPVLSEIMTRCWDTNPEVRPPFT 385
P+ ++ ++ V K +RP PN +CL + ++MT CW NP R
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 386 EIVRMLEN 393
+ + L
Sbjct: 321 RVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-111
Identities = 80/304 (26%), Positives = 134/304 (44%), Gaps = 53/304 (17%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
R + + +G +G+++RG++ GE+VA+KI + + E+ L+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-------SWFRETELYNTVMLR 60
Query: 195 HLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
H NI+ FI + ++T Y + GS+ +L Q + ++ L +A G
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 251 MAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-----GMTPE 297
+A++H F HRDLKS N+L+ + IAD G+A + Q+ G P
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 298 TGTYRWMAPEMIQHRP------YTQKVDVYSFGIVLWELITGL----------LPFQNMT 341
GT R+MAPE++ ++VD+++FG+VLWE+ + PF ++
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 342 AVQAAF-----AVVNKGVRPVIPND-----CLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
+F V RP IPN L L+++M CW NP R I + L
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 392 ENAE 395
+
Sbjct: 298 TKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 319 bits (818), Expect = e-107
Identities = 85/321 (26%), Positives = 139/321 (43%), Gaps = 54/321 (16%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
GL + TI R + + + +G FG+++RG + GE+VA+KI E
Sbjct: 28 SGSGLPLLVQRTI-ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER------- 79
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
+ E+ L+H NI+ FI A K +V++Y + GS+ +L R V
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TV 136
Query: 236 PLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++ +K AL A G+A++H HRDLKS N+L+ + + IAD G+A
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 288 EVQTE-----GMTPETGTYRWMAPEMI------QHRPYTQKVDVYSFGIVLWELITGL-- 334
GT R+MAPE++ +H ++ D+Y+ G+V WE+
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
Query: 335 --------LPFQNMTAVQAAF-----AVVNKGVRPVIPN-----DCLPVLSEIMTRCWDT 376
LP+ ++ + V + +RP IPN + L V+++IM CW
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 377 NPEVRPPFTEIVRMLENAETE 397
N R I + L +
Sbjct: 317 NGAARLTALRIKKTLSQLSQQ 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 312 bits (800), Expect = e-105
Identities = 82/321 (25%), Positives = 138/321 (42%), Gaps = 54/321 (16%)
Query: 117 HRYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + G++ + L + A+G FG +++ E VA+KI +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ--- 61
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQ 231
Q + EV L +KH NI++FIGA ++ + ++T + + GS+ FL
Sbjct: 62 ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 232 NRAVPLKLAVKQALDVARGMAYVHG----------LGFIHRDLKSDNLLISADKSIKIAD 281
V A +ARG+AY+H HRD+KS N+L+ + + IAD
Sbjct: 118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 282 FGVARI---EVQTEGMTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITG 333
FG+A + GT R+MAPE+++ R ++D+Y+ G+VLWEL +
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 334 -----------LLPFQNMTAVQAAF-----AVVNKGVRPVIPNDC-----LPVLSEIMTR 372
+LPF+ + VV+K RPV+ + + +L E +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 373 CWDTNPEVRPPFTEIVRMLEN 393
CWD + E R + +
Sbjct: 295 CWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-101
Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 68/325 (20%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
E ++DL L + +G +G +Y+G+ + VA+K+ Q F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFI 53
Query: 185 QE--VMMLATLKHLNIVRFIGACRK-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
E + + ++H NI RFI + RM + +V EY GS+ ++L+
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDW 110
Query: 238 KLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288
+ + A V RG+AY+H HRDL S N+L+ D + I+DFG++
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 289 VQTE---------GMTPETGTYRWMAPEMIQ-------HRPYTQKVDVYSFGIVLWELI- 331
E GT R+MAPE+++ ++VD+Y+ G++ WE+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 332 --TGLLPFQNMTAVQAAFA---------------VVNKGVRPVIPNDC------LPVLSE 368
T L P +++ Q AF V + RP P + L E
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 369 IMTRCWDTNPEVRPPFTEIVRMLEN 393
+ CWD + E R +
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAE 315
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 3e-80
Identities = 85/300 (28%), Positives = 143/300 (47%), Gaps = 22/300 (7%)
Query: 103 HALNDDALAQALMD-----HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN 157
+ + D L L+ + W +++++L + +G FG + G Y
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTE 216
G VA+K + K Q F E ++ L+H N+V+ +G ++ IVTE
Sbjct: 216 GNKVAVKCI--------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
Y GS+ +L R + +K +LDV M Y+ G F+HRDL + N+L+S D
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327
Query: 277 IKIADFGVAR--IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-G 333
K++DFG+ + Q G P +W APE ++ + ++ K DV+SFGI+LWE+ + G
Sbjct: 328 AKVSDFGLTKEASSTQDTGKLP----VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+P+ + V KG + P+ C P + ++M CW + RP F ++ LE+
Sbjct: 384 RVPYPRIPLKD-VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 6e-80
Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 18/278 (6%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
+ W +++++L + +G FG + G Y G VA+K + K
Sbjct: 7 AQDEFY-RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDAT 57
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ L+H N+V+ +G ++ IVTEY GS+ +L R +
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTP 296
+K +LDV M Y+ G F+HRDL + N+L+S D K++DFG+ + Q G P
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355
+W APE ++ + ++ K DV+SFGI+LWE+ + G +P+ + V KG +
Sbjct: 178 ----VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYK 232
Query: 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ C P + E+M CW + +RP F ++ LE+
Sbjct: 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-79
Identities = 82/278 (29%), Positives = 141/278 (50%), Gaps = 17/278 (6%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--DVAIKILERPENNPEKAQVME 180
G NYD+W ++ + M G +G++Y G + VA+K L K ME
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME 52
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L + V +
Sbjct: 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 171
Query: 300 T---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355
+W APE + + ++ K DV++FG++LWE+ T G+ P+ + Q + ++ K R
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYR 230
Query: 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P C + E+M CW NP RP F EI + E
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 3e-79
Identities = 86/301 (28%), Positives = 134/301 (44%), Gaps = 24/301 (7%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--D 160
L + D+W ++ L +G +G FG+++ G +
Sbjct: 85 LLSTQQPLTKKS---GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VA+K + + F QE +L H NIVR IG C ++ IV E
Sbjct: 142 VAVKSC--------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+GG FL R + + +K ++ D A GM Y+ IHRDL + N L++ +
Sbjct: 194 VQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 278 KIADFGVARIEVQTEGMTPETGT----YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT- 332
KI+DFG++R E G +W APE + + Y+ + DV+SFGI+LWE +
Sbjct: 253 KISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 333 GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
G P+ N++ Q V KG R P C + +M +CW P RP F+ I + L+
Sbjct: 312 GASPYPNLSNQQ-TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
Query: 393 N 393
+
Sbjct: 371 S 371
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-78
Identities = 84/304 (27%), Positives = 146/304 (48%), Gaps = 23/304 (7%)
Query: 103 HALNDDALAQAL------MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY 156
H+ D L L + NYD+W ++ + M G +G++Y G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 157 NGE--DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213
VA+K L K ME + F +E ++ +KH N+V+ +G C + + I
Sbjct: 242 KKYSLTVAVKTL--------KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+TE+ G++ +L + V + + A ++ M Y+ FIHR+L + N L+
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWEL 330
+ +K+ADFG++R+ + + T G +W APE + + ++ K DV++FG++LWE+
Sbjct: 354 NHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 331 IT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
T G+ P+ + Q + ++ K R P C + E+M CW NP RP F EI +
Sbjct: 413 ATYGMSPYPGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471
Query: 390 MLEN 393
E
Sbjct: 472 AFET 475
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 6e-78
Identities = 91/272 (33%), Positives = 141/272 (51%), Gaps = 17/272 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQ 185
DEW + L + G FG+++ G YNG VA+K L K M F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLA 57
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ ++ T G +
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIK 175
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
W APE I + +T K DV+SFGI+L E++T G +P+ MT + + +G R V P++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDN 234
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
C L ++M CW PE RP F + +LE+
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 2e-77
Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 31/298 (10%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENN 172
R E ++ ID L +G +G FG + G ED VA+K + + +N+
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNS 75
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC-----IVTEYAKGGSVRQFL 227
++ ++F E + H N++R +G C + ++ + K G + +L
Sbjct: 76 SQREI---EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ P + ++ +D+A GM Y+ F+HRDL + N ++ D ++ +ADFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 284 VARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLL 335
+++ P +W+A E + R YT K DV++FG+ +WE+ T G+
Sbjct: 193 LSKKIYSGDYYRQGRIAKMP----VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
Query: 336 PFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ + + + + G R P DCL L EIM CW T+P RP F+ + LE
Sbjct: 249 PYPGVQNHE-MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 5e-77
Identities = 104/352 (29%), Positives = 164/352 (46%), Gaps = 28/352 (7%)
Query: 54 GSVSMSVDNSSVGSNDSLTH----ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDA 109
GS S+SV + D++ H L + G + ++ + V + +D
Sbjct: 106 GSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDH-----YKKGNDG 160
Query: 110 LAQALMD--HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKIL 166
L Q L + D W I L + G FG+++ TYN VA+K +
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 167 ERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
K M + F E ++ TL+H +V+ K ++ I+TE+ GS+
Sbjct: 221 --------KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLD 271
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
FL + PL + + +A GMA++ +IHRDL++ N+L+SA KIADFG+A
Sbjct: 272 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
Query: 286 RIEVQTEGMTPETGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMT 341
R+ ++ T G +W APE I +T K DV+SFGI+L E++T G +P+ M+
Sbjct: 332 RV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390
Query: 342 AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + +G R P +C L IM RCW PE RP F I +L++
Sbjct: 391 NPE-VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-76
Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 32/289 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
++ I ++ +G +G FG + ED VA+K+L + + + E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIASSDIEE-- 71
Query: 183 FQQEVMMLATLKHLNIVRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
F +E + H ++ + +G + + ++ + K G + FL + P
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
L ++ +D+A GM Y+ FIHRDL + N +++ D ++ +ADFG++R
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 288 --EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQ 344
P +W+A E + YT DV++FG+ +WE++T G P+ + +
Sbjct: 192 YYRQGCASKLP----VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + G R P +C+ + ++M +CW +P+ RP FT + LEN
Sbjct: 248 -IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-76
Identities = 75/280 (26%), Positives = 134/280 (47%), Gaps = 17/280 (6%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQV 178
P+ Y W ID + L G FG + G + G+ DVAIK++ K
Sbjct: 9 PSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--------KEGS 60
Query: 179 MEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
M + F +E ++ L H +V+ G C K+ I+TEY G + +L R
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQT 119
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
+ ++ DV M Y+ F+HRDL + N L++ +K++DFG++R V + T
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSS 178
Query: 298 TGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353
G+ RW PE++ + ++ K D+++FG+++WE+ + G +P++ T + + +G
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG 237
Query: 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+R P+ + IM CW + RP F ++ + +
Sbjct: 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-76
Identities = 97/300 (32%), Positives = 145/300 (48%), Gaps = 20/300 (6%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 209 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 259
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-G 333
K+ADFG+AR ++ T G +W APE + +T K DV+SFGI+L EL T G
Sbjct: 320 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+P+ M + V +G R P +C L ++M +CW PE RP F + LE+
Sbjct: 379 RVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-76
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 40/297 (13%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
I R + + +GAFGK++ VA+K L +
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------KDPTLA 59
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ FQ+E +L L+H +IV+F G C +V EY K G + +FL
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
Q R +L + Q A +A GM Y+ F+HRDL + N L+ A+ +KI DFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 285 ARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLP 336
+R V M P RWM PE I +R +T + DV+SFG++LWE+ T G P
Sbjct: 180 SRDVYSTDYYRVGGHTMLP----IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 337 FQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ ++ + + +G P C + ++M CW P+ R EI ++L
Sbjct: 236 WFQLSNTE-VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 7e-76
Identities = 81/271 (29%), Positives = 137/271 (50%), Gaps = 17/271 (6%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQE 186
+W ID +L G FG ++ G + + VAIK + + M ++ F +E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEE 53
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L H +V+ G C ++ C+VTE+ + G + +L ++ L + LD
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLD 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
V GMAY+ IHRDL + N L+ ++ IK++DFG+ R V + T TGT +W
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKW 171
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362
+PE+ Y+ K DV+SFG+++WE+ + G +P++N + + ++ G R P
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDISTGFRLYKPRLA 230
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ +IM CW PE RP F+ ++R L
Sbjct: 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-75
Identities = 97/300 (32%), Positives = 145/300 (48%), Gaps = 20/300 (6%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 232 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 291
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 292 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 342
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-G 333
K+ADFG+AR ++ T G +W APE + +T K DV+SFGI+L EL T G
Sbjct: 403 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+P+ M + V +G R P +C L ++M +CW PE RP F + LE+
Sbjct: 462 RVPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 7e-75
Identities = 81/270 (30%), Positives = 132/270 (48%), Gaps = 17/270 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQEV 187
+ ++ + G FG + G + G+ DVA+K++ K M + F QE
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI--------KEGSMSEDEFFQEA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+ L H +V+F G C K IVTEY G + +L R + + ++ DV
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDV 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
GMA++ FIHRDL + N L+ D +K++DFG+ R V + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWS 172
Query: 305 APEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
APE+ + Y+ K DV++FGI++WE+ + G +P+ T + V++G R P+
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-VVLKVSQGHRLYRPHLAS 231
Query: 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ +IM CW PE RP F +++ +E
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 8e-75
Identities = 91/296 (30%), Positives = 135/296 (45%), Gaps = 43/296 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
I R + + +GAFGK++ + VA+K L E ++
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------KEASESAR 87
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
Q FQ+E +L L+H +IVRF G C + +V EY + G + +FL R +
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLA 145
Query: 234 ----AVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
P L + Q A VA GM Y+ GL F+HRDL + N L+ +KI DFG++
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 286 R-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF 337
R V M P RWM PE I +R +T + DV+SFG+VLWE+ T G P+
Sbjct: 206 RDIYSTDYYRVGGRTMLP----IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
++ + A + +G P C P + IM CW P+ R ++ L+
Sbjct: 262 YQLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-74
Identities = 90/343 (26%), Positives = 144/343 (41%), Gaps = 37/343 (10%)
Query: 77 HPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--DEWTIDL 134
+ + Y S + + + + + Y G + D +
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ-FQQE 186
+ + + GAFG++Y G +G VA+K L PE ++ F E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQDELDFLME 124
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQ-- 243
++++ H NIVR IG + + I+ E GG ++ FL R + P LA+
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 244 --ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVAR-------IEVQT 291
A D+A G Y+ FIHRD+ + N L++ + KI DFG+AR
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVV 350
M P +WM PE +T K D +SFG++LWE+ + G +P+ + + + V
Sbjct: 245 CAMLP----VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFV 299
Query: 351 NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
G R P +C + IMT+CW PE RP F I+ +E
Sbjct: 300 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-74
Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 37/301 (12%)
Query: 119 YPTEGLENY--DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERP 169
Y G + D + + + + GAFG++Y G +G VA+K L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--- 68
Query: 170 ENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL- 227
PE ++ F E ++++ H NIVR IG + + I+ E GG ++ FL
Sbjct: 69 ---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIA 280
R + P LA+ A D+A G Y+ FIHRD+ + N L++ + KI
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 281 DFGVAR-------IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT- 332
DFG+AR M P +WM PE +T K D +SFG++LWE+ +
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLP----VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 333 GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
G +P+ + + + V G R P +C + IMT+CW PE RP F I+ +E
Sbjct: 242 GYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300
Query: 393 N 393
Sbjct: 301 Y 301
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-74
Identities = 83/289 (28%), Positives = 138/289 (47%), Gaps = 33/289 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G G VAIK + N +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 72
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVP 236
+F E ++ ++VR +G + ++ E G ++ +L N V
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
++ + A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 288 --EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQ 344
+G+ P RWM+PE ++ +T DV+SFG+VLWE+ T P+Q ++ Q
Sbjct: 193 YYRKGGKGLLP----VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V +G P++C +L E+M CW NP++RP F EI+ ++
Sbjct: 249 -VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-74
Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 18/283 (6%)
Query: 128 DEWTIDLRKLNM-GTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
E +D + L + G FG + +G Y + VA+KIL + E N + +
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPAL---KDE 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++ L + IVR IG C +V E A+ G + ++L +QNR V K ++
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + +T
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 301 --YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
+W APE I + ++ K DV+SFG+++WE + G P++ M + A++ KG R
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERMG 240
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400
P C + ++M CW + E RP F + L N +++
Sbjct: 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-74
Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 19/290 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
I + L + G+FG + RG ++ VA+K L+ + +A
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DD 67
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
F +EV + +L H N++R G + +VTE A GS+ L R+ L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL-RKHQGHFLLGTLSR 125
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
A+ VA GM Y+ FIHRDL + NLL++ +KI DFG+ R + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 301 --YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
+ W APE ++ R ++ D + FG+ LWE+ T G P+ + Q + +G R
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKARF 407
P DC + +M +CW PE RP F + L E T +A F
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL----EAQPTDMRAEF 291
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-74
Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 39/293 (13%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ 182
I L + + FGK+Y+G G VAIK L + + ++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLR---EE 58
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----------QN 232
F+ E M+ A L+H N+V +G K ++ Y G + +FL R +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 233 RAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI- 287
R V L +A GM Y+ +H+DL + N+L+ ++KI+D G+ R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 288 ------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNM 340
++ + P RWMAPE I + ++ D++S+G+VLWE+ + GL P+
Sbjct: 179 YAADYYKLLGNSLLP----IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ ++ P+DC + +M CW+ P RP F +I L
Sbjct: 235 SNQD-VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 6e-74
Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 24/275 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ--- 182
+ + GAFG +Y+G + E VAIK L + +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++A++ + ++ R +G C V ++T+ G + ++ R + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 301 -YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
+WMA E I HR YT + DV+S+G+ +WEL+T G P+ + A + +++ KG R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQ 240
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P C + IM +CW + + RP F E++
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-74
Identities = 79/276 (28%), Positives = 138/276 (50%), Gaps = 18/276 (6%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I + + +G FG++Y G Y VA+K + ++
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKE 58
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F E +++ L H +IV+ IG + W I+ E G + +L R ++ + V
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLV 116
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
+L + + MAY+ + +HRD+ N+L+++ + +K+ DFG++R ++ E + T
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTR 175
Query: 301 --YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
+WM+PE I R +T DV+ F + +WE+++ G PF + V+ KG R
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKGDRLP 234
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ C PVL +MTRCWD +P RP FTE+V L +
Sbjct: 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-73
Identities = 89/303 (29%), Positives = 142/303 (46%), Gaps = 26/303 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQ 181
I + G FG++Y+G VAIK L KA E+
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTEK 88
Query: 182 Q---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ H NI+R G K I+TEY + G++ +FL + L+
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPE 297
L V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +E E
Sbjct: 149 L-VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 298 TGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353
+G RW APE I +R +T DV+SFGIV+WE++T G P+ ++ +N G
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
Query: 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN--AETEIMTTVRKARFRCCM 411
R P DC + ++M +CW RP F +IV +L+ + + T+ R +
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSI 326
Query: 412 TQP 414
P
Sbjct: 327 RLP 329
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-73
Identities = 91/333 (27%), Positives = 135/333 (40%), Gaps = 51/333 (15%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
+ L D L M R P + +GAFG++++ G
Sbjct: 12 TLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGL 71
Query: 160 D-------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212
VA+K+L E Q FQ+E ++A + NIV+ +G C C
Sbjct: 72 LPYEPFTMVAVKML--KEEASADMQ---ADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126
Query: 213 IVTEYAKGGSVRQFLTRRQNR--------------------AVPLKLAVKQ----ALDVA 248
++ EY G + +FL R P L+ + A VA
Sbjct: 127 LLFEYMAYGDLNEFL--RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGTY 301
GMAY+ F+HRDL + N L+ + +KIADFG++R + P
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP----I 240
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360
RWM PE I + YT + DV+++G+VLWE+ + GL P+ M + V G P
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPE 299
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+C L +M CW P RP F I R+L+
Sbjct: 300 NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-73
Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 29/288 (10%)
Query: 124 LENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
++ I ++ +G FG +Y GT D A+K L
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 69
Query: 177 QVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
QF E +++ H N++ +G C R +V Y K G +R F+ R +
Sbjct: 70 V---SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNP 125
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--------- 286
+K + L VA+GM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345
+ +T P +WMA E +Q + +T K DV+SFG++LWEL+T G P+ ++
Sbjct: 186 VHNKTGAKLP----VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD- 240
Query: 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ +G R + P C L E+M +CW E+RP F+E+V +
Sbjct: 241 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 6e-73
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 31/289 (10%)
Query: 124 LENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
L + I + + +G FG +Y G Y + AIK L
Sbjct: 8 LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL------SRIT 61
Query: 177 QVME-QQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
++ + + F +E +++ L H N++ IG + ++ Y G + QF+ R R
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRN 120
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------- 286
+K + L VARGM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 287 -IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQ 344
++ P +W A E +Q +T K DV+SFG++LWEL+T G P++++
Sbjct: 181 SVQQHRHARLP----VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ +G R P C L ++M +CW+ +P VRP F +V +E
Sbjct: 237 -LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 9e-73
Identities = 86/279 (30%), Positives = 136/279 (48%), Gaps = 23/279 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQ 182
I+ ++++ G G++ G VAIK L KA E+Q
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------KAGYTERQ 93
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G + + IVTEY + GS+ FL + ++L
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V V GM Y+ LG++HRDL + N+L+ ++ K++DFG++R +E + T
Sbjct: 154 -VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 299 GT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354
G RW APE I R ++ DV+SFG+V+WE++ G P+ NMT + + V +G
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEGY 271
Query: 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
R P C L ++M CW + RP F++IV +L+
Sbjct: 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-72
Identities = 84/322 (26%), Positives = 142/322 (44%), Gaps = 52/322 (16%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---- 158
H + + L + G D R L +G FGK+ Y+
Sbjct: 7 HHHHHHGALEVL----FQGPG----DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDG 58
Query: 159 --EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV--WCIV 214
E VA+K L + + P+ ++QE+ +L TL H +I+++ G C +V
Sbjct: 59 TGEMVAVKAL-KADAGPQ----HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GS+R +L ++ L + A + GMAY+H +IHRDL + N+L+ D
Sbjct: 114 MEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 275 KSIKIADFGVARI--------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIV 326
+ +KI DFG+A+ V+ +G +P W APE ++ + DV+SFG+
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 327 LWELIT---------------GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
L+EL+T + MT ++ ++ +G R P+ C + +M
Sbjct: 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMK 285
Query: 372 RCWDTNPEVRPPFTEIVRMLEN 393
CW+T RP F ++ +L+
Sbjct: 286 NCWETEASFRPTFENLIPILKT 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-72
Identities = 79/276 (28%), Positives = 136/276 (49%), Gaps = 18/276 (6%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I ++ +G +G FG +++G Y + VAIK + + +
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVRE 61
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F QE + + H +IV+ IG + VW I+ E G +R FL R+ L +
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASL-I 119
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++ +
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGK 178
Query: 301 --YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
+WMAPE I R +T DV+ FG+ +WE++ G+ PFQ + + G R
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERLP 237
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+P +C P L +MT+CW +P RP FTE+ L
Sbjct: 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-72
Identities = 91/299 (30%), Positives = 144/299 (48%), Gaps = 43/299 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L+ G GAFGK+ T G VA+K+L A + E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML------KPSAHLTE 69
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--- 235
++ E+ +L+ L H+NIV +GAC ++TEY G + FL R+++ +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 236 ---------PLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L L ++ + VA+GMA++ IHRDL + N+L++ + KI DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334
G+AR V+ P +WMAPE I + YT + DV+S+GI LWEL + G
Sbjct: 190 GLARDIKNDSNYVVKGNARLP----VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ M + ++ +G R + P + +IM CWD +P RP F +IV+++E
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-72
Identities = 80/321 (24%), Positives = 137/321 (42%), Gaps = 48/321 (14%)
Query: 112 QALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKI 165
+ L E+ D + R L +G FG + Y+ VA+K
Sbjct: 18 ENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 166 LERPENNPEKAQVMEQQ--FQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGG 221
L + E F++E+ +L +L+H NIV++ G C R ++ EY G
Sbjct: 78 L--------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
S+R +L + + R +KL ++ + +GM Y+ +IHRDL + N+L+ + +KI D
Sbjct: 130 SLRDYLQKHKERIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188
Query: 282 FGVARI--------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT- 332
FG+ ++ +V+ G +P W APE + ++ DV+SFG+VL+EL T
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESP----IFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244
Query: 333 ---------------GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377
G M ++ R P+ C + IMT CW+ N
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 303
Query: 378 PEVRPPFTEIVRMLENAETEI 398
RP F ++ ++ ++
Sbjct: 304 VNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-72
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 48/300 (16%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FG + Y+ E VA+K L + E
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEH 54
Query: 182 Q--FQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
F++E+ +L +L+H NIV++ G C R ++ EY GS+R +L + + R +
Sbjct: 55 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EV 289
KL ++ + +GM Y+ +IHRDL + N+L+ + +KI DFG+ ++ +V
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT----------------G 333
+ G +P W APE + ++ DV+SFG+VL+EL T G
Sbjct: 174 KEPGESP----IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
M ++ R P+ C + IMT CW+ N RP F ++ ++
Sbjct: 230 NDKQGQMIVFH-LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-72
Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 18/276 (6%)
Query: 128 DEWTIDLRKLNMG-TAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
+ + L + G FG + +G Y DVAIK+L + ++
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKA----DTEE 56
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E ++ L + IVR IG C+ + +V E A GG + +FL + +P+ +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGKREEIPVSNVAE 114
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + T +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 301 --YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357
+W APE I R ++ + DV+S+G+ +WE ++ G P++ M + A + +G R
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRME 233
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P +C P L +M+ CW E RP F + + +
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-72
Identities = 87/307 (28%), Positives = 141/307 (45%), Gaps = 45/307 (14%)
Query: 117 HRYPTEGLENY-DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED----VAIKILERPEN 171
H + + + +D + +G FG++ + + AIK +
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----- 60
Query: 172 NPEKAQVMEQQ---FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL 227
K + F E+ +L L H NI+ +GAC R + EYA G++ FL
Sbjct: 61 ---KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 228 TRRQNRAVPL------------KLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
R++R + L+ +Q A DVARGM Y+ FIHRDL + N+L+
Sbjct: 118 --RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 272 SADKSIKIADFGVARIE----VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVL 327
+ KIADFG++R + +T G P RWMA E + + YT DV+S+G++L
Sbjct: 176 GENYVAKIADFGLSRGQEVYVKKTMGRLP----VRWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 328 WELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTE 386
WE+++ G P+ MT + + + +G R P +C + ++M +CW P RP F +
Sbjct: 232 WEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290
Query: 387 IVRMLEN 393
I+ L
Sbjct: 291 ILVSLNR 297
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 4e-72
Identities = 85/297 (28%), Positives = 138/297 (46%), Gaps = 40/297 (13%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L +G +GAFG++ G D VA+K+L
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEH 74
Query: 181 QQFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ E+ +L + HLN+V +GAC + ++ E+ K G++ +L ++N VP K
Sbjct: 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 239 LAVKQ--------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
+A + + VA+GM ++ IHRDL + N+L+S +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 285 ARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLP 336
AR + + P +WMAPE I R YT + DV+SFG++LWE+ + G P
Sbjct: 195 ARDIYKDPDYVRKGDARLP----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 337 FQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + + + +G R P+ P + + M CW P RP F+E+V L N
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-72
Identities = 90/299 (30%), Positives = 142/299 (47%), Gaps = 44/299 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +GAFG++ G D VA+K+L + A
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 81
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334
G+AR + T G P +WMAPE + R YT + DV+SFG+++WE+ T G
Sbjct: 202 GLARDINNIDYYKKTTNGRLP----VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ + + F ++ +G R P +C L +M CW P RP F ++V L+
Sbjct: 258 SPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-72
Identities = 82/293 (27%), Positives = 134/293 (45%), Gaps = 29/293 (9%)
Query: 119 YPTEGLENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPEN 171
E ++ I ++ +G FG +Y GT D A+K L
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI 128
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR 230
QF E +++ H N++ +G C R +V Y K G +R F+ R
Sbjct: 129 TDIGE---VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RN 184
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ +K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 287 -----IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNM 340
+ +T P +WMA E +Q + +T K DV+SFG++LWEL+T G P+ ++
Sbjct: 245 KEFDSVHNKTGAKLP----VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300
Query: 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ +G R + P C L E+M +CW E+RP F+E+V +
Sbjct: 301 NTFD-ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 1e-71
Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 43/311 (13%)
Query: 115 MDHRYPTEGL--ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKIL 166
M H + D + R L + +G FG + Y+ VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVR 224
+ + P++ ++ FQ+E+ +L L IV++ G R +V EY G +R
Sbjct: 61 Q--HSGPDQ----QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
FL +R + + + + +GM Y+ +HRDL + N+L+ ++ +KIADFG+
Sbjct: 115 DFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 285 ARI--------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLL 335
A++ V+ G +P W APE + ++++ DV+SFG+VL+EL T
Sbjct: 174 AKLLPLDKDYYVVREPGQSP----IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 336 PFQNMT-------------AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRP 382
A+ ++ +G R P C + E+M CW +P+ RP
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 383 PFTEIVRMLEN 393
F+ + L+
Sbjct: 290 SFSALGPQLDM 300
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-71
Identities = 72/274 (26%), Positives = 130/274 (47%), Gaps = 20/274 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ- 182
+L G FG +++G + E V IK++E +K+ Q
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE------DKSGRQSFQA 61
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H +IVR +G C + +VT+Y GS+ + R+ A+ +L +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV-RQHRGALGPQLLLN 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ G +HR+L + N+L+ + +++ADFGVA + + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 301 -YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358
+WMA E I YT + DV+S+G+ +WEL+T G P+ + + ++ KG R
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGERLAQ 238
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
P C + +M +CW + +RP F E+
Sbjct: 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-71
Identities = 96/355 (27%), Positives = 151/355 (42%), Gaps = 48/355 (13%)
Query: 74 ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTID 133
+ + Y +G + L M L W +
Sbjct: 8 HHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELP 67
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVMEQQ-F 183
+L +G +GAFG++ G D VA+K+L A +
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------KSDATEKDLSDL 121
Query: 184 QQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L + R L+ +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYN 179
Query: 243 Q----------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
A VARGM Y+ IHRDL + N+L++ D +KIADFG+AR
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 287 I-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338
+ T G P +WMAPE + R YT + DV+SFG++LWE+ T G P+
Sbjct: 240 DIHHIDYYKKTTNGRLP----VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + F ++ +G R P++C L +M CW P RP F ++V L+
Sbjct: 296 GVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-71
Identities = 88/279 (31%), Positives = 136/279 (48%), Gaps = 23/279 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
+D +++ G FG++ G VAIK L K E+Q
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--------KVGYTEKQ 89
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G K IVTEY + GS+ FL + + ++L
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V +A GM Y+ +G++HRDL + N+LI+++ K++DFG+ R +E E
Sbjct: 150 -VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 299 GT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGV 354
G RW +PE I +R +T DV+S+GIVLWE+++ G P+ M+ Q V++G
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGY 267
Query: 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
R P DC L ++M CW + RP F +IV +L+
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-71
Identities = 89/299 (29%), Positives = 141/299 (47%), Gaps = 44/299 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +G FG++ G D VA+K+L + A
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 127
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334
G+AR + T G P +WMAPE + R YT + DV+SFG+++WE+ T G
Sbjct: 248 GLARDINNIDYYKKTTNGRLP----VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ + + F ++ +G R P +C L +M CW P RP F ++V L+
Sbjct: 304 SPYPGIPVEE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-71
Identities = 83/306 (27%), Positives = 143/306 (46%), Gaps = 53/306 (17%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W + L +G +G FGK+ + T VA+K+L E A E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML------KENASPSE 69
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ E +L + H ++++ GAC + ++ EYAK GS+R FL R++R V
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGY 127
Query: 240 AVKQ------------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
A +++GM Y+ + +HRDL + N+L++ +
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 276 SIKIADFGVARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLW 328
+KI+DFG++R +++G P +WMA E + YT + DV+SFG++LW
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIP----VKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 329 ELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
E++T G P+ + + F ++ G R P++C + +M +CW P+ RP F +I
Sbjct: 244 EIVTLGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 388 VRMLEN 393
+ LE
Sbjct: 303 SKDLEK 308
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-71
Identities = 76/292 (26%), Positives = 132/292 (45%), Gaps = 34/292 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FGK+ Y GE VA+K L +PE+
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN----HIA 68
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
++E+ +L L H NIV++ G C + ++ E+ GS++++L + +N+ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
+K A+ + +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ + IE E T +
Sbjct: 129 -LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 299 GT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT---------------GLLPFQNM 340
W APE + + DV+SFG+ L EL+T M
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
Query: 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
T + + +G R P +C + ++M +CW+ P R F ++ E
Sbjct: 248 TVTR-LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-70
Identities = 84/295 (28%), Positives = 129/295 (43%), Gaps = 39/295 (13%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
++W L G GAFGK+ T G VA+K+L A E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML------KSTAHADE 92
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
++ E+ +++ L +H NIV +GAC ++TEY G + FL R+
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 231 QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + + VA+GMA++ IHRD+ + N+L++ KI DFG+AR
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 287 I-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338
V+ P +WMAPE I YT + DV+S+GI+LWE+ + GL P+
Sbjct: 213 DIMNDSNYIVKGNARLP----VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + +V G + P + IM CW P RP F +I L+
Sbjct: 269 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-70
Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQ 185
+ + GAFG +Y+G + E VAIK L + ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILD 66
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++A++ + ++ R +G C V ++T+ G + ++ R + + + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
WMA E I HR YT + DV+S+G+ +WEL+T G P+ + A + +++ KG R P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPI 243
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
C + IM +CW + + RP F E++
Sbjct: 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-69
Identities = 84/340 (24%), Positives = 149/340 (43%), Gaps = 29/340 (8%)
Query: 71 LTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--- 127
+ ++P + + + D+ + + Y
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP 380
Query: 128 --DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME 180
++ I ++ +G +G FG +++G Y + VAIK + +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTSDSVR 435
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
++F QE + + H +IV+ IG + VW I+ E G +R FL R+ L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASL- 493
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------EVQTEGM 294
+ A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++G
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353
P +WMAPE I R +T DV+ FG+ +WE++ G+ PFQ + + G
Sbjct: 554 LP----IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENG 608
Query: 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
R +P +C P L +MT+CW +P RP FTE+ L
Sbjct: 609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-69
Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 48/308 (15%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKA 176
E +W L G GAFGK+ T G VA+K+L EKA
Sbjct: 34 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------KEKA 87
Query: 177 QVMEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
E++ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 235 VPLKLAVKQ---------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
++ + A VA+GM ++ +HRDL + N+L++
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 274 DKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIV 326
K +KI DFG+AR V+ P +WMAPE + YT K DV+S+GI+
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLP----VKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 327 LWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFT 385
LWE+ + G+ P+ + + ++ G + P + IM CW + RP F
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 323
Query: 386 EIVRMLEN 393
+ L
Sbjct: 324 NLTSFLGC 331
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 5e-67
Identities = 82/347 (23%), Positives = 141/347 (40%), Gaps = 25/347 (7%)
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
S SN S + P + + A M
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 124 LENYDEWTIDLRKLNM--------GTAFAQGAFGKLYRGTYNGE----DVAIKILERPEN 171
D + +KL + G FG + +G Y DVAIK+L +
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGT 375
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
++ +E ++ L + IVR IG C+ + +V E A GG + +FL +
Sbjct: 376 EKA----DTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGK 429
Query: 232 NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQ 290
+P+ + V+ GM Y+ F+HR+L + N+L+ KI+DFG+++ +
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 291 TEGMTPETGT---YRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346
T + +W APE I R ++ + DV+S+G+ +WE ++ G P++ M +
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-V 548
Query: 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
A + +G R P +C P L +M+ CW E RP F + + +
Sbjct: 549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-66
Identities = 58/284 (20%), Positives = 115/284 (40%), Gaps = 34/284 (11%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
I L + QG F K+++G V +K+L + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL------DKAHRNYS 56
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
+ F + M++ L H ++V G C +V E+ K GS+ +L ++ + +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWK 115
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFGVAR-IEVQT 291
++ A +A M ++ IH ++ + N+L+ ++ IK++D G++ + +
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 292 EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAV 349
W+ PE I++ + D +SFG LWE+ + G P + + +
Sbjct: 176 ILQER----IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQF 230
Query: 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ P L+ ++ C D P+ RP F I+R L +
Sbjct: 231 YEDRHQLPAPKAA-E-LANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-64
Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 18/252 (7%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F +Y+G T +VA L+ + Q+F++E ML L+H NIVRF
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 203 GA----CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--G 256
+ + + +VTE G+++ +L R + + +K+ + +G+ ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 257 LGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT 315
IHRDLK DN+ I+ S+KI D G+A ++ + GT +MAPEM + Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYE-EKYD 207
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVLSEIMTRCW 374
+ VDVY+FG+ + E+ T P+ + V GV+P +P + EI+ C
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 375 DTNPEVRPPFTE 386
N + R +
Sbjct: 268 RQNKDERYSIKD 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-60
Identities = 64/267 (23%), Positives = 113/267 (42%), Gaps = 38/267 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG++++ +G+ IK ++ ++EV LA L H+NIV
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVH 68
Query: 201 FIGA----------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ G K I E+ G++ Q++ +R+ + LA++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304
+ +G+ Y+H I+RDLK N+ + K +KI DFG+ T GT R+M
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 305 APEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
+PE I + Y ++VD+Y+ G++L EL+ + +I +
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFTDLRDGIISDIFDK 242
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVRML 391
++ + PE RP +EI+R L
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-57
Identities = 62/250 (24%), Positives = 124/250 (49%), Gaps = 10/250 (4%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK L + T +G IK + K + ++ ++EV +LA +KH NIV++
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKER---EESRREVAVLANMKHPNIVQYR 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + IV +Y +GG + + + ++ + + + + +VH +HR
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVDV 320
D+KS N+ ++ D ++++ DFG+AR+ T + GT +++PE+ +++PY K D+
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPYYLSPEICENKPYNNKSDI 208
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEV 380
++ G VL+EL T F+ + ++ G P + L ++++ + NP
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKRNPRD 267
Query: 381 RPPFTEIVRM 390
RP I+
Sbjct: 268 RPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-57
Identities = 59/270 (21%), Positives = 121/270 (44%), Gaps = 10/270 (3%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F ++YR +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKYY 98
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + + + + K + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVD 319
HRD+K N+ I+A +K+ D G+ R +T GT +M+PE I Y K D
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218
Query: 320 VYSFGIVLWELITGLLPFQ-NMTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMTRCWDTN 377
++S G +L+E+ PF + + + + + P +P+D L +++ C + +
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 378 PEVRPPFTEIVRMLENAETEIMTTVRKARF 407
PE RP T + + + +++
Sbjct: 279 PEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-56
Identities = 62/290 (21%), Positives = 113/290 (38%), Gaps = 38/290 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG + + + AIK + P + ++ +EV LA L+H IVR+
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-----EKVMREVKALAKLEHPGIVRYF 69
Query: 203 GAC------------RKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVAR 249
A ++ I + + +++ ++ R + + L +A
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------------EVQTEGMTP 296
+ ++H G +HRDLK N+ + D +K+ DFG+ T
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP 356
+ GT +M+PE I Y+ KVD++S G++L+EL+ PF V P
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFP 246
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM--LENAETEIMTTVRK 404
+ P ++ +P RP I+ E+ + T +R+
Sbjct: 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-55
Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 29/251 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+++R G A+K + +E +E++ A L IV
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---VKQALDVARGMAYVHGLGF 259
GA R+ I E +GGS+ Q + +Q +P A + QAL G+ Y+H
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQAL---EGLEYLHTRRI 171
Query: 260 IHRDLKSDNLLISAD-KSIKIADFGVA-RIEVQTEGMTPET-----GTYRWMAPEMIQHR 312
+H D+K+DN+L+S+D + DFG A ++ G + T GT MAPE++ +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSEIMT 371
P KVD++S ++ ++ G P+ + ++ IP C P+ ++ +
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 372 RCWDTNPEVRP 382
P R
Sbjct: 292 EGLRKEPVHRA 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-53
Identities = 75/252 (29%), Positives = 118/252 (46%), Gaps = 26/252 (10%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y G N +AIK + E+ Q +E+ + LKH NIV+++
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-------VKQALDVARGMAYVH 255
G+ + I E GGS+ L +++ PLK KQ L G+ Y+H
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQIL---EGLKYLH 139
Query: 256 GLGFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+HRD+K DN+LI + +KI+DFG + R+ TGT ++MAPE+I P
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 314 --YTQKVDVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370
Y + D++S G + E+ TG PF + A F V V P IP +
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259
Query: 371 TRCWDTNPEVRP 382
+C++ +P+ R
Sbjct: 260 LKCFEPDPDKRA 271
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-53
Identities = 58/308 (18%), Positives = 115/308 (37%), Gaps = 31/308 (10%)
Query: 110 LAQALMDHRYPTEGLENYDE---WTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIK 164
+ + H + + Y + ID + +G F + G ++G A+K
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW----CIVTEYAKG 220
+ E ++ Q+E M H NI+R + C + ++ + K
Sbjct: 61 RILCHEQQ------DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 221 GSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278
G++ + R +++ L + L + RG+ +H G+ HRDLK N+L+ +
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174
Query: 279 IADFGVARIE----------VQTEGMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGI 325
+ D G + + + T + APE+ H ++ DV+S G
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234
Query: 326 VLWELITGLLPFQNMTAVQAAFA-VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPF 384
VL+ ++ G P+ + + A V + L +++ +P RP
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI 294
Query: 385 TEIVRMLE 392
++ LE
Sbjct: 295 PLLLSQLE 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-52
Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 13/249 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G++G++++ +G A+K P P+ + EV + +H VR
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRL 122
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A + + + TE G S++Q ++P D +A++H G +H
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
D+K N+ + K+ DFG+ + G R+MAPE++Q Y DV+
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVF 239
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381
S G+ + E+ + Q + + P L ++ + +P++R
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296
Query: 382 PPFTEIVRM 390
++ +
Sbjct: 297 ATAEALLAL 305
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-52
Identities = 60/270 (22%), Positives = 102/270 (37%), Gaps = 36/270 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G FG +++ +G AIK ++P EQ +EV A L +H ++VR+
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRY 76
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGF 259
A + I EY GGS+ ++ K L V RG+ Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 260 IHRDLKSDNLLISADKSI-------------------KIADFGVARIEVQTEGMTPETGT 300
+H D+K N+ IS KI D G + E G
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEEGD 193
Query: 301 YRWMAPEMIQ-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359
R++A E++Q + + K D+++ + + +N + +G P IP
Sbjct: 194 SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE----IRQGRLPRIP 249
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
+E++ +PE RP +V+
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-51
Identities = 62/281 (22%), Positives = 111/281 (39%), Gaps = 53/281 (18%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGAFG++ + + AIK + + EVM+LA+L H +VR+
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR-------HTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 203 GA-------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A +K+ I EY + G++ + L + + R
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFR 123
Query: 250 ----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------- 298
++Y+H G IHRDLK N+ I +++KI DFG+A+ ++ +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 299 --------GTYRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349
GT ++A E++ Y +K+D+YS GI+ +E+I +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI---LKK 240
Query: 350 VNKGVR---PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
+ P ++ + V +I+ D +P RP +
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 52/261 (19%), Positives = 104/261 (39%), Gaps = 26/261 (9%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 121
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAPEMIQHRP----- 313
DLK N LI D +K+ DFG+A ++ T + ++ G +M PE I+
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 314 ------YTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNKGVRPVIPNDCLPVL 366
+ K DV+S G +L+ + G PFQ + + A+++ P+ L
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297
Query: 367 SEIMTRCWDTNPEVRPPFTEI 387
+++ C +P+ R E+
Sbjct: 298 QDVLKCCLKRDPKQRISIPEL 318
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-50
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 19/259 (7%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ R +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 71
Query: 203 GA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLG 258
R IV EY +GG + +T+ L + ++ + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 259 F-----IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQH 311
+HRDLK N+ + +++K+ DFG+ARI +T GT +M+PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSPEQMNR 190
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
Y +K D++S G +L+EL + PF + + + +G IP L+EI+T
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIPYRYSDELNEIIT 249
Query: 372 RCWDTNPEVRPPFTEIVRM 390
R + RP EI+
Sbjct: 250 RMLNLKDYHRPSVEEILEN 268
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-50
Identities = 53/261 (20%), Positives = 105/261 (40%), Gaps = 26/261 (9%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 74
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAPEMIQHRP----- 313
DLK N LI D +K+ DFG+A ++ T + ++ GT +M PE I+
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 314 ------YTQKVDVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIPNDCLPVL 366
+ K DV+S G +L+ + G PFQ + + A+++ P+ L
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 250
Query: 367 SEIMTRCWDTNPEVRPPFTEI 387
+++ C +P+ R E+
Sbjct: 251 QDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-50
Identities = 53/261 (20%), Positives = 106/261 (40%), Gaps = 26/261 (9%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRF 201
G K+++ + AIK + E + + ++ E+ L L+ + I+R
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 150
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAPEMIQHRP----- 313
DLK N LI D +K+ DFG+A ++ T + ++ GT +M PE I+
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 314 ------YTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNKGVRPVIPNDCLPVL 366
+ K DV+S G +L+ + G PFQ + + A+++ P+ L
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 269
Query: 367 SEIMTRCWDTNPEVRPPFTEI 387
+++ C +P+ R E+
Sbjct: 270 QDVLKCCLKRDPKQRISIPEL 290
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-48
Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 21/276 (7%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKL-NMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPEN 171
M H GL D +L +G+FG++++G N + VAIKI+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----- 55
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRR 230
+ E+A+ + QQE+ +L+ + ++ G+ K +W I+ EY GGS L
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG 114
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ +++ L +G+ Y+H IHRD+K+ N+L+S +K+ADFGVA Q
Sbjct: 115 PLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQ 168
Query: 291 -TEGMTPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAA 346
T+ GT WMAPE+I+ Y K D++S GI EL G P + ++
Sbjct: 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228
Query: 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRP 382
F + P + + L E + C + P RP
Sbjct: 229 FLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 71/263 (26%), Positives = 113/263 (42%), Gaps = 32/263 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA + E VAIK + N EK Q + +E+ ++ H NIV +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL------DVARGMAYVH 255
+ K +W +V + GGSV + + + ++ +V G+ Y+H
Sbjct: 80 TSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMI 309
G IHRD+K+ N+L+ D S++IADFGV+ +T GT WMAPE++
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 310 -QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL----- 363
Q R Y K D++SFGI EL TG P+ ++ + P +
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-PSLETGVQDKEML 257
Query: 364 ----PVLSEIMTRCWDTNPEVRP 382
++++ C +PE RP
Sbjct: 258 KKYGKSFRKMISLCLQKDPEKRP 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-47
Identities = 73/252 (28%), Positives = 124/252 (49%), Gaps = 33/252 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMN-LQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRM-VWCIVTEYAKGGSVRQFLTRR-----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ +W +V EY GGS+ +T Q AV ++ L + + ++H
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECL---QALEFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAPEMIQHR 312
IHRD+KSDN+L+ D S+K+ DFG Q T + + GT WMAPE++ +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSEIM 370
Y KVD++S GI+ E+I G P+ N ++A + + G P + P + + +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFL 250
Query: 371 TRCWDTNPEVRP 382
RC + + E R
Sbjct: 251 NRCLEMDVEKRG 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 72/269 (26%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQ 182
+W ++ +G +G FG +Y R + +A+K+L KAQ+ +E Q
Sbjct: 5 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQ 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++EV + + L+H NI+R G ++ EYA G+V + L ++ ++ +
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSK-FDEQRTAT 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GT 300
++A ++Y H IHRD+K +NLL+ + +KIADFG + V GT
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGT 170
Query: 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360
++ PEMI+ R + +KVD++S G++ +E + G PF+ T Q + +++ P+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISRV-EFTFPD 228
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
++++R NP RP E++
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 73/303 (24%), Positives = 140/303 (46%), Gaps = 31/303 (10%)
Query: 86 NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQ 145
+ F+ G VTH AL + ++D P L++Y + +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAAL-RMVVDQGDPRLLLDSYVK-------------IGE 55
Query: 146 GAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G+ G + G VA+K+++ + + EV+++ +H N+V
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMD-LRKQQRR-----ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 204 ACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +W ++ E+ +GG++ +++ + + + L + +AY+H G IHR
Sbjct: 110 SYLVGEELW-VLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQGVIHR 165
Query: 263 DLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
D+KSD++L++ D +K++DFG A+I GT WMAPE+I Y +VD++
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSEIMTRCWDTNPE 379
S GI++ E++ G P+ + + VQA + + P + + PVL + + R +P+
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 380 VRP 382
R
Sbjct: 285 ERA 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 69/250 (27%), Positives = 122/250 (48%), Gaps = 27/250 (10%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +Y+ + G+ VAIK + E++ ++ +E+ ++ ++V++
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQE-------IIKEISIMQQCDSPHVVKY 89
Query: 202 IGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLG 258
G+ K +W IV EY GSV + R ++A + L +G+ Y+H +
Sbjct: 90 YGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR 145
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAPEMIQHRPY 314
IHRD+K+ N+L++ + K+ADFGVA Q T+ M GT WMAPE+IQ Y
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL--PVLSEIMTR 372
D++S GI E+ G P+ ++ ++A F + P L ++ + +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDNFTDFVKQ 261
Query: 373 CWDTNPEVRP 382
C +PE R
Sbjct: 262 CLVKSPEQRA 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 24/212 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ---- 310
+HR++K N++ K+ DFG AR E GT ++ P+M +
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 311 ----HRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ Y VD++S G+ + TG LPF+
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 58/279 (20%), Positives = 101/279 (36%), Gaps = 37/279 (13%)
Query: 146 GAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ Y GE V ++ LE N M Q E+ + H NIV +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNE------MVTFLQGELHVSKLFNHPNIVPY 91
Query: 202 IGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGMAYVHGL 257
+W +VT + GS + + + L +A + L + + Y+H +
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA--------RIEVQTEGMTPETGTYRWMAPEMI 309
G++HR +K+ ++LIS D + ++ R V + W++PE++
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 310 QH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367
Q + Y K D+YS GI EL G +PF++M A Q N +P L
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---------EKLNGTVPCLL 258
Query: 368 EIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKAR 406
+ T + + ++ T
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-45
Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 26/252 (10%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ G A K++E ++ E + + E+ +LAT H IV+ +
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIE-TKSEEEL-----EDYIVEIEILATCDHPYIVKLL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGFI 260
GA I+ E+ GG+V + ++ V +Q L + ++H I
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKRII 139
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMI-----QHR 312
HRDLK+ N+L++ + I++ADFGV+ ++T + GT WMAPE++ +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSEIM 370
PY K D++S GI L E+ P + ++ + P + P+ + +
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKWSVEFRDFL 256
Query: 371 TRCWDTNPEVRP 382
D NPE RP
Sbjct: 257 KIALDKNPETRP 268
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 85/275 (30%), Positives = 128/275 (46%), Gaps = 34/275 (12%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FGK+Y+G +G VA+K L+ E+ Q E QFQ EV M++ H N++R G
Sbjct: 40 RGGFGKVYKGRLADGTLVAVKRLKE-----ERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVH---GLG 258
C +V Y GSV L R PL + AL ARG+AY+H
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAPEMIQHRPY 314
IHRD+K+ N+L+ + + DFG+A++ T T GT +APE +
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHVTTAVRGTIGHIAPEYLSTGKS 212
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL-------- 366
++K DV+ +G++L ELITG F ++ V+ ++ L L
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272
Query: 367 --SEIMTR-------CWDTNPEVRPPFTEIVRMLE 392
E + + C ++P RP +E+VRMLE
Sbjct: 273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 35/275 (12%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FGK+Y+G +G VA+K PE +Q ++F+ E+ L+ +H ++V IG
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRR-----TPESSQ-GIEEFETEIETLSFCRHPHLVSLIG 102
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIH 261
C +R ++ +Y + G++++ L + + + ++ + ARG+ Y+H IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 262 RDLKSDNLLISADKSIKIADFGVARIE-------VQTEGMTPETGTYRWMAPEMIQHRPY 314
RD+KS N+L+ + KI DFG+++ + T GT ++ PE
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK----GTLGYIDPEYFIKGRL 218
Query: 315 TQKVDVYSFGIVLWELITG------LLPFQNMTAVQAAFAVVNKG---------VRPVIP 359
T+K DVYSFG+VL+E++ LP + + + A N G + I
Sbjct: 219 TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278
Query: 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394
+ L + +C + E RP +++ LE A
Sbjct: 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 66/257 (25%), Positives = 108/257 (42%), Gaps = 30/257 (11%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEK 175
R P+ + W + +L G FG + R GE VAIK + E
Sbjct: 4 RSPSLPTQTCGPWEMK-ERLG------TGGFGYVLRWIHQDTGEQVAIKQCRQ-----EL 51
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFI------GACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ +++ E+ ++ L H N+V + + EY +GG +R++L +
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 230 RQNRAVPLKLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282
+N L D++ + Y+H IHRDLK +N+++ KI D
Sbjct: 112 FENCC---GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA 342
G A+ Q E T GT +++APE+++ + YT VD +SFG + +E ITG PF
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
Query: 343 VQAAFAVVNKGVRPVIP 359
V + I
Sbjct: 229 PVQWHGKVREKSNEHIV 245
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-44
Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG +Y+G N VA+K L + + ++QQF QE+ ++A +H N+V +G
Sbjct: 41 EGGFGVVYKGYVNNTTVAVKKLA-AMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHR 262
C+V Y GS+ L+ PL + K A A G+ ++H IHR
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAPE-MIQHRPYTQK 317
D+KS N+L+ + KI+DFG+AR + T T GT +MAPE + T K
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPK 214
Query: 318 VDVYSFGIVLWELITGLLPF------QNMTAVQAAFAVVNKGVRPVI-------PNDCLP 364
D+YSFG+VL E+ITGL Q + ++ K + I + +
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE 274
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ + ++C RP ++ ++L+
Sbjct: 275 AMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 54/158 (34%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTP 296
+ VA+GM ++ IHRDL + N+L+S +KI DFG+AR + + P
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVR 355
+WMAPE I R YT + DV+SFG++LWE+ + G P+ + + + +G R
Sbjct: 259 ----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P+ P + + M CW P RP F+E+V L N
Sbjct: 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ G D VA+K+L+ + E
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 69
Query: 179 MEQQFQQEV-MMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVP 236
+ E+ +++ HLN+V +GAC K ++ E+ K G++ +L ++N VP
Sbjct: 70 --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
K + +G Y +G I DLK I++ +S + F + E
Sbjct: 128 YKT---KGARFRQGKDY---VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
Query: 297 ETGTYR 302
Y+
Sbjct: 182 PEDLYK 187
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 64/265 (24%), Positives = 124/265 (46%), Gaps = 16/265 (6%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
++TID ++G +G FG +Y R N +A+K+L + + E +E Q ++E
Sbjct: 10 KFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG---VEHQLRRE 64
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+ + + L+H NI+R R ++ E+A G + + L + + + +
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEE 122
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWM 304
+A + Y H IHRD+K +NLL+ +KIADFG + V + T GT ++
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRTMCGTLDYL 179
Query: 305 APEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
PEMI+ + + +KVD++ G++ +E + G+ PF + + + P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-HTETHRRIVNV-DLKFPPFLSD 237
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389
+++++ +P R P ++
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVME 262
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 24/212 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ---- 310
+HR++K N++ K+ DFG AR E GT ++ P+M +
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 311 ----HRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ Y VD++S G+ + TG LPF+
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 54/306 (17%), Positives = 111/306 (36%), Gaps = 18/306 (5%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLN-MGTAFAQGAFGKLYRGTYNG 158
+ + ++D A + E L KL G A+ + +
Sbjct: 24 EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218
E I + + + P + ++ + N V + ++ I +
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 219 KGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ +++ ++ RR + + + + +A + ++H G +HRDLK N+ + D +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 278 KIADFGVARI-------------EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFG 324
K+ DFG+ T + GT +M+PE I Y+ KVD++S G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 325 IVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPF 384
++L+EL+ + V P++ P ++ +P RP
Sbjct: 264 LILFELLYSFSTQMERVRI---ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320
Query: 385 TEIVRM 390
T+I+
Sbjct: 321 TDIIEN 326
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-44
Identities = 67/291 (23%), Positives = 110/291 (37%), Gaps = 39/291 (13%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ +L + A+G F +Y + +G + A+K L E + QEV
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------KNRAIIQEVC 77
Query: 189 MLATLK-HLNIVRFIGAC--------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ L H NIV+F A + + ++TE KG V +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
+K R + ++H IHRDLK +NLL+S +IK+ DFG A +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 298 T-------------GTYRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPFQNMT 341
T + PE+I + P +K D+++ G +L+ L PF++
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED-- 255
Query: 342 AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
A +VN + V ++ NPE R E+V L+
Sbjct: 256 --GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 66/260 (25%), Positives = 120/260 (46%), Gaps = 12/260 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 96
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 154
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMI 309
Y+H IHRDLK NL ++ D +KI DFG+A +V+ +G + GT ++APE++
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIAPEVL 213
Query: 310 QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369
+ ++ +VDV+S G +++ L+ G PF+ ++ + + K IP PV + +
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKKN-EYSIPKHINPVAASL 271
Query: 370 MTRCWDTNPEVRPPFTEIVR 389
+ + T+P RP E++
Sbjct: 272 IQKMLQTDPTARPTINELLN 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 66/252 (26%), Positives = 117/252 (46%), Gaps = 22/252 (8%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +Y T VAIK + E ++F++EV + L H NIV
Sbjct: 20 GGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEE----TLKRFEREVHNSSQLSHQNIV 74
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
I + + +V EY +G ++ +++ + + + A+ + G+ + H +
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAPEMIQHRPYT 315
+HRD+K N+LI ++K++KI DFG+A+ + +T +T GT ++ +PE +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP----VLSEIMT 371
+ D+YS GIVL+E++ G PF TAV A + V P + D LS ++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVIL 249
Query: 372 RCWDTNPEVRPP 383
R + + R
Sbjct: 250 RATEKDKANRYK 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 66/260 (25%), Positives = 120/260 (46%), Gaps = 12/260 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 70
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMI 309
Y+H IHRDLK NL ++ D +KI DFG+A +V+ +G + GT ++APE++
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPNYIAPEVL 187
Query: 310 QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369
+ ++ +VDV+S G +++ L+ G PF+ ++ + + K IP PV + +
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-LKETYLRIKKN-EYSIPKHINPVAASL 245
Query: 370 MTRCWDTNPEVRPPFTEIVR 389
+ + T+P RP E++
Sbjct: 246 IQKMLQTDPTARPTINELLN 265
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 30/257 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI +
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATY 86
Query: 202 IGACRKRMV-------WCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGM 251
GA K+ W +V E+ GSV + + + +A ++ L RG+
Sbjct: 87 YGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAPEMIQ 310
+++H IHRD+K N+L++ + +K+ DFGV+ +T G GT WMAPE+I
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 311 -----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365
Y K D++S GI E+ G P +M ++A F + +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262
Query: 366 LSEIMTRCWDTNPEVRP 382
+ C N RP
Sbjct: 263 FQSFIESCLVKNHSQRP 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 73/247 (29%), Positives = 106/247 (42%), Gaps = 21/247 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y E VAIK + + Q +EV L L+H N +++
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNTIQYR 120
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G + W +V EY GS L + +++A AL +G+AY+H
Sbjct: 121 GCYLREHTAW-LVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNM 175
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI---QHRPYTQ 316
IHRD+K+ N+L+S +K+ DFG A I GT WMAPE+I Y
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 317 KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMTRCWD 375
KVDV+S GI EL P NM A+ A + + P + + + C
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNFVDSCLQ 291
Query: 376 TNPEVRP 382
P+ RP
Sbjct: 292 KIPQDRP 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 63/255 (24%), Positives = 115/255 (45%), Gaps = 23/255 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+F +YR + G +VAIK+++ K + M Q+ Q EV + LKH +I
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMID-------KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 199 VRFIG--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E G + ++L + + + A + GM Y+H
Sbjct: 74 LELYNYFEDSNYVY--LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPY 314
G +HRDL NLL++ + +IKIADFG+A +++ T GT +++PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
+ DV+S G + + L+ G PF V+ V +P+ +++ +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLL 247
Query: 375 DTNPEVRPPFTEIVR 389
NP R + ++
Sbjct: 248 RRNPADRLSLSSVLD 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 52/289 (17%), Positives = 100/289 (34%), Gaps = 55/289 (19%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILER-----------PENNPEKAQVMEQQFQQEVMMLATL 193
QG F K+ + + A+K E+ N+ + F+ E+ ++ +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 194 KHLNIVRFIGACRKRMVW------CIVTEYAKGGSV------RQFLTRRQNRAVPLKLAV 241
K+ + G + I+ EY + S+ L + +P+++
Sbjct: 101 KNEYCLTCEG------IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 242 KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-- 298
V +Y+H HRD+K N+L+ + +K++DFG + +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMVDKKIKGSR 211
Query: 299 GTYRWMAPEMIQHRP--YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG--- 353
GTY +M PE + KVD++S GI L+ + ++PF ++ F +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 354 -----------VRPVIPNDCLPVLSE----IMTRCWDTNPEVRPPFTEI 387
+ LS + NP R +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 29/258 (11%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +++ + DVA+K+L R + +P +F++E A L H IV
Sbjct: 21 GFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPS----FYLRFRREAQNAAALNHPAIV 75
Query: 200 RF--IGACRKRMVWC--IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
G IV EY G ++R + + K A++ D + + + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAPEMIQH 311
G IHRD+K N++ISA ++K+ DFG+AR + +T GT ++++PE +
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV------IPNDCLPV 365
+ DVYS G VL+E++TG PF + V A+ V + P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----AD 249
Query: 366 LSEIMTRCWDTNPEVRPP 383
L ++ + NPE R
Sbjct: 250 LDAVVLKALAKNPENRYQ 267
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 76/257 (29%), Positives = 122/257 (47%), Gaps = 29/257 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F K+ G +VAIKI+++ + NP Q+ +EV ++ L H NIV+
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLF 80
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
++ EYA GG V +L ++ K+A R + Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYT- 315
+HRDLK++NLL+ AD +IKIADFG + T G + G + APE+ Q + Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV---IPNDCLPVLSEIMTR 372
+VDV+S G++L+ L++G LPF ++ V +G + + DC +L +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLRGKYRIPFYMSTDCENLLKRFLV- 250
Query: 373 CWDTNPEVRPPFTEIVR 389
NP R +I++
Sbjct: 251 ---LNPIKRGTLEQIMK 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 65/260 (25%), Positives = 116/260 (44%), Gaps = 26/260 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++GK+ A+KIL++ + E ++E+ +L L+H N+++
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 201 --FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYV 254
+++M +V EY G + + V QA G+ Y+
Sbjct: 73 DVLYNEEKQKM--YMVMEYCVCGMQEML-----DSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPET--GTYRWMAPEMIQ- 310
H G +H+D+K NLL++ ++KI+ GVA T T G+ + PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 311 HRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369
++ KVD++S G+ L+ + TGL PF+ + F + KG IP DC P LS++
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKG-SYAIPGDCGPPLSDL 243
Query: 370 MTRCWDTNPEVRPPFTEIVR 389
+ + P R +I +
Sbjct: 244 LKGMLEYEPAKRFSIRQIRQ 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 51/321 (15%), Positives = 110/321 (34%), Gaps = 50/321 (15%)
Query: 107 DDALAQALMDH-RYPTEGLENYDEWTIDLRKLNMGTAFA-------------QGAFGKLY 152
DD L L+ P N EW L + T F +GAF ++Y
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 153 RGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
T N + +K+ + NP + + Q + L ++F A
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQ----LMERLKPSMQHMFMKFYSAH 136
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V E G++ + +N + +P L + A+ + + VH IH
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 263 DLKSDNLLIS-----------ADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAPEM 308
D+K DN ++ + + D G + +++ +G T + EM
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM 256
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368
+ ++P+ ++D + ++ ++ G + + + + + + +E
Sbjct: 257 LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHL------DMWNE 310
Query: 369 IMTRCWDTNPEVRPPFTEIVR 389
+ P +++R
Sbjct: 311 FFHVMLNIPDCHHLPSLDLLR 331
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 36/296 (12%), Positives = 74/296 (25%), Gaps = 46/296 (15%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
RKL + G ++ ED A+K+ N ++ + A
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAAR 118
Query: 193 LKHLNIVRFIGACRKRMVW--------------------------CIVTEYAKG--GSVR 224
L + R + ++ A +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 225 QFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L + L + R A + G +H DNL I D + + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELITGLLPFQNM 340
+ + E + +T ++ + G+ ++ + LPF +
Sbjct: 239 SALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEI-------MTRCWDTNPEVRPPFTEIVR 389
T P + + + + R + + R E +
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-39
Identities = 64/261 (24%), Positives = 116/261 (44%), Gaps = 31/261 (11%)
Query: 145 QGAFGK-LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFI 202
GA G +YRG ++ DVA+K + PE ++ EV +L +H N++R+
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADR----EVQLLRESDEHPNVIRYF 84
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVHGLGFI 260
+ R I E ++++++ ++ + L+ ++Q G+A++H L +
Sbjct: 85 CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS---GLAHLHSLNIV 140
Query: 261 HRDLKSDNLLISADKS-----IKIADFGVARIEVQTEG----MTPETGTYRWMAPEMIQ- 310
HRDLK N+LIS + I+DFG+ + + GT W+APEM+
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 311 --HRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL-PVL 366
T VD++S G V + +I+ G PF QA + + + P +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
Query: 367 SEIMTRCWDTNPEVRPPFTEI 387
E++ + +P+ RP +
Sbjct: 261 RELIEKMIAMDPQKRPSAKHV 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 32/256 (12%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G G +Y T VA+K++ ++P + Q+E L+ ++V
Sbjct: 43 GRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPV----FRTRMQREARTAGRLQEPHVV 97
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
G ++ + G + L R+ + AV + + H
Sbjct: 98 PIHDFGE-IDGQLY-VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAPEMIQHRP 313
G HRD+K +N+L+SAD + DFG+A E +T + GT +MAPE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLT-QLGNTVGTLYYMAPERFSESH 211
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN------KGVRPVIPNDCLPVLS 367
T + D+Y+ VL+E +TG P+Q + A +N VRP IP
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIP----VAFD 266
Query: 368 EIMTRCWDTNPEVRPP 383
++ R NPE R
Sbjct: 267 AVIARGMAKNPEDRYV 282
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-38
Identities = 61/258 (23%), Positives = 114/258 (44%), Gaps = 26/258 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPET--GTYRWMAPEMIQHRP 313
+G HRD+K +NLL+ ++KI+DFG+A + GT ++APE+++ R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 314 YT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMT 371
+ + VDV+S GIVL ++ G LP+ + ++ + + P + ++
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 372 RCWDTNPEVRPPFTEIVR 389
+ NP R +I +
Sbjct: 244 KILVENPSARITIPDIKK 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 9e-38
Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 22/254 (8%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD---VVGKIKREIQNLKLFRHPHIIKLY 77
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+ +V EY GG + ++ + ++ +A + + + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHM 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYT- 315
+HRDLK +N+L+ A + KIADFG++ + ++G T G+ + APE+I R Y
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
+VD++S G++L+ L+ G LPF + V F + G IP ++ ++
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG-VFYIPEYLNRSVATLLMHMLQ 247
Query: 376 TNPEVRPPFTEIVR 389
+P R +I
Sbjct: 248 VDPLKRATIKDIRE 261
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 41/276 (14%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILER--------------------PENNPEKAQVMEQQ 182
+G++G L + A+K+L + + + +Q
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 183 FQQEVMMLATLKHLNIVRF---IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
QE+ +L L H N+V+ + + +V E G V +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKP-LSEDQ 138
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
A D+ +G+ Y+H IHRD+K NLL+ D IKIADFGV+ ++ + T
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 299 GTYRWMAPEMIQ--HRPYT-QKVDVYSFGIVLWELITGLLPF--QNMTAVQAAFAVVNKG 353
GT +MAPE + + ++ + +DV++ G+ L+ + G PF + + + + +
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL---HSKIKSQ 255
Query: 354 VRPVIPN--DCLPVLSEIMTRCWDTNPEVRPPFTEI 387
P+ D L +++TR D NPE R EI
Sbjct: 256 -ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-37
Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 23/282 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ G +A K++ E P Q +E+ +L IV F
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAI----RNQIIRELQVLHECNSPYIVGFY 97
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIH 261
GA I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ +H
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
RD+K N+L+++ IK+ DFGV+ + + + GT +M+PE +Q Y+ + D++
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381
S G+ L E+ G P A + + G + P R +
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELE---LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 382 PPFTEIVRMLENAETEIMTTVRKARF---------RCCMTQP 414
P I +L+ E + F +C + P
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-37
Identities = 61/258 (23%), Positives = 114/258 (44%), Gaps = 26/258 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPET--GTYRWMAPEMIQHRP 313
+G HRD+K +NLL+ ++KI+DFG+A + GT ++APE+++ R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 314 YT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL-PVLSEIMT 371
+ + VDV+S GIVL ++ G LP+ + ++ + + P + ++
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 372 RCWDTNPEVRPPFTEIVR 389
+ NP R +I +
Sbjct: 244 KILVENPSARITIPDIKK 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 9e-37
Identities = 53/249 (21%), Positives = 98/249 (39%), Gaps = 32/249 (12%)
Query: 144 AQGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
A G G +Y NG V +K L + E + E LA + H +IV+
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAE----AQAMAMAERQFLAEVVHPSIVQ 143
Query: 201 ------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + IV EY G S+++ ++ +P+ A+ L++ ++Y+
Sbjct: 144 IFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY 314
H +G ++ DLK +N++++ ++ +K+ D G G GT + APE+++ P
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF-GYL--YGTPGFQAPEIVRTGP- 253
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
T D+Y+ G L L L + + ++ R
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSYGRLLRRAI 305
Query: 375 DTNPEVRPP 383
D +P R
Sbjct: 306 DPDPRQRFT 314
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 63/251 (25%), Positives = 118/251 (47%), Gaps = 21/251 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R N ++ +++ ++ + + T+ V F
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQE----QKRLLMDLDISMRTVDCPFTVTF 71
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHG-L 257
GA R+ VW I E S+ +F + ++ + + K A+ + + + ++H L
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI----QHRP 313
IHRD+K N+LI+A +K+ DFG++ V + G +MAPE I +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAV-QAAFAVVNKGVRPVIPNDCL-PVLSEIMT 371
Y+ K D++S GI + EL P+ + Q VV + P +P D + +
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPADKFSAEFVDFTS 248
Query: 372 RCWDTNPEVRP 382
+C N + RP
Sbjct: 249 QCLKKNSKERP 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 63/253 (24%), Positives = 115/253 (45%), Gaps = 21/253 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R + ++ ++Q ++ +++ + IV+F
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQF 86
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVR--QFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
GA R+ W I E + +++ + +P ++ K L + + ++ L
Sbjct: 87 YGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ----HRP 313
IHRD+K N+L+ +IK+ DFG++ V + T + G +MAPE I +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM--- 370
Y + DV+S GI L+EL TG P+ +V V KG P + N S
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265
Query: 371 -TRCWDTNPEVRP 382
C + RP
Sbjct: 266 VNLCLTKDESKRP 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 58/252 (23%), Positives = 111/252 (44%), Gaps = 18/252 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 201 FIGACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ E + + F+T R + +LA V + + H G
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGV 170
Query: 260 IHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT-QK 317
+HRD+K +N+LI ++ +K+ DFG + ++ T GT + PE I++ Y +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 229
Query: 318 VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377
V+S GI+L++++ G +PF++ + R + ++C ++ C
Sbjct: 230 AAVWSLGILLYDMVCGDIPFEHDEEIIRG----QVFFRQRVSSEC----QHLIRWCLALR 281
Query: 378 PEVRPPFTEIVR 389
P RP F EI
Sbjct: 282 PSDRPTFEEIQN 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAI+I+ + + + E+ +L L H I++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV E +GG + L + Q L + Y+
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 255
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ- 310
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++APE++
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 311 --HRPYTQKVDVYSFGIVLWELITGLLPF 337
Y + VD +S G++L+ ++G PF
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPF 344
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 48/353 (13%), Positives = 104/353 (29%), Gaps = 53/353 (15%)
Query: 78 PGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKL 137
PG + ++ +V + + D ++ +L + P E R L
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP---RTL 75
Query: 138 NMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQ------------------ 177
GT Q T GE + + E P A
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 178 ----VMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY----AKGGSVRQFLTR 229
+ +F ++ + ++R R V Y + + + L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++++ ++ L V R +A +H G +H L+ ++++ + + F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 253
Query: 288 EVQTEGMTPETGTYRWMAPEMIQHR-----------PYTQKVDVYSFGIVLWELITGLLP 336
V+ + + + PE+ R T D ++ G+V++ + LP
Sbjct: 254 -VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 337 FQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
A + + + IP ++ E R + +
Sbjct: 313 ITKDAA-LGGSEWIFRSCKN-IPQPV----RALLEGFLRYPKEDRLLPLQAME 359
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 23/254 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ T + VA+K + R M + ++E+ L L+H +I++
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSD---MHMRVEREISYLKLLRHPHIIKLY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EYA GG + ++ ++ ++ + + + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYT- 315
+HRDLK +NLL+ + ++KIADFG++ I T+G +T G+ + APE+I + Y
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
+VDV+S GIVL+ ++ G LPF + + F VN V+P+ P ++ R
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIV 244
Query: 376 TNPEVRPPFTEIVR 389
+P R EI R
Sbjct: 245 ADPMQRITIQEIRR 258
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 2e-35
Identities = 42/296 (14%), Positives = 91/296 (30%), Gaps = 51/296 (17%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
R L GT Q T GE + + E P A +Q ++EV+ L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI---KQMKEEVLRLRL 134
Query: 193 L----------------------KHLNIVRFIGACRKRMVWCIVTEY-------AKGGSV 223
L K + I +++ + + +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 224 RQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ L ++++ ++ L V R +A +H G +H L+ ++++ + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 282 FGVARIEVQTEGMTPETGTY---RWMAPEMIQHRP-----YTQKVDVYSFGIVLWELITG 333
F + ++P + A M+ T D ++ G+ ++ +
Sbjct: 255 FEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
LP + A+ + + IP +L + E R + +
Sbjct: 314 DLPNTDDAALGGSEWIFRS--CKNIPQPVRALLEGFLRY----PKEDRLLPLQAME 363
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 65/268 (24%), Positives = 111/268 (41%), Gaps = 46/268 (17%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG R E VA+K +E + +++ Q+E++ +L+H NIVRF
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------GMAYV 254
I+ EYA GG + + + + + D AR G++Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG------RFSE----DEARFFFQQLLSGVSYC 132
Query: 255 HGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQ 310
H + HRDLK +N L+ + +KI DFG ++ P++ GT ++APE++
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAPEVLL 190
Query: 311 HRPYT-QKVDVYSFGIVLWELITGLLPFQ---NMTAVQAAFAVVNKGV-----RPVIPND 361
+ Y + DV+S G+ L+ ++ G PF+ + + I +
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
C ++S I +P R EI
Sbjct: 251 CCHLISRIF----VADPATRISIPEIKT 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 57/254 (22%), Positives = 114/254 (44%), Gaps = 22/254 (8%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKIL--ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GAFG ++ ++V +K + E+ + + E+ +L+ ++H NI++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 201 FIGACRKRMVWCIVTE-YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V E + G + F+ R + LA + + Y+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYT-Q 316
IHRD+K +N++I+ D +IK+ DFG A G T GT + APE++ PY
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAY--LERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209
Query: 317 KVDVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
+++++S G+ L+ L+ PF + V+AA ++ + + ++S ++
Sbjct: 210 ELEMWSLGVTLYTLVFEENPFCELEETVEAAIH-----PPYLVSKELMSLVSGLL----Q 260
Query: 376 TNPEVRPPFTEIVR 389
PE R ++V
Sbjct: 261 PVPERRTTLEKLVT 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ + AIKI+ + + + +EV +L L H NI++
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLY 102
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E KGG + R + +KQ L + Y+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLHK 154
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+HRDLK +NLL+ D IKI DFG++ + + M GT ++APE+++ +
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KK 213
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMT 341
Y +K DV+S G++L+ L+ G PF T
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQT 241
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++ +G + IK + + +++QV +Q + E+ +L +L H NI++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINK-----DRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
IV E +GG + + + Q R L +KQ ++ +AY H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ 143
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY 314
+H+DLK +N+L S IKI DFG+A + E T GT +MAPE+ + R
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDV 202
Query: 315 TQKVDVYSFGIVLWELITGLLPF 337
T K D++S G+V++ L+TG LPF
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPF 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-35
Identities = 58/250 (23%), Positives = 105/250 (42%), Gaps = 20/250 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G G++++ + G +A+K + R N E+ ++ ++ ++L + IV+
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEE----NKRILMDLDVVLKSHDCPYIVQC 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFI 260
G I E + + L +R +P ++ K + + + + Y+ G I
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-----PYT 315
HRD+K N+L+ IK+ DFG++ V + G +MAPE I Y
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAV-QAAFAVVNKGVRPVIPNDCL--PVLSEIMTR 372
+ DV+S GI L EL TG P++N + V+ + P++P +
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PLLPGHMGFSGDFQSFVKD 266
Query: 373 CWDTNPEVRP 382
C + RP
Sbjct: 267 CLTKDHRKRP 276
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 55/279 (19%), Positives = 116/279 (41%), Gaps = 46/279 (16%)
Query: 145 QGAFGKL-YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFI 202
G+ G + ++G++ G VA+K + E+ ++ + H N++R+
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLID---------FCDIALMEIKLLTESDDHPNVIRYY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA-----LDVARGMAYVHGL 257
+ I E +++ + + LKL + +A G+A++H L
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 258 GFIHRDLKSDNLLISADKS-------------IKIADFGVARIEVQTEG-----MTPETG 299
IHRDLK N+L+S I I+DFG+ + + + +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 300 TYRWMAPEMIQ-------HRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVN 351
T W APE+++ R T+ +D++S G V + +++ G PF + + ++
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI 254
Query: 352 KGVRPVIPNDCLPVLSE---IMTRCWDTNPEVRPPFTEI 387
+ + +++E ++++ D +P RP ++
Sbjct: 255 FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAIKI+ + + + E+ +L L H I++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ IV E +GG + L + Q L + Y+
Sbjct: 80 IKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 130
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ- 310
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++APE++
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190
Query: 311 --HRPYTQKVDVYSFGIVLWELITGLLPF 337
Y + VD +S G++L+ ++G PF
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPPF 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 50/211 (23%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILER-------PENNPEKAQVMEQQFQQEVMMLATLKH 195
GA+G++ + AIK++++ ++ + + ++ E+ +L +L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVAR 249
NI++ + + +VTE+ +GG + R + +KQ L
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQILSG-- 158
Query: 250 GMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ Y+H +HRD+K +N+L+ ++ +IKI DFG++ + + GT ++AP
Sbjct: 159 -ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337
E+++ + Y +K DV+S G++++ L+ G PF
Sbjct: 218 EVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+HRDLK +N+L+ + D IKI DFG++ Q M GT ++APE+++
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y +K DV+S G++L+ L++G PF
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPF 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 55/204 (26%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ G++ A+K++ + K + ++ +EV +L L H NI++
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E GG + R+ + + ++Q L + Y+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSG---ITYMHK 144
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+HRDLK +NLL+ S D +I+I DFG++ ++ M + GT ++APE++
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GT 203
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y +K DV+S G++L+ L++G PF
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 67/254 (26%), Positives = 118/254 (46%), Gaps = 22/254 (8%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD---VVGKIRREIQNLKLFRHPHIIKLY 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EY GG + ++ + +L K++ + + G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHM 136
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPYT- 315
+HRDLK +N+L+ A + KIADFG++ + ++G T G+ + APE+I R Y
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPEVISGRLYAG 194
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
+VD++S G++L+ L+ G LPF + V F + G+ P P + ++
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDGIFY-TPQYLNPSVISLLKHMLQ 252
Query: 376 TNPEVRPPFTEIVR 389
+P R +I
Sbjct: 253 VDPMKRATIKDIRE 266
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 26/211 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 199 VRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
++ + +V + K G + + L+ ++ R + ++ L+V +
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLEV---IC 138
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ-- 310
+H L +HRDLK +N+L+ D +IK+ DFG + E + GT ++APE+I+
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 311 ----HRPYTQKVDVYSFGIVLWELITGLLPF 337
H Y ++VD++S G++++ L+ G PF
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 20/254 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNI 198
+G FG ++ G + VAIK++ R EV +L + H +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 199 VRFIGACRKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+R + + + +V E + ++T + + + V + + H
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR 158
Query: 258 GFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT- 315
G +HRD+K +N+LI + K+ DFG + + E T GT + PE I Y
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
V+S GI+L++++ G +PF+ + A + DC ++ RC
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERDQEILEA----ELHFPAHVSPDC----CALIRRCLA 269
Query: 376 TNPEVRPPFTEIVR 389
P RP EI+
Sbjct: 270 PKPSSRPSLEEILL 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF +++ G+ A+K +++ + + E+ +L +KH NIV
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKK------SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + GG R T + V ++Q L + Y+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHE 124
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
G +HRDLK +NLL + I I DFG++++E Q M+ GT ++APE++ +P
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKP 183
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y++ VD +S G++ + L+ G PF
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPF 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 71
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 123
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++PE+++ P
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y++ VD+++ G++L+ L+ G PF
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF 207
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 9e-34
Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 56/290 (19%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG++G + AIKI+ + + + +E+ + EV ++ L H NI R
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIARLY 94
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--------------------- 241
C+V E GG + L + +
Sbjct: 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 242 -------------KQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKS--IKIADF 282
K ++ R + Y+H G HRD+K +N L S +KS IK+ DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 283 GVARI-----EVQTEGMTPETGTYRWMAPEMIQ--HRPYTQKVDVYSFGIVLWELITGLL 335
G+++ + GMT + GT ++APE++ + Y K D +S G++L L+ G +
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 336 PFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE----IMTRCWDTNPEVR 381
PF + + V + N VLS +++ + N + R
Sbjct: 275 PFPGVND-ADTISQVLNK-KLCFENPNYNVLSPLARDLLSNLLNRNVDER 322
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG + R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+HRDLK +N+L+ D IKI DFG++ Q M GT ++APE+++
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y +K DV+S G++L+ L++G PF
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPF 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G++G++ A K + K V +F+QE+ ++ +L H NI+R
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIP-------KYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 202 IGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+V E GG ++ + +K L +AY H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA---VAYCH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
L HRDLK +N L S D +K+ DFG+A + M + GT +++P++++
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
Y + D +S G++++ L+ G PF
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPF 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 47/210 (22%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199
+G + R + G + A+KI+E +PE+ + + + ++E +L + H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 200 RFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
I + +V + + G + + L+ ++ R++ ++ L+ +++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEA---VSF 215
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ--- 310
+H +HRDLK +N+L+ + I+++DFG + E + GT ++APE+++
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275
Query: 311 ---HRPYTQKVDVYSFGIVLWELITGLLPF 337
H Y ++VD+++ G++L+ L+ G PF
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 4e-33
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G++ A K +++ + + V ++ ++EV +L ++H NI+
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ LD G+ Y+H
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYLHS 126
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
H DLK +N+++ + IK+ DFG+A GT ++APE++ +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
P + D++S G++ + L++G PF
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPF 211
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA +YR + A+K+L++ + ++ + E+ +L L H NI++
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V E GG + + + + R VKQ L+ +AY+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYLHE 166
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
G +HRDLK +NLL + D +KIADFG+++I M GT + APE+++
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG 353
Y +VD++S GI+ + L+ G PF + Q F +
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R + G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 94
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 146
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++PE+++ P
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y++ VD+++ G++L+ L+ G PF
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPF 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H NI+
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
H DLK +N+++ IK+ DFG+A GT ++APE++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
P + D++S G++ + L++G PF
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPF 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 47/205 (22%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H N++
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
H DLK +N+++ IK+ DFG+A GT ++APE++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
P + D++S G++ + L++G PF
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPF 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ L+ G+ Y+H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYLHS 132
Query: 257 LGFIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
L H DLK +N+++ IKI DFG+A GT ++APE++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
P + D++S G++ + L++G PF
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 39/202 (19%), Positives = 83/202 (41%), Gaps = 22/202 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG ++R + + K ++ + ++E+ +L +H NI+
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVK-------VKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
+ ++ E+ G + + + V V Q + + ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVCE---ALQFLHSH 121
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT 315
H D++ +N++ +S IKI +FG AR + + APE+ QH +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 316 QKVDVYSFGIVLWELITGLLPF 337
D++S G +++ L++G+ PF
Sbjct: 182 TATDMWSLGTLVYVLLSGINPF 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 51/205 (24%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G++ A I+ + + Q+ ++E + LKH NIVR
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLH 76
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + ++ + GG R++ + ++Q L+ + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLHCHQ 128
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHR 312
+G +HR+LK +NLL+ ++K+ADFG+A +E + + GT +++PE+++
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 313 PYTQKVDVYSFGIVLWELITGLLPF 337
PY + VD+++ G++L+ L+ G PF
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPF 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 44/204 (21%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + + ++ ++E+ ++ L+H +V
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFV------MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A ++ E+ GG ++ + ++Q G+ ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMH 272
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
++H DLK +N++ + +K+ DFG+ + + TGT + APE+ + +P
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
D++S G++ + L++GL PF
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPF 356
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 43/202 (21%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R G K + + + + E+ ++ L H ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
A + ++ E+ GG + + + + ++QA + G+ ++H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACE---GLKHMHEH 168
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT 315
+H D+K +N++ K+ +KI DFG+A E + T T + APE++ P
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 316 QKVDVYSFGIVLWELITGLLPF 337
D+++ G++ + L++GL PF
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPF 250
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 32/265 (12%), Positives = 75/265 (28%), Gaps = 49/265 (18%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ ++ T VA+ ++ P+ Q+ + L+ + + R
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGVARV 96
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ R +V E+ +GGS+++ A++ +A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
+ +S D + +A + D+
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATM--------------------------PDANPQDDIR 186
Query: 322 SFGIVLWELITGLLPFQ---NMTAVQAAFAVVN------KGVRPVIPNDCLPVLSEIMTR 372
G L+ L+ P + + A + IP +S + R
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP----FQISAVAAR 242
Query: 373 CWDTNPEVRPPFTEIVRMLENAETE 397
+ +R + ++ +++ A
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQATAV 266
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F + R G+ A+KI++ + + ++E + LKH +IV +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
+ +V E+ G + + +R + ++Q L+ + Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDN 149
Query: 258 GFIHRDLKSDNLLISA---DKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRP 313
IHRD+K +L+++ +K+ FGVA + GT +MAPE+++ P
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
Y + VDV+ G++L+ L++G LPF
Sbjct: 210 YGKPVDVWGCGVILFILLSGCLPF 233
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G+F L R + AIKILE K ++++ V +++ L H
Sbjct: 40 EGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------G 250
V+ + YAK G + +++ + R
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSA 142
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
+ Y+HG G IHRDLK +N+L++ D I+I DFG A+ + E GT ++++P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSP 201
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337
E++ + + D+++ G ++++L+ GL PF
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-30
Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 26/207 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRF 201
+G F + + G++ A K L++ + + E+ +L K ++
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINL 94
Query: 202 IGACRKRMVWCIVTEYAKGG--------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
++ EYA GG + + ++ + +KQ L+ G+ Y
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYY 146
Query: 254 VHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ 310
+H +H DLK N+L+ IKI DFG++R + GT ++APE++
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPF 337
+ P T D+++ GI+ + L+T PF
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPF 233
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG++++ G +A KI+ + +++ + E+ ++ L H N+++
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A + +V EY GG LT +KQ + G+ ++H
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE---GIRHMH 204
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP 313
+ +H DLK +N+L K IKI DFG+AR E + GT ++APE++ +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDF 264
Query: 314 YTQKVDVYSFGIVLWELITGLLPF 337
+ D++S G++ + L++GL PF
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPF 288
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 28/295 (9%)
Query: 60 VDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
N + L + + + +F+ L + L+ A
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQE---LTRLTHEYLSVAPFADYL 162
Query: 120 PTEGLENYDEWT-IDLRKLNMGTAFA------QGAFGK--LYRGTYNGEDVAIKILERPE 170
+ + +W ++ + + T F +G FG+ + G+ A K LE
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLE--- 218
Query: 171 NNPEKAQVMEQQFQQEVM----MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQF 226
K ++ +++ + + +L + +V A + C+V GG ++
Sbjct: 219 ----KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 274
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ P AV A ++ G+ +H ++RDLK +N+L+ I+I+D G+A
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 287 IEVQTEGMTPET--GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
V EG T + GT +MAPE++++ YT D ++ G +L+E+I G PFQ
Sbjct: 335 -HV-PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ G+ A+K+L +QEV +IV
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPK-----------ARQEVDHHWQASGGPHIVCI 87
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + I+ E +GG + + R ++A + A + D+ + ++H
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY 314
HRD+K +NLL D +K+ DFG A+ Q TP T ++APE++ Y
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKY 206
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMT 341
+ D++S G++++ L+ G PF + T
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNT 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNIV 199
G+FG+ L + +G A+KIL+ K +V++ + + E +L + +V
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V EY GG + F R+ A A + Y+H L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAPEMIQHRPYTQ 316
I+RDLK +NLLI I++ DFG A R++ +T + TPE +APE+I + Y +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---A--LAPEIILSKGYNK 217
Query: 317 KVDVYSFGIVLWELITGLLPF 337
VD ++ G++++E+ G PF
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 62/285 (21%), Positives = 122/285 (42%), Gaps = 28/285 (9%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
L D+ L + E LE +T ++++ + F +GAFG+ + +
Sbjct: 36 CLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKL 95
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+KIL K +++++ F++E +L I A +
Sbjct: 96 KNADKVFAMKILN-------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V +Y GG + L + +P ++A ++ + VH L ++HRD+K DN+L
Sbjct: 149 LYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQ-----HRPYTQKVDVYSF 323
+ + I++ADFG ++ + GT +++PE++Q Y + D +S
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 324 GIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368
G+ ++E++ G PF + V+ ++N R P V
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/283 (20%), Positives = 120/283 (42%), Gaps = 22/283 (7%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-F------AQGAFGK--LYRG 154
++ + A L +Y + L+ + + L+++ + F +GAF + + +
Sbjct: 23 GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214
G+ A+KI+ + ++ +V F++E +L I + A + +V
Sbjct: 83 KQTGQVYAMKIM-NKWDMLKRGEV--SCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GG + L + +P ++A ++ + VH LG++HRD+K DN+L+
Sbjct: 140 MEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC 198
Query: 275 KSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQ-------HRPYTQKVDVYSFGI 325
I++ADFG + GT +++PE++Q Y + D ++ G+
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368
+E+ G PF + + +V+ +P V E
Sbjct: 259 FAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 25/205 (12%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLN 197
G+FG+ L R +NG A+K+L+ K V+ + Q E +ML+ + H
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLK-QVEHTNDERLMLSIVTHPF 67
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G + ++ +Y +GG + L R+ R P +A A +V + Y+H
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQR-FPNPVAKFYAAEVCLALEYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAPEMIQHRPY 314
I+RDLK +N+L+ + IKI DFG A + T + TP+ Y +APE++ +PY
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD---Y--IAPEVVSTKPY 180
Query: 315 TQKVDVYSFGIVLWELITGLLPFQN 339
+ +D +SFGI+++E++ G PF +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYD 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 30/206 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+G+F + + + A+KI+ + ME Q+E+ L + H NIV+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKR---------MEANTQKEITALKLCEGHPNIVKL 71
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++ +V E GG + ++ + + + +++ + ++++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAPEMIQH 311
+G +HRDLK +NLL + + IKI DFG AR+ + + T + APE++
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPF 337
Y + D++S G++L+ +++G +PF
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPF 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 55/250 (22%), Positives = 107/250 (42%), Gaps = 25/250 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNI 198
+G+FGK + + + A+K + K + +E+ +E+ ++ L+H +
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V + + M +V + GG +R L +QN + ++ + Y+
Sbjct: 78 VNLWYSFQDEEDM--FMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQN 133
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRP--- 313
IHRD+K DN+L+ + I DF +A + + +T GT +MAPEM R
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTA--VQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371
Y+ VD +S G+ +EL+ G P+ ++ + P+ + ++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLK 252
Query: 372 RCWDTNPEVR 381
+ + NP+ R
Sbjct: 253 KLLEPNPDQR 262
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 61/252 (24%), Positives = 114/252 (45%), Gaps = 34/252 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G FGK L R G A+KIL K ++ + + + L +H
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILR-------KEVIIAKD-EVAHTVTESRVLQNTRHPF 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ A + C V EYA GG + F + R + A ++ + Y+H
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQH 311
++RD+K +NL++ D IKI DFG+ + EG++ GT ++APE+++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSEI 369
Y + VD + G+V++E++ G LPF N + ++ + +R + + +L+ +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239
Query: 370 MTRCWDTNPEVR 381
+ + +P+ R
Sbjct: 240 LKK----DPKQR 247
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G++ R + A+KI+++ + +P +E+ ++L +H NI+
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----------TEEIEILLRYGQHPNIITL 81
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+VTE KGG + ++F + R+ AV + + + + Y+H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITKTVEYLH 133
Query: 256 GLGFIHRDLKSDNLLISADK----SIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQ 310
G +HRDLK N+L + SI+I DFG A+ + + + T ++APE+++
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQN 339
+ Y D++S G++L+ ++TG PF N
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPFAN 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 37/208 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG +Y+ +GE VAIK +L+ +++F+ E+ ++ L H NIVR
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQ------------DKRFKNRELQIMRKLDHCNIVR 111
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F + K+ + V +Y +V + L KL + Q R
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF---R 167
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
+AY+H G HRD+K NLL+ D +K+ DFG A+ V+ E + YR AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--AP 225
Query: 307 E-MIQHRPYTQKVDVYSFGIVLWELITG 333
E + YT +DV+S G VL EL+ G
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G FG+ + G+ A K L K ++ +++ Q M +LA + I
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLN-------KKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG 256
V A + C+V GG +R + N A+ + G+ ++H
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRPY 314
I+RDLK +N+L+ D +++I+D G+A E++ + GT +MAPE++ Y
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 315 TQKVDVYSFGIVLWELITGLLPFQN 339
VD ++ G+ L+E+I PF+
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRA 391
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY 314
HRD+K +NLL + +K+ DFG A+ +T T ++APE++ Y
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 315 TQKVDVYSFGIVLWELITGLLPF 337
+ D++S G++++ L+ G PF
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPF 263
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G + + G VAIK LE ++ K M +E+ +L L+H N+V
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-----REIKLLKQLRHENLVNL 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ C+K+ W +V E+ ++ L N ++ + Q + G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSHNI 145
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAPEMI-QHRPYT 315
IHRD+K +N+L+S +K+ DFG AR + E E T YR APE++ Y
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYG 203
Query: 316 QKVDVYSFGIVLWELITG--LLP 336
+ VDV++ G ++ E+ G L P
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFP 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 51/219 (23%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA ++ ++ A+KI+E+ + + + +EV ML + H N++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
I + + +V E +GGS+ R+ + V V+ VA + ++H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQD---VASALDFLH 128
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI--------EVQTEGMTPETGTYRWM 304
G HRDLK +N+L + +KI DF + + T + G+ +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 305 APEMI-----QHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
APE++ + Y ++ D++S G++L+ L++G PF
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 29/253 (11%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
AL D AL ++ L Y + +R L M + +GAFG+ L R
Sbjct: 31 ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+K+L K +++++ F +E ++A +V+ A +
Sbjct: 91 KSTRKVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + N VP K A +V + +H +GFIHRD+K DN+L
Sbjct: 144 LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRP----YTQKVDVYSFG 324
+ +K+ADFG + + +T GT +++PE+++ + Y ++ D +S G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 325 IVLWELITGLLPF 337
+ L+E++ G PF
Sbjct: 261 VFLYEMLVGDTPF 273
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +++ G+ VAIK LE ++ K + +E+ ML LKH N+V
Sbjct: 13 EGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQLKHPNLVNL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ R++ +V EY +V L R Q +K Q L + + + H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHNC 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAPEMI-QHRPYT 315
IHRD+K +N+LI+ IK+ DFG AR + ++ E T YR +PE++ Y
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYG 181
Query: 316 QKVDVYSFGIVLWELITG--LLP 336
VDV++ G V EL++G L P
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWP 204
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 61/260 (23%), Positives = 117/260 (45%), Gaps = 31/260 (11%)
Query: 88 SVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGA 147
++ Q + V++ ++++ +D+++ + + +T+ ++ GA
Sbjct: 17 KIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEV-GDSTFTVL-KRYQNLKPIGSGA 74
Query: 148 FGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----F 201
G + +VAIK L RP N A+ + +E++++ + H NI+ F
Sbjct: 75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVF 130
Query: 202 IGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
V+ +V E ++ L + + + Q L G+ ++H
Sbjct: 131 TPQKTLEEFQDVY-LVMELMDANLCQVIQMELDHERMSYL-----LYQML---CGIKHLH 181
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMAPEMIQHRP 313
G IHRDLK N+++ +D ++KI DFG+AR + MTP T YR APE+I
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMG 239
Query: 314 YTQKVDVYSFGIVLWELITG 333
Y + VD++S G ++ E++
Sbjct: 240 YKENVDIWSVGCIMGEMVRH 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 63/252 (25%), Positives = 115/252 (45%), Gaps = 33/252 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQH 311
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++APE+I +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY 516
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSEI 369
+PY + VD ++FG++L+E++ G PF+ + +++ V + + + + +
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 576
Query: 370 MTRCWDTNPEVR 381
MT+ +P R
Sbjct: 577 MTK----HPGKR 584
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + + VA+K++ N +Q +E+ +L L+
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR---NEKR----FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 197 NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
N++ + R + C+ E ++ + + + + + L L K A + + + +
Sbjct: 160 NVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 255 HGLGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQTEGMTPETGT--YRWMAPEMIQ 310
H IH DLK +N LL +S IK+ DFG + E Q + + YR APE+I
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYR--APEVIL 272
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQN 339
Y +D++S G +L EL+TG
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPG 301
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 33/252 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKHLNI 198
+G FGK L + G A+KIL+ K ++ + + L +H +
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
+ + C V EYA GG + F + R A ++ + Y+H
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQH 311
++RDLK +NL++ D IKI DFG+ + EG+ GT ++APE+++
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSEI 369
Y + VD + G+V++E++ G LPF N + ++ + +R + + +LS +
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 383
Query: 370 MTRCWDTNPEVR 381
+ + +P+ R
Sbjct: 384 LKK----DPKQR 391
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 35/253 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM------LATLKHL 196
+G+FGK L R G+ A+K+L+ K +++ E M H
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDD-DVECTMTEKRILSLARNHP 84
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V E+ GG + +++R A A ++ + ++H
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQ 310
G I+RDLK DN+L+ + K+ADFG+ + EG+ GT ++APE++Q
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSE 368
Y VD ++ G++L+E++ G PF+ A++N V + D +L
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
Query: 369 IMTRCWDTNPEVR 381
MT+ NP +R
Sbjct: 258 FMTK----NPTMR 266
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 33/252 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L + AIK L+ K V+ + M+ +H
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + + L A A ++ G+ ++H
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQH 311
G ++RDLK DN+L+ D IKIADFG+ + E M + GT ++APE++
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSEI 369
+ Y VD +SFG++L+E++ G PF + ++ + + +L ++
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 252
Query: 370 MTRCWDTNPEVR 381
R PE R
Sbjct: 253 FVR----EPEKR 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKH 195
QG+FGK++ G+ + A+K+L+ KA + + + M L + H
Sbjct: 34 QGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRD-RVRTKMERDILVEVNH 85
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV+ A + ++ ++ +GG + F + + ++A + ++H
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRP 313
LG I+RDLK +N+L+ + IK+ DFG+++ + E + GT +MAPE++ R
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYMAPEVVNRRG 202
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQN 339
+TQ D +SFG++++E++TG LPFQ
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 42/210 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G+FG +++ + E VAIK + ++ N +E+ ++ +KH N+V
Sbjct: 50 NGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------------RELQIMRIVKHPNVVD 96
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F K+ + V EY +V + + KL + Q L R
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
+AY+H +G HRD+K NLL+ +K+ DFG A+I + E + YR AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210
Query: 307 EMI---QHRPYTQKVDVYSFGIVLWELITG 333
E+I + YT +D++S G V+ EL+ G
Sbjct: 211 ELIFGATN--YTTNIDIWSTGCVMAELMQG 238
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
+G +GK++ G G+ A+K+L+ KA ++ L +K
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEEVK 79
Query: 195 HLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
H IV I A ++ ++ EY GG + F+ + A +++ +
Sbjct: 80 HPFIVDLIYAFQTGGKL--YLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQ 310
++H G I+RDLK +N++++ +K+ DFG+ + + +T T GT +MAPE++
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEILM 194
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQN 339
+ + VD +S G ++++++TG PF
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 58/264 (21%), Positives = 114/264 (43%), Gaps = 48/264 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+K+++ K V + + V H
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 72 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEM 308
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++APE+
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEI 181
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF---------AVVNKGVR--PV 357
++ Y VD ++ G++++E++ G PF + + ++ K +R
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVR 381
+ VL + + +P+ R
Sbjct: 242 LSVKAASVLKSFLNK----DPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 63/252 (25%), Positives = 115/252 (45%), Gaps = 33/252 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 30 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQH 311
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++APE+I +
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY 195
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSEI 369
+PY + VD ++FG++L+E++ G PF+ + +++ V + + + + +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 255
Query: 370 MTRCWDTNPEVR 381
MT+ +P R
Sbjct: 256 MTK----HPGKR 263
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 30/203 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + +GE VAIK L RP + A+ + +E+++L ++H N++
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK----RAYRELLLLKHMQHENVIGLL 89
Query: 201 --FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
F A R + +V + + + + + ++ V Q L +G+
Sbjct: 90 DVFTPASSLRNFYDFY-LVMPFMQTDLQKIMGLKFSEEK-----IQYLVYQML---KGLK 140
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW-MAPE-MIQ 310
Y+H G +HRDLK NL ++ D +KI DFG+AR MT T RW APE ++
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVT-RWYRAPEVILS 197
Query: 311 HRPYTQKVDVYSFGIVLWELITG 333
Y Q VD++S G ++ E++TG
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+T+ R N+ GA G + +VAIK L RP N A+ + +E
Sbjct: 20 TFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK----RAYRE 74
Query: 187 VMMLATLKHLNIVR----FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVP 236
++++ + H NI+ F V+ IV E ++ L +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHER----- 128
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + Q L G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP
Sbjct: 129 MSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 297 ETGTYRWM-APEMIQHRPYTQKVDVYSFGIVLWELITG 333
T R+ APE+I Y + VD++S G ++ E+I G
Sbjct: 186 YVVT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLNI 198
G++G + G + G VAIK + ++ ++ F E+ +L H NI
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 199 VR----FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDV 247
+ F+ M ++ +VTE + Q + ++ + + + + L
Sbjct: 92 LGLRDIFVHFEEPAMHKLY-LVTELM-RTDLAQVIHDQR---IVISPQHIQYFMYHIL-- 144
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMA 305
G+ +H G +HRDL N+L++ + I I DF +AR + T YR A
Sbjct: 145 -LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--A 201
Query: 306 PE-MIQHRPYTQKVDVYSFGIVLWELITG 333
PE ++Q + +T+ VD++S G V+ E+
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 57/264 (21%), Positives = 114/264 (43%), Gaps = 48/264 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+++++ K V + + V H
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 115 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEM 308
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++APE+
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAPEI 224
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF---------AVVNKGVR--PV 357
++ Y VD ++ G++++E++ G PF + + ++ K +R
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVR 381
+ VL + + +P+ R
Sbjct: 285 LSVKAASVLKSFLNK----DPKER 304
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 62/252 (24%), Positives = 119/252 (47%), Gaps = 33/252 (13%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L R A+K+L+ K +++++ ++ +M L +KH
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A ++A + Y+H L
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAPEMIQH 311
++RDLK +N+L+ + I + DFG+ + E + + GT ++APE++
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 312 RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSEI 369
+PY + VD + G VL+E++ GL PF + + ++NK ++ P I N +L +
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 273
Query: 370 MTRCWDTNPEVR 381
+ + + R
Sbjct: 274 LQK----DRTKR 281
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ G+ VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 27 QGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 82
Query: 203 GACRKRMVWC--------IVTEYA----KG--GSVRQFLTRRQNRAVPLKLAVKQALDVA 248
CR + +V ++ G +V T + +K ++ L
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-----IKRVMQMLL--- 134
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-----IEVQTEGMTPETGT--Y 301
G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 302 RWMAPEMI-QHRPYTQKVDVYSFGIVLWELITG--LLP 336
R PE++ R Y +D++ G ++ E+ T ++
Sbjct: 195 R--PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQ----QEVMMLATLKHLN 197
QG FG + G G VAIK +++ P +F+ Q + LA L H N
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKVIQDP------------RFRNRELQIMQDLAVLHHPN 80
Query: 198 IVR----FIGACRKRMV---WCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQAL 245
IV+ F + +V EY ++ + R V K+ + Q +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 246 DVARGMAYVH--GLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGT-- 300
R + +H + HRD+K N+L+ AD ++K+ DFG A+ +E +
Sbjct: 140 ---RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 301 YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
YR APE + ++ YT VD++S G + E++ G
Sbjct: 197 YR--APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + E VAIKI++ N Q Q EV +L +
Sbjct: 64 KGSFGQVVKAYDRVEQEWVAIKIIK---NKKA----FLNQAQIEVRLLELMNKHDTEMKY 116
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV R C+V E ++ L R V L L K A + + ++
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 257 --LGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR 312
L IH DLK +N LL + +S IKI DFG + Q ++ YR +PE++
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGM 233
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQN 339
PY +D++S G +L E+ TG F
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLFSG 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
G F ++ N VA+KI+ +V + + E+ +L +
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 197 -----NIVR------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
+I++ G + +V E G ++ + + ++R +PL + +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHV--VMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 246 DVARGMAYVH-GLGFIHRDLKSDNLLIS------ADKSIKIADFGVARIEVQTEGMTPET 298
+ G+ Y+H G IH D+K +N+L+ IKIAD G A E T
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSI 196
Query: 299 GT--YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
T YR +PE++ P+ D++S +++ELITG F+
Sbjct: 197 QTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 41/203 (20%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR- 200
+G + +++ N E V +KIL +P V +++ ++E+ +L L+ NI+
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKIL-KP--------VKKKKIKREIKILENLRGGPNIITL 96
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ +V E+ +Q + + + + + L + + Y H +
Sbjct: 97 ADIVKDPVSRTPA--LVFEHVNNTDFKQLYQTLTDYDI--RFYMYEIL---KALDYCHSM 149
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGTYRWM-APE-MIQHRPY 314
G +HRD+K N++I + +++ D+G+A + + R+ PE ++ ++ Y
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDYQMY 208
Query: 315 TQKVDVYSFGIVLWELITGLLPF 337
+D++S G +L +I PF
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPF 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN- 197
+G FG++Y R G+ A+K L+ K ++ +Q + + ML+ + +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 198 --IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV A + + GG + L Q+ A ++ G+ ++H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PY 314
++RDLK N+L+ ++I+D G+A + + GT+ +MAPE++Q Y
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 315 TQKVDVYSFGIVLWELITGLLPFQ 338
D +S G +L++L+ G PF+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFR 392
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
W + ++ GA+G + G VAIK L RP + A+ + +E
Sbjct: 20 AWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK----RAYRE 74
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWC------IVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
+ +L ++H N++ + +V + G + + + + ++
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL 133
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
V Q L +G+ Y+H G IHRDLK NL ++ D +KI DFG+AR MT T
Sbjct: 134 VYQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVT 188
Query: 301 YRWM-APE-MIQHRPYTQKVDVYSFGIVLWELITG 333
RW APE ++ YTQ VD++S G ++ E+ITG
Sbjct: 189 -RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 49/236 (20%), Positives = 94/236 (39%), Gaps = 61/236 (25%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG + +G+ A+K +L+ + +++ E+ ++ L H+NI++
Sbjct: 17 TGSFGIVCEVFDIESGKRFALKKVLQ------------DPRYKNRELDIMKVLDHVNIIK 64
Query: 201 ----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---------------- 240
F + + + +++V + +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 241 ---------VKQALDVA----------RGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIA 280
+++ + R + ++H LG HRD+K NLL+ S D ++K+
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 281 DFGVARIEVQTEGMTPETGT--YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
DFG A+ + +E + YR APE M+ YT +D++S G V ELI G
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILG 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
GA+GK++ G G+ A+K+L+ KA ++++ E L ++
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEHIR 116
Query: 195 HLN-IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+V A ++ ++ +Y GG + F Q ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKL--HLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMI 309
++H LG I+RD+K +N+L+ ++ + + DFG+++ V E GT +MAP+++
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 310 Q--HRPYTQKVDVYSFGIVLWELITGLLPF 337
+ + + VD +S G++++EL+TG PF
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPF 262
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 23/200 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 94
Query: 201 --FIGACRKRM---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
F A V+ +VT G + + ++ ++ + Q L RG+ Y+H
Sbjct: 95 DVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQIL---RGLKYIH 149
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW-MAPE-MIQHRP 313
IHRDLK NL ++ D +KI DFG+AR + MT T RW APE M+
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVAT-RWYRAPEIMLNWMH 206
Query: 314 YTQKVDVYSFGIVLWELITG 333
Y Q VD++S G ++ EL+TG
Sbjct: 207 YNQTVDIWSVGCIMAELLTG 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-23
Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK--ILERPENNPEKAQVM 179
+E Y + L KL +G + +Y+G VA+K LE E P A
Sbjct: 1 METYIK----LDKLG------EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-- 48
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--L 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 49 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNV 102
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGM 294
KL + Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR I +T
Sbjct: 103 KLFLFQLL---RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y 157
Query: 295 TPETGT--YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG--LLP 336
E T YR P+ ++ Y+ ++D++ G + +E+ TG L P
Sbjct: 158 DNEVVTLWYR--PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-I-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G + +Y+G G VA+K + L+ E P A +E+ ++ LKH NIVR
Sbjct: 15 NGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-------REISLMKELKHENIVR 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-------LKLAVKQALDVARGMAY 253
+V E+ +++++ R P +K Q L +G+A+
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAPE- 307
H +HRDLK NLLI+ +K+ DFG+AR I V T + E T YR AP+
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYR--APDV 179
Query: 308 MIQHRPYTQKVDVYSFGIVLWELITG--LLP 336
++ R Y+ +D++S G +L E+ITG L P
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 3e-22
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIV 199
GA+G +Y+ ++G VA+K + R N + +EV +L L+ H N+V
Sbjct: 19 VGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 200 RFIGACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
R + C +V E+ +R +L + +P K ++Q L RG+
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL---RGL 133
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMAPEMI 309
++H +HRDLK +N+L+++ ++K+ADFG+ARI +TP T YR APE++
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR--APEVL 191
Query: 310 QHRPYTQKVDVYSFGIVLWELITG--LLP 336
Y VD++S G + E+ L
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-22
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ N GE A+K + R E E +E+ +L LKH NIV
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTI-------REISILKELKHSNIV 63
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
+ + +V E+ +++ L + K + Q L G+AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAPE-MIQH 311
+HRDLK NLLI+ + +KIADFG+AR I V+ T E T YR AP+ ++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR--APDVLMGS 175
Query: 312 RPYTQKVDVYSFGIVLWELITG--LLP 336
+ Y+ +D++S G + E++ G L P
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 5e-22
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G +G +Y+ G VA+K + R + E +E+ +L L H NIV I
Sbjct: 31 EGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPS---TAIREISLLKELHHPNIVSLID 86
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFIH 261
+V E+ + +++ L + +K+ + Q L RG+A+ H +H
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHRILH 142
Query: 262 RDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAPE-MIQHRPYT 315
RDLK NLLI++D ++K+ADFG+AR I V++ T E T YR AP+ ++ + Y+
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYR--APDVLMGSKKYS 198
Query: 316 QKVDVYSFGIVLWELITG--LLP 336
VD++S G + E+ITG L P
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFP 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 20 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VK----QALDVARGMAYVHGL 257
A + +V ++ + + + ++ ++ L + +K L +G+ Y+H
Sbjct: 79 DAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTL---QGLEYLHQH 131
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAPEMI-QH 311
+HRDLK +NLL+ + +K+ADFG+A+ + T + T YR APE++
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYR--APELLFGA 187
Query: 312 RPYTQKVDVYSFGIVLWELITG--LLP 336
R Y VD+++ G +L EL+ LP
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRVPFLP 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + R +++ E +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPS---SALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFI 260
+V E+ ++++ P +K + Q L +G+ + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRNVL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAPE-MIQHRPY 314
HRDLK NLLI+ + +K+A+FG+AR I V+ + E T YR P+ + + Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYR--PPDVLFGAKLY 179
Query: 315 TQKVDVYSFGIVLWELITGLLPF 337
+ +D++S G + EL P
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 54/225 (24%), Positives = 83/225 (36%), Gaps = 42/225 (18%)
Query: 145 QGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+GAFGK+ G VA+KI++ N + + E+ +L L
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVK---NVDR----YCEAARSEIQVLEHLNTTDPNST 76
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V+ + + CIV E G S F+ L K A + + + +
Sbjct: 77 FRCVQMLEWFEHHGHI--CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 254 VHGLGFIHRDLKSDNLLIS-------------------ADKSIKIADFGVARIEVQTEGM 294
+H H DLK +N+L + IK+ DFG A + +
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST 193
Query: 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
T YR APE+I ++Q DV+S G +L E G F
Sbjct: 194 LVSTRHYR--APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 44/203 (21%), Positives = 77/203 (37%), Gaps = 42/203 (20%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRF 201
G GK+ + E A+K+L+ ++EV + +IVR
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPK-----------ARREVELHWRASQCPHIVRI 76
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY 314
HRD+K +NLL + +K+ DFG A E Y
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKE-TTGEKY 175
Query: 315 TQKVDVYSFGIVLWELITGLLPF 337
+ D++S G++++ L+ G PF
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPF 198
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 55/227 (24%), Positives = 83/227 (36%), Gaps = 46/227 (20%)
Query: 145 QGAFGKLYR---GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+G FGK+ VA+KI+ N + + + E+ +L +K
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIR---NVGK----YREAARLEINVLKKIKEKDKENK 81
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V M CI E G + +FL + PL A + + +
Sbjct: 82 FLCVLMSDWFNFHGHM--CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 254 VHGLGFIHRDLKSDNLLISADK-------------------SIKIADFGVARIEVQTEGM 294
+H H DLK +N+L + SI++ADFG A + E
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD--HEHH 196
Query: 295 TP--ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
T T YR PE+I + Q DV+S G +L+E G FQ
Sbjct: 197 TTIVATRHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + N VAIK + E+ Q Q+ +E+ +L +H NI+
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKILLRFRHENIIGIN 91
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
++M V+ IV + + + L + L + Q L RG+
Sbjct: 92 DIIRAPTIEQMKDVY-IVQDLM-ETDLYKLL-----KTQHLSNDHICYFLYQIL---RGL 141
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGT--YRWMA 305
Y+H +HRDLK NLL++ +KI DFG+AR+ T +T T YR A
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR--A 199
Query: 306 PE-MIQHRPYTQKVDVYSFGIVLWELITG 333
PE M+ + YT+ +D++S G +L E+++
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 44/216 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNI 198
+G +G++Y+ T E VAIK + R E+ E A +EV +L L+H NI
Sbjct: 44 EGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAI-------REVSLLKELQHRNI 95
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAY 253
+ ++ EY L + ++ + K + Q + G+ +
Sbjct: 96 IELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLI---NGVNF 147
Query: 254 VHGLGFIHRDLKSDNLLISADKS-----IKIADFGVAR---IEVQTEGMTPETGT--YRW 303
H +HRDLK NLL+S + +KI DFG+AR I ++ T E T YR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYR- 204
Query: 304 MAPE-MIQHRPYTQKVDVYSFGIVLWELITG--LLP 336
PE ++ R Y+ VD++S + E++ L P
Sbjct: 205 -PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-----N 197
G FG++ N + A+K++ N + + + E +L +++ N
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVR---NIKK----YTRSAKIEADILKKIQNDDINNNN 97
Query: 198 IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G M C++ E G S+ + +TR ++ +++ + + Y+
Sbjct: 98 IVKYHGKFMYYDHM--CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 256 GLGFIHRDLKSDNLLI-------------------------SADKSIKIADFGVARIEVQ 290
+ H DLK +N+L+ + IK+ DFG A +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK-- 212
Query: 291 TEGMTP--ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN 339
++ T YR APE+I + + D++SFG VL EL TG L F+
Sbjct: 213 SDYHGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 46/244 (18%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT---YNGEDVAIKILERPEN 171
M+ + Y+ + ++ +GA+GK+++ G VA+K + R +
Sbjct: 1 MEKDGLCRADQQYEC----VAEIG------EGAYGKVFKARDLKNGGRFVALKRV-RVQT 49
Query: 172 N----PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWC-----IVTEYAK 219
P +EV +L L+ H N+VR C +V E+
Sbjct: 50 GEEGMPLSTI-------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 102
Query: 220 GGSVRQFLTRRQNRAVPL---KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +L + VP K + Q L RG+ ++H +HRDLK N+L+++
Sbjct: 103 Q-DLTTYLDKVPEPGVPTETIKDMMFQLL---RGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 277 IKIADFGVARIEVQTEGMTPETGT--YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG- 333
IK+ADFG+ARI +T T YR APE++ Y VD++S G + E+
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYR--APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 334 -LLP 336
L
Sbjct: 217 PLFR 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 39/215 (18%)
Query: 145 QGAFGKLYRG----TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G +G +Y+ + +D A+K +E A +E+ +L LKH N++
Sbjct: 31 RGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSAC-------REIALLRELKHPNVIS 82
Query: 201 FIGACRKRMVWCI--VTEYA----KGGSVRQFLTRRQNRAVPLKLA-VK----QALDVAR 249
+ + +YA ++ + V L VK Q L
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 139
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVAR---IEVQTEG-MTPETGT- 300
G+ Y+H +HRDLK N+L+ + +KIAD G AR ++ + P T
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 301 -YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
YR APE ++ R YT+ +D+++ G + EL+T
Sbjct: 200 WYR--APELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 44/216 (20%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + T+ GE VAIK + P + P A + +E+ +L KH NI+
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFAL----RTLREIKILKHFKHENIITIF 75
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
+ V+ I+ E + + + L + + Q L R +
Sbjct: 76 NIQRPDSFENFNEVY-IIQELM-QTDLHRVI-----STQMLSDDHIQYFIYQTL---RAV 125
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----------EVQTEGMTPETGT 300
+HG IHRDLK NLLI+++ +K+ DFG+ARI Q GM T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 301 --YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
YR APE M+ Y++ +DV+S G +L EL
Sbjct: 186 RWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 54/231 (23%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++G +Y ++VAIK + R + + + +E+ +L LK I+R
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK----RILREITILNRLKSDYIIRLY 91
Query: 201 --FIGACRKRM--VWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
I + ++ IV E A K FLT +K + L G
Sbjct: 92 DLIIPDDLLKFDELY-IVLEIADSDLKKLFKTPIFLTEEH-----IKTILYNLL---LGE 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----------------------E 288
++H G IHRDLK N L++ D S+K+ DFG+AR +
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 289 VQTEGMTPETGT--YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITGLLP 336
+ +T T YR APE ++ YT+ +D++S G + EL+ L
Sbjct: 203 NLKKQLTSHVVTRWYR--APELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
G G ++ + VAIK K + + Q + E+ ++ L H NI
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIK----------KIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 199 VR---FIGACRKRMVWC-----------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
V+ +G ++ IV EY + L + +L + Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQL 129
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARI----EVQTEGMTPETG 299
L RG+ Y+H +HRDLK NL I + D +KI DFG+ARI ++
Sbjct: 130 L---RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 300 T--YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
T YR +P ++ YT+ +D+++ G + E++TG
Sbjct: 187 TKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 51/287 (17%), Positives = 102/287 (35%), Gaps = 80/287 (27%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
+ + + ++ +RKL G + L + VA+K+++ E+ E
Sbjct: 24 GGYHLVKIGDLFNGRYHVIRKLGWGHF----STVWLSWDIQGKKFVAMKVVKSAEHYTET 79
Query: 176 AQVMEQQFQQEVMMLATLKHLN--------IVRFI------GACRKRMVWCIVTEYAKGG 221
A E+ +L ++++ + +V+ + G + C+V E G
Sbjct: 80 AL-------DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI--CMVFEVL-GH 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISAD------ 274
+ +++ + + +PL K V +G+ Y+H IH D+K +N+L+S +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189
Query: 275 -------------------------------------------KSIKIADFGVARIEVQT 291
+KIAD G A +
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249
Query: 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+T YR + E++ Y D++S + +EL TG F+
Sbjct: 250 FTEDIQTRQYR--SLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
G+FG +Y GT GE+VAIK+ E + Q E + ++ + I
Sbjct: 19 SGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V E G S+ L +R LK + A + + Y+H FIH
Sbjct: 71 RWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 262 RDLKSDNLLISADK---SIKIADFGVAR--IEVQTEGMTPE------TGTYRWMAPEMIQ 310
RD+K DN L+ K + I DFG+A+ + +T P TGT R+ +
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT-- 186
Query: 311 HRPYTQ--KVDVYSFGIVLWELITGLLPFQNMTA 342
H Q + D+ S G VL G LP+Q + A
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 65/239 (27%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
G++G + VAIK + R + + + +E+ +L L H ++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI----LREIAILNRLNHDHVVKVL 118
Query: 201 --FIGACRKRM--VWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
I ++ ++ +V E A + +LT +K + L
Sbjct: 119 DIVIPKDVEKFDELY-VVLEIADSDFKKLFRTP---VYLTELH-----IKTLLYNLL--- 166
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------------------- 287
G+ YVH G +HRDLK N L++ D S+K+ DFG+AR
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 288 -------EVQTEGMTPETGT--YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITGLLP 336
+ +T T YR APE ++ YT+ +DV+S G + EL+ +
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 58/228 (25%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA+G +++ GE VA+K + N AQ + +E+M+L L H NIV
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ----RTFREIMILTELSGHENIVNL 74
Query: 202 IGACR---KRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+ R R V+ +V +Y + L + V Q + +
Sbjct: 75 LNVLRADNDRDVY-LVFDYMETDLHAVIRA----NILEPVH-----KQYVVYQLI---KV 121
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----------------------E 288
+ Y+H G +HRD+K N+L++A+ +K+ADFG++R +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 289 VQTEGMTPETGT--YRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITG 333
+T T YR APE ++ YT+ +D++S G +L E++ G
Sbjct: 182 DDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 59/219 (26%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIV 199
G FG+L G Y E VAIK+ E + Q E L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +V E G S+ L +R LK + A+ + M YVH
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 260 IHRDLKSDNLLI-----SADKSIKIADFGVAR--IEVQTEGMTPE------TGTYRWMAP 306
I+RD+K +N LI + I I DF +A+ I+ +T+ P TGT R+M+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS- 185
Query: 307 EMIQ-HRPYTQ--KVDVYSFGIVLWELITGLLPFQNMTA 342
I H Q + D+ + G + + G LP+Q + A
Sbjct: 186 --INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-16
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
+G+FG ++ GT N + VAIK E + Q + E L I
Sbjct: 20 EGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G S+ L R +K A + + +H ++
Sbjct: 72 YYFGQEGLHNVLVIDLL-GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 262 RDLKSDNLLISADKS-----IKIADFGVAR--IEVQTEGMTPE------TGTYRWMAPEM 308
RD+K DN LI S I + DFG+ + + T+ P +GT R+M+
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 189
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA 342
R +++ D+ + G V + G LP+Q + A
Sbjct: 190 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 28/214 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
G+FG++Y GT E+VAIK+ E + Q E + L+ I
Sbjct: 17 SGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V + G S+ L +R + LK + A + + +VH F+H
Sbjct: 69 RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVAR--IEVQTEGMTPE------TGTYRWMAPEMIQ 310
RD+K DN L+ + + I DFG+A+ + T P TGT R+ + +
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--VNT 184
Query: 311 HRPYTQ--KVDVYSFGIVLWELITGLLPFQNMTA 342
H Q + D+ S G VL + G LP+Q + A
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 28/228 (12%), Positives = 79/228 (34%), Gaps = 36/228 (15%)
Query: 145 QGAFGKLYRGT----------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+ G LY + ++K+ + ++ + Q + + + K
Sbjct: 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-D-AKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAK--------GGSVRQFLTRRQNRAVPLKLAVKQALD 246
L + + V + G S++ L + + ++ A
Sbjct: 110 KLYSTPLLAIPT--CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTP 296
+ + ++H ++H ++ ++N+ + + + +A +G A + +P
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 297 ETGTYRWMAPEMIQHRPYTQ--KVDVYSFGIVLWELITGLLPFQNMTA 342
G +++ ++ H+ + D+ S G + + + G LP+ N
Sbjct: 228 HEGDLEFISMDL--HKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 5e-14
Identities = 41/244 (16%), Positives = 73/244 (29%), Gaps = 59/244 (24%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENN 172
H PTE L+ K+ +G FG++++ + VAIKI +E P+
Sbjct: 13 FSHCLPTEKLQR-------CEKI------GEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 173 PEKAQVMEQQFQQEVMMLATLKHL---------NIVRFIGAC------------------ 205
Q ++ E+++ L L +
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 206 ------------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K IV E+ GG + + + + K + Q + +A
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ---LTASLAV 176
Query: 254 VH-GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQH 311
L F HRDL N+L+ K+ + + + G+ Y E
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI 236
Query: 312 RPYT 315
+
Sbjct: 237 VVFC 240
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 43/230 (18%), Positives = 80/230 (34%), Gaps = 35/230 (15%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVM---MLATLKHLN 197
G FG +Y E A + +E EN P E +F Q V +
Sbjct: 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERK 103
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGS---VRQFL------TRRQNRAVPLKLAVKQALDVA 248
+ ++G +TE+ V + L QN ++ + +
Sbjct: 104 QLDYLGIPL--FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTPET 298
+ Y+H ++H D+K+ NLL+ + +AD+G++ + Q
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 299 GTYRWMAPEMIQHRPYTQ--KVDVYSFGIVLWELITGLLPFQNMTAVQAA 346
GT + + + H+ + DV G + + G LP++ A
Sbjct: 222 GTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 39/230 (16%), Positives = 80/230 (34%), Gaps = 40/230 (17%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQ--VMEQQFQQEV---MMLATLKHLNI 198
QG FG +Y + E V + P E +F Q +
Sbjct: 45 QGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104
Query: 199 VRFIGACRKRMVWCIVTEYAKG----------GSVRQFLTRRQNRAVPLK----LAVKQA 244
++++G + + + GS Q + + K L++ +
Sbjct: 105 LKYLGVPK--YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL-RI 161
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--IEVQTEGMTPE--- 297
LD+ + Y+H ++H D+K+ NLL++ + + D+G+A
Sbjct: 162 LDI---LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 298 ---TGTYRWMAPEMIQHRPYTQ--KVDVYSFGIVLWELITGLLPFQNMTA 342
GT + + + H + D+ G + + +TG LP+++
Sbjct: 219 RCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 37/184 (20%), Positives = 69/184 (37%), Gaps = 23/184 (12%)
Query: 118 RYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE- 174
Y T+ +E N+ + ++ +GA + R +Y DV IK +++ +
Sbjct: 318 NYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL 377
Query: 175 KAQVMEQQFQQEVMMLATLKHLNI----VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+ + + +E LA +K I + + KR I+ Y G + +
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR----IMMSYINGKLAKDVIEDN 433
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ A + + +H IH DL + N + DK + I DFG+ +I
Sbjct: 434 LDIAY----------KIGEIVGKLHKNDVIHNDLTTSNFIF--DKDLYIIDFGLGKISNL 481
Query: 291 TEGM 294
E
Sbjct: 482 DEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 418 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.98 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.8 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 95.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.4 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 93.81 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 92.52 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 92.18 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 92.08 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 91.67 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 91.29 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 91.06 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 90.69 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 90.05 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 89.82 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 89.18 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 88.02 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 87.74 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 87.71 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 87.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.36 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 86.56 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 85.6 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 85.43 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 85.35 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 85.21 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 84.56 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 84.27 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.24 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 83.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.1 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 82.46 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 82.28 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 82.05 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 81.42 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 80.7 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-62 Score=469.50 Aligned_cols=265 Identities=32% Similarity=0.631 Sum_probs=226.1
Q ss_pred CcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.+.|+|+.+++++.+.||+|+||+||+|++.+ .||||+++......+. .+.|.+|+.+|++++|||||+++++|.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ----FQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 46799999999999999999999999999865 5999999765444332 367999999999999999999999986
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
++ .+|||||||++|+|.+++... ...+++..+..++.||+.||+|||+++||||||||+||||+.++++||+|||+|+
T Consensus 103 ~~-~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 103 KD-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp SS-SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred CC-eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCce
Confidence 54 579999999999999999754 3569999999999999999999999999999999999999999999999999998
Q ss_pred eeccc---CCCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----
Q 014783 287 IEVQT---EGMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---- 356 (418)
Q Consensus 287 ~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 356 (418)
..... ......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+.+........+..+...
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 65432 22345689999999999964 358999999999999999999999999888777666666666543
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 357 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
..+..+++.+.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 345678999999999999999999999999999998876554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-62 Score=467.32 Aligned_cols=260 Identities=28% Similarity=0.528 Sum_probs=227.8
Q ss_pred ccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
-++|+..++++.++||+|+||+||+|++ +++.||||+++....... .+.|.+|+.+|++++|||||++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCCc
Confidence 3467788899999999999999999986 356899999975433222 2579999999999999999999
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (418)
+|+|.+...+|||||||++|+|.++|.... ...+++..++.++.||+.||+|||+++||||||||+
T Consensus 95 ~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 95 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp EEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999999999997532 235899999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014783 268 NLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAV 343 (418)
Q Consensus 268 NILl~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~ 343 (418)
||||++++++||+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654332 2344679999999999999999999999999999999999 89999999887
Q ss_pred HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 344 QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+... .+..+.+++.|..|++.+.+||.+||+.||++|||++||++.|+.+
T Consensus 255 ~~~~-~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVE-MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH-HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 7654 4566777788999999999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-62 Score=467.27 Aligned_cols=260 Identities=30% Similarity=0.535 Sum_probs=226.8
Q ss_pred cccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
+.|++++|.+.+.||+|+||+||+|++ +++.||||+++... . ...+.|.+|+.+|++++|||||+++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D----NARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 457888999999999999999999986 35689999996432 1 1236799999999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl 271 (418)
++|.+...+|||||||++|+|.++++... ...+++..++.++.||+.||+|||+++||||||||+||||
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 99999999999999999999999997532 3569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeecccceeecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014783 272 SADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF 347 (418)
Q Consensus 272 ~~~~~vkl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 347 (418)
+.++.+||+|||+|+........ ....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+...
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999865433222 23458999999999999999999999999999999999 999999998877655
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
. +..+.++..|..+++++.+||.+||+.||++|||++||++.|+++..
T Consensus 242 ~-i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 C-ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp H-HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 4 55566778889999999999999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=466.26 Aligned_cols=261 Identities=33% Similarity=0.568 Sum_probs=223.6
Q ss_pred ccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
.+.|+.+++.+.++||+|+||+||+|++. ++.||||+++... . ...+.|.+|+.+|++++|||||++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l 108 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--E----SARQDFQREAELLTMLQHQHIVRF 108 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--H----HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--H----HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 35677888999999999999999999863 5789999996432 1 123679999999999999999999
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 268 (418)
+++|.+...+|||||||++|+|.++++... ...+++..++.++.||+.||+|||+++||||||||+|
T Consensus 109 ~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N 188 (329)
T 4aoj_A 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188 (329)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence 999999999999999999999999997542 2468999999999999999999999999999999999
Q ss_pred EEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 014783 269 LLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQ 344 (418)
Q Consensus 269 ILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~ 344 (418)
|||+.++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999986543322 234579999999999999999999999999999999999 999999998877
Q ss_pred HHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 345 AAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.... +..+.++..|..+++.+.+||.+||+.||++|||++||++.|+.+..
T Consensus 269 ~~~~-i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 AIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHH-HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHH-HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 6544 55677888899999999999999999999999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-61 Score=470.78 Aligned_cols=265 Identities=31% Similarity=0.597 Sum_probs=233.0
Q ss_pred CcccccccccccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC-CCe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNI 198 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pni 198 (418)
.++|+|+.++|++++.||+|+||+||+|++.+ +.||||.+........ .+.|.+|+.+|+++.| |||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-----~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-----HHHHHHHHHHHHHcCCCCcE
Confidence 45799999999999999999999999998732 4799999975433221 2578999999999965 899
Q ss_pred EEEEeEEeeC-ceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 014783 199 VRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (418)
Q Consensus 199 v~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (418)
|+++++|.+. ..+|||||||++|+|.++|+... ...+++..++.++.||+.||+|||+++|||||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9999999764 57899999999999999997642 23588999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014783 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQN 339 (418)
Q Consensus 264 lkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~ 339 (418)
|||+|||++.++.+||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543322 234568999999999999999999999999999999998 9999999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 340 MTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+..+.....+..+.++..|..+++++.++|.+||+.||++|||+.||++.|+++.+
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 877677777888899999999999999999999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-61 Score=464.25 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=219.8
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++++.||+|+||+||+|++ +|+.||||++......... .+.+.+|+.+|++|+|||||++++++.++..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH----HHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 457899999999999999999997 6889999999876544322 3678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|||||||+||+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999999876667789999999999999999999999999999999999999999999999999986543
Q ss_pred cC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 291 TE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.. .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+....++... .+..+..+++++.+|
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHH
Confidence 32 2344679999999999999999999999999999999999999999998888777766654 445677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
|.+||+.||++|||++|+++
T Consensus 257 i~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=455.54 Aligned_cols=265 Identities=26% Similarity=0.441 Sum_probs=225.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.+.|++.++||+|+||+||+|++ +|+.||||++........ +.+.+|+.+|++++|||||++++++.++..+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG------GGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH------HHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35688889999999999999998 688999999975433321 4577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|||||||+||+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 147 ~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999999999975 35999999999999999999999999999999999999999999999999999876443
Q ss_pred -CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHHHH
Q 014783 292 -EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLSE 368 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 368 (418)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.. ...+ ..+..+++++.+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccccCCHHHHH
Confidence 345667999999999999999999999999999999999999999999888776655544 3333 233468899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH--HHHhhH--HHHhhhhhhcccc
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR--MLENAE--TEIMTTVRKARFR 408 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~--~L~~~~--~~~~~~~~~~r~~ 408 (418)
|+.+||+.||++|||++|+++ .|.+.. ..+.+.++++|+|
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l~pl~~~~rtR 346 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 346 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGGSTTTC--
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcccCccccccCCC
Confidence 999999999999999999987 344322 3444555555543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=454.07 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=220.8
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..+.|++.++||+|+||.||+|++ +|+.||||+++.... ..+|+.+|+.++|||||++++++.++..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 445678889999999999999998 688999999975432 2379999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccceeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEV 289 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~~~ 289 (418)
+|||||||+||+|.++++.. +.+++..+..++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+...
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999999864 4599999999999999999999999999999999999999988 69999999998754
Q ss_pred ccCC------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCC
Q 014783 290 QTEG------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-PVIPNDC 362 (418)
Q Consensus 290 ~~~~------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 362 (418)
.... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+...... ..+|+.+
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence 3221 22357999999999999999999999999999999999999999887766655565554433 2467789
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
++.+.+|+.+||+.||.+|||+.||++.|..+..++.
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999998877654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=446.25 Aligned_cols=248 Identities=21% Similarity=0.380 Sum_probs=219.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||+||+|+. +++.||||++.+..... ....+.+.+|+.+|++++|||||++++++.++..+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 35789999999999999999997 68899999997431110 11125788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|||||||+||+|.+++.+. +.+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999999864 45999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 ---EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ---~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....+ .+|..+++++.+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~d 263 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY--DFPEKFFPKARD 263 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTCCHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCcccCHHHHH
Confidence 234567899999999999999999999999999999999999999999888887777766543 467788999999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIV 388 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell 388 (418)
|+.+||+.||++|||++|++
T Consensus 264 li~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHccCCHhHCcChHHHc
Confidence 99999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=437.49 Aligned_cols=245 Identities=29% Similarity=0.537 Sum_probs=211.7
Q ss_pred ccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee----Cce
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMV 210 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~~ 210 (418)
+++.++||+|+||.||+|++ ++..||||++......... .+.|.+|+.+|++++|||||+++++|.+ +..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 46777899999999999998 5779999999765443322 3678999999999999999999999865 356
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEc-CCCCEEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~-~~~~vkl~DfGla~~ 287 (418)
+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999864 46999999999999999999999998 99999999999998 479999999999985
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPVL 366 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 366 (418)
... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..........+..+..+ ..+..+++++
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred CCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 433 34456789999999999875 59999999999999999999999998877766666666666554 4456678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+|+.+||+.||++|||++|+++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=457.40 Aligned_cols=266 Identities=26% Similarity=0.425 Sum_probs=227.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.+.|++.++||+|+||.||+|++ +|+.||||++........ +.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG------GGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH------HHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 46788999999999999999998 688999999976543322 4578999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|||||||+||+|.++++. ..+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 224 ~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999999999975 34999999999999999999999999999999999999999999999999999876433
Q ss_pred -CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014783 292 -EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSEI 369 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 369 (418)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..... ....+..+++.+.+|
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 345667899999999999999999999999999999999999999999888777665544322 223445788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH--HHHhhH--HHHhhhhhhcccc
Q 014783 370 MTRCWDTNPEVRPPFTEIVR--MLENAE--TEIMTTVRKARFR 408 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~--~L~~~~--~~~~~~~~~~r~~ 408 (418)
|.+||+.||++|||++|+++ .|.+.. ..+.+.++++|.|
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~pl~~~~rtR 423 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 423 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGGSGGGCC-
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCCCccccchhhhcCCC
Confidence 99999999999999999987 344432 3455556666554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=434.16 Aligned_cols=247 Identities=26% Similarity=0.441 Sum_probs=202.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.+|++.+.||+|+||+||+|++ +|+.||||++.+....... ..+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD---MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5788999999999999999987 6889999999765433221 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
|||||| +|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+......
T Consensus 90 ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999999 78999999764 569999999999999999999999999999999999999999999999999998776666
Q ss_pred CCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.....+||+.|||||++.+..| +.++|||||||++|||+||+.||.+.+..+....+.... ..+|..+++.+.+|+.
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLSPGAAGLIK 244 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 6667899999999999998886 579999999999999999999999887766655554433 3467788999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 014783 372 RCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~ 389 (418)
+||+.||++|||++|+++
T Consensus 245 ~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHSCSSGGGSCCHHHHHH
T ss_pred HHccCChhHCcCHHHHHc
Confidence 999999999999999886
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-59 Score=442.24 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=212.5
Q ss_pred cccccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
++.++|++++.||+|+||+||+|+. +++.||||++++........ ..+.+|+.+|++++|||||++++++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR----VRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC----C------CCCCCCCCTTEECEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH----HHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 4567899999999999999999986 35789999997543221111 25678999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
++..+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999999999999864 459999999999999999999999999999999999999999999999999998
Q ss_pred eecc-cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 287 IEVQ-TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 287 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
.... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.... ...|..++++
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~ 252 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPE 252 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHH
T ss_pred eccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCcCCHH
Confidence 6433 334456789999999999999999999999999999999999999999998888777766654 3467789999
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPF-----TEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~-----~ell~ 389 (418)
+.+|+.+||+.||++|||+ +|+++
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 9999999999999999984 56654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=434.62 Aligned_cols=252 Identities=31% Similarity=0.524 Sum_probs=204.5
Q ss_pred ccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc----e
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----~ 210 (418)
++|.+.+.||+|+||+||+|+++|+.||||++.... .. ...+.+|+..+.+++|||||+++++|.++. .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 457788899999999999999999999999986421 11 123345777778899999999999997653 5
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEcCCCCEEEeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
+|||||||++|+|.++++.. .++++.+.+++.|++.||+|||++ +||||||||+||||+.++++||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 89999999999999999753 489999999999999999999987 9999999999999999999999999
Q ss_pred ccceeecccCC-----CCCCCCCccccccccccCC------CCCCcchHHHHHHHHHHHHhCCCCCC----------CC-
Q 014783 283 GVARIEVQTEG-----MTPETGTYRWMAPEMIQHR------PYTQKVDVYSFGIVLWELITGLLPFQ----------NM- 340 (418)
Q Consensus 283 Gla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~t~~sDvwSlGv~l~elltg~~Pf~----------~~- 340 (418)
|+|+....... ....+||+.|||||++.+. .|+.++|||||||+||||+||..||. +.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99987644322 2235799999999999764 47789999999999999999976553 22
Q ss_pred ----CHHHHHHHHHhcCCCCCCCCC-----ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 341 ----TAVQAAFAVVNKGVRPVIPND-----CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 341 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
...+....+...+.++.+|.. ++..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 122333344556677777643 34678999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-56 Score=424.95 Aligned_cols=247 Identities=25% Similarity=0.452 Sum_probs=192.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc---
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 209 (418)
++|++.+.||+|+||+||+|++ +|+.||||+++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 4688899999999999999998 6889999999765322 12357889999999999999999999986544
Q ss_pred ---------eEEEEEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 210 ---------VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 210 ---------~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
.+|||||||++|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 37999999999999999976432 23456778899999999999999999999999999999999999999
Q ss_pred eecccceeecccCC-------------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 014783 280 ADFGVARIEVQTEG-------------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAA 346 (418)
Q Consensus 280 ~DfGla~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~ 346 (418)
+|||+|+....... .+..+||+.|||||++.+..|+.++|||||||++|||++ ||.........
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999986543221 234579999999999999999999999999999999996 78653332222
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+.....++.....++.+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222322222222234456788999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=445.70 Aligned_cols=343 Identities=31% Similarity=0.516 Sum_probs=278.0
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeecccccccC--Ccccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFRP--GKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~~--~~v~~-~~~~d~l~~~ 113 (418)
+|+|+++.| ...+|.|++||+..+... ...++||.|...+ +.|++. ....|.. ..+.+ ..+.++++..
T Consensus 93 ~G~FLvR~s---~~~~g~y~lsv~~~~~~~----~~~v~H~~I~~~~~g~~~i~-~~~~F~sl~eLv~~y~~~~~~l~~~ 164 (454)
T 1qcf_A 93 LGSFMIRDS---ETTKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQK 164 (454)
T ss_dssp TTCEEEEEC---SSSTTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSSC
T ss_pred CceEEEEEC---cCCCCeEEEEEEecccCC----CCceEEEEEEEcCCCcEEEe-CccccCCHHHHHHHHHhccCCcccc
Confidence 799999998 456789999998744321 2367899997655 666665 3333321 22222 3334555555
Q ss_pred HhcCCCCCCCC--CCCcccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHH
Q 014783 114 LMDHRYPTEGL--ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190 (418)
Q Consensus 114 l~~~~~~~~~~--~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il 190 (418)
+..++...... ...+.|++..++|++.+.||+|+||.||+|++ ++..||||+++..... .+.|.+|+.+|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l 237 (454)
T 1qcf_A 165 LSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANVM 237 (454)
T ss_dssp CCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHHH
T ss_pred ccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHHH
Confidence 54454433222 23578999999999999999999999999998 4678999999764432 25788999999
Q ss_pred HhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 014783 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (418)
Q Consensus 191 ~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIL 270 (418)
++++||||+++++++. ...+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 238 ~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 316 (454)
T 1qcf_A 238 KTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316 (454)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred hhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 9999999999999987 556899999999999999998654456899999999999999999999999999999999999
Q ss_pred EcCCCCEEEeecccceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014783 271 ISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF 347 (418)
Q Consensus 271 l~~~~~vkl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 347 (418)
++.++.+||+|||+++...... ......+++.|+|||++....++.++|||||||++|||++ |+.||.+....+...
T Consensus 317 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~ 396 (454)
T 1qcf_A 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396 (454)
T ss_dssp ECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred ECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998653321 1233456789999999998899999999999999999999 999999988877654
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+..+.+...|..+++.+.+||.+||+.||++|||+++|++.|+++...
T Consensus 397 -~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 397 -ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 4556778888889999999999999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=443.28 Aligned_cols=337 Identities=28% Similarity=0.537 Sum_probs=272.1
Q ss_pred hcCCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceeeccccccc--CCcccc-ccCchHHHH
Q 014783 36 LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTH-ALNDDALAQ 112 (418)
Q Consensus 36 ~~~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~ 112 (418)
+.+|+|++++| .+..|.|++||... ..++||.|....+.+++. ....|. .+.+.+ ..+.++++.
T Consensus 99 ~~~G~FlvR~S---~~~~g~~~Lsv~~~---------~~v~H~~I~~~~~~~~i~-~~~~F~sl~eLv~~y~~~~~~~~~ 165 (450)
T 1k9a_A 99 PETGLFLVRES---TNYPGDYTLCVSCE---------GKVEHYRIMYHASKLSID-EEVYFENLMQLVEHYTTDADGLCT 165 (450)
T ss_dssp CCTTEEEEEEC---SSSTTSEEEEEECS---------SSEEEEEEEEETTEEESS-SSSCBSSHHHHHHHHHHCCTTSSS
T ss_pred CCCceEEEEec---CCCCCceEEEEEeC---------CeeeEEEEEecCCceEec-cccccccHHHHHhhhcccccchhh
Confidence 35799999998 55678999999751 146899996655667765 222232 112221 223334443
Q ss_pred HHhcCCCCCCCCC-----CCcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHH
Q 014783 113 ALMDHRYPTEGLE-----NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187 (418)
Q Consensus 113 ~l~~~~~~~~~~~-----~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~ 187 (418)
.+..++....... ..+.|.++.++|++.+.||+|+||.||+|+++++.||||+++.... .+.|.+|+
T Consensus 166 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~ 237 (450)
T 1k9a_A 166 RLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEA 237 (450)
T ss_dssp CCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHH
T ss_pred hccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHH
Confidence 3333332222111 1467999999999999999999999999999999999999975432 15688999
Q ss_pred HHHHhCCCCCeEEEEeEEeeCc-eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 014783 188 MMLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (418)
Q Consensus 188 ~il~~l~hpniv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 266 (418)
.+|++++||||+++++++.... .+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||
T Consensus 238 ~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 317 (450)
T 1k9a_A 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317 (450)
T ss_dssp HHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred HHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence 9999999999999999987655 789999999999999999876555689999999999999999999999999999999
Q ss_pred CcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014783 267 DNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345 (418)
Q Consensus 267 ~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 345 (418)
+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 318 ~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 318 RNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp GGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred hhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999999854322 233467899999999999999999999999999999998 9999998877665
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
. ..+..+.++..|..+++.+.++|.+||+.||.+|||+.+|++.|+++..
T Consensus 396 ~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 396 V-PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp H-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 4 4456778888899999999999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=442.83 Aligned_cols=344 Identities=30% Similarity=0.503 Sum_probs=274.6
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
.|+|+++.| .+.+|.|++||+...... ...++||.|.... +.|++. ....|. +..+.+ ..+.++++..
T Consensus 88 ~G~FLvR~s---~~~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~~~-~~~~F~Sl~~Li~~y~~~~~~l~~~ 159 (452)
T 1fmk_A 88 RGTFLVRES---ETTKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYIT-SRTQFNSLQQLVAYYSKHADGLCHR 159 (452)
T ss_dssp TTEEEEEEC---SSSTTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-TTSEESSHHHHHHHHTTCCTTSSSC
T ss_pred CceEEEEeC---CCCCCceEEEEEeeccCC----CCcEEEEEEEEcCCCCEEEe-cCcccCCHHHHHHHhhhccccchhh
Confidence 499999988 456789999998643221 2367999997755 557765 333332 223332 3445566555
Q ss_pred HhcCCCCCC---CCCCCcccccccccccccCceeeeCceEEEEEEECC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHH
Q 014783 114 LMDHRYPTE---GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (418)
Q Consensus 114 l~~~~~~~~---~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i 189 (418)
+..++.... .....+.|+++.++|++.+.||+|+||.||+|++.+ ..||||+++...... +.|.+|+.+
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 232 (452)
T 1fmk_A 160 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 232 (452)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHH
T ss_pred ccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH-------HHHHHHHHH
Confidence 555443221 112357899999999999999999999999999954 689999997654332 468899999
Q ss_pred HHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 014783 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (418)
Q Consensus 190 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (418)
|++++||||+++++++.+ ..+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 999999999999999876 5689999999999999999865556699999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecccceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014783 270 LISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346 (418)
Q Consensus 270 Ll~~~~~vkl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 346 (418)
|++.++.+||+|||+++....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....+..
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 391 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391 (452)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999986543221 223356789999999998899999999999999999999 99999998887755
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
. .+..+.++..|..+++.+.++|.+||+.||++|||+++|++.|+++....
T Consensus 392 ~-~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 392 D-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp H-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred H-HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 4 45677788888899999999999999999999999999999999887544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=441.66 Aligned_cols=337 Identities=27% Similarity=0.521 Sum_probs=276.4
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
+|+|++++| .+.+|.|++||+.. ..++||.|.... +.+++. ....|. ...+.+ ....++++..
T Consensus 126 ~G~fLvR~s---~~~~~~~~lsv~~~---------~~v~h~~I~~~~~g~~~~~-~~~~F~sl~eLv~~~~~~~~g~~~~ 192 (495)
T 1opk_A 126 NGSFLVRES---ESSPGQRSISLRYE---------GRVYHYRINTASDGKLYVS-SESRFNTLAELVHHHSTVADGLITT 192 (495)
T ss_dssp TTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEECEECTTSCEESS-TTSCBSSHHHHHHHHTTCCTTSSSC
T ss_pred CceEEEEeC---CCCCCceEEEEeeC---------CeEEEEEEEecCCCceEec-cCccchhHHHHhhhhcccccccchh
Confidence 899999998 55678999999952 257999997754 556554 333332 122322 3344555444
Q ss_pred HhcCCCCCC------CCCCCcccccccccccccCceeeeCceEEEEEEEC--CceEEEEEeecCCCChHHHHHHHHHHHH
Q 014783 114 LMDHRYPTE------GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQ 185 (418)
Q Consensus 114 l~~~~~~~~------~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~ 185 (418)
+..++.... ....++.|++...+|++.+.||+|+||.||+|++. +..||||+++..... .+.|.+
T Consensus 193 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~ 265 (495)
T 1opk_A 193 LHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLK 265 (495)
T ss_dssp CCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------HHHHHH
T ss_pred ccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------hHHHHH
Confidence 443332111 11246789999999999999999999999999984 789999999764433 256889
Q ss_pred HHHHHHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 186 E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
|+.+|++++||||++++++|.....+||||||+++|+|.+++.......+++..++.++.||+.||+|||++||+|||||
T Consensus 266 E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 345 (495)
T 1opk_A 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345 (495)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 99999999999999999999999999999999999999999987666679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTA 342 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~ 342 (418)
|+|||++.++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 346 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp GGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998654322 1223346789999999998899999999999999999999 9999998876
Q ss_pred HHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 343 VQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
.+. ...+..+.+...|..+++.+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 426 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 426 SQV-YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp GGH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 654 4556778888888999999999999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=426.62 Aligned_cols=335 Identities=28% Similarity=0.499 Sum_probs=257.9
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceeeccccccc--CCccccccC-chHHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALN-DDALAQAL 114 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~~~~~~~~--~~~v~~~~~-~d~l~~~l 114 (418)
+|+|++++|. +.+ .|++||... ..++||.|...++.|.+. ...|. +..+.|... .+.+...
T Consensus 32 ~G~flvR~s~---~~~-~~~lsv~~~---------~~~~h~~i~~~~~~~~~~--~~~F~sl~~LI~~y~~~~~~l~~~- 95 (377)
T 3cbl_A 32 SGDFLVRESQ---GKQ-EYVLSVLWD---------GLPRHFIIQSLDNLYRLE--GEGFPSIPLLIDHLLSTQQPLTKK- 95 (377)
T ss_dssp TTEEEEEECC-----C-CEEEEC--------------CCEEEC----CCCCC------CCSHHHHHHHHHHHTCCC----
T ss_pred CCCEEEEEeC---CCC-cEEEEEEEC---------CCccchhhccccceEEec--ceeccchHHHHHHHhhccCCcccc-
Confidence 7999999983 334 899999852 146899998766655442 22232 222322111 0000000
Q ss_pred hcCCCCCCCCCCCcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHh
Q 014783 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192 (418)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~ 192 (418)
...........+.|.++.++|.+.+.||+|+||.||+|++ +++.||||+++.... . ...+.+.+|+.+|++
T Consensus 96 --~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~~ 168 (377)
T 3cbl_A 96 --SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-P----DLKAKFLQEARILKQ 168 (377)
T ss_dssp ----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-H----HHHTTTTHHHHHHTT
T ss_pred --cCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-H----HHHHHHHHHHHHHHh
Confidence 0001111123568999999999999999999999999998 578999999864322 1 122568899999999
Q ss_pred CCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 014783 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (418)
Q Consensus 193 l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~ 272 (418)
++||||+++++++.....+|+||||+++|+|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 169 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~ 247 (377)
T 3cbl_A 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT 247 (377)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc
Confidence 99999999999999999999999999999999999764 34589999999999999999999999999999999999999
Q ss_pred CCCCEEEeecccceeecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014783 273 ADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFA 348 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~ 348 (418)
.++.+||+|||+++........ ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.. .
T Consensus 248 ~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~ 326 (377)
T 3cbl_A 248 EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-E 326 (377)
T ss_dssp TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-H
T ss_pred CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H
Confidence 9999999999999864332111 11235678999999998899999999999999999998 99999998876654 4
Q ss_pred HHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 349 VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+..+.+...|..+++.+.++|.+||+.||++|||+++|++.|+++..+
T Consensus 327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 5667777888889999999999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=445.28 Aligned_cols=344 Identities=30% Similarity=0.508 Sum_probs=277.9
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
.|+|+++.| ....|.|++||+...... ...++||.|.... +.|++. ....|. ...+.+ ..+.++++..
T Consensus 171 ~G~FLvR~S---~~~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~i~-~~~~F~SL~eLv~~y~~~~~~~~~~ 242 (535)
T 2h8h_A 171 RGTFLVRES---ETTKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYIT-SRTQFNSLQQLVAYYSKHADGLCHR 242 (535)
T ss_dssp TTEEEEEEC---SSSTTCEEEEEEEEETTT----EEEEEEEEEBC-CCSCEEEE-TTEEESSHHHHHHHHHHCCTTSSSC
T ss_pred CCeEEEEec---CCCCCcEEEEEEeeccCC----CCceEEEEEEEcCCCcEEee-ccccccChHHhheeeccccCccccc
Confidence 599999988 455789999998633211 2367999998755 567776 223332 223322 3345555555
Q ss_pred HhcCCCCCC---CCCCCcccccccccccccCceeeeCceEEEEEEECC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHH
Q 014783 114 LMDHRYPTE---GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (418)
Q Consensus 114 l~~~~~~~~---~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i 189 (418)
+..++.... .....+.|++..++|++.+.||+|+||.||+|++.+ ..||||+++...... +.|.+|+.+
T Consensus 243 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 315 (535)
T 2h8h_A 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 315 (535)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHH
T ss_pred cccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH-------HHHHHHHHH
Confidence 554443211 112367899999999999999999999999999954 689999997654332 468899999
Q ss_pred HHhCCCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 014783 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (418)
Q Consensus 190 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (418)
|++++||||+++++++.+ ..+||||||+.+|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 999999999999999976 5689999999999999999865556699999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecccceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 014783 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAA 346 (418)
Q Consensus 270 Ll~~~~~vkl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~ 346 (418)
||+.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+..
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~ 474 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred EEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999997653221 1233456789999999998899999999999999999999 99999998887655
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
. .+..+.+...+..+++.+.+||.+||+.||++|||+++|++.|+++....
T Consensus 475 ~-~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 475 D-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp H-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred H-HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 4 45677788888899999999999999999999999999999999886544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=419.92 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=208.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 207 (418)
++|++++.||+|+||+||+|++ +|+.||||+++........ .+.+.+|+.+|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 5789999999999999999998 6899999999765444322 2567899999999999999999998754
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
...+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 357899999995 689999975 3569999999999999999999999999999999999999999999999999998
Q ss_pred eecc-----cCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----
Q 014783 287 IEVQ-----TEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---- 356 (418)
Q Consensus 287 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---- 356 (418)
.... .......+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..+....+......+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 6432 2234567899999999998875 56999999999999999999999999988877766554321111
Q ss_pred ------------------CC-------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ------------------VI-------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ------------------~~-------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. .+.+++++.+||.+||..||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 1245788999999999999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=431.77 Aligned_cols=249 Identities=20% Similarity=0.362 Sum_probs=221.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||.||+|+. +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh------hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 36789999999999999999998 6889999999754321 125678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC--CCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~--~~vkl~DfGla~~~~ 289 (418)
|||||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999999653 3469999999999999999999999999999999999999854 899999999999876
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 367 (418)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....+.. ..+..+++.+.
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 6665666789999999999999999999999999999999999999999999888777766654432 23356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+||.+||+.||.+|||+.|+++
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=430.20 Aligned_cols=253 Identities=19% Similarity=0.306 Sum_probs=210.2
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++++.||+|+||+||+|+. +|+.||||++.+................+++.+++.++|||||++++++.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4567899999999999999999998 78899999997532111111111122334567778889999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|||||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999999864 459999999999999999999999999999999999999999999999999998764
Q ss_pred ccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCChHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMT---AVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
.. .....+||+.|||||++.. ..|+.++|||||||++|||++|+.||.+.+ ..+....+... ....|..++++
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPE 420 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccCCHH
Confidence 43 3456799999999999964 579999999999999999999999997532 22322233332 34567789999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt-----~~ell~ 389 (418)
+.+|+.+||+.||.+|++ ++||++
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 999999999999999998 677765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=394.73 Aligned_cols=271 Identities=35% Similarity=0.620 Sum_probs=226.8
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..+.|++...+|++.+.||+|+||.||+|+++++.||||++......... .+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34678888999999999999999999999999999999999765544332 25788999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCEEEeec
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.....+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999999975321 23899999999999999999999999 999999999999999999999999
Q ss_pred ccceeecccC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 283 GVARIEVQTE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 283 Gla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.........+..
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 9997543322 234457999999999999999999999999999999999999999999888877666666777788889
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
+++.+.+++.+||+.||.+|||+.|+++.|+.+.....+
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999999998876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=403.01 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=196.9
Q ss_pred ccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
++|++.+.||+|+||+||+|+. +++.||||.+..... . ..+.+|+.+|+.+ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~-------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-P-------IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-H-------HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-H-------HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 5689999999999999999975 357899999865422 1 3567899999998 699999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfGla~~ 287 (418)
..+|||||||++|+|.+++. .+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999984 38999999999999999999999999999999999999877 7999999999975
Q ss_pred ecccC-----------------------------CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 288 EVQTE-----------------------------GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 288 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
..+.. .....+||+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43221 12345799999999999775 5899999999999999999999999
Q ss_pred CCCC-HHHHHHHHHh------------------------------------cCC----------------CCCCCCCChH
Q 014783 338 QNMT-AVQAAFAVVN------------------------------------KGV----------------RPVIPNDCLP 364 (418)
Q Consensus 338 ~~~~-~~~~~~~~~~------------------------------------~~~----------------~~~~~~~~~~ 364 (418)
...+ ..+.+..+.. ... ........++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 5443 3332222211 000 0011234678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
++.+|+.+||+.||++|||++|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 8999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=432.13 Aligned_cols=263 Identities=31% Similarity=0.594 Sum_probs=221.2
Q ss_pred cccccccccccc-CceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 129 EWTIDLRKLNMG-TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 129 ~~~i~~~~~~~~-~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
+|.++.+.+.+. +.||+|+||.||+|.+ .++.||||+++....... ..+.+.+|+.+|++++||||+++++
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG----GHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 355555555553 3799999999999976 356899999975433322 1257889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
++..+ .+++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 438 ~~~~~-~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 438 ICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EEecC-CEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 99654 57899999999999999975 3569999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 284 VARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+++....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.. ..+..+.++..
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~i~~~~~~~~ 593 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGC 593 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCC
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCC
Confidence 9976533221 223356789999999999999999999999999999998 99999998887654 55667778888
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
|..+++.+.+||.+||+.||++|||+++|++.|+++..++.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 89999999999999999999999999999999999987763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=428.16 Aligned_cols=264 Identities=27% Similarity=0.570 Sum_probs=222.7
Q ss_pred ccccccccccccC-ceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 129 ~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
.|.+...++.+.. .||+|+||.||+|.+ ++..||||+++....... .+.+.+|+.+|++++||||+++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMMREAQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-----HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3555666666665 799999999999987 345799999976533222 257889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
+|.. ..+|+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 404 ~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 404 VCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp EEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred Eecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 9976 4589999999999999999753 4569999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 284 VARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.. ..+..+.++..
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~i~~~~~~~~ 560 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRMEC 560 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-HHHHTTCCCCC
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCC
Confidence 9986533221 122345689999999998999999999999999999998 99999998877654 45667778888
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
|..+++.+.+||.+||+.||++||++.+|++.|+.+...+..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 889999999999999999999999999999999998876643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=374.92 Aligned_cols=260 Identities=31% Similarity=0.545 Sum_probs=232.2
Q ss_pred ccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
.+.++.++|++.+.||+|+||.||+|+++++.||||++......... .+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 35678889999999999999999999999999999999765444332 25788999999999999999999999876
Q ss_pred --ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
..+++||||+++|+|.+++.......+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 77899999999999999998765556999999999999999999999999 99999999999999999999999998
Q ss_pred ceeecccCCCCCCCCCccccccccccCCCCCC---cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQ---KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
+... ......||+.|+|||.+.+..++. ++||||||+++|||++|+.||......+........+.++..+..
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 160 KFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp CCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred eeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence 7532 233457899999999998765554 899999999999999999999999988888888888888889999
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+++.+.+++.+||+.||++|||++|+++.|+++..
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=393.70 Aligned_cols=267 Identities=31% Similarity=0.583 Sum_probs=230.7
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CC
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KH 195 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 195 (418)
....|.+..++|++++.||+|+||.||+|++. +..||||+++..... ...+.+.+|+.+++.+ +|
T Consensus 72 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h 146 (370)
T 2psq_A 72 EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKH 146 (370)
T ss_dssp CCTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-----HHHHHHHHHHHHHHHSCCC
T ss_pred ccccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-----HHHHHHHHHHHHHHHhcCC
Confidence 34468888999999999999999999999862 346999999654221 1235788999999999 89
Q ss_pred CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 014783 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIH 261 (418)
Q Consensus 196 pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH 261 (418)
|||++++++|.....+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+|
T Consensus 147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 226 (370)
T 2psq_A 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226 (370)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999999999999999999998643 235789999999999999999999999999
Q ss_pred CCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014783 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPF 337 (418)
Q Consensus 262 rDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf 337 (418)
|||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 227 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp SCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999986543322 233457889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.+....+.. ..+..+.++..|..+++.+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 307 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 307 PGIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp TTCCGGGHH-HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 987765543 456667777888899999999999999999999999999999999987644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.79 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=221.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
...+|++.+.||+|+||.||+|++ +|+.||||++......... .+.+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 356789999999999999999997 7889999999765444322 2568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999999765 4599999999999999999999999999999999999999999999999999987655
Q ss_pred cCCCCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+....+ ..|..+++.+.+|
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 244 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMSTDCENL 244 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHH
Confidence 5556677899999999999888775 799999999999999999999999888777666665543 3566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||+.||.+|||++|+++
T Consensus 245 i~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=372.71 Aligned_cols=260 Identities=29% Similarity=0.601 Sum_probs=228.8
Q ss_pred cccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
..|.++.++|++.+.||+|+||.||++++ +++.||||++....... +.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46899999999999999999999999998 77899999997654332 46889999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+....++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999999999999753 3468999999999999999999999999999999999999999999999999997
Q ss_pred eecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 287 IEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.... +..+.....+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLAS 233 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTSC
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhcCccCCCCCcCC
Confidence 543321 2334457789999999998899999999999999999999 9999999887765544 45556667777889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+.+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 999999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=380.05 Aligned_cols=271 Identities=32% Similarity=0.588 Sum_probs=235.9
Q ss_pred CCCCcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CC
Q 014783 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KH 195 (418)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 195 (418)
++....|++..++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+.+|+.+++++ +|
T Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h 86 (313)
T 1t46_A 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNH 86 (313)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCC
T ss_pred CCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-----HHHHHHHHHHHHhhcccC
Confidence 344567999999999999999999999999985 35689999997543221 125788999999999 99
Q ss_pred CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 014783 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------RAVPLKLAVKQALDVARGMAYVHGLGF 259 (418)
Q Consensus 196 pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~gL~yLH~~~i 259 (418)
|||+++++++......++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||
T Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 9999999999999999999999999999999986532 248999999999999999999999999
Q ss_pred ccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014783 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLL 335 (418)
Q Consensus 260 iHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~ 335 (418)
+||||||+|||++.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 246 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986543322 223346789999999998899999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 336 PFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 336 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
||............+..+.+...+..+++.+.+++.+||+.||.+|||+.|+++.|+++..+..
T Consensus 247 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 9988876666667777777777788899999999999999999999999999999999887643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=381.57 Aligned_cols=262 Identities=30% Similarity=0.559 Sum_probs=225.0
Q ss_pred cccccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
+++...+|++.+.||+|+||.||+|++. +..||||+++...... ..+.+.+|+.++++++||||++++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-----QRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4567789999999999999999999972 3459999997543221 23578899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.+...+|+||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999999999754 34699999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 285 ARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
++....... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+.... +..+.....+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 276 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEGYRLPAP 276 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTTCCCCCC
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCCCCCC
Confidence 986543221 223346788999999998899999999999999999999 9999999888775544 5556677778
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
..+++.+.+++.+||+.||++|||+.||++.|+.+....
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 889999999999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=387.20 Aligned_cols=269 Identities=33% Similarity=0.599 Sum_probs=233.7
Q ss_pred CCCCcccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-
Q 014783 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL- 193 (418)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 193 (418)
+.....|++..++|.+++.||+|+||.||+|++. +..||||++....... ..+.+.+|+.+++++
T Consensus 58 ~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 58 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-----DLSDLISEMEMMKMIG 132 (382)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHC
T ss_pred cccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH-----HHHHHHHHHHHHHHhc
Confidence 3455678999999999999999999999999862 2479999997543221 125788999999999
Q ss_pred CCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 014783 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGF 259 (418)
Q Consensus 194 ~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~i 259 (418)
+||||+++++++.....+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 99999999999999999999999999999999998754 2458999999999999999999999999
Q ss_pred ccCCCCCCcEEEcCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014783 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLL 335 (418)
Q Consensus 260 iHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~ 335 (418)
+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~ 292 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998654322 2334457889999999999999999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 336 PFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 336 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
||.+....+. ...+..+.+...+..+++.+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 293 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 293 PYPGVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp SSTTCCHHHH-HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCHHHH-HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 9998877664 4556667777788889999999999999999999999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=371.63 Aligned_cols=263 Identities=27% Similarity=0.564 Sum_probs=227.9
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
....|+++.++|++.+.||+|+||.||++++ ++..||||++....... +.+.+|+.++++++||||++++++
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4578999999999999999999999999998 45689999997654332 467899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.+...+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999997632 4599999999999999999999999999999999999999999999999999
Q ss_pred ceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 285 ARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
++...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.... +..+.....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHL 245 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCCCCTT
T ss_pred cccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-HhcccCCCCCCc
Confidence 97543321 2233457789999999998899999999999999999998 9999999887765544 555666777778
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+++.+.+++.+||+.||.+|||++|+++.|+++..+
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 899999999999999999999999999999988753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=373.81 Aligned_cols=247 Identities=26% Similarity=0.481 Sum_probs=217.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|.+ +++.||||++........ +.+.+|+.+++.++||||+++++++.....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK------ELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH------HHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH------HHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 46789999999999999999986 688999999875443321 4678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+++|+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999999763 4899999999999999999999999999999999999999999999999999765433
Q ss_pred C-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSEI 369 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 369 (418)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... ....+..+++.+.++
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 2 23456799999999999999999999999999999999999999999888776665554443 334466788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||+.||++|||++|+++
T Consensus 250 i~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhh
Confidence 99999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=368.79 Aligned_cols=261 Identities=28% Similarity=0.564 Sum_probs=227.7
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
++|++..++|++.+.||+|+||.||++++. +..||||++....... +.+.+|+.++++++||||+++++++.
T Consensus 1 g~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 357888899999999999999999999984 5589999997654432 46789999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred cCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccce
Confidence 999999999999999999999764 3458999999999999999999999999999999999999999999999999998
Q ss_pred eecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 287 IEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.... +..+.....+..++
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (268)
T 3sxs_A 153 YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-VSQGHRLYRPHLAS 231 (268)
T ss_dssp ECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCCCCTTSC
T ss_pred ecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-HHcCCCCCCCCcCh
Confidence 6543321 223446778999999998899999999999999999999 9999998887766544 44555666777789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+.+.+++.+||+.||.+|||+.|+++.|+.+..+
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=386.39 Aligned_cols=268 Identities=28% Similarity=0.517 Sum_probs=228.7
Q ss_pred cccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv 199 (418)
.+|+++.++|++.+.||+|+||.||+|++ ++..||||++....... ..+.+.+|+.+++++ +||||+
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 46899999999999999999999999986 34579999997543221 125788999999999 899999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
++++++.....+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976432 23789999999999999999999999
Q ss_pred cccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 014783 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334 (418)
Q Consensus 259 iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~ 334 (418)
|+||||||+|||++.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|+| |.
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999986543322 123346789999999998899999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
.||.+..........+..+..+..+..+++.+.+++.+||+.||.+|||+.|+++.|+.+......
T Consensus 273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 273 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 999988776666777788888888888999999999999999999999999999999998776543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=388.46 Aligned_cols=267 Identities=30% Similarity=0.594 Sum_probs=230.4
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCC
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 197 (418)
....|++..++|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++++ +|||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH-----HHHHHHHHHHHHhhcCCcc
Confidence 3567999999999999999999999999985 346899999965432221 25788999999999 7899
Q ss_pred eEEEEeEEeeCc-eEEEEEeecCCCCHHHHHhhhcC--------------------------------------------
Q 014783 198 IVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN-------------------------------------------- 232 (418)
Q Consensus 198 iv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------- 232 (418)
|+++++++.... .+++||||+++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999999998754 48999999999999999986432
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 233 --------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 233 --------------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 128899999999999999999999999999999999999999999999999997543322
Q ss_pred C---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 293 G---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 293 ~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
. .....||+.|+|||++.+..++.++||||||+++|||++ |..||.+....+.....+..+.....+..+++.+.+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 233457889999999999999999999999999999998 999999887666666777777778888889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
++.+||+.||.+|||+.|+++.|+.+...
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999988753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=369.79 Aligned_cols=258 Identities=36% Similarity=0.718 Sum_probs=216.0
Q ss_pred ccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
+++.++|++.+.||+|+||.||+|+++++.||||++........ ....+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI--SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 35667899999999999999999999999999999865432211 1123578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEcC--------CCCEEE
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISA--------DKSIKI 279 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlkp~NILl~~--------~~~vkl 279 (418)
+++||||+++++|.+++.. ..+++..++.++.|++.||+|||++| |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999999853 46999999999999999999999999 999999999999986 678999
Q ss_pred eecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 280 ADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+...................+
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 9999997654332 334579999999999999899999999999999999999999999999888877777777778888
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..+++.+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 89999999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=380.72 Aligned_cols=261 Identities=34% Similarity=0.577 Sum_probs=219.6
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.+.+..++|++++.||+|+||.||++++ +++.||+|.+.... . ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--E----ETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--H----HHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 3456778999999999999999999998 57899999985421 1 12367889999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
++...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred cCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 999999999999999999999764 4569999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCC---------------CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Q 014783 287 IEVQTEGM---------------TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ-----AA 346 (418)
Q Consensus 287 ~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~-----~~ 346 (418)
........ ....||+.|+|||++.+..++.++||||||+++|||++|..||....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 65332211 14579999999999999999999999999999999999999986533211 01
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 347 FAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
..... ...+..+++.+.+++.+||+.||++|||+.++++.|+.+...+..
T Consensus 237 ~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 237 RGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11111 224566778899999999999999999999999999999877654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=379.71 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=217.9
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||.||+++. +++.||||++++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 3567889999999999999999998 6889999999642110 0011246789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++...
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999999999764 458999999999999999999999999999999999999999999999999998532
Q ss_pred -ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 -QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 -~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.... ...|..+++.+.+
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 2333456689999999999999999999999999999999999999999888777666655543 3456778999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHH
Q 014783 369 IMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RP-----t~~ell~ 389 (418)
++.+||+.||++|| +++|+++
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 99999999999999 8999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=381.65 Aligned_cols=267 Identities=30% Similarity=0.554 Sum_probs=227.5
Q ss_pred cccccccccccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
..|.+..++|++.+.||+|+||.||+|++.+ +.||||+++..... ...+.+.+|+.++++++||||++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEEE
Confidence 3567788999999999999999999998843 78999999754321 12367889999999999999999
Q ss_pred EEeEEeeCceEEEEEeecCCCCHHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 201 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
+++++.....+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998642 156899999999999999999999999
Q ss_pred cccCCCCCCcEEEcCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 014783 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334 (418)
Q Consensus 259 iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~ 334 (418)
|+||||||+|||++.++.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999997543322 2234567899999999998899999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
.||.+....+.... +..+.....+..+++.+.+++.+||+.||++|||+.++++.|+++..+...
T Consensus 275 ~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 275 QPYYGMAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp CTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred CcCCCCChHHHHHH-HhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 99999887765544 444555667788999999999999999999999999999999998766543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=373.52 Aligned_cols=267 Identities=29% Similarity=0.603 Sum_probs=234.8
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
+.+++|++...+|++.+.||+|+||.||+|.+ ++..||||++...... .+.+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 45789999999999999999999999999998 4789999999653321 25688999999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
+++.....+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence 99999999999999999999999998766677999999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 283 GVARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 283 Gla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
|++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+........+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-~~~~~~~~~~~~~ 234 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERP 234 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTTCCCCCC
T ss_pred ccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhccCCCCCC
Confidence 99976543221 222346788999999998899999999999999999999 9999988776554 3455666777788
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
..+++.+.+++.+||+.||.+|||++|+++.|+.+..+..
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 8899999999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=384.42 Aligned_cols=253 Identities=20% Similarity=0.357 Sum_probs=218.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|++++.||+|+||.||+++. +|+.||||++..............+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5688899999999999999998 58899999998654432111111256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CEEEeecccceee
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~----~vkl~DfGla~~~ 288 (418)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999753 4699999999999999999999999999999999999998877 7999999999877
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 366 (418)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....+.. ..+..+++.+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 249 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 66555666789999999999999999999999999999999999999999988877666655443332 1224678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+|+.+||..||.+|||+.|+++
T Consensus 250 ~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 250 KDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=368.35 Aligned_cols=263 Identities=34% Similarity=0.603 Sum_probs=229.0
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
++|++..++|++.+.||+|+||.||+|++. +..||||++....... +.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH-------HHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 579999999999999999999999999984 5689999997654332 46889999999999999999999987
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.+ ..++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 54 57899999999999999976544469999999999999999999999999999999999999999999999999998
Q ss_pred eecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 287 IEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.. ..+..+.....+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QNLERGYRMVRPDNCP 236 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCC
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-HHHhcccCCCCccccc
Confidence 6543321 233456789999999998889999999999999999999 99999988876654 4455666777788899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
+.+.+++.+||+.||++|||++++++.|+++.....
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999887543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=364.08 Aligned_cols=259 Identities=29% Similarity=0.607 Sum_probs=228.0
Q ss_pred ccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
+|.++.++|++.+.||+|+||.||++++ +++.||+|++....... +.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 6899999999999999999999999998 67799999997654332 467899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999999999764 34689999999999999999999999999999999999999999999999999975
Q ss_pred eccc--CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 288 EVQT--EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 288 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+.... +..+.+...+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~ 232 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLAST 232 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCCTTSCH
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-HhcCCcCCCCccCcH
Confidence 4322 12234457789999999998889999999999999999999 9999998877665544 455666667778899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=374.68 Aligned_cols=266 Identities=29% Similarity=0.599 Sum_probs=230.2
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni 198 (418)
....|++..++|.+.+.||+|+||.||++++ +++.||||++..... .. ..+.+.+|+.++++++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~----~~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PS----ELRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HH----HHHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HH----HHHHHHHHHHHHhhCCCCce
Confidence 3457889999999999999999999999986 236899999865432 11 12578899999999999999
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------------RAVPLKLAVKQALDVARGMAYVHG 256 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~gL~yLH~ 256 (418)
+++++++.....+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986432 348899999999999999999999
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT- 332 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt- 332 (418)
+||+||||||+|||++.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999986543322 233457789999999998889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 333 GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 333 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
|..||.+....... ..+..+.....+..+++.+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 249 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 249 GGNPYPGIPPERLF-NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SCCSSTTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHH-HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999887765543 45566667777888999999999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=378.84 Aligned_cols=269 Identities=30% Similarity=0.554 Sum_probs=233.4
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEEC--C-----ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCC
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 197 (418)
..+.|++..++|++.+.||+|+||.||+|++. + ..||+|++....... ..+.+.+|+.+++.+ +|||
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-----EKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-----HHHHHHHHHHHHHhhcCCCC
Confidence 34579999999999999999999999999973 2 379999997543221 125788999999999 8999
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 265 (418)
|+++++++.....+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 9999999999999999999999999999997642 3457999999999999999999999999999999
Q ss_pred CCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 014783 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMT 341 (418)
Q Consensus 266 p~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~ 341 (418)
|+|||++.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999986543322 223446789999999998899999999999999999998 999999877
Q ss_pred HHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 342 AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
........+..+.....+..+++.+.+++.+||+.||.+|||+.|+++.|+++..+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp SSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 6666667777777777888889999999999999999999999999999999887653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=373.54 Aligned_cols=262 Identities=27% Similarity=0.524 Sum_probs=217.2
Q ss_pred cccccccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
.++..++|++.+.||+|+||.||++++ +++.||||++.... . ...+.+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--E----EHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 346678999999999999999999985 57899999986432 1 11257889999999999999999999
Q ss_pred EEeeC--ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 204 ACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 204 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
++... ..+++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence 98653 45899999999999999997643 3589999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--------------
Q 014783 282 FGVARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV-------------- 343 (418)
Q Consensus 282 fGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~-------------- 343 (418)
||+++....... .....++..|+|||.+.+..++.++||||||+++|||++|..||......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 999986543321 23345778899999999999999999999999999999999998643211
Q ss_pred -HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 344 -QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 344 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
......+..+.+...+..+++.+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1223345566677778899999999999999999999999999999999987755
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=380.86 Aligned_cols=261 Identities=30% Similarity=0.459 Sum_probs=215.3
Q ss_pred CcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
-.+|.++..+|++.+.||+|+||.||+|++.++.||||++..... ....+.+|+.++++++||||+++++++.
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-------QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-------HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 356888999999999999999999999999999999999854211 1134567999999999999999999998
Q ss_pred eCc----eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCcEEEc
Q 014783 207 KRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL----------GFIHRDLKSDNLLIS 272 (418)
Q Consensus 207 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----------~iiHrDlkp~NILl~ 272 (418)
... .+++||||+++|+|.+++... .+++..++.++.|++.||+|||+. ||+||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 743 479999999999999999763 499999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccceeecccCC---CCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCC---
Q 014783 273 ADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMT--- 341 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~--- 341 (418)
.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999999999986543322 233579999999999986 356678999999999999999999996532
Q ss_pred -------------HHHHHHHHHhcCCCCCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 342 -------------AVQAAFAVVNKGVRPVIPN-----DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 342 -------------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.............++..+. .+++.+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222233334443332 2345699999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=367.81 Aligned_cols=264 Identities=30% Similarity=0.589 Sum_probs=215.0
Q ss_pred CcccccccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
..+|++..++|++.+.||+|+||.||+|++. +..||||++...... ...+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCccceE
Confidence 3568888999999999999999999999873 346999998643221 223578899999999999999999
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
++++.+ ...|+||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 82 IGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEEECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEcc-CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECc
Confidence 999854 5678999999999999999754 34689999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 282 FGVARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 282 fGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
||+++....... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+.... +..+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-i~~~~~~~~ 238 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLPM 238 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCC
T ss_pred cccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-HHcCCCCCC
Confidence 999986543322 223456789999999998899999999999999999997 9999998877665444 445556667
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
+..+++.+.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 7889999999999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.60 Aligned_cols=263 Identities=29% Similarity=0.529 Sum_probs=224.8
Q ss_pred ccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
-+++..++|++.+.||+|+||.||+|++ +++.||||++....... ....+.+|+.++++++||||+++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-----hHHHHHHHHHHHHhCCCCCCCeE
Confidence 3567778999999999999999999985 34589999986432221 12468899999999999999999
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK- 275 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~- 275 (418)
++++......++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence 9999999999999999999999999986532 4589999999999999999999999999999999999999555
Q ss_pred --CEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014783 276 --SIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAV 349 (418)
Q Consensus 276 --~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~ 349 (418)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||......+... .
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~-~ 298 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-F 298 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-H
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-H
Confidence 59999999997543222 2233457899999999998999999999999999999998 999999988776554 4
Q ss_pred HhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+..+.....+..+++.+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 299 i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 555666677788999999999999999999999999999999988754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=367.41 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=220.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++++ +++.||||++........ ...+.+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 46789999999999999999987 678999999876544332 2236788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999999765 35999999999999999999999999999999999999999999999999999765432
Q ss_pred C--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCChHHH
Q 014783 292 E--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---VIPNDCLPVL 366 (418)
Q Consensus 292 ~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 366 (418)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+........+...... ..+..+++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 2 2234569999999999999999999999999999999999999999988877766666554332 2345688999
Q ss_pred HHHHHHhcccCCCCCC-CHHHHHHHHHhhHHH
Q 014783 367 SEIMTRCWDTNPEVRP-PFTEIVRMLENAETE 397 (418)
Q Consensus 367 ~~li~~cl~~dp~~RP-t~~ell~~L~~~~~~ 397 (418)
.+++.+||+.||.+|| +++++.+.|+.+..+
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 9999999999999998 899999999887643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=378.56 Aligned_cols=250 Identities=23% Similarity=0.411 Sum_probs=217.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|+. +++.||||++......... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 5688889999999999999998 5789999999866544322 256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~~~~ 289 (418)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 105 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999998753 4589999999999999999999999999999999999998654 59999999998766
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 367 (418)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.+.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 5555566789999999999999999999999999999999999999999888777666555544443322 35788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+|+.+||+.||++|||+.|+++.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999998863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=368.14 Aligned_cols=260 Identities=31% Similarity=0.642 Sum_probs=220.3
Q ss_pred CcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
...|.++.++|++.+.||+|+||.||+++++++.||||++..... .+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 346888999999999999999999999999999999999865431 256889999999999999999999975
Q ss_pred eC-ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 207 KR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 207 ~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
+. ..+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 54 47899999999999999998654445889999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.. ..+..+.....+..+++
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (278)
T 1byg_A 165 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAPDGCPP 241 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTTCCCCCCTTCCH
T ss_pred cccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCCCCCcccCCH
Confidence 754332 233467899999999998899999999999999999998 99999887765543 44556667777888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=375.14 Aligned_cols=253 Identities=21% Similarity=0.364 Sum_probs=217.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|++.+.||+|+||.||+++. +++.||||++..............+.+.+|+.+++.++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5678889999999999999998 58899999998654332111111256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CEEEeecccceee
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~----~vkl~DfGla~~~ 288 (418)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999753 4699999999999999999999999999999999999999887 8999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 366 (418)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+........ ....+++.+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 248 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence 555555667899999999999999999999999999999999999999998887776655554433221 224678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 249 KDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.27 Aligned_cols=260 Identities=31% Similarity=0.582 Sum_probs=214.6
Q ss_pred ccccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+++..+|++.+.||+|+||.||+|++. +..||||+++...... ..+.+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-----QRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 567789999999999999999999863 5689999996543211 235788999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+...+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999999999754 346999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 286 RIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
+....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+..+.+...+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-~~i~~~~~~~~~~ 273 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-KAVDEGYRLPPPM 273 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-HHHHTTEECCCCT
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCc
Confidence 86543221 112235678999999999999999999999999999998 99999988876654 4455666667777
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.++..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=374.09 Aligned_cols=270 Identities=31% Similarity=0.582 Sum_probs=231.9
Q ss_pred CCCCCcccccccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC
Q 014783 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193 (418)
Q Consensus 123 ~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l 193 (418)
.+.....|++..++|++.+.||+|+||.||+|++. +..||||++....... ..+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l 97 (334)
T 2pvf_A 23 ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-----DLSDLVSEMEMMKMI 97 (334)
T ss_dssp CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHH-----HHHHHHHHHHHHHHH
T ss_pred cCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHH-----HHHHHHHHHHHHHHh
Confidence 34556779999999999999999999999999863 4579999986543211 125788999999999
Q ss_pred -CCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 194 -KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 194 -~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
+||||+++++++.....+|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++|
T Consensus 98 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 177 (334)
T 2pvf_A 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177 (334)
T ss_dssp CCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 899999999999999999999999999999999986432 34889999999999999999999999
Q ss_pred cccCCCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 014783 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334 (418)
Q Consensus 259 iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~ 334 (418)
|+||||||+|||++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 178 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 257 (334)
T 2pvf_A 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257 (334)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986543322 233457789999999988889999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.||.+....+.. ..+..+.....+..+++.+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 258 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 258 SPYPGIPVEELF-KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CSSTTCCHHHHH-HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcCcCCHHHHH-HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 999988776644 445556666777889999999999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=368.48 Aligned_cols=264 Identities=34% Similarity=0.671 Sum_probs=212.7
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..+.|+|..++|++.+.||+|+||.||+|++.+ .||||+++........ .+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH----HHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 356788999999999999999999999998755 5999999765544322 25788999999999999999999966
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
. ...+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 90 T-APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred c-CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 4 45578999999999999999653 356999999999999999999999999999999999999999999999999999
Q ss_pred eeecc---cCCCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 014783 286 RIEVQ---TEGMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV-- 357 (418)
Q Consensus 286 ~~~~~---~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-- 357 (418)
+.... ........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+.....+..+....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 75432 22234457899999999996 56788999999999999999999999998777666666655443322
Q ss_pred --CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 358 --IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 358 --~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+..+++.+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 334688999999999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=380.96 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=211.4
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
+..++|++.+.||+|+||.||++++ +++.||||++++.... .....+.+.+|..+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc---chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 4567889999999999999999998 5789999999753111 111125677899999988 799999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999764 45999999999999999999999999999999999999999999999999999853
Q ss_pred c-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 V-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..... ..|..+++.+.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~ 252 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV--VYPTWLHEDAT 252 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 2 22334556899999999999998999999999999999999999999999988887777666543 35667889999
Q ss_pred HHHHHhcccCCCCCCCH------HHHHH
Q 014783 368 EIMTRCWDTNPEVRPPF------TEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~------~ell~ 389 (418)
+++.+||+.||.+||++ +|+++
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 99999999999999998 67765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=364.63 Aligned_cols=268 Identities=30% Similarity=0.574 Sum_probs=225.9
Q ss_pred cccccccccccccC-ceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 128 DEWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 128 ~~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
+++.++.++|++.+ .||+|+||.||+|.+ .++.||||++....... ...+.+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH----HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 45678888999988 999999999999965 35789999997543322 1236788999999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
+++ ....+++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 999 556789999999999999999763 45899999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014783 283 GVARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 283 Gla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 357 (418)
|++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.. ..+..+.++.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~ 240 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMG 240 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCC
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCCC
Confidence 99986543322 222346789999999998889999999999999999999 99999988876644 4455666777
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhhh
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVR 403 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~~ 403 (418)
.+..+++.+.+++.+||+.||.+|||+.++++.|+++........+
T Consensus 241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 7888999999999999999999999999999999999987765543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=374.21 Aligned_cols=247 Identities=18% Similarity=0.266 Sum_probs=216.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||++++ +++.||+|++.... .. ...+.+|+.+++.++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TD-----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HH-----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--cc-----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 5788899999999999999998 57899999986432 11 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCEEEeecccceeecc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQ 290 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~--~~~vkl~DfGla~~~~~ 290 (418)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999999653 346999999999999999999999999999999999999997 78999999999987655
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCChHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVLSE 368 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 368 (418)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......... ...+++.+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 54455567999999999999988999999999999999999999999998887777666655443321 2467889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
|+.+||..||.+|||+.|+++
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=384.38 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=216.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++.. +|+.||+|++......... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 35788899999999999999987 7889999999765443222 25688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---CCCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~---~~~~vkl~DfGla~~~ 288 (418)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999999764 4599999999999999999999999999999999999998 4678999999999765
Q ss_pred cccC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHH
Q 014783 289 VQTE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPV 365 (418)
Q Consensus 289 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 365 (418)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 4332 2345689999999999999999999999999999999999999999988877766666554443332 467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=363.13 Aligned_cols=267 Identities=28% Similarity=0.564 Sum_probs=229.0
Q ss_pred ccccccccccccC-ceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 129 ~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
+|.+..++|.+.. .||+|+||.||+|++ ++..||||++...... ...+.+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-----hHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 5677888888887 999999999999985 4678999999764321 12357889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
++ ....+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 99 455689999999999999999753 4569999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 284 VARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
++........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+.. ..+..+.++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~i~~~~~~~~ 234 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRMEC 234 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCCCC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHhcCCcCCC
Confidence 9986543222 223456899999999998889999999999999999998 99999988776654 44556667778
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhhh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVR 403 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~~ 403 (418)
+..+++.+.+++.+||+.||++||++.++++.|+.+..+.....+
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 889999999999999999999999999999999999887765443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=371.97 Aligned_cols=269 Identities=25% Similarity=0.519 Sum_probs=211.9
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEEEC--Cc---eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv 199 (418)
....++.+..++|++.+.||+|+||.||+|++. +. .||||++......... .+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv 88 (323)
T 3qup_A 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD----IEEFLREAACMKEFDHPHVA 88 (323)
T ss_dssp ---CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH----HHHHHHHHHHHTTCCCTTBC
T ss_pred HHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH----HHHHHHHHHHHHHCCCCcee
Confidence 345667788899999999999999999999863 22 7999998654322221 36788999999999999999
Q ss_pred EEEeEEeeCceE------EEEEeecCCCCHHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 014783 200 RFIGACRKRMVW------CIVTEYAKGGSVRQFLTRRQN----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (418)
Q Consensus 200 ~l~~~~~~~~~~------~lv~E~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (418)
++++++...... ++||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NI 168 (323)
T 3qup_A 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC 168 (323)
T ss_dssp CCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred hhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceE
Confidence 999999776554 999999999999999975432 2589999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecccceeecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014783 270 LISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345 (418)
Q Consensus 270 Ll~~~~~vkl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 345 (418)
|++.++.+||+|||+++........ ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999999865433222 23346789999999999999999999999999999999 9999998877665
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
... +..+.....+..+++.+.+++.+||+.||++|||+.++++.|+++....
T Consensus 249 ~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 YNY-LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHH-HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 544 4445556677788999999999999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=378.96 Aligned_cols=249 Identities=21% Similarity=0.384 Sum_probs=208.5
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
..+..++|++++.||+|+||.||+++. +++.||||++++....... ..+.+.+|..++.++ +||||+++++++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~---~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH---HHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 345678899999999999999999998 5789999999864332211 114567899999887 8999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+...+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999999999764 459999999999999999999999999999999999999999999999999998
Q ss_pred ee-cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCC
Q 014783 287 IE-VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT--------AVQAAFAVVNKGVRPV 357 (418)
Q Consensus 287 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~~ 357 (418)
.. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.....+.. ....
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~ 280 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIR 280 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCC
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccC
Confidence 63 33344556789999999999999999999999999999999999999996432 11222222222 2345
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPF 384 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~ 384 (418)
+|..+++.+.+|+.+||+.||.+||++
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 677889999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=369.83 Aligned_cols=248 Identities=24% Similarity=0.430 Sum_probs=216.9
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++.+.||+|+||.||+++. +|+.||||++++..... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 457889999999999999999998 68899999996421100 0112567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999999999763 4599999999999999999999999999999999999999999999999999986533
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....++... ...|..+++.+.+++
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 234 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLL 234 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence 2345689999999999999999999999999999999999999999988877776666654 345677889999999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 014783 371 TRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RP-----t~~ell~ 389 (418)
.+||+.||.+|| +++|+++
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhc
Confidence 999999999999 8888875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=370.27 Aligned_cols=246 Identities=22% Similarity=0.391 Sum_probs=209.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
+..++|++.+.||+|+||.||++++ +++.||||++......... ..+.+.+|..+++++ +||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH---HHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 3467889999999999999999998 5789999999865433221 225678999999988 899999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999999999764 45999999999999999999999999999999999999999999999999999853
Q ss_pred c-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCC
Q 014783 289 V-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM---------TAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 289 ~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~---------~~~~~~~~~~~~~~~~~~ 358 (418)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+... ...+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 238 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 238 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--CCCC
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--CCCC
Confidence 2 233345668999999999999999999999999999999999999999652 122222223332 3446
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPF 384 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~ 384 (418)
|..+++.+.+++.+||+.||.+||++
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 77889999999999999999999995
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=370.16 Aligned_cols=266 Identities=30% Similarity=0.543 Sum_probs=227.9
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn 197 (418)
...++|++..++|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.+++.++|||
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~ 89 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHH 89 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTT
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-----HHHHHHHHHHHHHhcCCCC
Confidence 345789999999999999999999999999763 5689999986543221 1256889999999999999
Q ss_pred eEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 014783 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (418)
Q Consensus 198 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 269 (418)
|+++++++......++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 169 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceE
Confidence 9999999999999999999999999999997532 14578999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014783 270 LISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQA 345 (418)
Q Consensus 270 Ll~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~ 345 (418)
|++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 249 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence 999999999999999975433221 223356889999999998899999999999999999999 8999998887765
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
...+. .+.....+..+++.+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 250 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 55444 444455677889999999999999999999999999999988754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=367.94 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=209.1
Q ss_pred cccccccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
..+..++|++.+.||+|+||.||+++. +++.||||+++........ .....+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhh--hHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 345678899999999999999999986 5789999999764322111 112467789999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999999999764 3589999999999999999999999999999999999999999999999999
Q ss_pred ceeecc-cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 285 ARIEVQ-TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 285 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
++.... .......+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.... ...|..++
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~ 245 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLT 245 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--CCCCTTSC
T ss_pred ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--CCCCCCCC
Confidence 975432 223445679999999999999999999999999999999999999999988877766665543 34567788
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RP-----t~~ell~ 389 (418)
+.+.+++.+||+.||.+|| ++.|+++
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 9999999999999999999 7777765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=357.11 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=219.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++......
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH----HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 36788899999999999999988 5789999999765444322 25688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---EEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~---vkl~DfGla~~~ 288 (418)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999999998765 45899999999999999999999999999999999999987655 999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PNDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 366 (418)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+......... ...+++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 6655556678999999999999999999999999999999999999999998887766665555444333 24678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||+.||++|||+.|+++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcccChhhCCCHHHHhc
Confidence 99999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=370.24 Aligned_cols=266 Identities=30% Similarity=0.587 Sum_probs=228.1
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpni 198 (418)
...|.+..++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+.+|+.+++++ +||||
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-----HHHHHHHHHHHHHhcccCCCe
Confidence 457889999999999999999999999985 34789999997543221 125688999999999 79999
Q ss_pred EEEEeEEeeCc-eEEEEEeecCCCCHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 014783 199 VRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (418)
Q Consensus 199 v~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 263 (418)
+++++++.... .+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 99999987654 58999999999999999986432 1278999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014783 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQN 339 (418)
Q Consensus 264 lkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~ 339 (418)
|||+|||++.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999976533222 123457889999999999999999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 340 MTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
....+.....+..+.....+..+++.+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 7765556666667777777888899999999999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=373.15 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=201.9
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
...++|++.+.||+|+||.||+++. +++.||||++....... +.+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 3557889999999999999999998 68899999997654332 35779999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--EEEeeccccee
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~--vkl~DfGla~~ 287 (418)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999999764 35999999999999999999999999999999999999987765 99999999985
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCC
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQK-VDVYSFGIVLWELITGLLPFQNMTA----VQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~-sDvwSlGv~l~elltg~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 362 (418)
...........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.......+....+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 544444556679999999999988887665 8999999999999999999976543 23333344444444444467
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
++.+.+|+.+||+.||++|||+.|+++.
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 8999999999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=366.83 Aligned_cols=263 Identities=29% Similarity=0.553 Sum_probs=220.5
Q ss_pred cccccccccccCceeeeCceEEEEEEEC------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
+++..++|++.+.||+|+||.||+|++. +..||||++...... . ....+.+|+.++++++||||+++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-K----QRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-H----HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-H----HHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4677888999999999999999999863 235999999754321 1 1256889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
++......++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999999999764 3569999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 284 VARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+++....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+... .+..+.+...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~ 271 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-AINDGFRLPT 271 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCCCCC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH-HHHCCCcCCC
Confidence 9986543221 122346789999999999999999999999999999999 999999888766544 4555666677
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
+..+++.+.+++.+||+.||.+||++.++++.|+++.....
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 78899999999999999999999999999999999876443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=362.59 Aligned_cols=263 Identities=27% Similarity=0.501 Sum_probs=221.2
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
.+...+..+.|++.+.||+|+||.||++++ +++.||||++........ .+.+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~ 87 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----IADLKKEIEILRNLYHENIVK 87 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-----HHHHHHHHHHHHTCCCTTBCC
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-----HHHHHHHHHHHHhCCCCCeee
Confidence 444556678899999999999999999984 578999999975432211 256889999999999999999
Q ss_pred EEeEEeeC--ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEE
Q 014783 201 FIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 201 l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vk 278 (418)
+++++... ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp EEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred eeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEE
Confidence 99999876 66899999999999999996543 4599999999999999999999999999999999999999999999
Q ss_pred EeecccceeecccC----CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCC--------------C
Q 014783 279 IADFGVARIEVQTE----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQN--------------M 340 (418)
Q Consensus 279 l~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~--------------~ 340 (418)
|+|||++....... ......||..|+|||++.+..++.++||||||+++|+|++|..|+.. .
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 99999998654432 23345688899999999998999999999999999999999887532 2
Q ss_pred CHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
.........+..+.+...+..+++.+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2333444556667777788889999999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=377.22 Aligned_cols=257 Identities=22% Similarity=0.374 Sum_probs=212.0
Q ss_pred cccccccccccCceeee--CceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 130 WTIDLRKLNMGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+..+..+|++.+.||+| +||.||++++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 33456789999999999 9999999998 588999999976544332 236788999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+...+|+||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999999999998766677999999999999999999999999999999999999999999999999988
Q ss_pred eeeccc--------CCCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 014783 286 RIEVQT--------EGMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR 355 (418)
Q Consensus 286 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 355 (418)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 643221 11223478999999999987 67999999999999999999999999876554433332211110
Q ss_pred --------------------------------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 356 --------------------------------------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 356 --------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
...+..+++.+.+|+.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 01234567889999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=377.24 Aligned_cols=254 Identities=20% Similarity=0.352 Sum_probs=215.1
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.+.+..++|++.+.||+|+||.||+++. +++.||||++....... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE---RNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4567788999999999999999999988 57789999986421100 011256789999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+...+|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 99999999999999999999975 3469999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCC
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMT---AVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~ 360 (418)
...........+||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+....+.. .....|.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~ 241 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPS 241 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCT
T ss_pred eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCC
Confidence 7766666677889999999999964 458999999999999999999999997433 2222222222 2345667
Q ss_pred CChHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPP-FTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt-~~ell~ 389 (418)
.+++.+.+|+.+||+.||.+||+ ++++++
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 78999999999999999999998 777664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=373.61 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=214.7
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
+..++|++.+.||+|+||.||+++. +++.||||+++...... ....+.+.+|..++..+ +||||+++++++.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc---chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 4567889999999999999999998 46789999997531100 01124677899999988 899999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999999764 35999999999999999999999999999999999999999999999999999853
Q ss_pred c-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 V-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.... ...|..+++.+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~ 249 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAV 249 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHH
Confidence 2 2233456689999999999999999999999999999999999999999988877766666654 345678899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHH
Q 014783 368 EIMTRCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt-----~~ell~ 389 (418)
+|+.+||+.||.+||+ ++++++
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999999995 566664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=361.46 Aligned_cols=258 Identities=31% Similarity=0.602 Sum_probs=218.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHH-HHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
+..++|++.+.||+|+||.||+|++ +++.||||++........... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3457788899999999999999998 688999999876543322111 1115788999999999999999999999776
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcCCCC-----EEEee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS-----IKIAD 281 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~~~~-----vkl~D 281 (418)
. ++||||+++++|.+++... ...+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 6999999999999998754 356999999999999999999999999 999999999999988776 99999
Q ss_pred cccceeecccCCCCCCCCCccccccccc--cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCCC
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMI--QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ--AAFAVVNKGVRPV 357 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~ 357 (418)
||+++.... ......||+.|+|||++ ....++.++||||||+++|+|++|+.||....... ........+..+.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999975332 34456799999999998 45568899999999999999999999998755333 3445566777888
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.+..+++.+.+++.+||+.||++|||++|+++.|+++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 8889999999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=375.03 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=214.0
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~ 207 (418)
.+..++|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|..++..+ +||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh---hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 34567889999999999999999998 57899999997531100 00124567889999877 99999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999999764 3599999999999999999999999999999999999999999999999999985
Q ss_pred ecc-cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 288 EVQ-TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 288 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.... +..|..+++.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 245 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEA 245 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--CCCCcccCHHH
Confidence 432 233456689999999999999999999999999999999999999999888877666555443 44667788999
Q ss_pred HHHHHHhcccCCCCCCCHH-HHH
Q 014783 367 SEIMTRCWDTNPEVRPPFT-EIV 388 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~-ell 388 (418)
.+|+.+||+.||.+||++. +++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHH
Confidence 9999999999999999997 665
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=363.80 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=209.6
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHH--------------------HHHHHHHHHHHHHH
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMM 189 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~i 189 (418)
+..++|++.+.||+|+||.||+|+. +++.||||++......... .....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457889999999999999999987 6789999999765322110 01112568899999
Q ss_pred HHhCCCCCeEEEEeEEee--CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 014783 190 LATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (418)
Q Consensus 190 l~~l~hpniv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (418)
+++++||||+++++++.. ...+|+||||+++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999986 568999999999999987653 346999999999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecccceeecccC-CCCCCCCCccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 014783 268 NLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAPEMIQHRP---YTQKVDVYSFGIVLWELITGLLPFQNMTAV 343 (418)
Q Consensus 268 NILl~~~~~vkl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGv~l~elltg~~Pf~~~~~~ 343 (418)
|||++.++.+||+|||+++...... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999998654332 234567999999999997765 478899999999999999999999988776
Q ss_pred HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 344 QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....+............+++.+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6655555555544445678899999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=370.18 Aligned_cols=258 Identities=27% Similarity=0.559 Sum_probs=215.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+..++|++.+.||+|+||.||+|++ +++ +||+|.+....... ..+.+.+|+.++++++||||++++++|
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHH-----HHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 3457889999999999999999987 444 35788775432211 125788999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.... .++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 8765 67899999999999999764 356999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 286 RIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
+....... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+. ...+..+.....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPI 243 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTT
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHHcCCCCCCCcc
Confidence 86543322 223356789999999999999999999999999999999 9999988776554 455666667777888
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=372.54 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=216.7
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++.+.||+|+||.||+++. +++.||||++....... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 457888999999999999999998 68899999996421100 0112567899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999999864 3599999999999999999999999999999999999999999999999999986533
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.... ...|..+++.+.+++
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 2345679999999999999999999999999999999999999999988877666666543 346678899999999
Q ss_pred HHhcccCCCCCCC-----HHHHHH
Q 014783 371 TRCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt-----~~ell~ 389 (418)
.+||+.||.+||+ ++|+++
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhcCHHhccCCccCCHHHHHh
Confidence 9999999999998 787765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=364.76 Aligned_cols=269 Identities=28% Similarity=0.539 Sum_probs=219.7
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
..+++.++.++|.+.+.||+|+||.||+|++. +..||||++......... .+.+.+|+.++++++||||++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH----HHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH----HHHHHHHHHHHhcCCCCCeee
Confidence 45677888999999999999999999999862 347999998765444322 256889999999999999999
Q ss_pred EEeEEeeCc-----eEEEEEeecCCCCHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 014783 201 FIGACRKRM-----VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (418)
Q Consensus 201 l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl 271 (418)
+++++.... ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 999987654 359999999999999999542 33569999999999999999999999999999999999999
Q ss_pred cCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014783 272 SADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF 347 (418)
Q Consensus 272 ~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~ 347 (418)
+.++.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 999999999999997654322 1223457889999999999999999999999999999999 999998877765544
Q ss_pred HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
. +..+..+..+..+++.+.+++.+||+.||.+|||+.++++.|+++...++
T Consensus 261 ~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 Y-LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp H-HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred H-HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 3 44555667778899999999999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=365.70 Aligned_cols=257 Identities=35% Similarity=0.645 Sum_probs=213.0
Q ss_pred cccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
++.++|++.+.||+|+||.||+++++++.||||.+.... . .+.+.+|+.++++++||||+++++++.+. .
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES---E-----RKAFIVELRQLSRVNHPNIVKLYGACLNP--V 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT---H-----HHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh---H-----HHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence 567788999999999999999999999999999985421 1 25788999999999999999999988743 6
Q ss_pred EEEEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCcEEEcCCCC-EEEeecccce
Q 014783 212 CIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHG---LGFIHRDLKSDNLLISADKS-IKIADFGVAR 286 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlkp~NILl~~~~~-vkl~DfGla~ 286 (418)
++||||+++++|.+++..... ..++...++.++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999975432 247888999999999999999999 89999999999999998886 7999999997
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCCCCCCCChHH
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........+..+..+..+++.
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHH
T ss_pred ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHH
Confidence 54322 3345699999999999999999999999999999999999999976432 22223334556666777789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
+.+++.+||+.||.+|||++++++.|+.+...+..
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999998765543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=360.68 Aligned_cols=257 Identities=20% Similarity=0.286 Sum_probs=216.5
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
+..++|++.+.||+|+||.||+|+. +++.||||++...... +.+.+|+.+++.+ +|+|++++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 3456789999999999999999996 7889999998754332 2467899999999 799999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-----EEEeecc
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFG 283 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~-----vkl~DfG 283 (418)
...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999999 99999999764 346999999999999999999999999999999999999987776 9999999
Q ss_pred cceeecccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Q 014783 284 VARIEVQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT---AVQAAFAVVNK 352 (418)
Q Consensus 284 la~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~---~~~~~~~~~~~ 352 (418)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9986543322 244569999999999999999999999999999999999999998743 33333222222
Q ss_pred CCC---CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 353 GVR---PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 353 ~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
... +.....+++.+.+++.+||+.||++|||+++|++.|+++..++
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 111 1223467899999999999999999999999999999998765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=367.50 Aligned_cols=261 Identities=31% Similarity=0.562 Sum_probs=221.7
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCce--EEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
++.++|++.+.||+|+||.||+|++ ++.. ||||.+....... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 3457888999999999999999986 5664 4999987532221 124688999999999 8999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~ 272 (418)
....+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997642 24689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014783 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~ 351 (418)
.++.+||+|||+++............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+.. ..+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-~~~~ 255 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLP 255 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHGG
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH-HHhh
Confidence 999999999999975443333444567889999999998889999999999999999998 99999988876644 4455
Q ss_pred cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 352 KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.+.....+..+++.+.+++.+||+.||.+|||++|+++.|+++..+.
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 66666777888999999999999999999999999999999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=385.03 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=217.2
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
++.+..++|++.+.||+|+||.||++++ +++.||||++.+...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT---CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4556778999999999999999999998 578999999964210000 00134778999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+...+|+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999998753 48999999999999999999999999999999999999999999999999998
Q ss_pred eecccC--CCCCCCCCccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 014783 287 IEVQTE--GMTPETGTYRWMAPEMIQHRP----YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG--VRPVI 358 (418)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~ 358 (418)
...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....++... ...+.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 654332 234668999999999998765 8899999999999999999999999988877766665543 22223
Q ss_pred CCCChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEV--RPPFTEIVRM 390 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~--RPt~~ell~~ 390 (418)
...+++.+.+|+.+||+.+|.+ ||+++|+++.
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 3468899999999999988988 9999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=364.90 Aligned_cols=261 Identities=30% Similarity=0.544 Sum_probs=220.9
Q ss_pred cccccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
++.+.|++.+.||+|+||.||++.+ +++.||||++..... .. ..+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQ----HRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hH----HHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 3445568999999999999999875 577899999975432 11 235788999999999999999999999
Q ss_pred ee--CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 206 RK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 206 ~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
.. ...+++||||+++++|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence 87 46789999999999999999753 38999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--------------HH
Q 014783 284 VARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV--------------QA 345 (418)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~--------------~~ 345 (418)
++........ .....+|..|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9987544321 23345788999999999989999999999999999999999999653221 12
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhh
Q 014783 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMT 400 (418)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~ 400 (418)
....+..+.....+..+++.+.+|+.+||+.||++|||+.|+++.|+.+..++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 3344566677778888999999999999999999999999999999999887753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=375.85 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=207.5
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~~ 208 (418)
+..++|++.+.||+|+||.||+++. +++.||||++.+....... ....+.+|..+ ++.++||||+++++++.+.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH---HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 4557889999999999999999998 5778999999765432211 12345667766 5778999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++..
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999999999764 45899999999999999999999999999999999999999999999999999853
Q ss_pred c-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 V-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
. ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....++... ...+..++..+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 267 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKPNITNSAR 267 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--CCCCSSSCHHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHH
Confidence 3 2334456789999999999999999999999999999999999999999988877776666653 345667889999
Q ss_pred HHHHHhcccCCCCCCCHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTE 386 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~e 386 (418)
+|+.+||+.||.+||++.+
T Consensus 268 ~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHcccCHHhCCCCCC
Confidence 9999999999999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=358.68 Aligned_cols=261 Identities=29% Similarity=0.580 Sum_probs=220.0
Q ss_pred ccccccccccccCceeeeCceEEEEEEECC-----ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
.|.+..++|++.+.||+|+||.||+|++.+ ..||||++....... ..+.+.+|+.+++.++||||+++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-----NKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH-----HHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch-----HHHHHHHHHHHHHhCCCCCcceEEE
Confidence 567888999999999999999999998632 359999987543211 1257889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
++.++ ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 81 IIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EECSS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEcCC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 98765 468999999999999999764 3568999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 284 VARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 284 la~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
++........ .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.. ..+..+.....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 237 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEKGDRLPKPD 237 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-HHHHHTCCCCCCT
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-HHHhcCCCCCCCC
Confidence 9976543321 233457889999999998899999999999999999998 99999877665544 3344555666777
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+++.+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 8899999999999999999999999999999988654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=365.73 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=217.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++++ +++.||||++..............+.+.+|+.++++++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35688899999999999999998 5789999999865433211111125688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CEEEeeccccee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARI 287 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~----~vkl~DfGla~~ 287 (418)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999975 34689999999999999999999999999999999999999888 799999999987
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPV 365 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 365 (418)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+....... ..+..+++.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 665555566679999999999999999999999999999999999999999888777665554433221 122467889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=362.80 Aligned_cols=250 Identities=31% Similarity=0.575 Sum_probs=204.3
Q ss_pred ccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHh--CCCCCeEEEEeEEee---
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRK--- 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~--- 207 (418)
-.++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 35688999999999999999999999999999986421 1345566666666 799999999998754
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEcCCCCEE
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------~~~iiHrDlkp~NILl~~~~~vk 278 (418)
...+++||||+++|+|.++++. ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 3468999999999999999954 45999999999999999999999 99999999999999999999999
Q ss_pred EeecccceeecccCC-----CCCCCCCccccccccccCC------CCCCcchHHHHHHHHHHHHhC----------CCCC
Q 014783 279 IADFGVARIEVQTEG-----MTPETGTYRWMAPEMIQHR------PYTQKVDVYSFGIVLWELITG----------LLPF 337 (418)
Q Consensus 279 l~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~t~~sDvwSlGv~l~elltg----------~~Pf 337 (418)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 999999976543322 2334799999999999876 456799999999999999999 8888
Q ss_pred CCCCH----HHHHHHH-HhcCCCCCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 338 QNMTA----VQAAFAV-VNKGVRPVIPN-----DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 338 ~~~~~----~~~~~~~-~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
..... ....... .....++..+. .+++.+.+++.+||+.||++|||+.|+++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 55321 2222222 23333444443 2567899999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=368.86 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=212.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
..+|++.+.||+|+||.||+|+. +++.||||++...... +.+.+|+.+++.+ +||||+++++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 36788999999999999999996 7889999998755332 2477899999999 99999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-----EEEeecccc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFGVA 285 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~-----vkl~DfGla 285 (418)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999999 99999999864 457999999999999999999999999999999999999998887 999999999
Q ss_pred eeecccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC
Q 014783 286 RIEVQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGV 354 (418)
Q Consensus 286 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~ 354 (418)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 86543322 2456799999999999999999999999999999999999999987432 222222211111
Q ss_pred CC---CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 355 RP---VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 355 ~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.. .....++ .+.+++.+||+.||.+||++++|++.|+++....
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11 1123355 9999999999999999999999999999887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=366.77 Aligned_cols=259 Identities=21% Similarity=0.349 Sum_probs=213.0
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+...+|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 3456789999999999999999998 488999999964322111 246779999999999999999999997655
Q ss_pred --eEEEEEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCEEEeec
Q 014783 210 --VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (418)
Q Consensus 210 --~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl----~~~~~vkl~Df 282 (418)
.+++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 78999999999999999986432 348999999999999999999999999999999999999 77888999999
Q ss_pred ccceeecccCCCCCCCCCcccccccccc--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQ--------HRPYTQKVDVYSFGIVLWELITGLLPFQNMT----AVQAAFAVV 350 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~~~ 350 (418)
|+++............||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....++
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9998776665566678999999999986 5779999999999999999999999996433 233333333
Q ss_pred hcCCCC-----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 351 NKGVRP-----------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 351 ~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
...... .++..+++.+.+++.+||+.||++|||++|+++...+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 322110 112234567889999999999999999999999888653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=361.91 Aligned_cols=245 Identities=25% Similarity=0.449 Sum_probs=211.4
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
.|...+.||+|+||.||+|+. +|+.||||++........ +.+.+|+.++++++||||+++++++......++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR------ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSH------HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHH------HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 345566899999999999988 688999999976543321 467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
||||+++++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 120 v~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999999999864 358999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCChHHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVLSEIM 370 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li 370 (418)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+... ..+. .+..+++.+.+++
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHHHH
Confidence 234567999999999999999999999999999999999999999988877665544433 2222 2335788999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~ 390 (418)
.+||+.||++|||+.|+++.
T Consensus 276 ~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTS
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.01 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=201.6
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~ 208 (418)
+..++|++.++||+|+||+||+|++ +++.||||++.......... ..+.+|+..+.++ +||||++++++|.+.
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR----ARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH----HHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 4457889999999999999999998 58899999987654443221 2344555555444 999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred CEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999999 77999998765 356999999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
..........||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+......+..+..+++.+.+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp C------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHH
T ss_pred ccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHH
Confidence 65555566679999999999886 699999999999999999999776654322 12222222233345567899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
++.+||+.||++|||++|+++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999885
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=366.96 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=215.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|+..+.||+|+||.||+|+. +++.||||++......... ..+.+.+|+.++++++||||+++++++......+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHH---HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 4578889999999999999997 6889999999765443321 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+||||+. |+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 131 lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9999996 6888888654 35689999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......+.........+..+++.+.+|
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 34567999999999984 56799999999999999999999999999888777777666665555566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||+.||++|||++++++
T Consensus 286 i~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcccChhhCcCHHHHhh
Confidence 99999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=370.99 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=213.3
Q ss_pred ccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
..++|++.+.||+|+||.||+|++ +++.||||++....... .+.+.+|+.+++.++||||+++++++.....+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 457889999999999999999998 57899999986543322 25688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999986543 2358999999999999999999999999999999999999999999999999998643
Q ss_pred ccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc--------
Q 014783 290 QTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ------AAFAVVNK-------- 352 (418)
Q Consensus 290 ~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~------~~~~~~~~-------- 352 (418)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+ ........
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 222 1233458999999999988899999999999999999999999997543211 11111111
Q ss_pred -CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 353 -GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 353 -~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
......+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11122333456789999999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=374.53 Aligned_cols=248 Identities=19% Similarity=0.332 Sum_probs=216.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|+. +++.||+|++..... .. ...+.+|+.+|+.++||||+++++++.+...++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LD----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HH----HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hh----HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 5788999999999999999988 678999999975431 11 246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCEEEeecccceeecc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQ 290 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~--~~~vkl~DfGla~~~~~ 290 (418)
+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999998753 346999999999999999999999999999999999999984 46799999999987655
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCChHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPVLSE 368 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 368 (418)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+...... ......+++.+.+
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 44445567999999999999999999999999999999999999999998877766665554333 2334567899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
|+.+||+.||++|||+.|+++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHhh
Confidence 999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=369.57 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=196.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|++ +++.||||++..... .+.+.+|+.++++++||||+++++++.....+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 45688899999999999999998 467899999975421 14677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfGla~~~ 288 (418)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999999753 45899999999999999999999999999999999999975 889999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCC--CCCCCChHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA-VVNKGVRP--VIPNDCLPV 365 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~ 365 (418)
..........||+.|+|||++.+..++.++|||||||++|||++|..||........... +....... .....++..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 554445567899999999999999999999999999999999999999987766553333 33333222 223567899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+|+.+||+.||++|||+.|+++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=368.64 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=207.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 35788899999999999999988 68899999997543321 124678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999999999865 345999999999999999999999999999999999999999999999999999864322
Q ss_pred ---CCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCCCCCCCChHHH
Q 014783 292 ---EGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVV-NKGVRPVIPNDCLPVL 366 (418)
Q Consensus 292 ---~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 366 (418)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............. ...........+++.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 22345679999999999987765 789999999999999999999998765533322222 2322223334678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.+|+.+||+.||++|||++|+++.
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999998763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=371.66 Aligned_cols=254 Identities=21% Similarity=0.352 Sum_probs=209.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|++ +++.||||++........ .....+.+.+|+.+++.++||||+++++++.+...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS-PGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS-SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-ccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35688899999999999999987 688999999863210000 000125688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---EEEeecccce
Q 014783 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVAR 286 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~---vkl~DfGla~ 286 (418)
|+||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888653 2345899999999999999999999999999999999999987654 9999999998
Q ss_pred eecccCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCh
Q 014783 287 IEVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCL 363 (418)
Q Consensus 287 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 363 (418)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+........ ....++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence 7654332 345679999999999999999999999999999999999999998743 333334444333221 114578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 89999999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=383.96 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=210.8
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.+.+..++|++.+.||+|+||.||+++. +++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh---hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 4556778899999999999999999987 67899999997431111 111246778999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
....+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++.+||+|||+|
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999999999999999764 458999999999999999999998 99999999999999999999999999999
Q ss_pred eeec-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChH
Q 014783 286 RIEV-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364 (418)
Q Consensus 286 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (418)
+... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..... ..|..+++
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~ 374 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--RFPRTLGP 374 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCH
T ss_pred eeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCCccCCH
Confidence 7532 23334567899999999999999999999999999999999999999999888777666665543 35677889
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 014783 365 VLSEIMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 365 ~l~~li~~cl~~dp~~RP-----t~~ell~ 389 (418)
.+.+|+.+||+.||.+|| +++|+++
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 999999999999999999 9999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=376.52 Aligned_cols=265 Identities=15% Similarity=0.236 Sum_probs=209.6
Q ss_pred cccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHH-H----HHHHHHHHHHHHhCCCCCeE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQV-M----EQQFQQEVMMLATLKHLNIV 199 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~-~----~~~~~~E~~il~~l~hpniv 199 (418)
+..++|++.+.||+|+||.||+|++. ++.||||++............ + ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34568899999999999999999873 468999998764321111100 1 12344567778888999999
Q ss_pred EEEeEEeeC----ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--C
Q 014783 200 RFIGACRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--A 273 (418)
Q Consensus 200 ~l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~--~ 273 (418)
++++++... ..+||||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998764 4589999999 99999999763 45699999999999999999999999999999999999999 8
Q ss_pred CCCEEEeecccceeecccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014783 274 DKSIKIADFGVARIEVQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA 345 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~ 345 (418)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 89999999999986543221 1334599999999999999999999999999999999999999985432221
Q ss_pred HHHHHhcCCCC---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 346 AFAVVNKGVRP---------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 346 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
........... ..+..+++.+.+++..||+.||++||++.+|++.|+++..+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11111111110 112467899999999999999999999999999999988754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=376.19 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=210.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
..+|++.+.||+|+||.||+|++ +++.||||++...... .......+.+|+.+++.++||||+++++++.....+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc---chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 46788999999999999999998 7889999998642110 001124688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999999 78999998764 45999999999999999999999999999999999999999999999999999876665
Q ss_pred CCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......... + .......|..+++.+.+|+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-i-~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-V-NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-C-CSSCCCCCTTSCHHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-H-HcCCCCCcccCCHHHHHHH
Confidence 55667789999999999988876 7899999999999999999999977543221111 1 1112345667889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.||.+|||++|+++
T Consensus 240 ~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTT
T ss_pred HHHcCCChhHCcCHHHHHh
Confidence 9999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=385.97 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=217.1
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
.++.+..++|++.+.||+|+||.||+|++ +++.||||++.+..... ....+.+.+|+.++..++||||++++++|
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK---RAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---TTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh---HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34556778999999999999999999998 56899999996421100 00012477899999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+...+|+|||||++|+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999999763 356999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC--CCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 286 RIEVQTEG--MTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 286 ~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+....... ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+..+....++........
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 76543322 23468999999999997 567999999999999999999999999998888777666543322223
Q ss_pred ---CCCChHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 014783 359 ---PNDCLPVLSEIMTRCWDTNPEV--RPPFTEIVR 389 (418)
Q Consensus 359 ---~~~~~~~l~~li~~cl~~dp~~--RPt~~ell~ 389 (418)
...+++.+.+||.+||..+|++ ||+++|+++
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 3458899999999999888888 999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.30 Aligned_cols=249 Identities=20% Similarity=0.330 Sum_probs=205.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ +++.||||++......... .+.+.+|+.++++++||||+++++++.+...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 5788899999999999999998 6789999999865543322 256779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||+.+ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99999965 666666543 356999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCC--------------
Q 014783 292 EGMTPETGTYRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITGLLP-FQNMTAVQAAFAVVNKGVR-------------- 355 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGv~l~elltg~~P-f~~~~~~~~~~~~~~~~~~-------------- 355 (418)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+....+....+......
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 3344567899999999997765 89999999999999999987777 5555555544443321000
Q ss_pred -------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 -------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 -------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....+.+++.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0112346789999999999999999999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=361.99 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=204.7
Q ss_pred cccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.+.+|+.++++++||||+++++++.+...++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE----GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC----------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc----hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 46788999999999999999998 78899999996543222 12256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||++ ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999997 5888888653 345999999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCC-----------
Q 014783 292 EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN---KGVRP----------- 356 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~---~~~~~----------- 356 (418)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.. .....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 33445678999999999876 5689999999999999999999999987766554444332 11000
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 --------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 --------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+.+++++.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011245678999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=353.47 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=214.5
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ ++..||+|++....... .+.+.+|+.++++++||||+++++++......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 5688889999999999999998 45689999987643322 146889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~~~ 289 (418)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999999998764 458999999999999999999999999999999999999 788999999999998766
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 367 (418)
.........||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+.......... ..+++.+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 65556667899999999998765 8999999999999999999999999988877766655544332211 25788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||++|||+.|+++
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=364.72 Aligned_cols=261 Identities=28% Similarity=0.514 Sum_probs=220.1
Q ss_pred cccccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
++.++|++.+.||+|+||.||++++ +++.||||++.... .. ..+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PD----QQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HH----HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HH----HHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4567889999999999999999985 56799999986542 11 125688999999999999999999998
Q ss_pred e--eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 206 R--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 206 ~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
. ....+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 6 4567899999999999999997643 358999999999999999999999999999999999999999999999999
Q ss_pred cceeecccC----CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH--------------HHH
Q 014783 284 VARIEVQTE----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA--------------VQA 345 (418)
Q Consensus 284 la~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~--------------~~~ 345 (418)
+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 998654322 22344688899999999998899999999999999999999999854332 233
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
....+..+.....+..+++.+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 445566677777888999999999999999999999999999999999977553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=356.20 Aligned_cols=267 Identities=22% Similarity=0.389 Sum_probs=210.2
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
...+|++.+.||+|+||.||+|.. +++.||||++......... ..+.+.+|+.++++++||||+++++++.....
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK---ARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 456788999999999999999997 6889999999754332221 23578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
+++||||+++++|.+++... ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999999752 3456899999999999999999999999999999999999999999999999999765
Q ss_pred cccC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCChHH
Q 014783 289 VQTE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT--AVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 289 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.. .......+......+..+..+++.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 4322 2234568999999999999999999999999999999999999996543 223333333333444444678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhh
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTV 402 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~ 402 (418)
+.+++.+||+.||.+|||+.++++.|+++......+-
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 9999999999999999999999999999987665443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=380.53 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=215.0
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
.++.+..++|++.+.||+|+||.||+++. +++.||||++.+.... .....+.+.+|..++..++||||+++++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34556778999999999999999999998 6889999999642110 011123577899999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+...+|+||||+++|+|.+++... +..+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||++
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 9999999999999999999999764 346999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC--CCCCCCCcccccccccc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---
Q 014783 286 RIEVQTEG--MTPETGTYRWMAPEMIQ-------HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG--- 353 (418)
Q Consensus 286 ~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~--- 353 (418)
+....... ....+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+..+....++...
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 86544332 23468999999999997 4578999999999999999999999999988877666665432
Q ss_pred CCCCCCCCChHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 014783 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVR---PPFTEIVR 389 (418)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~ell~ 389 (418)
..+..+..+++.+.+|+.+||. +|.+| |+++|+++
T Consensus 290 ~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1223345788999999999999 99998 58988875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=369.51 Aligned_cols=259 Identities=27% Similarity=0.569 Sum_probs=216.0
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCce----EEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+..++|++.+.||+|+||.||+|++ +++. ||+|.+........ .+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4557889999999999999999987 4443 78888754332211 13466899999999999999999998
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.. ...++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 85 PG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp CB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 64 5578999999999999999753 346888999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 286 RIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
+....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+.. ..+..+.....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLEKGERLAQPQI 241 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHHHTTCBCCCCTT
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHHHcCCCCCCCCc
Confidence 86543322 234467889999999998899999999999999999999 99999887765543 44556666677778
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
++..+.+++.+||+.||.+|||+.|+++.|+.+...-
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 8889999999999999999999999999999886544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=358.15 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=204.6
Q ss_pred ccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
++|++.+.||+|+||.||+|++ +++.||||++......... .+.+.+|+.++++++||||+++++++.....+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 5688899999999999999998 5889999998654322111 1467799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-C
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~ 292 (418)
||||+.+ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999965 999998753 356899999999999999999999999999999999999999999999999999754322 2
Q ss_pred CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------------CC
Q 014783 293 GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG----------------VR 355 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~----------------~~ 355 (418)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+.... +.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 23445789999999999764 58999999999999999999999999988776655543310 00
Q ss_pred C-----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 P-----------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~-----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+ .....+++.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 012346789999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=363.28 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=208.8
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEee
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~ 207 (418)
..++|++.+.||+|+||.||+|++ +++.||||++.......... .....+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS-CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc-ccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 356889999999999999999996 78899999987433211100 0012455677776666 49999999999976
Q ss_pred Cc-----eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 208 RM-----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 208 ~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.. .+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 5899999996 69999998766666999999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---C--
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---V-- 357 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~-- 357 (418)
|+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+ .
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 99987655555566789999999999999999999999999999999999999999988877665554321000 0
Q ss_pred --------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 358 --------------------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 358 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+.+++.+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11356788999999999999999999999876
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=354.51 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=206.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|.+.+.||+|+||.||+++. ++..||+|++........ .+.+.+|+.++++++||||+++++++.+...++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 5788899999999999999997 578999999976543222 256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeeccccee
Q 014783 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~ 287 (418)
+||||+++++|.+++... ....+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998653 34679999999999999999999999999999999999999 4567899999999987
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCChHHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV-IPNDCLPVL 366 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 366 (418)
...........||+.|+|||++. ..++.++||||||+++|+|++|+.||.+....+............. ....+++.+
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred cCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 65555556678999999999986 4689999999999999999999999998887665554443332222 223468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||+.||++|||+.|+++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=372.00 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=211.3
Q ss_pred ccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
..+.||+|+||.||+|+. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.....+++|||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 356799999999999987 6889999999754321 12578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE--cCCCCEEEeecccceeecccCCC
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI--SADKSIKIADFGVARIEVQTEGM 294 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl--~~~~~vkl~DfGla~~~~~~~~~ 294 (418)
|+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++........
T Consensus 167 ~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 167 YVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp CCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 99999999998753 3458999999999999999999999999999999999999 56788999999999877655555
Q ss_pred CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCChHHHHHHHHH
Q 014783 295 TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVLSEIMTR 372 (418)
Q Consensus 295 ~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 372 (418)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....++....... ....+++.+.+|+.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 666799999999999999999999999999999999999999999888877777666544332 224678999999999
Q ss_pred hcccCCCCCCCHHHHHH--HHHhh
Q 014783 373 CWDTNPEVRPPFTEIVR--MLENA 394 (418)
Q Consensus 373 cl~~dp~~RPt~~ell~--~L~~~ 394 (418)
||+.||.+|||+.|+++ .|.+.
T Consensus 326 ~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999998 55544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.54 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=202.6
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|++..++|++.+.||+|+||.||++++ +++.||||++........ ..+.+.++...++.++||||+++++++..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH----HHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 567788999999999999999999998 788999999965433222 12345556666888999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
....++||||++ |+|.+++.. .....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999996 599888764 2346799999999999999999999998 999999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCC
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMI----QHRPYTQKVDVYSFGIVLWELITGLLPFQNM-TAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~ 359 (418)
++............||+.|+|||.+ ....++.++||||||+++|+|++|+.||... ..................+
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 9876555555556799999999996 5667899999999999999999999999874 4444455555555554555
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 678899999999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.94 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=196.5
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|++ +++.||||++......... +.+.+|+.++++++||||+++++++.....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-----STAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSC-----HHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccH-----HHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 46788999999999999999987 5889999999765432211 4577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
|+||||++ ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999997 59999987643 24589999999999999999999999999999999999999999999999999986
Q ss_pred eccc-CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 014783 288 EVQT-EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV----------- 354 (418)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~----------- 354 (418)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 5422 23445678999999999976 4689999999999999999999999999887766555433100
Q ss_pred -----C----------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 -----R----------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 -----~----------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. +..+..+++.+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0112246788999999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=354.86 Aligned_cols=253 Identities=20% Similarity=0.375 Sum_probs=211.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||++++ +++.||||++..............+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4678889999999999999998 57899999998654332211111257889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CEEEeecccceee
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~----~vkl~DfGla~~~ 288 (418)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999764 4589999999999999999999999999999999999999877 8999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 366 (418)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... ..+..+++.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 55544556679999999999999999999999999999999999999999888776655544333221 1224678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||+.||++|||+.|+++
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHh
Confidence 99999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=373.36 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=195.2
Q ss_pred cccccc-CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeEEEEeEEee---
Q 014783 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA-TLKHLNIVRFIGACRK--- 207 (418)
Q Consensus 135 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~--- 207 (418)
++|.+. +.||+|+||.||++++ +++.||||++... ..+.+|+.++. ..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 445555 6899999999999998 5789999999632 24567888774 4589999999999865
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecc
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfG 283 (418)
...+||||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567899999999999999998755567999999999999999999999999999999999999997 7899999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCC--
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ----AAFAVVNKGVRPV-- 357 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~----~~~~~~~~~~~~~-- 357 (418)
+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....+...
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 9987655555566789999999999999999999999999999999999999997654321 1122223333222
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
....+++.+.+||.+||+.||++|||+.|+++.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 224678999999999999999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=355.23 Aligned_cols=265 Identities=29% Similarity=0.543 Sum_probs=219.1
Q ss_pred cccccccc--cccccCceeeeCceEEEEEEE--CCc---eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 128 DEWTIDLR--KLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 128 ~~~~i~~~--~~~~~~~lG~G~fg~Vy~~~~--~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
.++.++.. .|++.+.||+|+||.||+|++ ++. .||+|++....... ..+.+.+|+.++++++||||++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~ 86 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-----QVEAFLREGLLMRGLNHPNVLA 86 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHH-----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHH-----HHHHHHHHHHHHHhCCCCCeee
Confidence 34444444 445568999999999999986 332 79999986533221 1357889999999999999999
Q ss_pred EEeEEeeCceE-EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 201 FIGACRKRMVW-CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 201 l~~~~~~~~~~-~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
+++++.+.... ++||||+.+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEe
Confidence 99999766554 9999999999999999763 456899999999999999999999999999999999999999999999
Q ss_pred eecccceeeccc-----CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 014783 280 ADFGVARIEVQT-----EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKG 353 (418)
Q Consensus 280 ~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~ 353 (418)
+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||......+ ....+..+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~ 244 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQG 244 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTT
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcC
Confidence 999999754322 22334567899999999999999999999999999999999 555566555544 34455566
Q ss_pred CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 354 VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 354 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
.....+..+++.+.+++.+||+.||.+|||+.++++.|+++...+.
T Consensus 245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 6667778899999999999999999999999999999999987663
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.58 Aligned_cols=252 Identities=21% Similarity=0.351 Sum_probs=210.4
Q ss_pred ccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEEEEeEEee
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRK 207 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~ 207 (418)
.+..++|++.+.||+|+||.||++.. +++.||||++......... .+.+.+|+.+++.++| |||+++++++..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHH----HHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 45567899999999999999999987 6789999999765544322 2578899999999976 999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+|+|||+ .+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999999995 588999999864 4689999999999999999999999999999999999997 68899999999986
Q ss_pred ecccCC---CCCCCCCccccccccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 014783 288 EVQTEG---MTPETGTYRWMAPEMIQH-----------RPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNK 352 (418)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~~~~~ 352 (418)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......+..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 543221 234579999999999864 6789999999999999999999999987543 3444555666
Q ss_pred CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 66667777888999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=381.43 Aligned_cols=251 Identities=25% Similarity=0.450 Sum_probs=218.2
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+...+|.+++.||+|+||.||+|+. +|+.||||++...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH---HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4457889999999999999999998 6889999999642110 0111356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999999965 3569999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.... ...|..+++.+.+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 245 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLNPSVIS 245 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--CCCCTTCCHHHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--cCCCccCCHHHHH
Confidence 5555566789999999999988776 689999999999999999999999887766555544432 3456678899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
|+.+||+.||.+|||++|+++
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=363.57 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=209.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-- 209 (418)
.++|++.+.||+|+||.||++++ +++.||||++........ .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 36788899999999999999997 678999999976543322 22357889999999999999999999987654
Q ss_pred --eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 210 --~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 349999999999999999764 4589999999999999999999999999999999999999999999999999976
Q ss_pred ecccC----CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCC
Q 014783 288 EVQTE----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPND 361 (418)
Q Consensus 288 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~ 361 (418)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+...........+. .+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 54322 12334689999999999999999999999999999999999999999888877776666554432 2345
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHH-HHHHHHHhhH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFT-EIVRMLENAE 395 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~-ell~~L~~~~ 395 (418)
+++.+.+++.+||+.||++||+.. ++.+.|....
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 789999999999999999999654 4555665544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=373.04 Aligned_cols=263 Identities=30% Similarity=0.477 Sum_probs=212.6
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..++.+..++|++.+.||+|+||.||+|+. +++.||||++........ ...+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceEEEE
Confidence 445666778999999999999999999987 688999999875432211 13578999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEcCCCCEEEe
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
......++||||+.+|+|.+++..... ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999986432 3589999999999999999999999 99999999999999999999999
Q ss_pred ecccceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcC-
Q 014783 281 DFGVARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT----AVQAAFAVVNKG- 353 (418)
Q Consensus 281 DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~~~~~~- 353 (418)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ........+...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999998654322 2334569999999999988889999999999999999999999995211 000011111111
Q ss_pred ------------CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 354 ------------VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 354 ------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
.....+...+..+.+++.+||+.||.+|||+.||++.|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 11112223457899999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=352.00 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=213.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||.||++++ +++.||||++..... ........+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL---EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc---chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 3457899999999999999999988 566899999864211 11112356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999999999765 458999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
. .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+... ....|..+++.+.+|
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 161 S-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHH
T ss_pred c-ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHHHHH
Confidence 3 2234567899999999999999999999999999999999999999988877665544433 334566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~~ 390 (418)
+.+||+.||++|||++|+++.
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=360.31 Aligned_cols=255 Identities=24% Similarity=0.464 Sum_probs=211.6
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l 201 (418)
++..++|++.+.||+|+||.||+|++ ++ ..||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------GHHHHHHHHHHHHTSCCTTBCCE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 46678899999999999999999986 33 46999998643221 12578899999999999999999
Q ss_pred EeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC-----
Q 014783 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS----- 276 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~----- 276 (418)
++++......++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence 99999999999999999999999999764 344899999999999999999999999999999999999998887
Q ss_pred ---EEEeecccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014783 277 ---IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 277 ---vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~ 351 (418)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++ +.+||......... ....
T Consensus 157 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~ 232 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE 232 (289)
T ss_dssp CCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH
T ss_pred cceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh
Confidence 99999999864322 123357889999999987 679999999999999999999 55666665554433 3333
Q ss_pred cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 352 KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
. ....+...++.+.+++.+||+.||++|||+.|+++.|+++.+.-
T Consensus 233 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 D--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp T--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred c--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2 33455566778999999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.03 Aligned_cols=253 Identities=21% Similarity=0.412 Sum_probs=218.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCC--ChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCc
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN--NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~ 209 (418)
.+|++.+.||+|+||.||+|++ +|+.||||++..... .........+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5788889999999999999998 588999999976542 2233334456788999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999764 459999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCCCCCCCCccccccccccC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CC
Q 014783 290 QTEGMTPETGTYRWMAPEMIQH------RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--ND 361 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~ 361 (418)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........+ ..
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 5555666789999999999863 368899999999999999999999999888776665555544433222 45
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+.+++.+||+.||++|||+.|+++
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7788999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=368.50 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=210.9
Q ss_pred ccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEEEEeEEee
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRK 207 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~ 207 (418)
.+...+|++.+.||+|+||.||++.. +++.||||++........ ..+.+.+|+.+|+++. ||||+++++++..
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 34556799999999999999999987 578999999976544332 2367889999999996 5999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred CCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 999999999 5588999999864 4688999999999999999999999999999999999995 68999999999986
Q ss_pred ecccC---CCCCCCCCccccccccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 014783 288 EVQTE---GMTPETGTYRWMAPEMIQH-----------RPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFAVVNK 352 (418)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~~~~~ 352 (418)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......++..
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 54322 1345679999999999865 3689999999999999999999999987643 3445556666
Q ss_pred CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 66666777778999999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=366.59 Aligned_cols=267 Identities=27% Similarity=0.542 Sum_probs=219.7
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
....+|.++.++|++.+.||+|+||.||+|++.+ .||+|++.......... +.+.+|+.++++++||||++++++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQL----KAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCC----CCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHH----HHHHHHHHHHhcCCCCCEeEEEEE
Confidence 3467899999999999999999999999999865 59999987543322111 356689999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.....+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred EecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999999999753 34689999999999999999999999999999999999998 78999999999
Q ss_pred ceeecc------cCCCCCCCCCccccccccccC---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014783 285 ARIEVQ------TEGMTPETGTYRWMAPEMIQH---------RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349 (418)
Q Consensus 285 a~~~~~------~~~~~~~~gt~~y~aPE~~~~---------~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~ 349 (418)
++.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 875321 122334468999999999974 45789999999999999999999999998877766554
Q ss_pred HhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.........+..++..+.+++.+||+.||++|||+.++++.|+++..+.
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 4443333334467889999999999999999999999999999988754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=389.51 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=217.5
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||.||+++. +|+.||||++....... ......+.+|+.+|+.++||||+++++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 5677899999999999999999998 68899999996421110 011246789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+||||++||+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987655669999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCChHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+.. .....+..+++.+
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~ 416 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQA 416 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHH
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHH
Confidence 55555567899999999999999999999999999999999999999987532 2222332322 2345667789999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RP-----t~~ell~ 389 (418)
.+|+.+||+.||.+|| +++|+++
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 9999999999999999 7888875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=369.93 Aligned_cols=262 Identities=15% Similarity=0.257 Sum_probs=205.1
Q ss_pred cccccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHH-H----HHHHHHHHHHHHHhCCCCCeEEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQ-V----MEQQFQQEVMMLATLKHLNIVRF 201 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~-~----~~~~~~~E~~il~~l~hpniv~l 201 (418)
+..++|++.+.||+|+||.||+|++ ++..||||++........... . ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3456889999999999999999998 456899999976543221111 1 12346788999999999999999
Q ss_pred EeEEee----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC--
Q 014783 202 IGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-- 275 (418)
Q Consensus 202 ~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-- 275 (418)
++++.. ...+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999987 77899999999 999999997643 699999999999999999999999999999999999999887
Q ss_pred CEEEeecccceeecccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 014783 276 SIKIADFGVARIEVQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF 347 (418)
Q Consensus 276 ~vkl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~ 347 (418)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999986533221 134579999999999999999999999999999999999999996532211111
Q ss_pred HHHhcCCCCCCC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 348 AVVNKGVRPVIP---------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 348 ~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
...........+ ..+++.+.+++.+||+.||++|||+++|++.|+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111122 2678899999999999999999999999999988643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=363.05 Aligned_cols=258 Identities=27% Similarity=0.566 Sum_probs=214.0
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCce----EEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+...+|++.+.||+|+||.||+|++ +++. ||+|.+........ .+.+.+|+.++++++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 3457889999999999999999997 4554 57777654332221 25688999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.... .++|+|++.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8765 68999999999999999764 346999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 286 RIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
+....... .....+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+....+.. ..+..+.....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPI 243 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTT
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCcc
Confidence 86533222 223456789999999999999999999999999999999 99999987776543 45666667777888
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
++..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=361.42 Aligned_cols=263 Identities=28% Similarity=0.534 Sum_probs=220.3
Q ss_pred cccccccccccCceeeeCceEEEEEEE------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
..+..++|++.+.||+|+||.||++++ +++.||||++..... . ..+.+.+|+.++++++||||+++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~----~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--E----HLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--H----HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--H----HHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 345667889999999999999999985 578999999875322 1 1257889999999999999999999
Q ss_pred EEeeCc--eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 204 ACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 204 ~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
++.... .+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEec
Confidence 986543 689999999999999999764 34689999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---------------
Q 014783 282 FGVARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA--------------- 342 (418)
Q Consensus 282 fGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~--------------- 342 (418)
||+++....... .....++..|+|||.+.+..++.++||||||+++|||++|..||.....
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 999986543322 2334577889999999988899999999999999999999998864211
Q ss_pred HHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 343 VQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
.......+..+.+...+..+++.+.+++.+||+.||++|||+.||++.|+++..++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 112234455556667788899999999999999999999999999999999987763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=357.71 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=211.7
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~ 207 (418)
....++|++.+.||+|+||.||+|++ +++.||||++....... +.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 34567889999999999999999998 78899999997544332 4677999999999 89999999999976
Q ss_pred ------CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 208 ------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 208 ------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999876556799999999999999999999999999999999999999999999999
Q ss_pred cccceeeccc-CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 014783 282 FGVARIEVQT-EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR 355 (418)
Q Consensus 282 fGla~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 355 (418)
||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||...........+......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 9999765432 2234457899999999997 567899999999999999999999999998887776666555555
Q ss_pred CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+..+++.+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 5556678899999999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.29 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=204.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ +++.||||++........ ..+.+.+|+.++++++||||+++++++......+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 5688899999999999999998 588999999866543322 2356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999999887643 45999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 014783 292 EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK------------------ 352 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~------------------ 352 (418)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 23345678999999999976 57899999999999999999999999988876655433221
Q ss_pred -CCCCCCC----------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 -GVRPVIP----------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 -~~~~~~~----------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.....+ +.+++.+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0111111 346788999999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=379.96 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=211.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ ++..||||++......... ...+.+|+.+++.++||||+++++++.....+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4688899999999999999998 6789999999765432211 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~---~~vkl~DfGla~~~~ 289 (418)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++...
T Consensus 113 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999999998765 458999999999999999999999999999999999999764 559999999998776
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 367 (418)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.+.
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 6666667789999999999874 69999999999999999999999999998887776666655443332 46789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+.+||+.||.+|||+.|+++
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCChhhCccHHHHhc
Confidence 9999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=363.22 Aligned_cols=247 Identities=24% Similarity=0.435 Sum_probs=199.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc---
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 209 (418)
++|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 5688889999999999999998 688999999976543222 257889999999999999999999986543
Q ss_pred ------------------------------------------------------eEEEEEeecCCCCHHHHHhhhcC-CC
Q 014783 210 ------------------------------------------------------VWCIVTEYAKGGSVRQFLTRRQN-RA 234 (418)
Q Consensus 210 ------------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~-~~ 234 (418)
.+++||||+++++|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 37999999999999999986432 33
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-------------CCCCCCCCc
Q 014783 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------------GMTPETGTY 301 (418)
Q Consensus 235 ~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-------------~~~~~~gt~ 301 (418)
.++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5666789999999999999999999999999999999999999999999998654431 223456999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCC
Q 014783 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381 (418)
Q Consensus 302 ~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 381 (418)
.|+|||++.+..++.++||||||+++|||++|..|+.. .............+......++.+.+++.+||+.||++|
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999999999999999999999999998776522 111222222322222223345778999999999999999
Q ss_pred CCHHHHHH
Q 014783 382 PPFTEIVR 389 (418)
Q Consensus 382 Pt~~ell~ 389 (418)
||++|+++
T Consensus 318 ps~~~~l~ 325 (332)
T 3qd2_B 318 PEATDIIE 325 (332)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhh
Confidence 99999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=354.46 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=213.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 207 (418)
.+|++.+.||+|+||.||++++ +++.||||++.... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 5678889999999999999998 58899999997542 245689999999999999999998854
Q ss_pred -----------CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC
Q 014783 208 -----------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (418)
Q Consensus 208 -----------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~ 276 (418)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 456899999999999999998766667999999999999999999999999999999999999999999
Q ss_pred EEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 014783 277 IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP 356 (418)
Q Consensus 277 vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 356 (418)
+||+|||++.............||+.|+|||.+.+..++.++||||||+++|+|++|..|+... ......+.. .
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~---~ 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRD---G 234 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHT---T
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhc---c
Confidence 9999999998765555555667999999999999999999999999999999999999887432 112222222 2
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 357 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
.++..++..+.+++.+||+.||.+|||+.|+++.|..+.....
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 3455678899999999999999999999999999998876544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=381.24 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=213.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++++ +++.||||++......... ...+.+|+.++++++||||+++++++.....+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH----HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 46788999999999999999998 5889999998642211111 25678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---CCCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~---~~~~vkl~DfGla~~~ 288 (418)
|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999998765 4599999999999999999999999999999999999995 4567999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 366 (418)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.+
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 55555566789999999999976 49999999999999999999999999988888777666655544333 3578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=350.32 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=219.5
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCC---ChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEee
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN---NPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~ 207 (418)
.++|++.+.||+|+||.||+|++ +++.||||++..... .........+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46788899999999999999998 678999999976542 22233344577889999999996 9999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999764 4589999999999999999999999999999999999999999999999999987
Q ss_pred ecccCCCCCCCCCcccccccccc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQ------HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP-- 359 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 359 (418)
...........||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+.........+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 66555556678999999999985 4568999999999999999999999999888777666655554443333
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++.+.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 357889999999999999999999999886
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=366.07 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=210.4
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|++ +++.||||++........ .....+.+.+|+.++++++||||+++++++.+....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI-NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc-CHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 36788899999999999999988 577999999864311000 011135788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhc--------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 014783 212 CIVTEYAKGGSVRQFLTRRQ--------------------------------------NRAVPLKLAVKQALDVARGMAY 253 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi~~gL~y 253 (418)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999985210 1123577788999999999999
Q ss_pred HHhCCcccCCCCCCcEEEcCCC--CEEEeecccceeecccC-----CCCCCCCCccccccccccC--CCCCCcchHHHHH
Q 014783 254 VHGLGFIHRDLKSDNLLISADK--SIKIADFGVARIEVQTE-----GMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFG 324 (418)
Q Consensus 254 LH~~~iiHrDlkp~NILl~~~~--~vkl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlG 324 (418)
||++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999998653322 1345579999999999975 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 325 IVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN--DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 325 v~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++|||++|+.||.+....+....+.........+. .+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999998888877777665544332 47889999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=361.17 Aligned_cols=261 Identities=30% Similarity=0.557 Sum_probs=218.9
Q ss_pred ccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
++..++|++.+.||+|+||.||+|++ +++.||||++...... . ....+.+|+.++++++||||+++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-Q----DELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-H----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-h----hHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 46678899999999999999999983 4568999998643221 1 1256889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CC
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DK 275 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~ 275 (418)
++......|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999999986532 45889999999999999999999999999999999999994 44
Q ss_pred CEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014783 276 SIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 276 ~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~ 351 (418)
.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ..+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-EFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH-HHHh
Confidence 69999999987543222 1223457899999999988899999999999999999998 99999988776654 4455
Q ss_pred cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 352 KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+..+..+..+++.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 5556667778999999999999999999999999999999988753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=357.09 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=209.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++++ +++.||||++....... ....+.+.+|+.++++++||||+++++++.....+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 46788899999999999999997 57899999986543221 22336788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999999864 45899999999999999999999999999999999999999999999999999765432
Q ss_pred C--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHHH
Q 014783 292 E--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLS 367 (418)
Q Consensus 292 ~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 367 (418)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+...... ..+..+++.+.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCCccccCCCCCHHHH
Confidence 2 2234568999999999999999999999999999999999999998866543 33334433322 34567888999
Q ss_pred HHHHHhcccCCCCCC-CHHHHHHHHHhhHHHHh
Q 014783 368 EIMTRCWDTNPEVRP-PFTEIVRMLENAETEIM 399 (418)
Q Consensus 368 ~li~~cl~~dp~~RP-t~~ell~~L~~~~~~~~ 399 (418)
+++.+||+.||++|| +++++++.|+++.....
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 999999999999999 99999999998876553
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=368.91 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=197.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCc-
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~- 209 (418)
.++|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.+++.+. ||||+++++++....
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 36788999999999999999987 6889999999755444332 256779999999997 999999999997543
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+|+|||||. ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 6899999996 699999875 35899999999999999999999999999999999999999999999999999864
Q ss_pred cc----------------------cCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014783 289 VQ----------------------TEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA 345 (418)
Q Consensus 289 ~~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~ 345 (418)
.. ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 32 112334579999999999976 6799999999999999999999999999887766
Q ss_pred HHHHHhcCCCC---------------------------------------------CCCCCChHHHHHHHHHhcccCCCC
Q 014783 346 AFAVVNKGVRP---------------------------------------------VIPNDCLPVLSEIMTRCWDTNPEV 380 (418)
Q Consensus 346 ~~~~~~~~~~~---------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~ 380 (418)
...++...-.+ ..+..+++.+.+|+.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 65544211000 011256788999999999999999
Q ss_pred CCCHHHHHHH
Q 014783 381 RPPFTEIVRM 390 (418)
Q Consensus 381 RPt~~ell~~ 390 (418)
|||++|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=372.21 Aligned_cols=257 Identities=32% Similarity=0.590 Sum_probs=208.9
Q ss_pred cccccCceeeeCceEEEEEEE--C-C--ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-Cc
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--N-G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RM 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~-~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 209 (418)
.|++.+.||+|+||.||+|++ + + ..||||.++....... .+.+.+|+.++++++||||++++++|.. +.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-----HHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 466788999999999999986 2 2 3689999865433222 2578899999999999999999999754 55
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 789999999999999999753 3458899999999999999999999999999999999999999999999999997543
Q ss_pred ccCC-----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 290 QTEG-----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 290 ~~~~-----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
.... .....+|+.|+|||.+.+..++.++|||||||++|||++ |.+||...+..+... .+..+.+...|..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-~~~~~~~~~~p~~~~ 322 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQGRRLLQPEYCP 322 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-HHHTTCCCCCCTTCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-HHHcCCCCCCCCCCC
Confidence 3221 233457789999999999999999999999999999999 788998776555443 345566667788899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
+.+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=355.74 Aligned_cols=257 Identities=31% Similarity=0.564 Sum_probs=214.9
Q ss_pred ccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe-eC
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~ 208 (418)
.+|++.+.||+|+||.||+|++. ...||+|.+....... ..+.+.+|+.++++++||||+++++++. .+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-----EVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHH-----HHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHH-----HHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 46788899999999999999862 1258999986533221 1257889999999999999999999864 45
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 6789999999999999999753 456899999999999999999999999999999999999999999999999999765
Q ss_pred cccC-----CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 289 VQTE-----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 289 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+.... +..+.....+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 257 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYC 257 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-HHTTCCCCCCTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhcCCCCCCCccC
Confidence 3322 1233457789999999999999999999999999999999 7778877666554433 4455566677788
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
++.+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999988755
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=355.37 Aligned_cols=261 Identities=31% Similarity=0.553 Sum_probs=214.8
Q ss_pred ccccccccccCceeeeCceEEEEEEE---CCc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
.+..++|++.+.||+|+||.||+|++ +++ .||||++........ ...+.+.+|+.++++++||||+++++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 45667899999999999999999986 223 689999865432211 1236788999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.... .++|+||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 8765 789999999999999997643 45899999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 286 RIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.........+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCc
Confidence 86543321 223457789999999998889999999999999999999 9999999988887777777777777778
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 899999999999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=350.92 Aligned_cols=252 Identities=23% Similarity=0.412 Sum_probs=217.1
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
..+..++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE---KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc---hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 345567899999999999999999998 5678999998642110 01112568899999999999999999999999
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999999999999765 3589999999999999999999999999999999999999999999999999975
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+... ....|..+++.+.
T Consensus 164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 164 APS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPFLSDGSK 240 (284)
T ss_dssp CSS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHH
T ss_pred Ccc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--ccCCCCcCCHHHH
Confidence 433 2334567999999999999999999999999999999999999999988877665555443 3346677889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||.+|||++|+++
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhcCHhhCCCHHHHhh
Confidence 9999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=364.21 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=211.3
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIV 199 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpniv 199 (418)
+.+..+-.++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+..|+.+++.+. ||||+
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344455667899999999999999999998 77899999986321 12246678999999996 99999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC------
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------ 273 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~------ 273 (418)
++++++.....+++||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 999999998776667999999999999999999999999999999999999975
Q ss_pred -------------------CCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCC
Q 014783 274 -------------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL 334 (418)
Q Consensus 274 -------------------~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~ 334 (418)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 78999999999986432 334567999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCC------------------------CCCC--------------------CChHHHHHHH
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRP------------------------VIPN--------------------DCLPVLSEIM 370 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~------------------------~~~~--------------------~~~~~l~~li 370 (418)
.||......+....+....... ..|. ..++.+.+|+
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 9999887766544332211100 0011 1226778999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.||.+|||++|+++
T Consensus 337 ~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCChhhCCCHHHHhc
Confidence 9999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=381.81 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=218.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
-.++|++.+.||+|+||.||+++. +++.||||++.......... .+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH---HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346788999999999999999998 68899999997654321111 2568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~ 287 (418)
+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999998753 459999999999999999999999999999999999999 5678999999999987
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPV 365 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 365 (418)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+....+ ..+++.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 655554555679999999999976 69999999999999999999999999998888777766665554433 357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+|+.+||+.||.+|||+.|+++
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhh
Confidence 999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=368.69 Aligned_cols=255 Identities=23% Similarity=0.432 Sum_probs=210.3
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|++...+|++.+.||+|+||.||+|++ +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeee
Confidence 345567899999999999999999987 7889999998754322 2379999999999999999999844
Q ss_pred C--------------------------------------ceEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHH
Q 014783 208 R--------------------------------------MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDV 247 (418)
Q Consensus 208 ~--------------------------------------~~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi 247 (418)
. ..+++||||++ ++|.+.+.. .....+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 3 34889999997 588888764 345679999999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCcEEEc-CCCCEEEeecccceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHH
Q 014783 248 ARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGI 325 (418)
Q Consensus 248 ~~gL~yLH~~~iiHrDlkp~NILl~-~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv 325 (418)
+.||+|||++||+||||||+|||++ .++.+||+|||+|+............||+.|+|||++.+. .++.++|||||||
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999999999999999999999998 6889999999999877666666677899999999998775 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCC---------------------------CCCCCCCChHHHHHHHHHhcccCC
Q 014783 326 VLWELITGLLPFQNMTAVQAAFAVVNKGV---------------------------RPVIPNDCLPVLSEIMTRCWDTNP 378 (418)
Q Consensus 326 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dp 378 (418)
++|||++|+.||.+.+..+....++.... ....+..+++.+.+|+.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999999888776665543110 001345578899999999999999
Q ss_pred CCCCCHHHHHH--HHHhhH
Q 014783 379 EVRPPFTEIVR--MLENAE 395 (418)
Q Consensus 379 ~~RPt~~ell~--~L~~~~ 395 (418)
++|||+.|+++ .++++.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 99999999985 444443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=361.25 Aligned_cols=251 Identities=21% Similarity=0.340 Sum_probs=210.9
Q ss_pred cccccc-CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCce
Q 014783 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (418)
Q Consensus 135 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~ 210 (418)
.+|.+. +.||+|+||.||+|+. +++.||||++......... ...+.+|+.+++.+. ||||+++++++.....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345555 7899999999999988 5889999999764433221 246789999999994 6999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfGla~~ 287 (418)
+|+||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999999987655567999999999999999999999999999999999999997 78999999999987
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCChHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIPNDCLPV 365 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 365 (418)
...........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+...... ......+++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 66555555678999999999999999999999999999999999999999998887766655544332 3344568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhC
Confidence 999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.26 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=217.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|.+.+.||+|+||.||++++ +++.||+|++......... ..+.+.+|+.+++.++||||+++++++.....+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH---HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 46788999999999999999998 4779999998765433221 235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~- 290 (418)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999998764 4589999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
........||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... ....+..+++.+.+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLI 246 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHH
Confidence 22334457899999999999999999999999999999999999999988877665554443 3345677889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~ 390 (418)
.+||+.||++|||++|+++.
T Consensus 247 ~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 247 QKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHTCSSGGGSCCGGGGGGS
T ss_pred HHHcccChhhCcCHHHHhhC
Confidence 99999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=356.29 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=208.8
Q ss_pred ccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
+..++.||+|+||.||+|+++++.||||++........ ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568899999999999999999999999875432111 1123578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC--
Q 014783 217 YAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~-- 293 (418)
|+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999997533 35689999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhc----------CCCCCCC
Q 014783 294 -MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAA---FAVVNK----------GVRPVIP 359 (418)
Q Consensus 294 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~---~~~~~~----------~~~~~~~ 359 (418)
.....||+.|+|||.+.+ .++.++||||||+++|+|++|..||......... ...+.. ......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 234568999999999876 4899999999999999999999999765432111 111111 1111223
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
..+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=350.68 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=217.7
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.+.|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++.++||||+++++++.....+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 35688899999999999999987 578999999976543322 25688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999999864 45899999999999999999999999999999999999999999999999999765433
Q ss_pred C-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 292 E-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........... +..+..+..+..++..+.+++
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-IPKNNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHSCCCCCCSSCCHHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-hhcCCCCCCccccCHHHHHHH
Confidence 2 23455789999999999999999999999999999999999999998887665544 344555667778899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~~ 390 (418)
.+||+.||.+|||+.|+++.
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTC
T ss_pred HHHcCCChhhCcCHHHHhhC
Confidence 99999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.51 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=213.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChH-------HHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
.++|++.+.||+|+||.||+|+. +++.||||++........ ......+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 35788899999999999999998 578999999976542211 001123578899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEee
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIAD 281 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~D 281 (418)
+.+...+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999764 4599999999999999999999999999999999999999876 699999
Q ss_pred cccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP-- 359 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 359 (418)
||+++............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+....+....+
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 999987766555667789999999999874 59999999999999999999999999988887776666554433222
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++.+.+|+.+||+.||.+|||++|+++
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 467899999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.63 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=216.7
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|.+.+.||+|+||.||++++ +++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 46788999999999999999998 577999999976433221 1235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999999998764 45899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 292 -EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.... ...+..+++.+.+|+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 272 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLI 272 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHHHH
Confidence 23445679999999999999999999999999999999999999999888766655544433 345667889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.||++|||++|+++
T Consensus 273 ~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 273 QKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHTCSSGGGSCCGGGGGG
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=347.84 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=208.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~ 211 (418)
++|++.+.||+|+||.||+|++ +++.||||++......... ...+.+|+.++..+ +||||+++++++.+...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 5788899999999999999998 5889999999865443322 25677899999999 999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---------------
Q 014783 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--------------- 274 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~--------------- 274 (418)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999997642 2568999999999999999999999999999999999999844
Q ss_pred ----CCEEEeecccceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014783 275 ----KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV 349 (418)
Q Consensus 275 ----~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~ 349 (418)
..+||+|||++..... .....||+.|+|||.+.+. .++.++||||||+++|+|++|..|+..... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~ 239 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHE 239 (289)
T ss_dssp ---CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----HHH
T ss_pred cCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----HHH
Confidence 4799999999986543 2334699999999999776 567899999999999999999887755432 233
Q ss_pred HhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 350 VNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 350 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+..+..+..+..+++.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 4456666778889999999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=356.94 Aligned_cols=252 Identities=29% Similarity=0.563 Sum_probs=205.5
Q ss_pred cccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC--CCCCeEEEEeEEeeC---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFIGACRKR--- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~~~~~~~--- 208 (418)
.++|++.+.||+|+||.||+|+++++.||||++.... . ..+.+|..++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE----E-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----H-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc----c-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 4678899999999999999999999999999986421 1 2344555555554 899999999999877
Q ss_pred -ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEcCCCCEEE
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--------~iiHrDlkp~NILl~~~~~vkl 279 (418)
..+|+||||+++|+|.++++.. .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6899999999999999999753 599999999999999999999998 9999999999999999999999
Q ss_pred eecccceeecccCC-----CCCCCCCccccccccccCCCCCCc------chHHHHHHHHHHHHhC----------CCCCC
Q 014783 280 ADFGVARIEVQTEG-----MTPETGTYRWMAPEMIQHRPYTQK------VDVYSFGIVLWELITG----------LLPFQ 338 (418)
Q Consensus 280 ~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~~------sDvwSlGv~l~elltg----------~~Pf~ 338 (418)
+|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|||++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999976533222 124579999999999988776665 9999999999999999 77775
Q ss_pred CCCH-----HHHHHHHHhcCCCCCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 339 NMTA-----VQAAFAVVNKGVRPVIPN-----DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 339 ~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.... ............++..+. .+++.+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 5321 222222233444454443 5677899999999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=351.80 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=215.4
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe--eCc
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRM 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~~~ 209 (418)
.++|++.+.||+|+||.||++++ +++.||+|++......... .+.+.+|+.++++++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 46788899999999999999998 6789999999865544322 357889999999999999999999875 356
Q ss_pred eEEEEEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEcCCCCEEEeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.+++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 8999999999999999997632 345899999999999999999999999 999999999999999999999999
Q ss_pred ccceeecccCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 283 GVARIEVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 283 Gla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.... +..+..+.++..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-i~~~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-IREGKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCCCCTT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-HhhcccccCCcc
Confidence 99975433211 1234689999999999998999999999999999999999999998877665444 444555567778
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
+++.+.+++.+||+.||++|||+.||++.+..
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 89999999999999999999999999986543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=363.91 Aligned_cols=259 Identities=28% Similarity=0.496 Sum_probs=203.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHH--HHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM--LATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i--l~~l~hpniv~l~~~~~ 206 (418)
++.++.++|++.+.||+|+||.||+|+++++.||||++..... ..+..|..+ +..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCcchhhheeccc
Confidence 4567788999999999999999999999999999999964311 223334444 55689999999998653
Q ss_pred e-----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEc
Q 014783 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---------GFIHRDLKSDNLLIS 272 (418)
Q Consensus 207 ~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---------~iiHrDlkp~NILl~ 272 (418)
. ...+++||||+++|+|.+++... ..++..++.++.||+.||+|||+. ||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 2 33678999999999999999753 358889999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccceeeccc---------CCCCCCCCCccccccccccC-------CCCCCcchHHHHHHHHHHHHhCCCC
Q 014783 273 ADKSIKIADFGVARIEVQT---------EGMTPETGTYRWMAPEMIQH-------RPYTQKVDVYSFGIVLWELITGLLP 336 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~t~~sDvwSlGv~l~elltg~~P 336 (418)
.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 9999999999999865322 11234569999999999987 4567899999999999999999766
Q ss_pred CCC-CC-----------------HHHHHHHHHhcCCCCCCCCC------ChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 014783 337 FQN-MT-----------------AVQAAFAVVNKGVRPVIPND------CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392 (418)
Q Consensus 337 f~~-~~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dp~~RPt~~ell~~L~ 392 (418)
|.. .. ..+..........++.+|.. +++.+.+|+.+||+.||++|||+.|+++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 522 11 11111122233444555543 4458999999999999999999999999999
Q ss_pred hhHHHHh
Q 014783 393 NAETEIM 399 (418)
Q Consensus 393 ~~~~~~~ 399 (418)
++.....
T Consensus 315 ~ll~~~~ 321 (336)
T 3g2f_A 315 ELMMIWE 321 (336)
T ss_dssp HHHHCCC
T ss_pred HHHHHHH
Confidence 9886553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=348.28 Aligned_cols=249 Identities=29% Similarity=0.531 Sum_probs=211.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee---
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--- 207 (418)
+...|++.+.||+|+||.||+|.+ ++..||+|++......... .+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH----HHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 445678888999999999999998 5678999999765444322 3678899999999999999999999865
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEc-CCCCEEEeecc
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFG 283 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~-~~~~vkl~DfG 283 (418)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 45689999999999999999764 45899999999999999999999999 99999999999998 78999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDC 362 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 362 (418)
++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||............+..+..+ ..+..+
T Consensus 178 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 178 LATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp GGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred Ccccccc-cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence 9975433 23344579999999999875 58999999999999999999999998877666666656555443 345567
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
++.+.+++.+||+.||.+|||++|+++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 789999999999999999999999886
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=346.91 Aligned_cols=252 Identities=25% Similarity=0.444 Sum_probs=207.0
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
.+..++|++.+.||+|+||.||+|++ +++.||||++..... ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc---cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34567889999999999999999998 588999999864211 0111235788999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999999999764 35899999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
..........||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+... ....|..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVA 239 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHH
Confidence 55444455678999999999988765 68999999999999999999999887776655444332 2345667889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||++|||++|+++
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHh
Confidence 9999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.97 Aligned_cols=246 Identities=23% Similarity=0.397 Sum_probs=211.5
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|.+.+.||+|+||.||+++. +++.||||++....... .+.+.+|+.++++++||||+++++++.....+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 5788899999999999999998 68899999997543221 146789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~~~ 289 (418)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999999999764 358999999999999999999999999999999999999 778899999999997543
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 367 (418)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... ..+..+++.+.
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 N-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp C-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred C-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 2 22333468999999999999999999999999999999999999999888776665555543332 33456789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||++|||++|+++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.74 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=209.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE-eeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~~ 211 (418)
++|++.+.||+|+||.||+|++ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 5788999999999999999996 7889999998765433 2577999999999988766655554 667788
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~~ 288 (418)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999999 99999999753 3569999999999999999999999999999999999999 48889999999999865
Q ss_pred cccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC--
Q 014783 289 VQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVR-- 355 (418)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~-- 355 (418)
..... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... .+....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 44322 2445799999999999999999999999999999999999999976432 1111111111111
Q ss_pred -CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 356 -PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 356 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
...+..+++.+.+++.+||+.||++|||++++++.|+++..+.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1223567899999999999999999999999999999987765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=380.09 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=213.5
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||.||+++. +|+.||||++....... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 4567889999999999999999998 68899999996422110 011256789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
.+|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999999997643 34699999999999999999999999999999999999999999999999999987
Q ss_pred ecccCC-CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCC
Q 014783 288 EVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMT----AVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 288 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 362 (418)
...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+....+... ....|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCccc
Confidence 654333 334589999999999999999999999999999999999999997653 33333333333 33456788
Q ss_pred hHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPF-----TEIVR 389 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~-----~ell~ 389 (418)
++.+.+|+.+||+.||.+||++ +++++
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999999999999975 56654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=347.53 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=212.7
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
.+|.+...++.....||+|+||.||+|++ +++.||||.+....... .+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~ 88 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY------SQPLHEEIALHKHLKHKNIVQYLGSF 88 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH------HHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence 34555666677777999999999999998 67799999997653221 25688999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-CCCEEEeecc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFG 283 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-~~~vkl~DfG 283 (418)
.....+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg 168 (295)
T 2clq_A 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168 (295)
T ss_dssp EETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred EeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecc
Confidence 999999999999999999999986532 35678889999999999999999999999999999999997 8999999999
Q ss_pred cceeecccC-CCCCCCCCccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCCCCC
Q 014783 284 VARIEVQTE-GMTPETGTYRWMAPEMIQHRP--YTQKVDVYSFGIVLWELITGLLPFQNMTAVQ-AAFAVVNKGVRPVIP 359 (418)
Q Consensus 284 la~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~ 359 (418)
++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...........+.++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 2clq_A 169 TSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP 248 (295)
T ss_dssp TCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred cccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence 998654322 234457899999999997643 8899999999999999999999997654332 223333345566778
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++.+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=374.64 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=200.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--- 208 (418)
.++|++++.||+|+||.||+|.+ +++.||||++........ ..+.+.+|+.+|+.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChH----HHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 46889999999999999999987 688999999976533322 235788999999999999999999999654
Q ss_pred ---ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
..+|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 357999999965 57666643 3899999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR---------- 355 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---------- 355 (418)
+........+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....++...-.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 8776655566778999999999999999999999999999999999999999998876655544331100
Q ss_pred ----------CCC---------CC-----C------ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ----------PVI---------PN-----D------CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ----------~~~---------~~-----~------~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.. +. . .++.+.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 0 1467899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=360.16 Aligned_cols=244 Identities=22% Similarity=0.382 Sum_probs=205.1
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
.++|++.+.||+|+||.||+++. +++.||||++...... ..+|+.++.++ +||||+++++++.+...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 35688889999999999999998 5789999999765432 23677888887 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC----CCEEEeecccce
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVAR 286 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~----~~vkl~DfGla~ 286 (418)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999999999753 469999999999999999999999999999999999998543 359999999998
Q ss_pred eeccc-CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCC--CCCC
Q 014783 287 IEVQT-EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM---TAVQAAFAVVNKGVRP--VIPN 360 (418)
Q Consensus 287 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~---~~~~~~~~~~~~~~~~--~~~~ 360 (418)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||... ...+....+....+.. ..+.
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 65433 2344568999999999998888999999999999999999999999753 3444444443333322 2235
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 67899999999999999999999999886
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=363.74 Aligned_cols=253 Identities=14% Similarity=0.251 Sum_probs=209.3
Q ss_pred cccccccCceeeeCceEEEEEEEC----------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR--- 200 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~--- 200 (418)
.++|++.+.||+|+||.||+|++. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 478899999999999999999873 679999999753 24678999999999999887
Q ss_pred ------------EEeEEee-CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 014783 201 ------------FIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (418)
Q Consensus 201 ------------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (418)
+++++.. ...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 5677765 67889999999 999999998754567999999999999999999999999999999999
Q ss_pred cEEEcCCC--CEEEeecccceeecccC--------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 268 NLLISADK--SIKIADFGVARIEVQTE--------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 268 NILl~~~~--~vkl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
|||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999997654322 123447999999999999999999999999999999999999999
Q ss_pred CCCC-HHHHHHHHH---hcCCCCCCC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 338 QNMT-AVQAAFAVV---NKGVRPVIP-----NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 338 ~~~~-~~~~~~~~~---~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.... ......... ......... ..+++.+.+++.+||+.||++|||+++|++.|+++..+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 8764 222222211 111111111 245899999999999999999999999999999988765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=360.04 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=210.2
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
++..++|++.+.||+|+||.||++++ +++.||+|++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 45567889999999999999999998 4889999999764321 1235788999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999764 3589999999999999999999996 999999999999999999999999999975
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------------------
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-------------------- 347 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~-------------------- 347 (418)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+...
T Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 4332 2345679999999999999999999999999999999999999998766543211
Q ss_pred ----------------------HHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 348 ----------------------AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 348 ----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.........+..++..+.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111121122222346889999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=358.83 Aligned_cols=252 Identities=33% Similarity=0.588 Sum_probs=211.1
Q ss_pred cccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHh--CCCCCeEEEEeEEeeCc--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~~~-- 209 (418)
.++|++.+.||+|+||.||+|+++++.||||++.... .+.+.+|+.++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3678889999999999999999999999999985321 1456788888887 78999999999998775
Q ss_pred --eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEcCCCCEEE
Q 014783 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 210 --~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--------~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
.+++||||+++|+|.+++... .+++..++.++.|++.||.||| +.||+||||||+|||++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999753 5899999999999999999999 899999999999999999999999
Q ss_pred eecccceeecccC-----CCCCCCCCccccccccccCC------CCCCcchHHHHHHHHHHHHhC----------CCCCC
Q 014783 280 ADFGVARIEVQTE-----GMTPETGTYRWMAPEMIQHR------PYTQKVDVYSFGIVLWELITG----------LLPFQ 338 (418)
Q Consensus 280 ~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~t~~sDvwSlGv~l~elltg----------~~Pf~ 338 (418)
+|||++....... ......||+.|+|||++.+. .++.++||||||+++|||++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999998655433 23445799999999999765 334789999999999999999 78986
Q ss_pred CCC-----HHHHHHHHHhcCCCCCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 339 NMT-----AVQAAFAVVNKGVRPVIPN-----DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 339 ~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
... .......+.....++..+. .+++.+.+|+.+||+.||++|||+.|+++.|+++..+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 642 2222333334455555553 3456899999999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=359.25 Aligned_cols=263 Identities=20% Similarity=0.298 Sum_probs=212.5
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+.|.++.++|++.+.||+|+||.||+++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ------QDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH------HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34667888999999999999999999997 788999999865321 1235788999999999999999999998
Q ss_pred e----eCceEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 206 R----KRMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 206 ~----~~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
. .....++||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 6 344789999999999999999763 3456999999999999999999999999999999999999999999999
Q ss_pred eecccceeecccCC----------CCCCCCCccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HH
Q 014783 280 ADFGVARIEVQTEG----------MTPETGTYRWMAPEMIQHRP---YTQKVDVYSFGIVLWELITGLLPFQNMTAV-QA 345 (418)
Q Consensus 280 ~DfGla~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~t~~sDvwSlGv~l~elltg~~Pf~~~~~~-~~ 345 (418)
+|||++........ .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ..
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 99999875422110 12234789999999997654 789999999999999999999999532110 01
Q ss_pred HHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
....+........+..+++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 122233344445556788999999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=358.78 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=199.5
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||++++ +++.||||++........ ..+.+.+|+.++++++||||+++++++.....+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----cchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 46788899999999999999987 688999999975433221 225677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-----CCCCEEEeecccce
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVAR 286 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-----~~~~vkl~DfGla~ 286 (418)
|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 109 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999996 5999999764 3599999999999999999999999999999999999994 45569999999997
Q ss_pred eeccc-CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 014783 287 IEVQT-EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV------- 357 (418)
Q Consensus 287 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------- 357 (418)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+......+.
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 54322 234455789999999999874 489999999999999999999999999888776665543211110
Q ss_pred ---------C------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 358 ---------I------------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 358 ---------~------------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. +..+++.+.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0115688999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=348.88 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=207.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE-eeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~~ 211 (418)
++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 5788899999999999999996 7889999987654332 2467899999999988777666555 677788
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~~ 288 (418)
++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999 99999999753 3469999999999999999999999999999999999999 78899999999999865
Q ss_pred cccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCC-
Q 014783 289 VQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV---QAAFAVVNKGVRP- 356 (418)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~---~~~~~~~~~~~~~- 356 (418)
..... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 44322 23457999999999999999999999999999999999999999764321 1111111111111
Q ss_pred --CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHh
Q 014783 357 --VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIM 399 (418)
Q Consensus 357 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~ 399 (418)
.....+++.+.+++.+||+.||++|||++++++.|+++..+..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 1224678899999999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=351.89 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=198.7
Q ss_pred cccccc-CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCce
Q 014783 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (418)
Q Consensus 135 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 210 (418)
+.|++. +.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++.++ +||||+++++++.+...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456664 7899999999999986 68899999997654322 14678999999985 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---EEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~---vkl~DfGla~~ 287 (418)
+|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999999999865 45899999999999999999999999999999999999998776 99999999875
Q ss_pred ecccC--------CCCCCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH------------
Q 014783 288 EVQTE--------GMTPETGTYRWMAPEMIQH-----RPYTQKVDVYSFGIVLWELITGLLPFQNMTA------------ 342 (418)
Q Consensus 288 ~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~------------ 342 (418)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 43211 1223469999999999975 4588999999999999999999999976542
Q ss_pred ---HHHHHHHHhcCCCCCC--CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 343 ---VQAAFAVVNKGVRPVI--PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 343 ---~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......+.......+. ...+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1122222222222111 1357789999999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=357.90 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=198.5
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~ 204 (418)
..|++...+|++.+.||+|+||.||++++ +++.||||++..... ...+.+.+|+.+++++. ||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE------EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch------HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 45667778999999999999999999998 788999999865321 12256889999999996 9999999999
Q ss_pred Ee--------eCceEEEEEeecCCCCHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcC
Q 014783 205 CR--------KRMVWCIVTEYAKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISA 273 (418)
Q Consensus 205 ~~--------~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~~ 273 (418)
+. ....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC
Confidence 83 4456899999995 7999998753 3456999999999999999999999999 999999999999999
Q ss_pred CCCEEEeecccceeecccCCC-------------CCCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 274 DKSIKIADFGVARIEVQTEGM-------------TPETGTYRWMAPEMI---QHRPYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
++.+||+|||+++........ ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 999999999999865432211 134589999999998 5667899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
....... ..........+..+++.+.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 254 EDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 7654432 23334444455567788999999999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=361.68 Aligned_cols=246 Identities=22% Similarity=0.371 Sum_probs=208.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHH--HHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
++|++.+.||+|+||.||+|++ +++.||||++......... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5788899999999999999987 6889999999865432110 00001346689999999999999999999999999
Q ss_pred EEEEEeecCCC-CHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 211 WCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 211 ~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 999998753 459999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .. ......|..+++.+.+
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV--EAAIHPPYLVSKELMS 253 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT--TTCCCCSSCCCHHHHH
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH--hhccCCCcccCHHHHH
Confidence 5555556679999999999988876 8899999999999999999999976332 11 1223345568899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~ 390 (418)
|+.+||+.||++|||++|+++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=370.58 Aligned_cols=260 Identities=21% Similarity=0.348 Sum_probs=213.6
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc-
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~- 209 (418)
...+|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 456788999999999999999998 488999999964322111 246779999999999999999999998654
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCEEEeecc
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl----~~~~~vkl~DfG 283 (418)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 78999999999999999976432 349999999999999999999999999999999999999 777889999999
Q ss_pred cceeecccCCCCCCCCCccccccccccC--------CCCCCcchHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQH--------RPYTQKVDVYSFGIVLWELITGLLPFQNM----TAVQAAFAVVN 351 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDvwSlGv~l~elltg~~Pf~~~----~~~~~~~~~~~ 351 (418)
+++............||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+....++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 9987666555666789999999999865 56788999999999999999999999642 23344444443
Q ss_pred cCCCC-----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 352 KGVRP-----------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 352 ~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
..... .++..++..+.+++.+||+.||++|||++|+++.++++...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 32110 11123456788999999999999999999999999887653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=349.78 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=188.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 35788899999999999999997 6889999998642110 011125788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999999753 356899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 292 -EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+........ ....|..++..+.+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSFLSIEAKDLI 243 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--CCCCCTTSCHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--ccCCccccCHHHHHHH
Confidence 2233457899999999999989999999999999999999999999876544333222211 2345667889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.||++|||++++++
T Consensus 244 ~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTT
T ss_pred HHHcccCHhhCCCHHHHhc
Confidence 9999999999999999886
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=360.50 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=204.3
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|++ .++|++.+.||+|+||.||+|++ +|+.||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 21 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVFTP 95 (367)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred eee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence 444 46789999999999999999997 688999999976543322 23578899999999999999999999976
Q ss_pred Cc------eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 208 RM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 208 ~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
.. .+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEe
Confidence 53 469999999 8899999875 3589999999999999999999999999999999999999999999999
Q ss_pred cccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----- 355 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~----- 355 (418)
||+++.... ......+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+..+....++.....
T Consensus 172 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 172 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999986532 3455678999999999977 67999999999999999999999999988876655544321100
Q ss_pred ------------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ------------------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......+++.+.+|+.+||+.||.+|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0122456789999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=390.39 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=216.4
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
+.+..++|++++.||+|+||.||++++ +++.||||+++...... ....+.+.+|..++..+ +||+|+++++++.
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH---TTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc---HHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 456678999999999999999999998 57789999997421100 00124577899999988 7999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+...+||||||+++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|+
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999999999865 459999999999999999999999999999999999999999999999999998
Q ss_pred eec-ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 287 IEV-QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 287 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....++... ...|..++++
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~ 568 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKE 568 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--CCCCTTSCHH
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHH
Confidence 633 2334456789999999999999999999999999999999999999999988887777766554 3466788999
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPF-----TEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~-----~ell~ 389 (418)
+.+||.+||+.||.+||++ +||++
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 9999999999999999997 66654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=357.51 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=197.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc--
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-- 209 (418)
.++|++.+.||+|+||.||+|+. +++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 46788999999999999999987 688999999976544332 2356789999999999999999999997654
Q ss_pred ----eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 210 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 100 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999996 588888852 4889999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--------- 356 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--------- 356 (418)
+............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....++.....+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 87655444556789999999999999999999999999999999999999999988766555544321110
Q ss_pred -----------CC--------------CC------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 -----------VI--------------PN------DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 -----------~~--------------~~------~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. |. ..++.+.+|+.+||+.||.+|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 00 01567899999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.53 Aligned_cols=253 Identities=24% Similarity=0.450 Sum_probs=208.2
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
....++|++.+.||+|+||.||++++ +++.||||++........ ..+.+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 34567889999999999999999998 478999999976544432 235678999999999999999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 999999999999888887654 345999999999999999999999999999999999999999999999999999764
Q ss_pred ccc-CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Q 014783 289 VQT-EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-------------- 352 (418)
Q Consensus 289 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-------------- 352 (418)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+...
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 332 233456789999999999875 7899999999999999999999999988876655444321
Q ss_pred -----CCC-CC---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 -----GVR-PV---------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 -----~~~-~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.. +. ..+.+++.+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00 01246789999999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=345.33 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=208.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-----PENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH-----HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh-----hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 5678889999999999999998 588999999975433221 256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999998864 346899999999999999999999999999999999999999999999999999764322
Q ss_pred --CCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCChHHHH
Q 014783 292 --EGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK-GVRPVIPNDCLPVLS 367 (418)
Q Consensus 292 --~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 367 (418)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||............+.. .........+++.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 22345678999999999987765 78999999999999999999999876543222222222 222222345788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+||+.||.+|||++|+++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHCCCCchhCCCHHHHhc
Confidence 9999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=357.77 Aligned_cols=239 Identities=22% Similarity=0.414 Sum_probs=181.3
Q ss_pred cCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEEEe
Q 014783 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv~E 216 (418)
.+.||+|+||.||++++ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 37899999999999998 57899999996421 245678999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEeecccceeeccc-C
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQT-E 292 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~~~~~~-~ 292 (418)
|+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999999999764 4699999999999999999999999999999999999998766 8999999999865432 2
Q ss_pred CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCCCCC---CCCh
Q 014783 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV------QAAFAVVNKGVRPVIP---NDCL 363 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~~~---~~~~ 363 (418)
.....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......+..+.....+ ..++
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 334567899999999999999999999999999999999999999764331 1222333333221111 2478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+.+|+.+||+.||.+|||++|+++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 89999999999999999999998874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=372.04 Aligned_cols=258 Identities=16% Similarity=0.184 Sum_probs=201.3
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHH---HHHHhCCCCCeEEEE-
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV---MMLATLKHLNIVRFI- 202 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~---~il~~l~hpniv~l~- 202 (418)
+|....++|++.+.||+|+||.||+|++ +|+.||||++......... ..+.+.+|+ .++++++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 4555567899999999999999999986 6889999999754332211 125788999 555666899999988
Q ss_pred ------eEEeeCc-----------------eEEEEEeecCCCCHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHH
Q 014783 203 ------GACRKRM-----------------VWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYV 254 (418)
Q Consensus 203 ------~~~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yL 254 (418)
+++...+ ..|+||||+ +|+|.+++..... ..+++..++.++.||+.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 5555443 278999999 6899999986421 1233477888999999999999
Q ss_pred HhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccccCC-----------CCCCcchHHHH
Q 014783 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-----------PYTQKVDVYSF 323 (418)
Q Consensus 255 H~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDvwSl 323 (418)
|++||+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||
T Consensus 223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999999998532 23445567 999999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhHHHHh
Q 014783 324 GIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR--MLENAETEIM 399 (418)
Q Consensus 324 Gv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~--~L~~~~~~~~ 399 (418)
||++|||++|+.||...........+ ...+..+++.+.+|+.+||+.||++|||+.|+++ .++.+...+.
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence 99999999999999765543221111 1123567899999999999999999999999997 5666555443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=357.84 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=204.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|++ +|+.||||++........ .....+.+.+|+.+++.++||||+++++++.....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh-hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 46788899999999999999987 578999999865432211 111224677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+++ +|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999975 898888753 346888899999999999999999999999999999999999999999999999865332
Q ss_pred -CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---C---------
Q 014783 292 -EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---V--------- 357 (418)
Q Consensus 292 -~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~--------- 357 (418)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......+ .
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 234556799999999999754 58999999999999999999999999988877666554421110 0
Q ss_pred ---------C-----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 358 ---------I-----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 358 ---------~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
. ...+++.+.+|+.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 13456889999999999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=372.01 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=198.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCCh--HHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP--EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .........+.+|+.+|++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 46788999999999999999988 57899999997543211 11111123578999999999999999999998654
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC---CEEEeecccce
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVAR 286 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~---~vkl~DfGla~ 286 (418)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 57899999999999988864 35699999999999999999999999999999999999997544 59999999998
Q ss_pred eecccCCCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---C
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP---N 360 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~ 360 (418)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............+..+.....+ .
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 7665555566789999999999853 568899999999999999999999998755433333444444333222 4
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+.+|+.+||+.||++|||++|+++
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 57889999999999999999999999887
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=357.84 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=200.5
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ +++.||||++........ ...+.+|+.+++.++||||+++++++.....++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 5688899999999999999998 578999999865332111 123457999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 9999996 5999998764 456899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---C----------
Q 014783 292 EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP---V---------- 357 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---~---------- 357 (418)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+ .
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23344578999999999976 568999999999999999999999999988777655443311100 0
Q ss_pred ---------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 358 ---------------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 358 ---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....+++.+.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11245778999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=345.92 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=213.4
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++.+.||+|+||.||+|+. +++.||||++......... .+.+.+|+.++++++||||+++++++.....+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 36788999999999999999998 6889999999754332211 25678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC---CCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~---~~vkl~DfGla~~~ 288 (418)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999999998764 358999999999999999999999999999999999999764 47999999999866
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 366 (418)
..........||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++.+
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred cCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 544444455688999999998764 8999999999999999999999999988777666555554443333 4678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+||+.||++|||+.|+++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhc
Confidence 99999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=359.28 Aligned_cols=259 Identities=15% Similarity=0.240 Sum_probs=214.3
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEE-------ECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC---
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--- 194 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--- 194 (418)
....++.+..++|.+.+.||+|+||.||+|+ .+++.||||++.... ...+.+|+.+++.++
T Consensus 55 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---------PWEFYIGTQLMERLKPSM 125 (365)
T ss_dssp CSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---------HHHHHHHHHHHHHSCGGG
T ss_pred ccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---------hhHHHHHHHHHHHhhhhh
Confidence 3456778888999999999999999999993 267899999996532 135678888888887
Q ss_pred CCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 014783 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (418)
Q Consensus 195 hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl 271 (418)
|+||+++++++......|+||||+++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence 999999999999999999999999999999999753 34569999999999999999999999999999999999999
Q ss_pred cC-----------CCCEEEeecccceeec---ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 272 SA-----------DKSIKIADFGVARIEV---QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 272 ~~-----------~~~vkl~DfGla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
+. ++.+||+|||+|+... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 98 8999999999997543 223345567999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhHHHH
Q 014783 338 QNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR-PPFTEIVRMLENAETEI 398 (418)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~ell~~L~~~~~~~ 398 (418)
........ . ... . ......++.+.+++..|++.+|.+| |++.++.+.|+++....
T Consensus 286 ~~~~~~~~--~-~~~-~--~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 286 VKNEGGEC--K-PEG-L--FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEEETTEE--E-ECS-C--CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCce--e-ech-h--ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 54322110 0 000 0 1111346789999999999999999 67899999888887653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.62 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=208.8
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++.+.||+|+||.||+|++ +|+.||||++...... +.+.+|+.+++.++||||+++++++.....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 456788899999999999999998 4889999999764322 467899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+.+++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.....
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999999999743 45699999999999999999999999999999999999999999999999999976543
Q ss_pred cC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014783 291 TE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSE 368 (418)
Q Consensus 291 ~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 368 (418)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||................. ....+..+++.+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 32 23445789999999999999999999999999999999999999998887665554433321 12234457889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
++.+||+.||.+|||+.++++
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHccCChhhCcCHHHHHh
Confidence 999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=353.94 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=196.3
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..|.+..++|++.+.||+|+||.||++++ +++.||||++...... ...+.+.+|+.++++++||||+++++++
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-----TSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-----hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 35788889999999999999999999986 6889999998643221 1235678999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
......++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999999742 2456899999999999999999999999999999999999999999999
Q ss_pred eecccceeecccC------CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014783 280 ADFGVARIEVQTE------GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK 352 (418)
Q Consensus 280 ~DfGla~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~ 352 (418)
+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...............
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 9999987543221 1234568999999999865 56899999999999999999999999887766655444433
Q ss_pred CCCC--------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 GVRP--------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.... .....+++.+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 2211 223457889999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=351.27 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=209.6
Q ss_pred cccccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEe-
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACR- 206 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~- 206 (418)
.++|++.+.||+|+||.||+|++ +++.||||++.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC----chhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 46789999999999999999987 46789999987543221110 2345677766666 8999999999987
Q ss_pred ----eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 207 ----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 207 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5667899999997 69999998766667999999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR------- 355 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~------- 355 (418)
|+++............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....+....++.....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 9998765544455678999999999999999999999999999999999999999998877666555431000
Q ss_pred ------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ------------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+..+++.+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0123457889999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=383.26 Aligned_cols=264 Identities=30% Similarity=0.593 Sum_probs=223.9
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
...+|++..++|++.+.||+|+||.||+|++. +..||||.+...... ...+.+.+|+.++++++||||++
T Consensus 381 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~ 455 (656)
T 2j0j_A 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVK 455 (656)
T ss_dssp CGGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCCCCe
Confidence 34578888899999999999999999999873 346999998643221 22367889999999999999999
Q ss_pred EEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEe
Q 014783 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 201 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
+++++.+ ..+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 456 l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 456 LIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEec-CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence 9999854 5579999999999999999754 3468999999999999999999999999999999999999999999999
Q ss_pred ecccceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 014783 281 DFGVARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPV 357 (418)
Q Consensus 281 DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 357 (418)
|||+++....... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+.... +..+.+..
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-i~~~~~~~ 612 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLP 612 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHHTCCCC
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCCCC
Confidence 9999986543322 223456789999999998899999999999999999997 9999999888776544 44455667
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+..+++.+.+++.+||+.||.+|||+.||++.|+++..+
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 7888999999999999999999999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=364.68 Aligned_cols=246 Identities=21% Similarity=0.349 Sum_probs=207.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC------CCCCeEEEEeEE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL------KHLNIVRFIGAC 205 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l------~hpniv~l~~~~ 205 (418)
..+|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 45788999999999999999988 57899999996421 1224567788888877 577999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC--EEEeecc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFG 283 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~--vkl~DfG 283 (418)
.....+++||||+. ++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999995 69999998766667999999999999999999999999999999999999999987 9999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP------- 356 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~------- 356 (418)
++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....++...-.+
T Consensus 248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 248 SSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp TCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 997543 23445689999999999999999999999999999999999999999988776655443210000
Q ss_pred --------------------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHH
Q 014783 357 --------------------------------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTE 386 (418)
Q Consensus 357 --------------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 386 (418)
.++...++.+.+||.+||+.||++|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 011234678999999999999999999999
Q ss_pred HHH
Q 014783 387 IVR 389 (418)
Q Consensus 387 ll~ 389 (418)
+++
T Consensus 406 ~L~ 408 (429)
T 3kvw_A 406 ALR 408 (429)
T ss_dssp HHT
T ss_pred HhC
Confidence 987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=368.48 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=188.9
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.|.+ .++|++.+.||+|+||.||+|++ +++.||||++......... .+.+.+|+.+|+.++||||+++++++.
T Consensus 48 ~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 48 DWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID----CKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp SCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH----HHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 3444 36789999999999999999987 6789999999765443322 257889999999999999999999984
Q ss_pred eC-----ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 207 KR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
.. ..+|+||||+ +++|.+++.. ...+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred cCCcccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence 33 5689999998 5799999865 35699999999999999999999999999999999999999999999999
Q ss_pred cccceeecccC----------------------------CCCCCCCCccccccccc-cCCCCCCcchHHHHHHHHHHHHh
Q 014783 282 FGVARIEVQTE----------------------------GMTPETGTYRWMAPEMI-QHRPYTQKVDVYSFGIVLWELIT 332 (418)
Q Consensus 282 fGla~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~t~~sDvwSlGv~l~ellt 332 (418)
||+|+...... ..+..+||+.|+|||++ ....|+.++|||||||++|||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 99998643211 23345789999999986 56679999999999999999998
Q ss_pred -----------CCCCCCCCCH--------------------HHHHHHHHh----------------------cCCCC---
Q 014783 333 -----------GLLPFQNMTA--------------------VQAAFAVVN----------------------KGVRP--- 356 (418)
Q Consensus 333 -----------g~~Pf~~~~~--------------------~~~~~~~~~----------------------~~~~~--- 356 (418)
|+++|.+... .+....+.. .....
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence 6777766431 111111110 00000
Q ss_pred ----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ----VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+.+++.+.+|+.+||..||++|||++|+++
T Consensus 360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011345788999999999999999999999887
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=346.88 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=208.4
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE--eeCce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~--~~~~~ 210 (418)
++|++.+.||+|+||.||++.+ +++.||||++....... .....+.+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc--cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 5788999999999999999998 67899999986421100 001235788999999999999999999998 44567
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999765 88888776667899999999999999999999999999999999999999999999999999986532
Q ss_pred c---CCCCCCCCCccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHH
Q 014783 291 T---EGMTPETGTYRWMAPEMIQHRP--YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPV 365 (418)
Q Consensus 291 ~---~~~~~~~gt~~y~aPE~~~~~~--~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (418)
. .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+... ....+..+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~ 239 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPP 239 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHH
Confidence 2 1223456899999999997654 478999999999999999999999988776655544443 23456778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
+.+++.+||+.||.+|||+.|+++.
T Consensus 240 l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 240 LSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=363.87 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=202.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
.+|++.+.||+|+||.||+|++ +++.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 4678889999999999999998 588999999875432 223799999999999999999998532
Q ss_pred --ceEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeecc
Q 014783 209 --MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFG 283 (418)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfG 283 (418)
..+++||||+.+ +|.+++.. .....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 236799999965 77766653 234679999999999999999999999999999999999999965 568999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK---------- 352 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~---------- 352 (418)
+++............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....++..
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876555555667899999999999765 7999999999999999999999999998877666555431
Q ss_pred ----CCC----CC---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 ----GVR----PV---------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ----~~~----~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+. +. ++..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000 00 23356789999999999999999999999885
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=353.14 Aligned_cols=258 Identities=25% Similarity=0.438 Sum_probs=189.3
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHH-HHHhCCCCCeEEEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFI 202 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~ 202 (418)
....|.+..++|++.+.||+|+||.||+|++ +++.||||++........ ...+.+|+. +++.++||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeeee
Confidence 3457888999999999999999999999998 588999999976533221 134445555 77888999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEE
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIK 278 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vk 278 (418)
+++......++||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 999999999999999974 88887763 2346789999999999999999999999 999999999999999999999
Q ss_pred EeecccceeecccCCCCCCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 014783 279 IADFGVARIEVQTEGMTPETGTYRWMAPEMI----QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV 354 (418)
Q Consensus 279 l~DfGla~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~ 354 (418)
|+|||+++............||+.|+|||++ .+..++.++||||||+++|+|++|+.||............+..+.
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp ECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred EccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 9999999876554444555799999999999 466789999999999999999999999987554222111111222
Q ss_pred CCCC----CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 RPVI----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.. ...+++.+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 2222 2357899999999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.40 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=198.8
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.|.+ .++|++.+.||+|+||.||+|++ +++.||||++......... .+.+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID----CKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHH----HHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3444 36789999999999999999988 6789999999765443322 357889999999999999999999987
Q ss_pred eC-----ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEee
Q 014783 207 KR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (418)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~D 281 (418)
.. ..+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEcc
Confidence 65 56899999995 699999975 35699999999999999999999999999999999999999999999999
Q ss_pred cccceeecccC-----------------------CCCCCCCCccccccccc-cCCCCCCcchHHHHHHHHHHHHhC----
Q 014783 282 FGVARIEVQTE-----------------------GMTPETGTYRWMAPEMI-QHRPYTQKVDVYSFGIVLWELITG---- 333 (418)
Q Consensus 282 fGla~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~t~~sDvwSlGv~l~elltg---- 333 (418)
||+|+...... ..+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998654322 13556799999999986 566799999999999999999984
Q ss_pred -------CCCCCCCCH-----------------HHHHHHH-----------------------Hhc-CCCCCC-----CC
Q 014783 334 -------LLPFQNMTA-----------------VQAAFAV-----------------------VNK-GVRPVI-----PN 360 (418)
Q Consensus 334 -------~~Pf~~~~~-----------------~~~~~~~-----------------------~~~-~~~~~~-----~~ 360 (418)
.++|.+... .+.+..+ +.. ...... .+
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 444444320 1111111 110 011111 13
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+.+|+.+||+.||++|||++|+++
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 46889999999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=346.30 Aligned_cols=250 Identities=26% Similarity=0.471 Sum_probs=208.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++.+.||+|+||.||+|++ +++.||+|++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 346788999999999999999998 47899999986543221 2568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999998764 35599999999999999999999999999999999999999999999999999754321
Q ss_pred -cCCCCCCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCh
Q 014783 291 -TEGMTPETGTYRWMAPEMI-----QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCL 363 (418)
Q Consensus 291 -~~~~~~~~gt~~y~aPE~~-----~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 363 (418)
........||+.|+|||++ ....++.++||||||+++|+|++|..||...+.......+....... ..+..++
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 1223445789999999998 46678999999999999999999999999988877665555443322 3345678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 89999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.47 Aligned_cols=243 Identities=17% Similarity=0.332 Sum_probs=203.1
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEee--
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK-- 207 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-- 207 (418)
..++|++.+.||+|+||.||+|+. +++.||||++.... .+.+.+|+.++++++ ||||+++++++..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 346889999999999999999987 68899999986422 146789999999997 9999999999987
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccce
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVAR 286 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~ 286 (418)
....++||||+.+++|.+++.. +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 6678999999999999998753 88899999999999999999999999999999999999777 89999999998
Q ss_pred eecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH------------Hhc
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMT-AVQAAFAV------------VNK 352 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~-~~~~~~~~------------~~~ 352 (418)
............||..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+ +..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 7766666667789999999999977 679999999999999999999999995433 22222111 111
Q ss_pred C-----------------------CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 G-----------------------VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~-----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. .....+..+++.+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 001112226789999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.25 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=204.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee----
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 207 (418)
..+|++.+.||+|+||.||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 46889999999999999999998 6789999998655433221 1456799999999999999999999876
Q ss_pred ----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 208 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
...+|+||||+. ++|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -----CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 446899999996 4888877653 3459999999999999999999999999999999999999999999999999
Q ss_pred cceeecc-----cCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCC
Q 014783 284 VARIEVQ-----TEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN--KGVR 355 (418)
Q Consensus 284 la~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~--~~~~ 355 (418)
+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.. ....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986532 222345578999999999976 4589999999999999999999999999887665544432 1111
Q ss_pred CCCCCC----------------------------ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 PVIPND----------------------------CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~~~~~~----------------------------~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+...+. .++.+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111 1567899999999999999999999887
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.69 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=201.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChH--HHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
++|++.+.||+|+||.||+|++ +++.||||++........ ........+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5688899999999999999988 578999999865432111 11111245789999999999999999999987665
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---EEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~---vkl~DfGla~~ 287 (418)
+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 7999999999999999865 356999999999999999999999999999999999999987664 99999999986
Q ss_pred ecccCCCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCC
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI---PND 361 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~ 361 (418)
...........||+.|+|||++. ...++.++|||||||++|+|++|..||............+..+..... +..
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence 54433233456899999999973 567899999999999999999999999765443223333333322222 246
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++.+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 7889999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.74 Aligned_cols=256 Identities=23% Similarity=0.431 Sum_probs=194.4
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..|.+..++|++.+.||+|+||.||+|++ +++.||||++........ ..+.+.++..+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 45667788999999999999999999998 588999999976543222 123455566678889999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
.....+++||||+ ++.+..+... ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 5556555543 346799999999999999999999995 999999999999999999999999999
Q ss_pred ceeecccCCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
+.............||+.|+|||++. ...++.++||||||+++|+|++|+.||............+.....+..+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 97665544455567999999999994 5568999999999999999999999998754433333333334344333
Q ss_pred --CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 --NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 --~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++.+.+++.+||+.||.+|||++|+++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 357899999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=358.77 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=202.4
Q ss_pred cccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc---
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 209 (418)
..+|++.+.||+|+||.||+|++ .+..||+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 35788999999999999999998 4556999988654322 237999999999999999999985543
Q ss_pred ---eEEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCEEEeecc
Q 014783 210 ---VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFG 283 (418)
Q Consensus 210 ---~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~vkl~DfG 283 (418)
.+++||||+.++ +...+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 388999999764 4444332 2345799999999999999999999999999999999999999 79999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-------- 354 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-------- 354 (418)
+|+............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....++...-
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99877666666677899999999999765 599999999999999999999999999887776655543100
Q ss_pred ----------CC---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 ----------RP---------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ----------~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+ ..+..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 122347789999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=362.19 Aligned_cols=254 Identities=21% Similarity=0.383 Sum_probs=206.8
Q ss_pred cccccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~ 205 (418)
+..++|++.+.||+|+||.||+++. +++.||||+++........ ...+.+.+|+.+++.+ +||||+++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3457889999999999999999987 6789999998643210000 0013456899999999 699999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.....+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999999765 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeccc--CCCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCC
Q 014783 286 RIEVQT--EGMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQNMT----AVQAAFAVVNKGVRPV 357 (418)
Q Consensus 286 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~~~~----~~~~~~~~~~~~~~~~ 357 (418)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.. ..+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCC
Confidence 865322 22334579999999999985 357899999999999999999999996432 2222222222 2445
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRP-----PFTEIVRML 391 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~ell~~L 391 (418)
.+..+++.+.+|+.+||+.||++|| |++|+++..
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 6778889999999999999999999 999998743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=365.96 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=210.9
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC-CCeEEEEeEEeeCce
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMV 210 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~~ 210 (418)
.++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.+.| +++..+..++.....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 36789999999999999999997 5889999998765433 246789999999987 566667777778888
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---cCCCCEEEeeccccee
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl---~~~~~vkl~DfGla~~ 287 (418)
.+|||||+ +++|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999999 99999999753 3569999999999999999999999999999999999999 5889999999999987
Q ss_pred ecccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC-
Q 014783 288 EVQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNKGVR- 355 (418)
Q Consensus 288 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~~~~- 355 (418)
...... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 544322 1256799999999999999999999999999999999999999987543 2222222221111
Q ss_pred --CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 356 --PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 356 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
..++..+++++.+|+.+||+.||++||++.+|++.|+++...
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 122346788999999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=355.11 Aligned_cols=250 Identities=23% Similarity=0.405 Sum_probs=206.1
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..|++. ++|.+.+.||+|+||.||+|++ +|+.||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh----HHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 456664 6889999999999999999987 688999999976544332 236788999999999999999999999
Q ss_pred eeCceE------EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 206 RKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 206 ~~~~~~------~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
...... |+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 876654 99999996 68887763 34999999999999999999999999999999999999999999999
Q ss_pred eecccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 014783 280 ADFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-- 356 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-- 356 (418)
+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....++.....+
T Consensus 186 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 186 LDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp CSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999975432 2445678999999999987 679999999999999999999999999888766555443311000
Q ss_pred ---------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 ---------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+..+++.+.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 012356789999999999999999999999886
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=343.99 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=211.4
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEEEEe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIG 203 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~ 203 (418)
+....+..++|++.+.||+|+||.||++++ +++.||||++......... .+.+.+|+.++++++ ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHH----HHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccc----hHHHHHHHHHHHhccccCCceEEEEE
Confidence 344566778899999999999999999987 6789999999765444322 357889999999997 599999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
++.....+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecc
Confidence 9999999999999 5588999999764 4689999999999999999999999999999999999996 5899999999
Q ss_pred cceeecccCC---CCCCCCCccccccccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 014783 284 VARIEVQTEG---MTPETGTYRWMAPEMIQH-----------RPYTQKVDVYSFGIVLWELITGLLPFQNMTA-VQAAFA 348 (418)
Q Consensus 284 la~~~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~-~~~~~~ 348 (418)
+++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9986543221 234568999999999875 4688999999999999999999999987643 344445
Q ss_pred HHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 349 VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 349 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
.+........+..++..+.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 556666667777788999999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=353.79 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=201.4
Q ss_pred cccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChH-----HHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE-----KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~-----~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
...++|++.+.||+|+||.||+|.. +++.||||++........ ......+.+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 3457889999999999999999987 688999999865433211 1222346789999999999999999999998
Q ss_pred ee-----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEe
Q 014783 206 RK-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 206 ~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
.. ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 43 346899999996 6888888753 3469999999999999999999999999999999999999999999999
Q ss_pred ecccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Q 014783 281 DFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR---- 355 (418)
Q Consensus 281 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---- 355 (418)
|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9999986555555566789999999999976 67999999999999999999999999988776655544321110
Q ss_pred ------------------CC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ------------------PV--------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ------------------~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. .+..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00 12345778999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.57 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=203.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
.+|++.+.||+|+||.||++++ +++.||||++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 5789999999999999999987 6789999999643221 1235788999999999999999999999654
Q ss_pred -ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 36899999996 599999875 3499999999999999999999999999999999999999999999999999986
Q ss_pred ecccCC----CCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 014783 288 EVQTEG----MTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-------- 354 (418)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-------- 354 (418)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 543322 244579999999998754 4589999999999999999999999988776554444331100
Q ss_pred ----------------CCC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 ----------------RPV-----IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ----------------~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
... ....+++.+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 11356788999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=356.00 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=202.1
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC--------CCCeEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--------HLNIVR 200 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--------hpniv~ 200 (418)
.+-.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+.+|+.+++.++ ||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-------CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 34457899999999999999999987 6789999999642 112356789999999985 788999
Q ss_pred EEeEEe----eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcCCC
Q 014783 201 FIGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADK 275 (418)
Q Consensus 201 l~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~ 275 (418)
+++++. ....+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 556899999999 67887777765556799999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------------CEEEeecccceeecccCCCCCCCCCcccccc
Q 014783 276 -------------------------------------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (418)
Q Consensus 276 -------------------------------------------------~vkl~DfGla~~~~~~~~~~~~~gt~~y~aP 306 (418)
.+||+|||++..... ......||+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aP 262 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCC
Confidence 799999999986543 24556799999999
Q ss_pred ccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-cCCC------------------------
Q 014783 307 EMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA------VQAAFAVVN-KGVR------------------------ 355 (418)
Q Consensus 307 E~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~------~~~~~~~~~-~~~~------------------------ 355 (418)
|++.+..++.++|||||||++|||++|+.||...+. ......+.. .+..
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 999999999999999999999999999999976442 222111111 0000
Q ss_pred ---------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 ---------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ---------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+...++.+.+|+.+||+.||++|||++|+++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112234567889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=351.32 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=195.9
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
...++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+|+..+..++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 4457889999999999999999998 57899999986644332 24457788888999999999999986543
Q ss_pred e-------EEEEEeecCCCCHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEcC-CCCE
Q 014783 210 V-------WCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKSI 277 (418)
Q Consensus 210 ~-------~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~NILl~~-~~~v 277 (418)
. +++||||+.+ +|.+.+.. .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 3 7899999976 55555443 23456899999999999999999999 999999999999999997 8999
Q ss_pred EEeecccceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--
Q 014783 278 KIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-- 354 (418)
Q Consensus 278 kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-- 354 (418)
||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......++....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 99999999877665556667899999999998665 489999999999999999999999999887766655443110
Q ss_pred ----------------------------CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 ----------------------------RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+..+..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11122336789999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=360.57 Aligned_cols=263 Identities=14% Similarity=0.151 Sum_probs=193.0
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC--CCCCeEEEE--
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFI-- 202 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~-- 202 (418)
.|.....+|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+.+++.+ +||||++++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~~~~l~~~hp~iv~~~~~ 132 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLGESPEEARDRRR 132 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---HHHHHHHHHHHHHHHHC----------C
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---HHHHHHHHHHHHHHhcccChhhhhhcee
Confidence 4455566789999999999999999997 6789999999876543322 235677785544444 699988865
Q ss_pred -----eEEeeC-----------------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHH
Q 014783 203 -----GACRKR-----------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA------VKQALDVARGMAYV 254 (418)
Q Consensus 203 -----~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qi~~gL~yL 254 (418)
+++... ..+||||||++ |+|.+++.... ..++...+ +.++.||+.||+||
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 444332 34899999998 89999998642 23444555 67789999999999
Q ss_pred HhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHh
Q 014783 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELIT 332 (418)
Q Consensus 255 H~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~ellt 332 (418)
|++||+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 211 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999865322 224457799999999987 679999999999999999999
Q ss_pred CCCCCCCCCHHHHH-HH------HHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhHHHH
Q 014783 333 GLLPFQNMTAVQAA-FA------VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR--MLENAETEI 398 (418)
Q Consensus 333 g~~Pf~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~--~L~~~~~~~ 398 (418)
|+.||......... .. ..........+..+++.+.+|+.+||+.||++|||+.|+++ .++++...+
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 99999876432110 00 00011122223477899999999999999999999999986 455544443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=357.56 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=191.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.|.+. ++|++.+.||+|+||.||+|.+ +|+.||||++......... .+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 35553 6789999999999999999987 6889999999765443322 357789999999999999999999986
Q ss_pred eC------ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEe
Q 014783 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 207 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
.. ..+|+|+|++ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 54 5579999999 7899998864 459999999999999999999999999999999999999999999999
Q ss_pred ecccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------
Q 014783 281 DFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG------ 353 (418)
Q Consensus 281 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~------ 353 (418)
|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999986432 2445679999999999977 679999999999999999999999999888766554443210
Q ss_pred ----------------CC--CC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 ----------------VR--PV-----IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 ----------------~~--~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. +. ....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 00 01245678999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.52 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=213.3
Q ss_pred cccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHH-----------HHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA-----------QVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
+..++|++.+.||+|+||.||+|+++++.||||++.......... ....+.+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 445789999999999999999999999999999987432111000 000156889999999999999999
Q ss_pred EEeEEeeCceEEEEEeecCCCCHHHH------HhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcC
Q 014783 201 FIGACRKRMVWCIVTEYAKGGSVRQF------LTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISA 273 (418)
Q Consensus 201 l~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~ 273 (418)
+++++.....+|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 655445779999999999999999999999 99999999999999999
Q ss_pred CCCEEEeecccceeecccCCCCCCCCCccccccccccCC-CCCC-cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQ-KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||............+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999999999999865433 34556799999999999887 6666 99999999999999999999988776233333343
Q ss_pred cCCCCCCC-------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 KGVRPVIP-------------------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 ~~~~~~~~-------------------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+.. ..| ..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 267 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 267 TKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3321 222 567899999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=347.82 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=205.9
Q ss_pred ccccccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC------CeEEEEe
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------NIVRFIG 203 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp------niv~l~~ 203 (418)
-.++|++.+.||+|+||.||++.+ +++.||||++.... ...+.+.+|+.+++.++|+ +++++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------chhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 346889999999999999999987 57899999986421 1235677899999988765 4999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC----------
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---------- 273 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---------- 273 (418)
++.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 889999998766567899999999999999999999999999999999999987
Q ss_pred ---------CCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q 014783 274 ---------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQ 344 (418)
Q Consensus 274 ---------~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~ 344 (418)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999976432 3345679999999999999999999999999999999999999999887765
Q ss_pred HHHHHHhc--CCC----------------------------------------CCCCCCChHHHHHHHHHhcccCCCCCC
Q 014783 345 AAFAVVNK--GVR----------------------------------------PVIPNDCLPVLSEIMTRCWDTNPEVRP 382 (418)
Q Consensus 345 ~~~~~~~~--~~~----------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RP 382 (418)
....+... ... ...+..+++.+.+|+.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 44322110 000 011123457899999999999999999
Q ss_pred CHHHHHH
Q 014783 383 PFTEIVR 389 (418)
Q Consensus 383 t~~ell~ 389 (418)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999885
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=347.93 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=202.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 208 (418)
++|++.+.||+|+||.||+|++ +|+.||||++..... . .....+.+|+.++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-P----LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-H----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-c----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 6788899999999999999998 588999999964322 1 1235678999999999999999999988654
Q ss_pred -ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999996 699999875 3589999999999999999999999999999999999999999999999999986
Q ss_pred ecccC-----------CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 014783 288 EVQTE-----------GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR 355 (418)
Q Consensus 288 ~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~ 355 (418)
..... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 53221 1223468999999998754 67899999999999999999999999988765544333221000
Q ss_pred C------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 P------------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+ .....+++.+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 011357788999999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=347.02 Aligned_cols=249 Identities=23% Similarity=0.409 Sum_probs=203.5
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
.|++ .++|.+.+.||+|+||.||+|++ +|+.||||++........ ..+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3544 35788999999999999999987 688999999976543322 2357889999999999999999999997
Q ss_pred eCce------EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEe
Q 014783 207 KRMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (418)
Q Consensus 207 ~~~~------~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~ 280 (418)
.... +|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence 7653 499999996 68877763 348999999999999999999999999999999999999999999999
Q ss_pred ecccceeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------
Q 014783 281 DFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK------- 352 (418)
Q Consensus 281 DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~------- 352 (418)
|||+++.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 169 Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 169 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred ecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999976432 2344578999999999977 67899999999999999999999999988766554443321
Q ss_pred -------------------CCC---CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 -------------------GVR---PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 -------------------~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+ ......+++.+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001 1223457889999999999999999999999886
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=338.56 Aligned_cols=244 Identities=26% Similarity=0.463 Sum_probs=195.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 207 (418)
++|++.+.||+|+||.||+|+. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-------EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 5678889999999999999997 68899999986421 123578899999999999999999998854
Q ss_pred --------CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 208 --------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 208 --------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
...+|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 45789999999999999999753 346788999999999999999999999999999999999999999999
Q ss_pred eecccceeeccc---------------CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q 014783 280 ADFGVARIEVQT---------------EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAV 343 (418)
Q Consensus 280 ~DfGla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~ 343 (418)
+|||++...... .......||+.|+|||++.+. .++.++||||||+++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999999754321 122345689999999999765 68999999999999999998 66543332
Q ss_pred HHHHHHHhc---CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 344 QAAFAVVNK---GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 344 ~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......+.. ...+..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 222233322 2333455567788999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.62 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=197.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe-----
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR----- 206 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~----- 206 (418)
.++|++.+.||+|+||.||+|++ +++.||||++.... . ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--P----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--h----HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 36788999999999999999998 47899999987532 1 12357889999999999999999999873
Q ss_pred ---------eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCC
Q 014783 207 ---------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKS 276 (418)
Q Consensus 207 ---------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~ 276 (418)
+...+|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 3467899999997 699999864 4589999999999999999999999999999999999997 5679
Q ss_pred EEEeecccceeeccc----CCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014783 277 IKIADFGVARIEVQT----EGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 277 vkl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~ 351 (418)
+||+|||+++..... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||.+....+....+..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999865322 12233457899999998865 6789999999999999999999999998887665544432
Q ss_pred cCCC-----------------------C-----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 352 KGVR-----------------------P-----VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 352 ~~~~-----------------------~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.... + ..+..+++.+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 2100 0 012457889999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=355.48 Aligned_cols=245 Identities=21% Similarity=0.347 Sum_probs=182.6
Q ss_pred cccc-cCceeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee--C
Q 014783 136 KLNM-GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--R 208 (418)
Q Consensus 136 ~~~~-~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~ 208 (418)
.|.+ +++||+|+||.||+|++ +++.||||++...... ..+.+|+.+|++++||||+++++++.. .
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3444 56899999999999996 3678999999754332 356799999999999999999999954 6
Q ss_pred ceEEEEEeecCCCCHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----cCCCCE
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSI 277 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl----~~~~~v 277 (418)
..+|+||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 78999999995 58888886422 1248999999999999999999999999999999999999 677899
Q ss_pred EEeecccceeeccc----CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------
Q 014783 278 KIADFGVARIEVQT----EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAV--------- 343 (418)
Q Consensus 278 kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~--------- 343 (418)
||+|||+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999865432 223456789999999999874 5899999999999999999999999765432
Q ss_pred HHHHHHHhc-CCCCC-----------------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHH
Q 014783 344 QAAFAVVNK-GVRPV-----------------------------------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387 (418)
Q Consensus 344 ~~~~~~~~~-~~~~~-----------------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~el 387 (418)
+.+..++.. +.... .....++.+.+|+.+||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 222222211 10000 001125678899999999999999999999
Q ss_pred HH
Q 014783 388 VR 389 (418)
Q Consensus 388 l~ 389 (418)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.34 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=206.2
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEEE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRF 201 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l 201 (418)
...++..-.++|++.+.||+|+||.||+|++ +++.||||++..............+.+.+|+.++++++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3444555677899999999999999999987 68899999997643221000000124567999999996 5999999
Q ss_pred EeEEeeCceEEEEEeecCC-CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCEEE
Q 014783 202 IGACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKI 279 (418)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~vkl 279 (418)
++++......++|+|++.+ ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 9999999999999999976 8999999764 4589999999999999999999999999999999999999 7899999
Q ss_pred eecccceeecccCCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 280 ADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+|||+++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..... ....
T Consensus 192 ~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--~~~~ 262 (320)
T 3a99_A 192 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFF 262 (320)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCC
T ss_pred eeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--cccc
Confidence 99999986543 33445679999999999977665 688999999999999999999997532 12222 2335
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+..+++.+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5678899999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.72 Aligned_cols=245 Identities=21% Similarity=0.342 Sum_probs=176.2
Q ss_pred ccccccc-CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee---
Q 014783 134 LRKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (418)
Q Consensus 134 ~~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--- 207 (418)
.++|++. +.||+|+||.||+|++ +++.||||++.... ....+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----------KARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 3567774 4699999999999998 58899999996421 111123334667799999999999876
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecc
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfG 283 (418)
...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998766667999999999999999999999999999999999999986 4559999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh--cCCCCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA----VVN--KGVRPV 357 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~----~~~--~~~~~~ 357 (418)
+++.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........... +.. ......
T Consensus 177 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9986543 234456789999999999888899999999999999999999999976554332111 111 112222
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
....+++.+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23467899999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.02 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=203.3
Q ss_pred cccccccCceeeeCceEEEEEEE--CC-ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC------eEEEEeE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIGA 204 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------iv~l~~~ 204 (418)
.++|++.+.||+|+||.||+|++ ++ +.||||+++... ...+.+.+|+.+++.++|++ ++.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 46889999999999999999987 34 689999996421 12356778999999987665 9999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE-------------
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI------------- 271 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl------------- 271 (418)
+.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 6788888877655679999999999999999999999999999999999999
Q ss_pred ------cCCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014783 272 ------SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA 345 (418)
Q Consensus 272 ------~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~ 345 (418)
+.++.+||+|||+++... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567899999999998643 234556799999999999999999999999999999999999999998776654
Q ss_pred HHHHHhcCCC-C-----------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCC
Q 014783 346 AFAVVNKGVR-P-----------------------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPP 383 (418)
Q Consensus 346 ~~~~~~~~~~-~-----------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt 383 (418)
...+...... + ......+..+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 4332211000 0 001122457899999999999999999
Q ss_pred HHHHHH
Q 014783 384 FTEIVR 389 (418)
Q Consensus 384 ~~ell~ 389 (418)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=346.43 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=203.2
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CC-----CeEEEEeEE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HL-----NIVRFIGAC 205 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----niv~l~~~~ 205 (418)
.++|++.+.||+|+||.||+|++ +++.||||+++... .....+.+|+.+++.++ |+ +|+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 46889999999999999999987 57899999996421 12356778888888885 44 499999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEc--CCCCEEEee
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLIS--ADKSIKIAD 281 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~NILl~--~~~~vkl~D 281 (418)
.....+|+||||+. ++|.+++.......+++..+..++.||+.||.||| +.|||||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999995 59999998766567999999999999999999999 57999999999999995 477899999
Q ss_pred cccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV---- 357 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---- 357 (418)
||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....++.....+.
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999986532 34556899999999999999999999999999999999999999999887766555443110000
Q ss_pred ------------C------------------CC----------------------------CChHHHHHHHHHhcccCCC
Q 014783 358 ------------I------------------PN----------------------------DCLPVLSEIMTRCWDTNPE 379 (418)
Q Consensus 358 ------------~------------------~~----------------------------~~~~~l~~li~~cl~~dp~ 379 (418)
+ ++ ...+.+.+|+.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0 00 0014789999999999999
Q ss_pred CCCCHHHHHH
Q 014783 380 VRPPFTEIVR 389 (418)
Q Consensus 380 ~RPt~~ell~ 389 (418)
+|||++|+++
T Consensus 363 ~Rpta~e~L~ 372 (382)
T 2vx3_A 363 TRIQPYYALQ 372 (382)
T ss_dssp TSCCHHHHTT
T ss_pred hCCCHHHHhc
Confidence 9999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=349.40 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=201.1
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-----------CCC
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLN 197 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpn 197 (418)
.+...+|++.+.||+|+||.||+|++ +++.||||++.... ...+.+.+|+.+++++. |||
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 34567899999999999999999997 68899999986421 12256778999998886 899
Q ss_pred eEEEEeEEeeCc----eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEc
Q 014783 198 IVRFIGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLIS 272 (418)
Q Consensus 198 iv~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~ 272 (418)
|+++++++.... .+++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999999987654 789999999 89999999876666799999999999999999999998 999999999999995
Q ss_pred ------CCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH----
Q 014783 273 ------ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---- 342 (418)
Q Consensus 273 ------~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---- 342 (418)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 344799999999986543 24456799999999999999999999999999999999999999976542
Q ss_pred --HHHHHHHHhc-CC---------------------------------------CCCCCCCChHHHHHHHHHhcccCCCC
Q 014783 343 --VQAAFAVVNK-GV---------------------------------------RPVIPNDCLPVLSEIMTRCWDTNPEV 380 (418)
Q Consensus 343 --~~~~~~~~~~-~~---------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~ 380 (418)
.+....++.. +. ....+..+++.+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1222221110 00 01123345678899999999999999
Q ss_pred CCCHHHHHH
Q 014783 381 RPPFTEIVR 389 (418)
Q Consensus 381 RPt~~ell~ 389 (418)
|||++|+++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.67 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=198.3
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC----CCCCeEEEEe
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNIVRFIG 203 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l----~hpniv~l~~ 203 (418)
.+.-.++|++.+.||+|+||.||+|++ +++.||||++................+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 334457899999999999999999987 6789999999765433221111123456799999998 8999999999
Q ss_pred EEeeCceEEEEEee-cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-CCCCEEEee
Q 014783 204 ACRKRMVWCIVTEY-AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIAD 281 (418)
Q Consensus 204 ~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~vkl~D 281 (418)
++......++|+|+ +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 99988899999999 7899999999864 3589999999999999999999999999999999999999 889999999
Q ss_pred cccceeecccCCCCCCCCCccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 282 FGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYT-QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 282 fGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
||++..... .......||..|+|||++.+..+. .++||||||+++|+|++|+.||.... ..... ....+.
T Consensus 184 fg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--~~~~~~ 254 (312)
T 2iwi_A 184 FGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--ELHFPA 254 (312)
T ss_dssp CSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--CCCCCT
T ss_pred cchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--ccCCcc
Confidence 999986544 334556799999999999776664 58999999999999999999997532 12222 234566
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++.+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 78899999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.91 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=193.2
Q ss_pred cccccccccccccCceeeeCceEE-EEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKL-YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~V-y~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~ 205 (418)
+.+.+...+|.+.+.||+|+||.| |++..+++.||||++..... ..+.+|+.+|+.+ +||||+++++++
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---------~~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---------SFADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---------EECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---------HHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 346667778899999999999984 55666899999999865322 1245899999999 799999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---C--CCEEEe
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKIA 280 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~--~~vkl~ 280 (418)
.+...+||||||+. |+|.+++.... ...+...++.++.||+.||+|||++||+||||||+|||++. + ..+||+
T Consensus 88 ~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 88 KDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred ecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 99999999999995 69999997643 23444556789999999999999999999999999999953 2 358899
Q ss_pred ecccceeeccc----CCCCCCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014783 281 DFGVARIEVQT----EGMTPETGTYRWMAPEMIQ---HRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNK 352 (418)
Q Consensus 281 DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~ 352 (418)
|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ....
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~ 244 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGA 244 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTC
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-Hhcc
Confidence 99999865432 1234457999999999997 4567889999999999999999 999997655444322 1211
Q ss_pred C-CCCCCC-CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 G-VRPVIP-NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~-~~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. .....+ ...+..+.+|+.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 111111 223556889999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=343.88 Aligned_cols=240 Identities=22% Similarity=0.377 Sum_probs=185.2
Q ss_pred cccCceeeeCceEEEEE-EECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEEE
Q 014783 138 NMGTAFAQGAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVT 215 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv~ 215 (418)
...+.||+|+||+||.+ ..+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+...+|+||
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 44578999999999754 4589999999986421 13567899999876 8999999999999999999999
Q ss_pred eecCCCCHHHHHhhhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-------------CCE
Q 014783 216 EYAKGGSVRQFLTRRQNRA-----VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-------------KSI 277 (418)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-------------~~v 277 (418)
||+. |+|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9995 69999997643211 1223457899999999999999999999999999999754 489
Q ss_pred EEeecccceeecccCC-----CCCCCCCccccccccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 014783 278 KIADFGVARIEVQTEG-----MTPETGTYRWMAPEMIQH-------RPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQ 344 (418)
Q Consensus 278 kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~ 344 (418)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999986543321 234579999999999975 578999999999999999999 999997765443
Q ss_pred HHHHHHhcCCCCCC-----CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 345 AAFAVVNKGVRPVI-----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 345 ~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. .++........ +..+++.+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2 23333222211 1124578999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.24 Aligned_cols=223 Identities=22% Similarity=0.385 Sum_probs=181.2
Q ss_pred cccccc-CceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEEEEeEEee---
Q 014783 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (418)
Q Consensus 135 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~--- 207 (418)
.+|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 445555 7799999999999988 6789999999642 3456788887 56699999999999876
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecc
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfG 283 (418)
...+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678899999999999999998866667999999999999999999999999999999999999998 7889999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCC--
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV--RPVIP-- 359 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~-- 359 (418)
++.... +..++.++|||||||++|||++|+.||................. ....+
T Consensus 166 ~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 166 FAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp TCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred cccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 996432 23478899999999999999999999977654332111111000 11112
Q ss_pred --CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 --NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 --~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++.+.+++.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 457889999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=344.63 Aligned_cols=256 Identities=16% Similarity=0.195 Sum_probs=192.3
Q ss_pred cccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC-CCe--------
Q 014783 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNI-------- 198 (418)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pni-------- 198 (418)
+......|...+.||+|+||.||+|++ +|+.||||++........ ...+.+.+|+.+++.++| +|.
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 444556788889999999999999998 589999999874333221 112568899999999987 211
Q ss_pred -------EE------EEeEEee-----CceEEEEEeecCCCCHHHHHhh-----hcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014783 199 -------VR------FIGACRK-----RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAVKQALDVARGMAYVH 255 (418)
Q Consensus 199 -------v~------l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qi~~gL~yLH 255 (418)
+. ++.++.. ...++++|+++ +++|.+++.. .....+++..++.++.||+.||+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 11 1111111 22467778766 6899999852 22345778888999999999999999
Q ss_pred hCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCCCccccccccc----------cCCCCCCcchHHHHHH
Q 014783 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI----------QHRPYTQKVDVYSFGI 325 (418)
Q Consensus 256 ~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~sDvwSlGv 325 (418)
++|||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999999865433 455677 999999999 5667889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhHHHH
Q 014783 326 VLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM--LENAETEI 398 (418)
Q Consensus 326 ~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~--L~~~~~~~ 398 (418)
++|||++|+.||......+....++. ....+++.+.+|+.+||+.||++|||+.|+++. ++++...+
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 99999999999987654332211111 123567899999999999999999998888653 44444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=323.30 Aligned_cols=230 Identities=13% Similarity=0.155 Sum_probs=188.7
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
..+|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+.++.+++||||+++++++...+..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD---VLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH---HHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 36788899999999999999998 4889999999765443221 235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+||||++|++|.++++.. .....+.+++.||+.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999998542 3556788999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCChHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF---AVVNKGVRP--VIPNDCLPVL 366 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l 366 (418)
|++ .++.++|||||||++|||++|+.||.+.+..+... ..+...... ..+..+++.+
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 233 26889999999999999999999998765422110 001111111 1234678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+++.+||+.||++| |+.|+++.|+++...
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 999999999999999 999999999998654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.83 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=202.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 207 (418)
.+|++.+.||+|+||.||+|.+ +|+.||||++..... .. ..+.+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~----~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PK----NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HH----HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HH----HHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 6788899999999999999987 688999999865422 21 13578899999999999999999998755
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCC---EEEeec
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~---vkl~Df 282 (418)
....|+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 667899999999999999998643 235888999999999999999999999999999999999997765 999999
Q ss_pred ccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------HHH-hc
Q 014783 283 GVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF---------AVV-NK 352 (418)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~---------~~~-~~ 352 (418)
|++.............||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ... ..
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 99987665555566789999999999999999999999999999999999999997653322100 000 00
Q ss_pred C------C--C----CCCCCCChHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhH
Q 014783 353 G------V--R----PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTE-----IVRMLENAE 395 (418)
Q Consensus 353 ~------~--~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-----ll~~L~~~~ 395 (418)
. + . ...+..+++.+.+++.+||..||++|||+.| +.+.++++.
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0 0 0 0122235788999999999999999999988 444554444
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.86 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=198.2
Q ss_pred cccccccccCceeeeCceEEEEEEE---CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~ 208 (418)
+-..+|++.+.||+|+||.||++.+ +++.||||++..... .. ....+.+|+.++++++||||+++++++...
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AE----AQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HH----HHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HH----HHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 3457899999999999999999987 478999999865322 11 235688999999999999999999999876
Q ss_pred ce-----EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 209 MV-----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 209 ~~-----~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
.. .||||||+++++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence 54 7999999999999887753 59999999999999999999999999999999999999975 89999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-CCC
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP-NDC 362 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 362 (418)
+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+... .......+ ...
T Consensus 227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~ 293 (681)
T 2pzi_A 227 AVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKT 293 (681)
T ss_dssp TCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHH
T ss_pred cchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc---------cccccccccccc
Confidence 99865432 456799999999999765 48999999999999999999998865211 01110000 012
Q ss_pred hHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhHHHHh
Q 014783 363 LPVLSEIMTRCWDTNPEVRP-PFTEIVRMLENAETEIM 399 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RP-t~~ell~~L~~~~~~~~ 399 (418)
++.+.+++.+||+.||++|| +++++.+.|..+..++.
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 331 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence 46789999999999999999 57778888887766554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=332.12 Aligned_cols=244 Identities=17% Similarity=0.203 Sum_probs=188.0
Q ss_pred cccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChH--HHHHHHHHHHHHHHHHHhCC---------CCCeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLK---------HLNIVR 200 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~---------hpniv~ 200 (418)
+..++|++.+.||+|+||.||+|+++|+.||||++........ ......+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4567899999999999999999999999999999986542100 00001145778888888885 888888
Q ss_pred EEeEEe------------------------------eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Q 014783 201 FIGACR------------------------------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250 (418)
Q Consensus 201 l~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~g 250 (418)
+.+++. ....+||||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 877643 26789999999999977666643 458999999999999999
Q ss_pred HHHHH-hCCcccCCCCCCcEEEcCCC--------------------CEEEeecccceeecccCCCCCCCCCccccccccc
Q 014783 251 MAYVH-GLGFIHRDLKSDNLLISADK--------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI 309 (418)
Q Consensus 251 L~yLH-~~~iiHrDlkp~NILl~~~~--------------------~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~ 309 (418)
|+||| ++|||||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999999887 8999999999866432 34799999999999
Q ss_pred cCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCHHH-HHHHHHhcC-CCCCC----CCCChHHHHHHHHHhcccCCCCCC
Q 014783 310 QHRPYTQKVDVYSFGIV-LWELITGLLPFQNMTAVQ-AAFAVVNKG-VRPVI----PNDCLPVLSEIMTRCWDTNPEVRP 382 (418)
Q Consensus 310 ~~~~~t~~sDvwSlGv~-l~elltg~~Pf~~~~~~~-~~~~~~~~~-~~~~~----~~~~~~~l~~li~~cl~~dp~~RP 382 (418)
.+.. +.++|||||+++ .+++++|..||....... ....+.... ..... +..+++.+.+|+.+||+.|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 8776 899999998777 677888999985422111 111222111 11111 1246788999999999976
Q ss_pred CHHHHH
Q 014783 383 PFTEIV 388 (418)
Q Consensus 383 t~~ell 388 (418)
|++|++
T Consensus 324 sa~e~l 329 (336)
T 2vuw_A 324 SATDLL 329 (336)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=293.41 Aligned_cols=186 Identities=17% Similarity=0.155 Sum_probs=132.5
Q ss_pred ceeeeCceEEEEEE--ECCceEEEEEeecCCC----ChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEeeCceEEEE
Q 014783 142 AFAQGAFGKLYRGT--YNGEDVAIKILERPEN----NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~--~~~~~vAvK~~~~~~~----~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~lv 214 (418)
..+.|++|.+..++ +.|+.||+|++..... ..++.+...++|.+|+++|+++ .|+||+++++++.++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666553 3789999999976532 3334444557899999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-CC
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~-~~ 293 (418)
|||++|++|.+++... ..++.. +|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 9999999999999764 446654 57899999999999999999999999999999999999999999865432 22
Q ss_pred CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhC
Q 014783 294 MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG 333 (418)
Q Consensus 294 ~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg 333 (418)
....+||+.|+|||++.+. +..++|+||+|++++++.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 3445799999999999765 67789999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-31 Score=270.32 Aligned_cols=187 Identities=19% Similarity=0.205 Sum_probs=148.8
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChH--HHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
.+.||+|+||.||++++.++.+|+|.......... ......+.+.+|+.++++++||||+++..++......||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 56899999999999988999999998765332211 2223346789999999999999999555555566667999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC----
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~---- 293 (418)
+++++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 999999999865 5688999999999999999999999999999998 999999999987644221
Q ss_pred ----CCCCCCCccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014783 294 ----MTPETGTYRWMAPEMIQH--RPYTQKVDVYSFGIVLWELITGLLPFQ 338 (418)
Q Consensus 294 ----~~~~~gt~~y~aPE~~~~--~~~t~~sDvwSlGv~l~elltg~~Pf~ 338 (418)
.....||+.|+|||++.. ..|+..+|+||..+-..+...++.+|.
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124579999999999977 678889999999988888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=217.54 Aligned_cols=159 Identities=16% Similarity=0.146 Sum_probs=120.5
Q ss_pred cccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChH----HH--------HHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE----KA--------QVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 138 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~----~~--------~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
.+++.||+|+||.||+|++ +|+.||||+++....... .. ......+.+|+.+|++++| ++++++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 3558999999999999998 688999999964322110 00 0123578899999999994 555554
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.. ...|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred Eec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 443 45699999999999987 421 22457999999999999999999999999999999 99999999999
Q ss_pred ceeecccCCCCCCCCCccccccccccC----------CCCCCcchHHH
Q 014783 285 ARIEVQTEGMTPETGTYRWMAPEMIQH----------RPYTQKVDVYS 322 (418)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~t~~sDvwS 322 (418)
|+. +..++|||.+.. ..|...+|+|.
T Consensus 239 a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 239 SVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 963 345689998853 33455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.9e-22 Score=184.70 Aligned_cols=140 Identities=15% Similarity=0.152 Sum_probs=106.4
Q ss_pred ccccCceeeeCceEEEEEEE--CCce--EEEEEeecCCCChH------------------HHHHHHHHHHHHHHHHHhCC
Q 014783 137 LNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPE------------------KAQVMEQQFQQEVMMLATLK 194 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~~~------------------~~~~~~~~~~~E~~il~~l~ 194 (418)
|.+.+.||+|+||.||+|.+ +|+. ||||+++....... ........+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999987 8888 99999764321110 01222346889999999998
Q ss_pred CCCe--EEEEeEEeeCceEEEEEeecCC-C----CHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCC
Q 014783 195 HLNI--VRFIGACRKRMVWCIVTEYAKG-G----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKS 266 (418)
Q Consensus 195 hpni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp 266 (418)
|+++ +.+++. ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +.|||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 7753 344432 245899999932 3 77776532 224457789999999999999 99999999999
Q ss_pred CcEEEcCCCCEEEeeccccee
Q 014783 267 DNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 267 ~NILl~~~~~vkl~DfGla~~ 287 (418)
+|||++. .++|+|||+|..
T Consensus 200 ~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS--SEEECCCTTCEE
T ss_pred HHEEEcC--cEEEEECccccc
Confidence 9999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.8e-19 Score=171.14 Aligned_cols=138 Identities=18% Similarity=0.168 Sum_probs=99.6
Q ss_pred ccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCC---------------h-HHHHHHHHHHHHHHHHHHhCCCCCeE
Q 014783 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENN---------------P-EKAQVMEQQFQQEVMMLATLKHLNIV 199 (418)
Q Consensus 137 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---------------~-~~~~~~~~~~~~E~~il~~l~hpniv 199 (418)
|.++..||+|+||.||+|.. +|+.||||+++..... . .......-...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 67889999999999999987 7899999997632110 0 00111112234677788888655443
Q ss_pred --EEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC--
Q 014783 200 --RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-- 275 (418)
Q Consensus 200 --~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-- 275 (418)
..++. .. .+|||||+.|++|.++.. . +....++.||+.+|.|||+.|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~--~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SR--HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ET--TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cC--ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 23322 22 379999999988854421 1 23456789999999999999999999999999999877
Q ss_pred --------CEEEeecccce
Q 014783 276 --------SIKIADFGVAR 286 (418)
Q Consensus 276 --------~vkl~DfGla~ 286 (418)
.+.|+||+-+-
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=4e-13 Score=124.62 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=108.5
Q ss_pred cccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEE
Q 014783 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv 214 (418)
.|++...++.|+++.||+....++.+++|+......... ..+.+|+.+++.+. +..+.++++++...+..|+|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 355566778888899999988888999999864211111 24678999999884 67788899999888889999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (418)
|||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999776311 11234677899999999998
Q ss_pred ---------------------CCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 257 ---------------------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 257 ---------------------~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766678999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=114.20 Aligned_cols=125 Identities=13% Similarity=0.096 Sum_probs=93.0
Q ss_pred eeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEEEEeEEeeCceEEEEEeecCC
Q 014783 144 AQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 144 G~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~~~~~~~~lv~E~~~~ 220 (418)
+.|..+.||+... +|..+++|+...... ..+.+|+.+++.+.+.+ +.++++++...+..++||||++|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 3555699999976 467899999754311 24568888888885444 55688888877778999999999
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG------------------------------------------ 258 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~------------------------------------------ 258 (418)
.+|. ... .. ...++.+++..|..||+..
T Consensus 100 ~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8883 211 11 1245667777777777643
Q ss_pred ----------------cccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 259 ----------------FIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 259 ----------------iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776678999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=118.63 Aligned_cols=139 Identities=13% Similarity=0.252 Sum_probs=104.9
Q ss_pred CceeeeCceEEEEEEECCceEEEEEee--cCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEEEEeEEeeC---ceEEE
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILE--RPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKR---MVWCI 213 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~---~~~~l 213 (418)
+.|+.|.++.||+.+..+..+++|+.. ...... ....+.+|+.+++.+. +..+++++.++.+. +..|+
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~-----~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP-----SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC-----cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 568899999999998877889999865 221111 1145778999999997 45578889888766 34789
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG------------------------------------- 256 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~------------------------------------- 256 (418)
||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999988774311 1236677788889999999999997
Q ss_pred ---------------------CCcccCCCCCCcEEEcCCCC--EEEeecccceee
Q 014783 257 ---------------------LGFIHRDLKSDNLLISADKS--IKIADFGVARIE 288 (418)
Q Consensus 257 ---------------------~~iiHrDlkp~NILl~~~~~--vkl~DfGla~~~ 288 (418)
..++|+|++|.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999998753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.4e-10 Score=108.30 Aligned_cols=182 Identities=20% Similarity=0.224 Sum_probs=117.9
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCC--eEEEEeEEeeCc---eEEEE
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN--IVRFIGACRKRM---VWCIV 214 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn--iv~l~~~~~~~~---~~~lv 214 (418)
+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+.+....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 468999999999864 67899986421 11256789999998883 322 345555543332 34789
Q ss_pred EeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014783 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (418)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-------------------------------------- 256 (418)
||+++|.+|.+.... .++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999888654321 25666677777788888888875
Q ss_pred --------------------CCcccCCCCCCcEEEcC--CCCEEEeecccceeecccCCCCCCCCCcccccccccc----
Q 014783 257 --------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ---- 310 (418)
Q Consensus 257 --------------------~~iiHrDlkp~NILl~~--~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---- 310 (418)
..++|+|++|.||+++. .+.+.|+||+.+.................-..|+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 23799999999999998 4568999999987543211100000000001222111
Q ss_pred C-CCC---------CCcchHHHHHHHHHHHHhCCCCC
Q 014783 311 H-RPY---------TQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 311 ~-~~~---------t~~sDvwSlGv~l~elltg~~Pf 337 (418)
. ... ....+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 000 11268999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=4.6e-07 Score=85.80 Aligned_cols=133 Identities=19% Similarity=0.187 Sum_probs=89.5
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC---CeEEEEeEEe-eCceEEEEEe
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVRFIGACR-KRMVWCIVTE 216 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp---niv~l~~~~~-~~~~~~lv~E 216 (418)
+.++.|....||+. +..+++|+... . .....+.+|+.+|+.+.+. .+.+.+.++. ..+..++|||
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 45788888999987 67889998521 1 1125688999999999752 3556676664 3445689999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG---------------------------------------- 256 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---------------------------------------- 256 (418)
+++|.+|.+..-. .++......++.++...|..||+
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888663211 12333333344444444444442
Q ss_pred --------------------CCcccCCCCCCcEEEcC---CCC-EEEeecccceee
Q 014783 257 --------------------LGFIHRDLKSDNLLISA---DKS-IKIADFGVARIE 288 (418)
Q Consensus 257 --------------------~~iiHrDlkp~NILl~~---~~~-vkl~DfGla~~~ 288 (418)
..++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999997 455 589999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.6e-06 Score=80.07 Aligned_cols=130 Identities=20% Similarity=0.169 Sum_probs=91.0
Q ss_pred eeeeCce-EEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEEEeec
Q 014783 143 FAQGAFG-KLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 143 lG~G~fg-~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+..|..| .||+... .+..+.+|+-... . ...+.+|..+|+.+. +-.+.++++++...+..++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----V----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----H----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----C----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 4556665 6898765 4568999986431 1 245778999988884 333667888888888899999999
Q ss_pred CCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 014783 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL----------------------------------------- 257 (418)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----------------------------------------- 257 (418)
+|.++.+...... .....++.+++..|..||+.
T Consensus 103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9988876553211 11223444455555555531
Q ss_pred -----------------CcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 258 -----------------GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 258 -----------------~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999999887788999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=5.3e-07 Score=87.05 Aligned_cols=77 Identities=9% Similarity=0.088 Sum_probs=51.6
Q ss_pred Cce-eeeCceEEEEEEEC--------CceEEEEEeecCC---CChHHHHHHHHHHHHHHHHHHhCCC---CCeEEEEeEE
Q 014783 141 TAF-AQGAFGKLYRGTYN--------GEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGAC 205 (418)
Q Consensus 141 ~~l-G~G~fg~Vy~~~~~--------~~~vAvK~~~~~~---~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~ 205 (418)
+.| +.|....+|+.... +..+++|+..... .... ..+.+|+.+++.+.. -.+.+++.++
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------YRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------CCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------hHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 457 78888999988764 6789999864322 0000 235577777777742 3466788877
Q ss_pred eeC---ceEEEEEeecCCCCH
Q 014783 206 RKR---MVWCIVTEYAKGGSV 223 (418)
Q Consensus 206 ~~~---~~~~lv~E~~~~gsL 223 (418)
.+. +..++|||+++|.++
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 655 346899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.2e-06 Score=84.04 Aligned_cols=79 Identities=11% Similarity=-0.032 Sum_probs=46.7
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCC-ChHHHHHHHHHHHHHHHHHHhCCC--C-CeEEEEeEEeeCceEEEE
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPEN-NPEKAQVMEQQFQQEVMMLATLKH--L-NIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~~~~~E~~il~~l~h--p-niv~l~~~~~~~~~~~lv 214 (418)
+.||.|.++.||+++. .++.++||....... .........+.+..|..+++.+.. | .+.+++.+. ....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 4689999999999954 567899998653211 000000001345678888877632 3 344566543 3345799
Q ss_pred EeecCCC
Q 014783 215 TEYAKGG 221 (418)
Q Consensus 215 ~E~~~~g 221 (418)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=9.1e-06 Score=77.44 Aligned_cols=30 Identities=20% Similarity=0.385 Sum_probs=27.6
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.98 E-value=0.00012 Score=64.88 Aligned_cols=140 Identities=12% Similarity=0.165 Sum_probs=92.8
Q ss_pred CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCCC
Q 014783 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299 (418)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~g 299 (418)
-+|.+.|..+ +.+++++++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|.+.+ ..+. ..
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 4899999875 5689999999999999999877621 1112344567999999999998764 2111 12
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhccc---
Q 014783 300 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT--- 376 (418)
Q Consensus 300 t~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--- 376 (418)
...+.|||... ...+.+.=|||||+++|..+- .++....+..+++.|..||..|...
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD-------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALD-------------------YGLKENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHT-------------------TTCCTTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh-------------------cCCCcccchhhCHHHHHHHHHHHhcccc
Confidence 23466888764 344678889999999999874 2333444556777788888777644
Q ss_pred ----------------------CCCCCCCHHHHHHHHHh
Q 014783 377 ----------------------NPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 377 ----------------------dp~~RPt~~ell~~L~~ 393 (418)
.+..|+++++|++.-..
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 24577888888765544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=97.89 E-value=6.2e-07 Score=89.85 Aligned_cols=133 Identities=12% Similarity=0.069 Sum_probs=58.8
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceeeccccccc--CCccccccCchHHHHHHh
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQALM 115 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~~~~~~~~--~~~v~~~~~~d~l~~~l~ 115 (418)
+|+|++++| .+.+|.|++|++.. ..++||+|.. ++.|++. ...|. ++.|. |+++..+.
T Consensus 71 ~G~FLvR~S---~~~~g~~~Lsv~~~---------~~v~H~~I~~-~g~~~~~--~~~F~sl~~Lv~-----dGl~~~~~ 130 (463)
T 3cxl_A 71 EGSYLIRES---QRQPGTYTLALRFG---------SQTRNFRLYY-DGKHFVG--EKRFESIHDLVT-----DGLITLYI 130 (463)
T ss_dssp TTEEEEEEC---SSSTTCEEEEEECS---------SSEEEEECEE-SSSEESS--SCCBSCHHHHHH-----HHHHHHHH
T ss_pred CCeEEEecc---CCCCCCEEEEEEEC---------CEEEEEEEec-CCeEEEC--CCccCCHHHHHH-----HHHHhhhc
Confidence 799999998 55678999999962 1468999976 6667653 33332 12222 55555554
Q ss_pred cCCCCCCCCCCCcccccccccccccCceeeeCceEEEEEEECC--ceEEE------EEeecCCCChHHHHHHHHHHHHHH
Q 014783 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAI------KILERPENNPEKAQVMEQQFQQEV 187 (418)
Q Consensus 116 ~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAv------K~~~~~~~~~~~~~~~~~~~~~E~ 187 (418)
.++..... -...++ .+.+.|| ||.||+|.+.+ .+||| |..+......+. ...+.+|.
T Consensus 131 ~~~~~~~~----l~~~i~----~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~----~~~~~rea 195 (463)
T 3cxl_A 131 ETKAAEYI----AKMTIN----PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR----LTSLVRRA 195 (463)
T ss_dssp HHHTHHHH----HHTTSS----CSTTTSS---BCCC---------CCBGGGC----------------------------
T ss_pred cCCCcchh----hccccc----cccccCC---chhhhcccccccCCchhhhhccCccccccccccccc----cccccccc
Confidence 43311000 000111 4566777 99999999854 58888 665432222211 24677899
Q ss_pred HHHHhCCCCCeEEEEeEE
Q 014783 188 MMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 188 ~il~~l~hpniv~l~~~~ 205 (418)
.+++.+.|||+++.+++.
T Consensus 196 ~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 196 TLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp -----------CBCCCEE
T ss_pred cccccccccccCCCcceE
Confidence 999999999999987764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=6e-05 Score=71.37 Aligned_cols=74 Identities=19% Similarity=0.183 Sum_probs=58.7
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC---CCCeEEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+.|+.|....+|+...++..+++|+.... . ...+.+|+..|+.|. ...+++.+.++...+..++||||
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS-----Y----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG-----G----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc-----c----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 56889999999999887889999987532 1 145778888888874 35678888888877888999999
Q ss_pred cCCCCH
Q 014783 218 AKGGSV 223 (418)
Q Consensus 218 ~~~gsL 223 (418)
+++..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00011 Score=72.40 Aligned_cols=78 Identities=13% Similarity=0.124 Sum_probs=46.7
Q ss_pred HhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCCCCCCC--CCccccccccccCCC---CCCcchHHHHHHHHHH
Q 014783 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAPEMIQHRP---YTQKVDVYSFGIVLWE 329 (418)
Q Consensus 255 H~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~t~~sDvwSlGv~l~e 329 (418)
+...++|+|++|.|||++.++ ++|+||+.+............. -...|++|+...... -....++.+....+|+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 456799999999999999877 9999999987543211100000 013456665543211 1122444566777777
Q ss_pred HHhC
Q 014783 330 LITG 333 (418)
Q Consensus 330 lltg 333 (418)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00026 Score=65.89 Aligned_cols=74 Identities=16% Similarity=0.155 Sum_probs=51.1
Q ss_pred ccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC---CCeEEEEeEEeeCceEEEE
Q 014783 139 MGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~~~~~~~~lv 214 (418)
-.+.+|.|..+.||+.+. +|+.|.+|+......... ..|.+|+..|+.|.. -.+++.+++. . -++|
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~------~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv 88 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD------GLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA 88 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT------THHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh------hHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence 346789999999999998 789999998643322211 346789988888742 2344555543 2 2689
Q ss_pred EeecCCCC
Q 014783 215 TEYAKGGS 222 (418)
Q Consensus 215 ~E~~~~gs 222 (418)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99997764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0002 Score=67.62 Aligned_cols=139 Identities=14% Similarity=0.133 Sum_probs=77.6
Q ss_pred CceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEEEEeE------EeeCceEE
Q 014783 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGA------CRKRMVWC 212 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~------~~~~~~~~ 212 (418)
+.|+.|....+|+...++..+++|+....... ..+..|..++..+...+ +.+++.. ....+..+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDPLILTLYEKRVEK--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC---C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeCCccEEEEEeCCCCCH--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 46778888999999876668999998652111 23445666666663212 2333321 12235568
Q ss_pred EEEeecCCCCHH-----------HH---Hhhhc-C---C---CCCHHHHHH---------------HHHHHHHHHHHHHh
Q 014783 213 IVTEYAKGGSVR-----------QF---LTRRQ-N---R---AVPLKLAVK---------------QALDVARGMAYVHG 256 (418)
Q Consensus 213 lv~E~~~~gsL~-----------~~---l~~~~-~---~---~~~~~~~~~---------------i~~qi~~gL~yLH~ 256 (418)
++++|++|..+. +. ++... . . ......... +...+...++.+++
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999886531 11 11110 0 0 011111000 00123445556652
Q ss_pred -------CCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 257 -------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 257 -------~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999999876678999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0004 Score=65.97 Aligned_cols=137 Identities=16% Similarity=0.184 Sum_probs=71.6
Q ss_pred CceeeeCceE-EEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEEEEeEEeeCceEEEEEe
Q 014783 141 TAFAQGAFGK-LYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 141 ~~lG~G~fg~-Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~~~~lv~E 216 (418)
+.|+.|+... +|+.+.. +..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE 92 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence 3565665554 6677663 77788876533210 122345566555532 23456666654444 68999
Q ss_pred ecCCCCHHHHHhhhc------------------------CCCCCHHHHH-------HH-------------HHHHHHHHH
Q 014783 217 YAKGGSVRQFLTRRQ------------------------NRAVPLKLAV-------KQ-------------ALDVARGMA 252 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~------------------------~~~~~~~~~~-------~i-------------~~qi~~gL~ 252 (418)
++.+..+.+.+.... ...+...... .+ ...+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 997766655442110 0011111110 00 011122233
Q ss_pred HH------HhCCcccCCCCCCcEEEcCC----CCEEEeecccceee
Q 014783 253 YV------HGLGFIHRDLKSDNLLISAD----KSIKIADFGVARIE 288 (418)
Q Consensus 253 yL------H~~~iiHrDlkp~NILl~~~----~~vkl~DfGla~~~ 288 (418)
.| +...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 33 23479999999999999875 68999999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00041 Score=64.95 Aligned_cols=71 Identities=11% Similarity=0.125 Sum_probs=42.1
Q ss_pred cCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCceEEEEEeec
Q 014783 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~lv~E~~ 218 (418)
.+.|+.|....+|+. ..+++|+......... ...+|+.+++.+...++ .++++.+.+.+ ++++||+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~-------~r~~E~~~l~~l~~~g~~P~~~~~~~~~~--~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI-------NRANEAVAAREAAKAGVSPEVLHVDPATG--VMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC-------CHHHHHHHHHHHHHTTSSCCEEEECTTTC--CEEEECC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee-------CHHHHHHHHHHHHHcCCCCceEEEECCCC--EEEEeec
Confidence 467889999999998 6789998754311110 11356666665532222 35555443323 6899999
Q ss_pred -CCCCH
Q 014783 219 -KGGSV 223 (418)
Q Consensus 219 -~~gsL 223 (418)
+|.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0017 Score=61.23 Aligned_cols=136 Identities=13% Similarity=0.144 Sum_probs=76.2
Q ss_pred ceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCC--CeEEEEeE-----EeeCceEEE
Q 014783 142 AFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGA-----CRKRMVWCI 213 (418)
Q Consensus 142 ~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~-----~~~~~~~~l 213 (418)
.|+ |....||+... +|+.+++|+........ ..+..|..++..+... .+++++.. ....+..++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~-------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH-------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 456 77889998876 46689999986432222 2455677777666321 23444432 122445678
Q ss_pred EEeecCCCCHH-----------HHH---hhh-cC------CCCCHHHH----------------------HHHHHHHHHH
Q 014783 214 VTEYAKGGSVR-----------QFL---TRR-QN------RAVPLKLA----------------------VKQALDVARG 250 (418)
Q Consensus 214 v~E~~~~gsL~-----------~~l---~~~-~~------~~~~~~~~----------------------~~i~~qi~~g 250 (418)
++++++|..+. ..+ +.. .. ........ ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999875431 111 110 00 01121111 0111122222
Q ss_pred HHHH----HhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 251 MAYV----HGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 251 L~yL----H~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
++-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2221 124589999999999999 4 899999988764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00055 Score=67.71 Aligned_cols=70 Identities=13% Similarity=0.253 Sum_probs=46.1
Q ss_pred CceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCce
Q 014783 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMV 210 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~ 210 (418)
+.|+.|....||+.... +..+++|+.... ... ..+.+|..+++.+...++ +++++.+.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~-------~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE-------SHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH-------HHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcH-------HHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 46788888999999874 468999988432 110 133468888887743333 566666543
Q ss_pred EEEEEeecCCCC
Q 014783 211 WCIVTEYAKGGS 222 (418)
Q Consensus 211 ~~lv~E~~~~gs 222 (418)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 28899997643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00099 Score=64.68 Aligned_cols=141 Identities=14% Similarity=0.246 Sum_probs=80.0
Q ss_pred ccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~ 204 (418)
+.+++ +.|..|....+|+.+.. +..|++|+.-...... ..+.+|..+++.+. +.-..++++.
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~-------~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGV-------DSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCH-------HHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchH-------HHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 44443 45777888899998863 3689999852211111 24458888888774 2223566666
Q ss_pred EeeCceEEEEEeecCCCCHH--------------HHHhhhc------CCCCC--HHHHHHHHHHHH--------------
Q 014783 205 CRKRMVWCIVTEYAKGGSVR--------------QFLTRRQ------NRAVP--LKLAVKQALDVA-------------- 248 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~--------------~~l~~~~------~~~~~--~~~~~~i~~qi~-------------- 248 (418)
+.+ .+|+||++|.+|. +.+.+-. .+... +..+.++..++.
T Consensus 123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 654 2899999875542 1111111 11111 233444443331
Q ss_pred -----HHHHHHH----h----CCcccCCCCCCcEEEcCC----CCEEEeeccccee
Q 014783 249 -----RGMAYVH----G----LGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (418)
Q Consensus 249 -----~gL~yLH----~----~~iiHrDlkp~NILl~~~----~~vkl~DfGla~~ 287 (418)
..+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2233333 2 258999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.006 Score=60.71 Aligned_cols=72 Identities=13% Similarity=0.083 Sum_probs=46.4
Q ss_pred CceeeeCceEEEEEEECC--ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCceEEEEEee
Q 014783 141 TAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~lv~E~ 217 (418)
+.|+.|-...+|+....+ ..+++|+......... ...+|..++..|...++ .++++.+. + .+|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence 467888889999999865 7899998743221110 11378888888865444 46777663 2 259999
Q ss_pred cCCCCH
Q 014783 218 AKGGSV 223 (418)
Q Consensus 218 ~~~gsL 223 (418)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00065 Score=65.55 Aligned_cols=71 Identities=11% Similarity=0.166 Sum_probs=40.9
Q ss_pred CceeeeCceEEEEEEECC----------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEEEEeEEeeCc
Q 014783 141 TAFAQGAFGKLYRGTYNG----------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM 209 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~ 209 (418)
+.|+.|..-.+|+....+ ..+++|+........ .....|..+++.+...+ ..++++.. .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--NG 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence 457788888999998754 688899864321100 01246777777664323 34566544 22
Q ss_pred eEEEEEeecCCCC
Q 014783 210 VWCIVTEYAKGGS 222 (418)
Q Consensus 210 ~~~lv~E~~~~gs 222 (418)
++||||++|.+
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 58999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.012 Score=56.04 Aligned_cols=32 Identities=25% Similarity=0.466 Sum_probs=28.2
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998889999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.014 Score=57.45 Aligned_cols=29 Identities=34% Similarity=0.665 Sum_probs=26.1
Q ss_pred CcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 258 ~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
.++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7788999999998864
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.00059 Score=54.67 Aligned_cols=71 Identities=8% Similarity=0.121 Sum_probs=48.1
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceeeccc-cccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQ-SVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~~~~-~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
.|+|++++|. +.+ +||+||++... ...++||+|+...++|+|+... ..|. +++|.| ..+.++++..
T Consensus 37 ~GaFLVR~Se---~~~-~ySLSVR~~~~------~~~VKHYkI~~~~G~y~I~~~~~~~F~SL~eLV~yY~~~adGl~~~ 106 (125)
T 3maz_A 37 LGNMILRPGS---DSR-NYSITIRQEID------IPRIKHYKVMSVGQNYTIELEKPVTLPNLFSVIDYFVKETRGNLRP 106 (125)
T ss_dssp GCSEEEEECT---TSS-SEEEEEEECSS------SCEEEEEEEEEETTEEEECSSSCEEESSHHHHHHHHHHHTTTCCCB
T ss_pred CCcEEEEeCC---CCC-CEEEEEEecCC------CCCEeeeEEEEeCCEEEEecCCCcCcCCHHHHHHHHHhCCCcCccc
Confidence 7999999983 233 89999997422 2368999998877889987433 3343 345554 4567777777
Q ss_pred HhcCC
Q 014783 114 LMDHR 118 (418)
Q Consensus 114 l~~~~ 118 (418)
|..+|
T Consensus 107 L~~~c 111 (125)
T 3maz_A 107 FIAST 111 (125)
T ss_dssp CCC--
T ss_pred ccccc
Confidence 76666
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=93.81 E-value=0.0076 Score=46.98 Aligned_cols=54 Identities=17% Similarity=0.259 Sum_probs=36.9
Q ss_pred hHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 30 QGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 30 ~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
+......| +|+|++++| ++.+|.|+||+....... ...++|+.|.... +.|++.
T Consensus 18 e~lL~~~g~~~G~FLVR~S---~~~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~g~~~l~ 74 (106)
T 1aot_F 18 ERQLLSFGNPRGTFLIRES---ETTKGAYSLSIRDWDDMK----GDHVKHYKIRKLDNGGYYIT 74 (106)
T ss_dssp HHHHHTTTCCTTEECCBCB---SSSSSBBCCEEECCBTTT----BCCEEECCBEEETTTEEEEE
T ss_pred HHHHhhCCCCCcEEEEEeC---CCCCCCEEEEEEecccCC----CCcEEEEEEEEeCCCCEEEC
Confidence 33444444 799999998 555789999998543211 1257999998754 667775
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=92.52 E-value=0.016 Score=45.75 Aligned_cols=45 Identities=20% Similarity=0.389 Sum_probs=33.7
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC-CCCceee
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVS 90 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~-~~~~~i~ 90 (418)
+|+|++++| ++.+|.|+||+...... ...++|+.|... .+.|++.
T Consensus 35 ~G~FLVR~S---~~~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~~g~~~l~ 80 (114)
T 1blj_A 35 AGSFLIRES---ESNKGAFSLSVKDITTQ-----GEVVKHYKIRSLDNGGYYIS 80 (114)
T ss_dssp TTCEEBCBC---TTCSSCEEEEECBCCTT-----TCBCCCEEEEEETTTEEEEE
T ss_pred CceEEEEeC---CCCCCCEEEEEEEecCC-----CCcEEEEEEEEcCCCCEEEC
Confidence 799999998 55678999999964321 125789999875 4667775
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=92.18 E-value=0.011 Score=50.54 Aligned_cols=80 Identities=20% Similarity=0.264 Sum_probs=48.4
Q ss_pred HHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-c
Q 014783 31 GFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-A 104 (418)
Q Consensus 31 ~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~ 104 (418)
......| +|+|++++| .+..|.|+||++...... ...++||+|.... +.|++. +...|. +++|.+ .
T Consensus 88 ~lL~~~~~~~G~FLVR~S---~~~~g~y~LSv~~~~~~~----~~~v~H~~I~~~~~g~~~~~-~~~~F~sl~~LV~~y~ 159 (175)
T 4d8k_A 88 RQLLAPGNTHGSFLIRES---ESTAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNGGFYIS-PRITFPGLHELVRHYT 159 (175)
T ss_dssp HHHHSTTCCTTCEEEEEC---SSSTTCEEEEEEEECTTS----CEEEEEEEEEECSSSCEESS-TTSEESSHHHHHHHHH
T ss_pred HHHhcCCCCCCEEEEEEC---CCCCCeEEEEEEeCcccC----CCceEEEEEEECCCCCEEEC-CCCccCCHHHHHHHHh
Confidence 3444344 899999998 566789999998643211 1257999997654 667765 333443 233433 3
Q ss_pred cCchHHHHHHhcCC
Q 014783 105 LNDDALAQALMDHR 118 (418)
Q Consensus 105 ~~~d~l~~~l~~~~ 118 (418)
.+.++++..|..||
T Consensus 160 ~~~~gl~~~L~~Pc 173 (175)
T 4d8k_A 160 NASDGLCTRLSRPC 173 (175)
T ss_dssp HCCTTSSSCCCSBC
T ss_pred hCCCCCcccCCCcC
Confidence 34555555555544
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=92.08 E-value=0.0077 Score=46.83 Aligned_cols=46 Identities=20% Similarity=0.356 Sum_probs=33.4
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
+|+|+++.| ++.+|.|++|+....... ...++||.|.... +.|++.
T Consensus 27 ~G~FLVR~S---~~~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~g~~~l~ 73 (105)
T 1lkk_A 27 HGSFLIRES---ESTAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNGGFYIS 73 (105)
T ss_dssp TTCEEEEEC---SSSTTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS
T ss_pred CceEEEEEC---CCCCCcEEEEEEEcccCC----CCcEEEEEEEECCCCCEEEC
Confidence 799999998 555789999999643211 2367999998754 667765
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.67 E-value=0.27 Score=38.83 Aligned_cols=54 Identities=20% Similarity=0.291 Sum_probs=38.2
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
++......| +|+|++++| ++.+|.|+|||+....+ ...++||+|....+.|++.
T Consensus 33 Ae~lL~~~~~~G~FLVR~S---~~~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~g~~~i~ 87 (118)
T 2el8_A 33 AQLLLERYPECGNLLLRPS---GDGADGVSVTTRQMHNG-----THVVRHYKVKREGPKYVID 87 (118)
T ss_dssp HHHHHHHSSTTCSBEEEEC---CSSSSSEEEEECCCBTT-----BCCCEEECBCCBTTBCCBS
T ss_pred HHHHHhhCCCCcEEEEeeC---CCCCCceEEEEEEecCC-----CCcEEEEEEEEcCCEEEEe
Confidence 444454444 899999998 55678999999964321 1257999998755778775
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=91.29 E-value=0.012 Score=45.07 Aligned_cols=42 Identities=12% Similarity=0.132 Sum_probs=33.2
Q ss_pred cCCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 37 ~~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
.+|+|++++| .+.+|.|++|+... ..++|+.|....+.|++.
T Consensus 25 ~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~~~~~~ 66 (98)
T 3us4_A 25 EDGLFLVRES---ARHPGDYVLCVSFG---------RDVIHYRVLHRDGHLTID 66 (98)
T ss_dssp CTTCEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEEETTEEESS
T ss_pred CCcEEEEEeC---CCCCCcEEEEEEEC---------CceEEEEEEEeCCEEEEC
Confidence 3799999998 55678999999962 257899998766777765
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=91.06 E-value=0.012 Score=45.84 Aligned_cols=41 Identities=17% Similarity=0.214 Sum_probs=32.3
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
+|+|++++| .+.+|.|++|+... ..++|+.|....+.|++.
T Consensus 29 ~G~FLVR~S---~~~~g~~~LSv~~~---------~~v~H~~I~~~~g~~~l~ 69 (106)
T 3eaz_A 29 TGLFLVRES---TNYPGDYTLCVSSD---------GKVEHYRIMYHASKLSID 69 (106)
T ss_dssp TTEEEEEEC---TTSTTCEEEEEEET---------TEEEEEECEEETTEEESS
T ss_pred CCEEEEEEC---CCCCCcEEEEEEeC---------CceEEEEEEecCCEEEEC
Confidence 799999988 55678999999862 257899998666777765
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=90.69 E-value=0.025 Score=51.26 Aligned_cols=46 Identities=15% Similarity=0.257 Sum_probs=33.3
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCC----Cceeecccccc
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRH----NYSVSVGQSVF 96 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~----~~~i~~~~~~~ 96 (418)
+|+|++++| .+.+|.|+||+... ..++||+|..... .|++. ....|
T Consensus 36 dG~FLVR~S---~s~~G~y~LSv~~~---------~~v~H~~I~~~~~~g~~~~~~~-~~~~F 85 (246)
T 4fbn_A 36 DGSFLVRES---ETFVGDYTLSFWRN---------GKVQHCRIHSRQDAGTPKFFLT-DNLVF 85 (246)
T ss_dssp TTCEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEEECGGGCCEEEEE-TTEEE
T ss_pred CCEEEEEcC---CCCCCCEEEEEEEC---------CEEEEEEEEEECCCCceeEEec-CCccc
Confidence 899999998 67789999999862 2578999965542 25554 33344
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=90.05 E-value=0.059 Score=42.64 Aligned_cols=84 Identities=24% Similarity=0.265 Sum_probs=48.1
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcc--cC-CCCceeeccccccc--CCccc
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLK--PV-RHNYSVSVGQSVFR--PGKVT 102 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~--~~-~~~~~i~~~~~~~~--~~~v~ 102 (418)
++......+ +|+|++++| . .+|.|+||+........ ...++||.|. .. .+.|++. +...|. +++|.
T Consensus 21 Ae~lL~~~~~~G~FLVR~S-~---~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~~~g~~~~~-~~~~F~sl~~LV~ 92 (118)
T 3s9k_A 21 AEKLLLDTGKEGAFMVRDS-R---TPGTYTVSVFTKAIISE---NPCIKHYHIKETNDSPKRYYVA-EKYVFDSIPLLIQ 92 (118)
T ss_dssp HHHHHHHHCCTTCEEEEEC-S---STTCEEEEEEECCSCSS---SCEEEEEEEEECSCSSCCEEEE-CSCCCSCHHHHHH
T ss_pred HHHHHHhcCCCCeEEEEee-C---CCCCEEEEEEecccccC---CCceEEEEEeEEECCCCCEEEC-CCcccCCHHHHHH
Confidence 334454444 899999998 2 35899999997532211 2367999993 33 3667775 333343 23343
Q ss_pred c-ccCchHHHHHHhcCCCC
Q 014783 103 H-ALNDDALAQALMDHRYP 120 (418)
Q Consensus 103 ~-~~~~d~l~~~l~~~~~~ 120 (418)
+ ..+.+++...|..|+.+
T Consensus 93 ~y~~~~~~l~~~L~~Pv~~ 111 (118)
T 3s9k_A 93 YHQYNGGGLVTRLRYPVCG 111 (118)
T ss_dssp HHHHCCTTSSSCCCCCCCC
T ss_pred HheeCCCCCccCCCCcCCC
Confidence 3 33344454445544443
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=89.82 E-value=0.047 Score=44.27 Aligned_cols=50 Identities=10% Similarity=0.153 Sum_probs=34.8
Q ss_pred cCCCccccccccccCCCCceeEeeccCCCCC----CCC--cccccccCCcccCCCCcee
Q 014783 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGS----NDS--LTHILSHPGLKPVRHNYSV 89 (418)
Q Consensus 37 ~~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~----~~~--~~~~~~h~~i~~~~~~~~i 89 (418)
.+|+|++++| ++.+|.|+|||....... ..+ ....++||.|.....+|++
T Consensus 40 ~~G~FLVR~S---~s~~g~y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~~~~g~~l 95 (131)
T 2kno_A 40 DPGAFLIRDS---HSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKGVKI 95 (131)
T ss_dssp CTTBEEEEEC---SSSTTEEEEEEECSCCSSSSSSCCSCHHHHHEEEEEEECCSSCCCE
T ss_pred CCCeEEEecC---CCCCCCEEEEEEeCCCCcccccccccccCCceEEEEEEECCCCCEE
Confidence 4899999998 556789999999743110 000 0136799999877766887
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=89.18 E-value=0.051 Score=43.38 Aligned_cols=68 Identities=19% Similarity=0.272 Sum_probs=43.0
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC-CCCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~-~~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
+|+|++++| .+..|.|+||+... ..++||.|... .+.|++. +...|. +++|.+ ..+.+++...
T Consensus 39 ~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~-~~~~F~sl~eLV~~y~~~~~~l~~~ 105 (121)
T 2dly_A 39 TGAFLIRES---ESQKGDFSLSVLDE---------GVVKHYRIRRLDEGGFFLT-RRKVFSTLNEFVNYYTTTSDGLCVK 105 (121)
T ss_dssp TTCEEEEEC---SSSSSCEEEEEESS---------SCEEEEEEEECSSSCEEEE-TTEEESSHHHHHHHHTTCCSSSSSC
T ss_pred CCEEEEEcC---CCCCCceEEEEEEC---------CeEEEEEEEEcCCCCEEEC-CCCccCCHHHHHHHHhhCCCCCcee
Confidence 699999998 45578899999962 25789999774 4678875 334443 244443 2333444444
Q ss_pred HhcCC
Q 014783 114 LMDHR 118 (418)
Q Consensus 114 l~~~~ 118 (418)
|..++
T Consensus 106 L~~P~ 110 (121)
T 2dly_A 106 LEKPC 110 (121)
T ss_dssp CCSBC
T ss_pred CCeec
Confidence 44444
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=88.02 E-value=0.05 Score=43.04 Aligned_cols=52 Identities=15% Similarity=0.151 Sum_probs=36.1
Q ss_pred cchHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC--CCCceeec
Q 014783 28 FTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV--RHNYSVSV 91 (418)
Q Consensus 28 ~~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~--~~~~~i~~ 91 (418)
.++......| +|+|++++| ++.+|.|+||+... ..++|+.|... .+.+++..
T Consensus 25 ~Ae~lL~~~g~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~~g~~~~~~ 80 (117)
T 3pqz_A 25 ESQRLIGQQGLVDGLFLVRES---QRNPQGFVLSLCHL---------QKVKHYLILPSEEEGRLYFSM 80 (117)
T ss_dssp HHHHHHHHTTCCTTEEEEEEC---CC-CCCEEEEEEET---------TEEEEEEEEEECCTTCCEEES
T ss_pred HHHHHHhcCCCCCCEEEEEec---CCCCCcEEEEEEeC---------CeeEEEEEEEecCCCCEEEEE
Confidence 3445555545 899999998 55678999999962 25789999764 35555543
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.74 E-value=0.072 Score=42.32 Aligned_cols=48 Identities=17% Similarity=0.188 Sum_probs=34.2
Q ss_pred HHHHHhcCCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 31 GFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 31 ~~~~~~~~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
.......+|+|++++| .+..|.|+||+... ..++||.|.... +.|++.
T Consensus 30 ~lL~~~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 78 (119)
T 2ecd_A 30 YLLSSLINGSFLVRES---ESSPGQLSISLRYE---------GRVYHYRINTTADGKVYVT 78 (119)
T ss_dssp HHHHTSCTTBEEEEEE---SSSTTEEEEEEECS---------SCEEEECCCCCSSSCCCCC
T ss_pred HHhcCCCCCeEEEEeC---CCCCCCEEEEEEEC---------CeEEEEEEEEcCCCCEEEc
Confidence 3343223899999998 55678999999962 257899997654 556664
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.71 E-value=0.17 Score=40.62 Aligned_cols=41 Identities=7% Similarity=0.041 Sum_probs=31.9
Q ss_pred CCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 39 GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 39 ~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
|+|++++|. .+|.|+|||+... ...++||+|....+.|++.
T Consensus 45 G~FLVR~S~----~~g~y~LSv~~~~-------~~~vkH~rI~~~~~~~~i~ 85 (126)
T 2cr4_A 45 GLYCIRNSS----TKSGKVLVVWDET-------SNKVRNYRIFEKDSKFYLE 85 (126)
T ss_dssp TCEEEEECS----STTCEEEEEEETT-------TTEECCEECEEETTEEESS
T ss_pred CeEEEEecC----CCCCEEEEEEeCC-------CCCEEEEEEEECCCeEEEc
Confidence 999999993 5789999999731 1267999998776777764
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.50 E-value=0.065 Score=42.99 Aligned_cols=55 Identities=22% Similarity=0.317 Sum_probs=37.1
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
++......| +|+|++++| . .+|.|+|||.....+.. ...++||.|.... +.|++.
T Consensus 23 Ae~lL~~~g~~G~FLVR~S-s---~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g~~~l~ 79 (125)
T 2ge9_A 23 AEQLLKQEGKEGGFIVRDS-S---KAGKYTVSVFAKSTGDP---QGVIRHYVVCSTPQSQYYLA 79 (125)
T ss_dssp HHHHHHHHTCTTEEEEEEC-S---SSCCEEEEEEESSSSST---TCEEEEEECEEETTTEEESS
T ss_pred HHHHHhhcCCCceEEEEec-C---CCCCEEEEEEeccccCC---CCeEEEEEEEEcCCCCEEEC
Confidence 444555454 899999998 2 26899999996542211 1267999997764 557765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.36 E-value=0.98 Score=39.62 Aligned_cols=115 Identities=10% Similarity=0.041 Sum_probs=74.9
Q ss_pred CCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC
Q 014783 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (418)
Q Consensus 194 ~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~ 273 (418)
.||+++.. .+-.+.+.+.+.++.-..+-=+..++ ..+....++++.+|+....+++. -+|--|+|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 68888866 45555666656555443222222232 36778888999988887754443 367778999999999
Q ss_pred CCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014783 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPF 337 (418)
Q Consensus 274 ~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf 337 (418)
++.+++.--|+.... +|. .++...=+-.+=+++..+++++..|
T Consensus 115 ~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 115 DGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp TSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999987765322 221 1222233445677888899998877
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=86.56 E-value=0.057 Score=42.36 Aligned_cols=69 Identities=22% Similarity=0.219 Sum_probs=43.8
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
+|+|++++| .+..|.|++|+... ..++|+.|.... +.|++. +...|. ++.|.+ ..+.++++..
T Consensus 26 ~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~~~-~~~~F~sl~~LV~~y~~~~~~l~~~ 92 (112)
T 3k2m_A 26 NGSFLVRES---ESSPGQRSISLRYE---------GRVYHYRINTASDGKLYVS-SESRFNTLAELVHHHSTVADGLITT 92 (112)
T ss_dssp TTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECTTSCEESS-TTCCBSSHHHHHHHHHHCCTTSSSC
T ss_pred CceEEEEeC---CCCCCCEEEEEEeC---------CcEEEEEEEECCCCcEEEC-CCCeECCHHHHHHHHhhCCCCCccC
Confidence 899999988 55678999999962 257899997654 556654 333343 233433 3345555555
Q ss_pred HhcCCC
Q 014783 114 LMDHRY 119 (418)
Q Consensus 114 l~~~~~ 119 (418)
|..|+.
T Consensus 93 L~~P~~ 98 (112)
T 3k2m_A 93 LHYPAP 98 (112)
T ss_dssp CCEECC
T ss_pred CCCCCC
Confidence 555543
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=85.60 E-value=0.34 Score=36.68 Aligned_cols=50 Identities=20% Similarity=0.202 Sum_probs=36.3
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
++......+ +|+|+++.| .+.+|.|++|+... ..++|+.|.... +.|++.
T Consensus 15 Ae~lL~~~~~~G~FLVR~S---~~~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 66 (96)
T 1jyr_A 15 AEEMLSKQRHDGAFLIRES---ESAPGDFSLSVKFG---------NDVQHFKVLRDGAGKYFLW 66 (96)
T ss_dssp HHHHHHTCCSTTBEEEEEC---SSSTTCEEEEEEET---------TEEEEEECEECTTSCEESS
T ss_pred HHHHHhcCCCCcEEEEEec---CCCCCCEEEEEEeC---------CeEEEEEEEEcCCCCEEEC
Confidence 344555555 899999998 45578899999962 257899997654 567764
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=85.43 E-value=0.055 Score=41.91 Aligned_cols=43 Identities=12% Similarity=0.227 Sum_probs=32.2
Q ss_pred chHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC
Q 014783 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV 83 (418)
Q Consensus 29 ~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~ 83 (418)
++......| +|+|++++| ++.+|.|++|+... ..++|+.|...
T Consensus 17 Ae~lL~~~g~~~G~FLVR~S---~~~~g~~~LSv~~~---------~~v~H~~I~~~ 61 (105)
T 1nrv_A 17 SHRIIKQQGLVDGLFLLRDS---QSNPKAFVLTLCHH---------QKIKNFQILPC 61 (105)
T ss_dssp HHHHHHHTTCCTTEEEEEEC---SSCTTCEEEEEEET---------TEEEEEEEEEC
T ss_pred HHHHHHhcCCCCceEEEEeC---CCCCCCEEEEEEeC---------CEEEEEEEEEE
Confidence 444555554 899999998 55578999999862 25789999764
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=85.35 E-value=0.48 Score=36.33 Aligned_cols=50 Identities=14% Similarity=0.181 Sum_probs=35.6
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
++......| +|+|++++| ++.+|.|++|+... ..++|+.|.... +.|++.
T Consensus 16 Ae~lL~~~~~~G~FLVR~S---~~~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 67 (104)
T 1d4t_A 16 GEKLLLATGLDGSYLLRDS---ESVPGVYCLCVLYH---------GYIYTYRVSQTETGSWSAE 67 (104)
T ss_dssp HHHHHHHHCCTTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECTTSCEEEC
T ss_pred HHHHHHhcCCCCEEEEeeC---CCCCCCEEEEEEEC---------CeEEEEEEEECCCCeEEEe
Confidence 344454444 899999998 55678999999962 257899997644 556665
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=85.21 E-value=0.63 Score=37.27 Aligned_cols=50 Identities=14% Similarity=0.181 Sum_probs=35.9
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
++......| +|+|++++| ++..|.|++|+... ..++||+|.... +.|++.
T Consensus 16 Ae~lL~~~~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 67 (128)
T 1ka6_A 16 GEKLLLATGLDGSYLLRDS---ESVPGVYCLCVLYH---------GYIYTYRVSQTETGSWSAE 67 (128)
T ss_dssp HHHHHHHHCCTTCEEEEEC---SSSTTCEEEEEESS---------SCEEEEEEEECTTSCEEEE
T ss_pred HHHHHhcCCCCCEEEEeec---CCCCCCEEEEEEeC---------CEEEEEEEEECCCCeEEEe
Confidence 344454444 899999998 55578999999962 257899998654 567765
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=84.56 E-value=0.48 Score=36.66 Aligned_cols=50 Identities=16% Similarity=0.324 Sum_probs=34.8
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
++......| +|+|++++| ++.+|.|++|+... ..++|+.|....+.|.+.
T Consensus 19 Ae~lL~~~~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~~~~~~ 69 (109)
T 3tkz_A 19 AENLLLTRGVDGSFLARPS---KSNPGDFTLSVRRN---------GAVTHIKIQNTGDYYDLY 69 (109)
T ss_dssp HHHHHHHHCCTTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECSSCEESS
T ss_pred HHHHHhcCCCCCEEEEEec---CCCCCCEEEEEEEC---------CEEEEEEEEeCCCEEEec
Confidence 344454444 899999998 55578999999962 257899997654445443
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.27 E-value=0.071 Score=42.88 Aligned_cols=50 Identities=18% Similarity=0.260 Sum_probs=35.5
Q ss_pred chHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC--CCCceee
Q 014783 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV--RHNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~--~~~~~i~ 90 (418)
++......| +|+|++++| ++.+|.|+||+... ..++||+|... .+.|++.
T Consensus 38 Ae~lL~~~g~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~~G~~~~~ 91 (126)
T 2aug_A 38 AQRLIIQQGLVDGVFLVRDS---QSNPKTFVLSMSHG---------QKIKHFQIIPVEDDGEMFHT 91 (126)
T ss_dssp HHHHHHTTTCCTTEEEEEEC---SSSSCCEEEEEEET---------TEEEEEEEEEEEETTEEEEE
T ss_pred HHHHHhccCCCCCEEEEeec---CCCCCCEEEEEEcC---------CeEEEEEEEEECCCCeEEEE
Confidence 344555545 799999998 45578999999962 25789999764 3556554
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.24 E-value=2.5 Score=37.18 Aligned_cols=159 Identities=11% Similarity=0.104 Sum_probs=93.0
Q ss_pred CCCCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCcEEEc
Q 014783 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA-YVHGLGFIHRDLKSDNLLIS 272 (418)
Q Consensus 194 ~hpniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~-yLH~~~iiHrDlkp~NILl~ 272 (418)
.||++ --.+-.+++.+.+.++.-+++.-+..++. .+....++++.+|+.... ++ ..-+|--|+|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 68888 33334666666666665534433334432 677888888888776555 33 3446777899999999
Q ss_pred CCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014783 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK 352 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~ 352 (418)
.++.+++.-.|+-.. ++|.- .+..-=+-.+=+++..++.++..|.. . +.
T Consensus 119 ~~~~p~i~hRGi~~~----------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~------l---~~- 167 (219)
T 4ano_A 119 RALEPFFLHVGVKES----------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE------Y---LK- 167 (219)
T ss_dssp TTCCEEESCCEETTT----------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH------H---HH-
T ss_pred CCCcEEEEEcCCccc----------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH------H---Hh-
Confidence 999999998877532 22221 12122233566778888888776632 2 22
Q ss_pred CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhhhhc
Q 014783 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTVRKA 405 (418)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~~~~ 405 (418)
+.... ..++.+.+++ +. -|+++|.+.|+... +.....++.
T Consensus 168 ~le~~---k~~~f~~~I~----~a-----~tleel~~~L~~~y-~e~e~~~k~ 207 (219)
T 4ano_A 168 FHETL---KCSPIAKELW----QA-----DHLDAVLAVLEKWV-DEEEAKERA 207 (219)
T ss_dssp HTTTS---CCCHHHHHHH----HC-----SSHHHHHHHHHHHH-HHHHHHHHH
T ss_pred HHhhh---cCCHHHHHHH----cc-----CCHHHHHHHHHHHH-HHHHHHHhh
Confidence 22211 1223333333 22 46788888888776 444444433
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.76 E-value=0.13 Score=41.09 Aligned_cols=55 Identities=22% Similarity=0.228 Sum_probs=36.7
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
++......| +|+|++++| . ..|.|+|||.....+.. ...++||.|.... +.|++.
T Consensus 28 Ae~lL~~~~~~G~FLVR~S-~---~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g~~~l~ 84 (125)
T 2dm0_A 28 AEHLLRQESKEGAFIVRDS-R---HLGSYTISVFMGARRST---EAAIKHYQIKKNDSGQWYVA 84 (125)
T ss_dssp HHHHHHHHCSTTCBCEEEE-T---TEEEEEEEEECCCSSSS---SCCEEEEEEEECTTCCEESS
T ss_pred HHHHHhhcCCCCEEEEEec-C---CCCCEEEEEEeccccCC---CCcEEEEEEEEcCCCCEEEC
Confidence 344454443 899999999 2 25899999996542111 2257999997765 557764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.10 E-value=0.58 Score=45.30 Aligned_cols=29 Identities=28% Similarity=0.556 Sum_probs=25.3
Q ss_pred cccCCCCCCcEEE------cCCCCEEEeeccccee
Q 014783 259 FIHRDLKSDNLLI------SADKSIKIADFGVARI 287 (418)
Q Consensus 259 iiHrDlkp~NILl------~~~~~vkl~DfGla~~ 287 (418)
++|+|+.+.|||+ ++++.++|+||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998875
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.46 E-value=0.78 Score=36.20 Aligned_cols=50 Identities=12% Similarity=0.191 Sum_probs=36.1
Q ss_pred chHHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 29 ~~~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
++......| +|+|+++.| ++.+|.|+||+... ..++||+|.... +.|.+.
T Consensus 28 Ae~lL~~~g~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 79 (119)
T 2gsb_A 28 AYNLLMTVGQVCSFLVRPS---DNTPGDYSLYFRTN---------ENIQRFKICPTPNNQFMMG 79 (119)
T ss_dssp HHHHHHHTCCSSEEEEEEC---SSSTTCEEEEEECS---------SCBCCCCEEEETTTEEEES
T ss_pred HHHHHhhcCCCCeEEEEeC---CCCCCceEEEEEEC---------CEEEEEEEEEcCCCCEEEC
Confidence 344555555 799999998 55678999999863 257899997754 556654
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=82.28 E-value=0.17 Score=45.86 Aligned_cols=79 Identities=13% Similarity=0.141 Sum_probs=49.6
Q ss_pred chHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC-CCCceeeccccccc--CCcccc
Q 014783 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFR--PGKVTH 103 (418)
Q Consensus 29 ~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~-~~~~~i~~~~~~~~--~~~v~~ 103 (418)
++......| +|+|++++| ++.+|.|+||+... ..++|+.|... .+.|++. +...|. ++.|.+
T Consensus 18 Ae~lL~~~~~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~-~~~~F~sl~~LV~~ 84 (254)
T 2oq1_A 18 AEEHLKLAGMADGLFLLRQC---LRSLGGYVLSLVHD---------VRFHHFPIERQLNGTYAIA-GGKAHCGPAELCEF 84 (254)
T ss_dssp HHHHHHHTTCCTTCEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECTTSCEEET-TSCCBSSHHHHHHH
T ss_pred HHHHHhccCCCCcEEEEEeC---CCCCCCEEEEEEEC---------CeEEEEEEEEeCCCCEEeC-CCCccCCHHHHHHH
Confidence 444443334 899999998 55678999999952 25799999874 4667775 334443 244443
Q ss_pred -ccCchHHHHHHhcCCCC
Q 014783 104 -ALNDDALAQALMDHRYP 120 (418)
Q Consensus 104 -~~~~d~l~~~l~~~~~~ 120 (418)
..+.++++..|..|+..
T Consensus 85 y~~~~~~l~~~L~~p~~~ 102 (254)
T 2oq1_A 85 YSRDPDGLPCNLRKPCNR 102 (254)
T ss_dssp HHHCCTTSSSCCCSBCCC
T ss_pred HHhCCCCcccccccccCC
Confidence 33445555555555543
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=82.05 E-value=0.6 Score=35.51 Aligned_cols=49 Identities=14% Similarity=0.106 Sum_probs=35.3
Q ss_pred hHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC-CCCceee
Q 014783 30 QGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVS 90 (418)
Q Consensus 30 ~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~-~~~~~i~ 90 (418)
+......| +|+|++++| ++.+|.|++|+... ..++|+.|... ++.|++.
T Consensus 15 e~lL~~~g~~~G~FLVR~S---~~~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 66 (100)
T 1rja_A 15 VRRLQAEGNATGAFLIRVS---EKPSADYVLSVRDT---------QAVRHYKIWRRAGGRLHLN 66 (100)
T ss_dssp HHHHSSTTCSSCCEEEEEC---SSSSSCEEEEECTT---------SSCEEEEEEECSSSCEEEE
T ss_pred HHHHhccCCCCCEEEEEeC---CCCCCCEEEEEEEC---------CEEEEEEEEEcCCCcEEEC
Confidence 33444444 899999998 45568899999862 25689999775 4667765
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=81.42 E-value=0.44 Score=36.48 Aligned_cols=41 Identities=24% Similarity=0.275 Sum_probs=31.9
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
+|+|++++| ++.+|.|++||+.. ..++|+.|....+.|++.
T Consensus 27 ~G~FLVR~S---~~~~g~~~LSv~~~---------~~v~H~~I~~~~g~~~l~ 67 (102)
T 2cia_A 27 EGDFLIRDS---ESSPSDFSVSLKAS---------GKNKHFKVQLVDNVYCIG 67 (102)
T ss_dssp TTEEEEEEC---SSSTTCEEEEECCS---------SSCEEEEEEEETTEEEET
T ss_pred CcEEEEEEC---CCCCCCEEEEEEeC---------CeeEEEEEEecCCEEEEC
Confidence 899999998 55578999999962 146899998555667764
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=80.70 E-value=0.2 Score=45.36 Aligned_cols=79 Identities=16% Similarity=0.195 Sum_probs=49.0
Q ss_pred cchHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccC-CCCceeeccccccc--CCccc
Q 014783 28 FTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFR--PGKVT 102 (418)
Q Consensus 28 ~~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~-~~~~~i~~~~~~~~--~~~v~ 102 (418)
.++......| +|+|++++| ++.+|.|+||+... ..++|+.|... .+.|++. +...|. ++.|.
T Consensus 16 ~Ae~lL~~~g~~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~-~~~~F~sl~eLv~ 82 (254)
T 1a81_A 16 EAEDYLVQGGMSDGLYLLRQS---RNYLGGFALSVAHG---------RKAHHYTIERELNGTYAIA-GGRTHASPADLCH 82 (254)
T ss_dssp HHHHHHHHTTCCTTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECTTSCEEET-TSCCBSSHHHHHH
T ss_pred HHHHHHhcCCCCCcEEEEEec---CCCCCCEEEEEEEC---------CeeEEEEEEEcCCCCEEeC-CCCCcCCHHHHHH
Confidence 3444454444 899999998 55678999999952 25789999874 4667775 334443 23444
Q ss_pred c-ccCchHHHHHHhcCCC
Q 014783 103 H-ALNDDALAQALMDHRY 119 (418)
Q Consensus 103 ~-~~~~d~l~~~l~~~~~ 119 (418)
+ ..+.++++..|..|+.
T Consensus 83 ~y~~~~~~l~~~L~~p~~ 100 (254)
T 1a81_A 83 YHSQESDGLVCLLKKPFN 100 (254)
T ss_dssp HHTTCCTTSSSCCCEECC
T ss_pred HHHhCCCCceECCccccC
Confidence 3 3344455544554443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 418 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-83 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-78 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-74 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-73 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-72 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-69 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-66 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-62 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-61 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-61 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-61 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 6e-83
Identities = 88/275 (32%), Positives = 149/275 (54%), Gaps = 17/275 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+ Q F+ EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEV 55
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L +H+NI+ F+G + IVT++ +G S+ L + + + + A
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQT 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWM 304
A+GM Y+H IHRDLKS+N+ + D ++KI DFG+A ++ + G +G+ WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 305 APEMIQHR---PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR----PV 357
APE+I+ + PY+ + DVY+FGIVL+EL+TG LP+ N+ +V +G
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ ++C + +M C + RP F +I+ +E
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 3e-78
Identities = 78/268 (29%), Positives = 134/268 (50%), Gaps = 11/268 (4%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K ++ Q F E +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--------TAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEM 308
M Y+ G F+HRDL + N+L+S D K++DFG+ + + +W APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEA 171
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368
++ + ++ K DV+SFGI+LWE+ + ++ V KG + P+ C P + E
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 369 IMTRCWDTNPEVRPPFTEIVRMLENAET 396
+M CW + +RP F ++ LE+ +T
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 8e-74
Identities = 82/269 (30%), Positives = 132/269 (49%), Gaps = 11/269 (4%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQE 186
DEW + L + G FG+++ G YN VA+K L+ + + F E
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-------QGSMSPDAFLAE 58
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWM 304
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ + + +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 305 APEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLP 364
APE I + +T K DV+SFGI+L E++T + +G R V P++C
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L ++M CW PE RP F + +LE+
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 9e-73
Identities = 87/277 (31%), Positives = 134/277 (48%), Gaps = 12/277 (4%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQV 178
T+GL D W I L + QG FG+++ GT+ VAIK L+ +
Sbjct: 3 QTQGL-AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTM 54
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F QE ++ L+H +V+ + ++ IVTEY GS+ FL + + L
Sbjct: 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTP 296
V A +A GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ + +
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 297 ETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP 356
+W APE + +T K DV+SFGI+L EL T + V +G R
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P +C L ++M +CW PE RP F + LE+
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 225 bits (574), Expect = 7e-72
Identities = 76/283 (26%), Positives = 136/283 (48%), Gaps = 16/283 (5%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENN 172
MD P NYD+W ++ + M G +G++Y G + VA+K L+
Sbjct: 2 MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----- 51
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
+ + ++F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L
Sbjct: 52 --EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQ 290
+ V + + A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVV 350
+W APE + + ++ K DV++FG++LWE+ T + + + ++
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 351 NKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
K R P C + E+M CW NP RP F EI + E
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 3e-69
Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 12/263 (4%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+W ++ +G +G FG +Y + +A+K+L + + +E Q ++E
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG---VEHQLRRE 56
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + + L+H NI+R G ++ EYA G+V + L ++ + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 114
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+A ++Y H IHRD+K +NLL+ + +KIADFG + + T GT ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPP 173
Query: 307 EMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366
EMI+ R + +KVD++S G++ +E + G PF+ T + + V P+
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGA 231
Query: 367 SEIMTRCWDTNPEVRPPFTEIVR 389
++++R NP RP E++
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-69
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 17/267 (6%)
Query: 145 QGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG + +G Y DVAIK+L + ++ +E ++ L + IVR
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVL-----KQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
IG C+ +V E A GG + +FL + +P+ + V+ GM Y+ F+
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAPEMIQHRPYTQ 316
HRDL + N+L+ KI+DFG+++ + + +W APE I R ++
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 317 KVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWD 375
+ DV+S+G+ +WE ++ G P++ M + A + +G R P +C P L +M+ CW
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWI 250
Query: 376 TNPEVRPPFTEIVRMLENAETEIMTTV 402
E RP F + + + + + V
Sbjct: 251 YKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 7e-69
Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 11/264 (4%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID +L G FG ++ G + N + VAIK + + + E+ F +E ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-------EGAMSEEDFIEEAEVM 54
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ C+V E+ + G + + R Q + + LDV G
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAPEM 308
MAY+ IHRDL + N L+ ++ IK++DFG+ R + Q T +W +PE+
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368
Y+ K DV+SFG+++WE+ + + ++ G R P + +
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233
Query: 369 IMTRCWDTNPEVRPPFTEIVRMLE 392
IM CW PE RP F+ ++R L
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 8e-69
Identities = 81/277 (29%), Positives = 136/277 (49%), Gaps = 23/277 (8%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQ 181
+ T++ ++L G FG + +G Y + VA+KIL+ N+P ++
Sbjct: 4 DRKLLTLEDKEL------GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKD 53
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+ E ++ L + IVR IG C W +V E A+ G + ++L + NR V K +
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNII 110
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPE 297
+ V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ E + T
Sbjct: 111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 298 TGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRP 356
+W APE I + ++ K DV+SFG+++WE + G P++ M + A++ KG R
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGERM 229
Query: 357 VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
P C + ++M CW + E RP F + L N
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-68
Identities = 68/266 (25%), Positives = 130/266 (48%), Gaps = 13/266 (4%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ I+TEY G + +L ++R + ++ DV
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAPEM 308
M Y+ F+HRDL + N L++ +K++DFG++R + + RW PE+
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 309 IQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367
+ + ++ K D+++FG+++WE+ + G +P++ T + A + +G+R P+ +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 231
Query: 368 EIMTRCWDTNPEVRPPFTEIVRMLEN 393
IM CW + RP F ++ + +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 6e-68
Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 39/301 (12%)
Query: 126 NYDE-WTIDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQ 177
YD W L G GAFGK+ T VA+K+L +
Sbjct: 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADS 81
Query: 178 VMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR--- 233
+ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 234 ------------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
+ + + A VA+GM ++ +HRDL + N+L++ K
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201
Query: 276 SIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT 332
+KI DFG+AR + +WMAPE + YT K DV+S+GI+LWE+ +
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 333 -GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRML 391
G+ P+ + + ++ G + P + IM CW + RP F + L
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 392 E 392
Sbjct: 322 G 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (550), Expect = 7e-68
Identities = 68/250 (27%), Positives = 102/250 (40%), Gaps = 13/250 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y N E VAIK + + Q +EV L L+H N +++
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G + +V EY G + L + + +G+AY+H IHR
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ---HRPYTQKVD 319
D+K+ N+L+S +K+ DFG A I GT WMAPE+I Y KVD
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379
V+S GI EL P NM A+ A + + + + C P+
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256
Query: 380 VRPPFTEIVR 389
RP +++
Sbjct: 257 DRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 8e-66
Identities = 68/249 (27%), Positives = 118/249 (47%), Gaps = 13/249 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQM-NLQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + + + ++H IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
D+KSDN+L+ D S+K+ DFG I + + GT WMAPE++ + Y KVD++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSEIMTRCWDTNPEV 380
S GI+ E+I G P+ N ++A + + G P + + + RC D + E
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 381 RPPFTEIVR 389
R E+++
Sbjct: 261 RGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-65
Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 15/274 (5%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQE 186
I + L + G+FG + RG ++ VA+K L+ + +A F +E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DDFIRE 61
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + +L H N++R G + +VTE A GS+ L + Q L + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQ 119
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG----MTPETGTYR 302
VA GM Y+ FIHRDL + NLL++ +KI DFG+ R Q + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
W APE ++ R ++ D + FG+ LWE+ T G P+ + Q + +G R P D
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395
C + +M +CW PE RP F + L A+
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-65
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 16/254 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ A K+++ K++ + + E+ +LA+ H NIV+ +
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A I+ E+ GG+V + + R + + Y+H IHR
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHR 134
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAPEMIQ-----HRPYTQ 316
DLK+ N+L + D IK+ADFGV+ +T + GT WMAPE++ RPY
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 317 KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVV-NKGVRPVIPNDCLPVLSEIMTRCWD 375
K DV+S GI L E+ P + ++ + ++ P+ + + +C +
Sbjct: 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLE 254
Query: 376 TNPEVRPPFTEIVR 389
N + R +++++
Sbjct: 255 KNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-65
Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 17/257 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ + +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 69
Query: 203 GAC--RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--- 255
R IV EY +GG + +T+ ++ + + + ++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 256 --GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHR 312
G +HRDLK N+ + +++K+ DFG+AR + T GT +M+PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTR 372
Y +K D++S G +L+EL + PF + + A + G IP L+EI+TR
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDELNEIITR 248
Query: 373 CWDTNPEVRPPFTEIVR 389
+ RP EI+
Sbjct: 249 MLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-65
Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 18/269 (6%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ D R L +G+F +Y+G +VA L+ + + Q+F++E
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAE 60
Query: 189 MLATLKHLNIVRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
ML L+H NIVRF + + + +VTE G+++ +L ++ + + +K+
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 118
Query: 245 LDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTEGMTPETGTY 301
+ +G+ ++H IHRDLK DN+ I+ S+KI D G+A + + GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTP 177
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV-IPN 360
+MAPEM + Y + VDVY+FG+ + E+ T P+ + V GV+P
Sbjct: 178 EFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
+P + EI+ C N + R +++
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 1e-64
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 20/285 (7%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
P E + + + ID+ + + G FG++ G VAIK L
Sbjct: 12 PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSG 65
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
+ + F E ++ H N++ G K I+TE+ + GS+ F R+ +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQ 124
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------E 288
+ V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAF 347
RW APE IQ+R +T DV+S+GIV+WE+++ G P+ +MT
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN 244
Query: 348 AVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
A+ + R P DC L ++M CW + RP F +IV L+
Sbjct: 245 AIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 91/307 (29%), Positives = 145/307 (47%), Gaps = 36/307 (11%)
Query: 116 DHRY--PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKIL 166
++ Y PT+ L +W +L+ G GAFGK+ T VA+K+L
Sbjct: 3 NYVYIDPTQ-LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
P + E+ +L+ L H+NIV +GAC ++TEY G +
Sbjct: 62 -----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 226 FLTRRQNR----------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
FL R+++ A+ L+ + + VA+GMA++ IHRDL + N+
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 270 LISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIV 326
L++ + KI DFG+AR + +WMAPE I + YT + DV+S+GI
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 327 LWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFT 385
LWEL + G P+ M + ++ +G R + P + +IM CWD +P RP F
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 386 EIVRMLE 392
+IV+++E
Sbjct: 297 QIVQLIE 303
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-64
Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 14/272 (5%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQF 183
++ I ++ +G +G FG +++G Y VAIK + + + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-----CTSDSVREKF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QE + + H +IV+ IG + VW I+ E G +R FL R+ + L +
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILY 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTY 301
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361
+WMAPE I R +T DV+ FG+ +WE++ + + G R +P +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
C P L +MT+CW +P RP FTE+ L
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 2e-63
Identities = 81/300 (27%), Positives = 128/300 (42%), Gaps = 39/300 (13%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVM 179
+ +GAFG++++ VA+K+L E + M
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADM 59
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV---- 235
+ FQ+E ++A + NIV+ +G C C++ EY G + +FL V
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 236 ------------------PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ A VA GMAY+ F+HRDL + N L+ + +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 278 KIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-G 333
KIADFG++R + + RWM PE I + YT + DV+++G+VLWE+ + G
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 334 LLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
L P+ M + + V + G P +C L +M CW P RP F I R+L+
Sbjct: 240 LQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-63
Identities = 75/258 (29%), Positives = 122/258 (47%), Gaps = 16/258 (6%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G FG++Y+G VAIK L + F E ++ H NI
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAGIMGQFSHHNI 71
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+R G K I+TEY + G++ +F R ++ + V +A GM Y+ +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAPEMIQHRPY 314
++HRDL + N+L++++ K++DFG++R+ T + RW APE I +R +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
T DV+SFGIV+WE++T + +N G R P DC + ++M +CW
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250
Query: 375 DTNPEVRPPFTEIVRMLE 392
RP F +IV +L+
Sbjct: 251 QQERARRPKFADIVSILD 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 8e-63
Identities = 64/252 (25%), Positives = 120/252 (47%), Gaps = 14/252 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI+ + ++A + ++E+ + L H N+V+F
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G R+ + + EY GG + + + +P A + + G+ Y+HG+G HR
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 263 DLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAPEMIQHRPY-TQKV 318
D+K +NLL+ ++KI+DFG+A + + + GT ++APE+++ R + + V
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 319 DVYSFGIVLWELITGLLPFQNMT-AVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377
DV+S GIVL ++ G LP+ + + Q K ++ + N
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 247
Query: 378 PEVRPPFTEIVR 389
P R +I +
Sbjct: 248 PSARITIPDIKK 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-62
Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 19/284 (6%)
Query: 122 EGLENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
E ++ I ++ +G FG +Y GT A+K L N
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRI 66
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
QF E +++ H N++ +G C R +V Y K G +R F+ +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR E
Sbjct: 127 -PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 294 MTPET-----GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA 348
+ +WMA E +Q + +T K DV+SFG++LWEL+T P
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 349 VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
+ +G R + P C L E+M +CW E+RP F+E+V +
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-62
Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 24/280 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
+D + +G FG++ + + D AIK + ++ + F E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGEL 61
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------N 232
+L L H NI+ +GAC R + EYA G++ FL + +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+ + + A DVARGM Y+ FIHRDL + N+L+ + KIADFG++R +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 293 GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK 352
T RWMA E + + YT DV+S+G++LWE+++ + + +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLE 392
G R P +C + ++M +CW P RP F +I+ L
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 4e-62
Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 53/292 (18%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++RG + GE+VA+KI + + E+ L+H NI+ FI A
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFS-------SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 205 CRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH----- 255
K +V++Y + GS+ +L R V ++ +K AL A G+A++H
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 256 ---GLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAPE 307
HRDLKS N+L+ + + IAD G+A + GT R+MAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 308 MIQ------HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-------------- 347
++ H ++ D+Y+ G+V WE+ Q +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 348 -AVVNKGVRPVIPN-----DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V + +RP IPN + L V+++IM CW N R I + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-61
Identities = 87/293 (29%), Positives = 136/293 (46%), Gaps = 32/293 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
W + +L +G +GAFG++ G D VA+K+L + +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEK 60
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------ 231
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 232 --------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 284 VARIEVQTEGMT---PETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNM 340
+AR + +WMAPE + R YT + DV+SFG++LWE+ T
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240
Query: 341 TAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V+ F ++ +G R P++C L +M CW P RP F ++V L+
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-61
Identities = 72/258 (27%), Positives = 128/258 (49%), Gaps = 18/258 (6%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
GAFG +Y+G + E VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHV 73
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R +G C V I + G + ++ ++ + + + + +A+GM Y+
Sbjct: 74 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAPEMIQHRPYT 315
+HRDL + N+L+ + +KI DFG+A++ E + +WMA E I HR YT
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 316 QKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCW 374
+ DV+S+G+ +WEL+T G P+ + A +++ KG R P C + IM +CW
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPICTIDVYMIMVKCW 250
Query: 375 DTNPEVRPPFTEIVRMLE 392
+ + RP F E++
Sbjct: 251 MIDADSRPKFRELIIEFS 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-61
Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 30/294 (10%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ VA+K+L+ + E
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 60
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ +++ HLN+V +GAC + ++ E+ K G++ +L ++N VP
Sbjct: 61 -RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 238 KL--------------AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
K+ + + VA+GM ++ IHRDL + N+L+S +KI DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 284 VARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL-LPFQN 339
+AR + + +WMAPE I R YT + DV+SFG++LWE+ + P+
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 340 MTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
+ + + +G R P+ P + + M CW P RP F+E+V L N
Sbjct: 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 199 bits (506), Expect = 7e-61
Identities = 51/269 (18%), Positives = 104/269 (38%), Gaps = 20/269 (7%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQ 184
YD + I L +L GAFG ++R G K + P + + +
Sbjct: 28 YDYYDI-LEEL------GSGAFGVVHRCVEKATGRVFVAKFINTPY------PLDKYTVK 74
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
E+ ++ L H ++ A + ++ E+ GG + + ++ + +
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYM 133
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H +H D+K +N++ K+ +KI DFG+A E + T T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193
Query: 303 WMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPN 360
+ APE++ P D+++ G++ + L++GL PF ++ V +
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
P + + P R + +
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 198 bits (505), Expect = 8e-61
Identities = 52/249 (20%), Positives = 110/249 (44%), Gaps = 13/249 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + P + ++ ++E+ ++ L+H +V
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLH 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A ++ E+ GG + + + N+ + AV+ V +G+ ++H ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 263 DLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDV 320
DLK +N++ + +S +K+ DFG+ + + TGT + APE+ + +P D+
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 208
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLSEIMTRCWDTNP 378
+S G++ + L++GL PF + V + + + + + +P
Sbjct: 209 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADP 268
Query: 379 EVRPPFTEI 387
R +
Sbjct: 269 NTRMTIHQA 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 1e-60
Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G VAIK + N +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 67
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
+F E ++ ++VR +G + ++ E G ++ +L +
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 234 -AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI---EV 289
L ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL-LPFQNMTAVQAAFA 348
RWM+PE ++ +T DV+SFG+VLWE+ T P+Q ++ Q
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 349 VVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393
V+ +G P++C +L E+M CW NP++RP F EI+ ++
Sbjct: 248 VM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 57/242 (23%), Positives = 110/242 (45%), Gaps = 13/242 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ +G +A K++ + E + Q +E+ +L IV F
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLI-----HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIH 261
GA I E+ GGS+ Q L + +P ++ K ++ V +G+ Y+ +H
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMH 128
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
RD+K N+L+++ IK+ DFGV+ + + + GT +M+PE +Q Y+ + D++
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERLQGTHYSVQSDIW 187
Query: 322 SFGIVLWELITGLLPFQ--NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379
S G+ L E+ G P + ++ F +G P + + D+ P
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 380 VR 381
+
Sbjct: 248 MA 249
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 192 bits (489), Expect = 2e-59
Identities = 57/257 (22%), Positives = 118/257 (45%), Gaps = 16/257 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
++ + +V + K G + +L + + K K + + +H L
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQ------HR 312
+HRDLK +N+L+ D +IK+ DFG + E + GT ++APE+I+ H
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190
Query: 313 PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIM 370
Y ++VD++S G++++ L+ G PF + + +++ + P +D + +++
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250
Query: 371 TRCWDTNPEVRPPFTEI 387
+R P+ R E
Sbjct: 251 SRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-59
Identities = 53/295 (17%), Positives = 118/295 (40%), Gaps = 27/295 (9%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQ 182
E Y+++ I L +G FG ++R T + + K ++ + +
Sbjct: 2 ELYEKYMI-AEDL------GRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVL 47
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++E+ +L +H NI+ + ++ E+ G + + + + + V
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVS 106
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGT 300
V + ++H H D++ +N++ +S IKI +FG AR +
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 301 YRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--I 358
+ APE+ QH + D++S G +++ L++G+ PF T Q ++N
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR------MLENAETEIMTTVRKARF 407
+ + + R + R +E ++ +E T+++ T++ R+
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRY 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-57
Identities = 51/253 (20%), Positives = 104/253 (41%), Gaps = 12/253 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F + + AIKILE+ E +E +++ L H V+
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFVKLY 74
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ YAK G + +++ + + ++ + Y+HG G IHR
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAPEMIQHRPYTQKVD 319
DLK +N+L++ D I+I DFG A++ GT ++++PE++ + + D
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD 192
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPE 379
+++ G ++++L+ GL PF+ ++ P P +++ + +
Sbjct: 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDAT 250
Query: 380 VRPPFTEIVRMLE 392
R E+
Sbjct: 251 KRLGCEEMEGYGP 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-57
Identities = 58/248 (23%), Positives = 111/248 (44%), Gaps = 9/248 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK++ + + AIK L++ + +E ++ ++ +H +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + + + L A A ++ G+ ++H G ++R
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVY 321
DLK DN+L+ D IKIADFG+ + + GT ++APE++ + Y VD +
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWW 187
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381
SFG++L+E++ G PF + ++ P P +++ + + PE R
Sbjct: 188 SFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 382 PPFTEIVR 389
+R
Sbjct: 246 LGVRGDIR 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 6e-57
Identities = 58/252 (23%), Positives = 111/252 (44%), Gaps = 14/252 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF ++ + VAIK + + + E + E+ +L +KH NIV
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
++ + GG + + + + A + V + Y+H LG +HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 263 DLKSDNLLIS---ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVD 319
DLK +NLL D I I+DFG++++E ++ GT ++APE++ +PY++ VD
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191
Query: 320 VYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIP--NDCLPVLSEIMTRCWDTN 377
+S G++ + L+ G PF + + ++ P +D + + + +
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251
Query: 378 PEVRPPFTEIVR 389
PE R + ++
Sbjct: 252 PEKRFTCEQALQ 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-54
Identities = 51/253 (20%), Positives = 107/253 (42%), Gaps = 10/253 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E GG + FL +++ + + A + + G+ Y+H L H
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 263 DLKSDNLLISAD----KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 318
DLK +N+++ IKI DFG+A GT ++APE++ + P +
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 319 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVLSEIMTRCWDT 376
D++S G++ + L++G PF T + V ++ + + + R
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 257
Query: 377 NPEVRPPFTEIVR 389
+P+ R + ++
Sbjct: 258 DPKKRMTIQDSLQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 179 bits (456), Expect = 2e-54
Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 17/257 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G +++ DVA+K+L + + +F++E A L H IV
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+ IV EY G ++R + + K A++ D + + + H G
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAPEMIQHRPY 314
IHRD+K N++ISA ++K+ DFG+AR + +T GT ++++PE +
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLSEIMTR 372
+ DVYS G VL+E++TG PF + V A+ V + P L ++ +
Sbjct: 192 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251
Query: 373 CWDTNPEVRPPFTEIVR 389
NPE R +R
Sbjct: 252 ALAKNPENRYQTAAEMR 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (456), Expect = 5e-54
Identities = 64/260 (24%), Positives = 123/260 (47%), Gaps = 21/260 (8%)
Query: 130 WTID----LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
+++ LR L G+FG+++ +NG A+K+L++ K +
Sbjct: 1 YSLQDFQILRTL------GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHT 51
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E +ML+ + H I+R G + ++ +Y +GG + L + Q P +A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFY 109
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A +V + Y+H I+RDLK +N+L+ + IKI DFG A+ + GT +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDY 167
Query: 304 MAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363
+APE++ +PY + +D +SFGI+++E++ G PF + ++ ++N P
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFN 225
Query: 364 PVLSEIMTRCWDTNPEVRPP 383
+ ++++R + R
Sbjct: 226 EDVKDLLSRLITRDLSQRLG 245
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-53
Identities = 57/261 (21%), Positives = 110/261 (42%), Gaps = 27/261 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70
Query: 202 IGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 258 GFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY 314
HRD+K +NLL ++ + +K+ DFG A+ +T T ++APE++ Y
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 315 TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV--RPVIPNDCLPVLSE---- 368
+ D++S G++++ L+ G PF + + + + + + PN +SE
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 369 IMTRCWDTNPEVRPPFTEIVR 389
++ T P R TE +
Sbjct: 251 LIRNLLKTEPTQRMTITEFMN 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 177 bits (449), Expect = 2e-52
Identities = 49/242 (20%), Positives = 102/242 (42%), Gaps = 7/242 (2%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y G+ A+K L++ ++ + + + + +++T IV
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + + GG + L Q+ A ++ G+ ++H ++R
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVY 321
DLK N+L+ ++I+D G+A + + GT+ +MAPE++Q Y D +
Sbjct: 132 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 190
Query: 322 SFGIVLWELITGLLPFQNMTAV-QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEV 380
S G +L++L+ G PF+ + + + +P+ P L ++ +
Sbjct: 191 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 250
Query: 381 RP 382
R
Sbjct: 251 RL 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-51
Identities = 53/251 (21%), Positives = 103/251 (41%), Gaps = 16/251 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + ++ E + + + +LA V + + H G +
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 261 HRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPY-TQKV 318
HRD+K +N+LI ++ +K+ DFG + ++ T GT + PE I++ Y +
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191
Query: 319 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNP 378
V+S GI+L++++ G +PF++ + + ++ C P
Sbjct: 192 AVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRWCLALRP 243
Query: 379 EVRPPFTEIVR 389
RP F EI
Sbjct: 244 SDRPTFEEIQN 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 4e-51
Identities = 58/270 (21%), Positives = 99/270 (36%), Gaps = 30/270 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y GT GE+VAIK+ + Q E + ++ + I
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLE--------CVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 203 GAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
C + +V E + L +R LK + A + + Y+H FIH
Sbjct: 69 RWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVARIEVQTEG--------MTPETGTYRWMAPEMIQ 310
RD+K DN L+ K + I DFG+A+ TGT R+ +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 311 HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR------PVIPNDCLP 364
+++ D+ S G VL G LP+Q + A + V+
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 246
Query: 365 VLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394
+ + C + +P ++ + ++ N
Sbjct: 247 EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (425), Expect = 1e-49
Identities = 50/272 (18%), Positives = 93/272 (34%), Gaps = 32/272 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRF 201
+G+FG ++ GT N + VAIK R + P Q + E L I
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--------QLRDEYRTYKLLAGCTGIPNV 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G + L R +K A + + +H ++
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 262 RDLKSDNLLISA-----DKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAPEM 308
RD+K DN LI I + DFG+ + + +GT R+M+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 309 IQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR------PVIPNDC 362
R +++ D+ + G V + G LP+Q + A G + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394
+ M + + P + + +
Sbjct: 245 PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-49
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 10/241 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK+ G A+KIL R E K +V E +L +H +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEV--AHTVTESRVLQNTRHPFLTALK 71
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C V EYA GG + L+R + + A ++ + Y+H ++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAPEMIQHRPYTQKVDVY 321
D+K +NL++ D IKI DFG+ + + GT ++APE+++ Y + VD +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 322 SFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVR 381
G+V++E++ G LPF N + ++ + P P ++ +P+ R
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 382 P 382
Sbjct: 248 L 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 55/276 (19%), Positives = 111/276 (40%), Gaps = 33/276 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V ++ + + + + + + L +G+ Y+H +HR
Sbjct: 67 DAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMIQ-HRPYTQKVDV 320
DLK +NLL+ + +K+ADFG+A+ T + T + APE++ R Y VD+
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV----------------------- 357
++ G +L EL+ + + + + P
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244
Query: 358 ---IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390
I + L +++ + NP R T+ ++M
Sbjct: 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-46
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 35/276 (12%)
Query: 145 QGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75
Query: 202 IGAC-----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQ 316
+HRDLK N+L+++ IK+ADFG+ARI +T T + APE++ Y
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194
Query: 317 KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV------------------- 357
VD++S G + E+ F+ + V +++ P
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254
Query: 358 ------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
D + +++ +C NP R
Sbjct: 255 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 4e-46
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 18/278 (6%)
Query: 108 DALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKI 165
A L P++ D++ ++ L G+FG++ + +G A+KI
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDR-IKTL------GTGSFGRVMLVKHKESGNHYAMKI 73
Query: 166 LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
L++ + K + E +L + +V+ + + +V EY GG +
Sbjct: 74 LDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
L R A A + Y+H L I+RDLK +NLLI I++ DFG A
Sbjct: 131 HLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 286 RIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA 345
+ GT +APE+I + Y + VD ++ G++++E+ G PF +Q
Sbjct: 189 K--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 346 AFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPP 383
+V+ + P+ L +++ + R
Sbjct: 247 YEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-45
Identities = 63/295 (21%), Positives = 115/295 (38%), Gaps = 46/295 (15%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQ 181
+EN+ + + K+ +G +G +Y+ GE VA+K + +
Sbjct: 1 MENFQK----VEKI------GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPS 46
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+E+ +L L H NIV+ + +V E+ +++F+ +PL L
Sbjct: 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK 105
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT 300
+ +G+A+ H +HRDLK NLLI+ + +IK+ADFG+AR V T E T
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 301 YRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--- 356
+ APE++ Y + VD++S G + E++T F + + F + P
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 357 ------------------------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
+ ++++ +P R
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-44
Identities = 59/272 (21%), Positives = 129/272 (47%), Gaps = 26/272 (9%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQ 177
G+EN++ L+ L GA+GK++ G+ A+K+L + +KA+
Sbjct: 22 GIENFEL----LKVL------GTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAK 70
Query: 178 VMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
E + E +L ++ +V A + ++ +Y GG + L++R+
Sbjct: 71 TTEH-TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FT 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGM 294
++ + ++H LG I+RD+K +N+L+ ++ + + DFG+++ + +TE
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 295 TPETGTYRWMAPEMIQ--HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK 352
GT +MAP++++ + + VD +S G++++EL+TG PF + + +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
Query: 353 GVR--PVIPNDCLPVLSEIMTRCWDTNPEVRP 382
++ P P + + +++ R +P+ R
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 4e-43
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 46/296 (15%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQ 182
+E Y L K+ +G +G +Y+ N GE A+K + + + +
Sbjct: 1 MEKYHG----LEKI------GEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPST 46
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E+ +L LKH NIV+ + +V E+ + + A
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS 104
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
L + G+AY H +HRDLK NLLI+ + +KIADFG+AR
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 303 WMAPEMI--QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--- 357
W + + Y+ +D++S G + E++ G F ++ + P
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 358 ------------------------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
+++++ +P R + +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 55/266 (20%), Positives = 114/266 (42%), Gaps = 19/266 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G + N VAIK + +P + Q Q+ +E+ +L +H NI+
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R ++M + + G + + L + + + + RG+ Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAPEMIQH-RP 313
+HRDLK NLL++ +KI DFG+AR+ T +T T + APE++ + +
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRC 373
YT+ +D++S G +L E+++ F + ++ P + + +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 374 WDTNPEVRPPFTEIVRMLENAETEIM 399
+ + P+ + ++ +++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLL 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 63/281 (22%), Positives = 104/281 (37%), Gaps = 48/281 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ +GE VAIK + + + + +E+ ++ L H NIVR
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79
Query: 203 GAC------RKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVH 255
+ + +V +Y R R + +P+ + R +AY+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 256 GLGFIHRDLKSDNLLISADKSI-KIADFGVARIEVQTE-GMTPETGTYRWMAPEMIQHRP 313
G HRD+K NLL+ D ++ K+ DFG A+ V+ E ++ Y +
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 314 YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP----------------- 356
YT +DV+S G VL EL+ G F + V ++ P
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 357 ----------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
V P + +R + P R E
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-40
Identities = 50/277 (18%), Positives = 102/277 (36%), Gaps = 38/277 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + +++ + +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V E+ + N + ++ + +G+ + H +HR
Sbjct: 68 DVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAPEMI-QHRPYTQKVDV 320
DLK NLLI+ + +K+A+FG+AR + + E T + P+++ + Y+ +D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 321 YSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP------------------------ 356
+S G + EL P V + + +
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 357 ----VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389
+ +++ NP R E ++
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 55/289 (19%), Positives = 104/289 (35%), Gaps = 52/289 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ + G+ VA+K + +E+ +L LKH N+V I
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLI 75
Query: 203 GACRKRMV--------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
CR + +V ++ + L + + G+ Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF--TLSEIKRVMQMLLNGLYYI 133
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAPEMI 309
H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T + PE++
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 310 Q-HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN----------------- 351
R Y +D++ G ++ E+ T Q T +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 352 --------KGVRPVIPNDCLPVLS-----EIMTRCWDTNPEVRPPFTEI 387
KG + + + + +++ + +P R +
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 61/281 (21%), Positives = 105/281 (37%), Gaps = 48/281 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + G VAIK L RP + ++ +E+ +L ++H N++ +
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLL 83
Query: 203 GACRKR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + ++ + + +G+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTD----LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI-QHRPYT 315
G IHRDLK NL ++ D +KI DFG+AR MT T + APE+I YT
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYT 197
Query: 316 QKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV------------------ 357
Q VD++S G ++ E+ITG F+ + ++ P
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 358 -----------IPNDCLPVLSEIMTRCWDTNPEVRPPFTEI 387
I + P+ ++ + + E R E
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-37
Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 23/251 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA G + +VAIK L RP N ++ +E++++ + H NI+ +
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLL 82
Query: 203 GACRKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V E + + + G+ ++H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQ 316
G IHRDLK N+++ +D ++KI DFG+AR + MTP T + APE+I Y +
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 317 KVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDT 376
VD++S G ++ E++ + F + V+ + P P + +
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP------CPEFMKKLQPTVRN 251
Query: 377 NPEVRPPFTEI 387
E RP + +
Sbjct: 252 YVENRPKYAGL 262
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 6e-36
Identities = 39/222 (17%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 126 NYDEWTIDLRKLN---MGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVME 180
+Y+ ++ + + +G + +++ N E V +KIL+ V +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------VKK 73
Query: 181 QQFQQEVMMLATLK-HLNIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
++ ++E+ +L L+ NI+ + + +V E+ +Q + +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTD 128
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTP 296
++ + + Y H +G +HRD+K N++I + + +++ D+G+A +
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 297 ETGTYRWMAPE-MIQHRPYTQKVDVYSFGIVLWELITGLLPF 337
+ + PE ++ ++ Y +D++S G +L +I PF
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-35
Identities = 57/246 (23%), Positives = 100/246 (40%), Gaps = 17/246 (6%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++ +
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 83
Query: 203 GACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G + + ++ ++ + Q + RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ---ILRGLKYIHSA 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQK 317
IHRDLK NL ++ D +KI DFG+AR E + M+ Y Q
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 318 VDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTN 377
VD++S G ++ EL+TG F + ++ P + L +S R + +
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP--GAELLKKISSESARNYIQS 257
Query: 378 PEVRPP 383
P
Sbjct: 258 LTQMPK 263
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 2e-28
Identities = 43/217 (19%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F ++ N VA+KI+ +V + + E+ +L + + +
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 203 GACRKRMV--------------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ ++ G ++ + + ++R +PL + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 249 RGMAYVH-GLGFIHRDLKSDNLLISADK------SIKIADFGVARIEVQTEGMTPETGTY 301
G+ Y+H G IH D+K +N+L+ IKIAD G A + + T
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTR 193
Query: 302 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQ 338
+ +PE++ P+ D++S +++ELITG F+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 4e-18
Identities = 26/189 (13%), Positives = 62/189 (32%), Gaps = 25/189 (13%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G ++ + +K + + +K + +LA N R +
Sbjct: 10 EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ V + + + + + ++ V ++ + + +A + G +H D
Sbjct: 70 KLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGD 128
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQH----------RP 313
L N+L+S ++ I I DF + E+++ R
Sbjct: 129 LSQYNVLVS-EEGIWIIDFPQSV------------EVGEEGWREILERDVRNIITYFSRT 175
Query: 314 YTQKVDVYS 322
Y + D+ S
Sbjct: 176 YRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 418 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.43 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 96.3 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 92.52 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 91.57 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 91.48 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 90.93 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 90.51 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 90.42 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 90.32 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 88.35 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 87.54 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 81.91 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 80.22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-61 Score=451.65 Aligned_cols=264 Identities=33% Similarity=0.653 Sum_probs=225.3
Q ss_pred cccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
|+|+|+.++|++++.||+|+||+||+|++++ .||||+++........ .+.|.+|+.+|++++|||||++++++.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 6899999999999999999999999998765 5999999765444332 2578899999999999999999998865
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..++||||||++|+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred -cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 4578999999999999999754 34699999999999999999999999999999999999999999999999999986
Q ss_pred ecccC---CCCCCCCCccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----C
Q 014783 288 EVQTE---GMTPETGTYRWMAPEMIQHR---PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP----V 357 (418)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~aPE~~~~~---~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~----~ 357 (418)
..... ......||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+........+..+... .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 54322 23456799999999999643 58999999999999999999999999988777776666666543 2
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 358 IPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 358 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.+..+++.+.+|+.+||+.||++|||++||++.|+.+...+
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 45678999999999999999999999999999999877544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-61 Score=454.55 Aligned_cols=264 Identities=28% Similarity=0.563 Sum_probs=234.6
Q ss_pred CCCcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEE
Q 014783 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (418)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~ 202 (418)
+.+++|+|+.++|++.+.||+|+||+||+|++ +++.||||+++...... +.|.+|+.+|++++|||||+++
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-------EEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH-------HHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH-------HHHHHHHHHHHhCCCCCEecCC
Confidence 46789999999999999999999999999998 57899999987544332 4688999999999999999999
Q ss_pred eEEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
++|.+...+|||||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+||
T Consensus 80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccc
Confidence 99999999999999999999999998776778999999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 283 GVARIEVQTEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 283 Gla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
|+|+....... .....||+.|+|||++.+..|+.++|||||||++|||++|..||............+..+.++..|.
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc
Confidence 99986543322 2233478999999999999999999999999999999996666544444455667788888999999
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
.+++.+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999999998874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-60 Score=445.31 Aligned_cols=261 Identities=34% Similarity=0.605 Sum_probs=229.1
Q ss_pred CcccccccccccccCceeeeCceEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
-++|+|+.++|++.+.||+|+||.||+|+++ ++.||||+++...... +.|.+|+.+|++++|||||++++++
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH-------HHHHHHHHHHHhCCCCCEeEEEeee
Confidence 4789999999999999999999999999994 5789999997644332 4688999999999999999999988
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.++ .+|+||||+++|+|.+++.......+++..+++++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|
T Consensus 78 ~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 78 TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp CSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence 654 5689999999999999887655556999999999999999999999999999999999999999999999999999
Q ss_pred eeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 014783 286 RIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG-LLPFQNMTAVQAAFAVVNKGVRPVIPNDC 362 (418)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (418)
+...... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+ ....+..+.++..|..+
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGYRMVRPDNC 235 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTTC
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCCCCcccC
Confidence 8764432 23445789999999999988999999999999999999995 55566655554 44556778888889999
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 363 LPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
++.+.+|+.+||+.||++|||++||++.|+++.+
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-59 Score=434.30 Aligned_cols=256 Identities=29% Similarity=0.588 Sum_probs=216.5
Q ss_pred cccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
|+.++|++.+.||+|+||.||+|++ +++.||||+++...... +.|.+|+.++++++|||||+++++|.....
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 4567889999999999999999998 67789999997644332 468899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 99999999999999998754 45688999999999999999999999999999999999999999999999999986544
Q ss_pred cCC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 291 TEG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 291 ~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.. ..+..+.++..|..+++.+.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i~~~~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDISTGFRLYKPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHHHHTCCCCCCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HHHHhcCCCCCccccCHHHH
Confidence 332 233568999999999999999999999999999999999 57777776665544 45666788888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+|+.+||+.||++|||++||++.|+++..
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=434.44 Aligned_cols=266 Identities=28% Similarity=0.568 Sum_probs=229.4
Q ss_pred ccccccccccccCc-eeeeCceEEEEEEE----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 129 EWTIDLRKLNMGTA-FAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 129 ~~~i~~~~~~~~~~-lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
+|.+..+++.+... ||+|+||+||+|.+ ++..||||+++...... ..+.|.+|+.+|++++|||||++++
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEee
Confidence 46677788888874 99999999999976 34479999997543221 1357899999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
+|..+ .+|||||||++|+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 77 VCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred eeccC-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence 98754 578999999999999998653 3569999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 284 VARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+|+....... .....||+.|+|||++....++.++|||||||++|||+| |+.||.+.+..+.. ..+..+.++..
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-~~i~~~~~~~~ 233 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFIEQGKRMEC 233 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHHHTTCCCCC
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCC
Confidence 9986543322 234568999999999999999999999999999999998 99999998876654 55677888889
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHHhhhh
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEIMTTV 402 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~~~~~ 402 (418)
|..+++++.+||.+||+.||++|||+.+|++.|+.....+.+..
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 99999999999999999999999999999999999887765443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-59 Score=446.99 Aligned_cols=261 Identities=29% Similarity=0.552 Sum_probs=228.1
Q ss_pred cccccccccccccCceeeeCceEEEEEEECC-------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv 199 (418)
..|+|+.++|++++.||+|+||+||+|++.+ ..||||.+........ ...+.+|+.+|.++ +|||||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-----REALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH-----HHHHHHHHHHHHHhcCCCcEe
Confidence 4699999999999999999999999998732 2699999865432221 25688999999998 899999
Q ss_pred EEEeEEeeCceEEEEEeecCCCCHHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 200 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
++++++.+...+|+|||||++|+|.++++.... ..+++..++.++.||+.||+|||++|
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976432 35889999999999999999999999
Q ss_pred cccCCCCCCcEEEcCCCCEEEeecccceeecccCCC---CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CC
Q 014783 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GL 334 (418)
Q Consensus 259 iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~ 334 (418)
||||||||+|||++.++.+||+|||+|+........ ....||+.|+|||++.+..|+.++|||||||++|||+| |+
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 999999999999999999999999999865443322 23457999999999999999999999999999999998 89
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLEN 393 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~ 393 (418)
.||.+.+..+....++..+.++..|..+++.+.+||.+||+.||++|||++||++.|..
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99998887777788888999999999999999999999999999999999999999853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=424.87 Aligned_cols=253 Identities=26% Similarity=0.540 Sum_probs=226.1
Q ss_pred ccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
+.++|++.+.||+|+||+||+|++ +++.||||+++...... +.|.+|+.++++++||||++++|+|.++..+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-------HHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-------HHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 567899999999999999999999 56689999998755442 4688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+++|+|.+++... ...+++..+++++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999999999997654 346889999999999999999999999999999999999999999999999999865443
Q ss_pred CC--CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 EG--MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ~~--~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
.. .....||+.|+|||.+....++.++|||||||++|||+| |+.||.+.+..+... .+..+.++..|..+++.+.+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLRLYRPHLASEKVYT 232 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-HHHTTCCCCCCTTCCHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-HHHhCCCCCCcccccHHHHH
Confidence 32 234568999999999999999999999999999999998 899999999877654 45667888889999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
|+.+||+.||++|||++|+++.|.++
T Consensus 233 li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-58 Score=434.49 Aligned_cols=259 Identities=29% Similarity=0.559 Sum_probs=215.4
Q ss_pred ccccccccccCceeeeCceEEEEEEE--CCc---eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+++.++|++.+.||+|+||+||+|++ +++ .||||.+....... ..+.|.+|+.+|++++|||||+++++|
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 46678899999999999999999987 232 58888875433221 125789999999999999999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.....+|+|||||++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+|
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999999999988753 346999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCC------CCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 014783 286 RIEVQTEGM------TPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVI 358 (418)
Q Consensus 286 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 358 (418)
+........ ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+... .+..+.+++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~-~i~~~~~~~~ 254 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN-AIEQDYRLPP 254 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCCCCC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCC
Confidence 865433221 12357899999999999999999999999999999998 899999988876554 4566778888
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 359 PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 359 ~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
|..+++.+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 88999999999999999999999999999999988754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-58 Score=432.09 Aligned_cols=264 Identities=34% Similarity=0.590 Sum_probs=224.8
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
..++|+|+.++|++++.||+|+||+||+|++ +++.||||+++...... +.|.+|+.+|++++|||||+++++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH-------HHHHHHHHHHHhcccCCEeEEEEE
Confidence 4688999999999999999999999999998 45689999997554432 468899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
|.++ .+++||||+++|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+
T Consensus 81 ~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 9654 578999999999999999876556799999999999999999999999999999999999999999999999999
Q ss_pred ceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 285 ARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGL-LPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
|+...... ......||+.|+|||++....++.++|||||||++|||++|. +|+......+ ....+..+.+++.+..
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~ 238 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPPE 238 (285)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCCCCCTT
T ss_pred hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcCCCCCCcc
Confidence 98654332 233456899999999999999999999999999999999954 4555555544 4455667788888999
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
+++++.+|+.+||+.||++|||+++|+++|++.....
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999999999999999876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=427.65 Aligned_cols=253 Identities=31% Similarity=0.602 Sum_probs=216.6
Q ss_pred CceeeeCceEEEEEEEC----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEe
Q 014783 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E 216 (418)
++||+|+||+||+|.+. ++.||||+++....... ..+.|.+|+.+|++++|||||+++++|..+ .+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----HHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence 46999999999999862 35799999965433221 236789999999999999999999999654 5789999
Q ss_pred ecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccCC---
Q 014783 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (418)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~~--- 293 (418)
||++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999999763 4599999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 294 -MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 294 -~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.. ..+..+.++..|..+++++.+|+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHHHHHHH
Confidence 233468999999999999999999999999999999998 99999998876654 556678888899999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhHHHHhhh
Q 014783 372 RCWDTNPEVRPPFTEIVRMLENAETEIMTT 401 (418)
Q Consensus 372 ~cl~~dp~~RPt~~ell~~L~~~~~~~~~~ 401 (418)
+||+.||++|||+++|++.|++...++.+.
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence 999999999999999999999988776554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-58 Score=426.14 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=219.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
+|.+ ++|++++.||+|+||+||+|++ +++.||||++.+.... .....+.+.+|+.++++++|||||++++++.
T Consensus 2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc---ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 4554 6899999999999999999998 5789999998642111 1112357889999999999999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
++..+|||||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence 999999999999999999999764 459999999999999999999999999999999999999999999999999997
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+... ...+|..+++.+
T Consensus 155 ~~~~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~ 231 (263)
T d2j4za1 155 HAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGA 231 (263)
T ss_dssp CCCC-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHH
T ss_pred ecCC-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHH
Confidence 6543 3345568999999999999999999999999999999999999999998877766555443 345677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+|+.+||+.||++|||++|+++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCCHhHCcCHHHHHc
Confidence 99999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-58 Score=427.46 Aligned_cols=257 Identities=32% Similarity=0.654 Sum_probs=222.4
Q ss_pred ccccccccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK- 207 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 207 (418)
.|+|+.++|++++.||+|+||.||+|+++|+.||||+++.... .+.+.+|+.++++++||||++++|+|.+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 3999999999999999999999999999999999999965322 1468899999999999999999999865
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
...+|+||||+++|+|.+++.......+++..+++++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence 45689999999999999999876555689999999999999999999999999999999999999999999999999986
Q ss_pred ecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHH
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVL 366 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 366 (418)
.... .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..+.. ..+..+.++..|..+++++
T Consensus 153 ~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 153 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVEKGYKMDAPDGCPPAV 229 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHHTTTCCCCCCTTCCHHH
T ss_pred cCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCccCCHHH
Confidence 5432 344568899999999999999999999999999999998 79999887766654 4467788889999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+|+.+||+.||.+|||+.+|++.|+++.+
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=428.53 Aligned_cols=246 Identities=27% Similarity=0.486 Sum_probs=218.6
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 5789999999999999999987 68999999997543322 146889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
||||||+||+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999999999998765 35999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCChHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV-RPVIPNDCLPVLSEIM 370 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 370 (418)
......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...+. ....+..+++.+.+|+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 334566799999999999999999999999999999999999999999888877776665543 3345667889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 014783 371 TRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~ell~ 389 (418)
.+||+.||++|||++|+++
T Consensus 251 ~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=426.45 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=207.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee--Cc
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RM 209 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~ 209 (418)
.++|++.+.||+|+||+||+|++ +|+.||||++......... .+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 35788899999999999999988 6889999999776544322 2578899999999999999999999864 45
Q ss_pred eEEEEEeecCCCCHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEcCCCCEEEeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~-----iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
.+|||||||++|+|.+++... ....+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 689999999999999998753 3467999999999999999999999876 999999999999999999999999
Q ss_pred ccceeecccC-CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 283 GVARIEVQTE-GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 283 Gla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
|+|+...... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..+....+. .+..+.+|..
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 237 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYR 237 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCCCTT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 9998654432 3345689999999999999999999999999999999999999999988877655544 4445567788
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+++++.+|+.+||+.||++|||++|+++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-57 Score=424.68 Aligned_cols=259 Identities=29% Similarity=0.559 Sum_probs=216.8
Q ss_pred ccccccccccCceeeeCceEEEEEEECC------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
+|+.+.|++.+.||+|+||.||+|++.+ ..||||++....... ....|.+|+.+|++++|||||+++|+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-----HHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 4566778889999999999999998732 369999986543221 12568899999999999999999999
Q ss_pred EeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccc
Q 014783 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (418)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGl 284 (418)
+.+...+++|||||.++++.+++... ...+++..+..++.||+.||+|||+++||||||||+||||+.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999999988754 45699999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHHhcCCCCCCC
Q 014783 285 ARIEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLL-PFQNMTAVQAAFAVVNKGVRPVIP 359 (418)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~-Pf~~~~~~~~~~~~~~~~~~~~~~ 359 (418)
|+....... .....||+.|+|||++.+..++.++|||||||++|||+++.. ||...+.. .....+..+.+++.|
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTP 235 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCCCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccCCCCCc
Confidence 986543221 223468999999999999999999999999999999999544 45555554 455667888888899
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
..+++.+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999999987664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-57 Score=422.93 Aligned_cols=262 Identities=30% Similarity=0.600 Sum_probs=217.6
Q ss_pred ccccccccccccCceeeeCceEEEEEEEC-----CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEe
Q 014783 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (418)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~ 203 (418)
+|+|+.++|++++.||+|+||.||+|++. +..||||.++..... ...+.+.+|+.+|++++||||+++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 69999999999999999999999999873 236888887543221 12367889999999999999999999
Q ss_pred EEeeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
++.+ ..+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||
T Consensus 76 ~~~~-~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 76 VITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEec-CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 9964 5679999999999999988653 4568999999999999999999999999999999999999999999999999
Q ss_pred cceeecccC--CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014783 284 VARIEVQTE--GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPN 360 (418)
Q Consensus 284 la~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 360 (418)
+|+...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.... +..+.++..|.
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-i~~~~~~~~~~ 232 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLPMPP 232 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCCT
T ss_pred hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCC
Confidence 998654332 2334568999999999999999999999999999999998 8999998887765544 55677778888
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.+++.+.+||.+||+.||++|||++||++.|+++..+-
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999886653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=424.96 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=208.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++++.||+|+||+||+|++ +|+.||||++....... ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 5688899999999999999998 58899999997543221 1246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
||||||++|+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999999864 356999999999999999999999999999999999999999999999999999865432
Q ss_pred --CCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCCCCCCCChHHHH
Q 014783 292 --EGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVV-NKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 292 --~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 367 (418)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||............. ...........+++.+.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 22455689999999999988876 578999999999999999999997765433333333 33333333456789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+.+||+.||++|||++|+++
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-57 Score=425.71 Aligned_cols=248 Identities=26% Similarity=0.448 Sum_probs=216.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|++++.||+|+||.||+|++ +++.||||++....... .+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 4578899999999999999998 67899999997653322 146789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+|||||++|+|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999999998754 356999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCChHH
Q 014783 292 EGMTPETGTYRWMAPEMIQ-----HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-PVIPNDCLPV 365 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 365 (418)
......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+..+....+...... ...+..+++.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 2234568999999999984 456899999999999999999999999998887777766655432 3345678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-56 Score=423.48 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=218.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|+.++.||+|+||+||+|++ +++.||||++......... ..+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 3578889999999999999987 6789999999865544322 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|||||.+|+|..++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 99999999999776654 35699999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCCCCCccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014783 293 GMTPETGTYRWMAPEMIQH---RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEI 369 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~---~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 369 (418)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+.........+..+++.+.+|
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 345689999999999864 4589999999999999999999999999988887777777766666667789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 014783 370 MTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 370 i~~cl~~dp~~RPt~~ell~ 389 (418)
+.+||+.||++|||++|+++
T Consensus 247 i~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCcCChhHCcCHHHHHh
Confidence 99999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=416.13 Aligned_cols=246 Identities=29% Similarity=0.530 Sum_probs=210.8
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee----Cc
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RM 209 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~ 209 (418)
.|++.++||+|+||+||+|++ +++.||+|++......... .+.+.+|+++|++++|||||++++++.. ..
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 346677899999999999998 5779999999765444322 2578899999999999999999999864 45
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEc-CCCCEEEeecccce
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVAR 286 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlkp~NILl~-~~~~vkl~DfGla~ 286 (418)
.+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 689999999999999999764 45999999999999999999999998 99999999999996 57899999999998
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCChHH
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-VIPNDCLPV 365 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 365 (418)
.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..........+..+..+ ..+..++++
T Consensus 164 ~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 164 LKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred eccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 5433 33445689999999999876 59999999999999999999999998877766666666665544 345567889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 014783 366 LSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 366 l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHccCCHhHCcCHHHHhC
Confidence 999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-56 Score=426.24 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=202.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
+.|++.+.||+|+||+||+|++ +++.||||++........ .+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4588999999999999999998 588999999976543221 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---CCCCEEEeecccceeec
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~---~~~~vkl~DfGla~~~~ 289 (418)
||||||+||+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||+. .++.+||+|||+|+...
T Consensus 84 lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999975 35699999999999999999999999999999999999995 57899999999998776
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 367 (418)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+....+....... ..+..+++.+.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 6555666789999999999999999999999999999999999999999988877776666655443 33457889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+.+||+.||++|||++|+++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-57 Score=424.73 Aligned_cols=250 Identities=20% Similarity=0.375 Sum_probs=215.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.+|++++||||+++++++.++..+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC---HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 36789999999999999999998 68899999996421110 11125688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+|||||++|+|.+++... +.+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999999998765 45999999999999999999999999999999999999999999999999999865432
Q ss_pred ---CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 292 ---EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 292 ---~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... ..+|..+++.+.+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARD 239 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--CCCCTTCCHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--CCCCccCCHHHHH
Confidence 22345679999999999999999999999999999999999999999988877766665543 4567788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~~ 390 (418)
|+.+||+.||++|||++|++..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHccCCHhHCcCHHHHcCC
Confidence 9999999999999999997553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-56 Score=421.39 Aligned_cols=253 Identities=21% Similarity=0.364 Sum_probs=221.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++++.||+|+||+||+|++ +|+.||||++.+............+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4689999999999999999998 58899999997654333222122367889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC----CEEEeecccceee
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~----~vkl~DfGla~~~ 288 (418)
||||||++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999765 3599999999999999999999999999999999999999776 4999999999887
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVL 366 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 366 (418)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....... ..+..+++.+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence 66666677789999999999999999999999999999999999999999988888776665544332 2335688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 014783 367 SEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 367 ~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+|+.+||+.||++|||++|+++
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=424.77 Aligned_cols=265 Identities=30% Similarity=0.576 Sum_probs=220.3
Q ss_pred CCcccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCC
Q 014783 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (418)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn 197 (418)
..++|+|+.++|++++.||+|+||.||+|++. ++.||||+++....... .+.+.+|..++.++ +|+|
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 78 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH-----HHHHHHHHHHHHhhcCCCe
Confidence 34689999999999999999999999999862 35799999865432221 24667777777776 6899
Q ss_pred eEEEEeEEeeC-ceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 014783 198 IVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (418)
Q Consensus 198 iv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (418)
|+.+++++.+. ..+++|||||++|+|.++++... ...+++..++.++.||+.||+|||++|||||
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 99999998654 46899999999999999997542 2358899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCCC
Q 014783 263 DLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG-LLPFQ 338 (418)
Q Consensus 263 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg-~~Pf~ 338 (418)
||||+||||+.++++||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998654332 23345799999999999999999999999999999999985 67898
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+....+.....+..+.++..|..+++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 877767777778888899999999999999999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-56 Score=421.37 Aligned_cols=262 Identities=30% Similarity=0.548 Sum_probs=226.8
Q ss_pred cccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~ 200 (418)
-+|++++++|++.+.||+|+||+||+|++. ++.||||+++..... . ..+.|.+|+.+|++++||||++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~----~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-D----MQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-H----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-H----HHHHHHHHHHHHHhcCCCCccc
Confidence 358888999999999999999999999874 368999998653322 1 2367899999999999999999
Q ss_pred EEeEEeeCceEEEEEeecCCCCHHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014783 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLG 258 (418)
Q Consensus 201 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~ 258 (418)
++++|......++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9999999999999999999999999997532 234788899999999999999999999
Q ss_pred cccCCCCCCcEEEcCCCCEEEeecccceeecccC---CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhC-C
Q 014783 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG-L 334 (418)
Q Consensus 259 iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg-~ 334 (418)
||||||||+|||++.++.+||+|||+|+...... ......||+.|+|||.+.+..||.++|||||||++|||++| .
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999998553332 22345788999999999999999999999999999999997 5
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhH
Q 014783 335 LPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAE 395 (418)
Q Consensus 335 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~ 395 (418)
+||.+.+..+.... +..+.++..|..+++++.+|+.+||+.||++|||+.||++.|+++.
T Consensus 241 ~p~~~~~~~e~~~~-v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCHHHHHHH-HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 78988888776655 5566678888899999999999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=425.55 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=211.8
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
+..++|++.+.||+|+||+||+|++ +|+.||||+++....... .+.+.+|+.+|++++|||||+++++|.+..
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-----HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4567899999999999999999998 688999999976543322 257889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+|||||||++|+|.+++.+. +.+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999999999764 459999999999999999999997 59999999999999999999999999999865
Q ss_pred cccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------------
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF--------------------- 347 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~--------------------- 347 (418)
.+. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+...
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 443 3455689999999999999999999999999999999999999997654322110
Q ss_pred --------------------HHHhcCCCCCCC-CCChHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 014783 348 --------------------AVVNKGVRPVIP-NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR--MLENA 394 (418)
Q Consensus 348 --------------------~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~ell~--~L~~~ 394 (418)
........+..+ ...+.++.+|+.+||+.||++|||++|+++ .|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 001111112222 235688999999999999999999999987 45543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-55 Score=427.12 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=219.8
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||.||+|++ +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.++..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35789999999999999999998 6889999999654221 125788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC--CCCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~--~~~vkl~DfGla~~~~ 289 (418)
|||||||+||+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999999653 346999999999999999999999999999999999999964 5789999999998776
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 367 (418)
.........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+........ ....+++.+.
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 66666667899999999999999999999999999999999999999999888887777666554332 2345789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+.+||+.||++|||++|+++
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=416.67 Aligned_cols=258 Identities=31% Similarity=0.555 Sum_probs=216.9
Q ss_pred cccccccccCceeeeCceEEEEEEEC---C--ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 206 (418)
|+.++|++.+.||+|+||.||+|++. + ..||||++.+...... ...+.|.+|+.+|++++||||++++++|.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 56788999999999999999999862 2 3789999875443222 12367899999999999999999999997
Q ss_pred eCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
+. .+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 82 TP-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ec-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence 64 578999999999999988764 3469999999999999999999999999999999999999999999999999998
Q ss_pred eecccCC----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014783 287 IEVQTEG----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPND 361 (418)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 361 (418)
....... .....|++.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+...+.+++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence 7543322 233457889999999999999999999999999999998 89999999999988888888888888999
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 014783 362 CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENA 394 (418)
Q Consensus 362 ~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~ 394 (418)
+++.+.+|+.+||+.||++|||++||++.|+++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=419.85 Aligned_cols=266 Identities=33% Similarity=0.605 Sum_probs=234.2
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE-------CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCe
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpni 198 (418)
-.+|+|+.++|++++.||+|+||.||+|++ +++.||||+++....... ...+.+|+.+++++ +||||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCE
Confidence 347999999999999999999999999986 235899999975433222 25788999999999 69999
Q ss_pred EEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 014783 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (418)
Q Consensus 199 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (418)
|+++++|.+...+++|||||++|+|.++++... ...+++..+..++.||+.||+|||+++||||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999999997643 2358899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014783 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338 (418)
Q Consensus 263 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~ 338 (418)
||||+|||++.++.+||+|||+++....... .....||+.|+|||.+....++.++|||||||++|||+| |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543322 234568999999999999999999999999999999998 777788
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
..+..+...+++..+.++..|..+++.+.+||.+||+.||++|||++||+++|++...+
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 87777777788889999999999999999999999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-55 Score=425.12 Aligned_cols=248 Identities=19% Similarity=0.326 Sum_probs=220.2
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||.||+|++ +|+.||||++...... . .+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--D----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--H----HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--H----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688999999999999999997 6889999999754321 1 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--CCCCEEEeecccceeecc
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~--~~~~vkl~DfGla~~~~~ 290 (418)
||||||+||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999999987643 45699999999999999999999999999999999999998 578999999999998766
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCChHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP--VIPNDCLPVLSE 368 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 368 (418)
........||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..+....+....... ..+..+++++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 665666789999999999999999999999999999999999999999998888777766654432 344578899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 014783 369 IMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt~~ell~ 389 (418)
||.+||+.||.+|||++|+++
T Consensus 262 li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=420.32 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=220.1
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~ 209 (418)
|..++|++++.||+|+||.||+|+. +|+.||||++.+..... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 5678899999999999999999997 68899999997431110 011256789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeec
Q 014783 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (418)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~ 289 (418)
.+|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999999999864 458999999999999999999999999999999999999999999999999998653
Q ss_pred c-cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014783 290 Q-TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 290 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 368 (418)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... ...|..+++++.+
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~d 234 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHH
Confidence 3 334456789999999999999999999999999999999999999999988877666555543 4567789999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHH
Q 014783 369 IMTRCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt-----~~ell~ 389 (418)
||.+||+.||.+||+ ++|+++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhhccCCchhhcccccccHHHHHc
Confidence 999999999999995 788876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-55 Score=415.03 Aligned_cols=264 Identities=33% Similarity=0.625 Sum_probs=226.3
Q ss_pred CcccccccccccccCceeeeCceEEEEEEECC---------ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCC
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp 196 (418)
-.+|+|+.++|++++.||+|+||.||+|+..+ ..||||+++....... ...+.+|...+.++ +||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCC
Confidence 45699999999999999999999999998622 3799999975443222 25678899999888 899
Q ss_pred CeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 014783 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (418)
Q Consensus 197 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr 262 (418)
|||+++++|.++..+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+||||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 99999999999999999999999999999997543 2458999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014783 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQ 338 (418)
Q Consensus 263 Dlkp~NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~ 338 (418)
||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999999986544332 334568999999999999999999999999999999998 799998
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 339 NMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+.+..+. ...+..+.++..|..+++.+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 240 ~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 240 GVPVEEL-FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCCHHHH-HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHH-HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 8887654 56677788889999999999999999999999999999999999988754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-54 Score=405.26 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=222.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCCh---HHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeC
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP---EKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~---~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~ 208 (418)
++|++.+.||+|+||+||+|+. +|+.||||++.+..... ...+...+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788999999999999999998 78899999998755432 233445577899999999997 99999999999999
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+|||||||++|+|.++++.. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999764 46999999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCcccccccccc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CC
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQ------HRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVI--PN 360 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~ 360 (418)
..........||+.|+|||.+. ...++.++||||+||++|||++|+.||.+.+..+....+......... ..
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 6666666778999999999985 335789999999999999999999999999888777666666554333 34
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 361 DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 361 ~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.+++++.+|+.+||+.||.+|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 68899999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=417.67 Aligned_cols=260 Identities=31% Similarity=0.565 Sum_probs=223.0
Q ss_pred cccccccccCceeeeCceEEEEEEE--CCc--eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEe
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~ 206 (418)
|+.++|++.+.||+|+||.||+|++ ++. .||||.+........ .+.|.+|+.+|+++ +|||||+++++|.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 5668899999999999999999987 444 577888754332211 25688999999999 7999999999999
Q ss_pred eCceEEEEEeecCCCCHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 014783 207 KRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (418)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~ 272 (418)
+.+.+|+||||+++|+|.++++.. ....+++..++.++.||+.||.|||+++||||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999999753 235789999999999999999999999999999999999999
Q ss_pred CCCCEEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHh
Q 014783 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG-LLPFQNMTAVQAAFAVVN 351 (418)
Q Consensus 273 ~~~~vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg-~~Pf~~~~~~~~~~~~~~ 351 (418)
.++.+||+|||+|+............||..|+|||.+....|+.++|||||||++|||++| .+||.+.+..+.. ..+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-~~i~ 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLP 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH-HHHH
Confidence 9999999999999876555545556799999999999999999999999999999999995 5678888776654 4466
Q ss_pred cCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 352 KGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 352 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.+.++..|..+++++.+||.+||+.||++|||++||++.|+++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 7788888899999999999999999999999999999999988653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-55 Score=415.81 Aligned_cols=268 Identities=29% Similarity=0.531 Sum_probs=231.4
Q ss_pred CCCCCcccccccccccccCceeeeCceEEEEEEEC-------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 014783 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (418)
Q Consensus 123 ~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 195 (418)
..+..++|+|+.++|++++.||+|+||.||+|++. ++.||||+++...... ....|.+|+.++++++|
T Consensus 8 ~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-----~~~~~~~E~~il~~l~h 82 (308)
T d1p4oa_ 8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNC 82 (308)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCC
T ss_pred cCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-----HHHHHHHHHHHHHHcCC
Confidence 33455789999999999999999999999999863 4689999986543221 12568899999999999
Q ss_pred CCeEEEEeEEeeCceEEEEEeecCCCCHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 014783 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (418)
Q Consensus 196 pniv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 267 (418)
|||++++++|......++||||+++|+|.+++.... ...+++..+.+++.|++.||.|||+++|+||||||+
T Consensus 83 ~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~ 162 (308)
T d1p4oa_ 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 162 (308)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred CCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCC
Confidence 999999999999999999999999999999987532 134688899999999999999999999999999999
Q ss_pred cEEEcCCCCEEEeecccceeecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHH
Q 014783 268 NLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITG-LLPFQNMTAV 343 (418)
Q Consensus 268 NILl~~~~~vkl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg-~~Pf~~~~~~ 343 (418)
|||++.++++||+|||+|+....... .....||+.|+|||.+.+..++.++||||||+++|||+|| ..||.+.+..
T Consensus 163 NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred ceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986543322 2334689999999999999999999999999999999997 6889888887
Q ss_pred HHHHHHHhcCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 344 QAAFAVVNKGVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
+.... +..+.++..|..+++.+.++|.+||+.||++|||++||++.|++...
T Consensus 243 ~~~~~-i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRF-VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHH-HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 76654 45566778888999999999999999999999999999999987644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=416.41 Aligned_cols=256 Identities=27% Similarity=0.559 Sum_probs=216.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCc----eEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 207 (418)
..+|++++.||+|+||+||+|++ +|+ +||+|.++...... ..+.|.+|+.+|++++|||||+++++|.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-----THHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35789999999999999999987 343 68888886432221 12578999999999999999999999987
Q ss_pred CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
+. .++++|++.+|+|.+++... ...+++..+++++.||+.||+|||++|||||||||+|||++.++++||+|||+|+.
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred CC-eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 65 57888999999999988764 46799999999999999999999999999999999999999999999999999986
Q ss_pred ecccCC---CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCh
Q 014783 288 EVQTEG---MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELIT-GLLPFQNMTAVQAAFAVVNKGVRPVIPNDCL 363 (418)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (418)
...... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+. ...+..+.++..|..++
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPICT 239 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTTBC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcccC
Confidence 543322 223458999999999999999999999999999999998 8999988876654 45677788888899999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 364 PVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 364 ~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
+.+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999887643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-54 Score=404.37 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=215.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc---
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 209 (418)
++|++.+.||+|+||.||+|++ +|+.||||+++....... ...+.+.+|+.+|+.++||||+++++++....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4688899999999999999997 688999999976543322 22367899999999999999999999987643
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
.+||||||++|++|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||++.++.++|+|||.+...
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 489999999999999998764 45999999999999999999999999999999999999999999999999998754
Q ss_pred cccC----CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCC
Q 014783 289 VQTE----GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDC 362 (418)
Q Consensus 289 ~~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 362 (418)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+.....+.....+. ....+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 3222 23455799999999999999999999999999999999999999999998888877777665442 34578
Q ss_pred hHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhH
Q 014783 363 LPVLSEIMTRCWDTNPEVRP-PFTEIVRMLENAE 395 (418)
Q Consensus 363 ~~~l~~li~~cl~~dp~~RP-t~~ell~~L~~~~ 395 (418)
++.+.+++.+||+.||.+|| |++++++.|.++.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 89999999999999999999 8999999888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-54 Score=413.14 Aligned_cols=247 Identities=24% Similarity=0.431 Sum_probs=217.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||+||+|++ +|+.||||++++..... ....+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 46799999999999999999997 58899999996421110 01135788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
|+|||||+||+|..++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 9999999999999998764 4588899999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... ...|..+++.+.+++.
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLS 233 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998888777666553 3466788999999999
Q ss_pred HhcccCCCCCC-----CHHHHHH
Q 014783 372 RCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RP-----t~~ell~ 389 (418)
+||..||.+|+ |++++++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccchhhHHHHHc
Confidence 99999999996 8999886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-53 Score=415.71 Aligned_cols=254 Identities=19% Similarity=0.298 Sum_probs=209.4
Q ss_pred ccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCce
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~ 210 (418)
..++|++.+.||+|+||.||+|++ +|+.||||++.+................+|+.+++.++|||||++++++.+...
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 356789999999999999999998 688999999864321111111111223345777888899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~ 290 (418)
+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999986644
Q ss_pred cCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCChHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAF-AVVNKGVRPVIPNDCLPVLSE 368 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 368 (418)
. .....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+... ...........|..+++.+.+
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 3 3455689999999999964 569999999999999999999999997754332211 112233445667789999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHH
Q 014783 369 IMTRCWDTNPEVRPP-----FTEIVR 389 (418)
Q Consensus 369 li~~cl~~dp~~RPt-----~~ell~ 389 (418)
||.+||+.||++||| ++|+++
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHc
Confidence 999999999999999 688875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=410.27 Aligned_cols=248 Identities=18% Similarity=0.267 Sum_probs=217.6
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||+||+|++ +++.||||+++.... . ...+.+|+.+|+.++|||||++++++.++..+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--D-----QVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--H-----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--c-----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 35788999999999999999998 688999999965421 1 14578999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC--CCEEEeecccceeec
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEV 289 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~--~~vkl~DfGla~~~~ 289 (418)
|||||||+||+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999999999753 3469999999999999999999999999999999999999854 489999999998765
Q ss_pred ccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCChHHHH
Q 014783 290 QTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPV--IPNDCLPVLS 367 (418)
Q Consensus 290 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 367 (418)
.........+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+....+....+... ....+++.+.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 55555566799999999999999999999999999999999999999999998887777766554432 2236788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+.+||..||++|||++|+++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-53 Score=411.59 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=217.0
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceE
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 211 (418)
.++|++++.||+|+||.||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++|||||++++++.....+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV---KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc---CHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 46788999999999999999998 6889999998642111 011125688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~ 291 (418)
++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 9999999999999999765 3599999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014783 292 EGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIMT 371 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 371 (418)
......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+.......+.... +..|..+++.+.+|+.
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLR 270 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHH
Confidence 3445689999999999999999999999999999999999999999988877766665553 3456788999999999
Q ss_pred HhcccCCCCCC-----CHHHHHH
Q 014783 372 RCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 372 ~cl~~dp~~RP-----t~~ell~ 389 (418)
+||+.||.+|+ |++|+++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccccccHHHHHc
Confidence 99999999994 8999886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=402.44 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=212.1
Q ss_pred ccCceeeeCceEEEEEEEC---C--ceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-CceEE
Q 014783 139 MGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWC 212 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~~ 212 (418)
+.++||+|+||+||+|++. + ..||||.++.... ... .+.|.+|+.+|++++||||++++|+|.. +..++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGE----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHH----HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHH----HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 3568999999999999872 2 2689999864322 211 2679999999999999999999999875 46789
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|||||++|+|.+++... ...+++..+++++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999999998754 4567888899999999999999999999999999999999999999999999998654332
Q ss_pred C-----CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 293 G-----MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 293 ~-----~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
. .....||+.|+|||.+....++.++||||||+++|||+||..||............+..+.++..|..+++.+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 2 22346899999999999999999999999999999999977777654444434455667788888999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=409.30 Aligned_cols=244 Identities=22% Similarity=0.376 Sum_probs=203.4
Q ss_pred ccccccC-ceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEEEEeEEee---
Q 014783 135 RKLNMGT-AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK--- 207 (418)
Q Consensus 135 ~~~~~~~-~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~--- 207 (418)
++|++.. .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 5677664 599999999999997 6889999999642 3566899887654 89999999999865
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecc
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfG 283 (418)
...+|||||||+||+|.+++..+....+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 467899999999999999998765667999999999999999999999999999999999999985 4679999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCC--
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--PVIP-- 359 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~-- 359 (418)
+|+...........+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.......+...-.. ...|
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 999876666677788999999999999999999999999999999999999999776544333222222111 1122
Q ss_pred --CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 360 --NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 360 --~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
..+++++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 246788999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=406.95 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=212.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeEEEEeEEeeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA-TLKHLNIVRFIGACRKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~~~~~ 211 (418)
++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+.+|..++. .++|||||++++++.++..+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT---TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh---HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 5788899999999999999998 788999999974211000 01134556666655 68999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecc-
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~- 290 (418)
|||||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 79 yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999999765 4589999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014783 291 TEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLSEIM 370 (418)
Q Consensus 291 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 370 (418)
....+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+... .+..|..+++.+.+|+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence 33345568999999999999999999999999999999999999999998887766665544 3466778899999999
Q ss_pred HHhcccCCCCCCCHH-HHHH
Q 014783 371 TRCWDTNPEVRPPFT-EIVR 389 (418)
Q Consensus 371 ~~cl~~dp~~RPt~~-ell~ 389 (418)
.+||+.||.+|||+. |+++
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGG
T ss_pred HHhcccCCCCCcCHHHHHHh
Confidence 999999999999995 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=392.69 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=207.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++.+.||+|+||+||+|++ +|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 5788899999999999999998 58899999996543221 12357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeeccc-
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~- 291 (418)
+||||+. +.+.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9999995 56666666555677999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCCCCccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 014783 292 EGMTPETGTYRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--------------- 355 (418)
Q Consensus 292 ~~~~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--------------- 355 (418)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3344567999999999987665 578999999999999999999999998887766655431100
Q ss_pred -CCC-----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 356 -PVI-----------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 356 -~~~-----------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
... ...+++.+.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 12356789999999999999999999999873
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=396.97 Aligned_cols=253 Identities=31% Similarity=0.510 Sum_probs=203.9
Q ss_pred ccccccCceeeeCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc----e
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----~ 210 (418)
++|.+.+.||+|+||.||+|+++|+.||||+++... .. ......|+..+..++||||++++++|.+.. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 467788899999999999999999999999985421 11 122335666667889999999999997653 6
Q ss_pred EEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCcEEEcCCCCEEEeec
Q 014783 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADF 282 (418)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--------~~iiHrDlkp~NILl~~~~~vkl~Df 282 (418)
+|+|||||++|+|.+++++. .+++..+++++.|++.||+|||+ +|||||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999763 48999999999999999999996 59999999999999999999999999
Q ss_pred ccceeecccC-----CCCCCCCCccccccccccCCC------CCCcchHHHHHHHHHHHHhCCCCCCC------------
Q 014783 283 GVARIEVQTE-----GMTPETGTYRWMAPEMIQHRP------YTQKVDVYSFGIVLWELITGLLPFQN------------ 339 (418)
Q Consensus 283 Gla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~t~~sDvwSlGv~l~elltg~~Pf~~------------ 339 (418)
|+++...... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998764432 233467999999999987642 67799999999999999999877632
Q ss_pred ---CCHHHHHHHHHhcCCCCCCCCC-----ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHH
Q 014783 340 ---MTAVQAAFAVVNKGVRPVIPND-----CLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETE 397 (418)
Q Consensus 340 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~ 397 (418)
.............+.++.+|.. ++..+.+|+.+||+.||++|||+.||++.|+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1223333344455666666543 335689999999999999999999999999988754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=395.66 Aligned_cols=247 Identities=22% Similarity=0.298 Sum_probs=200.0
Q ss_pred cCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEEEEee
Q 014783 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (418)
Q Consensus 140 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~lv~E~ 217 (418)
+++||+|+||+||+|++ +|+.||||+++........ ....+.+.+|+.+|++++|||||++++++..+..+||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK-DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhh-HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46799999999999987 6889999998754432211 12235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-CCCC
Q 014783 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTP 296 (418)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~-~~~~ 296 (418)
+.++++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 98877665543 34568999999999999999999999999999999999999999999999999997654332 3345
Q ss_pred CCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Q 014783 297 ETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP------------------- 356 (418)
Q Consensus 297 ~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------- 356 (418)
.+||+.|+|||++.. ..|+.++|||||||++|||++|..||.+.+..+....+...-..+
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 679999999999865 468999999999999999999999999988877666554310000
Q ss_pred --CC-----CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 --VI-----PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 --~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. ....++.+.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 1245678999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=390.77 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=206.3
Q ss_pred ccccccCceeeeCceEEEEEEE--C-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhC---CCCCeEEEEeEEee-
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--N-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~- 207 (418)
++|++++.||+|+||+||+|++ + ++.||||+++......... ..+.+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH----HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 6889999999999999999997 2 5679999987543322111 2345677776655 89999999999853
Q ss_pred ----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 208 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
...++++||++.++.+... .......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 3468999999987666544 34455679999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------
Q 014783 284 VARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR-------- 355 (418)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~-------- 355 (418)
+++............||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....++.....
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998766666667788999999999999999999999999999999999999999998887766655431000
Q ss_pred -----------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 -----------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 -----------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
...+..+++.+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0123456788999999999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=392.86 Aligned_cols=244 Identities=24% Similarity=0.427 Sum_probs=203.3
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEEEEeEEeeCce
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMV 210 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~~~ 210 (418)
++|++++.||+|+||.||+|++ +|+.||||++.+..............+.+|+.+|++++ |||||++++++.+...
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688999999999999999998 68899999987543221100000123568999999996 8999999999999999
Q ss_pred EEEEEeecCC-CCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCC-CCEEEeecccceee
Q 014783 211 WCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIE 288 (418)
Q Consensus 211 ~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~-~~vkl~DfGla~~~ 288 (418)
+|+||||+.+ +++.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 6788888764 459999999999999999999999999999999999999854 79999999999865
Q ss_pred cccCCCCCCCCCccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCChHHHH
Q 014783 289 VQTEGMTPETGTYRWMAPEMIQHRPY-TQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRPVIPNDCLPVLS 367 (418)
Q Consensus 289 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 367 (418)
.. ...+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ .+... ....+..+++++.
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFRQRVSSECQ 232 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCSSCCCHHHH
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCCCCCCHHHH
Confidence 43 34556789999999999987765 577999999999999999999997632 22222 2346677899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 014783 368 EIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 368 ~li~~cl~~dp~~RPt~~ell~ 389 (418)
+|+.+||+.||++|||++|+++
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-51 Score=384.44 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=204.5
Q ss_pred ccccccCceeeeCceEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~l 213 (418)
++|++.+.||+|+||+||+|++ +|+.||||++........ ..+.+.+|+.+|++++||||+++++++......|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 5788999999999999999998 678999999966433221 12578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC-
Q 014783 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (418)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~- 292 (418)
++|++.++.+..+... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|.......
T Consensus 78 ~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999977666655543 3569999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------------
Q 014783 293 GMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR---------------- 355 (418)
Q Consensus 293 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~---------------- 355 (418)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 23445689999999999754 5799999999999999999999999998877766554321000
Q ss_pred -----------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 -----------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 -----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
......+++.+.+|+++||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112346788999999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-49 Score=376.54 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=202.9
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEEeEEeeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~ 211 (418)
.+|++.+.||+|+||.||+|++ +|+.||||++...... ..+.+|+.+++.++|+|+ +.+.+++.+....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3688999999999999999998 5889999998765433 246789999999987664 5556666788889
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC---CCCEEEeecccceee
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~---~~~vkl~DfGla~~~ 288 (418)
++||||+ +++|.+.+... ...+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+..
T Consensus 79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9999999 66777776543 456999999999999999999999999999999999999864 457999999999876
Q ss_pred cccCC--------CCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc---CC
Q 014783 289 VQTEG--------MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVV---NK---GV 354 (418)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~---~~---~~ 354 (418)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 44321 234579999999999999999999999999999999999999998766543322211 11 11
Q ss_pred CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHH
Q 014783 355 RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAET 396 (418)
Q Consensus 355 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~ 396 (418)
.+..+..+++++.+++.+||+.||++||++++|.+.|+++..
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 122345788999999999999999999999999999988764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=384.34 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=201.9
Q ss_pred cccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeC-----
Q 014783 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (418)
Q Consensus 136 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----- 208 (418)
+|+..++||+|+||+||+|++ +|+.||||++...... +.+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 577888999999999999998 6889999999765332 23799999999999999999998542
Q ss_pred -ceEEEEEeecCCCCHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeecccc
Q 014783 209 -MVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVA 285 (418)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla 285 (418)
..+|||||||.++.+..+.. ......+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 35799999997654333332 23455799999999999999999999999999999999999999775 8999999999
Q ss_pred eeecccCCCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK------------ 352 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~------------ 352 (418)
+............||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...+..+....++..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 88766666777789999999998865 47899999999999999999999999988877665554321
Q ss_pred --C-----CC--------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 --G-----VR--------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 --~-----~~--------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. +. ......+++.+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 0112346788999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-49 Score=374.38 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=210.1
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC-CCeEEEEeEEeeCceE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMVW 211 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~~~ 211 (418)
++|++++.||+|+||+||+|++ +|+.||||++...... ..+.+|+.+++.+.| +|++.+++++......
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 5788999999999999999997 6889999998654332 245688899999965 8999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcC-----CCCEEEeecccce
Q 014783 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-----DKSIKIADFGVAR 286 (418)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-----~~~vkl~DfGla~ 286 (418)
++||||+ +++|.+++... ...+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 78999998653 456999999999999999999999999999999999999974 5789999999998
Q ss_pred eecccC--------CCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc---
Q 014783 287 IEVQTE--------GMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTA---VQAAFAVVNK--- 352 (418)
Q Consensus 287 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~---~~~~~~~~~~--- 352 (418)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 754321 12345799999999999999999999999999999999999999975432 2222222211
Q ss_pred CCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhHHHH
Q 014783 353 GVRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRMLENAETEI 398 (418)
Q Consensus 353 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~L~~~~~~~ 398 (418)
.....++..+|+++.+++..||..+|++||+++.+.+.|+++..+.
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1112234568899999999999999999999999999888876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=382.99 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=204.4
Q ss_pred cccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
..|++ .++|++++.||+|+||+||+|++ +|+.||||+++....... ..+.+.+|+.+|+.++|||||+++++|
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 34666 57899999999999999999998 588999999976544332 236788999999999999999999999
Q ss_pred eeCc------eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 206 RKRM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 206 ~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
.... .+|+||||+ +.+|..+.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence 7654 479999999 6788877654 35999999999999999999999999999999999999999999999
Q ss_pred eecccceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---
Q 014783 280 ADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVR--- 355 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~--- 355 (418)
+|||+|+... ...+...||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..............
T Consensus 163 ~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 163 LDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 9999998653 335667899999999998764 5789999999999999999999999988766554433221100
Q ss_pred --------------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 356 --------------------------PVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 356 --------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
......+++.+.+|+.+||..||.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01223567889999999999999999999999873
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=381.01 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=198.5
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCc---
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--- 209 (418)
.+|++++.||+|+||+||+|+. +|+.||||++...... ...+.+.+|+.+|++++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-----HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 3589999999999999999987 6899999999653321 22357889999999999999999999996543
Q ss_pred -eEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceee
Q 014783 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (418)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~ 288 (418)
..+++++++.+|+|.+++... .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 223445556699999999753 5999999999999999999999999999999999999999999999999999865
Q ss_pred cccC----CCCCCCCCccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------
Q 014783 289 VQTE----GMTPETGTYRWMAPEMIQH-RPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKG---------- 353 (418)
Q Consensus 289 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~---------- 353 (418)
.... ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+.........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 4332 2344579999999999844 567899999999999999999999998887655444332210
Q ss_pred ------------CCC-------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 014783 354 ------------VRP-------VIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVRM 390 (418)
Q Consensus 354 ------------~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~~ 390 (418)
... ......++.+.+|+.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0122456789999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=373.87 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=198.3
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee----
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 207 (418)
.++|++.+.||+|+||+||+|++ +|+.||||++......... ...+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 47899999999999999999998 6889999998654333211 2467899999999999999999999854
Q ss_pred ----CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecc
Q 014783 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (418)
Q Consensus 208 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfG 283 (418)
...+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 345899999997766654433 34568999999999999999999999999999999999999999999999999
Q ss_pred cceeeccc-----CCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCC
Q 014783 284 VARIEVQT-----EGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNK--GVR 355 (418)
Q Consensus 284 la~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~--~~~ 355 (418)
+++..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99754322 223345799999999999765 6899999999999999999999999988876655443221 111
Q ss_pred CCCC-------------------C---------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 356 PVIP-------------------N---------DCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 356 ~~~~-------------------~---------~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
+... . ..++.+.+||.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1000 0 02456778999999999999999999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=365.96 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=205.8
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEeeCceEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 212 (418)
++|++++.||+|+||+||+|++ +++.||||+++....... ....+.+|+.+|+.++||||+++++++.....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 5789999999999999999998 678999999976543322 2367889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccceeecccC
Q 014783 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (418)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~~~~~~~ 292 (418)
+|+|++.+++|..++.. .+.+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+......
T Consensus 78 iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999999888887754 4568999999999999999999999999999999999999999999999999998765433
Q ss_pred -CCCCCCCCccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcC----------------
Q 014783 293 -GMTPETGTYRWMAPEMIQHRP-YTQKVDVYSFGIVLWELITGLLPFQN-MTAVQAAFAVVNKG---------------- 353 (418)
Q Consensus 293 -~~~~~~gt~~y~aPE~~~~~~-~t~~sDvwSlGv~l~elltg~~Pf~~-~~~~~~~~~~~~~~---------------- 353 (418)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||.. .+..+....+....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 333446779999999987665 69999999999999999999988644 44444333322100
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 354 -----------VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 354 -----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.....+...++.+.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122346788999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=374.67 Aligned_cols=242 Identities=17% Similarity=0.318 Sum_probs=199.7
Q ss_pred cccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEee--C
Q 014783 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK--R 208 (418)
Q Consensus 134 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~--~ 208 (418)
.++|++++.||+|+||+||+|++ +|+.||||+++... .+.+.+|+.+|+.+. ||||+++++++.. .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 46799999999999999999998 68899999986432 146789999999995 9999999999874 4
Q ss_pred ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCC-CEEEeeccccee
Q 014783 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (418)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~-~vkl~DfGla~~ 287 (418)
..+++|||||.+++|..+. +.+++..+..++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 5689999999999986653 3599999999999999999999999999999999999998765 699999999987
Q ss_pred ecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH------------h-c
Q 014783 288 EVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQA-AFAVV------------N-K 352 (418)
Q Consensus 288 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~-~~~~~------------~-~ 352 (418)
...........+|+.|+|||.+.+. .++.++||||+||+++||++|+.||........ ...+. . .
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 7666667777899999999998765 579999999999999999999999976543221 11110 0 0
Q ss_pred C----------------------CCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 353 G----------------------VRPVIPNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 353 ~----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
. ........+++++.+||++||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000111235788999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=380.34 Aligned_cols=254 Identities=21% Similarity=0.374 Sum_probs=207.9
Q ss_pred cccccccccCceeeeCceEEEEEEE-----CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC-CCeEEEEeEE
Q 014783 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGAC 205 (418)
Q Consensus 132 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~ 205 (418)
+..++|++++.||+|+||+||+|+. +|+.||||++++....... ...+.+.+|+.+|++++| |||+++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch--HHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 4567899999999999999999976 4679999998643211100 001457799999999976 8999999999
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
.+...+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999999997653 4788999999999999999999999999999999999999999999999999
Q ss_pred eeeccc--CCCCCCCCCccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCC
Q 014783 286 RIEVQT--EGMTPETGTYRWMAPEMIQHR--PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVN--KGVRPVIP 359 (418)
Q Consensus 286 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~ 359 (418)
+..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...+..+....+.. ....+..|
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 865332 223456799999999999765 478899999999999999999999977554332222222 12345567
Q ss_pred CCChHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 014783 360 NDCLPVLSEIMTRCWDTNPEVRP-----PFTEIVR 389 (418)
Q Consensus 360 ~~~~~~l~~li~~cl~~dp~~RP-----t~~ell~ 389 (418)
..+++.+.+|+.+||+.||++|| |++|+++
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 78999999999999999999999 4788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=376.24 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=192.7
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEEee-----
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 207 (418)
++|+++++||+|+||+||+|++ +|+.||||++......... .+.+.+|+.+|++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 6799999999999999999998 5899999999876554332 2568899999999999999999999964
Q ss_pred -CceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
...+|+|||||.++ +.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||+++
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 36789999999664 544443 348999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Q 014783 287 IEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGV------------ 354 (418)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~------------ 354 (418)
........+...+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......++....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 77666666777899999999999999999999999999999999999999988776655443321100
Q ss_pred ---------CCC-------------CC------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 355 ---------RPV-------------IP------NDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 355 ---------~~~-------------~~------~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
... .+ ...++.+.+|+++||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00 012457889999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=374.22 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=205.3
Q ss_pred CcccccccccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeE
Q 014783 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (418)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~ 204 (418)
.+-|++. ++|++++.||+|+||+||+|++ +|+.||||++......... .+.+.+|+.+|++++|||||+++++
T Consensus 11 ~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~ 85 (348)
T d2gfsa1 11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDV 85 (348)
T ss_dssp SSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred CccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3457774 6799999999999999999987 6899999999765544332 2567899999999999999999999
Q ss_pred EeeC-----ceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEE
Q 014783 205 CRKR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (418)
Q Consensus 205 ~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl 279 (418)
+... ...+++++++.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|+
T Consensus 86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp ECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccc
Confidence 8532 234566777889999999864 35999999999999999999999999999999999999999999999
Q ss_pred eecccceeecccCCCCCCCCCccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 014783 280 ADFGVARIEVQTEGMTPETGTYRWMAPEMIQHR-PYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNKGVRP-- 356 (418)
Q Consensus 280 ~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~~~~~~~~~~~~~~-- 356 (418)
+|||++.... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 163 ~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 163 LDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9999997543 234556799999999987665 46899999999999999999999999887766555443221111
Q ss_pred -------------------CC--------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 014783 357 -------------------VI--------PNDCLPVLSEIMTRCWDTNPEVRPPFTEIVR 389 (418)
Q Consensus 357 -------------------~~--------~~~~~~~l~~li~~cl~~dp~~RPt~~ell~ 389 (418)
.. ...+++.+.+||.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 1246788999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-41 Score=330.44 Aligned_cols=246 Identities=21% Similarity=0.362 Sum_probs=187.0
Q ss_pred ccccccCceeeeCceEEEEEEE--CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-----------CCCeEEE
Q 014783 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLNIVRF 201 (418)
Q Consensus 135 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpniv~l 201 (418)
.+|+++++||+|+||+||+|++ +|+.||||+++... ...+.+.+|+.+++.++ |+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 4689999999999999999987 68999999996431 12246678888888775 5789999
Q ss_pred EeEEeeC--ceEEEEEeecCCC-CHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEcCCCC-
Q 014783 202 IGACRKR--MVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKS- 276 (418)
Q Consensus 202 ~~~~~~~--~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~- 276 (418)
++++... ...+++++++..+ .............+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 9888543 3455666655443 44444455556778999999999999999999998 89999999999999987653
Q ss_pred -----EEEeecccceeecccCCCCCCCCCccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH------HH
Q 014783 277 -----IKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAV------QA 345 (418)
Q Consensus 277 -----vkl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDvwSlGv~l~elltg~~Pf~~~~~~------~~ 345 (418)
++++|||.|..... ......||+.|+|||++....++.++||||+||++++|++|+.||...... +.
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999975433 345567999999999999999999999999999999999999999654321 11
Q ss_pred HHHHHh-----------c---------------CC--------------CCCCCCCChHHHHHHHHHhcccCCCCCCCHH
Q 014783 346 AFAVVN-----------K---------------GV--------------RPVIPNDCLPVLSEIMTRCWDTNPEVRPPFT 385 (418)
Q Consensus 346 ~~~~~~-----------~---------------~~--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 385 (418)
....+. . .. ....+...++.+.+|+.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111000 0 00 0001122356789999999999999999999
Q ss_pred HHHH
Q 014783 386 EIVR 389 (418)
Q Consensus 386 ell~ 389 (418)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.3e-26 Score=204.22 Aligned_cols=168 Identities=15% Similarity=0.135 Sum_probs=120.1
Q ss_pred ccCceeeeCceEEEEEEE-CCceEEEEEeecCCCC------------hHHHHHHHHHHHHHHHHHHhCCCCCeEEEEeEE
Q 014783 139 MGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENN------------PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (418)
Q Consensus 139 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~------------~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 205 (418)
+++.||+|+||.||+|++ +|+.||||+++..... ..........+.+|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 567999999999999987 7899999987532211 001112234556789999999999999888653
Q ss_pred eeCceEEEEEeecCCCCHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcCCCCEEEeecccc
Q 014783 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (418)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~vkl~DfGla 285 (418)
. .+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||.|
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 2 269999998765532 3445567889999999999999999999999999999965 4899999999
Q ss_pred eeecccCCCCCCCCCcccccccc-----ccCCCCCCcchHHHHHHHH
Q 014783 286 RIEVQTEGMTPETGTYRWMAPEM-----IQHRPYTQKVDVYSFGIVL 327 (418)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~t~~sDvwSlGv~l 327 (418)
....... ...|....+ +-.+.|+.++|+||+.--+
T Consensus 150 ~~~~~~~-------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 150 VEVGEEG-------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETTSTT-------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ccCCCCC-------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 6532211 111221110 1134688999999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=9.3e-08 Score=85.83 Aligned_cols=129 Identities=18% Similarity=0.167 Sum_probs=85.4
Q ss_pred eCceEEEEEEECCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCC-CCCeEEEEeEEeeCceEEEEEeecCCCCHH
Q 014783 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224 (418)
Q Consensus 146 G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~lv~E~~~~gsL~ 224 (418)
++.+.||+...+++.+.||.......... ..+.+|..++..+. +--+.+++.++..++..++||++++|.++.
T Consensus 25 ~s~~~v~rv~~~~~~~vlk~~~~~~~~~~------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 25 MSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred CCCCcEEEEEeCCCeEEEEEcCCCcccch------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 44468999888888889998764332211 23557888777664 333567788888888889999999998875
Q ss_pred HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 014783 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHG------------------------------------------------ 256 (418)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~------------------------------------------------ 256 (418)
+..... .. ...++.+++..+..||+
T Consensus 99 ~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (263)
T d1j7la_ 99 EEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp HHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred cccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence 543210 01 11122233333333332
Q ss_pred -----------CCcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 257 -----------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 257 -----------~~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=5.7e-06 Score=73.31 Aligned_cols=136 Identities=14% Similarity=0.084 Sum_probs=81.5
Q ss_pred eeeeCc-eEEEEEEEC-CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEEEEeEEeeCceEEEEEeec
Q 014783 143 FAQGAF-GKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTEYA 218 (418)
Q Consensus 143 lG~G~f-g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~~~~lv~E~~ 218 (418)
+..|.. +.||+...+ +..+.+|........ .+..|...++.+.. -.+.+++.++.+++..++||+++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 444554 679998874 556888986543221 34567777766632 33567888888888889999999
Q ss_pred CCCCHHH--------------HHhhhc-----CC--CCCHHHHHHHHH--------------------HHHHHHHHHHhC
Q 014783 219 KGGSVRQ--------------FLTRRQ-----NR--AVPLKLAVKQAL--------------------DVARGMAYVHGL 257 (418)
Q Consensus 219 ~~gsL~~--------------~l~~~~-----~~--~~~~~~~~~i~~--------------------qi~~gL~yLH~~ 257 (418)
+|.++.+ .+.+-. .. ............ .....+..+.+.
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 8765421 111110 00 011111110000 122233344332
Q ss_pred -------CcccCCCCCCcEEEcCCCCEEEeeccccee
Q 014783 258 -------GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (418)
Q Consensus 258 -------~iiHrDlkp~NILl~~~~~vkl~DfGla~~ 287 (418)
.+||+|+.|.|||++.+..+-|+||+.+..
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 389999999999999877788999998854
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=4.2e-05 Score=72.52 Aligned_cols=80 Identities=11% Similarity=-0.022 Sum_probs=44.8
Q ss_pred CceeeeCceEEEEEEE--CCceEEEEEeecCCCC-hHHHHHHHHHHHHHHHHHHhCC---CCCeEEEEeEEeeCceEEEE
Q 014783 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (418)
Q Consensus 141 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~lv 214 (418)
+.||.|....||+.+. .++.|+||.-...... .+.......+...|...|+.+. ...+++++.+..+ ..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEEE
Confidence 4689999999999975 4668999965321000 0000000012335666666552 2346667765443 34689
Q ss_pred EeecCCCC
Q 014783 215 TEYAKGGS 222 (418)
Q Consensus 215 ~E~~~~gs 222 (418)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00057 Score=62.62 Aligned_cols=66 Identities=11% Similarity=0.109 Sum_probs=41.5
Q ss_pred eEEEEEEE-CCceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe--EEEEe-----EEeeCceEEEEEeecCC
Q 014783 149 GKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI--VRFIG-----ACRKRMVWCIVTEYAKG 220 (418)
Q Consensus 149 g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni--v~l~~-----~~~~~~~~~lv~E~~~~ 220 (418)
-.||+.+. +|+.|++|+.+...... +++..|...+..|....+ +..+. ........+.+++++.|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 48999987 78899999986543332 345677777776642222 11111 12345567889999876
Q ss_pred C
Q 014783 221 G 221 (418)
Q Consensus 221 g 221 (418)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.54 E-value=0.0026 Score=57.51 Aligned_cols=30 Identities=37% Similarity=0.480 Sum_probs=27.3
Q ss_pred CCcccCCCCCCcEEEcCCCCEEEeecccce
Q 014783 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (418)
Q Consensus 257 ~~iiHrDlkp~NILl~~~~~vkl~DfGla~ 286 (418)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988878899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.43 E-value=0.0035 Score=58.70 Aligned_cols=78 Identities=13% Similarity=0.247 Sum_probs=48.4
Q ss_pred ccccccccCceeeeCceEEEEEEEC---------CceEEEEEeecCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EEEE
Q 014783 133 DLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFI 202 (418)
Q Consensus 133 ~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~ 202 (418)
+.+++++ +.|+-|-.=.+|+.+.. .+.|.+++.-. .... ....+|..+++.+.-.++ .+++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-------hHHHHHHHHHHHHHhCCCCCeEE
Confidence 3444444 46777888899999863 24577777642 2221 123478888887743333 4677
Q ss_pred eEEeeCceEEEEEeecCCCCH
Q 014783 203 GACRKRMVWCIVTEYAKGGSV 223 (418)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL 223 (418)
+++.. .+|+||++|.+|
T Consensus 112 ~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT----EEEECCCCEEEC
T ss_pred EEcCC----ceEEEEeccccC
Confidence 77653 578999987544
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.30 E-value=2.8e-05 Score=61.60 Aligned_cols=106 Identities=13% Similarity=0.173 Sum_probs=65.3
Q ss_pred chHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc
Q 014783 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH 103 (418)
Q Consensus 29 ~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~ 103 (418)
+.......| +|+|++++| ++..|.|+||+... ..++|+.|.... +.|++. +...|. .++|.+
T Consensus 18 Ae~~L~~~g~~~G~FLVR~S---~~~~g~yvLSv~~~---------~~v~H~~I~~~~~g~~~l~-~~~~F~sl~~Lv~~ 84 (130)
T d2oq1a1 18 AEEHLKLAGMADGLFLLRQC---LRSLGGYVLSLVHD---------VRFHHFPIERQLNGTYAIA-GGKAHCGPAELCEF 84 (130)
T ss_dssp HHHHHHHTTCCTTCEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECTTSCEEET-TSCCBSSHHHHHHH
T ss_pred HHHHHHhcCCCCceEEEEec---CCCCccEEEEEeeC---------CceEEEEEEEcCCCceecc-CCCCcCCHHHHHHH
Confidence 344555555 699999998 66778999999952 157899996554 567765 333342 234443
Q ss_pred -ccCchHHHHHHhcCCCCCCCCCCC-cccccccccccccCceeeeCceEEEE
Q 014783 104 -ALNDDALAQALMDHRYPTEGLENY-DEWTIDLRKLNMGTAFAQGAFGKLYR 153 (418)
Q Consensus 104 -~~~~d~l~~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~lG~G~fg~Vy~ 153 (418)
..+.+++...|..|+......... ..|+. +.+.+|+|.||.||+
T Consensus 85 Y~~~~~gL~~~L~~P~~r~~~~~~~~~~~~~------~~~~~~~~~~~~~w~ 130 (130)
T d2oq1a1 85 YSRDPDGLPCNLRKPCNRPSGLEPQPGVFDC------LRDAMVRDYVRQTWK 130 (130)
T ss_dssp HHHCCTTSSSCCCSBCCCCTTCCCBCCHHHH------HHHHHHHHHHHHHHC
T ss_pred HhhCCCCCCccCCccCCCCCCCCCCcchHHH------HHHHHHHhhccCccC
Confidence 455667766677776543332211 11221 225688999988874
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.52 E-value=0.0075 Score=45.82 Aligned_cols=72 Identities=22% Similarity=0.330 Sum_probs=45.8
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
.|+|+++.| .+.+|.|++|+..... ..+.++|+.|.... +.|++. +...|. .+.|.+ ..+.++++..
T Consensus 35 ~G~FLVR~S---~~~~g~~~Lsv~~~~~-----~~~~v~H~~i~~~~~g~~~l~-~~~~F~sl~eLV~~y~~~~~gL~~~ 105 (114)
T d1blja_ 35 AGSFLIRES---ESNKGAFSLSVKDITT-----QGEVVKHYKIRSLDNGGYYIS-PRITFPTLQALVQHYSKKGDGLCQK 105 (114)
T ss_dssp TTCEEBCBC---TTCSSCEEEEECBCCT-----TTCBCCCEEEEEETTTEEEEE-TTEEESSHHHHHHHHHHCCSSSSSC
T ss_pred CceEEEecc---CCCCCCeEEEEEeecc-----CCCEEEEEEEEEcCCCCEEec-CCceECCHHHHHHHHhhCCCCCCcc
Confidence 699999998 5677999999985432 12367899997765 667775 333343 234433 3444555555
Q ss_pred HhcCC
Q 014783 114 LMDHR 118 (418)
Q Consensus 114 l~~~~ 118 (418)
|..||
T Consensus 106 L~~PC 110 (114)
T d1blja_ 106 LTLPC 110 (114)
T ss_dssp CCCCS
T ss_pred CCccC
Confidence 55554
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.57 E-value=0.0071 Score=45.02 Aligned_cols=73 Identities=26% Similarity=0.304 Sum_probs=43.6
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
.|+|++++| .+.+|.|++||....... ...++|+.|.... +.|++. +...|. ++.|.+ ..+.+++...
T Consensus 24 ~G~FLVR~S---~~~~g~~~Lsv~~~~~~~----~~~v~H~~i~~~~~g~~~~~-~~~~F~sl~~LV~~y~~~~~gL~~~ 95 (103)
T d1qcfa2 24 LGSFMIRDS---ETTKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQK 95 (103)
T ss_dssp TTCEEEEEC---SSSTTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSSC
T ss_pred CCcEEEEcc---CCCCCCeEEEEEecCCCc----CceEEEEEEEEcCCCceeec-CCcccCCHHHHHHHHhhCCCCCCcc
Confidence 699999998 667899999998532211 2367899997765 556654 333332 233433 3334444444
Q ss_pred HhcCC
Q 014783 114 LMDHR 118 (418)
Q Consensus 114 l~~~~ 118 (418)
|..||
T Consensus 96 L~~PC 100 (103)
T d1qcfa2 96 LSVPC 100 (103)
T ss_dssp CCSBC
T ss_pred CCccC
Confidence 44444
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.48 E-value=0.0046 Score=46.30 Aligned_cols=46 Identities=20% Similarity=0.356 Sum_probs=33.2
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
+|+|++++| ++.+|.|++|+....... ...+.|+.|.... +.|++.
T Consensus 27 ~GtFLVR~S---~~~~g~~~lsv~~~~~~~----~~~v~h~~i~~~~~~~~~~~ 73 (105)
T d1lkka_ 27 HGSFLIRES---ESTAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNGGFYIS 73 (105)
T ss_dssp TTCEEEEEC---SSSTTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS
T ss_pred CCcEEEEcc---CCCCCCEEEEEEEcccCC----CccEEEEEEEEcCCCCEEec
Confidence 799999988 567789999998543221 2357899997665 666665
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.93 E-value=0.006 Score=44.97 Aligned_cols=43 Identities=12% Similarity=0.112 Sum_probs=33.4
Q ss_pred hcCCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 36 LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 36 ~~~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
.++|+|++++| ++..|.|++||... ..++|+.|...++.|++.
T Consensus 23 ~~~G~FLVR~S---~~~~g~~vLSv~~~---------~~v~H~~I~~~~~~~~~~ 65 (97)
T d1jwoa_ 23 PEDGLFLVRES---ARHPGDYVLCVSFG---------RDVIHYRVLHRDGHLTID 65 (97)
T ss_dssp CCTTCEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEESSSEESST
T ss_pred CCCCeEEEEec---CCCCccEEEEEEec---------CceEEEEEEEcCCcEEec
Confidence 34899999988 56678999999852 146899997767777765
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.51 E-value=0.0069 Score=45.00 Aligned_cols=42 Identities=17% Similarity=0.179 Sum_probs=33.4
Q ss_pred cCCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 37 ~~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
.+|+|++++| ++..|.|+|||+.. ..++|+.|....+.|++.
T Consensus 24 ~~G~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~~~~~~ 65 (101)
T d1k9aa2 24 ETGLFLVRES---TNYPGDYTLCVSCE---------GKVEHYRIMYHASKLSID 65 (101)
T ss_dssp CTTEEEEEEC---SSSTTSEEEEEECS---------SSEEEEEEEEETTEEESS
T ss_pred CCCCEEEecc---CCCCCCEEEEEEeC---------CccEEEEEEEcCCCceec
Confidence 4799999987 56678999999852 146899998877777775
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.42 E-value=0.024 Score=43.89 Aligned_cols=78 Identities=17% Similarity=0.204 Sum_probs=50.1
Q ss_pred chHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc
Q 014783 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH 103 (418)
Q Consensus 29 ~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~ 103 (418)
++......| +|+|++++| ++..|.|+|||... ..++|+.|.... +.|++. +...|. .++|.+
T Consensus 17 Ae~lL~~~g~~dG~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~i~-~~~~F~sl~eLV~~ 83 (129)
T d1a81a1 17 AEDYLVQGGMSDGLYLLRQS---RNYLGGFALSVAHG---------RKAHHYTIERELNGTYAIA-GGRTHASPADLCHY 83 (129)
T ss_dssp HHHHHHHTTCCTTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEEECTTSCEEET-TSCCBSSHHHHHHH
T ss_pred HHHHHHhcCCCCccEEEEcc---CCCCcceEEEeeec---------ccceEEEEEEcCCCCeeec-CCcccCCHHHHHHH
Confidence 444555555 699999998 56678999999852 257899997655 567764 333343 234443
Q ss_pred -ccCchHHHHHHhcCCC
Q 014783 104 -ALNDDALAQALMDHRY 119 (418)
Q Consensus 104 -~~~~d~l~~~l~~~~~ 119 (418)
..+.+++...|..|+.
T Consensus 84 Y~~~~~gl~~~L~~P~~ 100 (129)
T d1a81a1 84 HSQESDGLVCLLKKPFN 100 (129)
T ss_dssp HTTCCTTSSSCCCEECC
T ss_pred HhhCCCCCcccCCCCCC
Confidence 4455666666666653
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.32 E-value=0.014 Score=43.10 Aligned_cols=41 Identities=12% Similarity=0.127 Sum_probs=31.7
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
.|+|++++| .+..|.|+|||... ..++|+.|.... +.|++.
T Consensus 25 ~G~FLvR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 66 (100)
T d1rjaa_ 25 TGAFLIRVS---EKPSADYVLSVRDT---------QAVRHYKIWRRAGGRLHLN 66 (100)
T ss_dssp SCCEEEEEC---SSSSSCEEEEECTT---------SSCEEEEEEECSSSCEEEE
T ss_pred CCeEEeecC---CCCCCCEEEEEEcC---------CCceEEEEEECCCCCEEec
Confidence 699999998 56678999999852 146899997655 567775
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.35 E-value=0.014 Score=43.55 Aligned_cols=72 Identities=17% Similarity=0.257 Sum_probs=42.1
Q ss_pred CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceeeccccccc--CCcccc-ccCchHHHHH
Q 014783 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (418)
Q Consensus 38 ~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~d~l~~~ 113 (418)
.|+|++++| .+..|.|+||+....... ...+.|+.+.... +.|++. +...|. .+.|.+ ..+.+++...
T Consensus 28 ~G~FLVR~S---~~~~g~y~LSv~~~~~~~----~~~i~h~~i~~~~~g~~~~~-~~~~F~sl~eLV~~y~~~~~gL~~~ 99 (106)
T d1o48a_ 28 RGTFLVRES---ETTKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYIT-SRTQFNSLQQLVAYYSKHADGLCHR 99 (106)
T ss_dssp TTCEEEEEC---SSSTTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-TTSEESSHHHHHHHHTTCCTTSSSC
T ss_pred CCcEEEEcc---cCCCCCEEEEEEecccCc----ccceEEEEEEEecCCCEEEc-CCeeECCHHHHHHHHhhCCCCCCcc
Confidence 799999998 567789999997533211 1246788886654 667765 333343 233433 3334444434
Q ss_pred HhcC
Q 014783 114 LMDH 117 (418)
Q Consensus 114 l~~~ 117 (418)
|..|
T Consensus 100 L~~p 103 (106)
T d1o48a_ 100 LTTV 103 (106)
T ss_dssp CCSB
T ss_pred CCCc
Confidence 4333
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.54 E-value=0.023 Score=42.24 Aligned_cols=44 Identities=11% Similarity=0.224 Sum_probs=31.4
Q ss_pred chHHHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC
Q 014783 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (418)
Q Consensus 29 ~~~~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~ 84 (418)
++......| +|+|++++| .+.+|.|+|||... ..+.|+.|....
T Consensus 17 Ae~lL~~~g~~dG~FLVR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~ 62 (105)
T d1nrva_ 17 SHRIIKQQGLVDGLFLLRDS---QSNPKAFVLTLCHH---------QKIKNFQILPCE 62 (105)
T ss_dssp HHHHHHHTTCCTTEEEEEEC---SSCTTCEEEEEEET---------TEEEEEEEEEC-
T ss_pred HHHHHhhcCCCCceEEEEeC---CCCCCCEEEEEEEC---------CceeEEEEEEec
Confidence 444555555 599999998 56678899999852 156899996644
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.91 E-value=0.3 Score=35.67 Aligned_cols=52 Identities=17% Similarity=0.274 Sum_probs=35.9
Q ss_pred HHHHhc--CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCC-CCceee
Q 014783 32 FYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVS 90 (418)
Q Consensus 32 ~~~~~~--~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~-~~~~i~ 90 (418)
.....| .|+|++++| .+.+|.|++|+.......+ ..+.|+.|.... +.|++.
T Consensus 21 ~L~~~g~~~G~FLVR~S---~~~~g~~~Lsv~~~~~~~~----~~v~h~~i~~~~~g~~~~~ 75 (104)
T d1g83a2 21 QLLSFGNPRGTFLIRES---ETTKGAYSLSIRDWDDMKG----DHVKHYKIRKLDNGGYYIT 75 (104)
T ss_dssp HHHSTTCCTTCEEEEEC---SSSTTCEEEEEEEECSSSC----EEEEEEEEEECTTSCEEET
T ss_pred HHHhcCCCCCcEEEecc---CCCCCCeEEEEEEeecCcC----CeEEEEEEEEcCCCCEEec
Confidence 344344 699999998 6677999999986543322 256899997655 556554
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.22 E-value=0.3 Score=36.09 Aligned_cols=48 Identities=17% Similarity=0.333 Sum_probs=35.9
Q ss_pred HHHHHhc-CCCccccccccccCCCCceeEeeccCCCCCCCCcccccccCCcccCCCCceee
Q 014783 31 GFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (418)
Q Consensus 31 ~~~~~~~-~~~~~~~~s~~~~~~~g~~s~sv~~~~~~~~~~~~~~~~h~~i~~~~~~~~i~ 90 (418)
......+ +|+|++++| .+..|.|+||++.. ..+.|+.|....+.|++.
T Consensus 17 ~lL~~~~~~G~FLvR~S---~~~~g~y~LSv~~~---------~~v~H~~I~~~~~~~~~~ 65 (109)
T d2shpa2 17 NLLLTRGVDGSFLARPS---KSNPGDLTLSVRRN---------GAVTHIKIQNTGDYYDLY 65 (109)
T ss_dssp HHHHHHCCTTEEEEEEC---SSSTTCEEEEEEET---------TEEEEEEEECSSSCEEET
T ss_pred HHHhhCCCCCeEEEEec---CCCCCCEEEEEEeC---------CcEEEEEEEEcCCeEEEc
Confidence 3443344 799999998 56678999999952 146899998877878775
|